Citrus Sinensis ID: 017175
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.965 | 0.796 | 0.713 | 1e-155 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.994 | 0.884 | 0.638 | 1e-147 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.938 | 0.852 | 0.633 | 1e-131 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.880 | 0.671 | 0.518 | 3e-96 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.768 | 0.704 | 0.583 | 3e-92 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.872 | 0.669 | 0.5 | 1e-90 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.773 | 0.683 | 0.531 | 6e-87 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.763 | 0.673 | 0.538 | 2e-86 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.885 | 0.816 | 0.484 | 2e-85 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.771 | 0.703 | 0.523 | 2e-85 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 548 bits (1413), Expect = e-155, Method: Compositional matrix adjust.
Identities = 271/380 (71%), Positives = 299/380 (78%), Gaps = 17/380 (4%)
Query: 1 MGWFPCAGKS---------SKNAKKKHHNKP-----IDQIPSTSEKLKVNSTVDVKKEA- 45
MG F C S N +K ++P I +PS EKL + K+E
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 46 -SKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
+DG IAAHTF FRELAA T NF D LGEGGFGRVYKGRL+ST QVVA+KQLDR
Sbjct: 61 LPRDG-LGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 105 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK 164
NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ LDW RM+IAAGAAKGLE+LHDKANPPVIYRD K SNILL EG+HPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284
GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVV LE+ITGRKAID+ GE
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 285 NLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344
NLVAWARPLF DRRKF ++ADP L+G++P R LYQALAVA+MC+QEQ RPLIADVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 345 LTYLACQKYDPESQPVQSSR 364
L+YLA Q YDP + +R
Sbjct: 360 LSYLANQAYDPSKDDSRRNR 379
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1340), Expect = e-147, Method: Compositional matrix adjust.
Identities = 261/409 (63%), Positives = 298/409 (72%), Gaps = 35/409 (8%)
Query: 1 MGWFPCAGKSSKNAKKKH-----------------HNKPIDQIPSTSEKLKVNSTVDVKK 43
MG F C+ KSSK ++ +K DQ +S+ KV+ DV
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 44 EASKDGGSDHIA----------------AHTFTFRELAAVTKNFRADCLLGEGGFGRVYK 87
E G D ++ A TFTF+ELA T NFR+DC LGEGGFG+V+K
Sbjct: 61 EGGV-GKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFK 119
Query: 88 GRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147
G +E +QVVAIKQLDRNG+QG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEY
Sbjct: 120 GTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEY 179
Query: 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207
MP GSLEDHLH LP KK LDW TRM+IAAGAA+GLEYLHD+ PPVIYRDLKCSNILLG
Sbjct: 180 MPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLG 239
Query: 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLE 267
E Y PKLSDFGLAK+GP GDKTHVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVVLLE
Sbjct: 240 EDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 299
Query: 268 IITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMC 327
+ITGRKAIDNT+ + NLV WARPLFKDRR F +M DP LQGQYPVRGLYQALA++AMC
Sbjct: 300 LITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMC 359
Query: 328 VQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRTGSSTPRIRREQ 376
VQEQP MRP+++DVV AL +LA KYDP S P SS S R R ++
Sbjct: 360 VQEQPTMRPVVSDVVLALNFLASSKYDPNS-PSSSSGKNPSFHRDRDDE 407
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 233/368 (63%), Positives = 278/368 (75%), Gaps = 15/368 (4%)
Query: 17 KHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCL 76
+ +NK + P T + N+ D KE + ++IAA TF+FRELA TKNFR +CL
Sbjct: 32 RDNNKTHPENPKTVNEQNKNN--DEDKEVT-----NNIAAQTFSFRELATATKNFRQECL 84
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEGGFGRVYKG+LE T +VA+KQLDRNGLQGN+EF+VEVLMLSLLHH +LVNLIGYCA
Sbjct: 85 IGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCA 144
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
DGDQRLLVYEYM GSLEDHL DL PD+ LDW TR+RIA GAA GLEYLHDKANPPVIY
Sbjct: 145 DGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIY 204
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDLK +NILL ++ KLSDFGLAKLGPVGDK HVS+RVMGTYGYCAPEY TGQLT KS
Sbjct: 205 RDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKS 264
Query: 257 DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRG 316
DVYSFGVVLLE+ITGR+ ID TR E NLV WA+P+FK+ +F ++ADP+L+G +P +
Sbjct: 265 DVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKA 324
Query: 317 LYQALAVAAMCVQEQPNMRPLIADVVTALTYL--------ACQKYDPESQPVQSSRTGSS 368
L QA+AVAAMC+QE+ +RPL++DVVTAL +L + YD QP + S
Sbjct: 325 LNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPDGSISVPHYDDPPQPSDETSVEDS 384
Query: 369 TPRIRREQ 376
RE+
Sbjct: 385 VAAEERER 392
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 181/349 (51%), Positives = 234/349 (67%), Gaps = 18/349 (5%)
Query: 11 SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKN 70
SK+A +K +++P+ Q+ ST+ S+ + + S H+ FTF +L T+N
Sbjct: 84 SKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHL--RKFTFNDLKLSTRN 141
Query: 71 FRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
FR + LLGEGGFG V+KG +E T VA+K L+ +GLQG++E+L E+ L
Sbjct: 142 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 201
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGA 179
L HPNLV L+GYC + DQRLLVYE+MP GSLE+HL LP L W+ RM+IA GA
Sbjct: 202 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGA 256
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKGL +LH++A PVIYRD K SNILL Y+ KLSDFGLAK P KTHVSTRVMGTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299
GY APEY MTG LT KSDVYSFGVVLLE++TGR+++D R GEHNLV WARP D+R+
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 376
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
F ++ DP L+G + ++G + +AA C+ P +RP ++DVV AL L
Sbjct: 377 FYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 174/298 (58%), Positives = 208/298 (69%), Gaps = 9/298 (3%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQV------VAIKQLDRNGLQGNRE 112
FT EL +TK+FR D +LGEGGFG VYKG ++ +V VA+K L++ GLQG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 113 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
+L EV L L HPNLV LIGYC + D RLLVYE+M GSLE+HL L W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPLSWSRR 174
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
M IA GAAKGL +LH+ A PVIYRD K SNILL Y KLSDFGLAK GP GD+THVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292
TRVMGTYGY APEY MTG LT +SDVYSFGVVLLE++TGRK++D TR + E NLV WARP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350
D+RK Q+ DP L+ QY VR +A ++A C+ + P RPL++DVV L L C
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 173/346 (50%), Positives = 229/346 (66%), Gaps = 18/346 (5%)
Query: 11 SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKN 70
S++A + +++P+ + ST+ S++ + + H+ F+F +L T+N
Sbjct: 78 SQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYSHLKK--FSFIDLKLATRN 135
Query: 71 FRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
FR + LLGEGGFG V+KG +E T VA+K L+ +GLQG++E+L E+ L
Sbjct: 136 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLG 195
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGA 179
L HPNLV L+GYC + DQRLLVYE+MP GSLE+HL LP L W+ RM+IA GA
Sbjct: 196 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGA 250
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKGL +LH++A PVIYRD K SNILL Y+ KLSDFGLAK P KTHVSTRVMGTY
Sbjct: 251 AKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 310
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299
GY APEY MTG LT KSDVYSFGVVLLE++TGR+++D R GEHNLV WARP D+R+
Sbjct: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 370
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
F ++ DP L+G + V+G + +AA C+ +RP +++VV L
Sbjct: 371 FYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 161/303 (53%), Positives = 205/303 (67%), Gaps = 12/303 (3%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ---------VVAIKQLDRNGLQG 109
FTF EL T+NFR D LLGEGGFG V+KG ++ T VVA+K+L G QG
Sbjct: 71 FTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQG 130
Query: 110 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GSLE+HL + L W
Sbjct: 131 HKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR--GAQPLTW 188
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
RM++A GAAKGL +LHD A VIYRD K +NILL ++ KLSDFGLAK GP GDKT
Sbjct: 189 AIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKT 247
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
HVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+++GR+A+D ++ E +LV W
Sbjct: 248 HVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDW 307
Query: 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
A P D+RK ++ D L GQYP +G Y A ++A C+ +RP +++V+ L L
Sbjct: 308 ATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLE 367
Query: 350 CQK 352
K
Sbjct: 368 STK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 161/299 (53%), Positives = 205/299 (68%), Gaps = 12/299 (4%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ---------VVAIKQLDRNGLQG 109
FTF EL TKNFR D LLGEGGFG V+KG ++ T+ VVA+KQL G QG
Sbjct: 74 FTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQG 133
Query: 110 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GSLE+HL + L W
Sbjct: 134 HKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRRGAQPLTW 191
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
RM++A GAAKGL +LH+ A VIYRD K +NILL ++ KLSDFGLAK GP GD T
Sbjct: 192 AIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNT 250
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
HVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE+I+GR+A+DN+ E++LV W
Sbjct: 251 HVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDW 310
Query: 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
A P D+RK ++ D L GQYP +G + A +A C+ +RP +++V+ L L
Sbjct: 311 ATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQL 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 175/361 (48%), Positives = 230/361 (63%), Gaps = 28/361 (7%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEK-----LKVNSTVDVKKEASKDGGSDHIAAHTF 59
P + S NAK + P +Q P+ +K K+ S ++ +D ++ + A F
Sbjct: 10 PLNHRVSANAKSE---SPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANPLIA--F 64
Query: 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLEST---NQV-----VAIKQLD-RNGLQGN 110
T+ EL +T NFR D +LG GGFG VYKG ++ +V VA+K D N QG+
Sbjct: 65 TYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQGH 124
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRL 167
RE+L EV+ L L HPNLV LIGYC + + R+L+YEYM GS+E++L LP L
Sbjct: 125 REWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLP-----L 179
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
W RM+IA GAAKGL +LH+ A PVIYRD K SNILL Y+ KLSDFGLAK GPVGD
Sbjct: 180 SWAIRMKIAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGD 238
Query: 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
K+HVSTR+MGTYGY APEY MTG LT SDVYSFGVVLLE++TGRK++D +R E NL+
Sbjct: 239 KSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLI 298
Query: 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347
WA PL K+++K + DP + +YPV+ + +A +A C+ P RPL+ D+V +L
Sbjct: 299 DWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEP 358
Query: 348 L 348
L
Sbjct: 359 L 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 157/300 (52%), Positives = 206/300 (68%), Gaps = 10/300 (3%)
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQ 108
+FTF EL A T+NFR D +LGEGGFG V+KG ++ T V+A+K+L+++G Q
Sbjct: 56 SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115
Query: 109 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD 168
G++E+L EV L HPNLV LIGYC + + RLLVYE+MP GSLE+HL + L
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
WT R+++A GAAKGL +LH+ A VIYRD K SNILL Y+ KLSDFGLAK GP GDK
Sbjct: 176 WTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDK 234
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288
+HVSTR+MGTYGY APEY TG LT KSDVYS+GVVLLE+++GR+A+D R GE LV
Sbjct: 235 SHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVE 294
Query: 289 WARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
WARPL ++RK ++ D LQ QY + + +A C+ + +RP + +VV+ L ++
Sbjct: 295 WARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHI 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | ||||||
| 255568155 | 375 | receptor serine-threonine protein kinase | 0.997 | 1.0 | 0.920 | 0.0 | |
| 37625033 | 376 | protein kinase-like protein [Vitis aesti | 0.997 | 0.997 | 0.912 | 0.0 | |
| 225448749 | 376 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.997 | 0.909 | 0.0 | |
| 224098142 | 372 | predicted protein [Populus trichocarpa] | 0.989 | 1.0 | 0.906 | 0.0 | |
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.929 | 0.852 | 0.0 | |
| 147866816 | 425 | hypothetical protein VITISV_003379 [Viti | 0.997 | 0.882 | 0.785 | 0.0 | |
| 224112923 | 334 | predicted protein [Populus trichocarpa] | 0.888 | 1.0 | 0.922 | 0.0 | |
| 449451703 | 383 | PREDICTED: serine/threonine-protein kina | 0.960 | 0.942 | 0.863 | 0.0 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.992 | 0.984 | 0.822 | 1e-180 | |
| 356572387 | 380 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.986 | 0.811 | 1e-179 |
| >gi|255568155|ref|XP_002525053.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535634|gb|EEF37300.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/376 (92%), Positives = 357/376 (94%), Gaps = 1/376 (0%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MGWFPCAGKSS +AKKK +P DQIPS+S+K K + +DVK E SKDGGSDHIAAHTFT
Sbjct: 1 MGWFPCAGKSSNDAKKKLKKRPDDQIPSSSDKTKPSLALDVK-ETSKDGGSDHIAAHTFT 59
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRADCLLGEGGFGRVYKGRLEST+QVVAIKQLDRNGLQGNREFLVEVLML
Sbjct: 60 FRELAAATKNFRADCLLGEGGFGRVYKGRLESTSQVVAIKQLDRNGLQGNREFLVEVLML 119
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 120 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 179
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 180 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 239
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAWARPLFKDRRKF
Sbjct: 240 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPLFKDRRKF 299
Query: 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPV 360
QMADP LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA QKYDPE+QP+
Sbjct: 300 PQMADPLLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLASQKYDPETQPI 359
Query: 361 QSSRTGSSTPRIRREQ 376
Q SRTG STPR RREQ
Sbjct: 360 QGSRTGISTPRTRREQ 375
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37625033|gb|AAQ96340.1| protein kinase-like protein [Vitis aestivalis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/375 (91%), Positives = 356/375 (94%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAWARPLFKDRRKF
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPLFKDRRKF 300
Query: 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPV 360
SQMADP L GQYP+RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA QKYDPE+QPV
Sbjct: 301 SQMADPMLHGQYPLRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLASQKYDPETQPV 360
Query: 361 QSSRTGSSTPRIRRE 375
QSSR GSSTPR RRE
Sbjct: 361 QSSRMGSSTPRSRRE 375
|
Source: Vitis aestivalis Species: Vitis aestivalis Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448749|ref|XP_002281418.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297736456|emb|CBI25327.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/375 (90%), Positives = 356/375 (94%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDL+CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLQCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAWARPLFKDRRKF
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPLFKDRRKF 300
Query: 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPV 360
SQMADP L GQYP+RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA QKYDPE+QPV
Sbjct: 301 SQMADPMLHGQYPLRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLASQKYDPETQPV 360
Query: 361 QSSRTGSSTPRIRRE 375
QSSR GSSTPR RRE
Sbjct: 361 QSSRMGSSTPRSRRE 375
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098142|ref|XP_002311125.1| predicted protein [Populus trichocarpa] gi|118486473|gb|ABK95076.1| unknown [Populus trichocarpa] gi|222850945|gb|EEE88492.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/376 (90%), Positives = 351/376 (93%), Gaps = 4/376 (1%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG F CAGKSSKN KK KP DQIPS+S+K K N DVK EASKDGGS+HIAAHTFT
Sbjct: 1 MGCFSCAGKSSKNDSKK---KPDDQIPSSSDKTKSNGAPDVK-EASKDGGSEHIAAHTFT 56
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELA TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML
Sbjct: 57 FRELANATKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 116
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL+DLPPDKKRLDW TRM+IAAGAA
Sbjct: 117 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLYDLPPDKKRLDWNTRMKIAAGAA 176
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLE+LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 177 KGLEHLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 236
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAWARPLFKDRRKF
Sbjct: 237 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPLFKDRRKF 296
Query: 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPV 360
+QMADP L GQYP RGLYQALAVAAMCVQEQPNMRPLIADVVTAL+YLA QKYDPE+ PV
Sbjct: 297 AQMADPLLHGQYPARGLYQALAVAAMCVQEQPNMRPLIADVVTALSYLALQKYDPETHPV 356
Query: 361 QSSRTGSSTPRIRREQ 376
Q SRTG STPR RREQ
Sbjct: 357 QGSRTGPSTPRTRREQ 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/372 (85%), Positives = 338/372 (90%), Gaps = 4/372 (1%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIP--STSEKLKVNSTVDVKKEASKDGGSDHIAAHT 58
MGWF C+GKS++ KKK KP+DQI +TSEKLK N + +VK EASK+GG DHIAA T
Sbjct: 1 MGWFLCSGKSNQATKKKR-KKPVDQIQVQTTSEKLKANPSFNVK-EASKNGGPDHIAAQT 58
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL 118
FTFRELAA TKNFR +CLLGEGGFGRVYKGR+ +TNQ VAIKQLDRNGLQGNREFLVEVL
Sbjct: 59 FTFRELAAATKNFRGECLLGEGGFGRVYKGRIANTNQAVAIKQLDRNGLQGNREFLVEVL 118
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD+ KKRLDW TRM+IAAG
Sbjct: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDVSLGKKRLDWNTRMKIAAG 178
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
AAKGLEYLHDKA+PPVIYRDLKCSNILLGE +HPKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 179 AAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKLSDFGLAKLGPVGDNTHVSTRVMGT 238
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298
YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAWARPLFKDRR
Sbjct: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPLFKDRR 298
Query: 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQ 358
KF MADP LQGQYP+RGLYQALAVAAMCVQEQPN+RPLI DVVTALTYLA Q YDP++Q
Sbjct: 299 KFLHMADPMLQGQYPLRGLYQALAVAAMCVQEQPNLRPLIVDVVTALTYLAAQTYDPDTQ 358
Query: 359 PVQSSRTGSSTP 370
PVQSSR STP
Sbjct: 359 PVQSSRVAPSTP 370
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866816|emb|CAN80987.1| hypothetical protein VITISV_003379 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/424 (78%), Positives = 348/424 (82%), Gaps = 49/424 (11%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDL CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLXCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA------------GEHNLVA 288
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN ++ G+
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNYKSCWGTQFGCMGPEFGDVEKTP 300
Query: 289 W-------------------------------------ARPLFKDRRKFSQMADPTLQGQ 311
W ARPLFKDRRKFSQMADP L GQ
Sbjct: 301 WNSPLPHPRLSCQKLVHTLPILPFALFYALANPILIFSARPLFKDRRKFSQMADPMLHGQ 360
Query: 312 YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRTGSSTPR 371
YP+RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA QKYDPE+QPVQSSR GSSTPR
Sbjct: 361 YPLRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLASQKYDPETQPVQSSRMGSSTPR 420
Query: 372 IRRE 375
RRE
Sbjct: 421 SRRE 424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112923|ref|XP_002316332.1| predicted protein [Populus trichocarpa] gi|222865372|gb|EEF02503.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/335 (92%), Positives = 320/335 (95%), Gaps = 1/335 (0%)
Query: 34 KVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLEST 93
K N +DVK EASKDG S++IAAHTFTFRELA TKNFRADCLLGEGGFGRVYKGRLEST
Sbjct: 1 KSNMALDVK-EASKDGSSEYIAAHTFTFRELANATKNFRADCLLGEGGFGRVYKGRLEST 59
Query: 94 NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153
NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL
Sbjct: 60 NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 119
Query: 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213
EDHLHDLPPDKKRLDW TRM++AAGAAKGLEYLHD ANPPVIYRDLKCSNILLGEGYHPK
Sbjct: 120 EDHLHDLPPDKKRLDWNTRMKVAAGAAKGLEYLHDSANPPVIYRDLKCSNILLGEGYHPK 179
Query: 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
LSDFGLAKLGPVGD+THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK
Sbjct: 180 LSDFGLAKLGPVGDETHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 239
Query: 274 AIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPN 333
AIDN+RAAGEHNLVAWARPLFKDRRKF+QMADP LQG YP+RGLYQALAVAAMCVQEQPN
Sbjct: 240 AIDNSRAAGEHNLVAWARPLFKDRRKFAQMADPLLQGHYPMRGLYQALAVAAMCVQEQPN 299
Query: 334 MRPLIADVVTALTYLACQKYDPESQPVQSSRTGSS 368
MRPLIADVVTAL+YLA Q YDPE+QPVQ SRTG S
Sbjct: 300 MRPLIADVVTALSYLASQNYDPETQPVQGSRTGPS 334
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451703|ref|XP_004143601.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/367 (86%), Positives = 334/367 (91%), Gaps = 6/367 (1%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPI----DQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAA 56
MGWF C+G S+K K++ ++ D IPSTSEKL V +T + K + KDGG+D IA
Sbjct: 1 MGWFLCSGISNKKEKQQQQHQVHKKDDDPIPSTSEKLMVKATFNGKNDTLKDGGADQIAG 60
Query: 57 HT--FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL 114
T F+FRELAA TK FRADCLLGEGGFG+VYKGRLES NQVVAIKQLDRNGLQGNREFL
Sbjct: 61 QTITFSFRELAAATKYFRADCLLGEGGFGQVYKGRLESINQVVAIKQLDRNGLQGNREFL 120
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW TRM+
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMK 180
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE YHPKLSDFGLAKLGPVGD THVSTR
Sbjct: 181 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEDYHPKLSDFGLAKLGPVGDNTHVSTR 240
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294
VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAWA+PLF
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWAQPLF 300
Query: 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354
KDRRKFSQMADP LQGQYPVRGLYQALAVAAMCVQEQP+MRPLIADVVTALTYLA QKYD
Sbjct: 301 KDRRKFSQMADPLLQGQYPVRGLYQALAVAAMCVQEQPHMRPLIADVVTALTYLASQKYD 360
Query: 355 PESQPVQ 361
PE+QPVQ
Sbjct: 361 PETQPVQ 367
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1644), Expect = e-180, Method: Compositional matrix adjust.
Identities = 311/378 (82%), Positives = 331/378 (87%), Gaps = 5/378 (1%)
Query: 1 MGWFPCAGKS---SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAH 57
MGW PC+G S +K K + + + QI +T KLK NS+ K+ SK+G DHIAA
Sbjct: 1 MGWIPCSGYSGTKNKVEKMEVQDSLVGQIKATPGKLKRNSSTK-SKDTSKNGNPDHIAAQ 59
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV 117
TF FRELA T+NFR DCLLGEGGFGRVYKGRLES NQVVAIKQLDRNGLQGNREFLVEV
Sbjct: 60 TFAFRELATATRNFRNDCLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG LEDHLHD+PP KKRLDW TRM+IAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKRLDWNTRMKIAA 179
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG+ THVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297
TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+++AGE NLVAWARPLFKDR
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPLFKDR 299
Query: 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357
RKFSQMADPTL GQYP RGLYQALAVAAMCVQEQ N+RP+IADVVTAL+YLA QKYDP +
Sbjct: 300 RKFSQMADPTLHGQYPPRGLYQALAVAAMCVQEQANLRPVIADVVTALSYLASQKYDPNT 359
Query: 358 QPVQSSRTGSST-PRIRR 374
VQSSR ST PR RR
Sbjct: 360 HTVQSSRHAPSTPPRTRR 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572387|ref|XP_003554350.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 309/381 (81%), Positives = 334/381 (87%), Gaps = 6/381 (1%)
Query: 1 MGWFPCAGKS---SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAH 57
MGW PC+G S +K K + + + QI +T+ KLK NS+ K+ SK+G DHIAA
Sbjct: 1 MGWIPCSGYSGTKNKVEKMEAQDSLVGQIKATTGKLKRNSSTK-SKDTSKNGNPDHIAAQ 59
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV 117
TF+FRELA T+NFRA+CLLGEGGFGRVYKGRLES NQVVAIKQLDRNGLQGNREFLVEV
Sbjct: 60 TFSFRELATATRNFRAECLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG LEDHLHD+PP KK+LDW TRM+IAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKQLDWNTRMKIAA 179
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG+ THVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297
TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+++AGE NLVAWARPLFKDR
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPLFKDR 299
Query: 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357
RKFSQMADPTLQGQYP RGLYQ +AVAAMCVQEQ NMRP+IADVVTAL+YLA Q+YDP +
Sbjct: 300 RKFSQMADPTLQGQYPPRGLYQVIAVAAMCVQEQANMRPVIADVVTALSYLASQRYDPNT 359
Query: 358 QPV-QSSRTGSST-PRIRREQ 376
Q QSSR T PR RR Q
Sbjct: 360 QHTGQSSRHAPGTPPRNRRGQ 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 376 | ||||||
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.912 | 0.668 | 0.834 | 1.1e-153 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.984 | 0.978 | 0.758 | 8.8e-150 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.906 | 0.747 | 0.764 | 7.2e-139 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.898 | 0.797 | 0.682 | 7.2e-123 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.851 | 0.829 | 0.704 | 6.5e-122 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.867 | 0.787 | 0.673 | 5.4e-118 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.859 | 0.889 | 0.685 | 2.3e-117 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.837 | 0.826 | 0.687 | 4.5e-114 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.869 | 0.840 | 0.649 | 9.7e-112 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.829 | 0.802 | 0.659 | 9.7e-112 |
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1499 (532.7 bits), Expect = 1.1e-153, P = 1.1e-153
Identities = 288/345 (83%), Positives = 309/345 (89%)
Query: 31 EKLKVNSTVDVKKE--ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKG 88
+K K + KKE A K+G + HIAA TFTFRELAA TKNFR +CLLGEGGFGRVYKG
Sbjct: 41 DKSKSRRGPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKG 100
Query: 89 RLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148
RLE+T Q+VA+KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM
Sbjct: 101 RLETTGQIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 160
Query: 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208
PLGSLEDHLHDLPPDK+ LDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLK SNILLG+
Sbjct: 161 PLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGD 220
Query: 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268
GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV LE+
Sbjct: 221 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 280
Query: 269 ITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCV 328
ITGRKAIDN RA GEHNLVAWARPLFKDRRKF +MADP+LQG+YP+RGLYQALAVAAMC+
Sbjct: 281 ITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCL 340
Query: 329 QEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRTGSSTPRIR 373
QEQ RPLI DVVTALTYLA Q +DP + Q+SR+GS P IR
Sbjct: 341 QEQAATRPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIR 385
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1462 (519.7 bits), Expect = 8.8e-150, P = 8.8e-150
Identities = 289/381 (75%), Positives = 311/381 (81%)
Query: 1 MGWFPCXXXXXXXXXXXXXXX-PIDQIPS-----TSEKLKVNSTVDVKKEASKDGGSDHI 54
MGW PC +D+ S TSEK + S++ SK GSDHI
Sbjct: 1 MGWIPCSGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAKSSLS----ESKSKGSDHI 56
Query: 55 AAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL 114
A TFTF ELA T+NFR +CL+GEGGFGRVYKG L ST+Q AIKQLD NGLQGNREFL
Sbjct: 57 VAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFL 116
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD+ P K+ LDW TRM+
Sbjct: 117 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMK 176
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IAAGAAKGLEYLHDK PPVIYRDLKCSNILL + Y PKLSDFGLAKLGPVGDK+HVSTR
Sbjct: 177 IAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTR 236
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294
VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID++R+ GE NLVAWARPLF
Sbjct: 237 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLF 296
Query: 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354
KDRRKFSQMADP LQGQYP RGLYQALAVAAMCVQEQPN+RPLIADVVTAL+YLA QK+D
Sbjct: 297 KDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFD 356
Query: 355 PESQPVQSSRTGSSTP-RIRR 374
P +QPVQ S TP R +R
Sbjct: 357 PLAQPVQGSLFAPGTPPRSKR 377
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1359 (483.5 bits), Expect = 7.2e-139, P = 7.2e-139
Identities = 263/344 (76%), Positives = 288/344 (83%)
Query: 23 IDQIPSTSEKLKVNSTVDVKKEA--SKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEG 80
I +PS EKL + K+E +DG IAAHTF FRELAA T NF D LGEG
Sbjct: 37 ISGLPSGGEKLSSKTNGGSKRELLLPRDG-LGQIAAHTFAFRELAAATMNFHPDTFLGEG 95
Query: 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140
GFGRVYKGRL+ST QVVA+KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ
Sbjct: 96 GFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 155
Query: 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK 200
RLLVYE+MPLGSLEDHLHDLPPDK+ LDW RM+IAAGAAKGLE+LHDKANPPVIYRD K
Sbjct: 156 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFK 215
Query: 201 CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260
SNILL EG+HPKLSDFGLAKLGP GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYS
Sbjct: 216 SSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYS 275
Query: 261 FGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQA 320
FGVV LE+ITGRKAID+ GE NLVAWARPLF DRRKF ++ADP L+G++P R LYQA
Sbjct: 276 FGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQA 335
Query: 321 LAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSR 364
LAVA+MC+QEQ RPLIADVVTAL+YLA Q YDP + +R
Sbjct: 336 LAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSKDDSRRNR 379
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
Identities = 241/353 (68%), Positives = 273/353 (77%)
Query: 27 PSTSEKLKVNSTVDVKKEA----------SKDGG-SDHIA---AHTFTFRELAAVTKNFR 72
PS S+ LKV+ DV KE +KD D + A TFTF EL+ T NF+
Sbjct: 41 PS-SDCLKVSICGDVSKEIVTKKDQLALDAKDTNVEDEVIVKKAQTFTFEELSVSTGNFK 99
Query: 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+DC LGEGGFG+VYKG +E NQVVAIKQLDRNG QG REF+VEVL LSL HPNLV LI
Sbjct: 100 SDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLI 159
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G+CA+G QRLLVYEYMPLGSL++HLHDLP K L W TRM+IAAGAA+GLEYLHD P
Sbjct: 160 GFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKP 219
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
PVIYRDLKCSNIL+ EGYH KLSDFGLAK+GP G +THVSTRVMGTYGYCAP+YA+TGQL
Sbjct: 220 PVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQL 279
Query: 253 TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312
T KSDVYSFGVVLLE+ITGRKA DNTR +LV WA PLFKDR+ F +M DP L+G Y
Sbjct: 280 TFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGDY 339
Query: 313 PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRT 365
PVRGLYQALA+AAMCVQEQP+MRP+IADVV AL +LA KYD + Q + T
Sbjct: 340 PVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSKYDRSHRQKQDNVT 392
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
Identities = 227/322 (70%), Positives = 269/322 (83%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
+ +E +K G +I+AH FTFREL TKNF D LGEGGFGRVYKG++E+ QVVA+K
Sbjct: 53 ISEEIAKLG-KGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVK 111
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
QLDRNG QGNREFLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM GSLEDHL +L
Sbjct: 112 QLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLEL 171
Query: 161 PPDKKR-LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219
+KK+ LDW TRM++AAGAA+GLEYLH+ A+PPVIYRD K SNILL E ++PKLSDFGL
Sbjct: 172 ARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGL 231
Query: 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279
AK+GP G +THVSTRVMGTYGYCAPEYA+TGQLT+KSDVYSFGVV LE+ITGR+ ID T+
Sbjct: 232 AKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTK 291
Query: 280 AAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIA 339
E NLV WA PLFKDRRKF+ MADP L+G+YP++GLYQALAVAAMC+QE+ RP+++
Sbjct: 292 PTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMS 351
Query: 340 DVVTALTYLACQKYDPESQPVQ 361
DVVTAL YLA K + + Q V+
Sbjct: 352 DVVTALEYLAVTKTEEDGQTVE 373
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1162 (414.1 bits), Expect = 5.4e-118, P = 5.4e-118
Identities = 225/334 (67%), Positives = 265/334 (79%)
Query: 51 SDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN 110
+++IAA TF+FRELA TKNFR +CL+GEGGFGRVYKG+LE T +VA+KQLDRNGLQGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT 170
+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GSLEDHL DL PD+ LDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230
TR+RIA GAA GLEYLHDKANPPVIYRDLK +NILL ++ KLSDFGLAKLGPVGDK H
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290
VS+RVMGTYGYCAPEY TGQLT KSDVYSFGVVLLE+ITGR+ ID TR E NLV WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL-- 348
+P+FK+ +F ++ADP+L+G +P + L QA+AVAAMC+QE+ +RPL++DVVTAL +L
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
Query: 349 ------ACQKYDPESQPVQSSRTGSSTPRIRREQ 376
+ YD QP + S RE+
Sbjct: 359 APDGSISVPHYDDPPQPSDETSVEDSVAAEERER 392
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 224/327 (68%), Positives = 263/327 (80%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
V K A+ G S+++ A FTFRELA TKNFR +CL+GEGGFGRVYKG+LE+ QVVA+K
Sbjct: 19 VAKNAN--GPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVK 76
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
QLDRNGLQG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPLGSLEDHL DL
Sbjct: 77 QLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDL 136
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
P +K LDW TR++IA GAAKG+EYLHD+A+PPVIYRDLK SNILL Y KLSDFGLA
Sbjct: 137 EPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLA 196
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
KLGPVGD HVS+RVMGTYGYCAPEY TG LT KSDVYSFGVVLLE+I+GR+ ID R
Sbjct: 197 KLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRP 256
Query: 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIAD 340
+ E NLV WA P+F+D ++ Q+ADP L+G YP + L QA+AVAAMC+ E+P +RPL++D
Sbjct: 257 SHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSD 316
Query: 341 VVTALTYLACQKYDPE--SQPVQSSRT 365
V+TAL++L S +Q +R+
Sbjct: 317 VITALSFLGASSNSSNTGSNHLQQNRS 343
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1125 (401.1 bits), Expect = 4.5e-114, P = 4.5e-114
Identities = 218/317 (68%), Positives = 257/317 (81%)
Query: 56 AHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV 115
A +FTF+ELAA T+NFR LLGEGGFGRVYKGRL+S QVVAIKQL+ +GLQGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 116 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
EVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GSLEDHL DL +++ L W TRM+I
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A GAA+G+EYLH ANPPVIYRDLK +NILL + + PKLSDFGLAKLGPVGD+THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295
MGTYGYCAPEYAM+G+LT+KSD+Y FGVVLLE+ITGRKAID + GE NLV W+RP K
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLK 301
Query: 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDP 355
D++KF + DP+L+G+YP R L A+A+ AMC+ E+ + RP I D+V AL YLA Q
Sbjct: 302 DQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSH 361
Query: 356 ESQPVQS-SRTGSSTPR 371
E++ V S S S TPR
Sbjct: 362 EARNVSSPSPEISRTPR 378
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 215/331 (64%), Positives = 250/331 (75%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
+ +E K G + F F+EL A T NF DC++GEGGFGRVYKG L S NQVVA+K
Sbjct: 56 ITEEIKKYGNVKN-CGRIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVK 114
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
+LDRNGLQG REF EV++LSL HPNLVNLIGYC + +QR+LVYE+MP GSLEDHL DL
Sbjct: 115 RLDRNGLQGTREFFAEVMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDL 174
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
P LDW TRMRI GAAKGLEYLHD A+PPVIYRD K SNILL ++ KLSDFGLA
Sbjct: 175 PEGSPSLDWFTRMRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLA 234
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
+LGP K HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGVVLLEII+GR+AID R
Sbjct: 235 RLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRP 294
Query: 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIAD 340
E NL++WA PL KDRR F+Q+ DP L G YPV+GL+QALA+AAMC+QE+ RPL+ D
Sbjct: 295 TEEQNLISWAEPLLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGD 354
Query: 341 VVTALTYLA--CQKYD-PESQPVQSSRTGSS 368
VVTAL +LA + D + P ++T SS
Sbjct: 355 VVTALEFLAKPIEVVDNTNTTPASPTQTSSS 385
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 209/317 (65%), Positives = 256/317 (80%)
Query: 39 VDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVA 98
V KE+ K+ I A +F FRELA T +FR + L+GEGGFGRVYKG++E T QVVA
Sbjct: 44 VGTNKESPKN-----IKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVA 98
Query: 99 IKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
+KQLDRNGLQGNREFLVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGSLEDHL
Sbjct: 99 VKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLL 158
Query: 159 DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218
D+ ++ LDW +R+RIA GAAKGLEYLH+KANPPVIYRD K SNILL + KLSDFG
Sbjct: 159 DVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFG 218
Query: 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278
LAKLG VGD +VS+RV+GTYGYCAPEY TGQLT+KSDVYSFGVVLLE+ITG++ ID T
Sbjct: 219 LAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTT 278
Query: 279 RAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI 338
R E NLV WA+P+F++ +F ++ADP LQG++P + L QA+A+AAMC+QE+P +RPLI
Sbjct: 279 RPCHEQNLVTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLI 338
Query: 339 ADVVTALTYLACQKYDP 355
+DVVTAL++++ + P
Sbjct: 339 SDVVTALSFMSTETGSP 355
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 376 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-60 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-57 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-56 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-56 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 9e-60
Identities = 77/195 (39%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGYC 135
LGEGGFG VY R + T + VAIK + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
D + LV EY GSL+D L + +L +RI +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 196 YRDLKCSNILLGEG-YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-YAMTGQLT 253
+RDLK NILL KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 254 LKSDVYSFGVVLLEI 268
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 7e-57
Identities = 79/199 (39%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 77 LGEGGFGRVYKGRLESTN----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG L+ VA+K L + Q EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C + + ++V EYMP G L D+L K L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
I+RDL N L+GE K+SDFGL++ D V + APE G+
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 252 LTLKSDVYSFGVVLLEIIT 270
T KSDV+SFGV+L EI T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 2e-56
Identities = 75/199 (37%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 77 LGEGGFGRVYKGRLESTN----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG+L+ VA+K L + Q EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C + + +V EYM G L +L + +L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
I+RDL N L+GE K+SDFGL++ D + APE G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 252 LTLKSDVYSFGVVLLEIIT 270
T KSDV+SFGV+L EI T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-56
Identities = 78/200 (39%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG L E T VA+K L + EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C G+ +V EYMP G L D L +L +++A AKG+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RDL N L+ E K+SDFGL++ D + APE G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 252 LTLKSDVYSFGVVLLEIITG 271
T KSDV+SFGV+L EI T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 94/283 (33%), Positives = 129/283 (45%), Gaps = 36/283 (12%)
Query: 77 LGEGGFGRVYKGRLE---STNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VYKG+L+ VA+K L + + R +FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
G C + + LV EYM G L D+L P+K L + A AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
K ++RDL N L+GE K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK---AIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303
G T KSDV+SFGV+L EI T G + N + + RK ++
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------------VLEYLRKGYRL 226
Query: 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346
P P LY+ + C Q P RP +++V L
Sbjct: 227 PKPEY---CPDE-LYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 4e-54
Identities = 77/206 (37%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLV 129
+ LGEG FG+VY R + T ++VAIK + + ++ +RE L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L D D+ LV EY G L D L L D+ R LEYL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H K +++RDLK NILL E H KL+DFGLA+ + ++T V GT Y APE
Sbjct: 114 HSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEV 167
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ D++S GV+L E++TG+
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-52
Identities = 77/199 (38%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG G FG VYK + + T ++VA+K L + ++ E+ +L L HPN+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D D LV EY G L D+L L +IA +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-T 253
I+RDLK NILL E K++DFGLAK + + ++T V GT Y APE + G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 254 LKSDVYSFGVVLLEIITGR 272
K DV+S GV+L E++TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL-----MLSLLHHPNLV 129
LLG G FG VY + T +++A+K ++ L G+ E +E L +LS L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 130 NLIGYC--ADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLE 184
G + + + EY+ GSL L LP R +T ++ +GL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-YTRQI------LEGLA 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH +++RD+K +NIL+ KL+DFG AK + + V GT + AP
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + +D++S G ++E+ TG+
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+GGFG VYK R + T + VAIK + + + + E+ +L HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
D+ +V E+ GSL+D L + L + + KGLEYLH +I+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIH 121
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYAMTGQLTL 254
RD+K +NILL KL DFGL+ + R ++GT + APE
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMVGTPYWMAPEVINGKPYDY 176
Query: 255 KSDVYSFGVVLLEIITGR 272
K+D++S G+ +E+ G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 83/266 (31%), Positives = 126/266 (47%), Gaps = 42/266 (15%)
Query: 77 LGEGGFGRVYKG----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK L + + N+E L E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C Q L+ + MPLG L D++ + K + + AKG+ YL +K
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL V +K + + + A E +
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 252 LTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLV----------------------A 288
T KSDV+S+GV + E++T G K + A +L+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKC 247
Query: 289 W-----ARPLFKD-RRKFSQMA-DPT 307
W +RP FK+ +FS+MA DP
Sbjct: 248 WMIDAESRPTFKELINEFSKMARDPQ 273
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 70/194 (36%), Positives = 107/194 (55%), Gaps = 8/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V++G L VAIK L + L ++F EV L L H +L++L C+
Sbjct: 14 LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
G+ ++ E M GSL L P+ + L + + +A A+G+ YL ++ I+
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL NIL+GE K++DFGLA+L + + ++S+ Y + APE A G + KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 74/237 (31%), Positives = 110/237 (46%), Gaps = 26/237 (10%)
Query: 77 LGEGGFGRVYKGRLE----STNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V R + +T + VA+K L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C R L+ EY+P GSL D+L + +++ + ++ KG++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST--RVMGTYGYCAPEYA 247
I+RDL NIL+ K+SDFGLAK+ P + + Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304
T + + SDV+SFGV L E+ T G+ + A L QM
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGIAQGQMI 231
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LGEG FG+VYKG L + VAIK L N + EF E ++S L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAG 178
L+G C +++EY+ G L + L P K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+EYL ++ ++RDL N L+GEG K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268
+ PE + G+ T +SD++SFGVVL EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 73/202 (36%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
LG+G FG+V R + T ++ A+K L + + +E L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 134 YCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLEYLHDKA 190
+ A + LV EY P G L HL + R R AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERAR-FYAAEIVLALEYLHSLG 113
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK NILL H KL+DFGLAK + +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLLGK 168
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
D +S GV+L E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 72 RADCL-----LGEGGFGRVYKGRLESTNQ-----VVAIKQLDRNGLQGNRE-FLVEVLML 120
+ D + LGEG FG+V+ G +VA+K L R+ F E +L
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELL 62
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HD--------LPPDKKRLDWT 170
+ H N+V G C +GD ++V+EYM G L L H L +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230
++IA A G+ YL A+ ++RDL N L+G K+ DFG+++ D
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
V M + PE M + T +SDV+SFGVVL EI T
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 75/198 (37%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G T +V A+K L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + +V EYM GSL D L + K+L + +AA A+G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDL NIL+GE K++DFGLA+L + T + + APE A G+ T+K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+SFG++L EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-32
Identities = 77/216 (35%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-----LMLSLLH 124
++R LGEG FG VY R ++VA+K L L+ + + ++ SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
PN+V L + D LV EY+ GSLED L K L + + I A LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALE 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKL----GPVGDKTHVSTRVMGTY 239
YLH K +I+RD+K NILL G KL DFGLAKL G + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 240 GYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGR 272
GY APE + + SD++S G+ L E++TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
N++ L+G G FG VYKG T VAIKQ+ ++ + + E+ +L L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLED---HLHDLPPD------KKRLDWTTRMRIAAG 178
+V IG D ++ EY GSL P + L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----------- 109
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMG 237
+GL YLH++ VI+RD+K +NIL + KL+DFG+A KL V V+G
Sbjct: 110 --QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVG 161
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
T + APE + SD++S G ++E++TG
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G+G FG+VY R +S ++ +K++D + + + RE + EV +L L+HPN++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 134 YCADGDQRLLVYEYMPLGSLEDHL------HDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ + +V EY G L + P+++ LDW ++ L+YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 246 ----YAMTGQLTLKSDVYSFGVVLLEIITGRKA 274
Y KSD++S G VL E+ T +
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 76 LLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG+G FG V R + +T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C +R LV EY+P GSL D+L ++RLD + A+ KG+EYL K
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPEY 246
++RDL NIL+ K+ DFGL K+ P DK + R G + Y APE
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G+G FG V G Q VA+K L + + FL E +++ L HPNLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G+ +V EYM GSL D+L + + ++ A +G+EYL +K +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+RDL N+L+ E K+SDFGLAK G K V + APE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 253 TLKSDVYSFGVVLLEIIT-GR 272
+ KSDV+SFG++L EI + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V++G +T V A+K L + G ++FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V E M GSL ++L + L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 249
RDL N+L+GE K++DFGLA++ G K + + APE A+
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--------WTAPEAALY 178
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GR 272
+ ++KSDV+SFG++L EI+T GR
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV--EVLMLSLL-HHPNLVNL 131
++GEG F V + + TN+ AIK LD+ L + + V E +L+ L HP ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D + V EY P G L ++ LD AA LEYLH K
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG- 122
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVM-------------- 236
+I+RDLK NILL + H K++DFG AK L P
Sbjct: 123 --IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 237 ---GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT Y +PE SD+++ G ++ +++TG+
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG VYKG L+ N VA+K + FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C +V E +P GSL L K RL ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RDL N L+GE K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 255 KSDVYSFGVVLLEIITG 271
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 249
RDL N L+GE + K++DFGL++L G K + + APE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 250 GQLTLKSDVYSFGVVLLEIIT 270
+ ++KSDV++FGV+L EI T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 85/289 (29%), Positives = 127/289 (43%), Gaps = 43/289 (14%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-----------WTTRMRIAAGAA 180
G C +G L+V+EYM G L L PD K L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
G+ YL A+ ++RDL N L+G+G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK----AIDNTRAAGEHNLVAWARPLFKD 296
+ PE + + T +SD++SFGVVL EI T K + NT A + R L +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECITQGRELERP 246
Query: 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
R ++ +QG C Q +P R +I D+ + L
Sbjct: 247 RTCPPEVYA-IMQG----------------CWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-28
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 35/210 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIG-Y 134
LG+G G VYK R + T ++ A+K++ +G + R+ L+ E+ L P +V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAGAAKGLEYLHDKANP 192
+G+ +V EYM GSL D L KK + IA KGL+YLH K +
Sbjct: 69 YKEGEIS-IVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 193 PVIYRDLKCSNILL---GEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPE--- 245
+I+RD+K SN+L+ GE K++DFG++K L D+ + T V GT Y +PE
Sbjct: 121 -IIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQ 173
Query: 246 ---YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y+ +D++S G+ LLE G+
Sbjct: 174 GESYSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 69/202 (34%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGR-LESTNQV--VAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNL 131
LG+G FG V +G S +V VA+K L + L +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G ++V E PLGSL D L +T A A G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST---RVMGTYGYCAPEYAM 248
I+RDL NILL K+ DFGL + P + +V +V + +CAPE
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
T + SDV+ FGV L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 69/206 (33%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVN 130
F LGEG +G VYK + T QVVAIK + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA---GAAKGLEYLH 187
G +V EY GS+ D + K L T IAA KGLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLKGLEYLH 116
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY 246
I+RD+K NILL E KL+DFG++ +L K + V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEV 170
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
K+D++S G+ +E+ G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 67/200 (33%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G VYK +T + VAIK++ + N+E ++ E+L++ HPN+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA---KGLEYLHDKANP 192
GD+ +V EYM GSL D + + + IA +GLEYLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTDII-----TQNFVRMNEPQ-IAYVCREVLQGLEYLHSQ--- 135
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
VI+RD+K NILL + KL+DFG A+L K + V+GT + APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVIKRKD 192
Query: 252 LTLKSDVYSFGVVLLEIITG 271
K D++S G++ +E+ G
Sbjct: 193 YGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIGYCA 136
G +GRV+ + +ST + AIK + + + + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 137 DGDQRL-LVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + L LV EY+P L SL +++ L D R+ A LEYLH +
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-------YIAEIVLALEYLH---SN 112
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS------TRVMGTYGYCAPEY 246
+I+RDLK NIL+ H KL+DFGL+K+G V + +++ R++GT Y APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+ + D +S G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGE FG++YKG L Q+VAIK L D N Q EF E +++ LHHPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD-------------KKRLDWTTRMRIAAG 178
+G +++EY+ G L + L P K LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+EYL ++ +++DL NIL+GE H K+SD GL++ D V + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE M G+ + SD++SFGVVL EI +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
++ ++G G VY N+ VAIK++D Q + + L EV +S +HPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+V GD+ LV Y+ GSL D + P LD + KGLEYL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYL 118
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTH-VSTRVMGTYGYCAP 244
H I+RD+K NILLGE K++DFG+ A L GD+T V +GT + AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 245 EYAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
E M K+D++SFG+ +E+ TG
Sbjct: 176 E-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G+VYK R + T ++VA+K++ ++ +E + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-------- 181
+ +V+EYM HDL L + ++ K
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL+YLH +++RD+K SNIL+ KL+DFGLA+ + T + T Y
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167
Query: 242 CAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
PE + + + D++S G +L E+ G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 70/204 (34%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG GGFGRV +++S N+ A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 134 YCADGDQRLLVY---EYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLEYLHDK 189
Y D++ +Y EY G L L D + D +T R A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARF-YIACVVLAFEYLHNR 112
Query: 190 ANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+IYRDLK N+LL GY KL DFG AK G KT GT Y APE +
Sbjct: 113 G---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIIL 165
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
D +S G++L E++TGR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 77 LGEGGFGRVYKGR---LESTNQ--VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ L T +VA+K L L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAGA 179
G C DGD ++V+EYM G L L PD K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A G+ YL A+ ++RDL N L+G K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE M + T +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G+ V AIK + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EYM G L ++L + K +L + + + + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE K+SDFGLA+ V D + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG--- 310
KSDV+SFGV++ E+ + K + +R S++ + G
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK-------------------MPYERFSNSEVVESVSAGYRL 220
Query: 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346
P + + C E+P RP +++ LT
Sbjct: 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G + + VAIK L + G FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L P+ +L + +AA A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 254
RDL+ +NIL+ E K++DFGLA+L + + R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 255 KSDVYSFGVVLLEIIT-GR 272
KSDV+SFG++L EI+T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 77 LGEGGFGRV----YKGRLESTNQVVAIKQLDR-NGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V Y + T ++VA+K L R G Q + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C++ + L+ EY+PLGSL D+L K +L+ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAM 248
I+RDL N+LL K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
+ + SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 47/284 (16%)
Query: 76 LLGEGGFGRVYKGRLESTNQV---VAIKQLDR-NGLQGNREFLVEVLMLSLLHHPNLVNL 131
++G+G FG VY G L ++ A+K L+R L+ +FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 132 IGYCADGD-QRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+G C + L+V YM G L + + P K L + AKG+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVMGTYGYC 242
A+ ++RDL N +L E + K++DFGLA+ V + T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH---NLVAWARPLFKDRRK 299
A E T + T KSDV+SFGV+L E++ TR A + + L + RR
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELM--------TRGAPPYPDVDSFDITVYLLQGRR- 220
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVT 343
LQ +Y LY+ V C +P MRP +++V+
Sbjct: 221 -------LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRLE--STNQV---VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + + VAIK + + ++ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRI---AAGAAKGLE 184
L+G + G L+V E M G L+ +L P+ + L T + AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YL K ++RDL N ++ E K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E G T KSDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++++T ++ A K+LD+ L +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D LV M G L+ H++++ + + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++YRDLK N+LL + + ++SD GLA G K GT GY APE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 254 LKSDVYSFGVVLLEIITGR 272
D ++ G L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGN---REFLVEVLMLSLLHHPNLVN 130
LLG G FG VY+G A+K+ L +G G ++ E+ +LS L HPN+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+G + D + E +P GSL L + + TR + GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHDR 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-----GTYGYCAP 244
++RD+K +NIL+ KL+DFG+AK V G+ + AP
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170
Query: 245 EYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
E G L +D++S G +LE+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 65/198 (32%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV R + + + A+K L + + ++ L E +L + HP LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D LV EY+P G L HL R AA LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD--- 121
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++YRDLK N+LL + K++DFG AK V +T+ + GT Y APE ++
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPEIILSKGYG 176
Query: 254 LKSDVYSFGVVLLEIITG 271
D ++ G+++ E++ G
Sbjct: 177 KAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G G V K T +++A+K + ++ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ + EYM GSL+ L + R+ +IA KGL YLH+K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM--------GTYGYCAPEYA 247
+RD+K SNIL+ KL DFG VS +++ GT Y APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERI 171
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
++KSD++S G+ L+E+ TGR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG +G VYK R + T ++VA+K++ + G+ L E+ +L L HPN+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKLL 64
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+EY DL KK LD ++ K GL
Sbjct: 65 DVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIMYQLLRGLA 112
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y H +++RDLK NIL+ KL+DFGLA+ + +T+ + V+ T Y AP
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAP 167
Query: 245 EYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
E + L S D++S G + E+ITG+
Sbjct: 168 E------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 77 LGEGGFGRVYKG--RLESTNQV-VAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG ++S +V VA+K L + + +EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C G+ +LV E PLG L +L P + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
++RDL N+LL + K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
G+ + KSDV+S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 30/264 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG V+K ++ +V A+KQ+D + + E + E +L+ L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + +V EY G L L + L R GL +LH K +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RD+K N+ L + K+ D G+AKL + D T+ + ++GT Y +PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 255 KSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPV 314
KSDV++ GVVL E TG+ D +N A + + PV
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD------ANNQGALILKIIRGVFP-------------PV 221
Query: 315 RGLY-QALA-VAAMCVQEQPNMRP 336
+Y Q LA + C+ + RP
Sbjct: 222 SQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 24/273 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
++ G G YKG+ +K++ D N + + E+ + L HPN+V LIG
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNIVKLIGL 751
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C L++EY+ +L + L + L W R +IA G AK L +LH + +P V
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+ +L I++ P L L L K +S+ Y APE T +T
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITE 857
Query: 255 KSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPV 314
KSD+Y FG++L+E++TG+ D ++V WAR + D DP+++G V
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSV 915
Query: 315 --RGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+ + + +A C P RP DV+ L
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNL 131
+G G FG V +GRL+ + VAIK L + G +FL E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G +++ EYM GSL+ L +D + + + G A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 243
++RDL NIL+ K+SDFGL++ + D T T G + A
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIRWTA 176
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE + T SDV+SFG+V+ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 9/205 (4%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLV-EVLMLSLLHHPN 127
+F+ LG+G +G VYK + S NQ A+K++D + Q RE V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+++ DG++ +V EY P G L + +K + RI +GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++ +++RDLK +NILL K+ D G++K+ K +++ +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ KSD++S G +L E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 72/198 (36%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G +V A+K L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + +V EYM GSL D L D + + L + +AA A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 255
RDL+ +NIL+G+G K++DFGLA+L + D + + + + APE A+ G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+SFG++L E++T GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVYKGR----LESTNQ-VVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
+G+G FGRV++ R L +VA+K L + +F E +++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------------DKKRLDWTTR 172
L+G CA G L++EYM G L + L P + L T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ IA A G+ YL ++ ++RDL N L+GE K++DFGL++ D S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE + T +SDV+++GVVL EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIGY 134
+G+G FG V K R +S +++ K++D + + ++ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 135 CADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D + L V EY G L + ++K ++ RI L H++++P
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 193 P--VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYA 247
V++RDLK +NI L + KL DFGLAK+ KT+V GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQL 182
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
KSD++S G ++ E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-24
Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 76 LLGEGGFGRVYKGRLE------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNL 128
LG G FG VY+G S VA+K L + Q +EFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEY 185
V L+G C + + ++ E M G L +L D ++ L + I AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
L I+RDL N L+ E + K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE + G+ T +SDV+SFGV++ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V+ G +V AIK + R G +F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV+E+M G L D+L + + T + + +G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL N L+GE K+SDFG+ + + D+ ST + +PE + + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 257 DVYSFGVVLLEIIT-GRKAIDNTRAAGE 283
DV+SFGV++ E+ + G+ +N R+ E
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN-RSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 75/206 (36%), Positives = 116/206 (56%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R D LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L ++ + +V E+M GSL D L + D K L + +AA A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ N I+RDL+ +NIL+G+ K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
+ G+ T+KSDV+SFG++L E++T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK R + T ++VAIK++ + L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
LV+E+M D + ++ L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG--I 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPEYAMT-G 250
++RDLK N+L+ KL+DFGLA+ PV TH V TR Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
+ D++S G + E+++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-23
Identities = 69/204 (33%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKG----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LLG G FG V+KG +S VAIK + DR+G Q +E +L + L H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLH----DLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L+G C G LV + PLGSL DH+ L P ++ L+W ++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI------AKGMYYL 125
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ +++R+L NILL +++DFG+A L DK + + + A E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
+ G+ T +SDV+S+GV + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQ-LDRNGLQGNREF-LVEVLMLSLLHHPNLVNLI 132
++GEG +G V K R ++T ++VAIK+ + + ++ L EV +L L H N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY+ L LE LPPD + W + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+I+RD+K NIL+ E KL DFG A+ + ++ V T Y APE
Sbjct: 119 HN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE--- 171
Query: 249 TGQLTLKS-------DVYSFGVVLLEIITGR------KAIDN----TRAAG----EHNLV 287
L + DV++ G ++ E++ G ID + G H +
Sbjct: 172 ---LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228
Query: 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336
+ P F +L+ +YP + AL C++ P R
Sbjct: 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-23
Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 39/290 (13%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK---------KRLDWTTRMRIAAGAAKG 182
G C +GD ++V+EYM G L L PD L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ YL A+ ++RDL N L+GE K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302
PE M + T +SDV+S GVVL EI T K +P ++ ++
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK-----------------QPWYQLSN--NE 230
Query: 303 MADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
+ + QG Q P + + C Q +P+MR I ++ + L LA
Sbjct: 231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 61/199 (30%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
G+G FG+V + T ++ A+K +++ R L E +L L+HP LVNL
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + LV + + G L HL K + LEYLH K +
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---I 121
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RD+K NILL E H ++DF +A T T GT GY APE ++
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSV 178
Query: 255 KSDVYSFGVVLLEIITGRK 273
D +S GV E + G++
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-23
Identities = 70/195 (35%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG V+ GRL + N VA+K R L + +FL E +L HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C Q+ +Y M L D L L + RL +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT--YGYCAPEYAMTGQL 252
I+RDL N L+ E K+SDFG+++ D + ST M + APE G+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 253 TLKSDVYSFGVVLLE 267
+ +SDV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-23
Identities = 63/200 (31%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ-LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG G V K RL++T + A+K ++ L E+ + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 136 ADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D + EY GSL+ + R+ +IA KGL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--- 125
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+I+RD+K SNILL KL DFG++ +L T GT Y APE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKPY 180
Query: 253 TLKSDVYSFGVVLLEIITGR 272
++ SDV+S G+ LLE+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
+G+G FG VYK + TNQVVAIK +D + E + E+ LS P + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
G + ++ EY GS D L D+ + + R + GLEYLH++
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYAMTGQ 251
I+RD+K +NILL E KL+DFG++ G T ++ +GT + APE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 252 LTLKSDVYSFGVVLLEIITG 271
K+D++S G+ +E+ G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 6e-23
Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLL-HHPNLVNL 131
+LG+G FG+V+ L+ TNQ AIK L ++ + + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 132 IGYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
YC + V EY+ G L H+ + D AA GL++LH K
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK 115
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
++YRDLK NILL H K++DFG+ K +GD + GT Y APE +
Sbjct: 116 G---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLG 170
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
+ D +SFGV+L E++ G+
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-23
Identities = 75/206 (36%), Positives = 112/206 (54%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R + LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L ++ + +V EYM GSL D L RL M AA A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQIASGMAYV-E 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ N ++RDL+ +NIL+GE K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
+ G+ T+KSDV+SFG++L E+ T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-23
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 77 LGEGGFGRVYKG-----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G ++ VA+K L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLH 187
LIG + R ++ E M G L+ L + P +R L + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ I+RD+ N LL G G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEI 268
E + G T K+DV+SFGV+L EI
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 71/212 (33%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM--------LSL 122
FR +LG G FG+V + T ++ AIK L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 123 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
HP LVNL C + + V EY G L H+H + R + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-----AVFYAACVVL 112
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTY 239
GL+YLH+ ++YRDLK N+LL K++DFGL K +G GD+T ST GT
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTP 165
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
+ APE T D + GV++ E++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V K R+ + AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR-------MRIAAGA 179
+G C L EY P G+L D L + P + T + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G++YL K I+RDL NIL+GE Y K++DFGL++ G + +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T SDV+S+GV+L EI++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 45/287 (15%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K R T Q+VAIK+ + + L E+ ML L HPNLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY L LE + +P K++ W T + + + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCH- 117
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKT-HVSTRVMGTYGYCAPE 245
K N I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 246 YAMTGQLTLKS--DVYSFGVVLLEIIT------GRKAIDN----TRAAGEHNLVAWARPL 293
+ G DV++ G V E++T G+ +D + G+ L+ + +
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD--LIPRHQQI 227
Query: 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAM-----CVQEQPNMR 335
F + F ++ P + + P+ + ++ A+ C+Q P R
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-22
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIG 133
++G G FG V+ R ++ ++V IKQ+ + + E +L LL HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+ ++V EY P G+L +++ L + L + ++ +A L ++H K
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTK 120
Query: 190 ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+++RDLK NILL + K+ DFG++K+ + K+ T V+GT Y +PE
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAID 276
KSD+++ G VL E+ + ++A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V + + + AIK L + + R+F E+ +L L HHPN++NL
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR-------MRIAAGA 179
+G C + + EY P G+L D L + P + T ++ A+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A G++YL +K I+RDL N+L+GE K++DFGL++ G++ +V + MG
Sbjct: 129 ATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRL 180
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T KSDV+SFGV+L EI++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 74 DCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHP 126
LGEG FG+V K + VA+K L + + + + + E+ M+ ++ H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP----DKKRLDWTTR--------MR 174
N++NL+G C +V EY G+L D L P +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
A A+G+E+L K I+RDL N+L+ E + K++DFGLA+ D +T
Sbjct: 137 FAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV+L EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 65/313 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQV----------------VAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ + + + VA+K L + + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDL-----------PPDKKR 166
LS L PN++ L+G C D D ++ EYM G L L H L PP
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 167 L--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+++ + +A A G++YL ++ ++RDL N L+GE K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI-----------ITGRK 273
GD + R + + A E + G+ T SDV++FGV L EI +T +
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 274 AIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPN 333
I+N AGE F+D+ + + P Q GLY+ + C
Sbjct: 250 VIEN---AGE---------FFRDQGRQVYLFRPPPCPQ----GLYELM---LQCWSRDCR 290
Query: 334 MRPLIADVVTALT 346
RP +D+ LT
Sbjct: 291 ERPSFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 88/275 (32%), Positives = 120/275 (43%), Gaps = 41/275 (14%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY TN+VVA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL+DFG A K+ + +GT + APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310
Q K DV+S G+ +E+ + + N A +A Q PTLQ
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------QNDSPTLQS 242
Query: 311 QY---PVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
RG C+Q+ P RP A+++
Sbjct: 243 NEWTDSFRGFVD------YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAIKQ++ Q +E ++ E+L++ HPN+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P K + ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 43/286 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV------EVLMLSLLHHPNLV 129
L+GEG +G V K + + T Q+VAIK+ L+ + +V E+ ML L H NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDH--LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
NLI + LV+E++ DH L DL LD + + +G+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY 246
+ +I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPEL 171
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGR------KAIDN----TRAAGEHNLVAWARPLFK 295
+ ++ D+++ G ++ E++TG ID + G NL+ + +F+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG--NLIPRHQEIFQ 229
Query: 296 DRRKFSQMADPTLQGQYPVRGLY-----QALAVAAMCVQEQPNMRP 336
F+ M P ++ P+ + L +A C++ P+ RP
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 76/272 (27%), Positives = 116/272 (42%), Gaps = 38/272 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG+VY T +++A+K+ + N + +E E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
++ + EY G+LE+ L + LD +GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRV---MGTYGYCAPEYAMTG 250
++RD+K +NI L KL DFG A L + T + V GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKN--NTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 251 QLTLK---SDVYSFGVVLLEIITGRK---AIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304
+ +D++S G V+LE+ TG++ +DN H + A +P D + S
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-VGAGHKPPIPDSLQLSPEG 237
Query: 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336
L C++ P RP
Sbjct: 238 KDFLD----------------RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQL-------DRNGLQGNREFLVEVLMLSLLHHP 126
LGEG + VYK R + T ++VAIK++ ++G+ N L E+ +L L HP
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHP 62
Query: 127 NLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLHD-----LPPDKKRLDWTTRMRIAAGA 179
N++ L+ + + LV+E+M LE + D P D K T
Sbjct: 63 NIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-------- 111
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDK-TH-VSTRVM 236
+GLEYLH +++RDLK +N+L+ KL+DFGLA+ G K TH V TR
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW- 167
Query: 237 GTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G + E++
Sbjct: 168 ----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 8e-22
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLL-HHPNLVNL 131
+LG+G FG+V L+ + A+K L ++ + + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ V E++ G L H+ D K R D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK N++L H K++DFG+ K GD ++ GT Y APE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T D +SFGV+L E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 8e-22
Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLL-HHPNLV 129
+LG+G FG+V L+ T+++ A+K L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 130 NLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
L C RL V EY+ G L H+ R D AA GL++LH+
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE 114
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +IYRDLK N+LL EG H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-I 167
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGR 272
++ Q + D ++ GV+L E++ G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 9e-22
Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVY------------KGRLESTNQ----VVAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ K E+ N +VA+K L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH-------DLPPDKKRLDWTTR 172
LS L PN+ L+G C ++ EYM G L L L + K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ +A A G+ YL + ++RDL N L+G+ Y K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + A E + G+ T KSDV++FGV L EI+T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSL-LHHPNLVNL 131
+LG+G FG+V L+ TN+ AIK L ++ + + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 132 IGYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+C + V EY+ G L H+ R D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+IYRDLK N+LL + H K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
+ D +SFGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI-GYC 135
LG+G FG+VYK + + T A K + + +F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ +L+ E+ G+L+ + +L + ++ + R + + L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
VI+RDLK NILL KL+DFG++ + + +GT + APE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181
Query: 254 -----LKSDVYSFGVVLLEIITGR 272
K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 76/198 (38%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R TN+VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM-TG 250
I+RD+K NILL E KL+DFG A L + +GT + APE AM G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEI 268
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGY 134
LLG+G FG V+KG L+ V A+K + Q + +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C QR +Y M L D L L K L ++ A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RDL N L+GE K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 255 KSDVYSFGVVLLEIIT 270
+SDV+S+G++L E +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 70 NFRADCLLGEGGFGRVYKG---RLESTN--QVVAIKQLDRNGLQGN-REFLVEVLMLSLL 123
N LGEG FG+V K RL+ VA+K L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPD 163
+HP+++ L G C+ LL+ EY GSL L + PD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
++ L + A ++G++YL A +++RDL N+L+ EG K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
D ++ + A E T +SDV+SFGV+L EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 71/210 (33%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 76 LLGEGGFGRVYKG----RLESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVN 130
+LG G FG VYKG E+ VAIK L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD---KKRLDWTTRMRIAAGAAKGLEYLH 187
L+G C + LV + MP G L D++H+ + + L+W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++ +++RDL N+L+ H K++DFGLA+L +K + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRKAID 276
+ T +SDV+S+GV + E++T G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 77 LGEGGFGRVYKGRLEST-----NQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LGE FG+VYKG L T Q VAIK L D+ EF E +M S L HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAG 178
L+G +++ Y L + L P K L+ + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+E+L ++ V+++DL N+L+ + + K+SD GL + D + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ +PE M G+ ++ SD++S+GVVL E+ +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 80/263 (30%), Positives = 119/263 (45%), Gaps = 32/263 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG VYKG T +VVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G + ++ EY+ GS D L P L+ T I KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP-----LEETYIATILREILKGLDYLHSERK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 256 SDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY--P 313
+D++S G+ +E+ G + R LF + + PTL+GQY P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHP---------MRVLF----LIPKNSPPTLEGQYSKP 228
Query: 314 VRGLYQALAVAAMCVQEQPNMRP 336
+ +A C+ + P RP
Sbjct: 229 FKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 64/252 (25%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLV----EVLMLSLLHHPNLVNL 131
+GEG +G+VYK R + T ++VA+K++ L +E F + E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 132 IGYCADGDQRL----------LVYEYMP---LGSLEDHLHDLPPD------KKRLDWTTR 172
D L LV+EYM +G LE L D K+ L+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
GL Y H K ++RD+KCSNILL KL+DFGLA+L + +
Sbjct: 128 ---------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291
+V+ T Y PE + + + DV+S G +L E+ T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-------------------KK 215
Query: 292 PLFKDRRKFSQM 303
P+F+ ++ +Q+
Sbjct: 216 PIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 29/272 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G+ + +V AIK + G +F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V E+M G L L+ L + +L + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 255
RDL N L+ K+SDFG+ + V D + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 256 SDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPV 314
SDV+SFGV++ E+ T G+ + +++ L++ P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------PKLASMT-- 229
Query: 315 RGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346
+Y+ V C E+P RP A+++ A+T
Sbjct: 230 --VYE---VMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 77 LGEGGFGRVY------------KGRLESTNQ--VVAIKQLDRNGLQGNR-EFLVEVLMLS 121
LGEG FG V+ +G E Q +VA+K L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKK--------RLDWTTRM 173
L +PN++ L+G C D ++ EYM G L L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 174 RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233
+A A G++YL A+ ++RDL N L+G Y K++DFG+++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + + A E + G+ T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 77 LGEGGFGRVYKGR---LESTNQV--VAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V + L ++ V VA+K L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYL 186
NL+G C G L++ EY G L + L +KR L + + AKG+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR-----RKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCA 243
K I+RDL N+LL G K+ DFGLA+ + D +V + R+ + A
Sbjct: 158 ASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMA 211
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE T +SDV+S+G++L EI +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-21
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVN 130
+LGEG FG V +G+L + + VA+K + + + EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 131 LIGYCADGDQR------LLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGA 179
LIG C + +++ +M G L L LP ++L T ++
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---EKLPLQTLLKFMVDI 122
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVM 236
A G+EYL +N I+RDL N +L E ++DFGL+K GD + ++ +
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T KSDV++FGV + EI T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 7e-21
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVYKGRLE--------------STNQ--VVAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ E S NQ +VA+K L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLP-----PDKKRLDWTTR 172
+S L PN++ L+ C D ++ EYM G L L H+ D + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ +A A G++YL ++ ++RDL N L+G+ Y K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + + + E + G+ T SDV++FGV L EI+T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEG FG V +G E T Q VA+K + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V E M G+L + L + + ++ + A+G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVG-DKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDL NIL+ E K+SDFGLA++G +G D + + + + APE + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+S+GV+L E+ + GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 9e-21
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 27/202 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R +T ++VAIK L+ + E + E+ ML HPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D+ +V EY GSL+D P + ++ + R KGL YLH+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHETG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYA- 247
I+RD+K +NILL E KL+DFG++ T + +GT + APE A
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 248 --MTGQLTLKSDVYSFGVVLLE 267
G K D+++ G+ +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G ++ +V A+K L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L + ++ + +A A+G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 254
RDL+ +N+L+ E K++DFGLA+ V + + R + + APE G T+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 255 KSDVYSFGVVLLEIIT 270
KSDV+SFG++L EI+T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 77 LGEGGFGRV----YKGRLESTNQVVAIKQLD-RNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V Y ++T + VA+K L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C + L+ E++P GSL+++L P +K +++ +++ A KG++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYA 247
++RDL N+L+ + K+ DFGL K DK + + + + + APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ + + SDV+SFGV L E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+GEG G V+K + T + VA+K++ L+G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDL-----PPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G +LV EYMP L + L D K RM + KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY---MRMLL-----KGVAYMHAN 118
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++RDLK +N+L+ K++DFGLA+L + S +V T Y APE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 250 GQ-LTLKSDVYSFGVVLLEIITGR 272
+ D+++ G + E++ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHH 125
F+ +LG G FG VYKG E VAIK+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKG 182
P++ L+G C +L + + MP G L D++ D + L+W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ YL ++ +++RDL N+L+ H K++DFGLAKL +K + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281
A E + T +SDV+S+GV + E++T G K D A+
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 71/271 (26%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG+G FG R + +V K+++ L + R+ L E+++LSLL HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + L+ EY G+L D + + + + + + Y+H KA +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH-KAG--I 122
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RD+K NI L + KL DFG++K+ +G + ++ V+GT Y +PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 255 KSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY-P 313
KSD+++ G VL E++T ++ D T N + +QG Y P
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT------NP--------------LNLVVKIVQGNYTP 220
Query: 314 VRGLYQA--LAVAAMCVQEQPNMRPLIADVV 342
V +Y + +++ +Q+ P RP +V+
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 73/213 (34%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V K R+ + AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHD---LPPD---------KKRLDWTTRMRIAAGA 179
+G C L EY P G+L D L L D L + AA
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G++YL K I+RDL NIL+GE Y K++DFGL++ G + +V + MG
Sbjct: 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 185
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T SDV+S+GV+L EI++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-20
Identities = 68/209 (32%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG- 133
++GEG +G+VYK R + T Q+VAIK +D E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 134 -----YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ DQ LV E GS+ D + L KRL I +GL YLH+
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
VI+RD+K NILL + KL DFG+ A+L + + GT + APE
Sbjct: 132 NK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEVI 185
Query: 246 ---YAMTGQLTLKSDVYSFGVVLLEIITG 271
+SDV+S G+ +E+ G
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-20
Identities = 77/263 (29%), Positives = 121/263 (46%), Gaps = 32/263 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG V+KG T +VVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ ++ EY+ GS D L P LD T I KGL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSEKK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 256 SDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY--P 313
+D++S G+ +E+ + H+ + + LF + PTL+G Y P
Sbjct: 182 ADIWSLGITAIEL---------AKGEPPHSELHPMKVLF----LIPKNNPPTLEGNYSKP 228
Query: 314 VRGLYQALAVAAMCVQEQPNMRP 336
++ +A C+ ++P+ RP
Sbjct: 229 LKEFVEA------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-20
Identities = 72/210 (34%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L + GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL DFG A + + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
Q K DV+S G+ +E+ + + N A
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLH-HPNLVNL 131
+LG+G FG+V RL+ + ++ A+K L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 132 IGYCADGDQRLL-VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
C RL V E++ G L H+ +R D AA L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK N+LL H KL+DFG+ K G KT ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D ++ GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 4e-20
Identities = 74/210 (35%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R TN+VVAIK++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL+DFG A + + +GT + APE + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
Q K DV+S G+ +E+ + + N A
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 62/224 (27%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF--------LVEVLML-SLLHHPN 127
LG+G FG VY R + T ++VAIK++ ++F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------ 181
+V L + D+ V+EYM E +L+ L K R + +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLM--KDR----KGKPFSESVIRSIIYQI 108
Query: 182 --GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----THVSTRV 235
GL ++H K +RDLK N+L+ K++DFGLA+ + + +VSTR
Sbjct: 109 LQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR- 162
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYS-------FGVVLLEIITGR 272
Y APE + L+S YS G ++ E+ T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 76 LLGEGGFGRVYKGRL----ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVN 130
+LG G FG VYKG E+ VAIK L N + N+E L E +++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L+G C +L V + MP G L D++ + +K R+ + AKG+ YL +
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDL N+L+ H K++DFGLA+L + + + + + A E +
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 251 QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280
+ T +SDV+S+GV + E++T G K D A
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 68/197 (34%), Positives = 110/197 (55%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G V+ +T Q VAIKQ++ Q +E ++ E+L++ L +PN+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH AN VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA-----LEFLH--AN-QVI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K N+LLG KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-19
Identities = 65/197 (32%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAI+Q++ Q +E ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 138
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P K + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E+I G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNLIGYC 135
G FG VY + ST AIK L ++ + + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 136 ADGDQRLLVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D LV EY+ SL L LP DW + A G+E LH +
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLP-----EDWAKQY--IAEVVLGVEDLHQRG-- 117
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+I+RD+K N+L+ + H KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGD 170
Query: 253 TLKSDVYSFGVVLLEIITG 271
SD +S G V+ E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLD---RNGLQGNREFLV---EVLMLSLLHHPNLV 129
+LG+G +G VY G L + Q++A+KQ++ N L +E+ EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+G C D + + E++P GS+ L+ P L + G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNN 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK----LGPVGDKTHVSTRVMGTYGYCAPE 245
V++RD+K +N++L KL DFG A+ +G G +++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277
KSD++S G + E+ TG+ + +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
+ +G G FGRV+ R + A+K + + L+ + E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 127 NLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
++ L + + DQR L + EY+P G L +L + R +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALE 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH K ++YRDLK NILL + H KL+DFG AK + D+T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITG 271
E + D ++ G+++ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHPN 127
LG G FG V+ + E +V +K L LQ EF E+ M L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGAAKG 182
+V L+G C + + ++ EY LG L+ L D L ++ + A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+++L +N ++RDL N L+ K+S L+K + + + +
Sbjct: 130 MDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWL 185
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
APE + KSDV+SFGV++ E+ T
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-19
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVL-----MLSLLHHPNL 128
LG G F Y+ R T ++A+KQ+ RN +E +VE L +++ L+HP++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 129 VNLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ ++G C D L V E+M GS+ L K+ + ++ +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH 120
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLA-KLGPVGDKT-HVSTRVMGTYGYCAP 244
+ +I+RD+K +N+L+ G +++DFG A +L G +++GT + AP
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E Q DV+S G V++E+ T +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 66/197 (33%), Positives = 107/197 (54%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAIKQ++ Q +E ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LDFLHSNQ---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 42/220 (19%)
Query: 79 EGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-F----LVEVLMLSLLHHPNLVNL-- 131
EG +G VY+ R + T ++VA+K+L ++ +E F L E+ +L L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GL 183
+ ++ D+ +V EY+ HDL K L T + K G+
Sbjct: 72 VVVGSNLDKIYMVMEYVE--------HDL----KSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
+LHD +++RDLK SN+LL K+ DFGLA+ G T+++ T Y A
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRA 174
Query: 244 PEYAM-TGQLTLKSDVYSFGVVLLEIIT------GRKAID 276
PE + + + D++S G + E++T G+ ID
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VY+ R ++ ++VA+K++ +R+G+ + L E+ +L L HPN+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVELK 72
Query: 133 GYCADG--DQRLLVYEY--MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
D LV EY L SL D++ + + ++ +GL+YLH+
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQL------LRGLQYLHE 126
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--Y 246
+I+RDLK SN+LL + K++DFGLA+ G T + T Y APE
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
T T D+++ G +L E++ +
Sbjct: 182 GCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ V AIK + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EYM G L ++L + KR + + + +G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ + K+SDFGL++ V D + S+ +G+ + PE + + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 254 LKSDVYSFGVVLLEIIT 270
KSDV++FGV++ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 11/196 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG V+KG T QVVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G + ++ EY+ GS D L P D+ ++ + + KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSEKK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 256 SDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNL 131
++G G FG V++G L+ + VAIK L + R +FL E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G +++ EYM G+L+ +L D + +R G A G++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAM 248
++RDL NIL+ K+SDFGL+++ P G T ++ + APE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
+ T SDV+SFG+V+ E+++
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G VYKGR + T Q+VA+K++ L+ E + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ L++E++ + L+ +L LP + +D +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V++RDLK N+L+ KL+DFGLA+ G V T + T Y APE +
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 252 L-TLKSDVYSFGVVLLEIITGR 272
+ D++S G + E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 73/221 (33%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH---PNLV 129
++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
+ D+ + + M G L HL H + +K+ MR A GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE-------MRFYATEIILGLEHM 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H++ V+YRDLK +NILL E H ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
G S D +S G +L +++ G + +H +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQG---NREFLV----EVLMLSLLHHP 126
L+G G FG VY G S+ +++A+KQ L R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+V +G D D + EY+P GS+ L++ ++ L +I KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI----LKGLNYL 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-----LGPVGDKTHVSTRVMGTYGY 241
H++ +I+RD+K +NIL+ K+SDFG++K + + G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE T K+D++S G +++E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLE 184
+V+L D LV M G L+ H++++ D++R + AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLE 116
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
LH + ++YRDLK NILL + H ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + T D + G ++ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++++T ++ A K+LD+ L+ G + L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 134 YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
Y + L LV M G L+ H++++ ++ L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
++YRD+K N+LL + + +LSD GLA G T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 253 TLKSDVYSFGVVLLEIITGR 272
+ D ++ G + E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQV---VAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
+GEG FG VY+G S VA+K RE FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + + +V E PLG L +L +K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTG 250
++RD+ N+L+ KL DFGL++ + D+++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 251 QLTLKSDVYSFGVVLLEII 269
+ T SDV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG+G FGRVY T + +A+KQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 125 HPNLVNLIGYCADGDQRLLVY-EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
H +V G C D+ L ++ EYMP GS++D L L T + +G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGV 117
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYC 242
EYLH +++RD+K +NIL + KL DFG +K L + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+PE K+DV+S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-18
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G +G VY R ST +AIK++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
++ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ- 128
Query: 192 PPVIYRDLKCSNILLGEGYHP--KLSDFG----LAKLGPVGDKTHVSTRVMGTYGYCAPE 245
+++RD+K N+L+ Y K+SDFG LA + P + GT Y APE
Sbjct: 129 --IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPE 179
Query: 246 YAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
G +D++S G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 69/211 (32%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM---LSLLHH--PNLVN 130
+G G G+VYK R + T V+A+KQ+ R G N+E +LM + L H P +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI----AAGAAKGLEYL 186
GY + E M + D L KR+ I K L YL
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKL------LKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPE 245
+K VI+RD+K SNILL + KL DFG++ +L V K TR G Y APE
Sbjct: 131 KEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYMAPE 184
Query: 246 Y----AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ +++DV+S G+ L+E+ TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 77/292 (26%), Positives = 129/292 (44%), Gaps = 42/292 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHH---PN 127
L+G G +G VY+G+ T +VVA+K ++ + + V EV +LS L PN
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ G G + ++ EY GS+ + P +K + R + A L+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
VI+RD+K +NIL+ + KL DFG+A L + + + +GT + APE
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVI 173
Query: 248 MTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306
G+ K+D++S G+ + E+ TG + A L+ ++P P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------P 220
Query: 307 TLQGQYPVRGLYQALA-VAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357
L+ G + L A C+ E+P R L A+ + ++ P S
Sbjct: 221 RLED----NGYSKLLREFVAACLDEEPKER-LSAEELLKSKWIKAHSKTPVS 267
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 73/232 (31%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L H+ + K+ + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE----PHAVFYAAEIAIGLFFLHSKG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTG 250
+IYRDLK N++L H K++DFG+ K G KT TR GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQ 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNT------RAAGEHNLVAWARPLFKD 296
D ++FGV+L E++ G+ D ++ EHN V++ + L K+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 25/198 (12%)
Query: 93 TNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYM 148
T VAIK L + + + F E + + L+HPN+V L+ L V+EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 149 PLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205
P +L + L LP R+ L H++ +++RDLK NI+
Sbjct: 62 PGRTLREVLAADGALPAG-------ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 206 L---GEGYHPKLSDFGLAKLGP-VGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 257
+ G H K+ DFG+ L P V D +T V+GT YCAPE +T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 258 VYSFGVVLLEIITGRKAI 275
+Y++G++ LE +TG++ +
Sbjct: 172 LYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 76 LLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVN 130
++G G FG V +GRL+ VAIK L ++G + R+FL E ++ HPN+++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G +++ E+M G+L+ L + + + + G A G++YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPEYA 247
++RDL NIL+ K+SDFGL++ T +G + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306
+ T SDV+S+G+V+ E+++ G + + N + +D R M P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE------QDYRLPPPMDCP 237
Query: 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
T L+Q + C Q+ N RP +V+ L
Sbjct: 238 TA--------LHQLM---LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 72/206 (34%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH---PNLV 129
++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
+ D+ + + M G L HL H + + + MR AA GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHM 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H++ V+YRDLK +NILL E H ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITG 271
G S D +S G +L +++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G V +ST + VA+K++D Q RE L EV+++ HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V E++ G+L D + R++ + K L +LH + VI
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQG---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 256 SDVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 196 VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 43/287 (14%)
Query: 77 LGEGGFGRVY--------KGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPN 127
LG+G FG VY KG E+ VA+K ++ + L+ EFL E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR---VAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKK----RLDWTTR--MRIAAGAAK 181
+V L+G + G L+V E M G L+ +L L P+ + R T + +++AA A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+ YL+ K ++RDL N ++ + K+ DFG+ + D + + +
Sbjct: 131 GMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
APE G T SD++SFGVVL EI + + G N
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSN---------------E 228
Query: 302 QMADPTLQGQY---PVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
Q+ + G Y P + + MC Q P MRP ++V L
Sbjct: 229 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++ +T ++ A K+L++ L +G +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV M G L H++++ + A GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+IYRDLK N+LL + ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
D ++ GV L E+I R RA GE
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF---RARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG FG++Y + +S ++ IK++D + ++ EV++L+ + HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ + +V EY G L ++ L + + L W ++ + GL+++HD+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDRK 121
Query: 191 NPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++RD+K NI L + G KL DFG+A+ + D ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 250 GQLTLKSDVYSFGVVLLEIIT 270
K+D++S G VL E+ T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV + + T + AIK L + ++ + E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
D ++ + E++ G L HL P D + A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------YHAELVLAFEYLHSKD 138
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK N+LL H K++DFG AK V D+T + GT Y APE +
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSK 190
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D ++ GV+L E I G
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKGR +T ++VA+K++ + +G + E+ ++ L H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
++ +LV+EYM L+ ++ D + LD T KG+ + H+ V+
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RDLK N+L+ + KL+DFGLA+ + T + V T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYST 180
Query: 256 S-DVYSFGVVLLEIITGR 272
S D++S G ++ E+ITGR
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHH 125
+ + ++G G FG V GRL+ + VAIK L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGL 183
PN+++L G ++V EYM GSL+ L HD + + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGM 119
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYG 240
+YL D ++RDL NIL+ K+SDFGL+++ + D + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE + T SDV+S+G+V+ E+++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +YRDLK NILL + H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ TL D + G ++ E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + VAIK ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR------LDWTTRMRIAAGAAKGLE 184
L+G + G L++ E M G L+ +L L P+ + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YL+ AN ++RDL N ++ E + K+ DFG+ + D + + + +P
Sbjct: 134 YLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E G T SDV+SFGVVL EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSL-LHHPNLVNL 131
+LG+G FG+V L+ T++V AIK L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D+ V EY+ G L + ++ D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
VIYRDLK NILL H KL+DFG+ K G + T +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D ++ GV++ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 76/228 (33%), Positives = 107/228 (46%), Gaps = 44/228 (19%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL-D--RNGLQGNREFLVEVLMLS-L 122
+ + + LG+G +G V+K T +VVA+K++ D RN R F E++ L L
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQEL 63
Query: 123 LHHPNLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLHD------LPPDKKRLDWTTRMR 174
HPN+V L+ A+ D+ + LV+EYM E LH L KR
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY------- 111
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHV 231
I K L+Y+H N VI+RDLK SNILL KL+DFGLA+ + V
Sbjct: 112 IMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
T + T Y APE + L S Y+ GV +L E++ G+
Sbjct: 169 LTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-LSLLHH---PNLVNLI 132
LG G G V K + T V+A K + + ++L L ++H P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 133 G-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G + + + + E+M GSL+ P + +IA +GL YL++
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RD+K SNIL+ KL DFG++ G + + ++ +GT Y +PE G+
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGK 178
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T+KSDV+S G+ ++E+ G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLH 124
NF+ + +G+G F VYK +VVA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD----WTTRMRIAAGAA 180
HPN++ + + ++ +V E G L + K+ + W +++ +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS--- 117
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE++H K +++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 118 -ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPY 171
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300
Y +PE KSD++S G +L E+ A+ + + NL + L K K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYS----LCK---KI 220
Query: 301 SQMADPTLQGQY---PVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+ P L + +R L + C+ P RP I+ V
Sbjct: 221 EKCDYPPLPADHYSEELRDL------VSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-17
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +AN +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FV 124
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RDL N+L+ E K+SDFGL K D + + + APE + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 255 KSDVYSFGVVLLEIIT-GR 272
KSDV+SFG++L EI + GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------FLVEVLMLSLLHH 125
L+G+G +GRVY +T +++A+KQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLE 184
N+V +G+ + + EY+P GS+ L +++ + + T + +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH K +++RDLK N+L+ K+SDFG++K + + G+ + AP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 245 EYAMTGQ--LTLKSDVYSFGVVLLEIITGRK 273
E + + K D++S G V+LE+ GR+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 22/232 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L H+ + K+ + AA + GL +LH +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISVGLFFLHRRG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTG 250
+IYRDLK N++L H K++DFG+ K V V+TR GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNT------RAAGEHNLVAWARPLFKD 296
D +++GV+L E++ G+ D ++ EHN V++ + L K+
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 72/229 (31%), Positives = 95/229 (41%), Gaps = 39/229 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL----MLSLLHHPNLVNL 131
LLG+G GRV+ RL+ T ++ A+K LD+ + R + VL +L+ L HP L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
LV +Y P G L L P K L AA LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG- 123
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-------------------- 231
++YRDLK NILL E H LSDF L+K V
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 232 ----STRVM---GTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
S R GT Y APE ++G D ++ G++L E++ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 38/288 (13%)
Query: 77 LGEGGFGRVYKG---RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG+V G R S +VV +K+L FL EV L+HPN++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHD------LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
G C + LLV E+ PLG L+++L K R+A A GL +L
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-----VLQRMACEVASGLLWL 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H +A+ I+ DL N L K+ D+GLA D + APE
Sbjct: 117 H-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 247 A-------MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299
+ T KS+++S GV + E+ T + + + + + +++
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVREQD- 227
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347
++ P L +Y R Y+ + + P RP +V LTY
Sbjct: 228 -IKLPKPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKG--RLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIG 133
LG G FG V KG ++ VAIK L + R E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
C + + +LV E G L L K + + + + + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMTG 250
++RDL N+LL ++ K+SDFGL+K LG D ++ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 251 QLTLKSDVYSFGVVLLE 267
+ + +SDV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V+L D LV M G L+ H++ + + + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ ++YRDLK NILL + H ++SD GLA P G + RV GT GY APE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D ++ G +L E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 77 LGEGGFGRVYKG--RLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG +++ + + VA+K L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L L K + + + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMT 249
++RDL N+LL ++ K+SDFGL+K LG D+ + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 250 GQLTLKSDVYSFGVVLLE 267
+ + KSDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQLD-----RNGLQGNREFLVEVLMLSLLHHPNLV 129
LGEG FG V +G+L + + VA+K + R+ ++ +FL E + + HPN++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 130 NLIGYCADGDQR------LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAK 181
LIG C + +++ +M G L L L + L ++ A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+EYL K+ I+RDL N +L E + ++DFGL+K GD +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T KSDV+SFGV + EI T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ + + LG G FG V+ +V A+K + + G FL E ++ L H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + ++ E+M GSL D L K+ L + +A A+G+ ++
Sbjct: 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ 120
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ I+RDL+ +NIL+ K++DFGLA++ + D + + + APE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
G T+KSDV+SFG++L+EI+T GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQV--VAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPN 127
LGEG FG+V E N+V VA+K L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 236 MGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T G + APE T +SDV+SFGV+L EI T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVE-VLMLSLLHHPNLVNLI 132
+G+G FG+V + ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSLN- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK NILL H L+DFGL K G KT ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 252 LTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK R + T +VVA+K+ LD + E+ +L L+HPN+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLEYL 186
++ LV+E++ DL KK +D + I K GL +
Sbjct: 68 IHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H V++RDLK N+L+ KL+DFGLA+ V +T+ V T Y APE
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 247 AMTGQL-TLKSDVYSFGVVLLEIITGRKAI 275
+ + + D++S G + E++T R+A+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V+L D LV M G L+ H++++ D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ ++YRDLK NILL + H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D + G ++ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
++GEG FGR + +++Q A+K++ + ++ +R+ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 132 I-GYCADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ ADG +V EY G L + L P+ L W +M + G++++
Sbjct: 64 KESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H+K V++RD+K NI L + KL DFG A+L + + +GT Y PE
Sbjct: 117 HEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEI 171
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
KSD++S G +L E+ T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGR---LESTNQ----VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V + ++ + VA+K L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLH-------DLPPD-----KKRLDWTTRMRI 175
++NL+G C ++ EY G+L + L D D +++L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL + I+RDL N+L+ E K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFG+++ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRD+K N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQ--VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V + N+ VA+K L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV+L EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGY 134
L+G G +G+VYKGR T Q+ AIK +D G + E E+ ML HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 135 CAD------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
DQ LV E+ GS+ D + + + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQ 129
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 245
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 181
Query: 246 YAMTGQ-----LTLKSDVYSFGVVLLEIITG 271
+ KSD++S G+ +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ----LDRNGLQGN--REFLVEVL-MLSLLHHPNL 128
+GEG +G VYK R +T + VA+K+ L G+ + RE + +L L HPN+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNI 63
Query: 129 VNLIGYCA--DGDQRL---LVYEYMP--LGSLEDHLHD--LPPDK-KRLDWTTRMRIAAG 178
V L+ C D+ L LV+E++ L + LPP+ K L
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL------- 116
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
+G+++LH +++RDLK NIL+ K++DFGLA+ + T V+ T
Sbjct: 117 -LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVT 169
Query: 239 YGYCAPEYAMTGQLTLKS--DVYSFGVVLLEI 268
Y APE + Q + + D++S G + E+
Sbjct: 170 LWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R +T ++ AIK + L+ +F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D+ + E+ GSL+D H P + ++ + +R + +GL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--- 249
++RD+K +NILL + H KL+DFG++ + +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 250 GQLTLKSDVYSFGVVLLEI 268
G D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ----LDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G +G VYK T +A+K+ LD + + ++E+ +L P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + EYM GSL D L+ + + RI KGL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY----A 247
+I+RD+K +N+L+ KL DFG++ L KT++ G Y APE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 248 MTGQLT--LKSDVYSFGVVLLEIITGR 272
T ++SDV+S G+ +LE+ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 66/232 (28%), Positives = 92/232 (39%), Gaps = 49/232 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----FLVEVLMLSLLHHPNLVNL 131
++G G FG V+ R + T QV A+K L R R E +L+ P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 132 IGYCADGDQRLL--VYEYMPLGSLEDHL---HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
Y + D+ L V EYMP G L + L P + R + + +A + L ++
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-YIAELVLALDSVHKLGFI 123
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT----------------- 229
H RD+K NIL+ H KL+DFGL K
Sbjct: 124 H---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 230 -----HVSTRVM-----GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
H RV GT Y APE L+ D +S GV+L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V ++ VA+K L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++ + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV++ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQ-VVAIKQLDRNGL---QGNRE-------FLVEVLML-SLL 123
LG G FG VYK R ++ Q ++A+K+++ + + RE + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
HPN+V + D+ +V + + L +H + L K+R I L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
YLH + +++RDL +NI+LGE ++DFGLAK K T V+GT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE K+DV++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R +++ + A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY+ G L HL ++R+ R R A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF-LVEV---LMLSLLHHPNLVNL 131
++G G + +V L+ T ++ A+K + + + + + V+ + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 132 IGYCADGDQRL-LVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C + RL V E++ G L H+ LP + R +A + L +LH
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNFLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPE 245
++ +IYRDLK N+LL H KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPE 166
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
D ++ GV++ E++ GR D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 63/282 (22%), Positives = 119/282 (42%), Gaps = 36/282 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
NF+ + +G G F VY+ + VA+K++ + + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N++ + + ++ +V E G L + K+ + T + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-------RK 299
KSD++S G +L E + A P + D+ +K
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLFSLCQK 219
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
Q P L ++ L + + +MC+ P+ RP I V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRE---LVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V + ++T + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A L+YLH + N
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNL 131
++G G + +V RL+ T ++ A+K + + + + + + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 132 IGYCADGDQRLL-VYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C + RL V EY+ G L H+ LP + R +A + L YLH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNYLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEY 246
++ +IYRDLK N+LL H KL+D+G+ K G GD T + GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEI 167
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
D ++ GV++ E++ GR D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 67/201 (33%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALGYLHSCD- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---------LVEVLMLSLLHHP 126
+G G +G V + T + VAIK++ + F L E+ +L L H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 127 NLVNLIGYCADGDQR-----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-IAAGAA 180
N++ L+ +V E M E LH + + L ++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQIL 113
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-----PVGDKT-HVSTR 234
+GL+YLH AN VI+RDLK SNIL+ K+ DFGLA+ G T +V TR
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 235 VMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
Y APE ++ T D++S G + E++T +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIG-YC 135
LG+G FG+VYK + + T + A K ++ + +++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
DG +++ E+ P G+++ + +L D+ + ++ I + L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICRQMLEALQYLHSMK---II 132
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-- 253
+RDLK N+LL KL+DFG++ + S +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 254 ---LKSDVYSFGVVLLEI 268
K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNL 131
++G G + +V RL+ +Q+ A+K + + + + + + + +P LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 132 IGYCADGDQRL-LVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C RL LV EY+ G L H+ LP + R AA L +LH
Sbjct: 62 HS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-------YAAEICIALNFLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPE 245
++ +IYRDLK N+LL H KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPE 166
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
+ D ++ GV++ E++ GR D
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 64 LAAVTKNFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNG--LQGNREFLVEV 117
+A LL EG FGR++ G L + V +K + + +Q L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQES 59
Query: 118 LMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSLEDHLHD--LPPDKKRLDWTTR-- 172
+L L H N++ ++ C DG+ ++Y YM G+L+ L L +T+
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGP-----VG 226
+ +A A G+ YLH + VI++D+ N ++ E K++D L++ L P +G
Sbjct: 120 VHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
D + + M A E + + + SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQL--------DRNGLQGNREFLVEVLMLSLLH 124
+LG+G FG+V+ K Q+ A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 125 HPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTR--MRIAAGAAK 181
HP +V L Y + +L L+ +++ G L L K + +T A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELAL 109
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L++LH +IYRDLK NILL E H KL+DFGL+K +K S GT Y
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
APE T +D +SFGV++ E++TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEG G V + T + VA+K++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
GD+ +V E++ G+L D + R++ + + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 257 DVYSFGVVLLEIITG 271
D++S G++++E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 8e-15
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLSL 122
+F LG G G V K + ++A IK RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 123 LHHPNLVNLIGY----CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
LH N ++G+ +DG+ + + E+M GSL+ L R+ +I+
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKA----GRIPENILGKISIA 107
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
+GL YL +K +++RD+K SNIL+ KL DFG++ G + D ++ +GT
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 161
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275
Y +PE T++SD++S G+ L+E+ GR I
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 35/218 (16%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNL 131
L+ G +G VY R + T Q A+K++++ L Q + F VE +L+ +P +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 132 IGYCADGDQRLL--VYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+C+ +R L V EY+ G +L ++ LP D R+ + A LEYL
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF-------AETVLALEYL 117
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-------STR----- 234
H N +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 235 -VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
V GT Y APE + D ++ G++L E + G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGY 134
++G G +G+VYKGR T Q+ AIK +D + E +E+ ML HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 135 ------CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
DQ LV E+ GS+ D + + + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHA 139
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 245
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 191
Query: 246 YAMTGQ-----LTLKSDVYSFGVVLLEIITG 271
+ +SD++S G+ +E+ G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+GEG FG+ + + + IK+++ + + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ +V +Y G L ++ L P+ + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RD+K NI L + KL DFG+A++ + ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
KSD+++ G VL E+ T + A + A NLV
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEG G V ++S+ ++VA+K++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
GD+ +V E++ G+L D + R++ + K L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 257 DVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+VYK + + T + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
+ ++ E+ G+++ + +L P + ++ + + A L YLH+ +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA-----LNYLHENK---I 124
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYAMTGQ 251
I+RDLK NIL KL+DFG++ T R +GT + APE M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 252 -----LTLKSDVYSFGVVLLEI 268
K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 36/282 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
NFR + +G G F VY+ VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N++ + ++ +V E G L + K+ + T + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-------RK 299
KSD++S G +L E + A P + D+ +K
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLCKK 219
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
Q P L + L Q + MC+ P RP I V
Sbjct: 220 IEQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 43/215 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G VYK R + T ++VA+K++ L+ E + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 132 --IGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------- 181
+ + + +L LV+E++ L DL KK +D + + K
Sbjct: 64 LDVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LG-PVGDKTHVSTRVMGT 238
G+ Y H V++RDLK N+L+ KL+DFGLA+ G PV TH V+ T
Sbjct: 110 QGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-T 162
Query: 239 YGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
Y APE + Q + D++S G + E++ R
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG+G FGRVY T + +A+KQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 125 HPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
H +V G D +R L E+MP GS++D L + + TR + +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TR-KYTRQILEG 118
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVM 236
+ YLH +++RD+K +NIL + KL DFG +K L G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT + +PE K+D++S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 69/234 (29%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L + + R + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+IYRDLK N++L H K++DFG+ K V KT GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-----GTPDYIAPEIIA 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNT------RAAGEHNLVAWARPLFKD 296
D ++FGV+L E++ G+ + ++ EHN VA+ + + K+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 70/236 (29%), Positives = 108/236 (45%), Gaps = 28/236 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIG 133
+G+GG+G+V+ + + T ++VA+K++ ++ L R L E +L+ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 134 YCADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
D + L EY+P G +L ++L L D R + M A A L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGYIH--- 124
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
RDLK N L+ H KL+DFGL+K G T+ ++ V+G+ Y APE
Sbjct: 125 ------RDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRGK 173
Query: 251 QLTLKSDVYSFGVVLLEIITGRK--AIDNTRAAGEHNLVAWA----RPLFKDRRKF 300
D +S G +L E + G + E NL W RP++ D R
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----REFLVEVLMLSLLHHPNLVNL 131
L+G+GG G VY ++ VA+K++ R L N + FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 132 IGYCADGDQRLLVYEYMP------LGSLEDHLHDLPPDKKRLDWTTR----MRIAAGAAK 181
C+DGD VY MP L SL + K L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-------------KLGPVGDK 228
+EY+H K V++RDLK NILLG + D+G A +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 229 THVST---RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T +++GT Y APE + + +D+Y+ GV+L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---------GNREFLVEVLMLSLLHHPN 127
+G+G FG+VY+ R + T ++ A+K L + + G R LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE---SPF 57
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+V L LV +YM G L HL + + R + + A LE+L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA-----LEHL 112
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H ++YRDLK NILL H L DFGL+K +KT + GT Y APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEV 167
Query: 247 AMTGQ-LTLKSDVYSFGVVLLEIITG 271
+ + T D +S GV++ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 76 LLGEGGFGRVYKGRLESTN---QVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
+LG+G FG V + +L+S + Q VA+K L D EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 131 LIGYC--ADGDQRL----LVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKG 182
LIG + RL ++ +M G L L + + L T +R A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+EYL K I+RDL N +L E ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T SDV++FGV + EI+T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 77 LGEGGFGRVYKGRLES---TNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG+V G + S QVV +K+L + +Q +FL E L H NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + LLV E+ PLG L+ +L + D TT R+A A GL +LH K N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNN 120
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA--MT 249
I+ DL N LL K+ D+GL+ D ++ + APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 250 GQL-----TLKSDVYSFGVVLLEI 268
G L T +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFL--VEVLMLSLLHHPNLVNLI 132
+G G FG V K + + ++A+K++ + + L ++V+M S P +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFY 69
Query: 133 GYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAGAAKGLEYLHDK 189
G +GD + E M + SL D + + + + +IA K L YL K
Sbjct: 70 GALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--K 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+I+RD+K SNILL + KL DFG++ G + D TR G Y APE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPERIDP 181
Query: 250 GQLT---LKSDVYSFGVVLLEIITGR 272
++SDV+S G+ L E+ TG+
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK----QLDRNGLQGNREFLVEVLMLSLLH---HPNLV 129
+G G +G VYK R + VA+K Q + +GL + + EV +L L HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREVALLKRLEAFDHPNIV 65
Query: 130 NLIGYCADG--DQRL---LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
L+ CA D+ LV+E++ L +L +PP + T + +GL+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLD 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS-TRVMGTYGYCA 243
+LH +++RDLK NIL+ G KL+DFGLA++ ++ T V+ T Y A
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRA 175
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEI 268
PE + D++S G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 70/225 (31%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 77 LGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL----QGNR---EFLVEVLMLSLLHHPN 127
LG+G F +YKG L +S +V Q L +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
LV L G C D+ ++V EY+ G L+ LH + L W ++ +A A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 188 DKANPPVIYRDLKCSNILL-----GEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
DK +++ ++ NIL+ EGY P KLSD G+ V + R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 241 YCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
+ APE GQ LT+ +D +SFG LLEI + + +T ++ E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRN-GLQGNREFLVE--VLMLSLLHHPNLVNLIG 133
LG G +G V K R T ++A+K++ Q + L++ + M S+ P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 134 YC-ADGDQRLLVYEYMPL--GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+GD V+ M + SL+ + + +IA K LEYLH K
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY---A 247
+ VI+RD+K SN+L+ KL DFG++ G + D T G Y APE
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTIDAGCKPYMAPERINPE 178
Query: 248 MTGQ-LTLKSDVYSFGVVLLEIITGRKAIDN 277
+ + +KSDV+S G+ ++E+ TGR D+
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-----REFLVEVLMLSLLHHPNLV 129
LGEG + VYKGR + T Q+VA+K++ +G RE +L L H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66
Query: 130 NLIGYCADGDQRLLVYEYM--PLGS-LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L LV+EY+ L ++D L RL +R GL Y
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYC 119
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174
Query: 247 AM-TGQLTLKSDVYSFGVVLLEIITGR 272
+ + + + D++ G + E+ TGR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNRE----FLVEVLMLSLLHHPNL 128
+LG+GG+G+V++ R T ++ A+K L + + N++ E +L + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V+LI G + L+ EY+ G L HL + ++ T ++ + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSE-ISLALEHLHQ 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYA 247
+ +IYRDLK NILL H KL+DFGL K G TH GT Y APE
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEIL 172
Query: 248 MTGQLTLKSDVYSFGVVLLEIITG---------RKAID 276
M D +S G ++ +++TG +K ID
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
+G+G FG+V + R T ++ A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANP 192
++ LV ++ G L HL + R D +R R A LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR----EGRFD-LSRARFYTAELLCALENLH-KFN- 113
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VIYRDLK NILL H L DFGL KL D + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 253 TLKSDVYSFGVVLLEIITG 271
T D ++ GV+L E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 70 NFRADCLLGEGGFGRVY------KGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLML 120
N+R LLG+G FGRVY GR + QV Q D + ++E E+ +L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQV----QFDPESPETSKEVSALECEIQLL 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLV--YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
L H +V G D ++ L EYMP GS++D L L + +
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQ 114
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMG 237
+G+ YLH +++RD+K +NIL + KL DFG +K + R V G
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
T + +PE K+DV+S G ++E++T +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG G FG VY T + +A+KQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 125 HPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
H +V G D +++ L EYMP GS++D L + + TR R +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TR-RYTRQILQG 118
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVM 236
+ YLH +++RD+K +NIL + KL DFG +K + G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
GT + +PE K+DV+S ++E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VYK R T +VVA+K++ +++G L E+ +L L HPN+V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHPNVVPLI 73
Query: 133 GYCAD-----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------ 181
+ +R VY P HDL L +++ K
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSVKLTESQIKCYMLQL 124
Query: 182 --GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---------GPVGDKTH 230
G+ YLH+ +++RD+K +NIL+ K++DFGLA+ G G T
Sbjct: 125 LEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 231 VSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
T ++ T Y PE + + T D++ G V E+ T R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + V+KGR + T +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPV 194
LV+EY L+ L D + ++I +GL Y H + V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---V 125
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLT 253
++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+ + + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
+ D++ G + E+ +GR + E +L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
+L ++F ++G G FG V R +S+ QV A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMR 174
+++ + +V L + A D + L V EYMP G L + + +D+P R +T +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF-YTAEVV 152
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVST 233
+A A + ++H RD+K N+LL + H KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT 202
Query: 234 RVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
V GT Y +PE + G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V + +S A+K L + + +E + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
++ V +Y+ G L HL ++R R R AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK NILL H L+DFGL K G ++T ++ GT Y APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 53/198 (26%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE--F----LVEVLMLSLLHHPNLVN 130
+G+G FG V+K R + T Q+VA+K++ L N + F L E+ +L LL H N+VN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 131 LIGYC---ADGDQR-----LLVYEYMPLGSLEDHLHDL------------PPDKKRLDWT 170
LI C A R LV+E+ HDL + K++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGD 227
+M + GL Y+H +++RD+K +NIL+ + KL+DFGLA+ L
Sbjct: 125 MKMLL-----NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 228 KTHVSTRVMGTYGYCAPE 245
+ RV+ T Y PE
Sbjct: 177 PNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK--QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG G G VYK T +++A+K LD ++ ++ + E+ +L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
++ + E+M GSL+ + +++ RIA KGL YL + +
Sbjct: 68 FFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW---SLKI 116
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++RD+K SN+L+ KL DFG++ +L KT+V GT Y APE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 254 LKSDVYSFGVVLLEIITGR 272
+ SDV+S G+ +E+ GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKGR + T+ +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
LV+EY+ L+ +L D ++ +GL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTL 254
+RDLK N+L+ E KL+DFGLA+ + KT+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 255 KSDVYSFGVVLLEIITGR 272
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 84 RVYKGRLESTNQVVAIKQL--DRNGLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140
+YKG N+ V I+ G + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 141 RL----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
L L+ EY G L + L +K L + T++ +A KGL L+ N P Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
++L + L+ E Y K+ GL K+ +V+ V +Y ++ + T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKD 203
Query: 257 DVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
D+YS GVVL EI TG+ +N ++L+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 77 LGEGGFGRVYKGR-LESTNQVVAIK----QLDRNGLQGNREFLVEVL-MLSLLHHPNLVN 130
+GEG +G+V+K R L++ + VA+K Q G+ + V VL L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 131 LIGYCA----DGDQRL-LVYEYMPLGSLEDHLHDLP----PDKKRLDWTTRMRIAAGAAK 181
L C D + +L LV+E++ L +L +P P + D ++ +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL------LR 121
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE + D++S G + E+ +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V R ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
D+ V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
++YRDLK NILL H L+DFGL K + T ++ GT Y APE
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPN 127
++ +G G +G V + + VAIK++ + + L E+ +L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 128 LVN----LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA-KG 182
++ L AD +V + M E LH + + L +R +G
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLLRG 119
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKT----HVSTRV 235
L+Y+H AN VI+RDLK SN+L+ E ++ DFG+A+ P K +V+TR
Sbjct: 120 LKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR- 175
Query: 236 MGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAI 275
Y APE ++ + T D++S G + E++ GR+ +
Sbjct: 176 ----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD---RNGLQGNREFLVEV-LMLSLLHHPNLVNLI 132
+GEG F V K + T + AIK + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 133 GYCADGDQ-RL-LVYEYMPLGSLEDHLHDLPPDKKR-LDWTTRMRIAAGAAKGLEYLHDK 189
D RL LV+E M + +L++L +KR L K L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----THVSTRVMGTYGYCAPE 245
+ +RD+K NIL+ + KL+DFG + + K ++STR Y APE
Sbjct: 120 G---IFHRDIKPENILI-KDDILKLADFGSCR--GIYSKPPYTEYISTR-----WYRAPE 168
Query: 246 YAMT-GQLTLKSDVYSFGVVLLEIIT 270
+T G K D+++ G V EI++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + V+KGR + T +VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA-GAAKGLEYLHDKANPPV 194
LV+EY L+ L + L ++I +GL Y H + +
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---I 124
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLT 253
++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+ + + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
D++ G +L E+ TGR + E +L+
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNL 131
++GEG +G V K R + T ++VAIK+ + + N E L E+ ML L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 132 IGYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY+ L LE+ + +PP+K R + ++ K + + H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHK 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+++RD+K N+L+ KL DFG A+ G + T + T Y +PE +
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLL 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
D++S G +L E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 70/207 (33%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG-- 133
+G+G +G+VYK + + A+K LD + E E +L SL +HPN+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 134 YCAD---GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
Y AD G Q LV E GS+ + + L +RLD I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--- 145
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
N +I+RD+K +NILL KL DFG+ A+L + + S +GT + APE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 202
Query: 250 GQ-----LTLKSDVYSFGVVLLEIITG 271
Q + DV+S G+ +E+ G
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFL-VEVLMLSLLHHPNLVN---- 130
+G+G +G V R + + IK+L+ RN + R+ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 131 ----------LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
++G+C GD +Y L++ L P+ + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
L+YLH+K +++RDLK N+ L K+ D G+A++ + ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
Y +PE KSDV++ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNL--I 132
+GEG +G VYK R TN+ +A+K+ L++ + E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKK--RLDWTTRMRIAAGAAKGLEYLHDK 189
+ ++RL LV+EY+ L L+ H+ P K RL T +I G A Y H
Sbjct: 70 VHS---EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHSH 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK-LG-PVGDKTHVSTRVMGTYGYCAPEY 246
V++RDLK N+L+ + KL+DFGLA+ G PV TH T Y APE
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 247 AM-TGQLTLKSDVYSFGVVLLEIITGR 272
+ + + D++S G + E++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLS 121
+F LG G G V K + + + ++A IK RN + + E+ +L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58
Query: 122 LLHHPNLVNLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P +V G + +DG+ + + E+M GSL+ L + KR+ +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVL 113
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL YL +K +++RD+K SNIL+ KL DFG++ G + D ++ +GT
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275
Y +PE +++SD++S G+ L+E+ GR I
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G+V T + VAIK+L R + + R + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 134 -YCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ VY L + L+++ +K D + + +GL+Y+H A
Sbjct: 82 VFTPASSLEDFQDVYLVTHL--MGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIH-SA 137
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT- 249
+I+RDLK SNI + E K+ DFGLA+ +V+TR Y APE +
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 190
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
D++S G ++ E++TG+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G V R + + + VA+K +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G++ ++ E++ G+L D + RL+ + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +ILL KLSDFG + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 256 SDVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFL----VEVLMLSL 122
NF +LG G +G+V+ R ++ A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 123 LHH-PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA- 179
+ P LV L Y D +L L+ +Y+ G L HL+ ++ + +R+
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFT-ESEVRVYIAEI 114
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMG 237
L++LH +IYRD+K NILL H L+DFGL+K L ++ + G
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCG 168
Query: 238 TYGYCAPEYAMTGQLTLKS--DVYSFGVVLLEIITG 271
T Y APE G D +S GV+ E++TG
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD----RNGLQGNREF----------LVEVLMLSL 122
LGEG +G+V K T ++VAIK++ N + +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ H N++ L+ +GD LV + M L + K RL + I G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-------LGPVGDKTHVSTRV 235
L LH ++RDL +NI + K++DFGLA+ + + R
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 236 MGTYG-----YCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
T Y APE M + D++S G + E++TG+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G FG V R + T Q VAIK++ + + R + E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 134 -YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ + + V E + LH L + L+ +GL+Y+H
Sbjct: 77 IFISPLEDIYFVTELL-----GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ- 251
V++RDLK SNIL+ E K+ DFGLA++ +VSTR Y APE +T Q
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQK 182
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
++ D++S G + E++ G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V + + + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
++ V +++ G L HL ++R R R AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-----RERSFPEPRARFYAAEIASALGYLH--- 113
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYAMT 249
+ ++YRDLK NILL H L+DFGL K G D T T GT Y APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK 170
Query: 250 GQLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG+ + ++VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 136 ADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ LV+EY+ ++ H L P+ +L +R GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQ 251
+++RDLK N+L+ + KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 252 LTLKSDVYSFGVVLLEIITGRKA 274
+ D++ G + +E+I G A
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 68/232 (29%)
Query: 78 GEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNL 128
G G +GRVYK + + + AIK+ + Q RE + +L L H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 129 VNLIGYC-ADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDW--------TTRMRIAAG 178
V+L+ D+ + L+++Y HDL W R+ I
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHRQAKRVSIPPS 108
Query: 179 AAK--------GLEYLHDKANPPVIYRDLKCSNILL-GEGYHP---KLSDFGLAKL--GP 224
K G+ YLH V++RDLK +NIL+ GEG K+ D GLA+L P
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 225 V-----GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIIT 270
+ D V+ T Y APE + + K+ D+++ G + E++T
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 77 LGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV ++ + VAIK+ +++ + ++ E +L+ ++HP VNL
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G D LV E++ G L KR AA EYL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN-- 151
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
++YRDLK N+LL + K++DFG AK+ V +T+ + GT Y APE +
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---LCGTPEYIAPEILLNVGH 205
Query: 253 TLKSDVYSFGVVLLEIITG 271
+D ++ G+ + EI+ G
Sbjct: 206 GKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 68/297 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K + T+++VA+K++ D G+ + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+EY DL KK D + I K GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ H V++RDLK N+L+ + KL+DFGLA+ + + + S V+ T Y P
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPP 168
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF--KD----- 296
+ +L S D++S G + E+ RPLF D
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA------------------GRPLFPGNDVDDQL 210
Query: 297 RRKFSQMADPTLQG--------QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+R F + PT + Y +Y A V P + D++ L
Sbjct: 211 KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV---PKLNSTGRDLLQNL 264
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R T ++ A+K + L+ +F + E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
++ + EY GSL+D H P + ++ + R + +GL YLH K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---T 249
++RD+K +NILL + KL+DFG+A + +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 250 GQLTLKSDVYSFGVVLLEI 268
G D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 76 LLGEGGFGRVYKG--RLESTNQV-VAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVN 130
+LG G FG + +G +L S ++ VAI L R G R FL E L L H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G G+ ++V EYM G+L+ L + +L M + G A G++YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG---YCAPEYA 247
+++ L +L+ K+S F + DK+ M + APE
Sbjct: 128 ---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ SDV+SFG+V+ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 80/268 (29%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNLV 129
LG G FG+V + +T + VA+K L L+ L ++ + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 130 NLIGYCAD-GDQRLLVYEYMPLGSLEDHLH------------------------DLPPD- 163
NL+G C G +++ E+ G+L ++L D+ D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 164 KKRLDWTTRMRIAAGA--------------------------------------AKGLEY 185
K+RLD T + +A + AKG+E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYC 242
L A+ I+RDL NILL E K+ DFGLA+ D +V R+ +
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWM 248
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
APE T++SDV+SFGV+L EI +
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLL 123
V ++ +GEG +G V + T VAIK++ + R L E+ +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRT-LREIKILRRF 60
Query: 124 HHPNLVNL------IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM---- 173
H N++ + + + D +V E M E L+ +L T +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLY-------KLIKTQHLSNDH 107
Query: 174 ------RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
+I +GL+Y+H AN V++RDLK SN+LL K+ DFGLA+ + D
Sbjct: 108 IQYFLYQIL----RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IAD 157
Query: 228 KTHVSTRVMGTY----GYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
H T + Y Y APE + + K+ D++S G +L E+++ R
Sbjct: 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
K+F L+G G FG V R ++T + A+K + ++ L F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLD-WTTRMRIAAGAAKG 182
P + L D D LV EY P G L L ++ D+ + + +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGY 241
+ Y+H RD+K N+L+ H KL+DFG A+L +K S +GT Y
Sbjct: 121 MGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDY 169
Query: 242 CAPEYAMT------GQLTLKSDVYSFGVVLLEIITGR 272
APE T G ++ D +S GV+ E+I GR
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 19/219 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG Q+VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 136 ADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ V+EYM + H L P RL +R GL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH-- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++RDLK N+L+ KL+DFGLA+ + +T+ S V T Y P+ + G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 253 TLKS--DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
S D++ G + +E++ G+ A E W
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 77 LGEGGFGRVYKG---RLESTNQV----VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG+G F +++KG + ++ V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C GD+ ++V EY+ GSL+ +L +K ++ + ++ +A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 190 ANPPVIYRDLKCSNILL------GEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
+ + ++ N+LL G P KLSD G++ V K + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEILLERI----PW 170
Query: 242 CAPEYAMTGQ-LTLKSDVYSFGVVLLEIITG 271
PE Q L+L +D +SFG L EI +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
R+L +++ ++G G FG V R +S+ +V A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLP-PDKKRLDWTTRMRI 175
+++ + P +V L +CA D + L V EYMP G L + + + P+K +T + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTR 234
A A + +H RD+K N+LL + H KL+DFG K+ G T
Sbjct: 154 ALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTA 203
Query: 235 VMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
V GT Y +PE + G + D +S GV L E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 70/263 (26%), Positives = 109/263 (41%), Gaps = 76/263 (28%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGN--REFLVEV-LMLSLLHHPNL 128
LG G FG+V + ++ + VA+K L + G + + + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHHLNV 73
Query: 129 VNLIGYCADGDQRLLV-YEYMPLGSLEDHLHDL-------------------PPDKK-RL 167
VNL+G C L+V EY G+L ++L KK RL
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 168 DWTTRMRIAAGA-------------------------------------AKGLEYLHDKA 190
D + + +A + A+G+E+L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYA 247
+ I+RDL NILL E K+ DFGLA+ D +V R+ + APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESI 247
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
T +SDV+SFGV+L EI +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
R+L +++ ++G G FG V R +ST +V A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIA 176
+++ + P +V L D +V EYMP G L + + +D+P R +T + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF-YTAEVVLA 154
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG----LAKLGPVGDKTHVS 232
A + ++H RD+K N+LL + H KL+DFG + K G V T V
Sbjct: 155 LDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 233 TRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
GT Y +PE + G + D +S GV L E++ G
Sbjct: 205 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG-- 133
+G+G +G+V+K + A+K LD + E E +L +L HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 134 YCAD---GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
Y D GDQ LV E GS+ D + +R++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY-AMT 249
I+RD+K +NILL KL DFG++ + +GT + APE A
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 250 GQL----TLKSDVYSFGVVLLEIITG 271
QL + DV+S G+ +E+ G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 65/247 (26%), Positives = 104/247 (42%), Gaps = 52/247 (21%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
+S S + + EL V + +G G G VYK T ++ A+K +
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVI-- 107
Query: 105 NGLQGNREFLV------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH-- 156
GN E V E+ +L ++HPN+V + ++ E+M GSLE
Sbjct: 108 ---YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 157 -----LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211
L D+ A G+ YLH + +++RD+K SN+L+ +
Sbjct: 165 ADEQFLADV---------------ARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKN 206
Query: 212 PKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLT-LKSDVYSFGVVL 265
K++DFG+++ L D + S +GT Y +PE T G D++S GV +
Sbjct: 207 VKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263
Query: 266 LEIITGR 272
LE GR
Sbjct: 264 LEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG G G V+K + + ++A IK RN + + E+ +L + P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLHECNSPYIV 66
Query: 130 NLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
G + +DG+ + + E+M GSL+ L R+ +++ KGL YL +
Sbjct: 67 GFYGAFYSDGEISICM-EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K +++RD+K SNIL+ KL DFG++ G + D ++ +GT Y +PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAI 275
+++SD++S G+ L+E+ GR I
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
++G+G +G V T + VAIK+++ + L E+ +L LL HP++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 134 YCADGDQR-----LLVYEYMPLGSLEDHLH-------DLPPDKKRLDWTTRMRIAAGAAK 181
+R +V+E M E LH DL P+ + +R
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS-TRVMGTYG 240
L+Y+H AN V +RDLK NIL K+ DFGLA++ T + T + T
Sbjct: 115 ALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 241 YCAPEY--AMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + + T D++S G + E++TG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G FG+V + + V V +K+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
C + LLV+EY LG L+ +L ++ R+A A G+ ++H K N
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHN-- 119
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA------ 247
++ DL N L K+ D+G+ D + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 248 -MTGQLTLKSDVYSFGVVLLEI 268
+T + T S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 18/150 (12%)
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGL 183
PN+V L Y D LV ++ G L H+ P++ W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYC 242
+ LH + ++ RDL +NILL + H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE + T D +S G +L E++TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
K+++ ++G G FG VY+ T++ VAIK++ ++ NRE L+ + L+H N
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHIN 120
Query: 128 LVNLIGY----CADGDQRLL----VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
++ L Y C +++ + V E++P ++ ++ + L +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK--LGPVGDKTHVSTRVM 236
+ L Y+H K + +RDLK N+L+ H KL DFG AK L +++ +R
Sbjct: 180 CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 237 GTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITG 271
Y APE + T D++S G ++ E+I G
Sbjct: 236 ----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 77 LGEGGFGRVY-----KGRLESTNQV---VAIKQLDRN-GLQGNREFLVEVLMLSLLHHPN 127
LG+G FG VY K E +V + + +L+ N +Q N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL------DWTTRMRIAAGAAK 181
+V + D ++ EY L+ L +L K L +W ++ +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+ Y+H + +++RDLK NI L K+ DFG+++L + ++T GT Y
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEI 268
+PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 71/262 (27%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPN 127
+LG G FG+V + +S+ VA+K L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 128 LVNLIGYCADGDQRLLV-YEYMPLGSLEDHLH----------DLPPDKKRLDWTT----- 171
+VNL+G C + L+V E+ G+L + L + P ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 172 -RMRIAAGAAKGLEYLHDK-----ANPP-------------------------------- 193
RI AG A L NPP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 194 --VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAM 248
I+RDL NILL E K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
T +SDV+SFGV+L EI +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
+ + + + +G G +G V + T + VAIK+L R + + R + E+ +L +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHM 71
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
H N++ L+ D Q LV YM + H L DK + +
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-------LVY 124
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GL+Y+H +I+RDLK N+ + E K+ DFGLA+ +V TR
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 178
Query: 238 TYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E++TG+
Sbjct: 179 --WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHH 125
NF +LG G +G+V+ R S + ++ A+K L + + Q + +L H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 126 ----PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
P LV L Y D +L L+ +Y+ G L HL ++R +
Sbjct: 61 IRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIV 115
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE+LH +IYRD+K NILL H L+DFGL+K D+ + GT
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIE 171
Query: 241 YCAPEYAMTGQLTLKS--DVYSFGVVLLEIITG 271
Y AP+ G D +S GV++ E++TG
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 87/335 (25%), Positives = 146/335 (43%), Gaps = 64/335 (19%)
Query: 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQ 64
Query: 133 G-YCADGDQRL-LVYEYMPLGSLEDHLHDL----------PPDKKRLDWTTRM--RIAAG 178
+ + D+++ L+++Y HDL +KK + M +
Sbjct: 65 KVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNIL-LGEGYHP---KLSDFGLAK-----LGPVGDKT 229
G+ YLH AN V++RDLK +NIL +GEG K++D G A+ L P+ D
Sbjct: 117 ILDGIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288
V T+ Y APE + + K+ D+++ G + E++T + I + R +
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED----IK 224
Query: 289 WARPLFKDR--RKFSQMADPTLQGQYPVRGL--YQALAVAAMCVQEQPNMRPLIADVVTA 344
+ P D+ R FS M P + +R + Y L Q + R +
Sbjct: 225 TSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTL---------QKDFRRTTYANSSL 275
Query: 345 LTYLACQKYDPESQP---VQSSRTGSSTPRIRREQ 376
+ Y+ K P+S+ +Q T T RI EQ
Sbjct: 276 IKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK----QLDRNGLQGNREFLVEV-LMLSLLHHPNLVNL 131
+GEG +G+VYK R ++T ++VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 132 IGY----CADGDQRL-LVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ +G L LV+EY+ L D P L T KG+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQLLKGVA 124
Query: 185 YLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLG--PVGDKTHVSTRVMGTYGY 241
+ H V++RDLK N+L+ + K++D GL + PV TH + T Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 242 CAPEYAMTG-QLTLKSDVYSFGVVLLEIITG 271
APE + + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EV 117
++F ++G G FG V +L++ ++V A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 118 LMLSLLHHP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
++ LH+ NL ++ Y GD L L ED L P D R +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YLAE 110
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
M IA + L Y+H RD+K NIL+ H +L+DFG + L + D T S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 233 TRVMGTYGYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
+ +GT Y +PE AM G+ + D +S GV + E++ G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 16/199 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
L G GRV+ V +K G +G L+E ++L ++HP+++ +
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLV 127
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
G +V + D L + L + I +GL YLH + +I+
Sbjct: 128 SGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIH 180
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K NI + + + D G A+ PV + + GT APE + K+
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKA 237
Query: 257 DVYSFGVVLLEIITGRKAI 275
D++S G+VL E++ I
Sbjct: 238 DIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFLVEVLML--SLLH 124
NF +LG G +G+V+ R + T ++ A+K L + L + VE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLE 59
Query: 125 H----PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
H P LV L Y + +L L+ +Y+ G + HL+ + +R +G
Sbjct: 60 HVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGE 113
Query: 180 A-KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVM 236
LE+LH ++YRD+K NILL H L+DFGL+K L ++T+
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFC 167
Query: 237 GTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITG 271
GT Y APE K+ D +S G+++ E++TG
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 80 GGFGRVYKGRLESTNQVVAIK------QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
G FG+VY GR ++ +++ A+K +++N + + E L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ LV EY+ G ++ LH D ++ + A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG--- 124
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKL 222
+I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G V + TN+ VAIK++ N + R L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 134 YCADGDQR-----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ +VYE M + LH + + L +GL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH- 125
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
AN V++RDLK SN+LL K+ DFGLA+ +K T + T Y APE +
Sbjct: 126 SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 249 T-GQLTLKSDVYSFGVVLLEIITGRKAI 275
+ T DV+S G + E++ GRK +
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVE 116
T E+ ++ + +G G +G V T VAIK+L R + L R + E
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-E 64
Query: 117 VLMLSLLHHPNLVNLIG-YCADG--DQRLLVYEYMP-----LGSLEDHLHDLPPDKKRLD 168
+ +L + H N++ L+ + D D+ Y MP LG L H ++L
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLS 116
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
+ KGL+Y+H +I+RDLK N+ + E K+ DFGLA+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
+V TR Y APE + T D++S G ++ E++TG+
Sbjct: 174 GYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 35/218 (16%)
Query: 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
C +G G +G VYK + + ++ A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 64
Query: 133 G-YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------G 182
+ + D+++ L+++Y + D H + + +++ G K G
Sbjct: 65 KVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 183 LEYLHDKANPPVIYRDLKCSNIL-LGEGYHP---KLSDFGLAK-----LGPVGDKTHVST 233
+ YLH AN V++RDLK +NIL +GEG K++D G A+ L P+ D V
Sbjct: 121 IHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 234 RVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIIT 270
T+ Y APE + + K+ D+++ G + E++T
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 31/193 (16%)
Query: 93 TNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----V 144
T Q VAIK+L R N R + VLM L++H N++ L+ Q+ L V
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNHKNIIGLLN--VFTPQKSLEEFQDV 96
Query: 145 YEYMPLGSLEDHLH-----DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL 199
Y M L ++ +L DL D +R+ + + G+++LH + +I+RDL
Sbjct: 97 YLVMEL--MDANLCQVIQMDL--DHERMSYLLYQMLC-----GIKHLH---SAGIIHRDL 144
Query: 200 KCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 259
K SNI++ K+ DFGLA+ G ++ V+ Y Y APE + D++
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIW 201
Query: 260 SFGVVLLEIITGR 272
S G ++ E+I G
Sbjct: 202 SVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EVLMLSLLH 124
++G G FG V ++++T QV A+K L++ + R+ LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 125 HP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ NL ++ Y GD L L ED L P D R + M +A +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YLAEMVLAIDS 117
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L Y+H RD+K N+LL + H +L+DFG + L + D T S +GT
Sbjct: 118 VHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167
Query: 240 GYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
Y +PE AM G+ + D +S GV + E++ G
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EVLMLSLLH 124
++G G FG V +++ T ++ A+K L++ + R LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 125 HP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ L ++ Y GD L L ED L P D R + M +A +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YIAEMVLAIHS 117
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L Y+H RD+K N+LL H +L+DFG + L D T S+ +GT
Sbjct: 118 IHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 240 GYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
Y +PE AM G+ + D +S GV + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQ--VVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG+G +G V R T++ VAIK++ + R L+ H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 132 IGY-CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+Y Y L +E LH + + L GL+Y+H A
Sbjct: 68 YDMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH-SA 124
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYA 247
N V++RDLK N+L+ K+ DFGLA+ P + + T + T Y APE
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRWYRAPEIM 181
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGRKAI 275
++ Q K+ DV+S G +L E++ GRK +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGT 238
A G+E+L A+ ++RDL N+L+ EG K+ DFGLA+ + D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T SDV+SFG++L EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 76/250 (30%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLHHP 126
++G G FG V + + T + A+K+L ++ + + R+ L E +P
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA------DNP 61
Query: 127 NLVNLIGYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT---TRMRIAAGAAK 181
+V L Y + D + L+ EY+P G + L K+ +T TR IA
Sbjct: 62 WVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL------MKKDTFTEEETRFYIAE-TIL 112
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG-DKTHVST------- 233
++ +H K I+RD+K N+LL H KLSDFGL G K+H +
Sbjct: 113 AIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSH 165
Query: 234 ---------------------------RVM-----GTYGYCAPEYAMTGQLTLKSDVYSF 261
R + GT Y APE + + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 262 GVVLLEIITG 271
GV++ E++ G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 26/179 (14%)
Query: 162 PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221
D LD +R ++ A+G+++L K I+RD+ N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 222 LGPVGDKTHVSTRVMGT----YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277
+ D +V V G + APE T++SDV+S+G++L EI + K+
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS--- 313
Query: 278 TRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336
P KF +M Q P + ++ MC +P RP
Sbjct: 314 ------------PYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 37/230 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G G V+ ++ VA+K++ Q + L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 137 DGDQRL--------------LVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
L +V EYM L ++ + L + RL +R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLR------ 125
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK-LGP-VGDKTHVSTRVMG 237
GL+Y+H AN V++RDLK +N+ + E K+ DFGLA+ + P K ++S ++
Sbjct: 126 -GLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 238 TYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
+ Y +P ++ T D+++ G + E++TG+ AG H L
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-----PLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 30/83 (36%), Positives = 45/83 (54%)
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+I+RD+K +NILL KL DFG +K+ V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 254 LKSDVYSFGVVLLEIITGRKAID 276
K+D++S GV+L E++T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 17/151 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLV-NLIG 133
LL G RVY L + ++ +K +RE EV +L LL V ++
Sbjct: 5 LLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
L+ E++ G D + + + A+ L LH
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLV 109
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ + DL NIL+ +G + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGT 238
A+G+E+L A+ ++RDL N+LL +G K+ DFGLA+ + D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLP 302
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T SDV+S+G++L EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKG+ +L K I+RDL NILL G K+ DFGLA+ D + S V+
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGN 275
Query: 240 G-----YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+S+G++L EI +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 37/212 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+G G +G V Q VA+K+L R L R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 135 CADGDQRLLVYEYMPLGSLED-------------HLHDLPPDKKRLDWTTRMRIAAGAAK 181
+ P S+E+ L+++ +K D + I +
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-LLR 129
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL+Y+H +I+RDLK SN+ + E ++ DFGLA+ +V+TR Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 242 CAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
APE + D++S G ++ E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL+YLH A +++RD+K N+L+ K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 241 YCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
Y APE M + T D++S G + E++ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 74 DCLLGEGGFGR--VYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNL 128
L+G+ V+ + + TN +VA+K+++ + + + E++ L HPN+
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNI 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ + + +V M GS ED L P+ L I L+Y+H
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHS 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLA--------KLGPVGDKTHVSTRVMGTYG 240
K I+R +K S+ILL LS + + V D S + +
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--- 173
Query: 241 YCAPEY---AMTGQLTLKSDVYSFGVVLLEIITG 271
+ +PE + G KSD+YS G+ E+ G
Sbjct: 174 WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 7e-07
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNLIG- 133
+G G FG V+ + + T + K + GL+ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 134 YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ +Q+L ++ E+ G L ++ +++ + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 193 P----VIYRDLKCSNILLGEGYH-----------------PKLSDFGLAKLGPVGDKTHV 231
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 232 STRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGR 272
+GT Y +PE + T KSD+++ G ++ E+ +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G V T VA+K+L R + + R + E+ +L + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 134 YCADGDQRLLVYEYMPLGSLED-------------HLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P SLE+ L+++ +K D + I
Sbjct: 84 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-IL 130
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL+Y+H + +I+RDLK SN+ + E K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 241 YCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278
Y APE + D++S G ++ E++TGR T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 66/268 (24%), Positives = 100/268 (37%), Gaps = 64/268 (23%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD------RNG---LQGNREFLVEVLMLSLLHHPN 127
+G G FG V R TN + A+K L RN ++ R+ L E +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L D D V +Y+P G + L L ++ L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL---------------------------- 219
I+RD+K NIL+ H KL+DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 220 --AKLGPVGDKTHVSTRV-----------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLL 266
+++ K R +GT Y APE + T D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 267 EIITGRKA-IDNTRAAGEHNLVAWARPL 293
E++ G+ + +T A + ++ W L
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 68/281 (24%), Positives = 103/281 (36%), Gaps = 63/281 (22%)
Query: 27 PSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFG--- 83
PS +E S +D EA D A + + FR L G FG
Sbjct: 109 PSGAEDSD-ASHLDFD-EAPPDAAGPVPLAQAKLKHDDEFLAH-FRVIDDLPAGAFGKIF 165
Query: 84 ----RVYKGRLE------STNQVVA-----IKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
R E STNQ I + + G + + E+L L L+H N+
Sbjct: 166 ICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225
Query: 129 VNLIGYCADGDQRLLVYE---YMPLGSLEDHLH------DLPPDKKRLDWTTRMRIAAGA 179
+ + + +L E YM + L+ + L TR I
Sbjct: 226 LKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQL 276
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA----------KLGPVGDKT 229
+EY+HDK +I+RD+K NI L L DFG A G VG
Sbjct: 277 LCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVA 333
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
S ++ GYC ++T D++S G++LL++++
Sbjct: 334 TNSPEILAGDGYC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 47/186 (25%), Positives = 75/186 (40%), Gaps = 21/186 (11%)
Query: 93 TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152
T + V IK R G E +L ++HP+++ L G L+ L
Sbjct: 116 TCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPR 164
Query: 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212
+ L+ K+ + + I + ++YLH+ +I+RD+K NI + HP
Sbjct: 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HP 218
Query: 213 K---LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII 269
L DFG A PV + GT APE D++S G+VL E+
Sbjct: 219 GDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 270 TGRKAI 275
T ++
Sbjct: 278 TCHDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
++S + H +L + G C G + ++V E++ G L+ L +K R+ ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQ 125
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNIL-----LGEGYHP--KLSDFGLAKLGPVGDKTHV 231
A L YL DK +++ ++ NIL L EG P KLSD G++ + + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 232 STRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEI 268
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 51 SDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGL 107
S +A TFT V K ++ +G G G V VA+K+L R N
Sbjct: 9 SVQVADSTFT------VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 62
Query: 108 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----VYEYMPL--GSLEDHLHDL 160
R + E+++L ++H N+++L+ Q+ L VY M L +L +H +
Sbjct: 63 HAKRAYR-ELVLLKCVNHKNIISLLNVFTP--QKSLEEFQDVYLVMELMDANLCQVIH-M 118
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
D +R+ + + G+++LH +I+RDLK SNI++ K+ DFGLA
Sbjct: 119 ELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
+ + T + T Y APE + D++S G ++ E++ G
Sbjct: 171 R---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 28/77 (36%), Positives = 43/77 (55%)
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+++RDLK +NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 254 LKSDVYSFGVVLLEIIT 270
K+D++S GV+L E++T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 77 LGEGGFGRVYK----GRLESTNQV-VAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V + G + N + VA+K L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL 157
NL+G C G L++ EY G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 26/203 (12%)
Query: 85 VYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRL 142
VY R T +V ++ D + EV++ HPN++ G
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75
Query: 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202
++ +M GS L P+ + I GA +GL YLH I+R++K S
Sbjct: 76 VISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNG---YIHRNIKAS 130
Query: 203 NILLGEGYHPKLSDFGLAKLGPV---GDKTHV-------STRVMGTYGYCAPEYA---MT 249
+IL+ LS GL+ L + G K V ST V+ + +PE +
Sbjct: 131 HILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLY 185
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
G +KSD+YS G+ E+ TGR
Sbjct: 186 G-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 58/245 (23%), Positives = 89/245 (36%), Gaps = 33/245 (13%)
Query: 40 DVKKEASKDGGSDHIAAHTFTFREL----------AAVTKNFRADCLLGEGGFGRVY--K 87
DV D + ++ T +E + V + L G G V+
Sbjct: 53 DVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCT 112
Query: 88 GRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147
+ + V +K + G E+ +L + H ++NLI +V
Sbjct: 113 KHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINLIHAYRWKSTVCMV--- 164
Query: 148 MPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204
MP + DL R L + I + L YLH + +I+RD+K NI
Sbjct: 165 MP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENI 216
Query: 205 LLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 263
L E + L DFG A KL D GT +PE K+D++S G+
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 264 VLLEI 268
VL E+
Sbjct: 276 VLFEM 280
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 54 IAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGN 110
I TFT V K ++ +G G G V + VAIK+L R N
Sbjct: 15 IGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK 68
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED--------HLHD--- 159
R + E++++ ++H N++ L+ + P SLE+ L D
Sbjct: 69 RAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 160 -----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214
+ D +R+ + + G+++LH +I+RDLK SNI++ K+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
DFGLA+ G ++ V+ Y Y APE + D++S G ++ E+I G
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G G V ++ VAIK+L R N R + E++++ ++H N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 134 Y------CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ LV E M + +L D +R+ + + G+++LH
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLC-----GIKHLH 136
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+I+RDLK SNI++ K+ DFGLA+ G ++ V+ Y Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVI 190
Query: 248 MTGQLTLKSDVYSFGVVLLEII------TGRKAID 276
+ D++S G ++ E++ GR ID
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 77 LGEGGFGRV-----YKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V Y VA+K L + RE L+ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL 157
NL+G C G L++ EY G L + L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 77 LGEGGFGRVYK----GRLESTNQV-VAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNLV 129
LG G FGRV + G S + + VA+K L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
NL+G C G ++ EY G L D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLML 120
+F ++G+G FG V + + T ++ A+K L ++ + + R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAG 178
P +V+L D L+ E++P G L L +D + TR +A
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE- 109
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
+E +H I+RD+K NIL+ G H KLSDFGL+
Sbjct: 110 CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 59/253 (23%), Positives = 92/253 (36%), Gaps = 73/253 (28%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLHHPN 127
LG G FG V R T + A+K L + + + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+V L D D V +Y+P G SL + P D R + + A + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF-YIAELTCAVESVHKMG 121
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA------------------------ 220
++H RD+K NIL+ H KL+DFGL
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 221 ---------------KLGPV---GDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVY 259
+L P+ + H ++ ++GT Y APE + T D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 260 SFGVVLLEIITGR 272
S GV+L E++ G+
Sbjct: 233 SVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 76 LLGEGGFGRVYKGR---LESTNQV--VAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNL 128
+LG G FG+V +G L + V VA+K L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
VNL+G C ++ EY G L ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 55/245 (22%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLM 119
++F + ++G G FG V + + T V A+K L + + + R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
L + V + D L+ E++P G D + L + T+ IA
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAE-T 110
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT---------- 229
++ +H I+RD+K N+LL H KLSDFGL +T
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 230 -----------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLL 266
++ +GT Y APE M D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 267 EIITG 271
E++ G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 77 LGEGGFGRVYKGRL------------ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH 124
LG G ++Y G L V +K LD + + F M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT--RMRIAAGAAKG 182
H ++V L G C + ++V E++ G L+ +H +K TT + ++A A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-----RKSDVLTTPWKFKVAKQLASA 117
Query: 183 LEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTY 239
L YL DK +++ ++ NILL EG + F KL G V +R +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERI 172
Query: 240 GYCAPEYAM-TGQLTLKSDVYSFGVVLLEI 268
+ APE + L++ +D +SFG L EI
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 55/246 (22%), Positives = 90/246 (36%), Gaps = 59/246 (23%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLML 120
+F + ++G G FG V + + T + A+K L + + + R+ LVE
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--- 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAG 178
+V + D L+ E++P G + L D ++ + +A
Sbjct: 59 ---DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---------------KLG 223
A L ++H RD+K N+LL H KLSDFGL
Sbjct: 116 AIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 224 PVGD------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
P D + ++ +GT Y APE M D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 266 LEIITG 271
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 6e-04
Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 63 ELAAVTKNF--RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEV 117
EL KN L +G FG+V + + T ++ K + N + E +V
Sbjct: 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQ 63
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LM +PN + L +L+ +Y+ G L D L + +L +I
Sbjct: 64 LMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIR 116
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAKLGPVGDKTHVS 232
+ L LH K N +I+ D+K N+L Y L D+GL K +G +
Sbjct: 117 QLVEALNDLH-KHN--IIHNDIKLENVL----YDRAKDRIYLCDYGLCK--IIGTPSCYD 167
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVY--SF-----GVVLLEIITG 271
GT Y +PE +K Y SF GV+ E++TG
Sbjct: 168 ----GTLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 63/250 (25%), Positives = 94/250 (37%), Gaps = 67/250 (26%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL------DRNGL---QGNREFLVEVLMLSLLHHPN 127
LG G FG V T+ + A+K L +RN + + R+ L E +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L D D V +Y+P G + L + + L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---------------------KLGP-- 224
I+RD+K NIL+ H KL+DFGL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 225 ---------VGD----------KTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 262
GD K H ++ ++GT Y APE + T D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 263 VVLLEIITGR 272
V+L E++ G+
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.87 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.47 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.99 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.45 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.3 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.97 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.76 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.37 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.21 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.18 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.98 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.82 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.44 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=399.63 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=219.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+|...++||+|||+.||.+++..+|+.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999997643 334567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+|..++|.++++. .+.+++.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999975 688999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
..+ ...+.||||.|.|||++.+..++..+||||+||+||.||.|++||+...-.+..+.+ ..-..
T Consensus 171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I----------k~~~Y--- 235 (592)
T KOG0575|consen 171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI----------KLNEY--- 235 (592)
T ss_pred ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH----------HhcCc---
Confidence 322 345689999999999999999999999999999999999999999976432211111 11111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.+|...+.++.+||.++|+.||.+|||+.+|+.+-..
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 2233556688999999999999999999999999876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-54 Score=378.04 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=217.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCc-eEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~e 146 (376)
.+.+..+.||+|..|+||+++++.|++.+|+|.+..+. ....+++.+|+.+++..+|||||.+|++|.+... .+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 34666788999999999999999999999999996543 3345679999999999999999999999999884 999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++|+|...+.. .+++++..+..++.+|++||.|||+ .+ ||||||||+|||++..|.|||||||.+.....
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999976 4789999999999999999999996 77 99999999999999999999999999986432
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ....++||..|||||.+.+..|+.++||||||++++|+++|+.||...... ...+.. .+..+++
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~----------Ll~~Iv~ 296 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFE----------LLCAIVD 296 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHH----------HHHHHhc
Confidence 2 456689999999999999999999999999999999999999999865111 111222 1223333
Q ss_pred CcCCCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 306 PTLQGQYPV-RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 306 ~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...- ..|. ..+.+++.|+..||++||.+||++.++++|-+-.+.
T Consensus 297 ~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 297 EPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 2111 2233 366789999999999999999999999999775554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=385.80 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=215.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-------hHHHHHHHHHHhhcCCCCccceeEEEecC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-------NREFLVEVLMLSLLHHPNLVNLIGYCADG 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 138 (376)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..... ...+.+|+.+|++|+|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 46678999999999999999999999999999999997643322 23467999999999999999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC---CceEEc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLS 215 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~---~~~kl~ 215 (376)
+..||||||+.||+|.+++-. ++.+.+.....+++|++.|+.|||++| |+||||||+|||++.+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999976 677888888999999999999999999 9999999999999766 789999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCC---CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL---TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
|||+|+... +.....+.|||+.|.|||++.++.+ ..++|||||||+||-+|+|.+||........ ...+
T Consensus 322 DFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQ 393 (475)
T ss_pred ccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHH
Confidence 999999743 3445667899999999999987653 3478999999999999999999986543210 0011
Q ss_pred hhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+....- ...+ ..-...+.+..+||.+||..||++|||+.|+|+|-|.-..
T Consensus 394 I~~G~y----~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 394 ILKGRY----AFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred HhcCcc----cccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 111100 0111 1113567789999999999999999999999999886544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=374.13 Aligned_cols=206 Identities=33% Similarity=0.503 Sum_probs=185.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
..+|...+.||.|+||+||+|+++.++..||||.+.+... ...+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4679999999999999999999999999999999987743 33455788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC------CceEEccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG------YHPKLSDFGL 219 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~------~~~kl~Dfg~ 219 (376)
|||.||+|.+|++. .+++++..+..++.||+.||++||+++ ||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987 568999999999999999999999999 9999999999999764 4689999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 283 (376)
++.+..+ ......||++.|||||++....|+.|+|+||+|+|+|+|++|..||+.....+.
T Consensus 162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 9976533 345678999999999999999999999999999999999999999997655433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=366.37 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=213.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeE-EEecCCc-eEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQ-RLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~-~~~~~~~-~~lv 144 (376)
..|+++++||.|.||.||++.+..+|..+|.|.++-... ...+++..|+.+|++|+|||||++++ .|.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458999999999999999999999999999999974333 33456889999999999999999998 4444444 8999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-CCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||.+|+|...++.+...++.+++..+|+++.|++.||..+|+.- +..|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999988888899999999999999999999999932 123999999999999999999999999999974
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
. .........+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+..- ......+ .. +.+
T Consensus 179 ~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI-~q-gd~--- 245 (375)
T KOG0591|consen 179 S--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKI-EQ-GDY--- 245 (375)
T ss_pred c--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHH-Hc-CCC---
Confidence 3 333445568999999999999999999999999999999999999999997622 2111111 00 011
Q ss_pred cCCcCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTLQGQYP-VRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+| ...+..+..||..|+..||+.||+...++..+.
T Consensus 246 ------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 ------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1123 456778999999999999999999655554443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=378.70 Aligned_cols=291 Identities=55% Similarity=0.954 Sum_probs=252.2
Q ss_pred cccccCHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEE
Q 017175 55 AAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134 (376)
Q Consensus 55 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 134 (376)
....|++.++..++++|....+||+|+||.||+|.... +..||||++.........+|.+|+.++.+++|||+|+++|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999999999999999999999876 48899998876543314559999999999999999999999
Q ss_pred EecCC-ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceE
Q 017175 135 CADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (376)
Q Consensus 135 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~k 213 (376)
|.+.+ ..+||+|||+.|+|.++++..... .++|..+++|+.++|+||+|||+...++|+||||||.|||+|+++..|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999873222 899999999999999999999999888999999999999999999999
Q ss_pred EcccccccccCCCCcceeeccc-ccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 214 LSDFGLAKLGPVGDKTHVSTRV-MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
|+|||+++..+.. ... .... .||.+|+|||.+..+..+.++|||||||+|.||++|+.+.+...+.....+..|..+
T Consensus 218 lsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999754331 111 1112 799999999999999999999999999999999999999998776666668888877
Q ss_pred hhhcccccccccCCcCC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 293 LFKDRRKFSQMADPTLQ-GQYPV-RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
..... .+.+++|+.+. +.++. .....+..+..+|++.+|.+||++.+|++.|..+...
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 66665 88999999987 66664 5777788999999999999999999999999766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-53 Score=368.50 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=212.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|+++++||+|+||.||.++.+.+++.||+|++++.... +.+....|..+|..++||.||.++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999999999999999999875443 345677899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
+||+.||.|...+.. ...+++..+..++.+|+.||.|||+.| |+||||||+|||+|.+|+++|+|||+|+...
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999975 678999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. .....++|||+.|||||++.+..|+..+|+||||+++|+|++|.+||...+..... ..+....
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~------~~I~~~k------- 241 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY------DKILKGK------- 241 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH------HHHhcCc-------
Confidence 22 22345589999999999999999999999999999999999999999987543211 1111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP----LIADVVTA 344 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----s~~ell~~ 344 (376)
....+.-.+.+.++++.++|..||++|. ++.+|-+|
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 1122233556888999999999999995 56666544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=355.14 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=219.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-c-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-Q-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.|+.+.++|+|+||+||+|+++.||+.||||++..... . -.+-.++|+.+|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999999999999999975433 2 22446799999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
||+. ++.+-+.. ....++...+..++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9986 44444444 3567899999999999999999999999 99999999999999999999999999997542
Q ss_pred CcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh--------hhhhhhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW--------ARPLFKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 297 (376)
.....+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+....+..-.+.. -+.+|...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3345567889999999999988 5899999999999999999999999998766554433322 23445555
Q ss_pred cccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.-+..+.-|......+ +..+..+.+|+..||+.||.+|++.++++.|
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 5555554444433222 3445588899999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=369.74 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=215.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
.-..+|.+++.||+|+|++|++|+.+.+++.||||++.+... ...+.+..|-..|.+| .||.|++++-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999999999999999876433 2335567788888888 799999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
|+|+||+++|+|.++|.. -+.+++..++.++.+|+.||+|||++| ||||||||+|||+|.+++++|+|||.++
T Consensus 150 YFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999987 478999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcc---------ee--ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 222 LGPVGDKT---------HV--STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 222 ~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
.+...... .. ...++||..|.+||++..+..+..+|||+||||+|+|+.|.+||.....- -.+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHH
Confidence 64332211 11 14589999999999999999999999999999999999999999876432 111
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+.++...- .++...+..+.+||.+.|..||.+|+++.+|-+|..+
T Consensus 297 qkI~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 297 QKIQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred HHHHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 22211111 3333444688899999999999999999999887543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=368.00 Aligned_cols=260 Identities=34% Similarity=0.533 Sum_probs=213.9
Q ss_pred cccCceecccCceEEEEEEECCCCeE-EEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCC-ceEEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQV-VAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 146 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e 146 (376)
..+.+.||.|+||.||+|.+. |.. ||+|++....... .+.|.+|+.+|.+++|||||+++|++.+.. .+++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 445556999999999999998 555 9999997654333 458999999999999999999999999887 7999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~~~~ 225 (376)
|+++|+|.++++.. ....+++..++.++.+|+.|+.|||++++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999763 46789999999999999999999999985 89999999999999998 999999999986332
Q ss_pred CCcceeecccccccCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.. .......||+.|||||++. ...|+.++||||||+++|||+||..||......... ..+
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----------------~~v 258 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA----------------SAV 258 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----------------HHH
Confidence 21 2223367999999999999 568999999999999999999999999987542110 011
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
.....+...+......+..|+.+||..||..||++.+|+..|+.+......
T Consensus 259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 111122233333555788899999999999999999999999988775544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=368.94 Aligned_cols=282 Identities=22% Similarity=0.308 Sum_probs=224.6
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchH-HHHHHHHHHhhcC-CCCccceeEEEecCC-ceE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRL 142 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~e~~~l~~l~-h~ni~~~~~~~~~~~-~~~ 142 (376)
.+-++|.+.++||.|.||.||+|+...+|..||||.+++.-....+ .-++|+..|++++ ||||+++.+++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4568999999999999999999999999999999999765433222 2458999999999 999999999999988 999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+|||||+ .+|+++++. .+..+++..++.|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999996 799999987 3778999999999999999999999999 99999999999999888999999999995
Q ss_pred cCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh-----hhhc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP-----LFKD 296 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~~ 296 (376)
.. .....+.++.|.+|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+....|....+..+-. .+..
T Consensus 160 v~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 33 2334566889999999999876 4689999999999999999999999998876554332221100 0000
Q ss_pred cc--------ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCCCCC
Q 017175 297 RR--------KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQ 358 (376)
Q Consensus 297 ~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~~~~ 358 (376)
.. .+..+....+..- ....+.++.+|+.+||.+||.+|||+.+++++-.+.......+..+
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L-~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~~a~ 305 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDL-LPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGSSAR 305 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHh-CcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccccccc
Confidence 00 0111111111111 1236778899999999999999999999999977666555544444
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=334.86 Aligned_cols=277 Identities=25% Similarity=0.323 Sum_probs=221.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.+|...++||+|.||.||+|++..+|+.||||++......+ .....+|+..|+.++|+||+.++++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47889999999999999999999999999999998664443 2456799999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|++ .+|...+++ ....++...+..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 699999987 5677999999999999999999999999 999999999999999999999999999975544
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh--hhhhhcccccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA--RPLFKDRRKFSQM 303 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 303 (376)
.. .....+-|.+|+|||.+.+. .|+..+|+||.|||+.||+-|.+.|.+....+....+-.. .+.-.....+..+
T Consensus 155 ~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 43 33334789999999999875 6999999999999999999999988876554433322110 0000011111111
Q ss_pred --------cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 304 --------ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 304 --------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
.............+.++.+|+.+||..||.+|+++.|++++-.+-..+...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 111112223334455679999999999999999999999998766544433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=370.49 Aligned_cols=254 Identities=28% Similarity=0.381 Sum_probs=221.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
..|+...+||+|+.|.||.|+...+++.||||.+........+-+.+|+.+|+.++|+|||.+++.|...+.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888999999999999999999999999999999887777788999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+||+|.+.+.. ..+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||+|.......
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 99999999865 56999999999999999999999999 9999999999999999999999999998643332
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......+|||.|||||++....|+++.||||||++++||+.|.+||-+..+.....++. .. -..
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~n--------g~P 487 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TN--------GTP 487 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hc--------CCC
Confidence 34567899999999999999999999999999999999999999998865532211111 10 011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.-..+...+..+.+|+.+||+.|+++|+++.|||+|-..
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 113344567789999999999999999999999998553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=362.81 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=216.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC----c-cchHHHHHHHHHHhhcC-CCCccceeEEEecCC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----L-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 139 (376)
...++|.+.+.||+|+||.|++|.+..+++.||+|++.+.. . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34678999999999999999999999999999999876641 1 22345668999999999 999999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEcccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFG 218 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg 218 (376)
.+|+||||+.||+|.+++.. ..++.+.++..+++|+++|++|||++| |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999976 578999999999999999999999999 9999999999999999 999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..... .....+...
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcC
Confidence 998753 2233456689999999999999877 86 7899999999999999999999974321 111111111
Q ss_pred ccccccccCCcCCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRG-LYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.- .+|... +.++.+|+.+||..||.+|+++.+|+.+-|...
T Consensus 239 ~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 EF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred Cc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11 122222 568889999999999999999999998877654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=355.06 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=213.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC--ceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~ 145 (376)
..+|...+.||+|+||.||++.+..+|...|||.+........+.+.+|+.+|+.++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345788899999999999999999999999999997664333667889999999999999999999755444 689999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~~ 224 (376)
||+++|+|.+++... +.++++..+..+++||++||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999873 227999999999999999999999999 999999999999999 7999999999987543
Q ss_pred C-CCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCc-ccccccchhhhhhhhhhcccccc
Q 017175 225 V-GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT-RAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
. ...........||+.|||||++..+ ..+.++|||||||++.||+||..||... ... ...+....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---------~~~~~ig~--- 237 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---------EALLLIGR--- 237 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---------HHHHHHhc---
Confidence 2 1222223457899999999999863 3345999999999999999999999874 111 00111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
. .....+|...+.++.+++.+||..+|++|||+.++|+|........
T Consensus 238 ---~-~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 238 ---E-DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---c-CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 0 0111445566778999999999999999999999999988665444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=348.51 Aligned_cols=267 Identities=26% Similarity=0.355 Sum_probs=216.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.+.|++...||.|..++||+|+...+++.||||+++...... .+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467999999999999999999999999999999998665444 4788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC-
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV- 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~- 225 (376)
||.+|++.+.+.... ...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+.....
T Consensus 105 fMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998754 345999999999999999999999999 99999999999999999999999998754322
Q ss_pred CCcceee-cccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVS-TRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
+...... ..++||+.|||||+++.. .|+.|+||||||++..||.+|..||....+.... ...+........
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLL- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcc-
Confidence 2222222 567899999999997653 7999999999999999999999999876543111 111111111000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
-.....+-.......++.+|..||..||++|||+.+++++-.+
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 0011111122334588899999999999999999999987553
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=335.03 Aligned_cols=248 Identities=28% Similarity=0.350 Sum_probs=211.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+|++.+.||.|+||.|.+++.+.+|..+|+|++.+...-.. +...+|-.+|+.+.||+++++++.+.+...+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 468999999999999999999999999999999987654443 44668999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||.|..+++. .+++++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+++....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999986 578999999999999999999999999 99999999999999999999999999986321
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
...+.||||.|+|||++..+.|+.++|.|||||++|||+.|.+||....+.. ....+.....
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~v------- 258 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGKV------- 258 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCcc-------
Confidence 2456899999999999999999999999999999999999999999876532 1222222221
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
.+|...+..+.+|+..+|+.|-.+|. ..++|-.|-+
T Consensus 259 -----~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 259 -----KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred -----cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence 34445556888999999999999992 3445554443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=366.88 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=216.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccC-Ccc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN-GLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+-|++++.||.|+-|.|-+|++..||+.+|||++.+. ... ....+.+|+.+|+.+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3488999999999999999999999999999999765 222 2345889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||.|.+++.. .+++++.++..++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999976 688999999999999999999999999 99999999999999999999999999985433
Q ss_pred CCcceeecccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
+ ....+.||++.|.+||++.+..|+ .++||||+|||||.||+|+.||++.........+ ..+.+
T Consensus 165 g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--------~~G~f---- 229 (786)
T KOG0588|consen 165 G---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--------QRGVF---- 229 (786)
T ss_pred C---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--------HcCcc----
Confidence 3 344567999999999999999885 7899999999999999999999954322111111 01111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+.|...+.++.+|+.+||..||++|.|++||++|.+-...
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 2334556688999999999999999999999999985544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=355.25 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=209.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|.+++.||+|+||.||+|+.+.||..+|+|++++...... ..+..|-.+|....+|.||++|..|.+.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 579999999999999999999999999999999987655433 44677889999889999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||++..+|.. ...+++..+..++.+++.|+..||..| +|||||||+|+|||..|++||+|||+|.....
T Consensus 221 EylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999976 678999999999999999999999999 99999999999999999999999999842111
Q ss_pred ----------------------CCcc-----------------------eeecccccccCcccccccccCCCCcccchhh
Q 017175 226 ----------------------GDKT-----------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260 (376)
Q Consensus 226 ----------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 260 (376)
.+.. ......+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0011257999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccccc-cchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC---
Q 017175 261 FGVVLLEIITGRKAIDNTRAAGE-HNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP--- 336 (376)
Q Consensus 261 lG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp--- 336 (376)
||||+||||.|.+||....+..- .++..|...+ .-+ -....+.++.+||.+||. ||++|.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----------~fP----~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----------KFP----EEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----------cCC----CcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999998765422 1222221111 000 011233688999999999 999997
Q ss_pred CHHHHHHHHHh
Q 017175 337 LIADVVTALTY 347 (376)
Q Consensus 337 s~~ell~~L~~ 347 (376)
.++||-+|-++
T Consensus 438 G~~EIK~HPfF 448 (550)
T KOG0605|consen 438 GAEEIKKHPFF 448 (550)
T ss_pred cHHHHhcCCcc
Confidence 47888777553
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=348.94 Aligned_cols=264 Identities=26% Similarity=0.340 Sum_probs=213.1
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------------chHHHHHHHHHHhhcCCCCcc
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------------GNREFLVEVLMLSLLHHPNLV 129 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~ni~ 129 (376)
.....++|++.+.||+|.||.|-+|++..+++.||||++.+.... ..+.+.+|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345567899999999999999999999999999999999754321 225788999999999999999
Q ss_pred ceeEEEec--CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC
Q 017175 130 NLIGYCAD--GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (376)
Q Consensus 130 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~ 207 (376)
+++++..+ .+.+|||+|||..|.+...-. ....+++.+++.++++++.||+|||.+| |+||||||.|+|++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 99999977 468999999999887755432 2333999999999999999999999999 99999999999999
Q ss_pred CCCceEEcccccccccCCCC---cceeecccccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 208 EGYHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
++|++||+|||.+.....+. ........+|||.|+|||.+.++. .+.+.||||+||+||+|+.|..||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999997643331 112223478999999999998742 35678999999999999999999986543
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. .+..+++..+.-.........+.+||.+||++||++|.++.+|..|.+...-
T Consensus 325 ~~----------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LE----------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HH----------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 21 2223333333322223455688899999999999999999999999886543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=351.80 Aligned_cols=251 Identities=29% Similarity=0.398 Sum_probs=214.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
...|+...+||+|.||.||+|.+..+++.||+|++......+ ..++.+|+.+|.+++++||.++|+.+..+..+|++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345888899999999999999999999999999998765443 5778899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
||.||++.+.+.. ...+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+......
T Consensus 92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999965 444588888999999999999999999 999999999999999999999999999764433
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.. ....++||+.|||||++....|+.++||||||++.+||++|.+|+....+.....+ +.+-..|
T Consensus 165 ~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP 229 (467)
T KOG0201|consen 165 VK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPP 229 (467)
T ss_pred hh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCC
Confidence 33 23668999999999999988999999999999999999999999998776322111 1122223
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.+.+ ..+..+.+|+..||..||+.||+|.++++|
T Consensus 230 ~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3333 445578899999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=348.28 Aligned_cols=271 Identities=24% Similarity=0.317 Sum_probs=211.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecC--CceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l 143 (376)
.+.|+.+++||+|.||.||+|++..+|+.||+|+++..... ...-..+||.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688899999999999999999999999999999866533 234567899999999999999999998776 68999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|+|||+. +|.-++.. ..-.+++.++..++.|++.||+|||++| |+|||||..|||||.+|.+||+|||+|+..
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999985 88887765 4567999999999999999999999999 999999999999999999999999999965
Q ss_pred CCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-hhhhhcccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-RPLFKDRRKFS 301 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 301 (376)
...... ..+..+-|.+|+|||++++. .|+.++|+||.||||.||+.|++.|.+....+....+... -..........
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 444333 24556789999999999986 6999999999999999999999999887654333222110 00000000000
Q ss_pred cccCCc---CCCCC-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 302 QMADPT---LQGQY-------PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 302 ~~~~~~---~~~~~-------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.+.... ....+ ....+...++|+..+|..||.+|.|+.++|..=.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 110000 00011 1123457788999999999999999999987644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=353.59 Aligned_cols=258 Identities=31% Similarity=0.454 Sum_probs=219.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
..+++++.||+|.||.||+|.+.. ...||+|.+.... .....|.+|+.+|++|+|+|||++++++..+..+|||||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 346677889999999999999985 3469999996653 34467889999999999999999999999988999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+.|+|.+++.. ..+..+.....+.++.||++|++||++++ +|||||.+.||||+++..+||+|||+++. ...+.
T Consensus 284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~-~~d~~ 357 (468)
T KOG0197|consen 284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL-IGDDE 357 (468)
T ss_pred ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc-cCCCc
Confidence 99999999986 35678999999999999999999999999 99999999999999999999999999993 23333
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
........-...|.|||.+..+.++.+||||||||+||||+| |+.|+......+ ..+.++..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~~le~G 420 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLELLERG 420 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHHHHhcc
Confidence 333444456678999999999999999999999999999999 889988765432 12233334
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.+-..|..++..+.+|+..||+.+|++|||++.+...|.++...
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 44466677888999999999999999999999999999988753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=354.89 Aligned_cols=250 Identities=31% Similarity=0.418 Sum_probs=217.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+.+.. +.+.+.+|+.+++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5789999999999999999999999999999999865433 34668899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+.| +|..++.. ...++++.+..++.+++.||.|||+++ |+|||+||.|||++.+|.+|+||||+++....
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9975 99999975 788999999999999999999999999 99999999999999999999999999997443
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........|||.|||||++.+..|+..+|+||||||+|||++|++||..... ...+..+..++.
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d~v-------- 217 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKDPV-------- 217 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcCCC--------
Confidence 44556678899999999999999999999999999999999999999986532 122222221111
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..|...+..+..++...|..||.+|.+-.+++.|-.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 123356678899999999999999999999998744
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=342.89 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=216.1
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---HHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.+..+|++.+.||+|.||.|-+|.....|+.||||.+++....+.++ +.+|+.++..|+||||+.+|++|++.+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 35678999999999999999999999999999999999877766554 678999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
|||||..+|.|++|+.. .+.+++.++..+++||.+|+.|+|.++ ++|||||.+|||+|.++++||+|||++-.
T Consensus 130 ivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999976 678999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
+..+ .....+||++.|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+.. .++++ +...
T Consensus 203 y~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQ-Is~G---- 268 (668)
T KOG0611|consen 203 YADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQ-ISRG---- 268 (668)
T ss_pred hccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHH-hhcc----
Confidence 4333 34566899999999999999887 48899999999999999999999987542 11111 1111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+...+ ..+....-||++||-.||++|.|+++|+.|-|
T Consensus 269 aYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 269 AYREP--------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred cccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11111 11224556999999999999999999999976
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=337.46 Aligned_cols=272 Identities=22% Similarity=0.302 Sum_probs=216.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEec--cCCccchHHHHHHHHHHhhcCCCCccceeEEEec-----C
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----G 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~ 138 (376)
.+...|...+.||.|+||.|+.|.++.+|+.||||++. .......+...+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 45667888899999999999999999999999999997 3445556778899999999999999999999865 3
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
..+|+|+|+| +.+|...++. ++.++...+..++.|++.||.|+|+.+ |+||||||.|++++.+..+||+|||
T Consensus 99 ~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 5789999999 4789988865 556999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh-----
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP----- 292 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----- 292 (376)
+|+...........+..+.|.+|+|||++.. ..|+.+.||||+|||+.||++|++.|.+.+.......+.....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9997654433444467889999999998865 4799999999999999999999999988765544333221110
Q ss_pred ---hhhcc------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 293 ---LFKDR------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 293 ---~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.+... ..........+..-+ +.....+.+|+.+||..||.+|+|++|.|+|--
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 00000 000011111111111 244568889999999999999999999998843
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=345.55 Aligned_cols=249 Identities=25% Similarity=0.313 Sum_probs=208.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368999999999999999999999999999999865432 23456778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~-------- 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGK-------- 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC--------
Confidence 1 2235699999999999998999999999999999999999999986543211 11111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
..++...+..+.+|+.+||+.||.+||+ +.++++|-+.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 0122233457889999999999999995 9999999765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=363.84 Aligned_cols=263 Identities=24% Similarity=0.284 Sum_probs=218.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEE-Eec------CC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGY-CAD------GD 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~-~~~------~~ 139 (376)
..++++.+.|.+|||+.||+|.+...|..||+|++-..+....+.+.+|+.+|++|. |+|||.++|. ... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 457889999999999999999999888999999998777778888999999999998 9999999993 321 13
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.++|+||||.||.|-+++..+ ...+|++.++++|+.++++|+.+||... +||||||||-+||||+.+|.+||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~R--lq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTR--LQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHH--HhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 568999999999999999763 3455999999999999999999999985 7799999999999999999999999999
Q ss_pred ccccCCCCcceee-------cccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 220 AKLGPVGDKTHVS-------TRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 220 ~~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
+............ -...-|+.|+|||++. +...+.|+|||||||+||-||....||+..-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 9743322211100 1135789999999874 66889999999999999999999999997522
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
.++++-.+.-.-....+..+.+||..||+.||.+||++-+++.++..++....
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 23344333333335678899999999999999999999999999998886443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=354.39 Aligned_cols=243 Identities=29% Similarity=0.452 Sum_probs=209.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcC-CCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l 143 (376)
.++|.++++||+|.||+|+++..+.+++.+|||++++...- +.+..+.|-.++.... ||.++.++..|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46799999999999999999999999999999999876543 3455677888888775 9999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+.||++..+.+ ...+++..+..++..|+.||.|||+++ |||||||.+|||+|.+|++||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999555443 477999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.. .....+++||||.|+|||++.+..|+..+|.|||||+|||||.|..||.+.+.++.... +
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds----------------I 580 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----------------I 580 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------------H
Confidence 32 23356779999999999999999999999999999999999999999998766533221 1
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI 338 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 338 (376)
++.. -.+|...+.+...++.++|..+|++|.-+
T Consensus 581 ~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 14566777899999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=326.30 Aligned_cols=273 Identities=23% Similarity=0.297 Sum_probs=216.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch--HHHHHHHHHHhhcCCCCccceeEEEec--CCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 144 (376)
+.|+.++.|++|+||.||+|+++.+++.||+|+++....... -..++|+.+|.+.+|||||.+-++... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 458889999999999999999999999999999975542221 245799999999999999999888754 4679999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||||+ -+|...+..+ .+++...++..++.|++.|+.|||.+. |+|||||++|+|++..|.+||+|||+|+...
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99997 4899988874 478999999999999999999999999 9999999999999999999999999999744
Q ss_pred CCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh--------hhhhh
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA--------RPLFK 295 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~ 295 (376)
.. ....+..+-|.+|+|||++.+. .|+...|+||+|||+.||+++.+.|.+....+..+.+-.. ++.+.
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 33 3345567889999999999886 6999999999999999999999999887654443222110 01111
Q ss_pred cc-----cccccccCCcCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 296 DR-----RKFSQMADPTLQGQYPVR-GLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 296 ~~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. ..+....-..+++.|... .+...++|+..+|..||.+|.|+.+.|.+=++...
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 00 011111111222233322 45678899999999999999999999999877664
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.51 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=205.6
Q ss_pred hcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecC-C
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 139 (376)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999752 3456799999875432 2345688999999999 799999999988764 4
Q ss_pred ceEEEEEccCCCchhhhhccCCC---------------------------------------------------------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPP--------------------------------------------------------- 162 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 162 (376)
.++++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999864211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCc
Q 017175 163 -DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241 (376)
Q Consensus 163 -~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 241 (376)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++................++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235788899999999999999999999 999999999999999999999999999753322221122234467889
Q ss_pred ccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHH
Q 017175 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQA 320 (376)
Q Consensus 242 ~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 320 (376)
+|||++.+..++.++|||||||++|+|++ |..||........ ... ....... ...+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~-~~~~~~~----------~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQ-RLKDGTR----------MRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHH-HHhcCCC----------CCCCCCCCHHH
Confidence 99999999899999999999999999997 9999986432210 001 1111000 01122334578
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 321 LAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 321 ~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+|+.+||+.||++|||+.+|++.|+.+-.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=316.49 Aligned_cols=254 Identities=28% Similarity=0.402 Sum_probs=217.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++++.||+|-||.||+|+.+.++-.||+|++.+.... ...++.+|+.+.+.|+||||+++|++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5699999999999999999999999999999999765433 2356889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||.+.|+|...+... ...++++...+.++.|++.||.|+|..+ ++||||||+|+|++..|.+||+|||.+...+
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999752 3567899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.......|||..|.|||+..+..++..+|+|++|++.||++.|.+||+.....+... .+. .. ++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------rI~----k~-~~-- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------RIR----KV-DL-- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------HHH----Hc-cc--
Confidence 223456899999999999999999999999999999999999999999765321111 111 11 11
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+|...+..+.++|.+||..+|.+|....+++.+-+-.+
T Consensus 240 -----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 -----KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -----cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 223445558889999999999999999999999987543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=314.99 Aligned_cols=268 Identities=26% Similarity=0.343 Sum_probs=219.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC-----ce
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QR 141 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~ 141 (376)
..+||++.+.||+|||+.||++....++..||+|++......+.+..++|+...++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4678999999999999999999999999999999998877778888999999999999999999998765443 48
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
|++++|...|+|.+.+......+..+++.+++.|+.+|++||.+||+.. +|+.||||||.|||+++.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999887777788999999999999999999999987 479999999999999999999999999997
Q ss_pred ccCCCCccee-------ecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 222 LGPVGDKTHV-------STRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 222 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
.....-.... ...-..|..|+|||.+.- ...+.++|||||||+||.|+.|.-||+..-..+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-------- 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-------- 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--------
Confidence 5332211111 112346788999998864 4578999999999999999999999985432111
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....++.+..+...-....+..+.++|..||+.||.+||++.+++..+..+.
T Consensus 250 ------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1112222322222222336678999999999999999999999999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.19 Aligned_cols=257 Identities=30% Similarity=0.360 Sum_probs=212.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.|++++.||.|.-|+||+|...+++..+|+|++.+...... .....|-.||+.++||.++.+|..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 458889999999999999999999999999999987655543 34566999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|....+. +.+..+++..+..++.+++-||+|||..| ||+|||||+||||-++|++.|+||+++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999877 35678999999999999999999999999 99999999999999999999999999743111
Q ss_pred ---------------------------------CCcc---------------------eeecccccccCcccccccccCC
Q 017175 226 ---------------------------------GDKT---------------------HVSTRVMGTYGYCAPEYAMTGQ 251 (376)
Q Consensus 226 ---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~ 251 (376)
.... .....++||.+|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 0112367999999999999999
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCC
Q 017175 252 LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQ 331 (376)
Q Consensus 252 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 331 (376)
.+.++|+|+|||++||||.|..||.+.....- +..++-..+.=......+..+.+||+++|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999987644311 11111111111111245678999999999999
Q ss_pred CCCCCC----HHHHHHHHH
Q 017175 332 PNMRPL----IADVVTALT 346 (376)
Q Consensus 332 P~~Rps----~~ell~~L~ 346 (376)
|++|.. +.||-+|-.
T Consensus 376 P~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhhhccccchHHhhcCcc
Confidence 999998 888877644
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=343.44 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=211.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4679999999999999999999999999999999875432 223568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999865 45689999999999999999999985 6 99999999999999999999999999875322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc-------
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR------- 298 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 298 (376)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+......... ........
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSIS 230 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccC
Confidence 1 1233569999999999998899999999999999999999999997654321110000 00000000
Q ss_pred -------------------------ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 299 -------------------------KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 299 -------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....+.............+..+.+|+.+||+.||++|||+.+|+++.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000000000011235578999999999999999999999999876544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=345.17 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=202.0
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975322 22345678999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999865 457899999999999999999999999 999999999999999999999999998742211 112
Q ss_pred ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCC
Q 017175 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ 311 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (376)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ....... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------~~~~~~~------------~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEE------------IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH------HHHHcCC------------CC
Confidence 23457999999999999999999999999999999999999999765432111 1111100 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 312 YPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
++...+..+.+|+.+||+.||++|| ++.++++|-+
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 2233455788999999999999999 8999998744
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=344.51 Aligned_cols=249 Identities=29% Similarity=0.366 Sum_probs=207.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56999999999999999999999999999999986532 223456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999875 456889999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~------- 232 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEKILAGRL------- 232 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCc-------
Confidence 1 1235799999999999999999999999999999999999999976533211 011111000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
.++...+..+.+|+.+||+.||.+||+ +.+++.|-+.
T Consensus 233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 112223446789999999999999997 7999988553
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=344.31 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=210.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999975422 23456778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999965 456899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+ ... .....
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~----~~~~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL------KYW----KETLQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH------Hhc----ccccc
Confidence 233467999999999999999999999999999999999999999865432211111 000 00011
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...........+.++.+++.+||..+|.+||++.+++++.+..
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 0000000123355788999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=336.12 Aligned_cols=268 Identities=23% Similarity=0.319 Sum_probs=205.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||.|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5699999999999999999999999999999998754322 234677899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++ ++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 489888865 2345789999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh--------hhhhhccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA--------RPLFKDRR 298 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 298 (376)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+........ .+.+....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12233568999999999876 46899999999999999999999999765433221111000 00000001
Q ss_pred ccccccCCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 299 KFSQMADPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 299 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.+.....+.... ......+.++.+|+.+||+.||.+|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 111111111110 00112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=319.25 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=214.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+.++|++.+.||+|.|+.|+++.+..+|+.+|+|+++... ..+.+++.+|+.+.+.|+||||+++.+.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 46678999999999999999999999999999999987543 3466789999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~~kl~Dfg~~ 220 (376)
|+|+|.|++|..-+-. ...+++..+...++||++||.|+|.++ |+|||+||+|+++- ..--+||+|||++
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999887754 356888999999999999999999999 99999999999993 3446899999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
.... ........+|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.+.... ..++...
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g---- 227 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAG---- 227 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhcc----
Confidence 8755 22344567899999999999999999999999999999999999999987543221 1111111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
....++... ...+.+..+|+++||..||.+|.|+.|.|.|-|--
T Consensus 228 ~yd~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 228 AYDYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred ccCCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 111222112 23345788999999999999999999998875543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=340.60 Aligned_cols=245 Identities=27% Similarity=0.355 Sum_probs=201.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 23356778999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99988865 456899999999999999999999999 999999999999999999999999998742211 112
Q ss_pred ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCC
Q 017175 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ 311 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (376)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ...... . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~~~~~~--------~----~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILME--------D----IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------HHhccC--------C----cc
Confidence 23457999999999999889999999999999999999999999765432110 000000 0 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 312 YPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
++...+..+.+|+.+||..||++|+ ++.+++++.+
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 2233445788999999999999997 8999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=331.32 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=210.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC-----ceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~ 142 (376)
.-.|.-.+++|.|+||.||.|....+++.||||++-... +.-.+|+.+|+.+.|||||++.-+|.... +..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345888899999999999999999999999999985432 23347999999999999999998886432 345
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAK 221 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg~~~ 221 (376)
+|||||+ .+|...++.+...+.+++.-.+.-++.||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 8999998 6999999876667888999999999999999999999999 9999999999999966 899999999999
Q ss_pred ccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh------hhh
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR------PLF 294 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------~~~ 294 (376)
....+... ....-|..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.+.+..+....+..+- .+.
T Consensus 175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 76666543 335678999999999886 69999999999999999999999999876554432221110 000
Q ss_pred hcc-----cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 295 KDR-----RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 295 ~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... ..+..+....+..-+....+.++.+|+.++|..+|.+|.++.|++.+-.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 000 1111222222211133345668899999999999999999999997743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=334.02 Aligned_cols=255 Identities=29% Similarity=0.401 Sum_probs=206.6
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
|+..+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 77889999999999999999999999999998754322 223567899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|..++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998887542 2346899999999999999999999999 9999999999999999999999999997533222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
......||..|+|||++.+..++.++|||||||++|+|++|..||............ ..... .
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~---------~-- 219 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVK---------E-- 219 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhh---------c--
Confidence 123357999999999999999999999999999999999999999865432111000 00000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
....++...+..+.+|+.+||+.||.+||+ +.+++++-+.
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 001222334557889999999999999997 8999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.24 Aligned_cols=269 Identities=23% Similarity=0.277 Sum_probs=206.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 469999999999999999999999999999999875432 233567789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777655432 356899999999999999999999999 999999999999999999999999999764322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh-hhh-------hhhhccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA-WAR-------PLFKDRR 298 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~-------~~~~~~~ 298 (376)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||......+...... ... ..+....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 211 1223568999999999998889999999999999999999999998654322111000 000 0000000
Q ss_pred ccccccCCcCCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 299 KFSQMADPTLQG------QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 299 ~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.......+.... ......+..+.+|+.+||+.||++|||+.++++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 111111111100 11112455789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=338.81 Aligned_cols=246 Identities=27% Similarity=0.349 Sum_probs=201.6
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875322 23345678999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988865 456899999999999999999999999 9999999999999999999999999987422211 11
Q ss_pred ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCC
Q 017175 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ 311 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (376)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ........ ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~~------------~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEE------------IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCC------------CC
Confidence 2335799999999999998999999999999999999999999976543211 01111000 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 312 YPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 312 ~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
++...+..+.+++.+||..||++|| ++.+++++-+.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 2223455788999999999999998 89999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=342.01 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=216.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCc-eEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~ 145 (376)
++|..++.+|+|+||.+++++++..+..|++|.+...... ..+...+|+.+++++.|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5799999999999999999999999999999999865433 33467889999999999999999999998887 89999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
+||+||+|.+.+... .+.-++++.+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+++....
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999773 2467899999999999999999999998 99999999999999999999999999997443
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. ......+||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+-.... ..+.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li------~ki~----------- 219 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI------LKIN----------- 219 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH------HHHh-----------
Confidence 33 3456689999999999999999999999999999999999999999876543211 1111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
+......+...+.++..+|..||+.+|+.||++.+||.+
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111223445667789999999999999999999999977
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=321.38 Aligned_cols=270 Identities=23% Similarity=0.318 Sum_probs=209.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCC-ccceeEEEecCC-----
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD----- 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~----- 139 (376)
...|...++||+|+||+||+|+.+.+|+.||+|+++..... .-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788899999999999999999999999999865432 2235679999999999999 999999998877
Q ss_pred -ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 140 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
..++|+||++ -+|..++.........++...+..++.||+.||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999996 6999999876543356777899999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
+++....... ..+..++|.+|+|||++.+. .|+...||||+|||++||++++..|.+....+....+-. ....+
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~---~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR---LLGTP 240 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH---HcCCC
Confidence 9986443332 24456799999999999987 799999999999999999999999987654322111100 00000
Q ss_pred --ccccccc---CC--cCCCCC-CH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 --RKFSQMA---DP--TLQGQY-PV-------RGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 --~~~~~~~---~~--~~~~~~-~~-------~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....... +- .+.... +. .......+++.+||+.+|.+|.|+..+++|--
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y 304 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY 304 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence 0000000 00 000000 11 11237888999999999999999999999843
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=344.36 Aligned_cols=271 Identities=22% Similarity=0.293 Sum_probs=213.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-C-----CCccceeEEEecCC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGD 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~~ 139 (376)
.+..+|.+.+.||+|+||.|.+|.+.+|++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++|...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3445899999999999999999999999999999999654 344556678999999987 4 48999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC--CceEEccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG--YHPKLSDF 217 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~--~~~kl~Df 217 (376)
+.|||+|.+. .+|+++++.. .-..++...++.++.||+.||.+||+.+ |||+||||+|||+.+- ..|||+||
T Consensus 262 HlciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 9999999995 7999999874 4566999999999999999999999999 9999999999999643 37999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----h
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----P 292 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~ 292 (376)
|+++...... ...+.+..|+|||++.+..|+.+.||||||||++||++|.+.|.+....+....+..+. .
T Consensus 336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 336 GSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred ccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9998633222 25678899999999999999999999999999999999999998876554433322110 0
Q ss_pred hhhcccccccccCC----------------------------------------cCCCCCCHHHHHHHHHHHHHcccCCC
Q 017175 293 LFKDRRKFSQMADP----------------------------------------TLQGQYPVRGLYQALAVAAMCVQEQP 332 (376)
Q Consensus 293 ~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~P 332 (376)
++..........+. .+...........+.+++.+||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 01100000111110 00001111335578999999999999
Q ss_pred CCCCCHHHHHHHHHhh
Q 017175 333 NMRPLIADVVTALTYL 348 (376)
Q Consensus 333 ~~Rps~~ell~~L~~~ 348 (376)
.+|+|+.+.++|-+.-
T Consensus 491 ~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 491 AERITPAQALNHPFLT 506 (586)
T ss_pred hhcCCHHHHhcCcccc
Confidence 9999999999997744
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=333.85 Aligned_cols=266 Identities=27% Similarity=0.412 Sum_probs=205.0
Q ss_pred hcCcccCceecccCceEEEEEEECC----------------CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES----------------TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVN 130 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~ 130 (376)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998642 3457999998754332 2356889999999999999999
Q ss_pred eeEEEecCCceEEEEEccCCCchhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 017175 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195 (376)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~ 195 (376)
+++++.+....++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998854211 1234788899999999999999999999 99
Q ss_pred ecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCC
Q 017175 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRK 273 (376)
Q Consensus 196 Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~ 273 (376)
||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975433333222333456789999999988899999999999999999987 556
Q ss_pred CCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 274 AIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
||........ .......+..... ......+...+..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765433211 1111111111000 0000112233457889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=338.67 Aligned_cols=243 Identities=28% Similarity=0.354 Sum_probs=199.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986432 22335577899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999865 456899999999999999999999999 9999999999999999999999999987522211 2233
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........... .++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~------------~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPL------------RFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC------------CCC
Confidence 467999999999999999999999999999999999999999764322 11111111110 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC---CHHHHHHHHH
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRP---LIADVVTALT 346 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rp---s~~ell~~L~ 346 (376)
...+..+.+++.+||+.||++|| ++.+++.|-+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 33445788999999999999997 5788887744
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=315.53 Aligned_cols=271 Identities=23% Similarity=0.331 Sum_probs=220.6
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc----ch----HHHHHHHHHHhhcC-CCCccceeEEE
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----GN----REFLVEVLMLSLLH-HPNLVNLIGYC 135 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~----~~~~~e~~~l~~l~-h~ni~~~~~~~ 135 (376)
..+-..|.-.+.||.|..++|.++.++.+|..+|+|++...... .. +.-..|+.+|+++. ||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788899999999999999999999999999998643211 11 33457999999875 99999999999
Q ss_pred ecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 136 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
+.+...++|+|.|+.|.|.+++.. ...+++....+|++|+++|++|||..+ |+||||||+|||++++.+++|+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999976 678999999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
|||+++....+.. ....||||+|+|||.+.. ..|+..+|+||+|||+|.||.|.+||-.....-....+.
T Consensus 166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im- 241 (411)
T KOG0599|consen 166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM- 241 (411)
T ss_pred ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH-
Confidence 9999998766654 445899999999998863 368889999999999999999999998765432221111
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC-CCCCCC
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY-DPESQP 359 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~-~~~~~~ 359 (376)
... .++..+.+ .+.+....+||.+||+.||.+|.|++|+|.|-+.++.... .++.+|
T Consensus 242 -----eGk---yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 242 -----EGK---YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred -----hcc---cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 111 11222222 2455678899999999999999999999999887665332 344444
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=354.43 Aligned_cols=256 Identities=21% Similarity=0.246 Sum_probs=209.4
Q ss_pred cCcccCceecccCceEEEEEEECCC-CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST-NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..|.+.+.||+|++|.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3499999999999999999998877 788999987655544455677899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653334557899999999999999999999999 9999999999999999999999999998643332
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ . ..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~~~--~----~~-- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVLYG--K----YD-- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC--C----CC--
Confidence 2223344679999999999999899999999999999999999999997643321 11111000 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..+...+..+.+++.+||..+|++||++.+++.+
T Consensus 290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122334578899999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.34 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=205.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36799999999999999999999999999999998754322 23456789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 678777754 2456889999999999999999999999 999999999999999999999999998743221
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc--------
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-------- 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 297 (376)
. .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ............
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccch
Confidence 1 122345689999999998754 588899999999999999999999986432100 000000000000
Q ss_pred cccccccCCcCCCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 298 RKFSQMADPTLQGQYP---------VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...............+ ...+..+.+|+.+||+.||++|||+.++++|-+.-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0000000000000000 012346789999999999999999999999877544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=342.79 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=205.0
Q ss_pred hcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34799999999999999999974 3456789999986543 23345688899999999 79999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC----------------------------------------------------------
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP---------------------------------------------------------- 162 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 162 (376)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 163 -------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 163 -------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235788899999999999999999999 999999999999999999999999999754332222
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ..... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~----------~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEG----------Y 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhC----------c
Confidence 22222345678999999999999999999999999999998 888987543221 0011 11100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
....+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 001112234578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=337.34 Aligned_cols=256 Identities=27% Similarity=0.317 Sum_probs=217.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcC-CCCccceeEEEecCCce
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 141 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 141 (376)
.+...|.+.+.||.|.||.||+|+.+.+|+.+|+|.+.+...... ..+.+|+.+|+++. ||||+.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 456789999999999999999999999999999999987665443 57889999999999 99999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC----CCceEEccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----GYHPKLSDF 217 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~----~~~~kl~Df 217 (376)
++|||+|.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+.. ++.++++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999763 3999999999999999999999999 999999999999953 357999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
|++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+ ...
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~~- 253 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LRG- 253 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------HcC-
Confidence 99987444 33455689999999999999899999999999999999999999999876543221111 000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.+ .+....-...+..+.++|..||..||..|+++.++|+|.|
T Consensus 254 -~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 -DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 00 1111222344668889999999999999999999999866
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=328.04 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=200.6
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEec----CCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~ 147 (376)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 67999999999999984 8899999997654333 3567799999999999999999999876 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
+++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999975 45688999999999999999999984 7 889999999999999999999999998753222
Q ss_pred CcceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
. ....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......+.. .......
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~------~~i~~~~------- 238 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY------DLIINKN------- 238 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhcC-------
Confidence 1 23468899999999976 67899999999999999999999999865432111 1111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 239 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 ---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0111222345578899999999999999999999999998765
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=335.99 Aligned_cols=248 Identities=28% Similarity=0.407 Sum_probs=200.6
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHH---hhcCCCCccceeEEEecCCceEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999999999999999997532 12234556666554 456799999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988753 56899999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. .......+|++.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~~~------- 217 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVNDE------- 217 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-------
Confidence 11 11223467999999999999989999999999999999999999999865432111 1111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
..++...+..+.+++.+||+.||.+|| ++.+++++.+
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 012223345778999999999999999 6888888753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=342.55 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=205.3
Q ss_pred cCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
++|++.+.||+|+||.||+|++... +..||+|.+...... ....+.+|+.+++.+ +|+||+++++++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4799999999999999999986443 357999999754322 335678899999999 799999999999999999
Q ss_pred EEEEEccCCCchhhhhccCC------------------------------------------------------------
Q 017175 142 LLVYEYMPLGSLEDHLHDLP------------------------------------------------------------ 161 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~------------------------------------------------------------ 161 (376)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeeccc
Q 017175 162 ------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235 (376)
Q Consensus 162 ------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 235 (376)
....++++..++.++.||+.||.|||+++ |+||||||+|||+++++.++|+|||++...............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01235788899999999999999999999 999999999999999999999999999754333222222233
Q ss_pred ccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCH
Q 017175 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPV 314 (376)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (376)
.++..|+|||++.+..++.++|||||||++|+|++ |..||........ .. ...... .....+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~----------~~~~~~~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG----------YQMSRPD 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc----------cCccCCC
Confidence 45678999999988899999999999999999997 9999976433211 00 000000 0001111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 315 RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 315 ~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=337.99 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=211.0
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
....+...+...||+|.||+||+|++.++ ||||+++..... ..+.|.+|+.++++-+|.||+-+.|++..... .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 34445677889999999999999999864 999999866544 34679999999999999999999999988777 9
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
||+.+|.|.+|+.+++. ...++.....+.|++||++|+.|||.++ |||||||..|||+.+++.|||+|||++..
T Consensus 464 IiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999987 4577899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
...-..........|...|||||+++.. +|+..+|||||||++|||++|..||.....+ .. + |.-..-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qI--i------fmVGrG 608 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QI--I------FMVGRG 608 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-he--E------EEeccc
Confidence 3222222222335688899999999753 6899999999999999999999999843222 11 0 000000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+.+.. ......+.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 -~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 -YLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0001100 1122456688899999999999999999999999988876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.28 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=202.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCC-CCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 145 (376)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999999999999999987532 2234567788999988876 56888999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998865 456899999999999999999999999 99999999999999999999999999864222
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~------~~i~~~--------- 216 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QSIMEH--------- 216 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHcC---------
Confidence 211 223457999999999999989999999999999999999999999865432111 111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI-----ADVVTAL 345 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~~L 345 (376)
...++...+..+.+++.+||..||.+|++. .+++++-
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp 258 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA 258 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 011222344578899999999999999976 7777663
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=339.65 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=205.6
Q ss_pred cCcccCceecccCceEEEEEEECCCC-eEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46999999999999999999876654 689999986432 22335677899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999875 457899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~------- 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILEGI------- 244 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhcCC-------
Confidence 21 2235799999999999988899999999999999999999999986543211 11111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
..++...+..+.+++.+||+.+|++|+ ++.+++++.+.
T Consensus 245 -----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 245 -----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 012223345678899999999999995 89999988653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.74 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=201.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.+|+..+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+...+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4577889999999999999999999999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.... ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 3467788899999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.......||..|+|||++.. ...+.++|||||||++|+|++|..||......+...... .....
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~------ 291 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICMS------ 291 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhcc------
Confidence 11233579999999998743 234568999999999999999999998433221111110 00000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+||.+||+.||++||++.|++++-+....
T Consensus 292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0011122345578899999999999999999999999875554
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.68 Aligned_cols=245 Identities=29% Similarity=0.423 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.++.+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 22334566788888766 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999998865 456899999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~------------ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEV------------ 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCCC------------
Confidence 23345799999999999988999999999999999999999999986543211 111111100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLI------ADVVTALT 346 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~~L~ 346 (376)
..+...+..+.+++.+||+.||++||++ .+++.|-+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 1122234578899999999999999998 77877744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=338.66 Aligned_cols=266 Identities=18% Similarity=0.200 Sum_probs=203.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
.+|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 579999999999999999999999999999997542 34678999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
. ++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 5 688888754 456899999999999999999999999 9999999999999999999999999986422111
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc-cchhhhhhhhhhccc----c----
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE-HNLVAWARPLFKDRR----K---- 299 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~----~---- 299 (376)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+. .........++...+ .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999998999999999999999999999987754322110 000000000000000 0
Q ss_pred ----ccc---------ccCCcCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 300 ----FSQ---------MADPTLQGQ--YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 300 ----~~~---------~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... ...+..... .....+..+.+|+.+||+.||++|||+.|++++-+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000 000000000 00123557889999999999999999999999887543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.10 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=205.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 368999999999999999999999999999999975322 22345678999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcce------------------------------------eecccccccCcccccccccCCCCcccchhhHHHHHHHHH
Q 017175 226 GDKTH------------------------------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII 269 (376)
Q Consensus 226 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 269 (376)
..... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHH
Q 017175 270 TGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL---IADVVTALT 346 (376)
Q Consensus 270 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ell~~L~ 346 (376)
+|..||........ ..........+ .. ......+..+.+||.+||. +|.+|++ +.+++++-+
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~~~~~~---~~-----~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIINWKETL---QF-----PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHcCCCcc---CC-----CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 99999986543211 11111100000 00 0011234577889999997 9999998 999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=337.84 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=200.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.+..++..||+|++..... .....+..|+.+++.++||||+++++++.+....|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975322 22345678999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
+|..++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99988865 4568999999999999999999997 78 9999999999999999999999999986422111 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~------i~~~~------------~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------ILMEE------------I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH------HhcCC------------C
Confidence 22335799999999999998999999999999999999999999976543211110 00000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
.++...+..+.+|+.+||+.||++|+ ++.+++++.+
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 12223345788999999999999997 9999998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.72 Aligned_cols=243 Identities=30% Similarity=0.437 Sum_probs=195.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhh-cCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++.... .........|..++.. .+||||+++++++......|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 1223445566666654 4799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998865 456899999999999999999999999 9999999999999999999999999997532222 2
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcC------------CC
Confidence 23345799999999999988999999999999999999999999986543211 1111110 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA-DVVTA 344 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~~ 344 (376)
.++...+..+.+++.+||+.+|++||++. +++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12233445778899999999999999875 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.76 Aligned_cols=260 Identities=34% Similarity=0.505 Sum_probs=209.5
Q ss_pred cCcccCceecccCceEEEEEEECCCC-----eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
++|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46889999999999999999886555 67999998754332 2346788999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC
Q 017175 143 LVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~ 210 (376)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 1156889999999999999999999999 99999999999999999
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 289 (376)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 999999999975433332223334567889999999988899999999999999999998 999997654321110
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
. .... .....+...+..+.+|+.+||+.||.+||++.+|+++|..+
T Consensus 238 --~-i~~~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 --M-IRSR----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --H-HHcC----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 0 0000 00112234456888999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.25 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=200.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2234577899999888 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999988864 467999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccc--ccchhhhhhhhhhcccccccccCCcC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG--EHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||+.....+ ......+....... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------KQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------CCC
Confidence 2234679999999999999999999999999999999999999997432211 11111111111110 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHHHHh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPL------IADVVTALTY 347 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ell~~L~~ 347 (376)
..+...+..+.+++.+||+.||.+|++ +.++++|-+.
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 122234457889999999999999997 7888877443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.59 Aligned_cols=242 Identities=27% Similarity=0.408 Sum_probs=202.8
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
++-||.|+.|.||+|+.+ ++.||||+++.- -..+|..|++|+|+||+.|.|+|.....+|||||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 345999999999999988 789999998532 22589999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+.++. ...++......|..+|+.|+.|||.+. |||||||.-||||+.+..|||+|||.++..... ...-
T Consensus 200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999976 678999999999999999999999999 999999999999999999999999999853222 1223
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
.++||..|||||++.+.+.+.|+|||||||+|||||||..||.+-+..- +. +.-. ...+.-..|
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----II-----wGVG-------sNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----II-----WGVG-------SNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eE-----Eecc-------CCcccccCc
Confidence 4789999999999999999999999999999999999999998654321 00 0000 111112334
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..++..+.-|+.+||+..|..||++++|+.||.-+..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 4555577779999999999999999999999985544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=330.03 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=207.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|++.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 469999999999999999999866555 389999865432 3345688899999999999999999998764 5779
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
+++|+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999875 2456889999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.............++..|+|||.+.+..++.++|||||||++|+|++ |..||+........ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~---- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE---- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHhCCC----
Confidence 43332222222345678999999999999999999999999999998 99999764332111 1111100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
....+...+..+.+++.+||..+|++||++.+++..|..+....
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111223446788999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=351.26 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=209.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCC----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 139 (376)
...++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999999999999999999765332 3345778999999999999999988765432
Q ss_pred ----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 140 ----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 140 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999998765445567999999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc
Confidence 9999975433222223344679999999999999999999999999999999999999997643221 1111111
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. .. ...+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 260 ~------~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 G------RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C------CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 00 11223345578899999999999999999999876
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.51 Aligned_cols=271 Identities=23% Similarity=0.345 Sum_probs=203.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecC-----CceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~ 142 (376)
+|++.+.||+|+||.||+|++..++..||||++... .......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999999999999999998643 223345678999999999999999999988543 2479
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689888864 456899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCc-ceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh---------h
Q 017175 223 GPVGDK-THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW---------A 290 (376)
Q Consensus 223 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------~ 290 (376)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322211 112234579999999999876 5789999999999999999999999976542211100000 0
Q ss_pred hhhhhc--cccccccc---CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 291 RPLFKD--RRKFSQMA---DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 291 ~~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...... ...+..+. .......+ ...+..+.+++.+||+.||++||++.+++++-+...
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000000 00000000 00000000 112346789999999999999999999999866544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.86 Aligned_cols=270 Identities=22% Similarity=0.272 Sum_probs=208.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999875422 233568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999865 45688999999999999999999974 6 99999999999999999999999999864321
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh-h------hccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL-F------KDRR 298 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~------~~~~ 298 (376)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||.................. . ....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 122356899999999999888999999999999999999999999764332111000000000 0 0000
Q ss_pred ---------------------ccccccCCcCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 ---------------------KFSQMADPTLQGQYP-VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ---------------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....+... .....+ ...+.++.+|+.+||+.||++|||+.+++.+-+.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcC-CCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000000 000000 113457889999999999999999999998876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.87 Aligned_cols=257 Identities=23% Similarity=0.239 Sum_probs=202.4
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999999999999999999975432 223457889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999865 456899999999999999999999999 999999999999999999999999997532100
Q ss_pred Cc---------------------------------------------ceeecccccccCcccccccccCCCCcccchhhH
Q 017175 227 DK---------------------------------------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 261 (376)
Q Consensus 227 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 261 (376)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcc--cCCCCCCCCHH
Q 017175 262 GVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCV--QEQPNMRPLIA 339 (376)
Q Consensus 262 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~~P~~Rps~~ 339 (376)
||++|+|++|..||......... ......... .........+.++.+|+.+|+ ..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHccccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999865432110 000000000 000011123457778888844 55666699999
Q ss_pred HHHHHHHh
Q 017175 340 DVVTALTY 347 (376)
Q Consensus 340 ell~~L~~ 347 (376)
+++.|-+.
T Consensus 301 ~~l~hp~f 308 (381)
T cd05626 301 DIKAHPFF 308 (381)
T ss_pred HHhcCccc
Confidence 99998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=322.13 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=205.0
Q ss_pred hcCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+..... .....+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999765 4467899999876532 223568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999865 2356899999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .. ....
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~------~~-~~~~----- 224 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI------KA-VEDG----- 224 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH------HH-HHCC-----
Confidence 2111 111112345678999999999999999999999999999875 99999765432111 00 0000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
... ..+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 225 -~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 11223345788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=329.79 Aligned_cols=243 Identities=31% Similarity=0.470 Sum_probs=196.1
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhh-cCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++.... .........|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987542 1223445667777765 5899999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999999865 356889999999999999999999999 99999999999999999999999999874322221
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~i~~~--------~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------QSIRMD--------NP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC--------CC----
Confidence 223457999999999999889999999999999999999999999765432111 110000 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA-DVVTA 344 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~~ 344 (376)
.++...+..+.+++.+||+.||++||++. +++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11222345778999999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=341.18 Aligned_cols=257 Identities=26% Similarity=0.312 Sum_probs=208.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+..|+.++..++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 469999999999999999999999999999999975322 23456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999976 367899999999999999999999999 99999999999999999999999999875332
Q ss_pred CC---------------------------cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 226 GD---------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 226 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001123356999999999999999999999999999999999999999865
Q ss_pred ccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHh
Q 017175 279 RAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-IADVVTALTY 347 (376)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~~L~~ 347 (376)
...... ......... ...+. ....+..+.+||.+||. +|.+||+ +.+++++.+.
T Consensus 234 ~~~~~~------~~i~~~~~~---~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 234 TLQETY------NKIINWKES---LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CHHHHH------HHHhccCCc---ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 432110 111110000 00000 01135578889999997 9999999 9999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=324.67 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=207.7
Q ss_pred cCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468889999999999999998743 3578999998765443 3467889999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 143 LVYEYMPLGSLEDHLHDLP----------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999987532 12355789999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---EC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH--
Confidence 9999999875322222222233456788999999999999999999999999999998 99998765432111 10
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
. .. .. ....+...+..+.+++.+||+.||++||++.||++.|.
T Consensus 237 -~-~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 -I-TQ-GR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -H-Hc-CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 00 00 01112233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=336.42 Aligned_cols=256 Identities=23% Similarity=0.277 Sum_probs=200.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 368999999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999865 467999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCcc---------------------------------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 017175 226 GDKT---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272 (376)
Q Consensus 226 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 272 (376)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHHH
Q 017175 273 KAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQ--EQPNMRPLIADVVTAL 345 (376)
Q Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~Rps~~ell~~L 345 (376)
.||......... ........ ....+. . ...+..+.+++.+++. .++..||++.+|++|-
T Consensus 234 ~Pf~~~~~~~~~------~~i~~~~~---~~~~p~---~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 234 PPFCSETPQETY------KKVMNWKE---TLIFPP---E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred CCCCCCCHHHHH------HHHHcCcC---cccCCC---c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence 999865432111 11111000 000000 0 1123467778877654 2334568999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=324.87 Aligned_cols=262 Identities=30% Similarity=0.443 Sum_probs=210.4
Q ss_pred cCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+..........+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5689999999999999999985 33456799999876554555678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 144 VYEYMPLGSLEDHLHDLP---------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986532 12235899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~------~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE------CI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HH
Confidence 99999875433222222223446778999999998889999999999999999998 899997654321110 00
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
... .. . ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 236 -~~~-~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 -TQG-RV-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HcC-Cc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 000 00 0 0111233468899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.80 Aligned_cols=271 Identities=22% Similarity=0.319 Sum_probs=203.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecC--------C
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------D 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~ 139 (376)
..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999999999999885432 2345799999999999999999887432 2
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFG 218 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg 218 (376)
.+++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999997 5777777554445677999999999999999999999999 99999999999998665 69999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccc-hhhhhh-h---
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN-LVAWAR-P--- 292 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~-~--- 292 (376)
+++....+. ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+... +..... +
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 997543322 12235789999999998764 68999999999999999999999998654321111 000000 0
Q ss_pred hhh-cccccc-----cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFK-DRRKFS-----QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+. ....+. ......+...++...+.++.+|+.+||+.||.+|||+.++++|-+.-.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 000 000000 011111111223334568899999999999999999999999877543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.72 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=201.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999875422 2223456677777776 4899999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998865 456899999999999999999999999 99999999999999999999999999874221
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~~~i~~~~-------- 217 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHN-------- 217 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC--------
Confidence 11 122346799999999999999999999999999999999999999986543211 11111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI-----ADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~~ 344 (376)
..++...+..+.+++.+||+.+|++|++. .+++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11223345578899999999999999984 677665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.93 Aligned_cols=245 Identities=29% Similarity=0.408 Sum_probs=199.6
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
++||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 22334566788888765 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999988865 456899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~-----~------- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDD-----V------- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC-----C-------
Confidence 23345799999999999988999999999999999999999999986543211 11111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRP-------LIADVVTALT 346 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rp-------s~~ell~~L~ 346 (376)
.++...+..+.+++.+||+.||++|| ++.+++++-+
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 11222345788999999999999999 8999988754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=331.17 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2334567788888766 799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999988864 457999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc--cchhhhhhhhhhcccccccccCCcC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE--HNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------~-- 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------K-- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------C--
Confidence 22346799999999999999999999999999999999999999964322111 1111111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHHHH
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPL------IADVVTALT 346 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ell~~L~ 346 (376)
...+|...+..+.+++.+||+.||++||+ +.++++|-+
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 01223344557889999999999999998 478877743
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.12 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=202.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999853211
Q ss_pred CCcc---------------------------------------------eeecccccccCcccccccccCCCCcccchhh
Q 017175 226 GDKT---------------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260 (376)
Q Consensus 226 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 260 (376)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCC---CC
Q 017175 261 FGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMR---PL 337 (376)
Q Consensus 261 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps 337 (376)
|||++|+|++|..||......... ......... +.-+ .....+..+.+||.+||. +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~---~~~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETY------RKIINWRET---LYFP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHH------HHHHccCCc---cCCC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999999765432111 111110000 0000 001234578899999998 67765 59
Q ss_pred HHHHHHHHHh
Q 017175 338 IADVVTALTY 347 (376)
Q Consensus 338 ~~ell~~L~~ 347 (376)
+.+++++.+.
T Consensus 299 ~~~~l~hp~~ 308 (377)
T cd05629 299 AHEIKSHPFF 308 (377)
T ss_pred HHHHhcCCCc
Confidence 9999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=331.28 Aligned_cols=244 Identities=28% Similarity=0.426 Sum_probs=196.4
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhh-cCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+|+.||+|++.... .........|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997532 1233455667777765 4799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999998865 456899999999999999999999999 9999999999999999999999999987422222 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------~~~~~~~--------~----~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------FESIRVD--------T----P 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC--------C----C
Confidence 23346799999999999999999999999999999999999999976543211 1111000 0 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA-DVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~~L 345 (376)
.++...+..+.+++.+||+.||++||++. ++++|-
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 12222345788999999999999999985 666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=338.49 Aligned_cols=255 Identities=23% Similarity=0.231 Sum_probs=201.4
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++|+||+++++.+.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999975432 223467789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999865 356889999999999999999999999 999999999999999999999999997421100
Q ss_pred C---------------------------------------------cceeecccccccCcccccccccCCCCcccchhhH
Q 017175 227 D---------------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 261 (376)
Q Consensus 227 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 261 (376)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---H
Q 017175 262 GVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL---I 338 (376)
Q Consensus 262 G~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~ 338 (376)
||++|+|++|..||......... ......... .........+..+.++|.+|+ .+|++|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~--------~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ------MKVINWQTS--------LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH------HHHHccCCC--------cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999999865432110 000000000 000001123456778888876 59999997 9
Q ss_pred HHHHHHHH
Q 017175 339 ADVVTALT 346 (376)
Q Consensus 339 ~ell~~L~ 346 (376)
.++++|-+
T Consensus 300 ~ei~~hp~ 307 (382)
T cd05625 300 DEIKAHPF 307 (382)
T ss_pred HHHhcCCC
Confidence 99988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=323.71 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=203.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||+|+||.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998654322 224567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
..++.........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9887654444567999999999999999999999999 99999999999999999999999999875333221 123
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... +.... ..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~----------~~~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR----------ILNDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh----------hcccC--CCCc
Confidence 357899999999999999999999999999999999999999754321110 000000 00100 0222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
...+..+.+++.+||+.||++|| ++++++++-+.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 33455788999999999999999 78999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=329.52 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=199.4
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997542 22334567788888877 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998865 457999999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........ .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~~i~~~~------------~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQSILEDE------------V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC------------C
Confidence 12335699999999999999999999999999999999999999976543211 11111100 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLI-----ADVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~~L 345 (376)
.++...+..+.+|+.+||+.||.+||++ .+++++-
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 1222344578899999999999999999 9998774
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=319.38 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=211.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+++.||||.+..... .....+.+|+.+++.++||||+++++++.+....++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999999999999998864322 22345788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444556899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... .. ...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~-~~------~~~ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI-EQ------CDY 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH-hc------CCC
Confidence 21 11223568899999999988889999999999999999999999986543211 1111110 00 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+. ......+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 226 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 111233457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=317.22 Aligned_cols=249 Identities=29% Similarity=0.418 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 369999999999999998999999998864432 2345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2346899999999999999999999999 9999999999999999999999999987532221111111
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (376)
....+..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..... ......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~----------~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQ----------GVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHc----------CCCCCC
Confidence 1123457999999988889999999999999999998 88888754332110 00000 011122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 313 PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=331.11 Aligned_cols=245 Identities=28% Similarity=0.380 Sum_probs=199.1
Q ss_pred ceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+.||+|+||.||+|++. .+++.||+|++..... .....+..|+.+++.++||||+++++++.+....|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 4688999999875321 2234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999865 456888999999999999999999999 9999999999999999999999999986422211
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .........
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~---------- 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGK---------- 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC----------
Confidence 12233579999999999998889999999999999999999999998654321 111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
...+...+..+.+++.+||+.+|++|| ++.+++++-+
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 012223345788999999999999999 8999988754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.05 Aligned_cols=262 Identities=29% Similarity=0.454 Sum_probs=211.6
Q ss_pred cCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+..........+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888999999999999999853 3456799999876665556678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc
Q 017175 144 VYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~ 211 (376)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 2245899999999999999999999999 999999999999999999
Q ss_pred eEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhh
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 290 (376)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--
Confidence 99999999975433332222334557889999999998899999999999999999999 9999875443211 00
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
. .... .. ...+...+..+.+++.+||+.+|++||++.+|++.|..+..
T Consensus 237 -~-~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 -C-ITQG-RV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -H-HhCC-CC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 0000 00 01112234578899999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=336.86 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=205.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999999999999999986432 12234567899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999854 45888999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcceeecccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+......
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~- 265 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHKNS- 265 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCCc-
Confidence 221 1122345799999999998753 478999999999999999999999986543211 1111111000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~ 347 (376)
+.. ......+..+.+||.+||..+|.+ |+++.++++|.+.
T Consensus 266 --~~~-----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 266 --LTF-----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred --CCC-----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 000 001123558889999999999988 9999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.79 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=219.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch--HHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+..-|.+.+.||+|-|++|-+|++.-+|+.||||++.+...... ..+..|+..|+.++|||||++|++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 44668999999999999999999999999999999987765543 4578999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-CCCCceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill-~~~~~~kl~Dfg~~~~~ 223 (376)
+|.-++|+|.+|+.+ ....+.+..+.+++.||+.|+.|+|... +|||||||+|+.+ ..-|-|||+|||++-.+
T Consensus 96 LELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999987 4678999999999999999999999999 9999999999876 67799999999999766
Q ss_pred CCCCcceeecccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..+.. ....||+..|-|||++.+..|+ +++||||||||||.|++|++||+.....+- +-.
T Consensus 170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTm 230 (864)
T KOG4717|consen 170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTM 230 (864)
T ss_pred CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhh
Confidence 55553 4557899999999999999998 568999999999999999999986543321 122
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
++|... ..|...+.++++||..||..||.+|.+.++|...-|
T Consensus 231 ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 231 IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 333332 346677889999999999999999999999998765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=319.53 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=211.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3569999999999999999999988 888999999877665667788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999763 2456899999999999999999999999 9999999999999999999999999997542221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... . ... .
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~---~~~-~---------- 219 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---D---QIT-A---------- 219 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---H---HHH-h----------
Confidence 11123346678999999988889999999999999999998 89999765422111 0 000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001112233445788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=329.23 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=199.9
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..+ +||||+.+++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2234577888888887 599999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999988864 456999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..................... .. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~--~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP--I 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC--C
Confidence 223467999999999999999999999999999999999999999754332222211111111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPL------IADVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps------~~ell~~L 345 (376)
.++...+..+.+++.+||..||++|++ +.++++|-
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 122334457789999999999999998 46777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=316.94 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=206.5
Q ss_pred cCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|.+..+ ...||+|.+...... ....+..|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5689999999999999999988644 457999988654332 235678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999865 2347899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~----~~~~~~----- 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IK----AVEDGY----- 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HH----HHHcCC-----
Confidence 2222222222345678999999998899999999999999999998 9999965432211 00 000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. ..+...+..+.+++.+||+.+|++||++.+|+++|..+
T Consensus 226 ~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RL-----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 11123345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.99 Aligned_cols=256 Identities=25% Similarity=0.289 Sum_probs=205.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368999999999999999999999999999999975422 23345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998762 357899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCcceeecccccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~-- 225 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQ-- 225 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCC--
Confidence 2221 223357999999999987 45678999999999999999999999976543211 11111100
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... . ......+..+.+|+.+||+ +|.+||++.+++.+-+
T Consensus 226 --~~~~--~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 226 --RFLK--F--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred --CccC--C--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 0000 0 0011234578889999998 9999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=323.53 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=197.7
Q ss_pred cCcccCceecccCceEEEEEEECC-CCeEEEEEEeccCCcc--chHHHHHHHHHHhhc---CCCCccceeEEEe-----c
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----D 137 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~ni~~~~~~~~-----~ 137 (376)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 4688999998654322 223456677777665 6999999999885 2
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 6898888653 2345899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhhhh---
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWARPL--- 293 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~--- 293 (376)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||......+....+ ......
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999753322 2233456899999999998889999999999999999999999999865432211111 000000
Q ss_pred -hhccccc-ccccCCcC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 294 -FKDRRKF-SQMADPTL---QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 294 -~~~~~~~-~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
+...... ........ ........+..+.+|+.+||+.||++|||+.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp 288 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence 0000000 00000000 0001112345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=338.74 Aligned_cols=256 Identities=22% Similarity=0.219 Sum_probs=202.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999865 456889999999999999999999999 99999999999999999999999999742110
Q ss_pred CC-----------------------------------------cceeecccccccCcccccccccCCCCcccchhhHHHH
Q 017175 226 GD-----------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 264 (376)
Q Consensus 226 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 264 (376)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113479999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHH
Q 017175 265 LLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP---LIADV 341 (376)
Q Consensus 265 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---s~~el 341 (376)
+|+|++|..||.......... ........ ... ......+..+.++|.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~~----~~~----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL------KVINWETT----LHI----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH------HHhccCcc----ccC----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999998664321110 00000000 000 001123446777888876 5999999 99999
Q ss_pred HHHHH
Q 017175 342 VTALT 346 (376)
Q Consensus 342 l~~L~ 346 (376)
+++-+
T Consensus 299 l~h~~ 303 (376)
T cd05598 299 KAHPF 303 (376)
T ss_pred hCCCC
Confidence 98855
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=329.89 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=204.9
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEec-CC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GD 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~ 139 (376)
.++|++.+.||+|+||.||+|.+.+ +++.||+|++..... ...+.+..|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3579999999999999999997543 357899999875432 2335677899999999 79999999998865 45
Q ss_pred ceEEEEEccCCCchhhhhccCCCC--------------------------------------------------------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPD-------------------------------------------------------- 163 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 163 (376)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988542110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcc
Q 017175 164 -KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242 (376)
Q Consensus 164 -~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 242 (376)
...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999999 9999999999999999999999999997643322222222345677899
Q ss_pred cccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHH
Q 017175 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQAL 321 (376)
Q Consensus 243 aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 321 (376)
|||++.+..++.++|||||||++|+|++ |..||......+. ......... ....+...+..+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~----------~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGT----------RMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccC----------CCCCCccCCHHHH
Confidence 9999999999999999999999999998 9999976432211 000111100 0011223345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 322 AVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 322 ~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+++.+||+.+|++||++.+|+++|.++-
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=330.44 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=202.1
Q ss_pred CcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhcC-CCCccceeEEEecCCce
Q 017175 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 141 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 141 (376)
+|++.+.||+|+||.||+|++. .+++.||+|++..... .....+..|+.+++.++ |+||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999864 4688999999864321 22345778999999995 89999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999865 456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ........
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 53222211 12345799999999999865 47889999999999999999999997543221110 01111111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
.++ .++...+..+.+++.+||+.||++|| ++.+++++-+
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 011 12223445788999999999999999 7889988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=336.07 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=204.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999999999999999986422 1223457789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999854 35889999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeecccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ..........
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~ 265 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKNS 265 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCcc
Confidence 22211 122346799999999999764 378899999999999999999999976532211 1111111000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTY 347 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~ 347 (376)
+........+..+.+++.+||..++.+ |+++.++++|-+.
T Consensus 266 --------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 266 --------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred --------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 000011123557788999999865543 8999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=316.73 Aligned_cols=256 Identities=29% Similarity=0.446 Sum_probs=208.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
..|.+.+.||+|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4588889999999999999999999999999998654 334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998652 2346899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... .. .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~-~~----------~ 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELL-EK----------G 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHH-HC----------C
Confidence 1 1112234568999999988899999999999999999998 8999876433211 0110 00 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122233446788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.55 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=204.5
Q ss_pred HhcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45779999999999999999998653 356799999864322 234467889999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPD------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 234678889999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... . .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---R----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----H
Confidence 99999875333322222222346788999999998889999999999999999999 78888754332111 0 0
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... .. ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 234 ~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcC-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0000 00 0111223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=316.55 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=216.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
-|.++.+||+|+||.||+|.++.+|+.+|||.+... .+.+.+..|+.++.++..|++|++||.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 477889999999999999999999999999998654 456789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
-|++.+.++. .++++++.++..+++..+.||+|||... -+|||||..|||++.+|..||+|||.+-. ..+.-
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ--LTDTM 183 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ--LTDTM 183 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch--hhhhH
Confidence 9999999876 5788999999999999999999999998 89999999999999999999999999865 33333
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.......||+.|||||++..-.|+.++||||||++..||..|++||....+.... |..+ .++...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FMIP------T~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FMIP------TKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------Eecc------CCCCCC
Confidence 3455688999999999999999999999999999999999999999977653211 1100 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
=..|...+.++.+++++||-..|++|-|+.++++|-
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 133556677899999999999999999999999874
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.04 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=206.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999999999999999765444556678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998864 456899999999999999999999999 9999999999999999999999999997532221
Q ss_pred cceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.......|+..|+|||.+. ...++.++|+|||||++|+|++|..||............ ......
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----------~~~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----------SKSNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----------ecCCCC
Confidence 1122346889999999884 345788999999999999999999999654322110000 000000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.+... .....+..+.+++.+||+.+|++||++.+|+++|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11110 0112345788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=314.50 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=212.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .....+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999998999999998864322 23456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|..++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765444566899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .......... .
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~------~--- 223 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK------C--- 223 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc------C---
Confidence 21 1122346889999999998888999999999999999999999999654321 1111000000 0
Q ss_pred CcCCCCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 306 PTLQGQYPV-RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+. ..+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 224 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 --DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011111 34457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=323.03 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=207.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.|++.+.||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999999999999999998654322 22456789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887542 2356899999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. ......|++.|+|||++.+..++.++||||+||++|+|++|..||.......... ........
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~~~~~~~~----------- 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--EVERRVKE----------- 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--HHHHHhhh-----------
Confidence 2 1223468999999999998889999999999999999999999998643321100 00000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~ 348 (376)
....++...+..+.+|+.+||..||.+|| ++.+++++-+..
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 00112233455788999999999999999 899999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=329.52 Aligned_cols=244 Identities=26% Similarity=0.353 Sum_probs=195.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 12234445544 45778999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999998865 457899999999999999999999999 9999999999999999999999999987422211 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~----------~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKP----------L-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC----------C--
Confidence 2334579999999999999999999999999999999999999998653321 111111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLI----ADVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~----~ell~~L 345 (376)
..+...+..+.+++.+||+.||.+||++ .+++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 1112234578899999999999999988 5777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=340.57 Aligned_cols=269 Identities=20% Similarity=0.247 Sum_probs=198.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC------CCccceeEEEecC-C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH------PNLVNLIGYCADG-D 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~~~~~~~-~ 139 (376)
..++|++.++||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999999999999999996432 222344557777766654 5688888888764 5
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCC--------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGY-------- 210 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~-------- 210 (376)
++|+||+++ |++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 788999988 6788888865 4579999999999999999999998 58 99999999999998765
Q ss_pred --------ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 211 --------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 211 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999875321 12234679999999999999999999999999999999999999998654322
Q ss_pred ccchhhhh-----------------hhhhhcccccccccCCcC----CC---CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 017175 283 EHNLVAWA-----------------RPLFKDRRKFSQMADPTL----QG---QYPVRGLYQALAVAAMCVQEQPNMRPLI 338 (376)
Q Consensus 283 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~ 338 (376)
....+... ...+..........++.. .. .........+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 21111100 000000000000000000 00 0001123467899999999999999999
Q ss_pred HHHHHHHHhhh
Q 017175 339 ADVVTALTYLA 349 (376)
Q Consensus 339 ~ell~~L~~~~ 349 (376)
.|+++|-+...
T Consensus 433 ~e~L~Hp~~~~ 443 (467)
T PTZ00284 433 RQMTTHPYVLK 443 (467)
T ss_pred HHHhcCccccc
Confidence 99999987654
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.62 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=206.7
Q ss_pred hcCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 140 (376)
.++|++.++||+|+||.||+|.+... +..||||++..... ...+.+.+|+.+++.+. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 46799999999999999999987432 35799999965432 23456889999999996 9999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC----------------------------------------------------------
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP---------------------------------------------------------- 162 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 162 (376)
.|+|||||++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998754210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 163 ----------------------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 163 ----------------------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 1134788889999999999999999999 999999999999999
Q ss_pred CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchh
Q 017175 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 287 (376)
++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence 99999999999875432222222223456788999999998899999999999999999997 88998754321100 0
Q ss_pred hhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...... .....+...+..+.+++.+||+.+|++||++.+|.+.|+.+-
T Consensus 351 ----~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ----NKIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 000000 000112234457889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=321.65 Aligned_cols=262 Identities=29% Similarity=0.423 Sum_probs=208.3
Q ss_pred hcCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||++.+... ...+|+|.+..... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 45799999999999999999987643 37899999875422 2335678899999999 79999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 141 RLLVYEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
.+++|||+++++|..++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 999999999999999986421 23456899999999999999999999999 999999999999999
Q ss_pred CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchh
Q 017175 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 287 (376)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-
Confidence 99999999999975433322222222345678999999988899999999999999999997 9999876533211110
Q ss_pred hhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.... .....+...+..+.+|+.+||..+|++|||+.++++.|..+-
T Consensus 247 ------~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 ------LKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0000 011122233457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=329.26 Aligned_cols=270 Identities=23% Similarity=0.274 Sum_probs=204.0
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCC----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 139 (376)
.+.++|++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45688999999999999999999999999999999986432 233456778999999999999999999986543
Q ss_pred --ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 140 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
..|+||||+.+ +|...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 47999999974 6666653 34788999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh---------h
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV---------A 288 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---------~ 288 (376)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..... .
T Consensus 168 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 168 GLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 998742211 1223357899999999999999999999999999999999999999865432110000 0
Q ss_pred -------hhhhhhhcccccc-----cccCCcC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 289 -------WARPLFKDRRKFS-----QMADPTL---QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 289 -------~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
............. +...... ........+..+.+|+.+||+.||++|||+.|++++-+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 0000000000000 0000000 0001112345788999999999999999999999997754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=317.00 Aligned_cols=258 Identities=29% Similarity=0.433 Sum_probs=203.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|++.+.||+|+||.||+|.+..+++ .+++|.+..... .....+..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 468889999999999999999977665 477787754322 22345677888889999999999999875 456788
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999965 2456899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... ...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-------~~~~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-------LLEKGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCC---c
Confidence 33332222334557788999999988899999999999999999998 999997654321111 111100 0
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
... +......+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 230 ~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 000 11123356789999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.22 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=200.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999999999999999987532 223345677888888776 577888999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999865 456999999999999999999999999 99999999999999999999999999874222
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~~~-------- 217 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQSIMEHN-------- 217 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC--------
Confidence 11 122345699999999999988999999999999999999999999986543211 11111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI-----ADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~~ 344 (376)
..++...+..+.+++.+||+.+|.+|++. .++.++
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 01222334577899999999999999974 566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=317.92 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=195.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||+|+||.||++.+..+|+.||+|.+...... ....+..|+.+++.++||||+++++++.+....++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998643322 233456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9887542 2345889999999999999999999999 9999999999999999999999999987533221 122
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...|+..|+|||++.+..++.++|||||||++|+|++|..||........ ........... ... . ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~------~~~--~---~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED------EVK--F---EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc------ccc--c---cc
Confidence 35689999999999988899999999999999999999999975432110 01111111000 000 0 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
...+..+.+|+.+||+.||++||+++|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12344788999999999999999996655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=328.78 Aligned_cols=244 Identities=27% Similarity=0.343 Sum_probs=197.8
Q ss_pred ceecccCceEEEEEEE---CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 75 CLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
+.||+|+||.||++++ ..+|+.||+|++..... .....+..|+.++++++||||+++++++.+....|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 35789999999975432 233456789999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999865 456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHHcCC------------
Confidence 122346799999999999988899999999999999999999999986543211 11111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHH
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTAL 345 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L 345 (376)
...+...+..+.+|+.+||+.||++||+ +.+++.+.
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~ 255 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHP 255 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCC
Confidence 0122233457889999999999999999 56676653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=322.03 Aligned_cols=272 Identities=23% Similarity=0.336 Sum_probs=207.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|.+.+.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5699999999999999999999999999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 488887765 2445889999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh--------hhhhhccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA--------RPLFKDRR 298 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 298 (376)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+........ .+.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12233468899999998865 46889999999999999999999999865443221111000 00000000
Q ss_pred ccccccCCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+.....+.... ......+.++.+|+.+||+.||.+|||+.|++++-+.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000000000000 001123457789999999999999999999999887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.85 Aligned_cols=262 Identities=31% Similarity=0.483 Sum_probs=221.4
Q ss_pred cCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.+....+.||+|+||.||+|+..+ ....||||.++..... ...+|.+|+.++..++|||||+++|+|.+++..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 345667889999999999998643 3467999999877665 5678999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 143 LVYEYMPLGSLEDHLHDLPP------D----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~------~----~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
+|+|||..|+|.+||..... . ..+++..+.+.|+.||+.|+.||-++. +|||||-.+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999976422 1 233889999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
||+|||+++..-..+......+..-..+|||||.++.+.|+.+|||||+||+|||+++ |..||......+....+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i---- 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI---- 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----
Confidence 9999999987555555554445556789999999999999999999999999999998 89999876543221111
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+-.+ -..|...+.++.+|+..||+.+|.+||++.||-..|.....
T Consensus 719 ------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 ------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 11111 25667778899999999999999999999999999998764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.48 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=194.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHH-HHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
++||+|+||.||+|++..+++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 1223344554 457788999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988864 456889999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+... ........ . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~----------~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHK----------P--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcC----------C--C
Confidence 2334579999999999998899999999999999999999999997653211 11111110 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH----HHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA----DVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~----ell~~L 345 (376)
.++...+..+.+++.+||+.+|.+||++. +++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 12233455788999999999999999764 665543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.99 Aligned_cols=255 Identities=27% Similarity=0.346 Sum_probs=207.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
++|.+.+.||+|++|.||.|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998654322 22457789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999865 356889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCccee-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
........ .....++..|+|||++.+..++.++||||||+++|+|++|..||...+..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~--------- 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKI--------- 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHH---------
Confidence 32211111 12345788999999999988999999999999999999999999764322110 000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.........+...+..+.+++.+||..+|.+||++.+++++.+
T Consensus 220 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 220 -ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 0000111223344557889999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=317.65 Aligned_cols=259 Identities=28% Similarity=0.387 Sum_probs=205.1
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4569999999999999999999976 6788999988654332 234688899999999999999999999998999
Q ss_pred EEEEEccCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLS 215 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~ 215 (376)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 1235899999999999999999999999 99999999999998655 58999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||.......... . .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~------~-~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME------F-V 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------H-H
Confidence 9999975422211111122334568999999998899999999999999999997 999998654321110 0 0
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... .....+...+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 235 ~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 001122333457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=332.24 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=205.0
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3445789999999999999999999999999999999864321 2234567899999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999864 45889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
...... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+....
T Consensus 191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~ 263 (371)
T cd05622 191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHK 263 (371)
T ss_pred EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC
Confidence 532221 1122346799999999998754 37889999999999999999999998654321 111111110
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHh
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTY 347 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~ 347 (376)
... .. ......+..+.++|.+||..++.+ |+++.+++++.+.
T Consensus 264 ~~~-~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 264 NSL-TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred Ccc-cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 000 00 011134557888999999844443 7899999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=319.86 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=210.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+|++.+.||+|++|.||+|.+..++..||+|.+..........+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46799999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999854 45789999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||......... .. ... ...
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~----~~~---------~~~ 233 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL----IAT---------NGT 233 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH----Hhc---------CCC
Confidence 1122346889999999998888999999999999999999999999765432110 00 000 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||..+|++||++.+|+++-+..
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~ 274 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence 00111223445788899999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.12 Aligned_cols=244 Identities=26% Similarity=0.340 Sum_probs=193.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHH-HHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|++..+++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999865321 1223344444 456778999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999865 456888999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~------------ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILNKPL------------ 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHhCCc------------
Confidence 23346799999999999999999999999999999999999999986543211 111111100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH----HHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA----DVVTAL 345 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~----ell~~L 345 (376)
..+...+..+.+++.+||+.+|.+||++. +++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 11123345788999999999999999876 455443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=329.84 Aligned_cols=272 Identities=20% Similarity=0.210 Sum_probs=207.0
Q ss_pred HHhcCcccCceecccCceEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 44568999999999999999999764 34678999988543 234579999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
+||++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999996 688888843 467999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh-ccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK-DRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 302 (376)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||..................+. ....+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 333332233346799999999999988999999999999999999999999976543221111100000000 0000000
Q ss_pred -----------ccCCcCCCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 -----------MADPTLQGQYP-------VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 -----------~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.........+. ......+.++|.+||..||++||++.+++.+-+....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00000000000 1124467889999999999999999999999876543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=314.54 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=211.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+|++.+.||+|++|.||+|.+..++..+|||.+..... .....+.+|+.+++.++|+||+++++++.+....+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999999998999999998865332 22356788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444567899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ......
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-------~~~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-------IEQCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh-------hhcCCC
Confidence 22 11223568899999999988889999999999999999999999996543210 010000 001111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+.. .+...+..+.+++.+||..+|++|||+.+|++.+.++.
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 11234557889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=317.67 Aligned_cols=259 Identities=29% Similarity=0.418 Sum_probs=206.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46799999999999999999988643 47899999865432 3345678899999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 1234788999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-------FV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-------HH
Confidence 9999875333222222233456789999999988889999999999999999998 999997544321111 01
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... ....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1000 00112223557889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=314.67 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=202.7
Q ss_pred cccCceecccCceEEEEEEECCC---CeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCc-----
Q 017175 71 FRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 140 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----- 140 (376)
|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987643 47899999875432 233568889999999999999999998866554
Q ss_pred -eEEEEEccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 141 -RLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 141 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
.++++||+++++|..++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885422 22356899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
|++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ . .... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~---~~~~-~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---Y---DYLR-H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHH-c
Confidence 99975433322211222335678999999988889999999999999999999 8899876443211 0 0000 0
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. ....+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0011223445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=317.85 Aligned_cols=259 Identities=32% Similarity=0.465 Sum_probs=204.3
Q ss_pred cCcccCceecccCceEEEEEEEC----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
..|++.+.||+|+||.||+|.+. .++..|++|.+..... .....+.+|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45888999999999999999853 3467899999875332 223567889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC
Q 017175 144 VYEYMPLGSLEDHLHDLP-------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~ 210 (376)
+|||+++++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 11235788999999999999999999999 99999999999999999
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 289 (376)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 999999999975433322222333456778999999988889999999999999999998 9899875432111 10
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
....... . ..+...+..+.+++.+||+.+|++||++.+|+++|..
T Consensus 238 ---~~~~~~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQL------L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCc------C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000 0 1112234478889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=334.22 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=203.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999999999999999996432 223345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCcc---------------------------------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC
Q 017175 226 GDKT---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272 (376)
Q Consensus 226 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 272 (376)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHH
Q 017175 273 KAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL---IADVVTALT 346 (376)
Q Consensus 273 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ell~~L~ 346 (376)
.||......... .......... ...+ . ...+..+.++|.+|+ .||.+|++ +.++++|-+
T Consensus 234 ~Pf~~~~~~~~~------~~i~~~~~~~--~~p~----~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 234 PPFCSETPQETY------RKVMNWKETL--VFPP----E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CCCCCCCHHHHH------HHHHcCCCce--ecCC----C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence 999865432111 1111000000 0000 0 113457788888876 49999984 789988855
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=315.89 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=206.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..+|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3578999999999999999999877666 489999865433 234567889999999999999999999875 4578
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
++++|+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999865 2456899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-------LLEKGER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCCc--
Confidence 433222211222345678999999988899999999999999999998 899997654321111 1111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
...+...+..+.+++.+||..||++||++.++++.|..+...
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011122345788999999999999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.67 Aligned_cols=251 Identities=35% Similarity=0.536 Sum_probs=197.1
Q ss_pred cCceecccCceEEEEEEEC----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 73 ADCLLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+.+.||.|.||.||+|.+. ..+..|+||.+..... ...+.+.+|+..+++++||||+++++++.+....++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999987 4467899999965332 2367889999999999999999999999988889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ ++|++|+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999873 2467899999999999999999999999 9999999999999999999999999998653333
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.............|+|||.+....++.++||||||+++|||++ |..||........ .... .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~~~~-~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------IEKL-KQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------HHHH-HTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-ccccc-------
Confidence 3333344557788999999999889999999999999999999 6788876533211 1111 11000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
...+...+..+.+++.+||..+|++||++.+|++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223345788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=314.81 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=206.5
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchH--HHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|++.+.||+|+||.||+|++..+++.||+|++......... ...+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 77889999999999999999999999999999876544433 2356999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ...+++..++.++.||++||.+||+.+ ++|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999973 467899999999999999999999999 999999999999999999999999999753 122
Q ss_pred ceeecccccccCcccccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-hhhhhcccccccccCC
Q 017175 229 THVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-RPLFKDRRKFSQMADP 306 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 306 (376)
........++..|+|||++. +..++.++||||||+++|+|++|..||......+........ ........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------
Confidence 22344567899999999998 788999999999999999999999999876222111111100 00000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.........+.+++.+||+.||++||++.+++++-+
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 224 ----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp ----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 000011268889999999999999999999997643
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=312.99 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=205.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+.+..|+.+++.++|+||+++++.+.+....|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999999999999999986432 334456778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988642 2355789999999999999999999999 999999999999999999999999998753222
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ...... ...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~--~~~-------- 217 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQ--GSY-------- 217 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhc--CCC--------
Confidence 1222345689999999999888899999999999999999999999976432111 000000 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
...+...+..+.+++.+||+.||++||++.+|+..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=311.78 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=201.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|.++. +..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 458889999999999999998764 5679999886443 33457888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998652 245889999999999999999999999 99999999999999999999999999875322221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||........... . .... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~------i-~~~~---~~---- 220 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM------I-SRGF---RL---- 220 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------H-HCCC---CC----
Confidence 1 1122335668999999988889999999999999999999 8999976543211110 0 0000 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122346789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=318.49 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=204.9
Q ss_pred cCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.+|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+..|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3478889999999999999987543 578999999754322 2355778999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC
Q 017175 143 LVYEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~ 210 (376)
+++||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985311 11245888999999999999999999999 99999999999999999
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 289 (376)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+. .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~-- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I-- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H--
Confidence 999999999875433332222333456789999999988889999999999999999998 8888876433211 1
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.. .... . ....+...+..+.+|+.+||+.+|++||++.+|++.|..
T Consensus 237 -~~-i~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 -EM-IRNR---------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HH-HHcC---------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00 0000 0 011223345578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=316.84 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=206.3
Q ss_pred cCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|.+.+.||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56888999999999999999743 3467899999876655556778899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 144 VYEYMPLGSLEDHLHDLPP-----------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
+|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875321 1135889999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH------H
Confidence 9999999875433322222233445788999999998899999999999999999998 89999754332111 0
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.. .... .. ..+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 236 ~~-~~~~------~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CI-TQGR------EL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH-HcCc------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 0000 00 111123346789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=328.84 Aligned_cols=269 Identities=23% Similarity=0.276 Sum_probs=203.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC-----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----- 138 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999999999999999987542 22345677899999999999999999988643
Q ss_pred -CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 139 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
...|+||||+++ +|...+. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 357999999974 6766663 34788999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-h--------
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-A-------- 288 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~-------- 288 (376)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..... .
T Consensus 164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999753221 1223357899999999999989999999999999999999999999765432111000 0
Q ss_pred -------hhhhhhhcccccccccCCcC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 289 -------WARPLFKDRRKFSQMADPTL--------QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 289 -------~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..............+..+.. ...........+.+|+.+||..||++|||+.|++++-+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 00000000000000000000 001111234577899999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=316.35 Aligned_cols=271 Identities=27% Similarity=0.416 Sum_probs=205.2
Q ss_pred cCc-ccCceecccCceEEEEEEE----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecC--Cc
Q 017175 69 KNF-RADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQ 140 (376)
Q Consensus 69 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 140 (376)
++| ++.+.||+|+||.||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 456 8999999999999988653 45678899999875432 2345678899999999999999999987653 46
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999864 45899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 221 KLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
.....+.... ......++..|+|||.+.+..++.++|||||||++|+|++|..||........ ......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhh
Confidence 7543322211 11223456779999999888899999999999999999999999865432100 000000000 00000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+.......+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111111223344568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.12 Aligned_cols=243 Identities=25% Similarity=0.338 Sum_probs=194.1
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHH-HHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 22234455554 46778999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988864 467899999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~~~----------~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILHKP----------L-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHcCC----------c--
Confidence 22346799999999999999999999999999999999999999986543211 11111100 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH----HHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIA----DVVTA 344 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~----ell~~ 344 (376)
..+...+..+.+++.+||+.+|.+||++. +++++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 11122345678899999999999999875 56554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=317.48 Aligned_cols=260 Identities=30% Similarity=0.441 Sum_probs=205.8
Q ss_pred CcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998743 235688998865432 234568889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCc
Q 017175 144 VYEYMPLGSLEDHLHDLPP--------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~N 203 (376)
++||+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998864211 1245789999999999999999999999 9999999999
Q ss_pred EEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 017175 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 282 (376)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875332222111223346778999999988889999999999999999998 999997654321
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... .... ......+...+..+.+++.+||+.+|++||++.++++.|+.+-
T Consensus 238 ~~~-------~~~~----------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFN-------LLKT----------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHH-------HHhC----------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 110 0110 0111112233457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=311.51 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=206.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999999999999999986542 23456688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998763 2457899999999999999999999999 9999999999999999999999999987533222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ...... ..
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~------~~---- 217 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILKIIR------GV---- 217 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHc------CC----
Confidence 122335688999999999998899999999999999999999999976542210 000000 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 -FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011122344578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=315.14 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=204.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+......|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57889999999999999999999999999999987665455556788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999999865 457899999999999999999999999 999999999999999999999999998653221
Q ss_pred ceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 229 THVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
........|+..|+|||++. ...++.++|+|||||++|+|++|..||........... ... .....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~~~-----~~~~~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MTK-----SNFQP 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------hhc-----cCCCC
Confidence 11223457899999999874 44688999999999999999999999865432211000 000 00001
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
+.... ....+..+.+++.+||+.+|++||++.+|+++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11100 01123467889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.11 Aligned_cols=256 Identities=29% Similarity=0.424 Sum_probs=205.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|++|.||+|.+.. +..||+|.+.... .....+.+|+.+++.++|+||+++++++......+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 3569999999999999999998754 5779999986543 3356688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999986532 356899999999999999999999999 9999999999999999999999999997643221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.. .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......... . ......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~-~~~~~~-------- 221 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL------Q-QVDQGY-------- 221 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------H-HHHcCC--------
Confidence 11 1111223457999999988899999999999999999999 99999754322110 0 000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
....+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0011223345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=308.30 Aligned_cols=251 Identities=27% Similarity=0.349 Sum_probs=213.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---HHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|..+++||+|.||.|.+++.+.+++.||+|++++.-...... -+.|-.+|+..+||.+..+--.|...+++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56899999999999999999999999999999998765544433 346888999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||..||.|..++.. ...+++.....+-.+|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||+++...
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988865 567899999999999999999999999 9999999999999999999999999998632
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
........+||||.|+|||++....|+.++|.|.+||++|||++|+.||.+.+......++- ...
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~ed-------- 384 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------MED-------- 384 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------hhh--------
Confidence 33344567899999999999999999999999999999999999999999876543322221 110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
-.+|...+.++..|+..+|..||.+|. ++.||.++-.
T Consensus 385 ----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 385 ----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred ----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 134555566888899999999999995 5778877644
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=317.90 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=212.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
...+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 34789999999999999999999998999999999987666666778899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999854 45789999999999999999999999 999999999999999999999999998753222
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||............ ....
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---------------~~~~ 231 (297)
T cd06656 169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------------ATNG 231 (297)
T ss_pred c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---------------ccCC
Confidence 1 1123356889999999999888999999999999999999999999765432110000 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+...+..+.+++.+||..+|++||++.+++++-+....
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 00011122344567889999999999999999999998654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=320.91 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=207.5
Q ss_pred hcCcccCceecccCceEEEEEEECC-------CCeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... ......+..|+.+++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999998643 23569999987542 23345677899999999 799999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...|+||||+++++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975321 1235889999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~-- 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-- 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence 9999999999999875332221111122234568999999988889999999999999999998 8888865432111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
... ... ......+...+..+.+|+.+||..+|++||++.++++.|..+...
T Consensus 252 ----~~~-~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 ----FKL-LKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ----HHH-HHc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 110 010 001122233455888899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=317.47 Aligned_cols=267 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhc---CCCCccceeEEEec-----CC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 139 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----~~ 139 (376)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999999999999999998753222 223455677766655 69999999998864 34
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 5888888653 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc-hhhhhh----hhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN-LVAWAR----PLF 294 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~----~~~ 294 (376)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|.+||......+... +..... ..+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 87532221 1233568999999999998899999999999999999999999997653322111 000000 000
Q ss_pred hccccc-ccccCCc---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 295 KDRRKF-SQMADPT---LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 295 ~~~~~~-~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
...... .....+. .........+..+.+++.+||+.||++|||+.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 000000 0000000 00011122345778999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.01 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=200.1
Q ss_pred cccCceecccCceEEEEEEECCCCe--EEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC------Cc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 140 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~ 140 (376)
|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.+++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999877665 68999886542 23345678899999999999999999987432 24
Q ss_pred eEEEEEccCCCchhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
.+++|||+++++|.+++... ......+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887431 123355899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ .. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHcC
Confidence 9976433322111223346778999999998899999999999999999999 7889975432211 10 01111
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
... ..+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 11122344688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=312.34 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=205.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.++||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3579999999999999999998754 5679999886543 2356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998652 2456888999999999999999999999 9999999999999999999999999997643222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......... . . .... ...
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~---~-~~~~------~~~ 223 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---S---A-LQRG------YRM 223 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---H---H-HHcC------CCC
Confidence 1 11122345678999999988889999999999999999998 99999754322110 0 0 0000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. ....+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PR----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11 112334788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.20 Aligned_cols=266 Identities=28% Similarity=0.420 Sum_probs=207.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCC----------------eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTN----------------QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVN 130 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~ 130 (376)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876543 56899998755332 3456888999999999999999
Q ss_pred eeEEEecCCceEEEEEccCCCchhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCc
Q 017175 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (376)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~N 203 (376)
+++++......+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999876321 1236899999999999999999999999 9999999999
Q ss_pred EEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCcccc
Q 017175 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTRAA 281 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~ 281 (376)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433332223334556788999999988889999999999999999998 66787654321
Q ss_pred cccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 282 GEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
. ........+... ........+...+.++.+++.+||+.+|++|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 111111111100 000001112233457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=323.85 Aligned_cols=265 Identities=20% Similarity=0.299 Sum_probs=197.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
...+|++.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++|+||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999999999999975433 23469999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
++. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 996 688888764 3467899999999999999999999999 999999999999999999999999998742211
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC-CCcccccccchh---hhhhhhhhc----cc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI-DNTRAAGEHNLV---AWARPLFKD----RR 298 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~---~~~~~~~~~----~~ 298 (376)
.......||+.|+|||++.+..++.++|||||||++|+|+++..++ ............ ......... ..
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1223456999999999999999999999999999999999865544 432211000000 000000000 00
Q ss_pred ccc---------cccCC--cCCC---CC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 299 KFS---------QMADP--TLQG---QY----PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 299 ~~~---------~~~~~--~~~~---~~----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.+. .+++. .... .+ ....+..+.+||.+||+.||++|||+.|+++|-+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 000 00000 0000 00 01123356679999999999999999999988553
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.27 Aligned_cols=252 Identities=35% Similarity=0.491 Sum_probs=206.5
Q ss_pred ceecccCceEEEEEEECCC---CeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+... +..|++|.+....... ...+.+|+.+++.++|+||+++++++.+...++++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 151 GSLEDHLHDLPPD-----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 151 ~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763211 477999999999999999999999999 99999999999999999999999999986443
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
...........++..|+|||.+....++.++|||||||++|+|++ |..||......... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~-~~-------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL------EYL-RK-------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH------HHH-Hc--------
Confidence 332222334567889999999988889999999999999999999 69999876432111 000 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
......+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222333568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.49 Aligned_cols=271 Identities=22% Similarity=0.303 Sum_probs=204.4
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecCC-----ceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~ 142 (376)
+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998643 2223456788999999999999999999998766 789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 578877754 467899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh---------hh
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA---------RP 292 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------~~ 292 (376)
...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+... ..
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 332221 112234688999999998874 5789999999999999999999999865443211111000 00
Q ss_pred hhh-ccccc-ccccC-CcCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFK-DRRKF-SQMAD-PTLQ--GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~-~~~~~-~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... ..... ..... +... -......+..+.+|+.+||+.||++|||+.+++++-+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 000 00000 00000 0000 0111223557889999999999999999999999876433
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=324.00 Aligned_cols=259 Identities=22% Similarity=0.240 Sum_probs=201.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|+.++..++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46999999999999999999999999999999986422 122345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999865 2456899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCcceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
... .......||+.|+|||++.. ..++.++|||||||++|+|++|..||......... ..........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~ 227 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHF 227 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcc
Confidence 221 11223469999999999863 45788999999999999999999999764332110 1111100000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~ 347 (376)
.+ . ......+..+.+++.+||..+++. |+++.+++++-+.
T Consensus 228 -~~-~-----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 228 -QF-P-----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred -cC-C-----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 00 0 001123457788999988664443 7899999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=319.36 Aligned_cols=261 Identities=31% Similarity=0.466 Sum_probs=203.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeE--EEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|.+..++.. +|+|.+..... .....+.+|+.++.++ +|+||+++++++.+....|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4688999999999999999998877754 57777654322 2335678899999999 899999999999999999999
Q ss_pred EEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 145 YEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999865321 1236889999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ..
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 234 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence 999999986321111 1111234667999999988889999999999999999998 9999975433211 00
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.. .. ......+...+..+.+|+.+||+.+|++||++.++++.|..+-...
T Consensus 235 ~~-~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KL-PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HH-hc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 00 0001111223446789999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=326.03 Aligned_cols=271 Identities=20% Similarity=0.285 Sum_probs=204.3
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecC---
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--- 138 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 138 (376)
...+.++|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34567899999999999999999999999999999999865322 2334577899999999999999999987543
Q ss_pred ---CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 139 ---DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 139 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
...|++++++ +++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence 3568999988 6899888743 56999999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hh----
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AW---- 289 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~---- 289 (376)
|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ..
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999753221 233578999999999877 46889999999999999999999999764322110000 00
Q ss_pred ----hhhhhhc-c----cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 290 ----ARPLFKD-R----RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 290 ----~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....... . ..+.......+. .........+.+|+.+||+.||.+|||+.++++|-+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000000 0 000000000000 000112335779999999999999999999999977654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.51 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=206.3
Q ss_pred hcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.+..... ...+.+.+|+.+++++ +|+||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999975 33456899999875432 2335688899999999 79999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.+++|||+++++|.+++... ....+++.+++.++.+++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999998652 2234899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~-- 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEG-- 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcC--
Confidence 75433322222223446788999999998899999999999999999998 99998754322110 0011100
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||..+|++||++.++++.|.++
T Consensus 261 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.15 Aligned_cols=268 Identities=22% Similarity=0.266 Sum_probs=203.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------ 138 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999999999999999987532 23345677899999999999999999987543
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...|+||||++ ++|..++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999997 47777663 34788999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hh--------
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AW-------- 289 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~-------- 289 (376)
++...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+ ..
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99753221 1223357899999999999999999999999999999999999999765432211110 00
Q ss_pred -------hhhhhhccccccc-----ccCC---cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 -------ARPLFKDRRKFSQ-----MADP---TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 -------~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..........+.. .... .............+.+||.+||+.||.+|||+.++++|-+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0000000000000 0000 00001111234578899999999999999999999998664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=317.58 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=203.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCe--EEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... ....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877664 46888876422 22345688899999999 699999999999999999999
Q ss_pred EEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 145 YEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865221 1235889999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 99999998632111 11111223557999999988889999999999999999997 9999976543211 01
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. . .......+...+..+.+|+.+||+.+|.+||++.++++.|..+..
T Consensus 230 ~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KL-P----------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HH-h----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 0 000111122334578899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=317.88 Aligned_cols=269 Identities=22% Similarity=0.276 Sum_probs=208.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|.+..++..+|+|.+...... ....+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3689999999999999999999999999999998654222 234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999875 3568999999999999999999997 57 999999999999999999999999998643211
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc-------
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK------- 299 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 299 (376)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 123357899999999998888999999999999999999999999754322111111000000000000
Q ss_pred -------------cccccCCcCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 300 -------------FSQMADPTLQGQYP-VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 300 -------------~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
........ ....+ ...+..+.+++.+||..+|++||++.+|+++.+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000 00001 113457889999999999999999999999988644
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=349.23 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=204.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEec--CCce
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 141 (376)
.+..+|.+.+.||+|+||.||+|.+..++..||+|++...... ....+..|+.+++.++||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4557899999999999999999999999999999998754332 34568889999999999999999998855 4568
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeecCCCCCcEEECC---------
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN----PPVIYRDLKCSNILLGE--------- 208 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~----~~i~Hrdikp~Nill~~--------- 208 (376)
||||||+++++|.+++.........+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987644344679999999999999999999998431 23999999999999964
Q ss_pred --------CCceEEcccccccccCCCCcceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 209 --------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 209 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999997532221 2234579999999999864 35889999999999999999999999754
Q ss_pred ccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 279 RAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... ..... +... ..... ...+..+.+||..||..+|.+||++.+++.+-+
T Consensus 247 ~~~~-----qli~~-lk~~------p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNFS-----QLISE-LKRG------PDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcHH-----HHHHH-HhcC------CCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 3211 11111 1100 00000 122457889999999999999999999996543
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.95 Aligned_cols=266 Identities=27% Similarity=0.429 Sum_probs=204.6
Q ss_pred cCcccCceecccCceEEEEEEECC----------------CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES----------------TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNL 131 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~ 131 (376)
++|++.+.||+|+||.||++.+.. ++..+|+|.+...... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986432 3457999998754322 34578899999999999999999
Q ss_pred eEEEecCCceEEEEEccCCCchhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcE
Q 017175 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (376)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Ni 204 (376)
++++.+.+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999876321 1234778899999999999999999999 99999999999
Q ss_pred EECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCccccc
Q 017175 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTRAAG 282 (376)
Q Consensus 205 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~ 282 (376)
+++.++.++|+|||++................++..|+|||+..++.++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433322222223345678999999888889999999999999999998 778887543321
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. .......+........ . ..+...+..+.+|+.+||+.||++||++.+|++.|++
T Consensus 242 ~---~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGRQVY-L------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhcccccc-C------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111000000 0 1112233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.64 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=203.3
Q ss_pred cCcccCceecccCceEEEEEEECCC--------------CeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST--------------NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIG 133 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~ 133 (376)
++|++.+.||+|+||.||+|.+..+ ...||+|.+...... ....+.+|+.+++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 235899998754322 2346888999999999999999999
Q ss_pred EEecCCceEEEEEccCCCchhhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEE
Q 017175 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP--------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (376)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nil 205 (376)
++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854211 1124788999999999999999999999 999999999999
Q ss_pred ECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCcccccc
Q 017175 206 LGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTRAAGE 283 (376)
Q Consensus 206 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~ 283 (376)
++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999875433322222223345778999999998889999999999999999998 5677775433211
Q ss_pred cchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 284 HNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.......+...... .....+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 242 ---~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11011111100000 000111123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.63 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=209.0
Q ss_pred hcCcccCceecccCceEEEEEEEC-------CCCeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
..+|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467899999999999999999752 234579999886442 23345688999999999 799999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...|++|||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999875321 1245788899999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-- 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence 9999999999999976433322222223446678999999988889999999999999999998 7888865432211
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
... ..... ....+...+..+.+++.+||+.+|++||++.++++.|.++....
T Consensus 249 ----~~~-~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 249 ----FKL-LKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ----HHH-HHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111 11100 00112234457888999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.74 Aligned_cols=249 Identities=33% Similarity=0.431 Sum_probs=208.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
..|.-++.||.|+||.||-|++..+.+.||||++.-.+. ..+.+++.|+..|+++.|||++.+-++|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 347778889999999999999999999999999986544 34567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||- |+..+.+.- ..+++.+.++..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.+....+
T Consensus 106 EYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9995 677777765 3678999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
...++|||.|||||++. .+.|+-++||||||++..||...++|+.+..+.... +..-.+-
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL---------YHIAQNe-- 241 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQNE-- 241 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH---------HHHHhcC--
Confidence 33578999999999997 467999999999999999999999998776543111 1110010
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.|.+. ....+..+++|+..||+.-|.+|||.++++.|-.
T Consensus 242 --sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 242 --SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred --CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 11111 2356778999999999999999999999988744
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.90 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=203.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888999999999999999999999999999986542 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 3678889999999999999999999 999999999999999999999999998753222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 306 (376)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||........... .......... ..+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-------CCC
Confidence 12335789999999999988999999999999999999999999976432211110 0100000000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. .....+..+.+++.+||+.+|++||++.+++++.+..
T Consensus 219 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 219 VL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred CC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 00 0112334678999999999999999999999986643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=323.08 Aligned_cols=258 Identities=21% Similarity=0.225 Sum_probs=201.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||++++..+++.+|+|++.+.. ......+..|+.++..++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999986422 122334778899999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999965 2456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
.. .......+||+.|+|||++. ...++.++|||||||++|+|++|..||........ ..........
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~- 226 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKER- 226 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcc-
Confidence 21 11223357999999999986 34678999999999999999999999986543211 1111111000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALT 346 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~ 346 (376)
..-+ ......+..+.+|+.+||..++.. |+++.++++|-+
T Consensus 227 --~~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 227 --FQFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred --ccCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0000 111223557888999988665544 689999998843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.97 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=202.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 468899999999999999998764 4569999987543 33467889999999999999999999999989999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
.+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998652 336899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ........ .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~------~~~~~~~~------~-- 220 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV------EKVSQGLR------L-- 220 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH------HHHhcCCC------C--
Confidence 11122345678999999988889999999999999999998 99999754432110 00000000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123457889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.43 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=201.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
.+|++.+.||+|+||.||+|.+.. +..+|+|++..... ....+.+|+.+++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 358899999999999999998864 66799999865433 3456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998652 346899999999999999999999999 99999999999999999999999999875322111
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. . .. .. .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~-~~------~---- 217 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E---SV-SA------G---- 217 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H---HH-Hc------C----
Confidence 11111224457999999998899999999999999999999 89999764332111 0 00 00 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.....+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 001112234557889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.55 Aligned_cols=267 Identities=20% Similarity=0.218 Sum_probs=201.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.++++++|+||+++++++......++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999999999999996432 2356899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+. ++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 688888754 2346999999999999999999999999 9999999999999999999999999997543222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccc-cccchhhhhhhhhhcc----ccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA-GEHNLVAWARPLFKDR----RKFSQ 302 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~ 302 (376)
.........||..|+|||++.+..++.++|||||||++|||++|..++...... ............+... ..+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222223457999999999999999999999999999999999988665332211 1010001011111000 00000
Q ss_pred c----------------cCCcCCC-CC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 303 M----------------ADPTLQG-QY--PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 303 ~----------------~~~~~~~-~~--~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. ..+.... .. .......+.+||.+||+.||.+|||+.|+|++-++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0 0000000 00 00223467889999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=327.47 Aligned_cols=262 Identities=31% Similarity=0.461 Sum_probs=214.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCe---E-EEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---V-VAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
++-.+.++||+|+||.||+|..+..+. . ||+|...... ......+++|++++++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445666899999999999998865422 3 8999887522 33456799999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++|||+|+||+|.+++... ...++..+...++.+.+.||+|||+++ ++||||-.+|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999873 346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcceeec-ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 222 LGPVGDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 222 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....+...
T Consensus 311 ~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-------------- 373 (474)
T KOG0194|consen 311 AGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-------------- 373 (474)
T ss_pred CCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH--------------
Confidence 532 111111 2235689999999999999999999999999999999 888998765432111
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCC
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDP 355 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~ 355 (376)
.+.-...+...+...+..+..++.+||..+|++||++.++.+.|+.+.....++
T Consensus 374 --kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 374 --KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred --HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111112222334455667888999999999999999999999999998876643
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=317.14 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=206.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.+.|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++|+||+++++.+.....+++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 36799999999999999999999999999999999776555567788899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999888754 2356899999999999999999999999 999999999999999999999999998642211
Q ss_pred cceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
........++..|+|||++. ...++.++|||||||++|+|++|..||....... ........
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~------ 230 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS------ 230 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcC------
Confidence 11123356889999999985 3457889999999999999999999997543211 00111000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+. ...+...+..+.+++.+||..+|++||++.+++++-+
T Consensus 231 -~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 231 -EPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred -CCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 0112233447888999999999999999999998765
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.82 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=206.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+..|+.+++.++|++|+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999999999999999987543322 2346789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988542 2345899999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||............ ...... ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~-------~~- 221 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE-------VQ- 221 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh-------hh-
Confidence 21 12346899999999999889999999999999999999999999864321100000 000000 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~~ 348 (376)
..++...+..+.+|+.+||+.||++||| +.+++++-+..
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 0112223446789999999999999999 89999986643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.83 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=207.3
Q ss_pred hcCcccCceecccCceEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
..+|.+.+.||+|+||.||+|.+.. ....+|+|.+..... .....+..|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3679999999999999999997632 345799998875432 2345678899999999 599999999999998
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999865321 2245889999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975332221111122234567999999988889999999999999999999 889987543321111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
. .... .....+...+..+.+++.+||..+|++||++.++++.|..+....
T Consensus 248 ~-------~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 248 L-------LREG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred H-------HHcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 0 0000 000122233457889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=324.31 Aligned_cols=258 Identities=21% Similarity=0.217 Sum_probs=201.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||++++..+++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 122344678899999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999975 2356899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCcc
Confidence 221 11233569999999999875 4678899999999999999999999976433211 11111100000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALT 346 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~ 346 (376)
. .. ......+..+.+++.+||..++++ |+++++++++.+
T Consensus 228 -~-~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 228 -Q-FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred -c-CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 0 00 001123457888999999876654 468999988754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.56 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=206.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5699999999999999999999999999999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++ ++|..++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 588888765 2456889999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-h-------hhhhccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-R-------PLFKDRR 298 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~-------~~~~~~~ 298 (376)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||............... . +......
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 112234578999999988764 5788999999999999999999999865432211100000 0 0000000
Q ss_pred ccccccCCcCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 299 KFSQMADPTLQGQ----YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 299 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.....+..... .....+..+.+||.+||+.||.+|||+.+++++-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000000111100 0112345778999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=313.46 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=205.6
Q ss_pred HhcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
..++|++.+.||+|+||.||+|..+. .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35789999999999999999997642 355799998864432 233457789999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
.++||||+++|+|.+++..... .....++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1234567788999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~------~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK------FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HH
Confidence 99999875333222222222345778999999998899999999999999999998 788987644321110 00
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..... ...+...+..+.+++.+||+.+|++|||+.++++.|...-
T Consensus 235 -~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 -MDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -HcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00000 0111223457889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=312.03 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=208.3
Q ss_pred hcCcccCceecccCceEEEEEEECC----CCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEec-CCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES----TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999875 35789999886432 2334567889999999999999999998766 5678
Q ss_pred EEEEEccCCCchhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPD----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
+++++|+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654222 156899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
|+++...............++..|+|||++.+..++.++|||||||++|++++ |..||....+... ... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAY----LKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHc
Confidence 99975433322222223446778999999988889999999999999999999 9999976543211 110 010
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. . ...+...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 235 ~~------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY------R----LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC------C----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 0 00111234478899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=344.46 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=206.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.++||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999999753222 2356889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 146 EYMPLGSLEDHLHDLPP-------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
||++|++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 1234667788999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCc----------------ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 219 LAKLGPVGDK----------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 219 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
++........ .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975411100 001122469999999999999999999999999999999999999997643211
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhc
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-LIADVVTALTYLAC 350 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~~~~ 350 (376)
... .. .+..+.... .....+..+.+++.+||..||++|| +++++++.|...-.
T Consensus 239 i~~-----~~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY-----RD---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-----hh---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 00 000000000 0012334678899999999999996 66777777776643
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=310.21 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=204.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCe---EEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468889999999999999999876554 79999986542 23345688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999865 2456899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceee-cccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 225 VGDKTHVS-TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 225 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
........ .....+..|+|||++.+..++.++|||||||++|+|++ |..||........ ... +...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~-i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKA-INDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHH-HhcC-----
Confidence 22211111 11223457999999988889999999999999999997 9999965432211 111 1100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011122345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.44 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=206.6
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
-|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+......++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 37888999999999999999999999999999976655556678889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... .
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~ 157 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I 157 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--c
Confidence 9999988754 2456899999999999999999999999 999999999999999999999999998653221 1
Q ss_pred eeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 230 HVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.......++..|+|||++. +..++.++|||||||++|+|++|..||........ ........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~------- 224 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------- 224 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcC-------
Confidence 1223356899999999984 34578899999999999999999999976432110 00000000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+. ...+...+..+.+++.+||+.+|.+||++.+++++-+..
T Consensus 225 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 266 (282)
T cd06643 225 PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT 266 (282)
T ss_pred CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence 000 011222345788999999999999999999999887643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=316.00 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=211.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
.+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++......|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998854 46899999999999999999999999 99999999999999999999999999875332221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...+....... ..... . +.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~------~~~~~--~-----~~- 234 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--T-----PE- 234 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcC--C-----cc-
Confidence 12335688999999999888899999999999999999999999987544211100 00000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...+...+..+.++|.+||..+|++||++.+|+.+=+...
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 0112223447888999999999999999999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.90 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=210.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 144 (376)
...|+++++||.||.+.||++...+ ...||+|++... +.....-+.+|+..|.+|+ |.+|++++|+-..++.+|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4579999999999999999998765 456777776543 2233456899999999997 99999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||=+ .+|..++... ....+.-.++.++.||+.|+.++|.+| |||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99864 6999999762 233443488999999999999999999 999999999999975 599999999998776
Q ss_pred CCCcceeecccccccCcccccccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-----------LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
.....-.....+||+.||+||.+.... .++++||||||||||+|+.|+.||.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------- 577 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------- 577 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------------
Confidence 666666667789999999999886432 45789999999999999999999985421
Q ss_pred hhcccccccccCCcCCCCCCHHHHH-HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLY-QALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....+..+.++....+|+..... ++.+++..||..||.+||++.+||++-.
T Consensus 578 --~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 578 --QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred --HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 11256677787776677654333 3999999999999999999999998743
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=307.80 Aligned_cols=255 Identities=31% Similarity=0.438 Sum_probs=202.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++|+||+++++.+.. ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 46799999999999999999988765 4599999875432 34568889999999999999999998754 568999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999652 2345789999999999999999999999 9999999999999999999999999997543322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.. ......++..|+|||...+..++.++|||||||++|+|++ |..||......... ... ... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~~-~~~------~~- 221 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQV-ERG------YR- 221 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HHH-hcC------CC-
Confidence 11 1122346678999999988889999999999999999999 88888754322110 000 000 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=307.34 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=208.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+.+...+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999999889999999997665556677889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999998865 2357899999999999999999999999 9999999999999999999999999987532211
Q ss_pred ceeecccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.......... . . .. .....
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~----~-~~----~~~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--L----I-SK----SNFPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----H-Hh----ccCCC
Confidence 112335688899999999776 78899999999999999999999997654221100 0 0 00 00000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
+. .......+..+.+++.+||..+|.+||++.+|+.+
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 11223445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=311.97 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=204.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.|+..+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+.+++.+.+.+..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999999999999999998654322 22346789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888642 2346999999999999999999999999 999999999999999999999999998653222
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|..||........... ........ .
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~--~~~~~~~~--------~- 221 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE--VDRRVLET--------E- 221 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhhhcc--------c-
Confidence 1 12235689999999999888999999999999999999999999986533211000 00000000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALT 346 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~ 346 (376)
..++...+..+.+|+..||+.||++||+ +.+++.+-+
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 0112223446788999999999999999 778887744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=312.82 Aligned_cols=273 Identities=28% Similarity=0.386 Sum_probs=203.8
Q ss_pred cCcccCceecccCceEEEEEEE----CCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--CCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~ 142 (376)
.+|++.+.||+|+||.||+|.. ..++..||+|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999974 45688999999876655556678899999999999999999998754 35689
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999865 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCccee-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
......... .....++..|+|||++.+..++.++|||||||++|+|++|..++......-.......... ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchHHHH
Confidence 433322111 1112344569999999888899999999999999999998877643321100000000000 00000000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
+.+.....-..+...+..+.+|+.+||..+|++|||+.+|++.|..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00010111111223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=310.42 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=203.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCe---EEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
..|++.+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 358899999999999999999876654 69999986542 22345788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998652 356899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcceeecc-c--ccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 225 VGDKTHVSTR-V--MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 225 ~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
.......... . ..+..|+|||.+.+..++.++|||||||++|||++ |..||......... . .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~---~---~i-~~~--- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---N---AI-EQD--- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH---H---HH-HcC---
Confidence 2221111111 1 12457999999998899999999999999999886 99999765432111 0 00 000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. ...+...+..+.+++.+||..+|++||++.+|+..|+.+
T Consensus 228 ---~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---YR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---Cc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011122344678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=306.68 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=196.6
Q ss_pred eecccCceEEEEEEE--CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45678999999864432 22456788999999999999999999875 45678999999999
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||.||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 356899999999999999999999999 99999999999999999999999999975433222111
Q ss_pred -ecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 232 -STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 232 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.....++..|+|||.+....++.++|||||||++|||++ |..||........ ... ... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----i~~----------~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM----IES----------GER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHC----------CCC
Confidence 122234678999999988889999999999999999998 9999986543211 110 110 001
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...+...+..+.++|.+||+.||++||++.+|...|+..
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112233445788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.62 Aligned_cols=265 Identities=26% Similarity=0.343 Sum_probs=206.6
Q ss_pred HHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEe---
Q 017175 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCA--- 136 (376)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~--- 136 (376)
++......++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3444456789999999999999999999999999999999886432 2235677899999998 6999999999874
Q ss_pred --cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 137 --DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 137 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345789999999999999987643334567899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
+|||++....... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||.........
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----- 238 (286)
T cd06638 166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----- 238 (286)
T ss_pred ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----
Confidence 9999987532221 11223468999999998853 45788999999999999999999999765332110
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... ....+.. ..+...+..+.+|+.+||+.+|++|||+.||+++++
T Consensus 239 ----~~~~----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 239 ----FKIP----RNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ----hhcc----ccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0000 0000000 011122346889999999999999999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.78 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=203.8
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+|.+...||+|++|.||+|.+..+++.+|+|.+....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999998889999999886543322 1457789999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999965 356889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc----ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 221 KLGPVGDK----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 221 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~~~ 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---------IFKI 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---------HHHH
Confidence 75432111 1111234588899999999988899999999999999999999999986432110 0000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. .... ...+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus 225 ~----~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 G----ENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred h----ccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 0011 12223344578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.03 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=205.5
Q ss_pred hcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcC-CCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 140 (376)
.++|.+.+.||+|+||.||+|++. .++..||+|++...... ....+..|+.++..+. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346888999999999999999864 34568999999754322 2346888999999997 9999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC----------------------------------------------------------
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP---------------------------------------------------------- 162 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 162 (376)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999865321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 163 ------------------------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 163 ------------------------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
....+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124677888999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence 9999999999999975322221111223457789999999998889999999999999999998 8899875432111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
........ .....+...+..+.+|+.+||..+|.+||++.+|+..|+.+
T Consensus 351 ----~~~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ----FYNAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----HHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00000000 00112223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=310.75 Aligned_cols=255 Identities=28% Similarity=0.375 Sum_probs=208.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36889999999999999999999999999999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999865 37899999999999999999999999 9999999999999999999999999997643321
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||...+..... .. .. ....+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~-~~------~~~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FL-IP------KNNPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HH-hh------hcCCCC
Confidence 1223456888999999999888999999999999999999999999765432110 00 00 000111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+... ..+..+.+++.+||..+|++||++++++++-+...
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 1111 03446888999999999999999999998766433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.05 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=204.7
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3579999999999999999998753 578899999875433 2345688899999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~N 203 (376)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864211 1234788899999999999999999999 9999999999
Q ss_pred EEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccc
Q 017175 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 282 (376)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875322221111222345677999999988899999999999999999997 888886543221
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. ... +.. ... . ..+...+..+.+|+.+||+.+|++||++.||++.|++
T Consensus 241 ~------~~~-~~~-~~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V------IYY-VRD-GNV---L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H------HHH-Hhc-CCC---C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 010 000 000 0 1122334578899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.70 Aligned_cols=248 Identities=31% Similarity=0.450 Sum_probs=200.2
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
++||+|+||.||+|.+.. ++.||+|.+...... ....+..|+.++++++|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 899999998765444 445788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ....+++..++.++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++.....+.......
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999865 2346889999999999999999999999 9999999999999999999999999987533222111111
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (376)
...++..|+|||.+.+..++.++|+|||||++|+|++ |..||........... ... ......
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~----------~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IES----------GYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------Hhc----------CCCCCC
Confidence 2234567999999988889999999999999999999 8888876543211110 000 000111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 313 PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+...+..+.+++.+||..+|++||++.+|++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.57 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=202.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecC------C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------D 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~------~ 139 (376)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4677999999999999999999999999999999986543 3445678899999988 699999999998753 4
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.+|++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 589999999999999998752 2356899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
+....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||.......... ..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~ 228 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LI 228 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HH
Confidence 87532211 1223456899999999986 3357889999999999999999999997543211100 00
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.. .. . ....+...+..+.+|+.+||..+|.+|||+.+++++-
T Consensus 229 ~~-~~-----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 229 PR-NP-----A---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred hc-CC-----C---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 00 00 0 0011112344788999999999999999999998763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.06 Aligned_cols=265 Identities=27% Similarity=0.392 Sum_probs=207.4
Q ss_pred hcCcccCceecccCceEEEEEEECCC-------CeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-------NQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
..+|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 2468999886432 22345788999999999 799999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999865321 2345788999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 9999999999999875332221111222334567999999999899999999999999999998 88888754322111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.. .... .....+...+..+.+++.+||+.+|++||++.++++.|..+....
T Consensus 247 -----~~-~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 -----KL-LKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----HH-HHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11 0000 001112233457889999999999999999999999999887533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=325.48 Aligned_cols=245 Identities=25% Similarity=0.313 Sum_probs=192.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhc---CCCCccceeEEEecCCceEEEEEccCC
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
||+|+||.||+|++..+++.||+|++...... .......|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998653222 222344566666554 699999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999988865 467899999999999999999999999 9999999999999999999999999987422221 1
Q ss_pred eecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ......... . +.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~---~-----~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIAFGKV---R-----FP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHHcCCC---C-----CC
Confidence 23346799999999998764 589999999999999999999999976543211 111100000 0 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHHHHHh
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRP----LIADVVTALTY 347 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rp----s~~ell~~L~~ 347 (376)
. ...+..+.+++.+||+.||.+|| ++.+++++-+.
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 0 11344778899999999999998 68888887553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=309.07 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=207.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+...... ....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578999999999999999999876654 5899988655432 34567889999999999999999999987 7889
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999875 2445899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..............++..|+|||.+....++.++|+|||||++|+|++ |..||......+... .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~--- 228 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-------LLEKGE--- 228 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHhCCC---
Confidence 443322211122234578999999988889999999999999999998 999998654321110 011100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....+...+..+.+++.+||..+|.+||++.++++.|..+..
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001112233467889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=306.33 Aligned_cols=251 Identities=31% Similarity=0.486 Sum_probs=205.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 356889999999999999999876 78899999976543 456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999998652 2236899999999999999999999999 9999999999999999999999999997542111
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
....++..|+|||.+....++.++||||||+++|+|++ |..||......+.. ......
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~--------- 215 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PHVEKG--------- 215 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhcC---------
Confidence 12335667999999988889999999999999999997 99999755332110 000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||..+|++||++.+++..|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00111223345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.65 Aligned_cols=263 Identities=29% Similarity=0.422 Sum_probs=202.0
Q ss_pred hcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEec-CC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GD 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~ 139 (376)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 357999999999999999999853 4578899999975432 2345678899999999 68999999998765 45
Q ss_pred ceEEEEEccCCCchhhhhccCCC---------------------------------------------------------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPP--------------------------------------------------------- 162 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 162 (376)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccc
Q 017175 163 ------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236 (376)
Q Consensus 163 ------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 236 (376)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999999 9999999999999999999999999987532222111122234
Q ss_pred cccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHH
Q 017175 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVR 315 (376)
Q Consensus 237 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (376)
++..|+|||.+.+..++.++|||||||++|+|++ |..||........ . . ........ ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~---~-~~~~~~~~----------~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F---C-RRLKEGTR----------MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H---H-HHHhccCC----------CCCCCC
Confidence 5678999999988899999999999999999997 8999875432110 0 0 00000000 011111
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 316 GLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 316 ~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+..+.+++.+||+.+|++||++.+|+++|+.+-
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.14 Aligned_cols=249 Identities=30% Similarity=0.478 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
++||+|+||.||+|.+..++ ..+|+|.+...... ....+..|+.+++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876554 78999998765442 4456889999999999999999999875 4568999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999975 346899999999999999999999999 9999999999999999999999999987543332211
Q ss_pred e-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 231 V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 231 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~----~~~~~---------- 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAM----LESGE---------- 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH----HHcCC----------
Confidence 1 111223567999999998899999999999999999998 9999976543211 111 11100
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
....+...+..+.+++.+||..+|++||++.+|++.|..+
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0011223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.03 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=208.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||.|+||.||+|.+..++..+|+|.+..........+..|+.+++.++|+||+++++++......|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56999999999999999999998889999999997665555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 85 DGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred CCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999999865 2356899999999999999999999999 999999999999999999999999998653221
Q ss_pred ceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 229 THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
........+++.|+|||++.. ..++.++|+|||||++|+|++|..||...+.... ........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~------ 224 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKILKSE------ 224 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHhcCC------
Confidence 112234568999999999853 3577899999999999999999999976533211 01110000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.+ ..+...+..+.+++.+||+.+|.+||++.+++++-+..
T Consensus 225 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (280)
T cd06611 225 -PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266 (280)
T ss_pred -CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence 0000 11223345788999999999999999999999986643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=306.13 Aligned_cols=251 Identities=27% Similarity=0.338 Sum_probs=207.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+|+.+++.++|+||+++++.+.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999998899999999865432 567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999865 3467899999999999999999999999 99999999999999999999999999875332221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......++..|+|||++.+..++.++||||||+++|+|++|..||.......... ... .... .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~~~----~~~~--~ 217 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------MIP----NKPP--P 217 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------hhc----cCCC--C
Confidence 2233458889999999988889999999999999999999999998654321100 000 0000 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011122344578899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=306.50 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=202.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++|+||+++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 4579999999999999999998764 56799999875433 3457889999999999999999999875 4568899999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998652 2345899999999999999999999999 9999999999999999999999999997533222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .... ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~-~~---------- 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV------LEQV-ER---------- 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHH-Hc----------
Confidence 11 1122345668999999988889999999999999999999 8899975432211 1110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
......+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111223345578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=307.78 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=204.1
Q ss_pred cCcccCceecccCceEEEEEEECCCC---eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57899999999999999999886443 37999998654322 235688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999875 2346899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCccee-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 225 VGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 225 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
....... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+.. . . +....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~---~-~~~~~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---K---A-IEEGY---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---H---H-HhCCC----
Confidence 3221111 111233568999999998889999999999999999886 99999765432111 0 0 00000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. ..+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 227 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 11122344778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=307.99 Aligned_cols=254 Identities=26% Similarity=0.338 Sum_probs=209.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45888899999999999999999999999999987543 23345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998854 45889999999999999999999999 9999999999999999999999999997533222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||........... ....
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----------------~~~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----------------IPKN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----------------hhcC
Confidence 112234688899999999888899999999999999999999999975433211000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+...+..+.+++.+||+.+|++||++.+++.+-+...
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 111223345667889999999999999999999999866543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=306.47 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=203.6
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec-CCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e 146 (376)
+|++.+.||.|++|.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++|+|++++++.+.. ....|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999999999999865432 234567889999999999999999998864 446789999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++.+++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998652 2356899999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........+++.|+|||++.+..++.++|||||||++|+|++|..||...+... ........ ..
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~------~~-- 219 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIEG------KL-- 219 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhc------CC--
Confidence 112334568999999999999899999999999999999999999997543211 11111110 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
...+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223345578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=306.47 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=203.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.++||+|+||.||+|.... ++.||+|.+..... ....+.+|+.+++.++|+||+++++++. ....+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 35679999999999999999998654 67899999875443 3467889999999999999999999874 457899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998652 3456899999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......++..|+|||++....++.++||||||+++|+|++ |..||........ . .. ....
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~-~~~~-------- 219 (260)
T cd05067 156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I---QN-LERG-------- 219 (260)
T ss_pred Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H---HH-HHcC--------
Confidence 11 11222346678999999988889999999999999999999 9999975432211 0 00 0000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.....+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 --YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.12 Aligned_cols=265 Identities=31% Similarity=0.415 Sum_probs=217.0
Q ss_pred cCcccCceecccCceEEEEEEECCCC-----eEEEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.+-+....||+|+||.||.|...... ..||+|.+.+. ......+|++|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45667789999999999999875533 34999999765 3445678999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLP---PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
|++|||.||+|..|+++.+ .....++..+.+.++.+|++|+.||++++ +|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998732 12566899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
|+.....+.........-...|||||.+..+.++.|+|||||||++||+++ |..||...+..+.... +...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-------~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-------VLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-------HHhCC
Confidence 995444443333333344578999999999999999999999999999999 8899987765422111 01111
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
+-+.|..++..+.+|+.+||+.+|++||++..|++.+..+.....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 123445566688899999999999999999999998887765433
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.86 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=201.7
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|++|.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 48889999999999999999999999999999865432 2235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+. ++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888876532 2356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhhhh----hhhhc---cc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWAR----PLFKD---RR 298 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~----~~~~~---~~ 298 (376)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||......... ....... ..+.. ..
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 122234578899999988754 5788999999999999999999999764322110 0000000 00000 00
Q ss_pred ccccccCCcCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 299 KFSQMADPTLQ---GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 299 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
........... .......+.++.+++.+||+.||++|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 00011234577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=305.12 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=207.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999999999999999986543 33445688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998752 2456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ...... ... .
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~--~~~----~-- 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQ--GNY----T-- 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHc--CCC----C--
Confidence 1 22345689999999999888889999999999999999999999976433211 111110 000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..+...+..+.+++.+||+.+|++||++.++++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123345788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.15 Aligned_cols=253 Identities=27% Similarity=0.371 Sum_probs=206.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+.|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 457778889999999999999998899999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999998853 56889999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ... ....+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~------~~~~~- 219 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIP------KNSPP- 219 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhh------cCCCC-
Confidence 11223468889999999998889999999999999999999999987543321100 000 00011
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......+..+.+++.+||+.+|++||++.+++.+-+..
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 11223445788999999999999999999999986643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=327.82 Aligned_cols=247 Identities=27% Similarity=0.394 Sum_probs=208.7
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchh
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 154 (376)
-+||+|.||+||-|++..|...+|||.+........+.+..|+.+-+.|+|.|||+++|.+.++.++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 35999999999999999999999999998877777788999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCceEEcccccccccCCCCccee
Q 017175 155 DHLHDLPPDKKRL--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 155 ~~l~~~~~~~~~~--~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
.+++. .=+++ ++.+.-.+.+||++||.|||++. |||||||-+|+|++ -.|.+||.|||.++... .-...
T Consensus 661 sLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~ 732 (1226)
T KOG4279|consen 661 SLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPC 732 (1226)
T ss_pred HHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcc
Confidence 99976 23445 78888999999999999999999 99999999999995 57899999999998632 22334
Q ss_pred ecccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh-hhhcccccccccCCcC
Q 017175 232 STRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP-LFKDRRKFSQMADPTL 308 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 308 (376)
...+.||..|||||++..+ .|+.++|||||||++.||.||++||....... .++++. +++ .
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMFkVGmyK------------v 796 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMFKVGMYK------------V 796 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhhhhccee------------c
Confidence 5567899999999999875 58999999999999999999999996432210 011111 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
....|...+.++..+|.+|+.++|.+||++.++|..-
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 2356678888999999999999999999999999653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=304.99 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=200.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEe-cCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~ 147 (376)
.+|++.+.||+|+||.||++... +..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++. .....+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46899999999999999999876 7789999986442 3456889999999999999999999764 45678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998652 2345889999999999999999999999 9999999999999999999999999987432211
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
....++..|+|||++.+..++.++|||||||++|+|++ |..||........ ... ....
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~------~~~-~~~~--------- 215 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPR-VEKG--------- 215 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH-HhcC---------
Confidence 12345668999999988889999999999999999997 9999875432111 010 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+++.+||+.+|++|||+.++++.|..+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00112223445788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.28 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=196.9
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCc
Q 017175 76 LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
.||+|+||.||+|.+. ..+..||+|++...... ..+.+.+|+.+++.++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999775 44567999998655322 2356889999999999999999999875 457899999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee-
Q 017175 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV- 231 (376)
Q Consensus 153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~- 231 (376)
|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 2456899999999999999999999999 99999999999999999999999999875333322111
Q ss_pred ecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||........... .... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~----------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-------IEQG----------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-------HHCC----------CCC
Confidence 111234578999999988889999999999999999996 9999986543211110 0000 011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..+...+..+.+++.+||..+|++||++.+|++.|..+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22233456888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=306.93 Aligned_cols=251 Identities=32% Similarity=0.477 Sum_probs=196.6
Q ss_pred ceecccCceEEEEEEECCCCe--EEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..++. .+++|.+..... .....+.+|+.++..+ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987775 468888764332 3345678899999999 799999999999999999999999999
Q ss_pred CchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 151 GSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 151 ~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 1235789999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++...... ........+..|+|||++....++.++|||||||++|+|++ |..||........ .... ..
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~-~~- 226 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKL-PQ- 226 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHH-hC-
Confidence 98531111 11111234567999999988889999999999999999997 9999975432211 1110 00
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......+...+..+.+++.+||..+|.+|||+.+++..|..+
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 227 ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000011222344788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.37 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=190.8
Q ss_pred CceecccCceEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--CCceEEEEEccC
Q 017175 74 DCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 149 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~ 149 (376)
.++||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ....|++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 4678899999865432 3456789999999999999999999854 456889999996
Q ss_pred CCchhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----CCCCceEEcccccc
Q 017175 150 LGSLEDHLHDLP-----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLA 220 (376)
Q Consensus 150 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill----~~~~~~kl~Dfg~~ 220 (376)
++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877765321 12235899999999999999999999999 9999999999999 45678999999999
Q ss_pred cccCCCCc-ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch---hhhhhhhhh
Q 017175 221 KLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL---VAWARPLFK 295 (376)
Q Consensus 221 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~ 295 (376)
........ ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||........... .......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 75432211 1112345789999999999774 589999999999999999999999975433211000 000000000
Q ss_pred cc--------cccc------ccc---CCcCCC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 296 DR--------RKFS------QMA---DPTLQG---------QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 296 ~~--------~~~~------~~~---~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.. .... ... ...... ......+..+.+|+.+||+.||.+|||++|+++|-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 00 0000 000 000000 00011234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=312.26 Aligned_cols=268 Identities=20% Similarity=0.237 Sum_probs=200.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|+||.||+|++..+|+.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 588899999999999999999999999999998653222 224567899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+. ++|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 578777754 2456899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccc-cccchh-hhh-------hhhhhcc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA-GEHNLV-AWA-------RPLFKDR 297 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~-~~~-------~~~~~~~ 297 (376)
.......++..|+|||++.+. .++.++|||||||++|+|++|..|+...... ...... ... .......
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999998765 4789999999999999999999886432211 100000 000 0000000
Q ss_pred cccccccCC---cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 RKFSQMADP---TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
......... ..........+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 000000000 0000111224567889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=307.20 Aligned_cols=268 Identities=27% Similarity=0.337 Sum_probs=204.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468999999999999999999999999999999864432 223457789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|..++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877643 346899999999999999999999999 999999999999999999999999999754332
Q ss_pred CcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhhhh-------hhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWARPL-------FKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~-------~~~~ 297 (376)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+.... ....... +...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999876 4578999999999999999999999976543211100 0000000 0000
Q ss_pred cccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
........+......+ ...+..+.+|+.+||+.+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 0000001111110000 12355788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=305.92 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec--CCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~ 145 (376)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+..|+.+++.++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48889999999999999999999999999999875433 233567789999999999999999998754 45678999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-----DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-----~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998765444677999999999999999999999 777 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... ..
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~---- 224 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKI-KE---- 224 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HHHHH-hc----
Confidence 86433221 1233568999999999998889999999999999999999999998654221 11100 00
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
......+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00112233445678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=309.35 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=202.4
Q ss_pred CcccCceecccCceEEEEEEE----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecC--CceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 142 (376)
-|++.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999974 4568889999986443 23345688999999999999999999998775 5689
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||++|++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999999865 2345899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccc---------cccchhhhhhh
Q 017175 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA---------GEHNLVAWARP 292 (376)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---------~~~~~~~~~~~ 292 (376)
....... .......++..|+|||++.+..++.++|||||||++|+|+++..|+...... ......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-R 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-H
Confidence 4332221 1122345677899999998888999999999999999999987765332110 000000000 0
Q ss_pred hhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..... .....+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 00111223455788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=307.73 Aligned_cols=252 Identities=30% Similarity=0.426 Sum_probs=199.2
Q ss_pred ceecccCceEEEEEEECCCC------eEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLESTN------QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+.||+|+||.||+|.+.... +.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999886543 7899998865432 3345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-----ceEEccccc
Q 017175 148 MPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-----HPKLSDFGL 219 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-----~~kl~Dfg~ 219 (376)
+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865321 2245788999999999999999999999 99999999999999887 899999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
+................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .. . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~---~-~~~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQ---H-VTAG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HH---H-HhcC-
Confidence 875433322222223346788999999999899999999999999999998 9999975432211 00 0 0000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.....+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 230 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 ---------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000112234557889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=309.84 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=210.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.....+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 568899999999999999999999999999998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999998865 3568999999999999999999997 57 999999999999999999999999998642111
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc-----cchhhhhhhhhhcccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE-----HNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 301 (376)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+...........
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 11235689999999999888899999999999999999999999986543211 01111111111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.+.+. ....+..+.+|+.+||+.||++||++.|+++++..+...
T Consensus 230 ---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 230 ---PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred ---CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00000 011345788999999999999999999999998776653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.35 Aligned_cols=258 Identities=29% Similarity=0.343 Sum_probs=207.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3689999999999999999999999999999999765433 3356788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998642 2456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcc---------------------------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 226 GDKT---------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 226 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111246889999999999888999999999999999999999999765
Q ss_pred ccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHHHHh
Q 017175 279 RAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL----IADVVTALTY 347 (376)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~ell~~L~~ 347 (376)
+..... ... ......-......+..+.+++.+||..+|++||+ +.+++.+-+.
T Consensus 236 ~~~~~~------~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 236 NRDETF------SNI----------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred chHHHH------HHH----------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 432110 000 0111100111124568899999999999999999 8888876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.18 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=199.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhhcCCCCccceeEEEec--CCce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 141 (376)
.+|+..+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999999999999999999864322 123457789999999999999999998875 3567
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999865 345889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc-ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... ........++..|+|||.+.+..++.++|||||||++|+|++|..||........ . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~---~~-------- 220 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---I---FK-------- 220 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---H---HH--------
Confidence 4322111 1111234588899999999988899999999999999999999999975432110 0 00
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.........++......+.+++ +||..+|++||++++|+++-
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 221 --IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred --HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 0000011122333445666777 68889999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.73 Aligned_cols=248 Identities=28% Similarity=0.365 Sum_probs=206.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 368999999999999999999999999999999865432 23456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999865 367899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-------- 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKILEGK-------- 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC--------
Confidence 2 233568999999999988888999999999999999999999997654211 011111000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
..++...+..+.+++.+||..+|.+|+ ++++++++-+
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 012222345788999999999999999 8899987754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.95 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=203.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+...... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 568889999999999999999877665 4788888654322 233678899999999999999999998754 5678
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
+++|+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999865 2346889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.............++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCCCC--
Confidence 33222212223345778999999988899999999999999999997 89999764322111 111111000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111233467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=312.04 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=206.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.|.....||+|+||.||++.+..++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555677999999999999999899999999987655455567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 99999998743 45889999999999999999999999 9999999999999999999999999986432211
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ... .....+..
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~-------~~~~~~~~ 238 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------RRI-------RDNLPPRV 238 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-------HhcCCCcc
Confidence 1123356899999999998888999999999999999999999999764432110 000 00111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.. ....+..+.+++.+||..+|.+|||+.+++++-+...
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 11 1123446788999999999999999999999866444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.86 Aligned_cols=255 Identities=31% Similarity=0.466 Sum_probs=205.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++......+++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4679999999999999999999764 5779999987543 3346788999999999999999999999998999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999762 2356899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........++..|+|||.+.+..++.++|+|||||++|+|++ |..||........ ...... ..
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~~~~---~~------ 221 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV------LEQVER---GY------ 221 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHc---CC------
Confidence 111112234568999999998889999999999999999998 9999975432211 011100 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
....+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.08 Aligned_cols=272 Identities=18% Similarity=0.224 Sum_probs=199.9
Q ss_pred cCceeccc--CceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 73 ADCLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 73 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.++||+| +|+.||++.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 688999999999999999999975432 22345778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998642 1345899999999999999999999999 99999999999999999999999987543211110
Q ss_pred -c----eeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhh-hhhhhh----
Q 017175 229 -T----HVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAW-ARPLFK---- 295 (376)
Q Consensus 229 -~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~-~~~~~~---- 295 (376)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 01122356778999999976 35899999999999999999999999753221100 00000 000000
Q ss_pred --c-----------cccccc------cc---CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 296 --D-----------RRKFSQ------MA---DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 296 --~-----------~~~~~~------~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. ...... .. ............+..+.+|+.+||+.||++|||+.+++++.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0 000000 00 000000111233557889999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.18 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=205.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+|+..+.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999999999999998643311 23567889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKL 222 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~ 222 (376)
|+||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999865 356889999999999999999999999 99999999999998776 599999999865
Q ss_pred cCCCCc--ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 223 GPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 223 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
...... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||............ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~--------- 221 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---F--------- 221 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---H---------
Confidence 332211 11122346889999999998888999999999999999999999999754322111100 0
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
...........+...+..+.+++.+||..+|++||++.+++.+-
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 222 -KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred -HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 00000111233344556888999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.93 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=201.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 33445568999999999999999889999999987766566677889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccccccccCC
Q 017175 149 PLGSLEDHLHDLPPDKKRL--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~~~ 225 (376)
++++|.+++... ...+ ++..+..++.|++.||.|||+.+ |+||||||+||+++. .+.++|+|||++.....
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999998752 2334 78888999999999999999999 999999999999976 67999999999865322
Q ss_pred CCcceeecccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.. .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||......... .+......
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~-------- 228 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK-------- 228 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc--------
Confidence 21 1122345889999999986643 788999999999999999999999753321100 00000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.....+......+.+++.+||+.+|.+|||+.+++++-
T Consensus 229 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 229 ----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred ----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 01122333445788999999999999999999999873
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=305.58 Aligned_cols=257 Identities=28% Similarity=0.381 Sum_probs=204.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCC------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD------ 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~------ 139 (376)
..++|++.+.||+|++|.||+|.+..+++.+++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999875543 346688999999998 6999999999997644
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.+++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998764334567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||........ .....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFKIP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHHhh
Confidence 8653221 122233568999999998754 3467899999999999999999999975432110 00000
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. . ..+. ...+...+..+.+|+.+||..||++|||+.+++++
T Consensus 232 ~---~----~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 R---N----PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c---c----CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 0000 11122245578899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.61 Aligned_cols=253 Identities=31% Similarity=0.454 Sum_probs=201.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|.+...||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 5699999999999999999988765 458999886543 33456788999999999999999999875 45688999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999652 2345889999999999999999999999 99999999999999999999999999975432221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .. ....
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~-~~~~---------- 219 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL------EQ-VERG---------- 219 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HH-HHcC----------
Confidence 1 1122346678999999988889999999999999999999 89999764322110 00 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.....+...+..+.+++.+||..+|++||++.+|++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001122345578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.23 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=202.8
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc----------chHHHHHHHHHHhhcCCCCccceeEEEecCC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 139 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 139 (376)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+..|+.+++.++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999999989999999988532111 1235678999999999999999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999875 356899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
+................|+..|+|||.+.... ++.++|+||||+++|+|++|..||...+.... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~-~~~~~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----M-FKLGN-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----H-HHhhc--
Confidence 87532221111223356889999999987654 78999999999999999999999965432110 0 00000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
......... ......+..+.+++.+||..+|++||++.+++++-
T Consensus 227 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 227 KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 000011111 11123356888999999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=303.60 Aligned_cols=256 Identities=28% Similarity=0.368 Sum_probs=193.6
Q ss_pred ceecccCceEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.+. .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3457799999875432 23346788999999999999999999999999999999999999
Q ss_pred chhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 152 SLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 152 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
+|.+++..... .....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865321 2234667788899999999999999999 9999999999999999999999999987532222212
Q ss_pred eecccccccCcccccccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 231 VSTRVMGTYGYCAPEYAMTG-------QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
......++..|+|||++.+. .++.++|||||||++|+|++ |..||............ .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--------VREQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--------hhcccCC
Confidence 22234578889999998642 35789999999999999996 99999765432211000 0001111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...+... ...+..+.+++..|+ .+|++|||+.+|+..|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 123346778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.02 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=205.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999999999999999986532 23345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988652 2345789999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+. ....... ..
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~~--~~------- 218 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRG--SY------- 218 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhcC--CC-------
Confidence 112234688899999999888899999999999999999999999975432211 1111000 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
...+...+..+.++|.+||+.+|++||++.+|+++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01122335578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.12 Aligned_cols=272 Identities=29% Similarity=0.419 Sum_probs=206.0
Q ss_pred cCcccCceecccCceEEEEEEECC----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEec--CCce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 141 (376)
..|++.+.||+|+||.||+|.+.. ++..+|+|.+...... ....+.+|+.+++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 457888999999999999998643 4789999999765443 45678899999999999999999999877 5678
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999752 336899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
......... ......++..|+|||.+.+..++.++|||||||++|+|++|..|+......... ...... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~-~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQ-GQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-cccccc-ccccHHHH
Confidence 643222111 111234556799999998888999999999999999999999998654321100 000000 00000000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...+........+...+..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000011111111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=326.53 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=213.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+-|.++..||.|+||.||+|..+.++...|.|++........++++-|+.+|..+.||+||++++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34778889999999999999999999999999998777777889999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
.||-+...+.. .+..+++.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+-. ....
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKST 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhH
Confidence 99999888876 4678999999999999999999999999 99999999999999999999999999853 2222
Q ss_pred ceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 229 THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
......++|||+|||||+... .+|+.++||||||++|.||..+.+|-....+.. .++.....
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---------VllKiaKS---- 250 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLKIAKS---- 250 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---------HHHHHhhc----
Confidence 333456899999999998753 579999999999999999999999987554321 11111100
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+|+ .---|...+..+.+++.+||..||+.||++.+|++|-+
T Consensus 251 -ePP-TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 251 -EPP-TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred -CCC-cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 111 01123445668889999999999999999999998854
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.77 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=203.6
Q ss_pred cCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688999999999999999987543 3468999886554 2344578899999999999999999998876 457899
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999965 2345899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.... .......++..|+|||.+....++.++|||||||++|+|++ |..||........... +....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-------~~~~~----- 225 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-------IENGE----- 225 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCC-----
Confidence 2211 11122334568999999988889999999999999999986 9999976543211100 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. ..+...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 226 -~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 -RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 1122334578889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.94 Aligned_cols=259 Identities=27% Similarity=0.364 Sum_probs=202.6
Q ss_pred HHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEec---
Q 017175 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD--- 137 (376)
Q Consensus 62 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--- 137 (376)
.+.....+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 333445678999999999999999999999999999999986543 2335677889999888 69999999999853
Q ss_pred ---CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 138 ---GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 138 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
...+|++|||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988652 2345888899999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
+|||++...... ........|+..|+|||++. +..++.++|+|||||++|+|++|..||...........
T Consensus 163 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~--- 237 (282)
T cd06636 163 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL--- 237 (282)
T ss_pred eeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence 999998743211 11123356899999999886 34678899999999999999999999975432111000
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.. ....+.. .....+..+.+|+.+||+.||.+||++.+|+++
T Consensus 238 ----~~------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 ----IP------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----Hh------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 0000000 111234578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.30 Aligned_cols=247 Identities=30% Similarity=0.453 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
++||+|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999865 5788999998754332 234678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 999865 2345789999999999999999999999 999999999999999999999999998643222111 111
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (376)
...++..|+|||++.+..++.++||||||+++|+|++ |..||......... .. ... ......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~------~~-~~~----------~~~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR------EQ-VEK----------GYRMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HH-HHc----------CCCCCC
Confidence 1234567999999988889999999999999999998 99999754322110 00 000 001112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 313 PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 313 ~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2234457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=307.31 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=210.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+|.+.+.||+|+||.||++.+..++..||+|.+........+.+.+|+.+++.++||||+++++.+......|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36799999999999999999999888999999998765555566788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999854 45789999999999999999999999 9999999999999999999999999886533222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+......... . ...
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~---------~~~ 232 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T---------NGT 232 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------c---------CCC
Confidence 12233468899999999988889999999999999999999999997654322111000 0 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+...+..+.+++.+||..+|++||++.+++.+-+...
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 000112223446888999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.69 Aligned_cols=250 Identities=30% Similarity=0.429 Sum_probs=200.3
Q ss_pred ceecccCceEEEEEEECC-CC--eEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLES-TN--QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|++|.||+|.+.. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998855 33 3699999987665 455678899999999999999999999988 889999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976321 56899999999999999999999999 9999999999999999999999999997643322111
Q ss_pred -eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 231 -VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 231 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ........ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~---~------ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL------KKIDKEGE---R------ 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCC---c------
Confidence 1123457788999999988899999999999999999998 99999754332111 11100000 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.12 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=205.5
Q ss_pred HHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecC--
Q 017175 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-- 138 (376)
Q Consensus 62 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-- 138 (376)
..+....++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 344455788999999999999999999999999999999986532 2235667899999888 799999999998653
Q ss_pred ---CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 139 ---DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 139 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3589999999999999988654334567899999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|..||........ ..
T Consensus 171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~--- 243 (291)
T cd06639 171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF--- 243 (291)
T ss_pred ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH---
Confidence 9999875332221 12234688999999998643 367899999999999999999999976432111 00
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..... ....+ ..+......+.++|.+||+.+|++||++.+++++-
T Consensus 244 -~~~~~--~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 244 -KIPRN--PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred -HHhcC--CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 00000 00000 11122334688999999999999999999999873
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=302.55 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=201.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhhcCCCCccceeEEEecC--Cce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 141 (376)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468999999999999999999999999999998864321 1234677899999999999999999988763 467
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999865 345788999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... .. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~~------- 221 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AI-FKI------- 221 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HH-HHH-------
Confidence 53221111 11223458899999999988889999999999999999999999997543211 00 000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.........+...+..+.+++.+||. +|++||++.+|+++-
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 222 ---ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred ---hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 00011122344556678889999994 999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.58 Aligned_cols=271 Identities=24% Similarity=0.285 Sum_probs=205.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-----chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488889999999999999999988999999999765433 234567899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+ +++|.+++... ...+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998652 236999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh----hhhhccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR----PLFKDRR 298 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~~ 298 (376)
... .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||......+..... .... ..+....
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 322 11223356788999998865 45789999999999999999998888754432111000 0000 0000000
Q ss_pred ccccccCCcCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQ-----GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
........... .......+..+.+++.+||..+|++|||+.+++.+=+.-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 00000000000 0111233567889999999999999999999999755444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=301.01 Aligned_cols=252 Identities=35% Similarity=0.482 Sum_probs=202.2
Q ss_pred cccCceecccCceEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+++.+.||.|+||.||+|.+...+ ..||+|.+...... ....+..|+.+++.++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999998766 88999999765433 4567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987521 122899999999999999999999999 99999999999999999999999999976443
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...... . .
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~------~~~~~~-~-~----- 221 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV------LEYLKK-G-Y----- 221 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHhc-C-C-----
Confidence 322111 12337789999999988889999999999999999998 7888875332111 111000 0 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011122455788899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.95 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=203.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58899999999999999999999999999999875432 2345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg~~~~~~~~ 226 (376)
+++++|.+++... ....+++..++.++.+++.||.|||+++ ++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999652 2345899999999999999999999999 9999999999999855 45799999999754322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.... ....... .
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~--~------- 217 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSG--T------- 217 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhc--C-------
Confidence 2 12235688999999999888889999999999999999999999976543211 1110000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001122334578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.22 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=205.6
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|++|.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58899999999999999999998999999999876542 2245688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+ +++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998652 366999999999999999999999999 9999999999999999999999999987643332
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhh-------hhhhhccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWA-------RPLFKDRR 298 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~-------~~~~~~~~ 298 (376)
. .......++..|+|||++.+. .++.++|||||||++|+|++|.+||........... .... ++.+....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 112335689999999998654 468999999999999999999888865432111000 0000 00000000
Q ss_pred ccccccCCcCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 299 KFSQMADPTLQ----GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 299 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....+..+... .......+..+.+++.+||..+|++||++++++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 00000000000 0011123468889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.02 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=192.1
Q ss_pred ceecccCceEEEEEEECCCCe-------EEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+.||.|+||.||+|.+...+. .+|+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998865443 4888888655444556788899999999999999999999998999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc--------eEEccccc
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--------PKLSDFGL 219 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~--------~kl~Dfg~ 219 (376)
+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998752 346899999999999999999999999 999999999999987765 68999998
Q ss_pred ccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCC-CCCCCcccccccchhhhhhhhhhcc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++|. .||...+..... ......
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYEDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHHcc
Confidence 864221 1234688899999999864 5789999999999999999985 666544322110 011110
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1122223346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=306.51 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=200.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|++|.||+|.++.+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5799999999999999999999989999999998654322 224466899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 4899888652 346899999999999999999999999 9999999999999999999999999986432211
Q ss_pred cceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccc-cccchh-hhh----hhhhhccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA-GEHNLV-AWA----RPLFKDRRKF 300 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~-~~~----~~~~~~~~~~ 300 (376)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...... ... ...+......
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11222356889999999875 45889999999999999999999999754311 100000 000 0000000000
Q ss_pred ---cc-----ccCCcCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 301 ---SQ-----MADPTLQGQYP-VRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 301 ---~~-----~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.. .....+....+ ......+.+++.+||+.+|++||++.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 00 00000000000 01125778899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=300.27 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=201.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468889999999999999998864 67899998865433 3456889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999865 2346889999999999999999999999 99999999999999999999999999875322211
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .... ... ...
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~-~~~---~~~---- 220 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VETI-NAG---FRL---- 220 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHH-hCC---CCC----
Confidence 11112335678999999988889999999999999999998 9999975432211 1110 000 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+...+..+.+|+.+||+.+|++||++.+++++|.
T Consensus 221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011123457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.32 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=206.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++|+||+++++.+......|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36889999999999999999999999999999886542 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
+++++|..++.... ....+++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999998886521 13478999999999999999999997 57 999999999999999999999999998653211
Q ss_pred CcceeecccccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||........ ......
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~-------- 221 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSA-------- 221 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHH--------
Confidence 12234688899999998543 357899999999999999999999975432111 000000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+... .....+...+..+.+++.+||+.+|++||++.+++.+-+....
T Consensus 222 --~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 222 --IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred --Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 0000 0012233355678899999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=309.08 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=206.4
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
|.....||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+..+...+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44556799999999999999988999999998765545556788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|..++.. ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999988743 56899999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......|+..|+|||++.+..++.++|||||||++|+|++|..||......... ....... ....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-------~~~~-- 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRDSP-------PPKL-- 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhccC-------CCCc--
Confidence 223356899999999998888999999999999999999999999754432111 0000000 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+..+.+++.+||+.+|++||++.+|+++-..+..
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 0111233467889999999999999999999998775543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=300.15 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=192.9
Q ss_pred ceecccCceEEEEEEECC---CCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEe-cCCceEEEEEccC
Q 017175 75 CLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMP 149 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~ 149 (376)
+.||+|+||.||+|.+.. .+..+|+|.+.... ......+.+|+.+++.++||||+++++++. .....+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999885432 233467888999999999999999999775 4556889999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|.+++... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998652 344677888999999999999999999 999999999999999999999999998743221111
Q ss_pred --eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 230 --HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 230 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.......++..|+|||.+.+..++.++|||||||++|+|++| .+||....... ... .... .. ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~---~~~~-~~------~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV---YLLQ-GR------RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHhc-CC------CC
Confidence 111223467789999999888899999999999999999995 56666433211 110 0000 00 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011122346889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=299.85 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=202.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34679999999999999999998654 5569999886542 234568889999999999999999999887 77899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999998652 2456788999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......++..|+|||++....++.++|+|||||++|+|++ |..||......... .......
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~------- 220 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGY------- 220 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCC-------
Confidence 21 11122345678999999988889999999999999999998 89999764322111 0001000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=305.66 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=200.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHH-HhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+..|+.. ++.++||||+++++++......|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 368899999999999999999999999999999875432 223345556654 566789999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|++ ++|.+++.........+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 688887765433456799999999999999999999997 8 99999999999999999999999999875322
Q ss_pred CCcceeecccccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
. .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...... ... .......
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~~----- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQVVEE----- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHHHhc-----
Confidence 1 11223468889999998865 45688999999999999999999999753211 000 0000000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+... ....+..+.+++.+||..+|++||++.+++++-+....
T Consensus 224 --~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 224 --PSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --CCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000000 01234578899999999999999999999987665543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.12 Aligned_cols=268 Identities=26% Similarity=0.364 Sum_probs=205.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999999999999999986532 2234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|++++.+..+... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665543 455899999999999999999999999 999999999999999999999999998764333
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh-h-------hhhhhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW-A-------RPLFKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~ 297 (376)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....... . ...+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122345688999999999888 789999999999999999999999975432211000000 0 0000000
Q ss_pred ccccc--ccCCc----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 298 RKFSQ--MADPT----LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 298 ~~~~~--~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..... ..+.. ....++...+..+.+||.+||..+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 00000 0001122235688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.41 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=203.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999988899999999865432 2335688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999865 346889999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........ .... .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~-~~~~~---- 219 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKI-GRSKE---- 219 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHH-Hhccc----
Confidence 222 123456889999999987776 89999999999999999999999976532110 0000 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011222334577889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=301.47 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=201.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+|++.+.||+|+||.||+|.+. +++.+|+|.+...... ....+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999874 6889999988643211 12457789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999865 356889999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 224 PVG----DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 224 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
... ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+...... . ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~-~~~~-- 223 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF------Y-IGAH-- 223 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH------H-hhhc--
Confidence 211 11112223568999999999998889999999999999999999999997543221100 0 0000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.. ..+ ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 224 -~~-~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 224 -RG-LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -cC-CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 011 1222344578899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=301.17 Aligned_cols=241 Identities=24% Similarity=0.382 Sum_probs=190.0
Q ss_pred ceecccCceEEEEEEECCC------------CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 75 CLLGEGGFGRVYKGRLEST------------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
+.||+|+||.||+|+.... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999985422 3358999886654444557788999999999999999999999989999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc-------eEEc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-------PKLS 215 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~-------~kl~ 215 (376)
++|||+++++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988764 2456899999999999999999999999 999999999999987664 8999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCcccccccchhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEII-TGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
|||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......... ..
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HH
Confidence 9999864321 12245788999999887 456899999999999999998 588887654321110 00
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... . .. ........+.+|+.+||+.||++||++.+|+++|+
T Consensus 222 ~~~--~-~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YEG--Q-CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Hhc--C-cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 00 01112347889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.70 Aligned_cols=268 Identities=26% Similarity=0.374 Sum_probs=203.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999999988999999998654322 23467789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|..+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887654 345899999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhhh-------hhhhhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWA-------RPLFKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~-------~~~~~~~ 297 (376)
. .......++..|+|||++.+. .++.++|||||||++|+|++|..||......+.. ...... ...+...
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 122335688999999998753 4778999999999999999999999754322110 000000 0000000
Q ss_pred cccccccCCcCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 298 RKFSQMADPTLQG-----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 298 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.....+..+.... ......+..+.+|+.+||..+|++||++.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 0000000111000 01123356788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=302.90 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=203.3
Q ss_pred cCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
++|++...||.|+||.||+|+.+. +.+.|++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578899999999999999999754 3467999988654433 3456889999999999999999999999989999
Q ss_pred EEEEccCCCchhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPD-----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
+||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998753211 126899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ... ..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~---~~~-~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL---NRL-QA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH---HHH-Hc
Confidence 9986432211 111223356778999999988888999999999999999998 788886543211 11 000 00
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... ....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 234 -~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00111223447889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=299.21 Aligned_cols=259 Identities=28% Similarity=0.400 Sum_probs=208.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||.|+||.||+|.+..++..+|+|++..... .....+.+|+.+++.++|+||+++++.+......+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468999999999999999999988899999999875432 2456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865211 246899999999999999999999999 9999999999999999999999999987544332
Q ss_pred cce--eecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 228 KTH--VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 228 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... ......|+..|+|||++... .++.++|+|||||++|+|++|..||......... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~-------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN-------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC-------C
Confidence 221 22335689999999998877 7899999999999999999999999765432110 000000 0
Q ss_pred CCcCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 305 DPTLQGQY-PVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 305 ~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.+...... ....+..+.+++.+||..||++||++.+|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111100 12334578899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.25 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=188.8
Q ss_pred eecccCceEEEEEEECC------------------------CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccce
Q 017175 76 LLGEGGFGRVYKGRLES------------------------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~ 131 (376)
.||+|+||.||+|.... ....|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997532 124589998865544444567889999999999999999
Q ss_pred eEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-
Q 017175 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY- 210 (376)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~- 210 (376)
++++.+....++||||+++++|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998864 3457899999999999999999999999 99999999999997643
Q ss_pred ------ceEEcccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHH-hCCCCCCCccccc
Q 017175 211 ------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEII-TGRKAIDNTRAAG 282 (376)
Q Consensus 211 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~ 282 (376)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4799999987642111 12357788999998875 56899999999999999995 6899997654321
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... .+.... ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 230 ~~~-------~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KER-------FYEKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH-------HHHhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 110 111000 011112236788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=303.49 Aligned_cols=266 Identities=25% Similarity=0.298 Sum_probs=207.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecC--CceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~ 145 (376)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368889999999999999999999999999999875433 3345688999999999999999999988653 4689999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887654334566899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||......... ........... ....+.+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~ 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSYIVNM--PNPELKD 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHHHhcC--Cchhhcc
Confidence 21 12345788999999998889999999999999999999999999865321000 01111100000 0000000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
... .....+..+.+++.+||..+|++|||+.|++++-+.
T Consensus 231 -~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 231 -EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred -CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 000 001234578899999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=316.11 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=215.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
...|.+.+.||+|.|+.|.+|++..++..||||++.+..... ...+.+|+.+++.++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456999999999999999999999999999999998765433 355889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+.+|.+.+++.. ..+..+..+..++.|+++|++|||+++ |+|||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999986 567777999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-- ...
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------------------~Lr 264 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------------------ELR 264 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------------------ccc
Confidence 334556899999999999998876 48899999999999999999999965321 111
Q ss_pred CCcCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQG--QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+..+.+ ..+...+.++.++|+++|-++|.+|+++.++.++-|.-..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 111111 1223345577789999999999999999999988765443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=299.77 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=209.4
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+|++.+.||+|++|.||+|.+..+++.|++|++..... .....+..|+.++..++|+||+++++++......++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 58889999999999999999999999999999876544 34567889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999975 3678999999999999999999999 99 9999999999999999999999999987543222
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ..... ....+
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~-------~~~~~- 221 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAIC-------DGPPP- 221 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHh-------cCCCC-
Confidence 1 12245688999999999888899999999999999999999999976643111111 11111 00011
Q ss_pred CCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 308 LQGQYPVR-GLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 308 ~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+.. .+..+.+++.+||..+|++||++.+++++-+
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~ 258 (264)
T cd06623 222 ---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258 (264)
T ss_pred ---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence 11222 4457889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=308.11 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=189.8
Q ss_pred ceecccCceEEEEEEECC--CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--CCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~ 150 (376)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999754 567899999865432 3457789999999999999999998854 567899999996
Q ss_pred CchhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----CCCCceEEccccccc
Q 017175 151 GSLEDHLHDLP-----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAK 221 (376)
Q Consensus 151 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill----~~~~~~kl~Dfg~~~ 221 (376)
++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57777764311 12235889999999999999999999999 9999999999999 566799999999997
Q ss_pred ccCCCCcc-eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch---hhhhhhhhhc
Q 017175 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL---VAWARPLFKD 296 (376)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~ 296 (376)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........... .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 54322211 112335689999999998764 588999999999999999999999975432211000 0000000000
Q ss_pred --------------ccccccccC---------CcC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 297 --------------RRKFSQMAD---------PTL---QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 297 --------------~~~~~~~~~---------~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
......... ... ...........+.+|+.+||+.||.+|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 000000000 000 0000112234678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=300.20 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=190.3
Q ss_pred ceecccCceEEEEEEECC--CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC
Q 017175 75 CLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999996532 345789998764432 22346788999999999999999999999999999999999999
Q ss_pred chhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 152 SLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 152 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
+|.+++..... .....++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999876322 1233567888999999999999999999 9999999999999999999999999986432222111
Q ss_pred eecccccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 231 VSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||......+.. ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~--~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVRE--QDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhc--cCcc
Confidence 1223446778999998753 356789999999999999999 78888755332110 000000 0011
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...+. .+...+..+.+++..|+ .||++||++.+|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12233446667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=303.63 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=205.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
.|...+.||+|++|.||+|.+..+++.+++|.+..........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 46667899999999999999988899999999875544455668899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|.+++.. .++++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999999864 46889999999999999999999999 9999999999999999999999999886432221
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ....... ..+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~-------~~~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDN-------LPPKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhc-------CCCCCc
Confidence 112235689999999999888899999999999999999999999976433211 1111000 001111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.+...+..+.+++.+||+.+|++||++.+++++-+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 11123457889999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.24 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=202.7
Q ss_pred CcccCceecccCceEEEEEEECC-CCeEEEEEEeccCCc----------cchHHHHHHHHHHhh-cCCCCccceeEEEec
Q 017175 70 NFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGL----------QGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 137 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~ 137 (376)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .....+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 678999998864321 122346678887764 789999999999999
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSD 216 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~D 216 (376)
....+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543445679999999999999999999996 67 99999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh-
Confidence 99997533322 22345688999999999988899999999999999999999999975432211 000000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... .+... ...+..+.+++.+||+.||++||++.|+..++.
T Consensus 228 -~~~----~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -AVY----EPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -ccC----CcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00001 122347889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.60 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=201.2
Q ss_pred CcccCceecccCceEEEEEEECC--CCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecC--CceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~ 142 (376)
+|++.+.||+|++|.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999988 78999999997633 23345677899999999999999999999988 8899
Q ss_pred EEEEccCCCchhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC----CCceEEccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPD-KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----GYHPKLSDF 217 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~----~~~~kl~Df 217 (376)
+||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999974 676666443222 247899999999999999999999999 999999999999999 999999999
Q ss_pred ccccccCCCCc-ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-------hh
Q 017175 218 GLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-------VA 288 (376)
Q Consensus 218 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-------~~ 288 (376)
|++........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||........... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875332221 1112234678999999988764 578999999999999999999999976543320000 00
Q ss_pred hhhh----------hhhcccccccccCCcCCCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 289 WARP----------LFKDRRKFSQMADPTLQGQYP---------V--RGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 289 ~~~~----------~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.... .+..........+......++ . ..+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000000000000000000111 0 234578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.96 Aligned_cols=250 Identities=27% Similarity=0.352 Sum_probs=205.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58899999999999999999999999999999975432 234678889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999865 357899999999999999999999999 999999999999999999999999998754332
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .........
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------
Confidence 2 12335688899999999888899999999999999999999999987653211 000000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI--ADVVTA 344 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~--~ell~~ 344 (376)
.....+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 1112223344688899999999999999999 776643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=298.43 Aligned_cols=247 Identities=29% Similarity=0.459 Sum_probs=198.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4589999999999999999865 47889999986542 335688999999999999999999998664 579999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999998752 2345889999999999999999999999 999999999999999999999999998753221
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......... ......
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------- 213 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKG---------- 213 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCC----------
Confidence 112234567999999988899999999999999999998 99999765432110 111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0011112334578899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.59 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=205.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+-|++.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 347788999999999999999988899999999865432 2335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999854 46899999999999999999999999 9999999999999999999999999986533221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........ . ... .. . ..
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~---~~~-~~-~-----~~-- 218 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---L---FLI-PK-N-----NP-- 218 (277)
T ss_pred h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---H---HHH-hc-C-----CC--
Confidence 1 12234688899999999888889999999999999999999999975432110 0 000 00 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...+...+..+.+++.+||+.+|.+||++.+++.+-....
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 219 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 1112233457888999999999999999999999855443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.88 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=204.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|+||.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999999888999999998765543 456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999865 345889999999999999999999999 9999999999999999999999999987643322
Q ss_pred ccee--ecccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 228 KTHV--STRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 228 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||...+... ..... ... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~-~---- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFH-VGA-G---- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHH-Hhc-C----
Confidence 2111 11346788999999998766 8899999999999999999999997543210 00000 000 0
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..+.+.. ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 223 -~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 01124567889999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.00 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=204.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4788899999999999999999999999999987543 233456778999999886 999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998854 36899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. .......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||........... .....
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------~~~~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------------IPKSK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------------cccCC
Confidence 32 122335689999999988754 568899999999999999999999976533211000 00001
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.+.+... ..+..+.+++.+||+.||++||++.+++.+-+.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 1111111 134578899999999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=301.98 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=200.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999999999999999986543322 2356789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 677776643 2345788889999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh--------cc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK--------DR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 297 (376)
. .......++..|+|||++.+. .++.++|||||||++|+|++|..||+........ .......+. ..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhhh
Confidence 1 112334578999999998764 5788999999999999999999999765431100 000000000 00
Q ss_pred cccccccCCcCCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQY---------PVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
............... .......+.+++.+||..||++|||+.+++.+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~ 289 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHP 289 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCC
Confidence 000000000000000 001245778899999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.86 Aligned_cols=270 Identities=24% Similarity=0.289 Sum_probs=205.1
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecC-----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----- 138 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4568899999999999999999999999999999998643 223345677899999999999999999988643
Q ss_pred -CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 139 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 588887743 2889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-h--------
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-A-------- 288 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~-------- 288 (376)
|++....... ......++..|+|||++.+..++.++|||||||++|+|++|..||...+..+....+ .
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9997532221 122346889999999999999999999999999999999999999765432110000 0
Q ss_pred h-------hhhhhhccc-----ccccccCC----cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 289 W-------ARPLFKDRR-----KFSQMADP----TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 289 ~-------~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
+ ......... .+...... ......+...+..+.+++.+||+.||++|||+.+++.+-+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 0 000000000 00011100 000111223455788999999999999999999999887643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=300.86 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=207.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+|++.+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 57888999999999999999999999999999876533 33456888999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999998752 2678999999999999999999999 88 9999999999999999999999999986432111
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.... ............ ..+
T Consensus 156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~- 222 (265)
T cd06605 156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-------PPP- 222 (265)
T ss_pred ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-------CCC-
Confidence 1125688999999999988999999999999999999999999975532111 111111111100 000
Q ss_pred CCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 308 LQGQYPVR-GLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 308 ~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..+.. .+..+.++|.+||..+|++|||+.+++.+-+.
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 223 ---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred ---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 11111 45578899999999999999999999987664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.45 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=209.8
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|.+.+.||.|++|.||++.+..++..|++|.+..... .....+..|+.+++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58889999999999999999998999999999976543 3456688899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764333577999999999999999999999999 9999999999999999999999999997533322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........ .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~--~-------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILKG--Q-------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhcC--C--------
Confidence 22334568999999999988889999999999999999999999997654221 11111000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||..+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011222344578899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.45 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=190.6
Q ss_pred eecccCceEEEEEEECCC--CeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCc
Q 017175 76 LLGEGGFGRVYKGRLEST--NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
.||+|+||.||+|..... ...+++|.+..... .....+.+|+.+++.++||||+++++.+.+....|+||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34567777664432 344678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceee
Q 017175 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232 (376)
Q Consensus 153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 232 (376)
|.+++..........++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333445677888999999999999999999 999999999999999999999999998642222111122
Q ss_pred cccccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 233 TRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 233 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||........ ....... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~--~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIKD--QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhh--cccccC
Confidence 34568899999998753 245788999999999999997 5678865432111 0111110 111112
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
++.+. ......+.+++..|| .+|++||++.+|++.|+
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 223446778999999 67999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=299.29 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=199.7
Q ss_pred cccCceecccCceEEEEEEEC---CCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCC------
Q 017175 71 FRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 139 (376)
|++.+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 357899999986543 223456788999999999999999999886532
Q ss_pred ceEEEEEccCCCchhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
..+++++|+.+++|..++... ......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998886431 112235788999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
|++................+++.|++||.+.+..++.++|||||||++|+|++ |..||......... .. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~---~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---NY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH---HH----HHc
Confidence 99875433322222223345678999999988889999999999999999999 88888754332110 00 000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.... ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 01122345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=304.19 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=202.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecC--CceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv 144 (376)
++|++.+.||.|+||.||+|.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46899999999999999999999999999999997543222 23467899999999999999999998877 889999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||++ ++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 5898888652 346899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh-------hhhh
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR-------PLFK 295 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~-------~~~~ 295 (376)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+ .... ..+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 122334578899999998764 4688999999999999999999999765332111000 0000 0000
Q ss_pred c-----ccccccccCCcCCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 296 D-----RRKFSQMADPTLQGQYPVR-GLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 296 ~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. ...........+...++.. .+..+.+++.+||+.+|++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000111111111222222 35678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.16 Aligned_cols=256 Identities=25% Similarity=0.327 Sum_probs=202.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999875532 22346778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999965 356899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCcc-------------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 226 GDKT-------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 226 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH
Confidence 1100 01112457889999999988889999999999999999999999997543221 0111
Q ss_pred hhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHH
Q 017175 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL---IADVVTALT 346 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~ell~~L~ 346 (376)
.... ....+.. ....+..+.+++.+||+.+|++||+ +.+++++-+
T Consensus 228 ~~~~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 228 VISD-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred HHhc-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0000 0000110 1123456789999999999999998 566666644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.32 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=200.7
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|+..+.||.|++|.||+|++..+++.||||.+...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999999999999999998654322 234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+. ++|..++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6888887652 2456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhhhh-----------hhh
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWAR-----------PLF 294 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~-----------~~~ 294 (376)
.......++..|+|||++.+.. ++.++|||||||++|+|++|..||......... ....... ..-
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1122345788999999887644 688999999999999999999999754322110 0000000 000
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.....+......... ......+..+.++|.+||+.||.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000 0011234467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.71 Aligned_cols=239 Identities=28% Similarity=0.462 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEECCCC----------eEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 75 CLLGEGGFGRVYKGRLESTN----------QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999998766 45888877654333 5678899999999999999999999988 778999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-------ceEEccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-------HPKLSDF 217 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-------~~kl~Df 217 (376)
|||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998752 236899999999999999999999999 99999999999999887 7999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|++..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||........... +
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-------~ 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------Y 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-------H
Confidence 99875322 2224567789999999876 78899999999999999999 5777766532211100 0
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... . ..+......+.+++.+||..+|.+||++.++++.|+
T Consensus 220 ~~~-~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQ-H-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcC-C-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 001111257889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.25 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=194.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhh---cCCCCccceeEEEecCCceEEEEEccC
Q 017175 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSL---LHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~---l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
+||+|+||.||++.+..+++.+|+|.+...... ......+|..+++. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654322 11223444444433 469999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998865 456999999999999999999999999 9999999999999999999999999986432211
Q ss_pred eeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 230 HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ..... . ..
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~-------~----~~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT-------L----TV 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHh-------h----cC
Confidence 123468999999999864 568899999999999999999999997543221110 00000 0 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~~ 349 (376)
....+...+..+.+++.+||..||++|| ++.++++|.++..
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 1122333456888999999999999999 6999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=290.91 Aligned_cols=261 Identities=21% Similarity=0.245 Sum_probs=205.6
Q ss_pred HHhcCcccC-ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecC----C
Q 017175 66 AVTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG----D 139 (376)
Q Consensus 66 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~----~ 139 (376)
.++++|++. ++||-|-.|.|..+.++.+++.+|+|++.. ..+..+|+.+--.. .|||||.++++|++. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356677764 679999999999999999999999999843 35566788765544 599999999998653 4
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCceEEcc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSD 216 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~~kl~D 216 (376)
.+.+|||.|+||.|...+... ....+++.++..|+.||..|+.|||+.+ |.||||||+|+|.. .+..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence 567999999999999999873 4567999999999999999999999999 99999999999996 455799999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||+++.-. ........+-|+.|.|||++....|+...|+||+||++|-||+|.+||........ ....+.-+..
T Consensus 208 fGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~ 281 (400)
T KOG0604|consen 208 FGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRT 281 (400)
T ss_pred cccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhc
Confidence 99998522 22334557899999999999999999999999999999999999999986543211 0000000000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...++.++.+ ...+....++|+.+|..+|.+|.|+++++++-|--+
T Consensus 282 --gqy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 282 --GQYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred --cCccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 0112222222 234668889999999999999999999999988444
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.98 Aligned_cols=274 Identities=23% Similarity=0.328 Sum_probs=204.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecC--CceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ...+.+|+.+++.++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457999999999999999999999999999999986543222 23456899999999999999999998764 56899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888887652 356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh-hh----hh---h
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW-AR----PL---F 294 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~----~~---~ 294 (376)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. .. .. +
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3322 11222346788999999865 4578999999999999999999999986543221111100 00 00 0
Q ss_pred hccccccccc-CCcCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 295 KDRRKFSQMA-DPTLQGQ---YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 295 ~~~~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.......... ....... .....+..+.++|.+||+.||++|||+.+++.+-+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000000000 0000000 001125577899999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=297.73 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=208.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|++|.||++.+..+++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58889999999999999999999999999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|..++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998664444567899999999999999999999999 999999999999999999999999999764333
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..... ... . ..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~------~~~-~----------~~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------YKV-Q----------RG 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-h----------cC
Confidence 222346889999999999888999999999999999999999999765432110 000 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.....+.....++.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112223455678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.11 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=204.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58889999999999999999999999999999865422 3345677899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc-eEEcccccccccCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-PKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~-~kl~Dfg~~~~~~~~ 226 (376)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998652 2345799999999999999999999999 999999999999988864 699999998754322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ........ . .
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~--~----~-- 219 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQG--Y----F-- 219 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcc--c----C--
Confidence 112223468899999999988889999999999999999999999997543211 11111000 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.......+..+.+++.+||..+|++|||+.+++.+-
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 011123345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=308.86 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=219.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch-HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
....+.++||+|-||.|.+|.... +..||+|+++....... .+|..|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 457888999999999999998765 68999999987654444 7899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|+.|+|..++...... .+......+|+.||+.|++||.+.+ ++||||.+.|+|++.++++||+|||+++....++
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999874222 2455566789999999999999999 9999999999999999999999999999877888
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh--CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
........+-..+|||||.+..+.++.++|+|+||+++||+++ ...||.....+. .+.-...++.....
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~------ 762 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR------ 762 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc------
Confidence 7777777888999999999999999999999999999999976 668887654321 11111122222111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...-.-|.-++..+.+++.+||..+-++||++++|..+|+..+
T Consensus 763 -~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 -QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1111234456678889999999999999999999999998754
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=302.59 Aligned_cols=253 Identities=33% Similarity=0.420 Sum_probs=202.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999988999999998644322 234678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 577776643 2356899999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
.. ....++..|+|||++. ...++.++||||||+++|+|++|..||......... ... ... .
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~-~~~-~-- 230 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHI-AQN-D-- 230 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHH-hcC-C--
Confidence 21 2346888999999884 356889999999999999999999999765432110 000 000 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+. ..+...+..+.+++.+||+.+|++||++.+|+.+.+...
T Consensus 231 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 231 ---SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ---CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 011224457889999999999999999999999877544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.40 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=206.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
.|+..+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 37888999999999999999998899999999977655556778899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998652 257899999999999999999999999 99999999999999999999999999875433321
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...... . .. .........
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~-~~~~~~~~~---- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IA-TNGPPGLRN---- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HH-hcCCCCcCc----
Confidence 234568899999999988888999999999999999999999997653211000 0 00 000011100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+..+.+++.+||+.||++|||+.+++++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124578899999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.07 Aligned_cols=247 Identities=28% Similarity=0.369 Sum_probs=202.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||.|++|.||+|++..+++.+|+|.+...... ....+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999754322 335688899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999965 345899999999999999999999999 9999999999999999999999999997643322 123
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... +........++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~----------~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYND----------ILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHH----------HhccCCCCCCC
Confidence 3468899999999988889999999999999999999999998654211 010111 11001111223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
...+..+.+++.+||+.+|++||+ +.|++++-+.
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 333568899999999999999999 8999987664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=292.83 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=209.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecC--CceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~ 145 (376)
+|+..+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+.+++.++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998999999999876543 3456788999999999999999999999988 8899999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999876 237999999999999999999999999 99999999999999999999999999976443
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
...........++..|+|||.+.+...+.++||||||+++|+|++|..||...... ..... ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~----------~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALY----------KIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHH----------hccc
Confidence 33211123456889999999998888999999999999999999999999865411 00000 0001
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.......+...+..+.+++.+||..+|++||++.+++.+-
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 1111123334466889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.79 Aligned_cols=271 Identities=24% Similarity=0.336 Sum_probs=198.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCC------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 139 (376)
-++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999998644322 2234567999999999999999999986643
Q ss_pred --ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 140 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
..++||||+. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 578877754 2346899999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcc--eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh--
Q 017175 218 GLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP-- 292 (376)
Q Consensus 218 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 292 (376)
|++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999754322211 112234578899999988664 478899999999999999999999976543221111111000
Q ss_pred ---hhhcccccc---cccCC-cCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 293 ---LFKDRRKFS---QMADP-TLQGQY-----PVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 293 ---~~~~~~~~~---~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.+....... ....+ ...... +......+.+||.+||..||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 000000000 00000 000000 001234667899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=307.75 Aligned_cols=270 Identities=21% Similarity=0.290 Sum_probs=201.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecC-----Cc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4578999999999999999999999999999999986432 22345677899999999999999999987654 35
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.|+++||+. ++|...+.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 588777743 56899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc-ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc--
Q 017175 221 KLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD-- 296 (376)
Q Consensus 221 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 296 (376)
........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..... ......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCC
Confidence 75322211 111223568999999998755 46889999999999999999999999764321100 000000000
Q ss_pred ccccccccCCc---------CCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 297 RRKFSQMADPT---------LQGQ-----YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 297 ~~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......+.+.. .... .....+..+.+++.+||+.+|++||++.+++++-+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00000000000 0000 0012245788999999999999999999999995533
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.98 Aligned_cols=267 Identities=21% Similarity=0.251 Sum_probs=199.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcC-CCCccceeEEEecCCc-----
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 140 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~----- 140 (376)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3689999999999999999999999999999998654322 2356778999999995 6999999999877665
Q ss_pred eEEEEEccCCCchhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPD-KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFG 218 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg 218 (376)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 788887653222 456899999999999999999999999 999999999999998 8899999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ...... ....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~-~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKL-LGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHH-hCCC
Confidence 9875322211 1122357889999998865 45789999999999999999999999764322110 000000 0000
Q ss_pred --ccccccc-------CCcCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 298 --RKFSQMA-------DPTLQ----GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 298 --~~~~~~~-------~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....... -+... .......+..+.++|.+||..||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00000 00011245578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=298.66 Aligned_cols=268 Identities=24% Similarity=0.328 Sum_probs=202.7
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+|++.+.||.|++|.||+|.+..+|..||+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488999999999999999999999999999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++ +|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 84 8888876532 1346899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhhh----hhhccccccc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWARP----LFKDRRKFSQ 302 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 302 (376)
.......++..|++||++.+. .++.++|||||||++|+|++|..||......+.... ...... .+........
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112234578899999988664 578899999999999999999999986543221110 000000 0000000000
Q ss_pred ccCCc------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 303 MADPT------LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 303 ~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..... .........+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0001112335578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.07 Aligned_cols=276 Identities=20% Similarity=0.265 Sum_probs=206.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEec----CCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~ 140 (376)
+..+|++.+.||+|++|.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3578999999999999999999999999999999987542 2334567789999999999999999998753 356
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 899999995 689888864 455899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCc--ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-h----h
Q 017175 221 KLGPVGDK--THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-R----P 292 (376)
Q Consensus 221 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~----~ 292 (376)
........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||............... . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 65322221 111223578899999999866 46889999999999999999999999765432111100000 0 0
Q ss_pred hhhc--ccccccccCC-cCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 293 LFKD--RRKFSQMADP-TLQG-----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 293 ~~~~--~~~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+.. ........+. .... ......+..+.++|.+||+.+|++||++.+++.+.+.-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0000 0000000000 0000 0112235678999999999999999999999999886544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=333.87 Aligned_cols=262 Identities=24% Similarity=0.280 Sum_probs=212.3
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+..-.++|.++++||+|+||.|.+++.+.+++.||+|++++... .+..-|..|-.+|..-+.+=|+.++-+|.+..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 33445789999999999999999999999999999999986332 233457778888887788999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
+|+|||||+||+|-.++..+ .++++..+..++..|+-||.-||+.| +|||||||+|||+|..|++||+|||.|
T Consensus 150 LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred eEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999773 37999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
...... ....+...+|||.|.+||++.. +.|+..+|+||+||++|||+.|..||....-.+- ...+..
T Consensus 223 lkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT------Y~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET------YGKIMN 295 (1317)
T ss_pred HhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH------HHHHhc
Confidence 764322 2334556789999999999963 5689999999999999999999999986543211 111111
Q ss_pred cccccccccCCcCCCCCC--HHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHHhhhc
Q 017175 296 DRRKFSQMADPTLQGQYP--VRGLYQALAVAAMCVQEQPNMRPL---IADVVTALTYLAC 350 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps---~~ell~~L~~~~~ 350 (376)
. .-.-.|| ...+.++.+||.+.+. +|+.|.. ++++-.|..+..-
T Consensus 296 h----------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 296 H----------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred h----------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 1 1111222 2356688889998774 6888888 9999988876553
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=305.26 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=203.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC-----C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~ 139 (376)
+..+|.+.+.||+|+||.||+|++..++..||||.+.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4568999999999999999999999999999999986532 22334567899999999999999999987654 3
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..|+++||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 5799999996 688888864 456999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc--
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD-- 296 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 296 (376)
+....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+........ ......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~ 229 (337)
T cd07858 155 ARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI---TELLGSPS 229 (337)
T ss_pred ccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH---HHHhCCCC
Confidence 97543221 12233568899999998865 46889999999999999999999999765321110000 000000
Q ss_pred --------ccc-------cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 --------RRK-------FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 --------~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
... .......... ......+..+.+++.+||+.+|++|||+.+++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 000 0000000000 0112345678899999999999999999999999554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.26 Aligned_cols=278 Identities=19% Similarity=0.224 Sum_probs=192.1
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCe-EEEEEEec-----------------cCCccchHHHHHHHHHHhhcCCC
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQ-VVAIKQLD-----------------RNGLQGNREFLVEVLMLSLLHHP 126 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~ 126 (376)
..+..+|++.+.||+|+||.||+|..+.... ..++|.+. .........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 4567899999999999999999987643222 22222110 01112234577899999999999
Q ss_pred CccceeEEEecCCceEEEEEccCCCchhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEE
Q 017175 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLP-PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (376)
Q Consensus 127 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nil 205 (376)
||+++++++.+.+..|+|++++. ++|.+++.... ..........+..++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99999999999999999999995 57777764321 11223446678889999999999999999 999999999999
Q ss_pred ECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCccccccc
Q 017175 206 LGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA-IDNTRAAGEH 284 (376)
Q Consensus 206 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~ 284 (376)
++.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|+|++|..+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999975432221 122346799999999999999999999999999999999998754 4322111111
Q ss_pred chhhhhhhhhhcccc-------cccccCCc-C---CCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 285 NLVAWARPLFKDRRK-------FSQMADPT-L---QGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 285 ~~~~~~~~~~~~~~~-------~~~~~~~~-~---~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.+.......-..... +...++.. + ....+ ...+..+.+++.+||+.||.+|||+.|++++-++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 111100000000000 00000000 0 00000 0123467788999999999999999999988664
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=298.35 Aligned_cols=259 Identities=26% Similarity=0.362 Sum_probs=210.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..+.|++.+.||+|++|.||+|.+..++..|++|.+..... ....+.+|+.+++.++|+||+++++.+......|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45668889999999999999999998899999999976544 45678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999762 237999999999999999999999999 999999999999999999999999998643222
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... .. .. .....
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~-~~-~~~~~---- 235 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LI-TT-KGIPP---- 235 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-Hh-cCCCC----
Confidence 1 11223457889999999988889999999999999999999999997544321100 00 00 00000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. ..+...+..+.+++.+||+.+|.+||++.+++++.....
T Consensus 236 -~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 -L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0 011123457889999999999999999999998776444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.67 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=199.8
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 46667889999999999999999999999999875432 23456788999999886 99999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 148 MPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 148 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
+. ++|.++.... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 4555443211 11246789999999999999999999975 7 99999999999999999999999999864322
Q ss_pred CCcceeecccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.. ......|+..|+|||++.+. .++.++|||||||++|+|++|..||..... ..........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------- 225 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------- 225 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-------
Confidence 11 11234688999999999776 688999999999999999999999975431 0010000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...+.+........+..+.+|+.+||+.+|++|||+.+|+.+-+..
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0011111122223455788999999999999999999999886643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=301.37 Aligned_cols=254 Identities=32% Similarity=0.434 Sum_probs=202.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
..|...+.||+|+||.||+|++..++..+|+|.+...... ....+..|+.+++.++|+|++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3478889999999999999999989999999998654322 2346788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+. |+|.+.+.. ....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 477776643 2456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||......... .......
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~----- 240 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE----- 240 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc-----
Confidence 12346888999999874 356889999999999999999999998754321110 0000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.+. ......+..+.+++.+||+.+|.+||++.+++++++.+...
T Consensus 241 --~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 --SPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --CCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 000 01112344688999999999999999999999998876643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=341.95 Aligned_cols=258 Identities=26% Similarity=0.335 Sum_probs=210.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++-++.-..+||.|.||.||.|.+..+|+..|+|.+.... ....+.+.+|..++..++|||+|++||+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 44557888899999999999999999999999999886432 2334567789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
.||||.+|+|.+.+.. +.-.++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999865 444666777788999999999999999 999999999999999999999999999754
Q ss_pred CCCCcc--eeecccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 224 PVGDKT--HVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 224 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
...... .......||+.|||||++.+. ....++|||||||++.||+||+.||...+.. +..+...
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----~aIMy~V------ 1454 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----WAIMYHV------ 1454 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----hHHHhHH------
Confidence 333211 112346899999999999864 4567899999999999999999999876542 1111000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
-..-..++|...+.+..+++.+||..||++|+++.+|+++-.
T Consensus 1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 001112455567789999999999999999999999998754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=297.20 Aligned_cols=263 Identities=24% Similarity=0.275 Sum_probs=196.6
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCccceeEEEecC--CceEEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 146 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv~e 146 (376)
|++.+.||+|+||.||+|.+..++..||+|++..... ........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999999999999999999875422 22233457888888885 99999999999987 88999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 577777754 2356899999999999999999999999 999999999999999 99999999999753222
Q ss_pred CcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh-h-------hhhhhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW-A-------RPLFKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~ 297 (376)
. ......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+..+....... . ...+...
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 1123458899999997654 4578899999999999999999999976543221100000 0 0000000
Q ss_pred cccccccCCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 298 RKFSQMADPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 298 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.. .....+.... ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 230 RH-MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred cc-ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 00 0000000000 00123467899999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=293.20 Aligned_cols=253 Identities=25% Similarity=0.297 Sum_probs=201.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhhcCCCCccceeEEEecC--Cce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~ 141 (376)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999999999999999875321 12335678899999999999999999998764 457
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999865 345889999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCc-ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... ........++..|+|||++.+..++.++|+|||||++|+|++|..||....... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~-~~~-------- 220 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----A-IFK-------- 220 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----H-HHH--------
Confidence 5322111 111123568899999999988889999999999999999999999997543211 0 000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..........+...+..+.+++.+||. +|..||++.+++.|.
T Consensus 221 --~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 221 --IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred --HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 011111123344555678899999999 579999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=304.21 Aligned_cols=275 Identities=25% Similarity=0.338 Sum_probs=204.2
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhc-CCCCccceeEEEecC--Cc
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--DQ 140 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~ 140 (376)
.+.++|++.+.||+|+||.||+|.+..++..+|+|++... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3567899999999999999999999988999999988542 223334577899999999 999999999988653 46
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 899999997 599888854 26888999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh------
Q 017175 221 KLGPVGDKT---HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA------ 290 (376)
Q Consensus 221 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~------ 290 (376)
......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 754333221 12233568999999998765 45788999999999999999999999754332111000000
Q ss_pred ------hhhhhcccccccccCCcC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 291 ------RPLFKDRRKFSQMADPTL--QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 291 ------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...... ..+........ ........+..+.++|.+||+.+|++|||+.+++++-+.-..
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 235 EDIESIKSPFAA-TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHhhhHH-HhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 00000000000 000111235678899999999999999999999988544333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=299.55 Aligned_cols=254 Identities=23% Similarity=0.307 Sum_probs=204.2
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
|....+||+|+||.||++....+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 33446799999999999999999999999998655545556788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~ 171 (292)
T cd06657 102 GALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 171 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence 999998743 45899999999999999999999999 9999999999999999999999999986532221 1
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... .... ....+.+.
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~----------~~~~~~~~- 237 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----------DNLPPKLK- 237 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----------hhCCcccC-
Confidence 123356889999999998888899999999999999999999999764332110 0000 00011110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+..+.+++.+||+.+|.+||++.+++++=+...
T Consensus 238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~ 275 (292)
T cd06657 238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275 (292)
T ss_pred -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence 01123446788999999999999999999999755443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.58 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=199.1
Q ss_pred HHHHHHHhcCcccCcee--cccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEec
Q 017175 61 FRELAAVTKNFRADCLL--GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD 137 (376)
Q Consensus 61 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 137 (376)
..+...+.+.|.+.+.+ |+|+||.||++.++.++..+|+|.+........ |+.....+ +|+||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445566788888777 999999999999999999999999865433221 22222222 69999999999999
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSD 216 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~D 216 (376)
.+..|+||||+++++|.+++.. ...+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999865 347899999999999999999999999 99999999999999988 999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++...... ....++..|+|||++.+..++.++|||||||++|+|++|..||....... .....+....
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--- 223 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--- 223 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---
Confidence 9998753211 22468899999999998899999999999999999999999998543221 1111111110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHH
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-IADVVTALT 346 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~~L~ 346 (376)
.. ....+...+..+.+++.+||+.+|.+||+ +.+++++=+
T Consensus 224 --------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 224 --------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred --------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 00 00112234557889999999999999996 699987643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=297.65 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=200.4
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|++.+.||.|++|.||+|.+..+|..||+|++...... ....+.+|+.+++.++|||++++++++.+....|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998754322 2346778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 5 68999886522 246899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhhhhhhh-------hc---
Q 017175 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWARPLF-------KD--- 296 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~-------~~--- 296 (376)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||......... .......... ..
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 112223568899999988664 5788999999999999999999999765432110 0000000000 00
Q ss_pred -ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 297 -RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 297 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
...+........ .......+..+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 01112234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=295.62 Aligned_cols=249 Identities=28% Similarity=0.390 Sum_probs=199.0
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||+|+||.||+|.+..+|+.||+|.+...... ....+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998654322 234567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9998652 2246899999999999999999999999 999999999999999999999999998753221 1122
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...++..|+|||++.+..++.++|||||||++|+|++|..||............ ...... .....+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~------------~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL--KRRTLE------------MAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH--Hhcccc------------ccccCC
Confidence 345788999999998888999999999999999999999999765431110000 000000 001122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
...+..+.+++.+||+.+|++|| ++.+++.+-+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 23355788999999999999999 77778877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.30 Aligned_cols=203 Identities=32% Similarity=0.462 Sum_probs=176.4
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEecC------CceEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLL 143 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~l 143 (376)
+...+.||+||||.||+|+++.+|+.||||.++.. .....+...+|++++++++|+|||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 55667899999999999999999999999999864 345567788999999999999999999876554 35689
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC----CCCceEEccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG----EGYHPKLSDFGL 219 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~----~~~~~kl~Dfg~ 219 (376)
|||||.||+|...+.. +.+...+++.+.+.++.++..||.|||++| |+||||||.||++- ..-..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999976 445677999999999999999999999999 99999999999993 233479999999
Q ss_pred ccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
|+....+. .....+||..|++||++.+ +.|+..+|.|||||++|+++||..||.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99755444 5566899999999999984 7899999999999999999999999976543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=290.96 Aligned_cols=249 Identities=29% Similarity=0.431 Sum_probs=206.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58889999999999999999998899999999977654 3456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999865 367899999999999999999999999 9999999999999999999999999997643322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .... .. ...
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~~-~~--~~~-------- 215 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALFR-IV--QDD-------- 215 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHH-Hh--ccC--------
Confidence 2 1233568899999999988788999999999999999999999997543210 0000 00 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....+...+..+.+++.+||..+|++||++.+++.+
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 011222334578899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=283.27 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=199.0
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+++..||.|..|.|++++.+.+|..+|||.+.+.+-. +.+.+++.+.++.+.+ +|+||+.+|+|......++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 355667899999999999999999999999999876443 4456777887776655 89999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|. --+..++.. -..++++..+-.+...+++||.||.++.. |+|||+||.|||+|+.|.+||||||++-....
T Consensus 173 Ms-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-- 244 (391)
T KOG0983|consen 173 MS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD-- 244 (391)
T ss_pred HH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec--
Confidence 84 344555544 35679999999999999999999987654 99999999999999999999999999864322
Q ss_pred cceeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
....+...|.+.|||||.+.- ..|+.++||||||++++||.||..||.+-+.+-. . ...... -.
T Consensus 245 -SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe----~-ltkvln-------~e 311 (391)
T KOG0983|consen 245 -SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE----V-LTKVLN-------EE 311 (391)
T ss_pred -ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH----H-HHHHHh-------cC
Confidence 223455679999999999864 3689999999999999999999999997543210 0 000000 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.|.+... ...+..+.+++..||+.|+.+||...++++|-.
T Consensus 312 PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 312 PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 1111111 124558889999999999999999999998744
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=301.55 Aligned_cols=254 Identities=29% Similarity=0.395 Sum_probs=210.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.|+..++||+||||.||-+..+.||+-||.|.+.+..... ....++|-.+|.+++.+.||.+--+|+..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45888999999999999999999999999999987654332 234678999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
..|.||+|.-++.... +..+++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+++|+|+|+|.....
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998753 367999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
+.. ....+||.+|||||++.++.|+...|.|||||++|+|+.|+.||.....-.....+ -+.....
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv--drr~~~~--------- 405 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV--DRRTLED--------- 405 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--HHHHhcc---------
Confidence 543 23348999999999999999999999999999999999999999765332111000 0111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-----HHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIA-----DVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-----ell~~ 344 (376)
...++...+.++.+|....|+.||++|...+ ++-+|
T Consensus 406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 1134455666888999999999999997554 55554
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.09 Aligned_cols=272 Identities=20% Similarity=0.281 Sum_probs=199.7
Q ss_pred ceeccc--CceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
..||.| +||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC-cc
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD-KT 229 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 229 (376)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+....... ..
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987632 345889999999999999999999999 9999999999999999999999997653211111 00
Q ss_pred e----eecccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhh------h-------
Q 017175 230 H----VSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVA------W------- 289 (376)
Q Consensus 230 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~------~------- 289 (376)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||......... .... +
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 00112356679999999764 4789999999999999999999999765321110 0000 0
Q ss_pred -hhhhhhcc--------------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 290 -ARPLFKDR--------------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 290 -~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
........ ...............+...+..+.+|+.+||+.||++|||+.+++++-+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00000000 000001111111122334567889999999999999999999999988765543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.39 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=209.3
Q ss_pred CHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecC
Q 017175 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG 138 (376)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~ 138 (376)
+|.+.+.+++ +.||+|+|+.|-.+....+|..||||++.+........+.+|+.++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4556666654 57999999999999999999999999999887777788999999999986 99999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLS 215 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~ 215 (376)
..+|+|||.|.||.|...+.. ..-+++.++.+++++|+.||.|||.+| |.|||+||+|||...-+ -||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999976 577999999999999999999999999 99999999999996544 47999
Q ss_pred ccccccccCCC-----CcceeecccccccCcccccccc---c--CCCCcccchhhHHHHHHHHHhCCCCCCCcccc----
Q 017175 216 DFGLAKLGPVG-----DKTHVSTRVMGTYGYCAPEYAM---T--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA---- 281 (376)
Q Consensus 216 Dfg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---- 281 (376)
||++..-.... .........+|+..|||||+.. + ..|+.+.|.||||||+|-||+|.+||.+.=..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 99887421111 1111223478999999999763 2 35889999999999999999999999764211
Q ss_pred cccchhhhhh-hhhhcc-cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 282 GEHNLVAWAR-PLFKDR-RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 282 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+.-..-...+ .+|... .-..++.+..+ ...+.+..+++..+|..++.+|.++..++.+-+
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 0000111111 111110 01112222211 245678889999999999999999999988655
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.01 Aligned_cols=272 Identities=23% Similarity=0.272 Sum_probs=207.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCC-----ceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~ 142 (376)
+|++.+.||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999889999999987543 333457889999999999999999999988765 789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
++|+|+. ++|..++.. ...+++..++.++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 588888865 347999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcc-eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-hh----hhh
Q 017175 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-RP----LFK 295 (376)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~----~~~ 295 (376)
....... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...........+... .. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 4333210 112334688899999999887 7899999999999999999999999765432111100000 00 000
Q ss_pred --cccccccccC---C---cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 296 --DRRKFSQMAD---P---TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 296 --~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.......... . ..........+..+.+++.+||+.+|++||++.+++.+-+.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000 0 0000111223557889999999999999999999999866444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=294.09 Aligned_cols=271 Identities=20% Similarity=0.264 Sum_probs=200.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4689999999999999999999999999999998654322 23567789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~~~ 225 (376)
|++ ++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5787777542 2334678889999999999999999999 999999999999985 56799999999975322
Q ss_pred CCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhhhhhhcc----cc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWARPLFKDR----RK 299 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~----~~ 299 (376)
. ........+++.|+|||++.+. .++.++|||||||++|+|++|..||......+.... ........... ..
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 1112334678899999988664 578999999999999999999999976543211100 00000000000 00
Q ss_pred ccccc--CCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 300 FSQMA--DPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 300 ~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..... -+.... ......+..+.+++.+||+.+|++||++.+++++-+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 00000 000000 0112234568899999999999999999999987554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=294.96 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=207.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC--C----CccceeEEEecCC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--P----NLVNLIGYCADGD 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~----ni~~~~~~~~~~~ 139 (376)
.+.++|.+...+|+|.||.|..+.+..++..||||+++... ...++.+-|+.+|.++.+ | -++.+.+||...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45889999999999999999999999999999999996432 333456679999998842 2 3677888999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC------------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG------------ 207 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~------------ 207 (376)
+.|||+|.+ |.++.+++... .-.+++...+..++.|+++++++||+.+ ++|.||||+|||+.
T Consensus 165 hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 999999998 67999999773 4567899999999999999999999999 99999999999993
Q ss_pred --------CCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 017175 208 --------EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (376)
Q Consensus 208 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 279 (376)
.+..|+++|||.++.... .....+.|..|+|||++++-.|+.++||||+||||+||++|...|...+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 134689999999985221 2355789999999999999999999999999999999999999998766
Q ss_pred cccccchhhhhhhhhhc--------c--------cccccccCCcCCC----------------CCCHHHHHHHHHHHHHc
Q 017175 280 AAGEHNLVAWARPLFKD--------R--------RKFSQMADPTLQG----------------QYPVRGLYQALAVAAMC 327 (376)
Q Consensus 280 ~~~~~~~~~~~~~~~~~--------~--------~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~c 327 (376)
..+.. ++.+.+... . +.+ ...+....+ .....+...|++|+.+|
T Consensus 314 n~EHL---aMMerIlGp~P~~mi~r~~~~Kyf~~~rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 314 NLEHL---AMMERILGPIPSRMIKKTRKEKYFRRGRL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cHHHH---HHHHHhhCCCcHHHhhhhhhHhhhhcccc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 32211 111111110 0 000 000000000 11224455899999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhhh
Q 017175 328 VQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 328 l~~~P~~Rps~~ell~~L~~~~ 349 (376)
|..||.+|+|+.|+++|-.+-.
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HccCccccccHHHHhcCHHhhc
Confidence 9999999999999999876543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.93 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=201.2
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC--CceEEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 146 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e 146 (376)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999997653 22335678899999999999999999999887 88999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 488888765 2357899999999999999999999999 999999999999999999999999999754333
Q ss_pred CcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh-hhhhh-hhcccccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA-WARPL-FKDRRKFSQM 303 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~ 303 (376)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............. ..... .........+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11223457888999998765 457899999999999999999999997654321111000 00000 0000000000
Q ss_pred -----------cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 304 -----------ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 304 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
....+...+....+..+.+++.+||+.+|++||++++++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 000000000011255788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.11 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=194.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHH---HHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVL---MLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~---~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
.||+|+||.||+|.+..+++.||+|.+....... ...+..|.. .++...||||+.+++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987543221 112333433 3444579999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
|++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998864 457999999999999999999999999 999999999999999999999999998643221
Q ss_pred eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......|+..|+|||++.++ .++.++||||+||++|+|++|..||............ .... ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~--------~~~~-- 216 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL--------TMAV-- 216 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh--------ccCC--
Confidence 12234689999999999754 6899999999999999999999999865332111100 0000 0011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~~ 349 (376)
..+...+..+.+++.+||..+|.+|| ++.+++++-+...
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 12222355788999999999999999 9999998766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.57 Aligned_cols=263 Identities=23% Similarity=0.309 Sum_probs=203.7
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67788999999999999999989999999998754333 3456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++ +|..++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 88887765 2357899999999999999999999999 9999999999999999999999999987543332
Q ss_pred ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc--ccccccccC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD--RRKFSQMAD 305 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 305 (376)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+...... ..... ......+.+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTS 228 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchh
Confidence 122234688899999998876 78999999999999999999999997654322111100 00000 000000000
Q ss_pred ---------C----cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 306 ---------P----TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 306 ---------~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
+ ..........+..+.++|.+||+.||.+||++.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 0 000011123466889999999999999999999998763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=304.19 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=201.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecC--------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-------- 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-------- 138 (376)
+..+|.+.+.||.|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 357899999999999999999999999999999999776656667788999999999999999999876543
Q ss_pred ------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCc
Q 017175 139 ------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYH 211 (376)
Q Consensus 139 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~ 211 (376)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 35789999997 588888743 46899999999999999999999999 99999999999997 4567
Q ss_pred eEEcccccccccCCCCc-ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 212 PKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
++|+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 89999999875322111 111122457889999998755 4678899999999999999999999976543211100000
Q ss_pred hhhhh-h-ccc----cccc-ccCCcCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 ARPLF-K-DRR----KFSQ-MADPTLQG-----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 ~~~~~-~-~~~----~~~~-~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..+.. . ... .... ........ ......+..+.+|+.+||+.||++||++.+++.+-+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 00000 0 000 0000 00000000 0111234578899999999999999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=292.41 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=197.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||.|+||.||+|.+..+++.+++|.+..... .....+.+|+.+++.++|+||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999875543 3345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc-----
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----- 228 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 228 (376)
.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999875 247899999999999999999999999 99999999999999999999999999875333211
Q ss_pred -ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 -THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~--------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILNGKI--------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhcCCc---------
Confidence 11223356888999999998888999999999999999999999999765432111 11000000
Q ss_pred CCCCCCHH--HHHHHHHHHHHcccCCCCCCCCH---HHHHHHH
Q 017175 308 LQGQYPVR--GLYQALAVAAMCVQEQPNMRPLI---ADVVTAL 345 (376)
Q Consensus 308 ~~~~~~~~--~~~~l~~li~~cl~~~P~~Rps~---~ell~~L 345 (376)
..+.. .+..+.+++.+||+.+|.+||++ .+++++-
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 01111 24578899999999999999999 6666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=288.06 Aligned_cols=245 Identities=23% Similarity=0.280 Sum_probs=192.0
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHH-HhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+..+++.||+|.+....... ...+..|..+ ....+|+|++++++++...+..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999987543222 1233444444 3445799999999999999999999999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999865 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .......... ...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~--------~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRIN--------WPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcccC--------CCC
Confidence 2234688899999999888889999999999999999999999975433211 0111000000 000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCH---HHHHHHHH
Q 017175 311 QYPVRGLYQALAVAAMCVQEQPNMRPLI---ADVVTALT 346 (376)
Q Consensus 311 ~~~~~~~~~l~~li~~cl~~~P~~Rps~---~ell~~L~ 346 (376)
......+..+.+++.+||+.+|++||++ .|++.+-+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence 1112344578899999999999999965 57766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.33 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=212.8
Q ss_pred cCcccCceecccCceEEEEEEECCC----CeEEEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST----NQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
...+..++||.|.||.||.|....- ..-||||..+.+ ...+.+.|+.|..+++.++||||++++|++.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 4455668899999999999987432 345899988764 44556789999999999999999999999976 46899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|||.++.|.|..|++. +...++......++.||+.||.|||+.. +|||||...|||+.....|||+|||+++..
T Consensus 468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999987 5678999999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
....... .+...-..-|||||.+.-..++.++|||.|||.+||++. |..||..-...+....+
T Consensus 542 ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------------- 605 (974)
T KOG4257|consen 542 EDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------------- 605 (974)
T ss_pred cccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe---------------
Confidence 4444332 334456678999999999999999999999999999987 99999876544322111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...-+-.+|+.++..+.-|..+||..+|.+||.+.+|...|.++-.
T Consensus 606 --EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 --ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1122235566777788899999999999999999999877766543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.72 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=197.4
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEecc----CCccchHHHHHHHHHHhhcCCCCccceeEEEecCCc--eEEEE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR----NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVY 145 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~lv~ 145 (376)
++..+||+|+|-+||+|.|..+|..||=-.++. ......+.+..|+.+|+.|+||||+++|+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 456789999999999999999998876433322 222334678999999999999999999999987655 77899
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~~~~ 224 (376)
|.+..|+|..|+.+ .++++...+..|++||++||.|||++. +||+|||||-+||||+ ..|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987 567888999999999999999999985 7899999999999997 46899999999998632
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccc-ccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA-AGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.. .....+|||.|||||+.- ..|+..+||||||+++.||+|+..||..-.. +..+..+.- -..+..+..+
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S----GiKP~sl~kV 268 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS----GIKPAALSKV 268 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc----CCCHHHhhcc
Confidence 21 233378999999999885 7899999999999999999999999975432 111111100 0011222222
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
. ..++.+||.+||.. .++|||+.|||.+-.
T Consensus 269 ~------------dPevr~fIekCl~~-~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 269 K------------DPEVREFIEKCLAT-KSERLSAKELLKDPF 298 (632)
T ss_pred C------------CHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence 2 23778899999999 999999999997754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=292.25 Aligned_cols=262 Identities=17% Similarity=0.178 Sum_probs=187.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCccch-----------HHHHHHHHHHhhcCCCCcccee
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQGN-----------REFLVEVLMLSLLHHPNLVNLI 132 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~ni~~~~ 132 (376)
..++|++.++||+|+||.||+|.+..+ +..+|+|+......... .....++..+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999998877 66777776543221111 0112233445567899999999
Q ss_pred EEEecCC----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 133 GYCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 133 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
+.+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 8765543 3467888774 466666543 233578889999999999999999999 999999999999999
Q ss_pred CCceEEcccccccccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 017175 209 GYHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283 (376)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 283 (376)
++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999754322111 111224699999999999999999999999999999999999999986632211
Q ss_pred cchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 284 HNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
........+. ..+..... .....+..+.+++..|+..+|++||++.+|.+.|+
T Consensus 242 --~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 --LIHAAKCDFI-----KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred --HHHHhHHHHH-----HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110000000 00000000 01122457889999999999999999999998763
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.79 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=219.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+.++..+||.|.||.||.|.|+...-.||||.++.+ ....+.|+.|..+|+.++|||+|+++|+|.....+|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34567778999999999999999999999999999655 35567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|..|+|.+|++++ +...++-..++.++.||.+|++||..++ +|||||...|+|+.++..||++|||+++... ++
T Consensus 345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt-gD 418 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT-GD 418 (1157)
T ss_pred ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc-CC
Confidence 9999999999874 4566777888999999999999999999 9999999999999999999999999998643 33
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........-..-|.|||-+.-+.++.++|||+|||+|||+.| |-.||.+.+.. ....++..
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qVY~LLEk 481 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYGLLEK 481 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HHHHHHhc
Confidence 3333333445678999999999999999999999999999998 77888876532 12233344
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.++-+-|..++..+.+|++.||+++|.+||++.|+-+.++.+-.
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 44445566777789999999999999999999999988877654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.75 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=200.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+|.+.+.||+|+||.||++.+..++..+++|++.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999998777777777665322 12233566789999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988754444567999999999999999999999999 999999999999975 579999999987532
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ....... ...
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-------~~~ 221 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV-------EGP 221 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH-------cCC
Confidence 221 1223356888999999998888899999999999999999999999643221 1000100 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.+ ..+...+..+.+++.+||..+|++||++.+++++
T Consensus 222 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 1233445688899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.29 Aligned_cols=253 Identities=31% Similarity=0.398 Sum_probs=201.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
..|+..+.||+|+||.||+|++..++..+|+|.+..... .....+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 457788899999999999999999999999999864322 22346778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 577777643 2356889999999999999999999999 99999999999999999999999999875321
Q ss_pred CCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.....++..|+|||.+. ...++.++|||||||++|+|++|..||.......... . ... ..
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~-~~--- 230 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQ-NE--- 230 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------H-Hhh-cC---
Confidence 12346888999999975 3467889999999999999999999987543221100 0 000 00
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+. ......+..+.+||.+||..+|++||++.+++.+.+....
T Consensus 231 --~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 231 --SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --CCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 000 0112344578899999999999999999999999776653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.45 Aligned_cols=274 Identities=22% Similarity=0.299 Sum_probs=204.3
Q ss_pred HhcCccc-CceecccCceEEEEEEECCCCeEEEEEEeccCCccc--------------hHHHHHHHHHHhhcCCCCccce
Q 017175 67 VTKNFRA-DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------------NREFLVEVLMLSLLHHPNLVNL 131 (376)
Q Consensus 67 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~ni~~~ 131 (376)
+.++|.. .+.||.|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567764 577999999999999999999999999986543222 1246789999999999999999
Q ss_pred eEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc
Q 017175 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~ 211 (376)
++++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 999999999999999997 689888864 456899999999999999999999999 999999999999999999
Q ss_pred eEEcccccccccCCCC------------cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 212 PKLSDFGLAKLGPVGD------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
++|+|||++....... .........++..|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987533110 01111223468889999998764 4689999999999999999999999866
Q ss_pred ccccccchh-hhhhhh----hhcccc------cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 279 RAAGEHNLV-AWARPL----FKDRRK------FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 279 ~~~~~~~~~-~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...+....+ ...... +..... .......... ......+..+.+++.+||+.+|++||++.+++.+.+.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 432211100 000000 000000 0000000000 0111234578899999999999999999999998876
Q ss_pred hh
Q 017175 348 LA 349 (376)
Q Consensus 348 ~~ 349 (376)
-.
T Consensus 317 ~~ 318 (335)
T PTZ00024 317 KS 318 (335)
T ss_pred CC
Confidence 43
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=298.05 Aligned_cols=275 Identities=23% Similarity=0.305 Sum_probs=206.4
Q ss_pred CHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
...++..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34456678899999999999999999999999999999999987532 2234567789999999999999999998854
Q ss_pred C------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc
Q 017175 138 G------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 138 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~ 211 (376)
. ...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 3 3467888887 7899888753 46899999999999999999999999 999999999999999999
Q ss_pred eEEcccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hh
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AW 289 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~ 289 (376)
++|+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ ..
T Consensus 159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999875321 1223468899999998866 46889999999999999999999999754432111100 00
Q ss_pred hh----hhhhcc-----c----ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 290 AR----PLFKDR-----R----KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 290 ~~----~~~~~~-----~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.. ...... . .........+ .......+..+.+++.+||+.||.+||++.+++.+-+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 000000 0 0000000000 0001123456889999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.27 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=205.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 144 (376)
++|.+.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+.+++.+. |+||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468999999999999999999999999999999875322 22356778999999998 99999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 347999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcc------------------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccch
Q 017175 225 VGDKT------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286 (376)
Q Consensus 225 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 286 (376)
..... .......++..|+|||++....++.++|+||||+++|+|++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 22210 112234678999999999888899999999999999999999999986542110
Q ss_pred hhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHHH
Q 017175 287 VAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI----ADVVTAL 345 (376)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~ell~~L 345 (376)
...... .....+...+..+.+++.+||+.+|.+||++ ++++++.
T Consensus 231 ---~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 231 ---FQKILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred ---HHHHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 011100 0111222334578899999999999999999 8888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=294.96 Aligned_cols=249 Identities=32% Similarity=0.428 Sum_probs=198.6
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.|...+.||+|+||.||+|++..++..|++|++...... ....+..|+.+++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 377778899999999999999999999999998654332 23457789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-- 172 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-- 172 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC--
Confidence 996 577777654 2456899999999999999999999999 9999999999999999999999999986421
Q ss_pred CcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...+...... ..... ..
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~--~~--- 237 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN--DS--- 237 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhc--CC---
Confidence 122356889999999984 3568889999999999999999999997654321110 00000 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+. ......+..+.+|+.+||+.+|.+||++.+++.+-+.
T Consensus 238 --~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 238 --PT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred --CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00 0111223468889999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=283.50 Aligned_cols=281 Identities=22% Similarity=0.237 Sum_probs=207.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec-C
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-G 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~ 138 (376)
.....|+..+.||+|.||.||+|..++++. .+|||+++.... .-.....+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 344579999999999999999997655433 689999975422 223556799999999999999999998877 7
Q ss_pred CceEEEEEccCCCchhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC----CceE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG----YHPK 213 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~----~~~k 213 (376)
..+++++||.+. +|...++..+. ....++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 789999999974 88888765332 2356899999999999999999999999 9999999999999877 9999
Q ss_pred EcccccccccCCCCcce-eecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch---hh
Q 017175 214 LSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL---VA 288 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~ 288 (376)
|+|||+++.....-..- .....+-|.+|+|||.+.+. .|+.+.||||+|||+.||++-.+.|...+....... ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999998754333222 23446789999999999986 589999999999999999999998876544322211 11
Q ss_pred hhhhhhhcccc--------cccccCC---------cCCCCCCH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 017175 289 WARPLFKDRRK--------FSQMADP---------TLQGQYPV--------RGLYQALAVAAMCVQEQPNMRPLIADVVT 343 (376)
Q Consensus 289 ~~~~~~~~~~~--------~~~~~~~---------~~~~~~~~--------~~~~~l~~li~~cl~~~P~~Rps~~ell~ 343 (376)
...+++.-.+. +..+.+- ....+... ..+....+|+.++|..||-+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11112211100 0000000 00000000 01234778999999999999999999999
Q ss_pred HHHhhhc
Q 017175 344 ALTYLAC 350 (376)
Q Consensus 344 ~L~~~~~ 350 (376)
+.-+...
T Consensus 337 h~yF~~d 343 (438)
T KOG0666|consen 337 HPYFTED 343 (438)
T ss_pred ccccccC
Confidence 8766554
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=294.01 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=200.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCC----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 139 (376)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999999999999999875432 22345678999999999999999999987654
Q ss_pred ------ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceE
Q 017175 140 ------QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (376)
Q Consensus 140 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~k 213 (376)
.+++|+||+++ +|...+.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 67676654 2356899999999999999999999999 99999999999999999999
Q ss_pred EcccccccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
|+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+ ..
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~---~~ 232 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI---SR 232 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HH
Confidence 999999875433221 112223467889999988653 5788999999999999999999999754322111100 00
Q ss_pred hhhcc--cccccccC--------------CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 293 LFKDR--RKFSQMAD--------------PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 293 ~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..... .....+.. ...... ....+..+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00000000 000000 11224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=300.33 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=199.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecC-----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----- 138 (376)
.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 3457899999999999999999999989999999998653222 234577899999999999999999998654
Q ss_pred -CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 139 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
..+++|+||+. .+|..+. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred CceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence 24689999996 4776654 235889999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh----h
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR----P 292 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----~ 292 (376)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||................ +
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 162 GLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred CCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 998753221 123467889999999876 468899999999999999999999998654321111000000 0
Q ss_pred hhhcc------cccccccCCcCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFKDR------RKFSQMADPTLQGQY---PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+... ............... ....+..+.+|+.+||+.||++||++.+++.+-+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 00000 000000000000000 0123456789999999999999999999998844333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=285.20 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=199.0
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEccC
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
+-+..||.|+||+|++..++.+|+..|||.++.... .+..+++.|.....+. ++||||++||+...+...|+.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 345579999999999999999999999999987665 4556788888776655 59999999999999999999999996
Q ss_pred CCchhhhhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 150 LGSLEDHLHD-LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 150 ~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
.+|..+... +...+.++++..+-.|....+.||.||....+ |||||+||+|||++..|.+||||||++-.+. .
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~ 220 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV---D 220 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH---H
Confidence 566554322 22356779999999999999999999987654 9999999999999999999999999986421 1
Q ss_pred ceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-hhhhhcccccccccC
Q 017175 229 THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-RPLFKDRRKFSQMAD 305 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 305 (376)
....+.-.|...|||||.+.. ..|+.+||+||||++|||+.||+.|+...+.. .... +...... ..+..
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv~gdp---p~l~~ 292 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVVIGDP---PILLF 292 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHHcCCC---CeecC
Confidence 112334568899999999964 35999999999999999999999999876541 1111 1111111 11111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.......+..+..+|..||.+|-+.||...++.++-.
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 0111235668899999999999999999999987644
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=293.95 Aligned_cols=271 Identities=25% Similarity=0.340 Sum_probs=198.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCC------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 139 (376)
.++|++.+.||+|+||.||+|.+..+++.+|+|++....... ...+.+|+.+++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999986543222 235678999999999999999999875433
Q ss_pred --ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 140 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
.+++|++|+. ++|...+.. ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999996 467776654 2457999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcc---------eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh
Q 017175 218 GLAKLGPVGDKT---------HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 218 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 287 (376)
|++......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998753322111 111234578889999988654 5789999999999999999999999765432111100
Q ss_pred h-hhhh----hhhcccccccccCCcCCCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 288 A-WARP----LFKDRRKFSQMADPTLQGQYP-------VRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 288 ~-~~~~----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
. .... ............+.......+ ......+.+++.+||+.+|++|||+.+++.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 0 0000 000000000000000000011 11224678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=287.85 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=197.5
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhc---CCCCccceeEEEecCCc-----
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 140 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~----- 140 (376)
|++.+.||+|+||.||+|.++.++..||+|.+....... ...+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999999889999999997443221 23455677777665 59999999999988776
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 58888876522 235899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh-cc--
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK-DR-- 297 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~-- 297 (376)
....... ......++..|+|||++.+..++.++|+|||||++|+|++|..||......+.... ....... ..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK--IFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH--HHHHcCCCChHh
Confidence 7543221 11234578899999999988999999999999999999999999976543211100 0000000 00
Q ss_pred ---------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 298 ---------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 298 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
..+........ ..........+.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000000 11112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=298.45 Aligned_cols=272 Identities=22% Similarity=0.273 Sum_probs=203.5
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCC--
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD-- 139 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 139 (376)
+..+.++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 445778999999999999999999999999999999998643222 2345778999999999999999999987643
Q ss_pred ----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 140 ----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 140 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
.+++||+|+ +++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 458999999 6799888753 56899999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc-hhh-----
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN-LVA----- 288 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~----- 288 (376)
|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.......... ...
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998753221 123467889999999876 357889999999999999999999997653221100 000
Q ss_pred ---hhhhhhhc-ccccccccCCcCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 289 ---WARPLFKD-RRKFSQMADPTLQ---GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 289 ---~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+....... .......+..... .......+..+.+++.+||+.||++|||+.+++.+-+.-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 00000000 0000000000000 0011123446889999999999999999999998765443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.87 Aligned_cols=265 Identities=28% Similarity=0.510 Sum_probs=208.2
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.....|...+.||+|+||.||+|.+..++..||+|.+...... ...|+..+++++||||+++++++.+....|+||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3445688889999999999999999888999999998643321 224688899999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.++++. +++..+..++.|++.||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999853 7899999999999999999995533349999999999999998888775 555432111
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||+.... .......+....+.. .......+
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 906 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWID 906 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeC
Confidence 1123688999999999999999999999999999999999999954322 222333343322221 22333444
Q ss_pred CcCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 306 PTLQG--QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 306 ~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+.+.. ..+......+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 44433 2344566678899999999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.43 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=194.7
Q ss_pred CceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchhhhhc
Q 017175 81 GFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158 (376)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 158 (376)
++|.||.++...+++.||+|++... .......+..|+.+++.++|+||+++++++.+....+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456666677778999999999754 23344678899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc-----eeec
Q 017175 159 DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT-----HVST 233 (376)
Q Consensus 159 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~ 233 (376)
.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+......... ....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 53 2345889999999999999999999999 999999999999999999999999988643222111 1112
Q ss_pred ccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh----hhhc------ccccc
Q 017175 234 RVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP----LFKD------RRKFS 301 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~------~~~~~ 301 (376)
...++..|+|||++... .++.++|+|||||++|+|++|..||........ ....... .+.. .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcC
Confidence 24577889999998763 588999999999999999999999986432210 0000000 0000 00000
Q ss_pred c----ccCC----cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 Q----MADP----TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 ~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. ..++ ..........+..+.+|+.+||..||++|||+.+++++-+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 0 0000 0011122344567889999999999999999999999877543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=299.59 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=209.7
Q ss_pred HHHHHHHhcCccc--CceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEe
Q 017175 61 FRELAAVTKNFRA--DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCA 136 (376)
Q Consensus 61 ~~~~~~~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 136 (376)
.++...+..-|++ .++||+|.||+||-|+++.+|+.||||++.+... .....+.+|+.+|..++||.||.+...|+
T Consensus 554 iqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E 633 (888)
T KOG4236|consen 554 IQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE 633 (888)
T ss_pred hhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec
Confidence 3444445555665 4889999999999999999999999999986543 33456888999999999999999999999
Q ss_pred cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC---CceE
Q 017175 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPK 213 (376)
Q Consensus 137 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~---~~~k 213 (376)
..+..++|||.+.| +..+++.. ....++++..-..++.||+.||.|||.++ |+|+||||+|||+.+. -.+|
T Consensus 634 T~ervFVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvK 707 (888)
T KOG4236|consen 634 TPERVFVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVK 707 (888)
T ss_pred CCceEEEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCcee
Confidence 99999999999975 55555433 35788999999999999999999999999 9999999999999644 4689
Q ss_pred EcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
|||||++++... .......+||+.|+|||++.++.|...-|+||+|||+|--|+|..||...+...+ -+.
T Consensus 708 lCDFGfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQ----- 777 (888)
T KOG4236|consen 708 LCDFGFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQ----- 777 (888)
T ss_pred eccccceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhh-----
Confidence 999999997432 2345568899999999999999999999999999999999999999975432110 000
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+..-+..+.... ..+..+++||..+|+..-++|.|....+++.|-
T Consensus 778 -----NAaFMyPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 778 -----NAAFMYPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred -----ccccccCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 011111222222 344578899999999999999999999887663
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=303.57 Aligned_cols=255 Identities=26% Similarity=0.337 Sum_probs=216.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+++.+..||-||||.|=++..+.....+|+|++++...-+. +.+..|-.+|..++.|.||++|-.|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 356677889999999999998886655689999987654443 45677999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|-|-||.|+..+.+ .+.+++..+..++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||+++....
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999976 678999999999999999999999999 99999999999999999999999999987554
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
+. ...++||||.|.|||++.++..+.++|.||||+++||||+|.+||...++..-.+.+- .. +.
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------kG---id---- 636 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------KG---ID---- 636 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------hh---hh----
Confidence 44 3567899999999999999999999999999999999999999999887653322221 10 00
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHhhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTYLA 349 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~~~ 349 (376)
...+|........+|+.+++..+|.+|.. +.+|-.|-|+..
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 12455566678889999999999999976 788988887654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.01 Aligned_cols=243 Identities=28% Similarity=0.408 Sum_probs=204.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch---HHHHHHHHHHhhcC-CCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l 143 (376)
..+|.++.+||+|+||.|.+|..+++.+.||||++++.-.... +--+.|-.+|.... -|.+++++..|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3568999999999999999999999999999999987644332 22345777776654 5788999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+.||+|-..++. -.++.+..+..++.+|+-||-+||++| |++||||.+|||++.+|++||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999998876 456778889999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
..+.. ....++|||.|+|||++.-.+|+..+|.||+||+|||||.|++||++.+.++.. ..+
T Consensus 501 i~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF----------------~aI 562 (683)
T KOG0696|consen 501 IFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----------------QAI 562 (683)
T ss_pred ccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHH
Confidence 44332 345689999999999999999999999999999999999999999988765321 112
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL 337 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 337 (376)
.+.. -.+|...+.++.+++...|..+|.+|..
T Consensus 563 ~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2211 1466677889999999999999999953
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=320.99 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecC-----
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----- 138 (376)
.....+|+.+.+||+||||.||+++++-+|..||||+|.... ......+.+|+..|.+|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 356677899999999999999999999999999999998664 22335688999999999999999987532100
Q ss_pred --------------------------------------------------------------------------------
Q 017175 139 -------------------------------------------------------------------------------- 138 (376)
Q Consensus 139 -------------------------------------------------------------------------------- 138 (376)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 017175 139 ----------------------------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184 (376)
Q Consensus 139 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~ 184 (376)
..+||-||||+..+|.+++... ...-....+|+++++|++||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence 0257889999877777777652 111146788999999999999
Q ss_pred HHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC----------------CCCcceeecccccccCcccccccc
Q 017175 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP----------------VGDKTHVSTRVMGTYGYCAPEYAM 248 (376)
Q Consensus 185 ~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~ 248 (376)
|+|+.| ||||||||.||++++++.|||+|||+++... .+......+..+||..|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999997511 111122335578999999999997
Q ss_pred cCC---CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHH
Q 017175 249 TGQ---LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAA 325 (376)
Q Consensus 249 ~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 325 (376)
+.. |+.|+|+|||||||+||+. ||...... ..++ .. +. .+.+.. . ..+.......-..+|.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~iL---~~-LR-~g~iP~----~--~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASIL---TN-LR-KGSIPE----P--ADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHHH--HHHH---Hh-cc-cCCCCC----C--cccccccchHHHHHHH
Confidence 654 9999999999999999985 57654221 0000 00 00 111111 1 1222223334456999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 017175 326 MCVQEQPNMRPLIADVVT 343 (376)
Q Consensus 326 ~cl~~~P~~Rps~~ell~ 343 (376)
+||+.||.+||||.|+|.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.30 Aligned_cols=268 Identities=22% Similarity=0.243 Sum_probs=197.1
Q ss_pred CcccCceecccCceEEEEEEECCC--CeEEEEEEeccCC--ccchHHHHHHHHHHhhc-CCCCccceeEEEec----CCc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLEST--NQVVAIKQLDRNG--LQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~ 140 (376)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999888 8899999986432 12235677899999998 49999999987543 245
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.|++++|+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 689888854 467899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc--eeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh---------
Q 017175 221 KLGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA--------- 288 (376)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~--------- 288 (376)
......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 753322211 11223568999999998765 468999999999999999999999997654221100000
Q ss_pred hhhhhhhcc-----cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 289 WARPLFKDR-----RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 289 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
......... ..........+. ......+..+.+++.+||+.||++|||+.+++.+-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 000000000 000000000000 001112457889999999999999999999997755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=295.22 Aligned_cols=269 Identities=23% Similarity=0.297 Sum_probs=202.7
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEec-CCce
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 141 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~ 141 (376)
..++++|++.+.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456789999999999999999999999999999999886432 2234567789999999999999999999865 5678
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++++||+ +++|..++.. ..+++..+..++.|+++||.|||+.+ ++||||+|.||+++.++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 5688888753 45788889999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh----hhhh
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR----PLFK 295 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~----~~~~ 295 (376)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ .... ....
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 42211 123457889999998766 56899999999999999999999999765432111000 0000 0000
Q ss_pred c--ccccccccCC-cCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 296 D--RRKFSQMADP-TLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 296 ~--~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. .......... ......+ ...+..+.++|.+||+.+|++||++.+++.+-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 0 0000000000 0000111 1234678899999999999999999999988553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=256.94 Aligned_cols=269 Identities=21% Similarity=0.275 Sum_probs=207.9
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.|.-.++||+|.||+||+|++..+++.||+|.++.....+ -....+|+.+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999999999999999998654322 24577999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|. .+|..+... .+..++...+..++.|+++||.++|+++ +.|||+||.|++++.+|.+||+|||+++......
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 96 688888766 4677899999999999999999999999 9999999999999999999999999998744332
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh--hcccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF--KDRRKFSQM 303 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 303 (376)
.-.+..+-|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++.|.+.+..+....+-+.-... .....+..+
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 222334679999999999886 58899999999999999987 677787776554332221111000 011112222
Q ss_pred cCCcCCCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 304 ADPTLQGQYP---------VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.|-....-++ +.....-++++.+.|.-+|.+|.++++.+++--+
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 2211111111 2233356789999999999999999999887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.07 Aligned_cols=248 Identities=26% Similarity=0.316 Sum_probs=204.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+...|.+...+|.|+||.|-.+.+..+++..++|++.+.. .+..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 5678999999999999999999999999999999997652 2233566555444 6999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-CCCCceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill-~~~~~~kl~Dfg~~~~~~ 224 (376)
|.+.|+-|.+.+.. .+.....+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.+....
T Consensus 396 e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888765 23333778889999999999999999 9999999999999 699999999999998633
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ....+-|..|.|||++....|++++||||||++||+||+|..||....... . +.
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-----e--------------i~ 523 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-----E--------------IH 523 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-----H--------------HH
Confidence 22 334578899999999999999999999999999999999999998764430 0 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+.+....+..+.+|+.+||+.||.+|+++.++..+-+....
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 1111122224566789999999999999999999999999887443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.11 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=202.6
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|+..+.||+|++|.||+|....+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999999999999999997653 233456778999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+ ++|.+++... ...+++..++.++.+++.||.|||+.+ |+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5899998762 246899999999999999999999999 99999999999999999999999999875332221
Q ss_pred ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhh----hhhhc------
Q 017175 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWAR----PLFKD------ 296 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~----~~~~~------ 296 (376)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||......+.... ..... ..+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234567889999998776 788999999999999999999999976543211100 00000 00000
Q ss_pred -ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 297 -RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 297 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
...+...........+ ...+..+.+++.+||..+|++||++.+++.+-
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 0000000000000011 12255789999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.15 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=197.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|++|.||+|.+..+++.||||.+...... ....+..|+.++.... |+||+++++++.+....|++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 5688999999999999999999998999999999754332 2344566776666654 9999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+ .+ |+||||+|+||++++++.++|+|||++.....
T Consensus 95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 577776654 23478999999999999999999997 57 99999999999999999999999999865322
Q ss_pred CCcceeecccccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
.. ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... ...........
T Consensus 168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~--- 236 (296)
T cd06618 168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEEP--- 236 (296)
T ss_pred CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCCC---
Confidence 11 112345788999999987553 7889999999999999999999997532210 00111111100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
+... .....+..+.+|+.+||+.||++||++.+++++.+..
T Consensus 237 ----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 237 ----PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred ----CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 0000 0012344788999999999999999999999887644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=287.14 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=199.1
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|++.+.||+|++|.||+|.+..+++.|+||.+..... .......+|+..++.++ |+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998899999999865432 22234557899999999 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 78998888652 1347899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccch-hhhhhh----hhhccccccc
Q 017175 229 THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL-VAWARP----LFKDRRKFSQ 302 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 302 (376)
......++..|+|||++.+ ..++.++|+||||+++|+|++|..||......+.... ...... .+........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1223468889999998854 4578999999999999999999999976543211100 000000 0000000000
Q ss_pred ccCCcCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 303 MADPTLQ-------GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 303 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.....+. .......+..+.+++.+||+.+|++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00111124578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=311.77 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=219.4
Q ss_pred CcccCceecccCceEEEEEEECCCCe---EEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
...+.++||.|.||.||+|+.+..|+ .||||.++..... ...+|+.|+.+|-+++||||+++.|+........||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 35788999999999999999987764 5999999765433 3467999999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+.|+|..||+. ....+++.++..+++.|+.|+.||-+.+ +|||||.+.|||++.+-.+|++|||+++....
T Consensus 710 EyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999987 3566999999999999999999999999 99999999999999999999999999997544
Q ss_pred CCcceeec-ccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 226 GDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 226 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
+......+ ...-..+|.|||.+....++.+|||||+||+|||.++ |..||-+....+..+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka----------------- 846 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA----------------- 846 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-----------------
Confidence 44222211 1223479999999999999999999999999999887 8899866543221111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
++..++-.-|.+++..|.+|+..||++|-.+||.+.+|+..|.++..++..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 122333345667788999999999999999999999999999999886655
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=297.95 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=203.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCc---
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 140 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--- 140 (376)
.+.++|++.+.||+|++|.||+|++..+++.||+|++.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999999999999999986432 2233557789999999999999999988866554
Q ss_pred ---eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 141 ---RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 141 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
.++|+||+ +++|.+++.. .++++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 5799998854 56999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh---h
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR---P 292 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~---~ 292 (376)
|++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+ .... .
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 999753222 2234678899999988653 6789999999999999999999999765432111000 0000 0
Q ss_pred hhhc------ccccccccCCcCCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 293 LFKD------RRKFSQMADPTLQGQY---PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 293 ~~~~------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.. ...+...........+ ....+..+.+++.+||+.+|++|||+.+|+++-+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 0000 0000000000000000 112356788999999999999999999999886543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=286.79 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=199.3
Q ss_pred CcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
.|++.+.||.|+||.||+|.+. .+|..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999874 4688999999865322 2235577899999999 489999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999865 356889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ............
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS--- 227 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc---
Confidence 5322211 112235688999999998753 46789999999999999999999997432111 111111111110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
.+ .++...+..+.+++.+||..+|++|| ++.+++.+-.
T Consensus 228 -----~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 228 -----EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred -----CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 00 12223445778899999999999997 7888887744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.61 Aligned_cols=241 Identities=32% Similarity=0.398 Sum_probs=197.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
||.|+||.||++.+..+++.+|+|.+...... ....+..|+.+++.++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999998765433 334678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeec
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (376)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999865 346899999999999999999999999 9999999999999999999999999987532221 1233
Q ss_pred ccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||...+... ........ ...++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~------------~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILKD------------PLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhcC------------CCCCC
Confidence 4568889999999988888999999999999999999999997654311 01111100 01122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH---HHHHHH
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRPLI---ADVVTA 344 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rps~---~ell~~ 344 (376)
...+..+.+++.+||..||++||++ .+++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 2335578899999999999999999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=291.84 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=206.8
Q ss_pred HHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-------hHHHHHHHHHHhhcCCCCccceeEEE
Q 017175 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-------NREFLVEVLMLSLLHHPNLVNLIGYC 135 (376)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~ 135 (376)
+-..+.++|-++.+||+|||+.||+|.+....+.||+|+-..+.... .+...+|..+-+.|.||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 33456678999999999999999999998889999999876543222 13367899999999999999999998
Q ss_pred e-cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCc
Q 017175 136 A-DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYH 211 (376)
Q Consensus 136 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~ 211 (376)
. +.+.+|-|+|||+|.+|.-|+.. ...+++.++..|+.||+.||.||.+.. +||||-||||.|||+. ..|.
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccce
Confidence 5 56778999999999999999975 677999999999999999999999874 7799999999999994 5678
Q ss_pred eEEcccccccccCCCCcc-----eeecccccccCcccccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 212 PKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
+||+|||++++....... ...+...||.+|++||++.-+ ..+.++||||+|||+|..+.|+.||.......
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999999875443322 233457899999999988643 47889999999999999999999998653221
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYP--VRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. +. ... .++. ...-.|| +..+.+..++|++||+..-++|.+..+++.+
T Consensus 692 d--IL-------qeN----TIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 692 D--IL-------QEN----TILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred H--HH-------hhh----chhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 0 00 000 0000 0001122 2334578889999999999999999998754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.72 Aligned_cols=146 Identities=30% Similarity=0.451 Sum_probs=132.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+..|+.+++.++|+||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997543322 256778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999865 346889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=299.79 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=210.4
Q ss_pred cCcccCceecccCceEEEEEEECCC-C--eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST-N--QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++.+..++||+|.||+|++|.|... | -.||||.+...... ...+|++|+.+|.+|+|+|++++||+..+ ...-||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3456678999999999999988643 2 35999999876555 56789999999999999999999999988 677899
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
+|.+++|+|.+.+++ .....+-...+..++.||+.|+.||.+++ +|||||-..|+|+-....|||+|||+.+.+.
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999987 34566888889999999999999999999 9999999999999888899999999999866
Q ss_pred CCCcceee-cccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 225 VGDKTHVS-TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 225 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.++..+.. ....-...|+|||.+....++.++|+|++||++|||++ |..||.+.........
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~---------------- 327 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN---------------- 327 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------
Confidence 55443322 22334568999999999999999999999999999999 7899988765422211
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+|..-+-.-+..++..+.+++..||..+|++||++..|.+.+-
T Consensus 328 -iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 -IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1211122345567889999999999999999999999975443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=283.99 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=198.2
Q ss_pred CcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
+|++.+.||+|++|.||++.+. .++..||+|.+..... .....+..|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 4578899999864322 2234577899999999 599999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999864 356889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
....... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ............
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS--- 227 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc---
Confidence 5332221 1122346889999999987654 7889999999999999999999996432211 001111111110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.. ..+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01 1122234577889999999999999997766555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.76 Aligned_cols=226 Identities=24% Similarity=0.254 Sum_probs=181.8
Q ss_pred cCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchhhhhcc
Q 017175 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159 (376)
Q Consensus 80 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 159 (376)
|.+|.||++.+..+++.||+|.+.... ....|...+....||||+++++++.+....+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999996543 223445555556799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeeccccccc
Q 017175 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (376)
Q Consensus 160 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (376)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999999 999999999999999999999999987643221 12244677
Q ss_pred CcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHH
Q 017175 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQ 319 (376)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (376)
.|+|||.+.+..++.++|+||+||++|+|++|..|+........ . ......+...+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~----~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------T----HTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------c----ccccCCcccCCHH
Confidence 89999999888899999999999999999999988764311100 0 0000122233457
Q ss_pred HHHHHHHcccCCCCCCCCH-----HHHHHH
Q 017175 320 ALAVAAMCVQEQPNMRPLI-----ADVVTA 344 (376)
Q Consensus 320 l~~li~~cl~~~P~~Rps~-----~ell~~ 344 (376)
+.+++.+||+.||++||++ ++++.|
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 8889999999999999996 666543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=303.05 Aligned_cols=257 Identities=28% Similarity=0.382 Sum_probs=215.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEec-----CC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD-----GD 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~-----~~ 139 (376)
.-++.|.+...||.|.+|.||+++...+++..|+|+...... ..+.+..|+.+++.+. |||++.++++|.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 345679999999999999999999999999999999876543 3456778999998875 9999999999853 57
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.+|||||||.||+..++++... +.++.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||+|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999998754 788999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
+..... ........+||+.|||||++... .|+.++|+||||++..||.-|.+|+-+..+.. .+|
T Consensus 170 SaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF 238 (953)
T KOG0587|consen 170 SAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALF 238 (953)
T ss_pred eeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhc
Confidence 976332 22334567899999999999643 57889999999999999999999998766531 122
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
.. ..+|...-.-+...+..+.++|..||..|-++||++.++++|-
T Consensus 239 ~I------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 239 LI------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred cC------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 21 1233333333556778999999999999999999999998763
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.95 Aligned_cols=272 Identities=29% Similarity=0.435 Sum_probs=209.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh--cCCCCccceeEEEecCC----ceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~----~~~ 142 (376)
...++..+||+|.||.||+|... ++.||||++... ..+.+..|-.+++. ++|+||+++++.-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 44667788999999999999887 699999999643 34567777777765 57999999999876655 899
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeeecCCCCCcEEECCCCceEEcc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------NPPVIYRDLKCSNILLGEGYHPKLSD 216 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~------~~~i~Hrdikp~Nill~~~~~~kl~D 216 (376)
||++|.+.|+|.+|+.. ..++|....+++..|++||+|||+.. +++|+|||||..||||.++++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999965 67999999999999999999999843 57899999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCC-CC-----cccchhhHHHHHHHHHhCCCCCCCcc-cc--------
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-----LKSDVYSFGVVLLEIITGRKAIDNTR-AA-------- 281 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~~ll~g~~p~~~~~-~~-------- 281 (376)
||++..+..+.........+||.+|||||++.+.. +. .+.||||+|.+||||++....++... +.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998877776666666689999999999997642 22 36899999999999999776553211 10
Q ss_pred -cccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 282 -GEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 282 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
+........+......+....+.+ .+.+. .....+.+.+..||..||+-|.|+.=+.++++.+......
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPD-AWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChh-hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111112222222222222222 22221 3455788899999999999999999999999998875543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=278.40 Aligned_cols=271 Identities=20% Similarity=0.267 Sum_probs=205.1
Q ss_pred HHh-cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC--------CCCccceeEEEe
Q 017175 66 AVT-KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA 136 (376)
Q Consensus 66 ~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~~~~ 136 (376)
.|. .+|.+.++||.|-|++||+|.+..+.+.||+|+++.. ....+..+.||.+|++++ ..+||++++.|.
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 455 8999999999999999999999999999999988543 345567789999999874 247999999996
Q ss_pred c----CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC---
Q 017175 137 D----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG--- 209 (376)
Q Consensus 137 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~--- 209 (376)
. +.++|||+|++ |.+|..+|... .-+.++...+.+|++||+.||.|||..+. |||.||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEID 227 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccc
Confidence 5 56899999999 77898888763 34678999999999999999999998764 9999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 017175 210 -------------------------------------------------------------------------------- 209 (376)
Q Consensus 210 -------------------------------------------------------------------------------- 209 (376)
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 017175 210 -------------------------------------------------------------------------------- 209 (376)
Q Consensus 210 -------------------------------------------------------------------------------- 209 (376)
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence
Q ss_pred ---CceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc-
Q 017175 210 ---YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN- 285 (376)
Q Consensus 210 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~- 285 (376)
-.+||+|||-|+.. ....+.-+.|..|+|||++.+..|+..+||||++|++|||+||...|+.........
T Consensus 388 ~~di~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD 462 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD 462 (590)
T ss_pred ccceeEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence 01234444433320 111223357889999999999999999999999999999999999997654432211
Q ss_pred --hhhh------------------hhhhhhcccccccccCCcCCC---------CCCHHHHHHHHHHHHHcccCCCCCCC
Q 017175 286 --LVAW------------------ARPLFKDRRKFSQMADPTLQG---------QYPVRGLYQALAVAAMCVQEQPNMRP 336 (376)
Q Consensus 286 --~~~~------------------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rp 336 (376)
.++. .+.+|...+.+..+-.-.... .++.....++.+|+.-||+.+|++||
T Consensus 463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 1111 123333333333332222211 34556777999999999999999999
Q ss_pred CHHHHHHHHHh
Q 017175 337 LIADVVTALTY 347 (376)
Q Consensus 337 s~~ell~~L~~ 347 (376)
||.++++|-+-
T Consensus 543 tA~~cl~hPwL 553 (590)
T KOG1290|consen 543 TAAQCLKHPWL 553 (590)
T ss_pred cHHHHhcCccc
Confidence 99999999773
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=272.25 Aligned_cols=275 Identities=23% Similarity=0.342 Sum_probs=207.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEec--------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 137 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------- 137 (376)
.+.|.-..+||+|.||.||+|+.+++|+.||+|++-..... --....+|+.+|..+.|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34577788999999999999999999999999987532211 12456789999999999999999987743
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
...+|+|+.+|+. +|.-.+.. ...+++..++..++.++++||.|+|+.. |+|||+||+|+||+.+|.++|+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 2348999999974 78777765 4578999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcce--eecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh----
Q 017175 218 GLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA---- 290 (376)
Q Consensus 218 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---- 290 (376)
|+++.+....... ..++.+-|..|++||.+.+. .|+++.|||+.|||+.+|++|.+-+...........+...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997654443221 23445679999999999875 7999999999999999999999988766443322222211
Q ss_pred ----hhhhhcccccccccCC-cCCCCC--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 291 ----RPLFKDRRKFSQMADP-TLQGQY--------PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 291 ----~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
++.......+..+-.+ ...+.+ +.....+..+|+.++|..||.+|+++.+++.|-.+..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 1111111111111111 111111 1122447889999999999999999999998876654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=271.67 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=201.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+|.++.+||+|+|+.|.+++.+++.+.||+|++++. ...+......|-.++.+- +||.+|-++..|.....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5799999999999999999999999999999999764 334445566777777664 599999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
.||++||+|--.++. +..++++.+..+..+|+-||.|||+.| |++||||.+|+|+|..|++||+|+|+++...
T Consensus 330 ieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999887765 677999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcc-cccccchhhh-hhhhhhccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR-AAGEHNLVAW-ARPLFKDRRKFSQ 302 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~ 302 (376)
......+.++|||.|.|||++.+..|+..+|.|+|||+++||+.|+.||+.-- ...+.+...+ ++.++..
T Consensus 403 --~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------ 474 (593)
T KOG0695|consen 403 --GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------ 474 (593)
T ss_pred --CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------
Confidence 23345667899999999999999999999999999999999999999997431 1111222222 2222211
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL 337 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 337 (376)
.+ .+|...+.....++...|.+||.+|..
T Consensus 475 ----qi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 475 ----QI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11 223333445556888999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.80 Aligned_cols=256 Identities=30% Similarity=0.434 Sum_probs=216.8
Q ss_pred cccCceecccCceEEEEEEECCCC----eEEEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+..++||+|+||+||+|.+-..| .+||+|++... ..+....++.|+..|..++|||++++++++.... .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 455788999999999999985544 46899988654 3445678999999999999999999999997765 77899
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
+|+++|+|.++++. .+..+.....+.|..||++|+.|||.+. ++||||-.+||||..-..+|+.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 4677888999999999999999999999 99999999999999999999999999998666
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
...........-.+-|||-|.+....|+.++|||||||++|||+| |..|+++....+..++..
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle---------------- 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE---------------- 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------
Confidence 655554454556678999999999999999999999999999999 999999876654332221
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..-+-..|+..+.++..++.+||..|+..||+++++...+.++++
T Consensus 915 -~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 -KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 111224456677788999999999999999999999999988876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=281.77 Aligned_cols=204 Identities=27% Similarity=0.327 Sum_probs=174.9
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchH---HHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
|..++.||-|+||.|++++..+|...||+|.+++.+.-... .+..|-.||..-.++-||++|-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 67778899999999999999999999999999765443322 245688889888999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc----
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG---- 223 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~---- 223 (376)
++||++-.+|.. .+-+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||+|||+|.-+
T Consensus 711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998876 466889999999999999999999999 999999999999999999999999998521
Q ss_pred -----CCCCcce-------------------------------eecccccccCcccccccccCCCCcccchhhHHHHHHH
Q 017175 224 -----PVGDKTH-------------------------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLE 267 (376)
Q Consensus 224 -----~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 267 (376)
..++... ..-..+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1111000 0112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCcccc
Q 017175 268 IITGRKAIDNTRAA 281 (376)
Q Consensus 268 ll~g~~p~~~~~~~ 281 (376)
|+.|+.||-...+.
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999876554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=266.30 Aligned_cols=270 Identities=23% Similarity=0.341 Sum_probs=202.6
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHh--hcCCCCccceeEEEecCC---
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS--LLHHPNLVNLIGYCADGD--- 139 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~--~l~h~ni~~~~~~~~~~~--- 139 (376)
..+..+.++.+.||+|.||.||+|.++ |+.||||++...+ .+.+.+|.++.+ .|+|+||+.++++-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 456678999999999999999999999 7889999996432 344556666665 579999999998765443
Q ss_pred -ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeeecCCCCCcEEECCCCceE
Q 017175 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-----KANPPVIYRDLKCSNILLGEGYHPK 213 (376)
Q Consensus 140 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-----~~~~~i~Hrdikp~Nill~~~~~~k 213 (376)
.+|||++|.+.|+|.+|+.. ..++....++++..++.||++||. +|++.|.|||||..||||..+|..-
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 57899999999999999964 679999999999999999999996 5778899999999999999999999
Q ss_pred EcccccccccCCCC-c-ceeecccccccCcccccccccCC----CC--cccchhhHHHHHHHHHhC----------CCCC
Q 017175 214 LSDFGLAKLGPVGD-K-THVSTRVMGTYGYCAPEYAMTGQ----LT--LKSDVYSFGVVLLEIITG----------RKAI 275 (376)
Q Consensus 214 l~Dfg~~~~~~~~~-~-~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DiwslG~il~~ll~g----------~~p~ 275 (376)
|+|+|+|....... . .......+||.+|||||++...- +. ..+||||||.++||++.. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997543332 1 12223468999999999996532 11 358999999999999863 3455
Q ss_pred CCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 276 DNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...-+.+.. +..+.... -...+................+.+++..||..||.-|.|+-.|-..|.++..
T Consensus 437 yd~Vp~DPs-~eeMrkVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPS-FEEMRKVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCC-HHHHhcce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 543222111 11100000 0011111111222334566788889999999999999999999999998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=292.04 Aligned_cols=267 Identities=19% Similarity=0.228 Sum_probs=174.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC----CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEE------Eec
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST----NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY------CAD 137 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~------~~~ 137 (376)
.++|.+.+.||+|+||.||+|.+..+ +..||+|++...... +....+ .++...+.++..++.. ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 46899999999999999999999988 899999988643221 111111 1111222222222211 245
Q ss_pred CCceEEEEEccCCCchhhhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPP----------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp 201 (376)
....++|+||+.+++|.+++..... .........+..++.||+.||.|||+.+ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 6678999999999999998864210 0011223456789999999999999999 99999999
Q ss_pred CcEEECC-CCceEEcccccccccCCCCcceeecccccccCcccccccccC----------------------CCCcccch
Q 017175 202 SNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG----------------------QLTLKSDV 258 (376)
Q Consensus 202 ~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di 258 (376)
+|||++. ++.+||+|||++.....+.. .......+|+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 67999999999975332221 223446789999999976432 23446799
Q ss_pred hhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc---ccccccCCcCCC----CC--CHHHHHHHHHHHHHccc
Q 017175 259 YSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR---KFSQMADPTLQG----QY--PVRGLYQALAVAAMCVQ 329 (376)
Q Consensus 259 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~--~~~~~~~l~~li~~cl~ 329 (376)
|||||++|||+++..+++... ..+...+..... .+.....+.... .+ .........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999776654321 000000000000 000001111000 00 00112245589999999
Q ss_pred CCCCCCCCHHHHHHHHHhhh
Q 017175 330 EQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 330 ~~P~~Rps~~ell~~L~~~~ 349 (376)
.||++|||+.++++|-+.-.
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred CCcccCCCHHHHhCCcCcCC
Confidence 99999999999999966533
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=260.29 Aligned_cols=240 Identities=32% Similarity=0.439 Sum_probs=194.3
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchhhhhcc
Q 017175 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159 (376)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 159 (376)
+||.||+|.+..+++.+|+|++....... ...+.+|+..++.++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665544 67888999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeeccccccc
Q 017175 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (376)
Q Consensus 160 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (376)
...+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 223889999999999999999999999 9999999999999999999999999997643322 233456888
Q ss_pred CcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHH
Q 017175 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQ 319 (376)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (376)
.|++||.+.+..++.++||||||+++|+|++|..||...... .............. .......+..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----LELFKKIGKPKPPF---------PPPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHhccCCCC---------ccccccCCHH
Confidence 999999998888899999999999999999999999763211 00000000000000 0000003347
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 320 ALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 320 l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
+.+++.+||..+|++||++.+++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8889999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=278.83 Aligned_cols=280 Identities=21% Similarity=0.239 Sum_probs=214.5
Q ss_pred cccCHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC------CCccc
Q 017175 57 HTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH------PNLVN 130 (376)
Q Consensus 57 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~ 130 (376)
+.+.+.-...+..+|.+....|+|-||+|..|.+..-|..||||+|..+.... +.=+.|+.+|++|+. -|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHH
Confidence 34455556678899999999999999999999999999999999998764432 344579999999963 48999
Q ss_pred eeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-
Q 017175 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG- 209 (376)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~- 209 (376)
++-.|.+.+++|||+|.+. .+|.+.+..+.. +..+....+..++.|++-||..|..+| |+|.||||+||||++.
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999885 799999988654 456888999999999999999999999 9999999999999865
Q ss_pred CceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
..+||||||.|....... .+-+.-+..|.|||++.+-.|+...|+||+||+||||.||+..|.+........+..-
T Consensus 574 ~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 467999999997533332 2223456789999999999999999999999999999999999987644332222111
Q ss_pred hh---------------hhhhcccccccc----------------cCC------cCCC--CCC---HHHHHHHHHHHHHc
Q 017175 290 AR---------------PLFKDRRKFSQM----------------ADP------TLQG--QYP---VRGLYQALAVAAMC 327 (376)
Q Consensus 290 ~~---------------~~~~~~~~~~~~----------------~~~------~~~~--~~~---~~~~~~l~~li~~c 327 (376)
+. +-|....++..+ +.| .+.+ .++ ......+.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 00 000000000000 000 0000 111 23456888999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q 017175 328 VQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 328 l~~~P~~Rps~~ell~~L~ 346 (376)
|..||++|.|..+.|.|-.
T Consensus 730 l~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPF 748 (752)
T ss_pred hccChhhcCCHHHHhcCCc
Confidence 9999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=244.95 Aligned_cols=205 Identities=25% Similarity=0.324 Sum_probs=172.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.......||+|++|.|-+.++..+|...|+|.+...- .+...+.++|+.+.... .||.+|.+||.+......|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 34445667999999999999999999999999997432 33445677888877654 59999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
.|+ -+|..+.......+..+++..+-+|+..++.||.|||++-+ ++|||+||.|||++.+|++|+||||.+-.+...
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 996 58888877666678899999999999999999999999765 999999999999999999999999998642211
Q ss_pred CcceeecccccccCccccccccc----CCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 279 (376)
-..+...|...|||||.+.. ..|+.++||||||++++||.+++.||+...
T Consensus 203 ---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 ---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 11222468889999998854 379999999999999999999999999764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=284.83 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=206.2
Q ss_pred cCcccCceecccCceEEEEEEECC-------CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCccceeEEEecCC
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 139 (376)
++..+.+.||+|+||.|++|.... ....||||.+..... .+.+.+..|+.+++.+. |+||+.+++++....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344666799999999999997431 145799999875433 44567899999999986 999999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLP---P-------DK--KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~ 207 (376)
..++|+||+..|+|.++++..+ . .. ..++..+.+.++.||+.|++||++.. ++||||-.+|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999998744 0 01 23899999999999999999999999 99999999999999
Q ss_pred CCCceEEcccccccccCCCCcceeecccc--cccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccc
Q 017175 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVM--GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEH 284 (376)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 284 (376)
.+..+||+|||+++.......... .... -...|||||.+....|+.++||||+||+||||++ |..||.+.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 999999999999985333332221 1112 2456999999999999999999999999999999 889998632110
Q ss_pred chhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 285 NLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. .+.+.+..+-..|..+..++.+++..||+.+|++||++.++.+.+...
T Consensus 530 ---~l-----------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ---EL-----------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HH-----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 00 111122222344555677888999999999999999999999998884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=275.75 Aligned_cols=270 Identities=19% Similarity=0.220 Sum_probs=183.1
Q ss_pred hcCcccCceecccCceEEEEEEEC----------------CCCeEEEEEEeccCCccchH--------------HHHHHH
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE----------------STNQVVAIKQLDRNGLQGNR--------------EFLVEV 117 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~~--------------~~~~e~ 117 (376)
.++|.+.++||+|+||.||+|.+. ..++.||||.+........+ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 458999999999999999999752 23567999998654322222 233467
Q ss_pred HHHhhcCCCCc-----cceeEEEec--------CCceEEEEEccCCCchhhhhccCCC--------------------CC
Q 017175 118 LMLSLLHHPNL-----VNLIGYCAD--------GDQRLLVYEYMPLGSLEDHLHDLPP--------------------DK 164 (376)
Q Consensus 118 ~~l~~l~h~ni-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~ 164 (376)
.++.+++|.++ ++++++|.. ....++||||+++++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 566676643 3568999999999999998864210 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccc
Q 017175 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244 (376)
Q Consensus 165 ~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 244 (376)
..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....+... ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23567788999999999999999999 999999999999999999999999999653322211 11123458899999
Q ss_pred cccccCC--------------------CC--cccchhhHHHHHHHHHhCCC-CCCCcccccc-cchhhhhhhhhhccccc
Q 017175 245 EYAMTGQ--------------------LT--LKSDVYSFGVVLLEIITGRK-AIDNTRAAGE-HNLVAWARPLFKDRRKF 300 (376)
Q Consensus 245 E~~~~~~--------------------~~--~~~DiwslG~il~~ll~g~~-p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 300 (376)
|.+.... ++ .+.||||+||++|+|++|.. ||........ ..........+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r----- 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR----- 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----
Confidence 9886432 11 24699999999999999875 7754321100 000000000000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQP---NMRPLIADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~ell~~L~~ 347 (376)
........-......+....+|+.+||..+| .+|+|+.|+|+|-+.
T Consensus 455 -~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 455 -MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred -hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 0000000001112335578889999999866 689999999999775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=256.84 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=200.3
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecC-----CceE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 142 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~ 142 (376)
+.+-.+.||.|+||.||.+.+..+|+.||+|++... .....+.+.+|+.+|..++|.|++..++...-. ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345668899999999999999999999999998642 333456788999999999999999998877543 2457
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+++|.|. .+|...+-. .+.++.+.+.-+++||++||.|||+.+ |.||||||.|+|++.+..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8888885 577776644 677888999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh--h-----hh
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR--P-----LF 294 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~-----~~ 294 (376)
....+... .+.-+-|..|+|||++++. .|+.+.||||+|||+.||+..+..|....+......+...- + -.
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 44443332 2334578899999999986 58999999999999999999999887765543333222100 0 00
Q ss_pred hccccccccc-----CCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 295 KDRRKFSQMA-----DPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 295 ~~~~~~~~~~-----~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...+....++ .+.+.- .-+.....+...++.++|.+||++|.+..+.+.++-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0001001111 111100 111223346677899999999999999999987753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=271.98 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=173.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch--------HHHHHHHHHHhhcC---CCCccceeEEEec
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--------REFLVEVLMLSLLH---HPNLVNLIGYCAD 137 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~ni~~~~~~~~~ 137 (376)
..|+..+.||.|+||.|++|.++.+...|+||.+.+...-.. -.+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 459999999999999999999999999999999876543211 12457999999997 9999999999999
Q ss_pred CCceEEEEEcc-CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcc
Q 017175 138 GDQRLLVYEYM-PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (376)
Q Consensus 138 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~D 216 (376)
.+++||+||.. +|.+|.+++.. ..++++.++..|++|++-|+++||+.+ |+|||||.+|+.++.+|.+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999965 56799999975 678999999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDN 277 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~ 277 (376)
||.+.....+. ...++||..|.|||++.+..| +..-|||+||++||.++....||.+
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99986533332 345789999999999998877 4567999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=282.29 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=191.3
Q ss_pred cccCceecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFG-RVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
|.-.+++|.|+.| .||+|... |+.||||.+-... ..-..+|+..|+..+ |||||++++.-.+..+.||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4445678999887 78999988 7899999884332 134568999999875 999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---C--CceEEccccccccc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---G--YHPKLSDFGLAKLG 223 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~--~~~kl~Dfg~~~~~ 223 (376)
. .+|.+++..-............+.++.|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 7999999762111122222456788999999999999999 999999999999965 3 46899999999876
Q ss_pred CCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 224 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 224 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..+... .......||.+|+|||++....-+.++|||||||++|+.++| .+||...-..+. .+......+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee
Confidence 555432 223557899999999999988888899999999999999996 899986432110 1111111111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+.. ....++.+||.+|+.++|..||++.+|+.|-.+..
T Consensus 734 ~L~~---------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 734 HLEP---------LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eecc---------CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 1100 11117889999999999999999999987744433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.73 Aligned_cols=265 Identities=23% Similarity=0.273 Sum_probs=204.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecC------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------ 138 (376)
...+|.-+..+|.|+- .|..|.+...+++||+|++... .....+...+|+.++..+.|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4578999999999999 8889999999999999998654 222345677899999999999999999998543
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...|+|||+|. .+|...+. ..++-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||.|||
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 35799999996 79988875 35777889999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh---------h
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA---------W 289 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------~ 289 (376)
+++..... ...+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+.+..+....+. +
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99853222 23455789999999999999999999999999999999999999998664332211110 0
Q ss_pred hhhhhhcccccc------------c-ccCCcCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 290 ARPLFKDRRKFS------------Q-MADPTLQG--QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 290 ~~~~~~~~~~~~------------~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..++......+. + +.|..+.. +.+......+.+++.+||-.||++|.++.++|+|-
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 111111111111 1 11111111 11223455788899999999999999999999884
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=236.60 Aligned_cols=265 Identities=17% Similarity=0.245 Sum_probs=201.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecC--CceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv 144 (376)
.++|++.+++|+|.++.||.|+...+++.++||+++.. ..+.+.+|+.+|..|. ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46799999999999999999999999999999999643 3467889999999998 99999999999775 456799
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~ 223 (376)
+||+...+..... ..++.-.+..++.+++.||.|+|+.| |.|||+||.|+++|. .-.++|+|+|++...
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999887776655 45788899999999999999999999 999999999999985 457999999999876
Q ss_pred CCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccc-cccchhh----------hhh
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA-GEHNLVA----------WAR 291 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~----------~~~ 291 (376)
..+..... .+.+..|--||.+..- .|+..-|+|||||++..|+..+.||-..... +..-.+. +..
T Consensus 184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 66654433 3577789999998764 5888999999999999999999998654322 1111110 000
Q ss_pred h-hhhcccccccccCCcCCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 292 P-LFKDRRKFSQMADPTLQG--------QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 292 ~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
. .+.-...+..++....+. +...-.+.++.+|+.+.|..|-.+|+|+.|.+.|-.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0 000011111111111100 00011245888999999999999999999999886644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=273.60 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=209.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|.....+|.|.||.||+|+++.+++..|+|+++.....+..-+..|+.+++..+||||+.+++.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46799999999999999999999999999999999988777777788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|.||+|.+..+. ...+++.++...+++.+++|.|||+.+ -+|||||-.||++++.|.+|++|||.+-. .+.
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq--ita 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ--ITA 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh--hhh
Confidence 999999987764 678999999999999999999999999 89999999999999999999999999864 223
Q ss_pred cceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.......+.||+.|||||+.. .+.|...+|||++|++..|+-.-++|.....+. +.++-.... . .
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------r~l~LmTkS--~-~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------RALFLMTKS--G-F 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---------HHHHHhhcc--C-C
Confidence 333445578999999999874 568999999999999999998877776544332 111111110 0 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
++.... -.......+.+|+..||..+|.+||+++.+|.|
T Consensus 233 qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 233 QPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111111 112334577889999999999999999988764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=240.13 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=191.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEE-EecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGY-CADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~-~~~~~~~~l 143 (376)
.+.+.|.+.+.||+|.||.+-+|.++.++..+++|.+.... ....+|.+|...--.|. |.||+..|+. |+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45678999999999999999999999999999999997653 44577888887655554 8999998875 566778889
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC--CCCceEEccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAK 221 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~--~~~~~kl~Dfg~~~ 221 (376)
++||++.|+|..-+.. ..+.+.....++.|+++||.|+|+.+ +||||||.+||||- +.-+|||||||+++
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999998854 56888999999999999999999999 99999999999993 33489999999987
Q ss_pred ccCCCCcceeecccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
...... .....+..|.+||++... ...+.+|||.||+++|.+|+|+.||..... .......|.+-+...
T Consensus 172 k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 172 KVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRK 245 (378)
T ss_pred ccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhccc
Confidence 522221 123356679999977532 346789999999999999999999994332 233333322211111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.+.....+ ...+..+..+..+-|..++++|-...+....
T Consensus 246 --------~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 --------NPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred --------CccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11111111 1233467779999999999999555444433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=246.73 Aligned_cols=272 Identities=24% Similarity=0.350 Sum_probs=220.1
Q ss_pred CHHHHHHHhcCcccCceecccCceEEEEEEECCCC-----eEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeE
Q 017175 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIG 133 (376)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~ 133 (376)
...++.....|++...++-+|.||.||.|++...+ +.|.+|.+.... .-....++.|..++.-+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566667788999999999999999999876432 345566664322 122345677888888889999999999
Q ss_pred EEec-CCceEEEEEccCCCchhhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 134 YCAD-GDQRLLVYEYMPLGSLEDHLHDLP----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 134 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
++.+ ....++++.++.-|+|..++..+. ...+.++..+...++.|++.|++|||+++ ++|.||...|++|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 8755 566788899999999999997332 23355777888899999999999999999 999999999999999
Q ss_pred CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchh
Q 017175 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 287 (376)
.-.+||+|=.+++....++......+-.....||+||.+.+..|+.++|+|||||+||||+| |+.|+...++.+....
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y- 510 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY- 510 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-
Confidence 99999999999998777777666666667889999999999999999999999999999999 8999988776532221
Q ss_pred hhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
+....+-..|.+++++++.++..||...|++||+++++..-|..+..+
T Consensus 511 ----------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 511 ----------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ----------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 122223344567788999999999999999999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=232.57 Aligned_cols=212 Identities=38% Similarity=0.568 Sum_probs=184.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchhh
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED 155 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~ 155 (376)
||+|++|.||++....+++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999765433 34678899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccccccccCCCCcceeecc
Q 017175 156 HLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTR 234 (376)
Q Consensus 156 ~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 234 (376)
++... ...+++..++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98652 146899999999999999999999999 999999999999999 89999999999975433221 1233
Q ss_pred cccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC
Q 017175 235 VMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP 313 (376)
Q Consensus 235 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (376)
..+...|++||.+... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5578899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 314 VRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 314 ~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..+.+++.+||+.+|++||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=243.12 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=201.0
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECC---CCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCC
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 139 (376)
+..+.+.|...++||+|.|++||++.+.. .++.||+|.+...... ..+..|+.+|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34566789999999999999999998877 7889999999765433 45889999999986 999999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFG 218 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg 218 (376)
...+|+||++.....++... ++...+..+++.++.||.++|.+| |+||||||.|+|.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999999998855 778999999999999999999999 999999999999974 5678999999
Q ss_pred ccccc-----------------CC--CC-----------------------cceeecccccccCcccccccccC-CCCcc
Q 017175 219 LAKLG-----------------PV--GD-----------------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLK 255 (376)
Q Consensus 219 ~~~~~-----------------~~--~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 255 (376)
++... .. +. .........||++|+|||++.+. ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98610 00 00 00011224699999999999865 46889
Q ss_pred cchhhHHHHHHHHHhCCCCCCCcccccc-c-chhhh--------hhhhhhc---------------ccccccc----cCC
Q 017175 256 SDVYSFGVVLLEIITGRKAIDNTRAAGE-H-NLVAW--------ARPLFKD---------------RRKFSQM----ADP 306 (376)
Q Consensus 256 ~DiwslG~il~~ll~g~~p~~~~~~~~~-~-~~~~~--------~~~~~~~---------------~~~~~~~----~~~ 306 (376)
+||||.|||+..++++..||-....+-. . .+... ....... ...+..+ +.+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 9999999999999999999965422111 0 00000 0000000 0000000 000
Q ss_pred c-----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 307 T-----LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 307 ~-----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
. .........+..+.+|+.+||..||.+|.|+++.|.|-.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 0 000111123448889999999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=229.31 Aligned_cols=199 Identities=36% Similarity=0.478 Sum_probs=174.2
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778999999999999999988999999999876554 56678889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 150 LGSLEDHLHDLPPDKKR-LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+++|.+++... .. +++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999998752 23 889999999999999999999999 99999999999999999999999999876433320
Q ss_pred ceeecccccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 017175 229 THVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 277 (376)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335678899999998 666778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=264.01 Aligned_cols=201 Identities=16% Similarity=0.225 Sum_probs=142.4
Q ss_pred hcCC-CCccceeEEE-------ecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 017175 122 LLHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193 (376)
Q Consensus 122 ~l~h-~ni~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~ 193 (376)
.++| +||++++++| .+...+++++|++ +++|.+++.. ....+++..++.++.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 6888888877 2334677888988 5799999964 2456999999999999999999999999
Q ss_pred eeecCCCCCcEEECCCC-------------------ceEEcccccccccCCCCc--------------ceeecccccccC
Q 017175 194 VIYRDLKCSNILLGEGY-------------------HPKLSDFGLAKLGPVGDK--------------THVSTRVMGTYG 240 (376)
Q Consensus 194 i~Hrdikp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~ 240 (376)
|+||||||+||||+..| .+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455556665542110000 000112458899
Q ss_pred cccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHH
Q 017175 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQA 320 (376)
Q Consensus 241 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 320 (376)
|+|||++.+..++.++|||||||+||||++|..|+...... .. .... ....+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~---~~~~------~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MS---SLRH------RVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HH---HHHH------hhcChhh-----hhcCHHH
Confidence 99999999999999999999999999999998887642210 00 0000 0011111 0112245
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 321 LAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 321 ~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+++.+||+.+|.+||++.+++++.+..
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~~~~ 269 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSEFIN 269 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhchhhh
Confidence 5788999999999999999999887643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=219.54 Aligned_cols=264 Identities=21% Similarity=0.226 Sum_probs=199.2
Q ss_pred CcccCceecccCceEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhhcC----CCCccceeEEE-ecCCceEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREFLVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLL 143 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~ni~~~~~~~-~~~~~~~l 143 (376)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|..++..+. .+++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999987764 678888876543333335667888888876 36999999999 57788999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-----CceEEcccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-----YHPKLSDFG 218 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-----~~~kl~Dfg 218 (376)
||+.+ |.+|.++..... ...++..++..++.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 789999876643 578999999999999999999999999 9999999999999754 468999999
Q ss_pred ccc--ccCCCCc---ce--e-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 219 LAK--LGPVGDK---TH--V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 219 ~~~--~~~~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
+++ ....... .. . .....||..|+++.+..+...+.+.|+||++.++.+|+.|..||.............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~-- 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE-- 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH--
Confidence 998 3211111 01 1 233569999999999999999999999999999999999999997655332211100
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
... .. ..... .....+..+..+...+-..+...+|....+...|..+....
T Consensus 251 ~~~-~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDP-RK-----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHh-hh-----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 00 00000 11112234455555566689999999999999988776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=204.57 Aligned_cols=169 Identities=22% Similarity=0.185 Sum_probs=127.5
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
|+|.+++.. .+..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688888865 2456999999999999999999999886 999999999999999 9998753221
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (376)
...||+.|+|||++.+..++.++|||||||++|+|++|..||....... ............ . .+. ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~---~-~~~-~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGMPA---D-DPR-DR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHhcc---C-Ccc-cc
Confidence 1258999999999999999999999999999999999999997543211 001111110000 0 000 00
Q ss_pred CCCHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 311 QYPVRGLY--QALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 311 ~~~~~~~~--~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+..... .+.+++.+||..+|++||++.++++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11122222 68899999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=202.31 Aligned_cols=206 Identities=26% Similarity=0.366 Sum_probs=177.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.-.|++.++||+|.||.+++|.+.-+++.||||.-... .+..++..|+...+.|. .++|...|-+..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 456799999999999999999999999999999975443 34567778998888886 799999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-----CCCceEEcccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-----EGYHPKLSDFGLA 220 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-----~~~~~kl~Dfg~~ 220 (376)
|.+ |.+|.++..- .+.+++..++.-++.|++.-++|+|++. +|+|||||+|+||. ....+.++|||++
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 998 7888888765 3678999999999999999999999999 99999999999995 3446899999999
Q ss_pred cccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccc
Q 017175 221 KLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (376)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 281 (376)
+........ .......||.+||+-....+...+.+.|+-|||-++++.|-|..||.+..++
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 865443321 1223467999999999999999999999999999999999999999987665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=214.76 Aligned_cols=170 Identities=17% Similarity=0.122 Sum_probs=131.3
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECC-CCeEEEEEEeccCC-----ccchHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
...+..+|.+.+.||+|+||.||+|.+.. +++.+|||++.... ......+.+|+.+++.++|+|++..+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34567889999999999999999998876 67888999875331 11234588999999999999998633222
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCC-CCCcEEECCCCceEEcc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL-KCSNILLGEGYHPKLSD 216 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdi-kp~Nill~~~~~~kl~D 216 (376)
...|+||||++|++|... .. .. ...++.++++||.|||+.| |+|||| ||+|||++.++.++|+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 11 11 1467889999999999999 999999 99999999999999999
Q ss_pred cccccccCCCCccee------ecccccccCcccccccccC
Q 017175 217 FGLAKLGPVGDKTHV------STRVMGTYGYCAPEYAMTG 250 (376)
Q Consensus 217 fg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 250 (376)
||++........... -....++..|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999986433321111 1345688899999988643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=236.85 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=195.9
Q ss_pred cCc-ccCceecccCceEEEEEEECCCCeEEEEEEeccC--Cccch----HHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 69 KNF-RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGN----REFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 69 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
+.| ....++|.|++|.|+.+........++.|.+... ..... ..+..|+.+-..++|+|++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 5678899999998988887766666666655421 11111 1255677778889999998888877776666
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
+-.||||++ +|..++.. ...++..++-.++.|++.|+.|+|+.| |.|||+||+|++++.+|.+||+|||.+.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence 666999998 99999865 357888999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcc--eeecccccccCcccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 222 LGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 222 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
....+.+. ......+|+..|+|||++.+..|++. .||||.|++++.|++|+.||......+...... .....
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~~- 543 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSDQ- 543 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----ccccc-
Confidence 76555554 45567889999999999999999865 799999999999999999998765543221000 00000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....... .......+..-+.++.+||+.+|.+|.|+++|++.=|
T Consensus 544 --~~~~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 544 --RNIFEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred --cccccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 0000000 0001123345667999999999999999999997644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=191.22 Aligned_cols=206 Identities=26% Similarity=0.326 Sum_probs=172.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC-CCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 145 (376)
....|.+.++||.|+||.+|+|....+|+.||||.-... .....+..|..+.+.|++ ..|..+..+..+..+..+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 457899999999999999999999999999999976543 233567789999998874 78888888888889999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Dfg~~~~ 222 (376)
+.+ |.+|.++..- ....++..+++-++-|++.-++|+|.++ ++||||||+|+|+.- ...+.|+|||+++.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 7899988765 3567889999999999999999999999 999999999999953 34689999999975
Q ss_pred cCCCCc-----ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccc
Q 017175 223 GPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (376)
Q Consensus 223 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 281 (376)
.-.... .....+..||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||.+..+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 322221 11224467999999988888778889999999999999999999999987664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=198.90 Aligned_cols=262 Identities=32% Similarity=0.427 Sum_probs=198.1
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCC-CccceeEEEecCCceEEEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv~e 146 (376)
|.+...||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999987 678999987654432 56788999999999988 79999999977777899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~~~~ 225 (376)
++.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999776542111 36899999999999999999999999 99999999999999988 799999999874333
Q ss_pred CCcce----eecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 226 GDKTH----VSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 226 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
..... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~ 232 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT 232 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC
Confidence 32211 2355789999999999987 57888999999999999999999997655431 000000000000000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
. .................+.+++..|+..+|..|.+..+....
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000001111012223567789999999999999999988876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=189.29 Aligned_cols=173 Identities=12% Similarity=0.121 Sum_probs=134.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhhcCCCCccceeEEEe
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---------FLVEVLMLSLLHHPNLVNLIGYCA 136 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~ni~~~~~~~~ 136 (376)
.+.++|+..++||.|+||.||++.. ++..+|+|.+.......... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 5678999999999999999999755 36679999997543333222 578999999999999999998866
Q ss_pred cC--------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 137 DG--------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 137 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
.. ...+++|||++|.+|.++.. +++ ....+++.+|..+|+.| ++|||++|.||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999988731 222 24569999999999999 999999999999999
Q ss_pred CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 017175 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270 (376)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 270 (376)
+| ++|+|||......... .. ...+....|+.++|+||||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 9999999886431111 00 114445567789999999999876643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=189.39 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=194.9
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
..+..+|.+...|..|+|++.++ .+++|++... .....++|..|.-.|+-+.||||+.+++.|.......++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 45566788999999999999954 4667776533 3334467889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeec-CCCCCcEEECCCCceEE--cccccccccCC
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYR-DLKCSNILLGEGYHPKL--SDFGLAKLGPV 225 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hr-dikp~Nill~~~~~~kl--~Dfg~~~~~~~ 225 (376)
+.|+|+..++.. ..-.++..++.+++.+|++|++|||+..+ ++-| .|....+++|++-+.+| +|--++..
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999873 34457778999999999999999999863 5554 58899999999877665 34332221
Q ss_pred CCcceeecccccccCcccccccccCCCC---cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.......|.||+||.+..++-+ .++|+|||++++|||.|...||....+.+-- -.
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------------mk 400 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------------MK 400 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----------------hh
Confidence 1123467899999999887644 5789999999999999999999876553211 11
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+.-+.++-.+|+..+.....|+.-|+..||.+||.+..|+-.|+++.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22233445667777888899999999999999999999998888653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=191.38 Aligned_cols=235 Identities=18% Similarity=0.253 Sum_probs=152.8
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcC----------CCCccceeEEEe
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLH----------HPNLVNLIGYCA 136 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~----------h~ni~~~~~~~~ 136 (376)
.+.....||.|+++.||.+.+..+|+.+|+|++...... ..+.+.+|......+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678899999999999999999999999998644322 2345555555444432 223333333322
Q ss_pred c---------C---C-----ceEEEEEccCCCchhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 017175 137 D---------G---D-----QRLLVYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196 (376)
Q Consensus 137 ~---------~---~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~H 196 (376)
. . . ..+++|+-+. ++|..++... ......+.....+.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 1 1 2367888774 6887775421 111223445556777899999999999999 999
Q ss_pred cCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccC--------CCCcccchhhHHHHHHHH
Q 017175 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--------QLTLKSDVYSFGVVLLEI 268 (376)
Q Consensus 197 rdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~il~~l 268 (376)
+||+|+|++++.+|.++|+||+.... .+... .. ...+..|.|||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r--~g~~~--~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVR--AGTRY--RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEE--TTEEE--EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHee--cCcee--ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988764 22221 11 3455789999977442 468889999999999999
Q ss_pred HhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 017175 269 ITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMR 335 (376)
Q Consensus 269 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 335 (376)
++|..||+.......... ....+. +.+..+.+||.++|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999997644322111 112444 566688899999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=179.11 Aligned_cols=138 Identities=15% Similarity=0.067 Sum_probs=108.6
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCcc--c-------h-----------------HHHHHHHHHHhhcCCCC
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--G-------N-----------------REFLVEVLMLSLLHHPN 127 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~n 127 (376)
...||+|++|.||+|.+. +|+.||||+++..... . . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999987 7999999999754221 1 0 11234999999998887
Q ss_pred ccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeecCCCCCcEEE
Q 017175 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL-HDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 128 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~~~~i~Hrdikp~Nill 206 (376)
+........ ...+|||||++|+++...... ...+++..+..++.|++.+|.++ |+.| |+||||||+||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 754443322 223899999998776554322 35688999999999999999999 6889 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 017175 207 GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~ 222 (376)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-25 Score=204.30 Aligned_cols=226 Identities=27% Similarity=0.368 Sum_probs=181.3
Q ss_pred eecccCceEEEEEEE---CCCCeEEEEEEeccCCccch--HHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEccC
Q 017175 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
.+|+|.||.|++++. ...|..+|+|+..+...... .....|-.++...+ ||.++++...++.....++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998643 34577899998875433221 12345777777777 9999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 229 (376)
||.|...+.. ...+.+.....+...++-|++.+|..+ ++|||+|++||+++.+|++++.|||+++.......
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999888765 456777888888999999999999999 99999999999999999999999999986433322
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
.|||..|||||++. .....+|.||||+++++|++|..||.... ...+... .
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~Il~~------------~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKRILKA------------E 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHHHhhh------------c
Confidence 28999999999997 66788999999999999999999998710 0111110 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLI 338 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 338 (376)
-..|......+.+++..++..+|..|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 13456667788889999999999999755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=171.71 Aligned_cols=139 Identities=17% Similarity=0.088 Sum_probs=110.4
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--------------------------hHHHHHHHHHHhhcCCC
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------------------------NREFLVEVLMLSLLHHP 126 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ 126 (376)
+.+.||+|++|.||+|.+. +|+.||||+++...... ......|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987542110 11234688999999999
Q ss_pred CccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEE
Q 017175 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNIL 205 (376)
Q Consensus 127 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nil 205 (376)
++.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ .| |+||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 88655544433 24899999998755433211 2457788999999999999999999 99 999999999999
Q ss_pred ECCCCceEEcccccccc
Q 017175 206 LGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 206 l~~~~~~kl~Dfg~~~~ 222 (376)
++ ++.++|+|||++..
T Consensus 151 l~-~~~~~liDFG~a~~ 166 (190)
T cd05145 151 YH-DGKPYIIDVSQAVE 166 (190)
T ss_pred EE-CCCEEEEEccccee
Confidence 99 78999999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=210.33 Aligned_cols=248 Identities=22% Similarity=0.214 Sum_probs=180.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccch---HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.|...+.||.+.|=.|.+|++.. |. |+||++-+.. .-.. .+-..|++ ...+++||.+++.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 57778899999999999998875 54 8899986544 2222 33344555 55678999999988877778888998
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC-
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP- 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~- 224 (376)
+|.. -+|++.+.. +.-+...+.+.|+.|++.||..+|..| |+|+|||.+||||+.=+=+.|+||-.-+...
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9985 589998864 455788889999999999999999999 9999999999999998889999997754321
Q ss_pred -CC---CcceeecccccccCcccccccccC----------C-CCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhh
Q 017175 225 -VG---DKTHVSTRVMGTYGYCAPEYAMTG----------Q-LTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVA 288 (376)
Q Consensus 225 -~~---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 288 (376)
.+ +......+-..-..|.|||.+... . .+++.||||+||++.||++ |++||+..+-.....--.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 11 111222222233579999988642 1 5678999999999999988 788887542110000000
Q ss_pred hhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 289 WARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
......+..+-|. .++++|..|++.||++|.++++.|+.-
T Consensus 253 -----~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 253 -----DDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred -----cCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 0000112222222 566799999999999999999999873
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=201.29 Aligned_cols=251 Identities=19% Similarity=0.182 Sum_probs=184.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~ 142 (376)
.-...|.|.+.||+|+||.||+|.... |+.||+|+-......+. .--.+++.+|+ -+.|..+..++...+..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344679999999999999999999877 99999998765544332 11223333443 355666666777778889
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-------CCCceEEc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-------EGYHPKLS 215 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-------~~~~~kl~ 215 (376)
+|+||.+.|+|.+++.. .+.+++..++.++.||+..++.||..+ |||+||||+|+||. +..-++|+
T Consensus 771 lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999973 677999999999999999999999999 99999999999993 34468999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
|||.+...............++|-.+--+|+..+..|+.++|.|.|+-+++.||.|...-. .
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~------------------~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV------------------K 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh------------------c
Confidence 9999975444444444555789999999999999999999999999999999999975320 0
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
. .....++..+.. .....-+.+++..+|..|-..=|...+|...++.+-.
T Consensus 906 ~--g~~~~~~~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 N--GSSWMVKTNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred C--Ccceeccccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 0 001111111110 0112244557777887555555777777766665543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=163.46 Aligned_cols=187 Identities=20% Similarity=0.147 Sum_probs=139.2
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc----hHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG----NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.+...|++|+||.|+++.. .+..++.+.+....... ...+.+|+.+|+++. |+++++++++ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998766 37788877776543311 124678999999996 5889999886 45699999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCC-CCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL-KCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdi-kp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+.|.+|...... . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654311 1 1347789999999999999 999999 79999999999999999999985433
Q ss_pred CCcc----ee-------ecccccccCcccccccccC-CCC-cccchhhHHHHHHHHHhCCCCCCCc
Q 017175 226 GDKT----HV-------STRVMGTYGYCAPEYAMTG-QLT-LKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 226 ~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
.... .. ......++.|++|+...-- ..+ ...+.++.|+-+|.++|+..++-..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 00 0112367888888754322 223 4568889999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=165.42 Aligned_cols=136 Identities=21% Similarity=0.227 Sum_probs=108.3
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-----CCCCccceeEEEecCC---c-eE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---Q-RL 142 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~---~-~~ 142 (376)
.-...||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++++++++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6555555 69998765555567789999999999 5799999999998864 3 33
Q ss_pred EEEEc--cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeecCCCCCcEEECC----CCceEEc
Q 017175 143 LVYEY--MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL-EYLHDKANPPVIYRDLKCSNILLGE----GYHPKLS 215 (376)
Q Consensus 143 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al-~~LH~~~~~~i~Hrdikp~Nill~~----~~~~kl~ 215 (376)
+|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999954 235555 35678888887 9999999 999999999999974 3479999
Q ss_pred ccccc
Q 017175 216 DFGLA 220 (376)
Q Consensus 216 Dfg~~ 220 (376)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=175.78 Aligned_cols=197 Identities=23% Similarity=0.244 Sum_probs=139.8
Q ss_pred CCCCccceeEEEecC---------------------------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHH
Q 017175 124 HHPNLVNLIGYCADG---------------------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIA 176 (376)
Q Consensus 124 ~h~ni~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 176 (376)
+|||||++..+|.+. ...|+||..++ .+|..++-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 599999998876432 24689999886 599999854 456677778899
Q ss_pred HHHHHHHHHHhhCCCCCeeecCCCCCcEEE--CCCC--ceEEcccccccccCCCC----cceeecccccccCcccccccc
Q 017175 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILL--GEGY--HPKLSDFGLAKLGPVGD----KTHVSTRVMGTYGYCAPEYAM 248 (376)
Q Consensus 177 ~~i~~al~~LH~~~~~~i~Hrdikp~Nill--~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~ 248 (376)
.|+++|+.|||.+| |.|||+|.+|||+ ++++ .++++|||++....... ........-|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 3333 46899999986422211 111112234778899999886
Q ss_pred cCC------CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHH
Q 017175 249 TGQ------LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALA 322 (376)
Q Consensus 249 ~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 322 (376)
..+ .-.++|.|+.|-+.||++....||...-.... . ...+.+.--|.+ +...+..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~-----------~r~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-D-----------TRTYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-c-----------hhhhhhhhCCCC----cccCChHHHH
Confidence 432 23589999999999999999999987321100 0 011112222222 2344457889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHH
Q 017175 323 VAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 323 li~~cl~~~P~~Rps~~ell~~L 345 (376)
|+...|+.||++|+++.=.+..|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999987655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=197.02 Aligned_cols=211 Identities=26% Similarity=0.371 Sum_probs=149.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
...+|..+++|..|+||.||+++++.+.+++|+ +++++... .+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee-----------------
Confidence 456799999999999999999999999999999 45443221 111 22222344433
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+-...+.. -..++.. ++.|++|||+.+ |+|||+||+|.+|+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~----~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333332 2334433 267999999999 999999999999999999999999998642211
Q ss_pred Ccc------------ee-ecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 227 DKT------------HV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 227 ~~~------------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
... .. ....+||+.|.|||++....|+..+|+|++|+|+|+.+-|+.||.+..+++.... .
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~------v 270 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------V 270 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh------h
Confidence 110 01 1235899999999999999999999999999999999999999998766533221 1
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 336 (376)
+.....+.+- +.....++.++|.++|+.+|..|-
T Consensus 271 isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 271 ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1211111111 223344788899999999999995
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=176.18 Aligned_cols=217 Identities=29% Similarity=0.418 Sum_probs=163.1
Q ss_pred HhhcCCCCccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-eecC
Q 017175 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV-IYRD 198 (376)
Q Consensus 120 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i-~Hrd 198 (376)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++|+.||.|||+.. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4578899999999999999999999999999999999976 4677899999999999999999999876 5 9999
Q ss_pred CCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCC-------CCcccchhhHHHHHHHHHhC
Q 017175 199 LKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-------LTLKSDVYSFGVVLLEIITG 271 (376)
Q Consensus 199 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ll~g 271 (376)
++..|+++|....+||+|||+.................-..-|.|||.+.... .+.+.||||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987643211111122223455799999997641 46679999999999999999
Q ss_pred CCCCCCccccccc-chhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 272 RKAIDNTRAAGEH-NLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 272 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..||+........ .++.. ... ......-|.+.... .....+..++.+||..+|.+||++..+-..+..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~---~~~---~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR---VKK---GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH---HHh---cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999875433221 11111 111 00111111111000 222267889999999999999999999988887665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-22 Score=181.90 Aligned_cols=177 Identities=24% Similarity=0.343 Sum_probs=132.6
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
.+.||.|++|.-.+|.+|+... ......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999643 235567888999999999999999 77 9999999999999999999999999
Q ss_pred cccccCCCC----cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 219 LAKLGPVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 219 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+........ .....+...||..||+||.+.+..|+.++||||||+||+||+. =...++......
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~----------- 470 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT----------- 470 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh-----------
Confidence 987543333 1223355789999999999999999999999999999999998 333333221110
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 342 (376)
......+++....++| .-..|+.++|...|.+||++.+..
T Consensus 471 ----d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 471 ----DIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ----hhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 0111222222222333 224599999999999999555443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=161.52 Aligned_cols=142 Identities=15% Similarity=0.104 Sum_probs=111.4
Q ss_pred CcccCceecccCceEEEEEE-ECCCCeEEEEEEeccCCccc------------------------hHHHHHHHHHHhhcC
Q 017175 70 NFRADCLLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQG------------------------NREFLVEVLMLSLLH 124 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 124 (376)
-|.+.+.||+|++|.||+|. +..+|+.||+|++....... ...+..|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 66789999999987542110 012457999999987
Q ss_pred CCC--ccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCC
Q 017175 125 HPN--LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202 (376)
Q Consensus 125 h~n--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~ 202 (376)
+.+ +..+++. ...++||||++|++|...... ........+..++.|++.+|.+||+.+. ++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 533 3344432 235899999998888765422 2345666778999999999999999875 999999999
Q ss_pred cEEECCCCceEEcccccccc
Q 017175 203 NILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 203 Nill~~~~~~kl~Dfg~~~~ 222 (376)
||+++ ++.++|+|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=154.46 Aligned_cols=134 Identities=22% Similarity=0.293 Sum_probs=112.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|++|.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 46779999865433211 1346789999999999999888777777788899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
|++|++|.+++... .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988541 12 77889999999999999999 99999999999999 78999999998863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=148.77 Aligned_cols=139 Identities=16% Similarity=0.050 Sum_probs=108.7
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc----------------------chHHHHHHHHHHhhc
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------------------GNREFLVEVLMLSLL 123 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l 123 (376)
.....|.+.+.||+|+||.||+|... +|+.||||++...... .......|+.++..+
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 33344888999999999999999875 6999999987643210 011256788888888
Q ss_pred CCC--CccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 017175 124 HHP--NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (376)
Q Consensus 124 ~h~--ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp 201 (376)
.++ .+...++. ...++||||++|++|...... .....++.+++.++.++|+.+ ++||||+|
T Consensus 91 ~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 91 YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 777 44444442 345899999999988765421 235678899999999999999 99999999
Q ss_pred CcEEECCCCceEEcccccccc
Q 017175 202 SNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 202 ~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||++++++.++|+|||.+..
T Consensus 154 ~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred ccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=149.56 Aligned_cols=130 Identities=23% Similarity=0.311 Sum_probs=105.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.||+|++|.||+|.+. +..+++|........ ....+.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 678999986543211 124466899999999988776665566666778999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
++|++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999887431 10 78999999999999999 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=169.86 Aligned_cols=139 Identities=24% Similarity=0.308 Sum_probs=112.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--cc------chHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQ------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
.....|...+.||+|+||.||+|.+... .+++|+..... .. ....+.+|+.+++.++|++++....++.+
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3345567789999999999999987643 34444432111 11 12457789999999999999988877777
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
....++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999874 34678999999999999999 9999999999999 6779999999
Q ss_pred ccccc
Q 017175 218 GLAKL 222 (376)
Q Consensus 218 g~~~~ 222 (376)
|++..
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-20 Score=181.37 Aligned_cols=262 Identities=24% Similarity=0.255 Sum_probs=196.7
Q ss_pred cCcccCceecccCceEEEEEEECC-CCeEEEEEEeccCC--ccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 144 (376)
..|.+.+.||+|+|+.|-++.... +...+|.|.+.... ......+..|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457778889999999999887643 34557777776543 122233445777777777 99999999999999999999
Q ss_pred EEccCCCchhhhh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeecCCCCCcEEECCCC-ceEEccccccc
Q 017175 145 YEYMPLGSLEDHL-HDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-DKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAK 221 (376)
Q Consensus 145 ~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~ 221 (376)
++|..|+++.+.+ .. .....+...+..++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||++.
T Consensus 100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888 33 2225677788899999999999999 888 99999999999999999 99999999998
Q ss_pred ccCC-CCcceeeccccc-ccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 222 LGPV-GDKTHVSTRVMG-TYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 222 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
.... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++.....+..... + .....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-~----~~~~~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-W----KSNKG 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-e----ccccc
Confidence 7655 344444455678 9999999999885 4567889999999999999999999876544311100 0 00000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+. ............+++.+++..+|..|.+.+++-..-+...
T Consensus 249 ~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 249 RFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccc--------cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000 0111233446677999999999999999999865544333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=138.87 Aligned_cols=134 Identities=19% Similarity=0.162 Sum_probs=96.8
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHH----------------------HHHHHHHHhhcCCC--C
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNRE----------------------FLVEVLMLSLLHHP--N 127 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--n 127 (376)
.+.||+|+||.||+|.+. +++.||||++...... .... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 7899999998653221 1111 12455555555443 2
Q ss_pred ccceeEEEecCCceEEEEEccCCCchhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEE
Q 017175 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDH-LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNIL 205 (376)
Q Consensus 128 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nil 205 (376)
+.+.++. ...++||||++++.+... +... .. ...+..++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 245899999998543321 1110 01 15678899999999999999 88 999999999999
Q ss_pred ECCCCceEEcccccccc
Q 017175 206 LGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 206 l~~~~~~kl~Dfg~~~~ 222 (376)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.9e-17 Score=141.00 Aligned_cols=135 Identities=21% Similarity=0.190 Sum_probs=104.5
Q ss_pred Cceec-ccCceEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhhcCCCCc--cceeEEEec
Q 017175 74 DCLLG-EGGFGRVYKGRLESTNQVVAIKQLDRNGL-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCAD 137 (376)
Q Consensus 74 ~~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~ 137 (376)
...|| .||.|+||.+... +..++||.+...+. .....+.+|+.++..+.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 8888999988775 67899998854321 122457789999999998775 667766443
Q ss_pred CC-c---eEEEEEccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 138 GD-Q---RLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 138 ~~-~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
.. . .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.| |+||||||+|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 22 2 2599999997 689888754 345544 3678999999999999 9999999999999998999
Q ss_pred EEcccccccc
Q 017175 213 KLSDFGLAKL 222 (376)
Q Consensus 213 kl~Dfg~~~~ 222 (376)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-17 Score=131.81 Aligned_cols=135 Identities=21% Similarity=0.171 Sum_probs=112.2
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC--CCccceeEEEecCCceEEEEEccCC
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.+.||.|.++.||++.... ..+++|....... ...+..|+..++.++| .++.+++.+....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45679999999999999864 6799998865433 4567889999999986 5899999988888889999999988
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+.+..+ +......++.+++.++.++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766543 4456677899999999999986323399999999999999989999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=148.18 Aligned_cols=252 Identities=23% Similarity=0.240 Sum_probs=187.8
Q ss_pred HhcCcccCceecc--cCceEEEEEEE--CCCCeEEEEEEe--ccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCC
Q 017175 67 VTKNFRADCLLGE--GGFGRVYKGRL--ESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~--~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 139 (376)
+...+.+...+|. |.+|.||.+.. ..++..+|+|.= ..........-.+|+...+.++ |+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4456788899999 99999999988 778889999983 3332233333446777777776 999999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeecCCCCCcEEECCC-CceEE
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKL 214 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl 214 (376)
..++-+|+|. .+|..+.+. ...-++...++..+.+..+ ||.++|+.+ ++|-|+||+||++..+ ...++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 9999999995 788888765 2344788889999999999 999999999 9999999999999988 88999
Q ss_pred cccccccccCCCCcceee---cccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVS---TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|||+......+...... ....|...|++||.+ ++.++..+||++||.++.+...+..+.........
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-------- 335 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-------- 335 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc--------
Confidence 999998765544422111 223688899999977 55778899999999999999998776654311100
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVT 343 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 343 (376)
.++..-.+..++-...+..+...+.+|++.+|..|++++.+..
T Consensus 336 ---------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 ---------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000000111222233345555899999999999998876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-14 Score=135.86 Aligned_cols=185 Identities=16% Similarity=0.154 Sum_probs=137.4
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
|++ ...+-++.+..-.|..+.++.+|.|+..............+.+..|+.++||||+++++.++.....|+|+|.+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV-- 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV-- 91 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--
Confidence 444 33334444433356677788999999887655444456778899999999999999999999999999999998
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
-.|..++.. +....+..-+.||+.||.|||+.++ ++|++|.-+.|+|+..|..||++|.++........
T Consensus 92 ~Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 92 RPLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred ccHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 477777765 3366677789999999999986554 99999999999999999999999998854222111
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 271 (376)
.......-..|..|+.+.... -..|.|-|||++++++.|
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 111112223466676554333 346999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-15 Score=132.69 Aligned_cols=208 Identities=23% Similarity=0.311 Sum_probs=145.4
Q ss_pred HHHhhcCCCCccceeEEEecC-----CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 017175 118 LMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192 (376)
Q Consensus 118 ~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~ 192 (376)
.-|-++-|.||++++.++.+. ....+++|||..|+|..++++....+..+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344456799999999887654 3578999999999999999987778888999999999999999999999985 7
Q ss_pred CeeecCCCCCcEEECCCCceEEcccccccccC--CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 017175 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP--VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270 (376)
Q Consensus 193 ~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 270 (376)
||+|+++..+.|++..+|-+|+.----..... ............+-++|.+||.=..-..+.++|||+||....+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 79999999999999999888875321111000 0001111122346789999996655566788999999999999988
Q ss_pred CCCCC-CCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 271 GRKAI-DNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 271 g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+..-- ...........+ .. .+...-+... +.++.+||+..|..||++++++.|..-
T Consensus 278 lEiq~tnseS~~~~ee~i--a~-------~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI--AN-------VIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred heeccCCCcceeehhhhh--hh-------heeeccCccc------------cCcCcccccCCCCCCcchhhhhcCcee
Confidence 76432 221111000000 00 0000111111 238899999999999999999877543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=132.06 Aligned_cols=140 Identities=21% Similarity=0.140 Sum_probs=95.6
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccch----------------------------------------HHH
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----------------------------------------REF 113 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~ 113 (376)
.+.||.|++|.||+|+.+ +|+.||||+.+..-.... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999975 589999999854321100 013
Q ss_pred HHHHHHHhhcC----CCCccceeEEE-ecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 017175 114 LVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-GLEYLH 187 (376)
Q Consensus 114 ~~e~~~l~~l~----h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~-al~~LH 187 (376)
.+|...+..+. +.+-+.+-..+ ......++||||++|++|.+..... ....+ ...++..++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 34554444442 22222222222 2244578999999999998876421 11122 2345555555 478899
Q ss_pred hCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 188 ~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
..| ++|+|++|.||+++.++.++++|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=3e-14 Score=137.25 Aligned_cols=145 Identities=18% Similarity=0.144 Sum_probs=96.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc----------------------------------hH---
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG----------------------------------NR--- 111 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------~~--- 111 (376)
..|.. +.||+|++|.||+|+.+.+|+.||||+.+..-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 78999999999999999889999999987441100 01
Q ss_pred ---HHHHHHHHHhhcC----CCCccceeEEEec-CCceEEEEEccCCCchhhhh--ccCCCCCCCCCHHHHHHHHHHHHH
Q 017175 112 ---EFLVEVLMLSLLH----HPNLVNLIGYCAD-GDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAK 181 (376)
Q Consensus 112 ---~~~~e~~~l~~l~----h~ni~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~i~~ 181 (376)
++.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.+.. .........+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1333444444432 3444444444433 45678999999999998742 2211111123344444444444
Q ss_pred HHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcccccccccC
Q 017175 182 GLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSDFGLAKLGP 224 (376)
Q Consensus 182 al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~Dfg~~~~~~ 224 (376)
...| ++|+|+||.||+++.+| .++++|||++....
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4578 99999999999999888 99999999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.2e-13 Score=112.45 Aligned_cols=131 Identities=18% Similarity=0.077 Sum_probs=96.1
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCcc-ceeEEEecCCceEEEEEccCCCc
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
.+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356889999999999875 77899998755432 123456789999888755544 455443 234579999999987
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 153 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+.... . ....++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 0 11345678999999999987 11249999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-12 Score=110.09 Aligned_cols=136 Identities=14% Similarity=0.073 Sum_probs=98.7
Q ss_pred CceecccCceEEEEEEECC------CCeEEEEEEeccCCc---------------------cc-hHH----HHHHHHHHh
Q 017175 74 DCLLGEGGFGRVYKGRLES------TNQVVAIKQLDRNGL---------------------QG-NRE----FLVEVLMLS 121 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~---------------------~~-~~~----~~~e~~~l~ 121 (376)
...||.|--+.||.|.... .+..+|||+.+.... .. ... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998654 357899998742110 00 111 237899998
Q ss_pred hcCC--CCccceeEEEecCCceEEEEEccCCCchhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeec
Q 017175 122 LLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSLED-HLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL-HDKANPPVIYR 197 (376)
Q Consensus 122 ~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~~~~i~Hr 197 (376)
++.. -++..++++ ...++||||+.+..+.. .+.. ..++......+..+++.+|..| |..+ ++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8864 456666654 46689999997643322 2221 2345566778889999999999 8899 9999
Q ss_pred CCCCCcEEECCCCceEEcccccccc
Q 017175 198 DLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 198 dikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
||++.||++++ +.+.|+|||.+..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCcee
Confidence 99999999974 6899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=129.27 Aligned_cols=252 Identities=20% Similarity=0.185 Sum_probs=180.0
Q ss_pred HHHhcCcccCceecccCceEEEEEEEC-CCCeEEEEEEeccCCccch--HHHHHHHHHHhhcC-CCCccceeEEEecCCc
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLE-STNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~ 140 (376)
.....+|..+..||.|.|+.|+.+... .++-.|++|.+...-.... ..-..|+.+...+. |.+++.++..+..-..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567888999999999999988655 6678899998865433322 22345776666665 8888988888777777
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGL 219 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg~ 219 (376)
.|+-.|||.++++..... ....+.+...+.+..|++.++.++|+.. ++|+|++|.||++..+ +..++.|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence 889999999998877663 2455778888999999999999999999 9999999999999876 7789999999
Q ss_pred ccccCCCCcceeecccccccCcc--cccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYC--APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
+..+.. ......+..+++ +++......+..++|++|||..+++.++|...-+.....
T Consensus 414 ~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------------- 472 (524)
T KOG0601|consen 414 WTRLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------------- 472 (524)
T ss_pred ccccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------------
Confidence 863111 111123444455 444444556788999999999999999987654433211
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+.. ......+.. ...+..+...++..++..||.+.++..+..+..
T Consensus 473 ---~~i~~-~~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ---LTIRS-GDTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ---eeeec-ccccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00000 000011111 246666888899999999999999887766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-11 Score=109.86 Aligned_cols=265 Identities=15% Similarity=0.150 Sum_probs=164.3
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh-cCCCCccceeEE----E--ec-CCceEE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL-LHHPNLVNLIGY----C--AD-GDQRLL 143 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~----~--~~-~~~~~l 143 (376)
....-||+|+-+.+|-.-.- ...+.|++.........+. +.+|.. -.||-+-.-+.| . -+ +...-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567999999999965332 2246788876654433332 222322 245543321211 1 11 223567
Q ss_pred EEEccCCCchhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
+|+.++|..--..+..- ...-....|..+++.++.++.|.+.||..| .+-+|+.++|+|+++++.|.|.|=+.-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 88888765322222211 112233678999999999999999999999 999999999999999999999986654
Q ss_pred cccCCCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccc---chhhhhh
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRAAGEH---NLVAWAR 291 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~---~~~~~~~ 291 (376)
... .........+|...|.+||.-. +-.-+...|.|.||+++++||.| ++||.+....... .......
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 432 2333445578999999999765 23456789999999999999997 8999765322110 0001111
Q ss_pred hhhhccc-ccccccCCcCCCCCCH-HHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHhhhc
Q 017175 292 PLFKDRR-KFSQMADPTLQGQYPV-RGLYQALAVAAMCVQE--QPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 292 ~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~--~P~~Rps~~ell~~L~~~~~ 350 (376)
-.|..-. .......+.. ..|. -....+..|..+|+.. ++.-|||++.++..|..+..
T Consensus 242 g~f~ya~~~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 GRFAYASDQRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ceeeechhccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0111000 0011111111 1111 1234566688888876 46789999999999887765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.1e-13 Score=135.22 Aligned_cols=249 Identities=20% Similarity=0.208 Sum_probs=176.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+.+.+.+-+-.|.++.++.+.-..+|...++|.......-. .+....+-.++-..++|.++...-.+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 355677778899999999999888888767777654322111 11222222222223456666555444456678999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
++|+.+++|...++.. ...+..-+...+..+..++++||... +.|||++|.|++...+|+.+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999998763 34566666777888899999999998 9999999999999999999999998432100
Q ss_pred CC--------C---------------------cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 017175 225 VG--------D---------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (376)
Q Consensus 225 ~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 275 (376)
.. . .........||+.|.+||.+.+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 001122356899999999999999999999999999999999999999
Q ss_pred CCcccccccchhhhhhhhhhcccccccccCCcC-CCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 017175 276 DNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL-QGQYPVRGLYQALAVAAMCVQEQPNMRPLIA 339 (376)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 339 (376)
....+... + ..+..... ....+...++...+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~----------f------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI----------F------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh----------h------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 87655321 1 11111111 1123345566888899999999999998877
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-11 Score=98.06 Aligned_cols=131 Identities=24% Similarity=0.300 Sum_probs=102.0
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCcc--c------hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--G------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..+++|+-+.++.+.+. |..+++|.=...... . ...-.+|+.++.++.--.|.-.+-+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46889999999999775 555666643222111 1 1234579999998887777777777778888899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
|++|..|.+.+... ...++..+-..+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888651 2456777888889999999 99999999999998775 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-10 Score=108.22 Aligned_cols=218 Identities=17% Similarity=0.151 Sum_probs=153.8
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec----CCceEEEEEccCC-Cchhh
Q 017175 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPL-GSLED 155 (376)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~~~-~~L~~ 155 (376)
.-.+.|++...-+|..|++|+++............-+.+++++.|.|||++.++|.. +..+++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 346899999999999999999965544444445567889999999999999998863 4568899999885 46766
Q ss_pred hhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 156 HLHDL-----------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 156 ~l~~~-----------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
+.... ...+...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|..+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54332 123455788999999999999999999999 9999999999999999899998888776533
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... . |-+.. -.+-|.=.||.++..|.+|..--...+......
T Consensus 445 ~d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~------------------- 486 (655)
T KOG3741|consen 445 EDP--------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH------------------- 486 (655)
T ss_pred CCC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH-------------------
Confidence 222 0 11111 235688899999999999965322211110000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
........+.++++++.-....++++ -++.+++.+
T Consensus 487 ----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 00111233446666777777777776 567777654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.2e-11 Score=103.53 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=107.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCC--CccceeEEEecCC---ceEEEEEcc
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD---QRLLVYEYM 148 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~~~---~~~lv~e~~ 148 (376)
+.|+.|..+.||++...+ |..+++|....... .....+..|+.+++.+.+. ++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 57899998765432 1345678899999998753 4577777766542 568999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-------------------------------------- 190 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-------------------------------------- 190 (376)
+|.++...+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888776521 34667777778888888888888531
Q ss_pred ---------------CCCeeecCCCCCcEEECC--CCceEEcccccccc
Q 017175 191 ---------------NPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKL 222 (376)
Q Consensus 191 ---------------~~~i~Hrdikp~Nill~~--~~~~kl~Dfg~~~~ 222 (376)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-10 Score=94.29 Aligned_cols=143 Identities=21% Similarity=0.223 Sum_probs=107.3
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
...+|-+|+-+.|+++.+. |+.+.||.=...... ......+|+..|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999887 777778753221111 123456799999988766776666677788888899
Q ss_pred EEccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEcccccc
Q 017175 145 YEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLA 220 (376)
Q Consensus 145 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~Dfg~~ 220 (376)
|||++| .++.+++.... ...........++..|-+.+.-||.++ |+|+||..+||++..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999986 37788776521 222233333788999999999999999 99999999999996554 3589999998
Q ss_pred cc
Q 017175 221 KL 222 (376)
Q Consensus 221 ~~ 222 (376)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=9e-10 Score=92.32 Aligned_cols=124 Identities=21% Similarity=0.174 Sum_probs=80.4
Q ss_pred EEEEEEECCCCeEEEEEEeccCCcc---------------------ch-----HHHHHHHHHHhhcCCC--CccceeEEE
Q 017175 84 RVYKGRLESTNQVVAIKQLDRNGLQ---------------------GN-----REFLVEVLMLSLLHHP--NLVNLIGYC 135 (376)
Q Consensus 84 ~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~~-----~~~~~e~~~l~~l~h~--ni~~~~~~~ 135 (376)
.||.|... .|..+|+|+.+..... .. ....+|+..|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999874 4789999987532100 00 2355799999998865 466666553
Q ss_pred ecCCceEEEEEccC--CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 136 ADGDQRLLVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY-LHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 136 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~-LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
..+|||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||++.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4479999998 6555443322 11134456677788885555 57999 9999999999999988 99
Q ss_pred EEcccccccc
Q 017175 213 KLSDFGLAKL 222 (376)
Q Consensus 213 kl~Dfg~~~~ 222 (376)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.3e-09 Score=95.23 Aligned_cols=140 Identities=16% Similarity=0.091 Sum_probs=99.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccc-----------hHHHHHHHHHHhhcCCCCc--cceeEEEec----
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----------NREFLVEVLMLSLLHHPNL--VNLIGYCAD---- 137 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni--~~~~~~~~~---- 137 (376)
+.+-......|+++... |+.|.||......... ...+.+|+..+..+...+| ..++.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444456666553 7889999774433110 1136788888888764443 344555543
Q ss_pred -CCceEEEEEccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-------
Q 017175 138 -GDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE------- 208 (376)
Q Consensus 138 -~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~------- 208 (376)
....++|||++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23468999999875 7888875321 234566778899999999999999999 999999999999975
Q ss_pred CCceEEccccccc
Q 017175 209 GYHPKLSDFGLAK 221 (376)
Q Consensus 209 ~~~~kl~Dfg~~~ 221 (376)
+..+.|+||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4689999999885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-09 Score=93.23 Aligned_cols=135 Identities=19% Similarity=0.103 Sum_probs=101.3
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc----------------------chHHHHHHHHHHhhcCCC--
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------------------GNREFLVEVLMLSLLHHP-- 126 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~-- 126 (376)
+.+...||-|--|.||.|.+. .|..+|||.-+....+ ......+|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567789999999999999987 4888999975321110 012356799999988755
Q ss_pred CccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 127 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
.+.+.+++ +.-.+||||++|-.|...- ++....-.++..|++-+.-+-..| ++|+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 77777766 3456999999986654432 234445556667777777777888 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 017175 207 GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~ 222 (376)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999977653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=85.35 Aligned_cols=105 Identities=24% Similarity=0.249 Sum_probs=82.6
Q ss_pred HHHHHHHHHHhhcCCCC--ccceeEEEecC----CceEEEEEccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 017175 111 REFLVEVLMLSLLHHPN--LVNLIGYCADG----DQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183 (376)
Q Consensus 111 ~~~~~e~~~l~~l~h~n--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al 183 (376)
....+|...+..|..-+ +...+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 45678888887776433 45556665542 2458999999874 799888652 2256677889999999999
Q ss_pred HHHhhCCCCCeeecCCCCCcEEECCCC---ceEEcccccccc
Q 017175 184 EYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLAKL 222 (376)
Q Consensus 184 ~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~Dfg~~~~ 222 (376)
.-||..| |+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.8e-08 Score=82.02 Aligned_cols=138 Identities=14% Similarity=0.112 Sum_probs=102.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccC---C---ccchHHHHHHHHHHhhcCCCC--ccceeEEEec-----CCceEE
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRN---G---LQGNREFLVEVLMLSLLHHPN--LVNLIGYCAD-----GDQRLL 143 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~---~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~-----~~~~~l 143 (376)
-|.||-|.|+..... |..+-+|.-... . +.....+.+|+..+..|..-+ +.++. ++.. ...-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 477999999997765 446888876411 1 235578999999999886432 44444 3321 123578
Q ss_pred EEEccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc--eEEcccccc
Q 017175 144 VYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~--~kl~Dfg~~ 220 (376)
|+|-+.| .+|.+++... ...+.+......++.+++.++.-||+.| +.|+|+.+.||+++.+|. +.++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997753 4888887542 2235677778899999999999999999 999999999999987777 999999877
Q ss_pred cc
Q 017175 221 KL 222 (376)
Q Consensus 221 ~~ 222 (376)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.1e-09 Score=105.11 Aligned_cols=151 Identities=21% Similarity=0.233 Sum_probs=102.2
Q ss_pred HHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceee-------cccccccCcccccccccC
Q 017175 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS-------TRVMGTYGYCAPEYAMTG 250 (376)
Q Consensus 178 ~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 250 (376)
+++.|+.|+|..-+ +||++|.|++|.++.++..||+.|+.+.....+...... ....-...|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999997654 999999999999999999999999998653332221110 112245689999999998
Q ss_pred CCCcccchhhHHHHHHHHHhCC-CCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHccc
Q 017175 251 QLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQ 329 (376)
Q Consensus 251 ~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 329 (376)
..+.++|++||||++|.+..|. .-+.......... +....+..-.-.+....+.++++=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999544 4443322111111 011111111111223445578888899999
Q ss_pred CCCCCCCCHHHHHHH
Q 017175 330 EQPNMRPLIADVVTA 344 (376)
Q Consensus 330 ~~P~~Rps~~ell~~ 344 (376)
.++..||++.++...
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988887543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-08 Score=96.85 Aligned_cols=140 Identities=17% Similarity=0.127 Sum_probs=90.4
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccch----------------------------------------HHHH
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----------------------------------------REFL 114 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~ 114 (376)
.-|+.++-|.||+|+.+. |+.||||+.+..-.... -++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 668999999999999976 99999998754321100 0133
Q ss_pred HHHHHHhhcC-----CCCccceeEEE-ecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 017175 115 VEVLMLSLLH-----HPNLVNLIGYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188 (376)
Q Consensus 115 ~e~~~l~~l~-----h~ni~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~ 188 (376)
+|...+.++. .++| .+-.++ +-.....|+|||++|..+.+...- ....++...+.....++ -+..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~--f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRA--FLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHH--HHHHHHh
Confidence 4555544442 2332 222333 335677899999999888887422 12334433322222221 1233334
Q ss_pred CCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 189 ~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
.| ++|.|.+|.||+++.+|.+.+.|||+.....
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 67 9999999999999999999999999986533
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=80.54 Aligned_cols=138 Identities=12% Similarity=0.111 Sum_probs=93.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHH---------HHHHHHHHhhcCC---CCccceeE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---------FLVEVLMLSLLHH---PNLVNLIG 133 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~ni~~~~~ 133 (376)
.+..+|...+++-......|.+.... |..+++|..+.......+. ..+.+..+..+.. -....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45578888899988887788776654 7889999886544332222 2234443444432 23333333
Q ss_pred EEe-----cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC
Q 017175 134 YCA-----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (376)
Q Consensus 134 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~ 208 (376)
+.+ .....+++|||++|..|.+... +++ .+...+.+++.-||..| ++|+|++|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 222 2345578999999988876532 222 24456778899999999 999999999999996
Q ss_pred CCceEEccccccc
Q 017175 209 GYHPKLSDFGLAK 221 (376)
Q Consensus 209 ~~~~kl~Dfg~~~ 221 (376)
+ .++++||+..+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 5 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.7e-07 Score=79.42 Aligned_cols=140 Identities=14% Similarity=0.151 Sum_probs=85.0
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccceeEEEecCCceEEEEEccCCCc
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
..||+|..+.||+.. +..+++|...... ......+|..+++.+..-+ +.+.+++..+.+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 468999999999842 4457889876432 2345688999998886433 4677888877778889999999863
Q ss_pred -hhhh---------------------hccCCCCCCCCCHH--HHHHHHH-------HHHH-HHHHHhh-CCCCCeeecCC
Q 017175 153 -LEDH---------------------LHDLPPDKKRLDWT--TRMRIAA-------GAAK-GLEYLHD-KANPPVIYRDL 199 (376)
Q Consensus 153 -L~~~---------------------l~~~~~~~~~~~~~--~~~~i~~-------~i~~-al~~LH~-~~~~~i~Hrdi 199 (376)
+... ++........+... .....+. .+.. ...+|.. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11111111111100 0000000 0011 1122221 11234799999
Q ss_pred CCCcEEECCCCceEEccccccc
Q 017175 200 KCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 200 kp~Nill~~~~~~kl~Dfg~~~ 221 (376)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-09 Score=100.09 Aligned_cols=189 Identities=18% Similarity=0.113 Sum_probs=141.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC-ccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~ 147 (376)
..|...+-.++|+++.+++.+...+...+ .+.+... .....++++|.+++||| .+..++-+..+...++.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 34555666899999999999887665554 6655433 44556899999999999 77777888888899999999
Q ss_pred cCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 148 MPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 148 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
+.++ +....... ....+...+...+.+.-+++++++|+.. =+|+| ||+..+ +..+..||+....+...
T Consensus 316 ~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 9877 22221111 1233444455667777788999999885 58998 777665 68999999998754433
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 277 (376)
. ......+|+.++|||+...+.++...|.|++|+-..+|.-|.+|-..
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 3 33446799999999999999999999999999988888888777654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.5e-07 Score=77.30 Aligned_cols=152 Identities=18% Similarity=0.129 Sum_probs=103.5
Q ss_pred cccCHHHHHHHhcCcccCceec---ccCceEEEEEEECCCCeEEEEEEeccCCccch-----------------------
Q 017175 57 HTFTFRELAAVTKNFRADCLLG---EGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----------------------- 110 (376)
Q Consensus 57 ~~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------- 110 (376)
...+...+..+..+..+....| .|--+.||+|.. .++..+|+|++........
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3456667777888877766655 566779999876 4478899999854321111
Q ss_pred -HHHHHHHHHHhhcC--CCCccceeEEEecCCceEEEEEccCCCc-hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 017175 111 -REFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLGS-LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186 (376)
Q Consensus 111 -~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~L 186 (376)
.....|+.-|+++. +=.+.+.+++. ...|||||+.... -.=.|. ..++...++..+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHH
Confidence 11335677776664 33455556554 3469999985431 111111 12233336778888999999888
Q ss_pred hh-CCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 187 HD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 187 H~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
.. .+ +||+||+.-|||+. ++.+.|+|||-+..
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 77 77 99999999999999 78999999999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-06 Score=76.97 Aligned_cols=143 Identities=22% Similarity=0.228 Sum_probs=82.3
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC--CccceeEEEec---CCceEEEEEccC
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP--NLVNLIGYCAD---GDQRLLVYEYMP 149 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~---~~~~~lv~e~~~ 149 (376)
+.|+.|..+.||++.... ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568999999999998875 47899987544 3446677888888887633 34566654322 334689999999
Q ss_pred CCchhh----------------hh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 017175 150 LGSLED----------------HL---HDLPPDKKRLDWTT---------RMRI------------AAGAAK-GLEYLHD 188 (376)
Q Consensus 150 ~~~L~~----------------~l---~~~~~~~~~~~~~~---------~~~i------------~~~i~~-al~~LH~ 188 (376)
|..+.. .+ +............. .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887777 11 11100111111100 0000 111222 2333332
Q ss_pred ----CCCCCeeecCCCCCcEEEC-CCCceEEccccccc
Q 017175 189 ----KANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK 221 (376)
Q Consensus 189 ----~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~ 221 (376)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1233499999999999999 66677899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-06 Score=70.78 Aligned_cols=130 Identities=20% Similarity=0.180 Sum_probs=94.0
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccc-eeEEEecCCceEEEEEccC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVN-LIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~~~~~~lv~e~~~ 149 (376)
-+..+.|++|.+|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.-.++-+ +|.+..+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 345678999999999999998 5689999765543 3456778999999888665544 4444332 35599999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCC-CCcEEECCCCceEEcccccccc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK-CSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdik-p~Nill~~~~~~kl~Dfg~~~~ 222 (376)
|-.|.+.-.. .+ .+-+..++++..-|-..| |-|..|+ |..+++-.++.+.|+||..+..
T Consensus 96 G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG-------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc-------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8788776532 11 223445667767777888 9999996 6666666666999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-06 Score=74.84 Aligned_cols=140 Identities=21% Similarity=0.197 Sum_probs=84.2
Q ss_pred ecccCc-eEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEccCCCchh
Q 017175 77 LGEGGF-GRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (376)
Q Consensus 77 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 154 (376)
|..|.. +.||++... +..+.+|+..... ...+..|+.+++.+. +--+.+++++....+..++||++++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444555 789998654 4678888875443 334667888888875 444567777777666789999999987776
Q ss_pred hhh-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----C
Q 017175 155 DHL-------------------HDLPPDKKRLDWT--TRMRIAA--------------------GAAKGLEYLHD----K 189 (376)
Q Consensus 155 ~~l-------------------~~~~~~~~~~~~~--~~~~i~~--------------------~i~~al~~LH~----~ 189 (376)
... +.......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111111111100 0000000 01111222211 1
Q ss_pred CCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 190 ~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
..+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999998778899998875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.6e-06 Score=68.64 Aligned_cols=128 Identities=22% Similarity=0.235 Sum_probs=90.9
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCC----------------ccchHHHHHHHHHHhhcC------CCCccce
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----------------LQGNREFLVEVLMLSLLH------HPNLVNL 131 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~ni~~~ 131 (376)
...||+|+.-.||.--+ +...+||+..... .....+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45799999999996432 3446899987655 122345666776666555 7899999
Q ss_pred eEEEecCCceEEEEEccCC------CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEE
Q 017175 132 IGYCADGDQRLLVYEYMPL------GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (376)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nil 205 (376)
+|+.+++...-+|+|.+.. .+|.+++.. ..++. . +...+-+-..||-+++ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999997532 378888843 44555 3 3333445567788888 999999999999
Q ss_pred ECCC--C--ceEEcc
Q 017175 206 LGEG--Y--HPKLSD 216 (376)
Q Consensus 206 l~~~--~--~~kl~D 216 (376)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9422 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-05 Score=83.34 Aligned_cols=149 Identities=17% Similarity=0.250 Sum_probs=91.8
Q ss_pred CceecccCceEEEEEEECCCC--eEEEEEEeccCCc-cchHHHHHHHHHHhhcC-CCCc--cceeEEEecC---CceEEE
Q 017175 74 DCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 144 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--~~~~~~~~~~---~~~~lv 144 (376)
...++.|.+..+|+......+ ..+++|+...... .....+.+|+.+++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 466889999999998765432 4678887654322 23356789999999986 6655 7777777664 457899
Q ss_pred EEccCCCchhhh-----------------------hccCCCC-------CCCCC--HHHHHHHHH---------------
Q 017175 145 YEYMPLGSLEDH-----------------------LHDLPPD-------KKRLD--WTTRMRIAA--------------- 177 (376)
Q Consensus 145 ~e~~~~~~L~~~-----------------------l~~~~~~-------~~~~~--~~~~~~i~~--------------- 177 (376)
|||++|..+.+. ++..... ..+.. ..++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999987643211 1111110 00101 112211111
Q ss_pred HHHHHHHHHhhCCC--------CCeeecCCCCCcEEECC-CCc-eEEcccccccc
Q 017175 178 GAAKGLEYLHDKAN--------PPVIYRDLKCSNILLGE-GYH-PKLSDFGLAKL 222 (376)
Q Consensus 178 ~i~~al~~LH~~~~--------~~i~Hrdikp~Nill~~-~~~-~kl~Dfg~~~~ 222 (376)
.+...+.+|..+-+ ..++|+|+++.||+++. ++. +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566644322 23999999999999975 333 57999998864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.2e-06 Score=69.93 Aligned_cols=103 Identities=27% Similarity=0.308 Sum_probs=80.5
Q ss_pred HHHHHHhhcCC-CCccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 017175 115 VEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193 (376)
Q Consensus 115 ~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~ 193 (376)
.|..+++.+++ +++.+++|+|- .+++.||...+++....... ..-...+|..+.+|+.++++.+.+|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 58888888885 69999999993 35688999766554210000 01123689999999999999999999865455
Q ss_pred eeecCCCCCcEEECCCCceEEcccccccc
Q 017175 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 194 i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+.-.|++|+|+-++++|++|++|.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88999999999999999999999988753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.9e-05 Score=65.30 Aligned_cols=125 Identities=25% Similarity=0.337 Sum_probs=87.4
Q ss_pred cCcccCceecccCc-eEEEEEEECCCCeEEEEEEecc---CCc------------------cchHHHHHHHHHHhhcC--
Q 017175 69 KNFRADCLLGEGGF-GRVYKGRLESTNQVVAIKQLDR---NGL------------------QGNREFLVEVLMLSLLH-- 124 (376)
Q Consensus 69 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~e~~~l~~l~-- 124 (376)
..++.++.||.|.- |.||++... |+.||+|++.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 999999877 78999999321 110 11124667777766664
Q ss_pred -CCCc--cceeEEEecC------------------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 017175 125 -HPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183 (376)
Q Consensus 125 -h~ni--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al 183 (376)
+.++ ++.+||..-. ....||.||.+... .+. ..-+.+|.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHH
Confidence 5566 8888887321 11246667665322 122 22355677778
Q ss_pred HHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 184 ~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
..+|..| |+-+|+++.|.. .=+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999 999999999997 4489999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.4e-05 Score=76.94 Aligned_cols=139 Identities=22% Similarity=0.192 Sum_probs=87.2
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccch--------------------------------H------HHHHH
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--------------------------------R------EFLVE 116 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------~------~~~~e 116 (376)
+.||.-+.|.||+|+.+. |+.||||+-+.. .... + +|.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 679999999999999987 999999975432 1110 0 12233
Q ss_pred HHHHhh----cCCCCc---cceeEEEec-CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 017175 117 VLMLSL----LHHPNL---VNLIGYCAD-GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188 (376)
Q Consensus 117 ~~~l~~----l~h~ni---~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~ 188 (376)
.+-..+ +.|-+. |.+-.++.+ .....|+||||+|..+.+.-.- ....++...+..-+.+.. +.-|=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHHh
Confidence 333222 234441 112223322 4567899999999877765321 234455554443333322 223334
Q ss_pred CCCCCeeecCCCCCcEEECC----CCceEEccccccccc
Q 017175 189 KANPPVIYRDLKCSNILLGE----GYHPKLSDFGLAKLG 223 (376)
Q Consensus 189 ~~~~~i~Hrdikp~Nill~~----~~~~kl~Dfg~~~~~ 223 (376)
.| ++|+|-+|.||++.. ++.+.+.|||+....
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 57 999999999999983 678999999998753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-05 Score=68.60 Aligned_cols=73 Identities=12% Similarity=0.095 Sum_probs=45.4
Q ss_pred ceecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC---CccceeEEEecC---CceEEEEEc
Q 017175 75 CLLGEGGFG-RVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~~~---~~~~lv~e~ 147 (376)
..|+.|+.. .||+.. ..+++|..... .....+.+|+.++..+... -+..+++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457767666 588752 24778865432 1234678899999887632 344445443332 234889999
Q ss_pred cCCCchh
Q 017175 148 MPLGSLE 154 (376)
Q Consensus 148 ~~~~~L~ 154 (376)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=8.6e-06 Score=83.30 Aligned_cols=196 Identities=19% Similarity=0.168 Sum_probs=139.6
Q ss_pred HHHHHHHhhcCCCCccceeEEEecCCce----EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 017175 114 LVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189 (376)
Q Consensus 114 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 189 (376)
..|+..+.+..|+|++.++.+....... .+..++|..-++...+.. ...++....+.+..++.+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3466777788899999999887654332 244578887788877765 56788999999999999999999999
Q ss_pred CCCCeeecCCCCC---cEEECCCCceEEc--ccccccccCCCCcceeecccccccCcccccccccCCCCc--ccchhhHH
Q 017175 190 ANPPVIYRDLKCS---NILLGEGYHPKLS--DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL--KSDVYSFG 262 (376)
Q Consensus 190 ~~~~i~Hrdikp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG 262 (376)
. ..|.-+... +..++..+.+.++ ||+.+......... ....-+..+.++|.......+. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 7 777776665 5556677777777 99988764333321 2233455678888877665554 47999999
Q ss_pred HHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 017175 263 VVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342 (376)
Q Consensus 263 ~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell 342 (376)
..+..+..|..+-..... ...+++... . ....+...+|+.-++++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~~~-------------------~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-------------------PVSLLDVLS----T----SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccccc-------------------hhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhhh
Confidence 999999988765443211 011111111 0 0456788999999999999999999
Q ss_pred HHHH
Q 017175 343 TALT 346 (376)
Q Consensus 343 ~~L~ 346 (376)
.+..
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=8e-05 Score=65.29 Aligned_cols=75 Identities=19% Similarity=0.186 Sum_probs=47.4
Q ss_pred ceecccCceEEEEEEECC-CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEccCCCc
Q 017175 75 CLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
+.|..|-...+|++.... .+..|++|+....... .-...+|+.+++.+...++ .++++.+. . .++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 457778888999987543 3567889977543221 1233468888888864334 44444332 1 37999998876
Q ss_pred hh
Q 017175 153 LE 154 (376)
Q Consensus 153 L~ 154 (376)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 53
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.7e-05 Score=69.94 Aligned_cols=154 Identities=18% Similarity=0.161 Sum_probs=87.3
Q ss_pred HHHHhcCccc-----CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccceeEE--
Q 017175 64 LAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGY-- 134 (376)
Q Consensus 64 ~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~-- 134 (376)
+..+..+|.+ .+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++..
T Consensus 4 l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 4 LASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred HHHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 3344445543 445777877899988654 34688998764 22345666888777775332 4444331
Q ss_pred ----EecCCceEEEEEccCCCchhh----h----------hcc----CCCC---CCCCCHHHHH----------HHHHHH
Q 017175 135 ----CADGDQRLLVYEYMPLGSLED----H----------LHD----LPPD---KKRLDWTTRM----------RIAAGA 179 (376)
Q Consensus 135 ----~~~~~~~~lv~e~~~~~~L~~----~----------l~~----~~~~---~~~~~~~~~~----------~i~~~i 179 (376)
....+..++|+++++|..+.. . ++. .... .....+.... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 223456789999998866432 0 011 0000 0001111100 011122
Q ss_pred HHHHHHHhhC----CCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 180 AKGLEYLHDK----ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 180 ~~al~~LH~~----~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
..++.++... .+..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3344444431 122399999999999999987778999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00015 Score=65.87 Aligned_cols=78 Identities=12% Similarity=0.021 Sum_probs=55.7
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC---CCccceeEEEecC---CceEEEE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH---PNLVNLIGYCADG---DQRLLVY 145 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~---~~~~lv~ 145 (376)
.-.+.||.|..+.||.....+ + .+++|..+. ......+..|...++.+.- -.+.++++++.+. +..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 334679999999999986543 3 466776432 1123567889999988863 3678888877543 5689999
Q ss_pred EccCCCch
Q 017175 146 EYMPLGSL 153 (376)
Q Consensus 146 e~~~~~~L 153 (376)
|+++|.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998755
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=67.33 Aligned_cols=159 Identities=15% Similarity=0.090 Sum_probs=83.7
Q ss_pred cCHHHHHHHhcCccc-----CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccce
Q 017175 59 FTFRELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNL 131 (376)
Q Consensus 59 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~ 131 (376)
.+..++..+...|.+ .+.|+.|....+|..... +..+++|++... ....+..|+.++..|...+ +.++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 445555555566755 244667777789988754 336889987621 2233444555555553212 3333
Q ss_pred eE------EEecCCceEEEEEccCCCchh-----------hhh---ccCCC----C---CCCC-CHHHHHH---------
Q 017175 132 IG------YCADGDQRLLVYEYMPLGSLE-----------DHL---HDLPP----D---KKRL-DWTTRMR--------- 174 (376)
Q Consensus 132 ~~------~~~~~~~~~lv~e~~~~~~L~-----------~~l---~~~~~----~---~~~~-~~~~~~~--------- 174 (376)
+. +....+..+++++|++|..+. ..+ +.... . ...+ .+.....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345678999999886431 111 11000 0 0011 1111111
Q ss_pred ---HHHH-HHHHHHHHhhC----CCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 175 ---IAAG-AAKGLEYLHDK----ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 175 ---i~~~-i~~al~~LH~~----~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
.+.+ +...+..+... -+..+||+|+.|.||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 123499999999999999765568999998863
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00015 Score=64.57 Aligned_cols=139 Identities=14% Similarity=0.025 Sum_probs=78.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEccCCCchhh
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSLED 155 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 155 (376)
+..|-...+|+... ++..+++|........-.-...+|..+++.+...++ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45677789998863 366788987654322211134678888888864433 34444332 368999999866542
Q ss_pred h-----------------hccCCCCCCCCCHH-HHHHHHHH---------HHHHHHHHhhC-----CCCCeeecCCCCCc
Q 017175 156 H-----------------LHDLPPDKKRLDWT-TRMRIAAG---------AAKGLEYLHDK-----ANPPVIYRDLKCSN 203 (376)
Q Consensus 156 ~-----------------l~~~~~~~~~~~~~-~~~~i~~~---------i~~al~~LH~~-----~~~~i~Hrdikp~N 203 (376)
. ++.......+++.. .+..+..+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12221111222221 11111111 11112222111 12248999999999
Q ss_pred EEECCCCceEEcccccccc
Q 017175 204 ILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~ 222 (376)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00025 Score=66.56 Aligned_cols=75 Identities=17% Similarity=0.154 Sum_probs=51.6
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccC----C---ccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEEE
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRN----G---LQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv 144 (376)
+.||.|.+..||++.+...++.++||.-... + .-.......|...|+.+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998754468999985311 1 112345666888887753 2456666665 44667899
Q ss_pred EEccCCC
Q 017175 145 YEYMPLG 151 (376)
Q Consensus 145 ~e~~~~~ 151 (376)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0004 Score=63.54 Aligned_cols=158 Identities=18% Similarity=0.186 Sum_probs=87.9
Q ss_pred CHHHHHHHhcCccc-----CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--cccee
Q 017175 60 TFRELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLI 132 (376)
Q Consensus 60 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~ 132 (376)
+-+++..+..+|.+ .+.++.|....+|++... +..+++|+..... ....+..|+.++..|...+ +.+++
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 34555556556655 345677777899988643 3357889875421 1234556777777764322 34443
Q ss_pred EE------EecCCceEEEEEccCCCchhh-----------h---hcc----CCCCCC---CC-CHHHHH-----------
Q 017175 133 GY------CADGDQRLLVYEYMPLGSLED-----------H---LHD----LPPDKK---RL-DWTTRM----------- 173 (376)
Q Consensus 133 ~~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~----~~~~~~---~~-~~~~~~----------- 173 (376)
.. ....+..+++++|++|..+.. . ++. +..... .+ .|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 32 122456789999998754321 0 111 100000 00 111000
Q ss_pred -HHHHHHHHHHHHHhh----CCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 174 -RIAAGAAKGLEYLHD----KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 174 -~i~~~i~~al~~LH~----~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
.....+..+++++.. ..+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123334555532 112349999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.3e-05 Score=69.97 Aligned_cols=134 Identities=14% Similarity=0.047 Sum_probs=95.3
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-----c------------h-----HHHHHHHHHHhhcCC--C
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----G------------N-----REFLVEVLMLSLLHH--P 126 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~------------~-----~~~~~e~~~l~~l~h--~ 126 (376)
+.+.+.||-|--+.||.+-+.. |.+.++|.-+..... . + -...+|+..|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 6788999999999999998764 788889864321110 0 0 123468888888763 2
Q ss_pred CccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 127 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
-+.+.+++ +.-++|||++.|..|...-+- ...-.+...++.-+.-|-.+| +||+|..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 34555554 355789999988777654321 122334555566677788899 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 017175 207 GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~ 222 (376)
++++.++++||--+..
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999976653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0018 Score=58.88 Aligned_cols=136 Identities=18% Similarity=0.213 Sum_probs=82.6
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEecc--CCccchHHHHHHHHHHhhcCC--CCccceeEEEecCC--ceEEEEEcc
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGD--QRLLVYEYM 148 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~--~~~lv~e~~ 148 (376)
..+..|..-.+|..... ++.++++ ... ..........+|+.+++.+.- --+...++.+.++. ..|.||+|+
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 33433444455555444 7778888 432 222333456678888887652 23444566666655 669999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHH-HHHHHHHHHHhhC--------------------------------------
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIA-AGAAKGLEYLHDK-------------------------------------- 189 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~-~~i~~al~~LH~~-------------------------------------- 189 (376)
.|..+.+..... ... .+++ ..++..|.-||+-
T Consensus 108 eGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 885444433220 000 1111 2444444455542
Q ss_pred ------------C-----CCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 190 ------------A-----NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 190 ------------~-----~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
- .+.++|+|+.+.|++++.++.+-++||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1 14699999999999999999999999999974
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=2.8e-05 Score=81.65 Aligned_cols=159 Identities=14% Similarity=0.009 Sum_probs=116.8
Q ss_pred HHHHHhhcCCCCccceeEEEec--CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--C
Q 017175 116 EVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--N 191 (376)
Q Consensus 116 e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~ 191 (376)
|...++...|+++...+.-... ...-|..++|+.+|.+.+.+.+.......+...-+.....+.+.+..-+|+.. .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4444555678888877665543 33457899999999999998775444455555544444444466666666532 2
Q ss_pred CCeeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhC
Q 017175 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271 (376)
Q Consensus 192 ~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 271 (376)
...+|+++|+.|.++..+-.++++++|+.+. ............+++.|++|++...-.++.++|+|..|+-+|.+..|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKI--knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKI--KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccc--cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 3479999999999999999999999999983 12222233446788899999988888888889999999999999999
Q ss_pred CCCCC
Q 017175 272 RKAID 276 (376)
Q Consensus 272 ~~p~~ 276 (376)
..+|-
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 88774
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0015 Score=59.57 Aligned_cols=142 Identities=23% Similarity=0.245 Sum_probs=81.5
Q ss_pred ceecccCceEEEEEEECC------CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLES------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~ 147 (376)
+.|..|-...+|++.... +++.+++|+..... .......+|+.++..+...++ .+++.++.. .+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345566667899887543 25789999875442 222345678888888764333 345555532 358999
Q ss_pred cCCCchhhh-----------------hccCCCCC--C---CCC--HHHHHH--------------------------HHH
Q 017175 148 MPLGSLEDH-----------------LHDLPPDK--K---RLD--WTTRMR--------------------------IAA 177 (376)
Q Consensus 148 ~~~~~L~~~-----------------l~~~~~~~--~---~~~--~~~~~~--------------------------i~~ 177 (376)
++|..+... ++...... . ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888765431 11111110 0 010 101100 112
Q ss_pred HHHHHHHHHhh------CCCCCeeecCCCCCcEEECCC----CceEEccccccc
Q 017175 178 GAAKGLEYLHD------KANPPVIYRDLKCSNILLGEG----YHPKLSDFGLAK 221 (376)
Q Consensus 178 ~i~~al~~LH~------~~~~~i~Hrdikp~Nill~~~----~~~kl~Dfg~~~ 221 (376)
.+...+.+|-. ..+..++|+|+.+.||+++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233334432 123458999999999999874 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0033 Score=56.63 Aligned_cols=74 Identities=18% Similarity=0.238 Sum_probs=47.5
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEEEEEccC
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
-...|+.|....+|... .+++.+.||+-.. .....+..|..-|+.|. --.+.+++++....+..+|||||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34568889999999877 5578899998752 22345777888888874 3467788988887777899999987
Q ss_pred CC
Q 017175 150 LG 151 (376)
Q Consensus 150 ~~ 151 (376)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0042 Score=56.80 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=91.3
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cch------------------------HHHHHHHHHHhhcCC
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGN------------------------REFLVEVLMLSLLHH 125 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~------------------------~~~~~e~~~l~~l~h 125 (376)
.+-..|..|--+.||.|.... |..+|||+++-.-+ .+. -....|+.-|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567888899999987654 77799998742210 000 113357777777765
Q ss_pred CCccceeEEEecCCceEEEEEccCCCch-hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcE
Q 017175 126 PNLVNLIGYCADGDQRLLVYEYMPLGSL-EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (376)
Q Consensus 126 ~ni~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Ni 204 (376)
..|.-.--+.. ..-.|||+++....- .-.| ....++...+..+-.+++.-+.-|...++ +||.||+--|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 44332211111 234689999842211 1112 23456777788888888888888876554 99999999999
Q ss_pred EECCCCceEEcccccccc
Q 017175 205 LLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 205 ll~~~~~~kl~Dfg~~~~ 222 (376)
|+-+ |.+.|+|.+-+..
T Consensus 297 Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred eEEC-CEEEEEEcccccc
Confidence 9865 5899999988764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.01 Score=54.89 Aligned_cols=73 Identities=16% Similarity=0.143 Sum_probs=46.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEec----cCC---ccchHHHHHHHHHHhhcC--CCC-ccceeEEEecCCceEEEE
Q 017175 76 LLGEGGFGRVYKGRLESTNQVVAIKQLD----RNG---LQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~~---~~~~~~~~~e~~~l~~l~--h~n-i~~~~~~~~~~~~~~lv~ 145 (376)
.||.|....||++.+...++.|+||.-. ..+ .-.......|...|+... .|. +.++| +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 4799999999999986444679999742 111 222344556777776654 353 44443 33455667999
Q ss_pred EccCC
Q 017175 146 EYMPL 150 (376)
Q Consensus 146 e~~~~ 150 (376)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0025 Score=54.88 Aligned_cols=29 Identities=34% Similarity=0.353 Sum_probs=21.1
Q ss_pred CeeecCCCCCcEEE-CCCCceEEccccccc
Q 017175 193 PVIYRDLKCSNILL-GEGYHPKLSDFGLAK 221 (376)
Q Consensus 193 ~i~Hrdikp~Nill-~~~~~~kl~Dfg~~~ 221 (376)
.++|+|+.|.||++ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.011 Score=54.99 Aligned_cols=142 Identities=16% Similarity=0.166 Sum_probs=80.4
Q ss_pred eecccCceEEEEEEECC----CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEccCC
Q 017175 76 LLGEGGFGRVYKGRLES----TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
.|..|-.-.+|++.... .++.|++|+........ -.-.+|..+++.+..-++ .++++.+..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45557778899986532 24678999876543222 223578888888864444 3556665433 57899887
Q ss_pred Cchhhh-----------------hccCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hh-C
Q 017175 151 GSLEDH-----------------LHDLPPDKK--RLDWTTRMRIAAGA-----------------AKGLEYL----HD-K 189 (376)
Q Consensus 151 ~~L~~~-----------------l~~~~~~~~--~~~~~~~~~i~~~i-----------------~~al~~L----H~-~ 189 (376)
.+|... ++....... ...+..+..++.++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 111111111 11122222332211 1112222 11 1
Q ss_pred CCCCeeecCCCCCcEEECC-CCceEEcccccccc
Q 017175 190 ANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKL 222 (376)
Q Consensus 190 ~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~ 222 (376)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999976 46899999988763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.016 Score=54.58 Aligned_cols=73 Identities=16% Similarity=0.101 Sum_probs=48.5
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEecc----CCc---cchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEE
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDR----NGL---QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~---~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~l 143 (376)
.+.||.|....||+..+. +..++||.-.. .+. ........|+..|+.+. -.++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 456899999999998874 45688997541 111 12333445666666554 246777887776 45678
Q ss_pred EEEccCC
Q 017175 144 VYEYMPL 150 (376)
Q Consensus 144 v~e~~~~ 150 (376)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.012 Score=52.89 Aligned_cols=30 Identities=30% Similarity=0.376 Sum_probs=25.5
Q ss_pred CeeecCCCCCcEEECCCCc-eEEcccccccc
Q 017175 193 PVIYRDLKCSNILLGEGYH-PKLSDFGLAKL 222 (376)
Q Consensus 193 ~i~Hrdikp~Nill~~~~~-~kl~Dfg~~~~ 222 (376)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.011 Score=54.20 Aligned_cols=28 Identities=25% Similarity=0.301 Sum_probs=24.9
Q ss_pred CeeecCCCCCcEEECCCCceEEccccccc
Q 017175 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 193 ~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3899999999999988 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.014 Score=54.04 Aligned_cols=142 Identities=15% Similarity=0.185 Sum_probs=78.0
Q ss_pred eecccCceEEEEEEECCC---CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEccCCC
Q 017175 76 LLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLG 151 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~ 151 (376)
.|..|-.-.+|++...+. +..|++|+...... ..-.-.+|..+++.+..-++ .++++++..+ +|.+|++|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 344476778888865432 33788998754332 22223468888888875555 3556555322 588888776
Q ss_pred chhhh-----------------hccCCCCCC--CCCHHHHHHHHHHH----------------------HHHHHH----H
Q 017175 152 SLEDH-----------------LHDLPPDKK--RLDWTTRMRIAAGA----------------------AKGLEY----L 186 (376)
Q Consensus 152 ~L~~~-----------------l~~~~~~~~--~~~~~~~~~i~~~i----------------------~~al~~----L 186 (376)
+|... ++....... .--+..+..+..++ ..-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 55321 111111111 11122222222111 111221 1
Q ss_pred hhC-CCCCeeecCCCCCcEEECC-CCceEEcccccccc
Q 017175 187 HDK-ANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKL 222 (376)
Q Consensus 187 H~~-~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~ 222 (376)
... .+..++|+|+.+.||++++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 1234899999999999974 57899999998863
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0067 Score=55.45 Aligned_cols=73 Identities=21% Similarity=0.143 Sum_probs=56.4
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
..+.|++|++- |+.+.- + ....+.++..++.+.+..++-+...-+ +-|||+...||+|+ +|.|.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEe
Confidence 34556777765 444422 2 224678889999998888888876553 99999999999999 999999999
Q ss_pred ccccc
Q 017175 218 GLAKL 222 (376)
Q Consensus 218 g~~~~ 222 (376)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.015 Score=53.29 Aligned_cols=30 Identities=20% Similarity=0.203 Sum_probs=27.5
Q ss_pred CeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 193 ~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
.+||+|+.++||+++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.025 Score=52.01 Aligned_cols=137 Identities=22% Similarity=0.306 Sum_probs=78.8
Q ss_pred CceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC------ccceeE----EEecCCceEEEEEccCC
Q 017175 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN------LVNLIG----YCADGDQRLLVYEYMPL 150 (376)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~----~~~~~~~~~lv~e~~~~ 150 (376)
.--.+|+....+ ..+++|+.+.. ....++..|+..+..|.-.+ +...-| ......+.+-+++|++|
T Consensus 37 ~eN~~f~~~~~~--g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTED--GRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecC--CCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence 445788887653 33489988665 44456667888777764211 222212 22222367788999998
Q ss_pred Cchhh-hh------------------ccC----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHhhCC----
Q 017175 151 GSLED-HL------------------HDL----PPDKKRLDWTT-------------RMRIAAGAAKGLEYLHDKA---- 190 (376)
Q Consensus 151 ~~L~~-~l------------------~~~----~~~~~~~~~~~-------------~~~i~~~i~~al~~LH~~~---- 190 (376)
..+.. .. ..+ +.......|.. -.....++...+..+.+.-
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 77762 10 011 11111222220 0112334444455444431
Q ss_pred C---CCeeecCCCCCcEEECCCCc-eEEccccccc
Q 017175 191 N---PPVIYRDLKCSNILLGEGYH-PKLSDFGLAK 221 (376)
Q Consensus 191 ~---~~i~Hrdikp~Nill~~~~~-~kl~Dfg~~~ 221 (376)
+ ..+||+|+.|.||+++.+.. +.++|||-+.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 22899999999999999885 8899999886
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.019 Score=53.82 Aligned_cols=75 Identities=20% Similarity=0.174 Sum_probs=48.2
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEecc---CC---ccchHHHHHHHHHHhhcC--CCC-ccceeEEEecCCceEEE
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NG---LQGNREFLVEVLMLSLLH--HPN-LVNLIGYCADGDQRLLV 144 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~---~~~~~~~~~e~~~l~~l~--h~n-i~~~~~~~~~~~~~~lv 144 (376)
.+.||.|.-..||++.+...+..|+||.-.. .+ .-......-|...|+.+. .|. +.++| +.+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 4578999999999999854356789996421 11 122345566888887664 454 44444 3345566788
Q ss_pred EEccCC
Q 017175 145 YEYMPL 150 (376)
Q Consensus 145 ~e~~~~ 150 (376)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0043 Score=59.11 Aligned_cols=50 Identities=26% Similarity=0.347 Sum_probs=39.8
Q ss_pred chHHHHHHHHHHhhcCCCCccceeEEEecC-CceEEEEEccCCCchhhhhcc
Q 017175 109 GNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYEYMPLGSLEDHLHD 159 (376)
Q Consensus 109 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 159 (376)
...++.-...+++.+.|+|...++++.... ....+|||++ +.+|.+.+..
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345677788999999999999999887653 3477899999 4799988754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.067 Score=45.97 Aligned_cols=74 Identities=26% Similarity=0.327 Sum_probs=48.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEEEEEccCCCc
Q 017175 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~~~ 152 (376)
.+.-|..-..|...+- ..++.+|.-... ....+..|+.-|..|. .-.+.+++.+..+..+.|+||||++.+.
T Consensus 23 ~v~gG~inea~~v~dg--~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 23 EVSGGDINEAWRLRDG--TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccCCccccceeEeecC--CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444444332 456888854322 2345666777666664 4568888999999999999999998765
Q ss_pred hh
Q 017175 153 LE 154 (376)
Q Consensus 153 L~ 154 (376)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.026 Score=48.13 Aligned_cols=118 Identities=13% Similarity=0.084 Sum_probs=72.5
Q ss_pred cCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCCCchhhhhc
Q 017175 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158 (376)
Q Consensus 80 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 158 (376)
|+.++.-.+..+- | +..+|+++.-... ...-+..++.++.+++ .|+++..= +...+-++.|+|.-...
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 4444444444332 2 3456777654443 3345667888887653 56666622 34456688998842111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 159 DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 159 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
. -..++.-=+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|-+...
T Consensus 142 ---------~---~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll 191 (308)
T PF07387_consen 142 ---------N---FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL 191 (308)
T ss_pred ---------c---hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh
Confidence 0 0112222246788889432 129999999999999999999999987653
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.1 Score=49.17 Aligned_cols=75 Identities=19% Similarity=0.200 Sum_probs=44.0
Q ss_pred ceecccCceEEEEEEECCCC-eE-----EEEEEeccCCccchHHHHHHHHHHhhcCCCCcc-ceeEEEecCCceEEEEEc
Q 017175 75 CLLGEGGFGRVYKGRLESTN-QV-----VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~-~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e~ 147 (376)
+.|..|-...+|++...... .. |.++... ......-.-.+|+.+++.+...++. ++++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 44555878899998754321 22 4444322 1111111234689999988765554 45555542 589999
Q ss_pred cCCCchh
Q 017175 148 MPLGSLE 154 (376)
Q Consensus 148 ~~~~~L~ 154 (376)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.12 Score=49.68 Aligned_cols=76 Identities=9% Similarity=0.059 Sum_probs=45.3
Q ss_pred CceecccCceEEEEEEECCC--------CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCcc-ceeEEEecCCceEEE
Q 017175 74 DCLLGEGGFGRVYKGRLEST--------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLV 144 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv 144 (376)
.+.|..|-.-.+|++..... ++.|.+++.-..... .-.-..|..+++.+...+|- ++++.+. -+.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~-lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE-LYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc-eeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 34455666678888875421 467888887543222 11334578777777654444 4555543 2467
Q ss_pred EEccCCCchh
Q 017175 145 YEYMPLGSLE 154 (376)
Q Consensus 145 ~e~~~~~~L~ 154 (376)
.+|++|.+|.
T Consensus 185 ~efi~g~~l~ 194 (442)
T PTZ00296 185 EEWLYGDPLR 194 (442)
T ss_pred EEeeCCccCC
Confidence 8999876443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.51 Score=43.55 Aligned_cols=92 Identities=16% Similarity=0.088 Sum_probs=50.2
Q ss_pred ccCHHHHHHHhcCcccC-----ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccc
Q 017175 58 TFTFRELAAVTKNFRAD-----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVN 130 (376)
Q Consensus 58 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~ 130 (376)
..+-..+..+...+-+. ..| .+.-..||...... +..+++|+.+.. ......+..|+..+..|.... ++.
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~~-~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDED-GRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecCC-CCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 34444455555554332 122 23445789886543 567889987533 234456667887777664211 222
Q ss_pred ee---E--EEecCCceEEEEEccCCCc
Q 017175 131 LI---G--YCADGDQRLLVYEYMPLGS 152 (376)
Q Consensus 131 ~~---~--~~~~~~~~~lv~e~~~~~~ 152 (376)
.. | ....++..+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1 1223456778999987754
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.3 Score=44.27 Aligned_cols=31 Identities=29% Similarity=0.253 Sum_probs=25.4
Q ss_pred CCeeecCCCCCcEEECCC--C---ceEEcccccccc
Q 017175 192 PPVIYRDLKCSNILLGEG--Y---HPKLSDFGLAKL 222 (376)
Q Consensus 192 ~~i~Hrdikp~Nill~~~--~---~~kl~Dfg~~~~ 222 (376)
..++|+|++..|||+..+ | .++++||-+++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 459999999999999654 3 689999988763
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 376 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-44 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-22 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-22 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 532 bits (1372), Expect = 0.0
Identities = 115/303 (37%), Positives = 163/303 (53%), Gaps = 20/303 (6%)
Query: 57 HTFTFRELAAVTKNFRADC------LLGEGGFGRVYKGRLESTNQVVAIKQL----DRNG 106
H+F+F EL VT NF +GEGGFG VYKG + N VA+K+L D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITT 70
Query: 107 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ ++F E+ +++ H NLV L+G+ +DGD LVY YMP GSL D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPP 129
Query: 167 LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226
L W R +IA GAA G+ +LH+ I+RD+K +NILL E + K+SDFGLA+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
+T +++R++GT Y APE + G++T KSD+YSFGVVLLEIITG A+D R L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 243
Query: 287 VAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346
+ + + + D + + +VA+ C+ E+ N RP I V L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 347 YLA 349
+
Sbjct: 303 EMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 116/305 (38%), Positives = 162/305 (53%), Gaps = 5/305 (1%)
Query: 43 KEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL 102
+A ++ +L T NF L+G G FG+VYKG L VA+K+
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRR 71
Query: 103 DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP 162
QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+L+ HL+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 163 DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222
+ W R+ I GAA+GL YLH +I+RD+K NILL E + PK++DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282
G D+TH+ST V GT GY PEY + G+LT KSDVYSFGVVL E++ R AI +
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
NL WA + Q+ DP L + L + A C+ RP + DV+
Sbjct: 249 MVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 343 TALTY 347
L Y
Sbjct: 308 WKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 513 bits (1323), Expect = 0.0
Identities = 131/312 (41%), Positives = 182/312 (58%), Gaps = 6/312 (1%)
Query: 56 AHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-REFL 114
F+ REL + NF +LG GGFG+VYKGRL +VA+K+L QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
EV M+S+ H NL+ L G+C +RLLVY YM GS+ L + P + LDW R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IA G+A+GL YLHD +P +I+RD+K +NILL E + + DFGLAKL D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH--NLVAWARP 292
V GT G+ APEY TG+ + K+DV+ +GV+LLE+ITG++A D R A + L+ W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352
L K+++ + D LQG Y + Q + VA +C Q P RP +++VV L +
Sbjct: 255 LLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313
Query: 353 YDPESQPVQSSR 364
E Q + R
Sbjct: 314 RWEEWQKEEMFR 325
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 8e-89
Identities = 73/312 (23%), Positives = 110/312 (35%), Gaps = 29/312 (9%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL 118
L + + + G FG V+K +L N+ VA+K Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 119 MLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
L + H N++ IG G L+ + GSL D L + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 175 IAAGAAKGLEYLH-------DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
IA A+GL YLH D P + +RD+K N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 228 KTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282
+ +GT Y APE L+ D+Y+ G+VL E+ + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 283 EHNLVA--WARPLFKDRRKF--SQMADPTLQGQYPVRGLYQALA-VAAMCVQEQPNMRPL 337
P +D ++ + P L+ + L C R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 338 IADVVTALTYLA 349
V +T +
Sbjct: 306 AGCVGERITQMQ 317
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-70
Identities = 85/295 (28%), Positives = 134/295 (45%), Gaps = 57/295 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNLV 129
+G+GGFG V+KGRL VVAIK L +G +EF EV ++S L+HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
L G + +V E++P G L L D + W+ ++R+ A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 190 ANPPVIYRDLKCSNILLGEG-----YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
NPP+++RDL+ NI L K++DFGL++ H + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 245 EYAMTGQL---TLKSDVYSFGVVLLEIITGRK--------AIDNTRAAGEHNLVAWARPL 293
E + + T K+D YSF ++L I+TG I E L RP
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RP- 249
Query: 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
+ P +R + + +C P RP + +V L+ L
Sbjct: 250 -----TIPEDCPP------RLRNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-70
Identities = 92/342 (26%), Positives = 143/342 (41%), Gaps = 53/342 (15%)
Query: 15 KKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRAD 74
K HH+ P + +T ++ + + DG I +E
Sbjct: 2 KHHHHHHP-------MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK---------- 44
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLI 132
+G G FG V++ VA+K L EFL EV ++ L HPN+V +
Sbjct: 45 --IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G +V EY+ GSL LH +++LD R+ +A AKG+ YLH++ NP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
P+++R+LK N+L+ + Y K+ DFGL++L + S GT + APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPS 216
Query: 253 TLKSDVYSFGVVLLEIITGR---KAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309
KSDVYSFGV+L E+ T + ++ + V FK +R +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VG-----FKCKR-------LEIP 261
Query: 310 GQYP--VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
V + + C +P RP A ++ L L
Sbjct: 262 RNLNPQVAAIIE------GCWTNEPWKRPSFATIMDLLRPLI 297
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-69
Identities = 72/339 (21%), Positives = 121/339 (35%), Gaps = 45/339 (13%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VE 116
E + N + L+G G +G VYKG L+ + VA+K + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 117 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT 171
+ + L+ H N+ I + LLV EY P GSL +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 172 RMRIAAGAAKGLEYLH------DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---- 221
R+A +GL YLH D P + +RDL N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 222 --LGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVLLEIITGR 272
L G++ + + +GT Y APE + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 273 KAIDNTRAAGEHNL----VAWARPLFKDRRKF--SQMADPTLQGQYPVRGLYQALAVAAM 326
+ + E+ + P F+D + + P + L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 327 --CVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSS 363
C + R + L ++ ++
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM-MIWERNKSVSPTA 330
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-68
Identities = 87/300 (29%), Positives = 130/300 (43%), Gaps = 39/300 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V K + + VAIKQ++ + + F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV EY GSL + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 197 RDLKCSNILLGEGY-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDLK N+LL G K+ DFG A D T G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 256 SDVYSFGVVLLEIITGR---KAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312
DV+S+G++L E+IT R I + WA + R P L
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWA--VHNGTR-------PPLIKNL 229
Query: 313 P--VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRTGSSTP 370
P + L C + P+ RP + ++V +T+L + + +P+Q S P
Sbjct: 230 PKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLM-RYFPGADEPLQYPCQHSLPP 282
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 45/284 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G GGFG+VY+ VA+K D + Q E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C LV E+ G L L KR+ + A A+G+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 193 PVIYRDLKCSNILLGEGYHP--------KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
P+I+RDLK SNIL+ + K++DFGLA+ +T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR---KAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
E + SDV+S+GV+L E++TG + ID A VA
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---GVA-----MNKLA--- 232
Query: 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+ P + + C P+ RP +++ L
Sbjct: 233 ----LPIPSTCP-EPFAK---LMEDCWNPDPHSRPSFTNILDQL 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-65
Identities = 76/310 (24%), Positives = 116/310 (37%), Gaps = 36/310 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+ K T +V+ +K+L R + R FL EV ++ L HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + EY+ G+L + + W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL------------GPVGDKTHVSTRVMGTYGYCAP 244
RDL N L+ E + ++DFGLA+L V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304
E K DV+SFG+VL EII A + + + + ++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD----YLPRTMDFGLNVRGFLDRYCPPN 247
Query: 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA---CQKYDPESQPVQ 361
P + + C P RP + L L Q Q
Sbjct: 248 CPP--------SFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296
Query: 362 SSRTGSSTPR 371
R T R
Sbjct: 297 LDRGFWETYR 306
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-65
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
L E G ++KGR + + +K L R+F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 135 CADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
C + +MP GSL + LH+ +D + ++ A A+G+ +LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ- 251
+ L ++++ E ++S + + S M + APE A+ +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 252 ---LTLKSDVYSFGVVLLEIITGR 272
+D++SF V+L E++T
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 61/308 (19%), Positives = 105/308 (34%), Gaps = 51/308 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG+VY GR + VAI+ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C ++ +L + D K LD +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++DLK N+ G ++DFGL + G + G + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 252 L---------TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-----RPLFKDR 297
+ SDV++ G + E+ A + W +P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNL--- 263
Query: 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357
+ + + C + RP ++ L L ++ S
Sbjct: 264 --------SQIGMGKEISDILLF------CWAFEQEERPTFTKLMDMLEKLP-KRNRRLS 308
Query: 358 QPVQSSRT 365
P ++
Sbjct: 309 HPGHFWKS 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-62
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG VYKG+ + VA+K L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
Q +V ++ SL HLH + + + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---YAMTGQ 251
I+RDLK +NI L E K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
+ +SDVY+FG+VL E++TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-58
Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 33/297 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G +G V+ G+ + VA+K + E+ L+ H N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
G Q L+ +Y GSL D+L LD + +++A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA +GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 243 APE------YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA-AGEHNLVAWARPLFK 295
PE Q + +D+YSFG++L E+ + ++ + + P ++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 296 DRRKF--SQMADPTLQGQYPVRGLYQALA-VAAMCVQEQPNMRPLIADVVTALTYLA 349
D R+ + P+ ++ + + + C P R V L ++
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G +G V++G + + VA+K + + + E+ +L H N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
Q L+ Y +GSL D+L LD + +RI A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV--STRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA + + +GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 243 APE------YAMTGQLTLKSDVYSFGVVLLEIITG 271
APE + D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-55
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G FG V++G+ + VA+K + R + E+ +L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
+ Q LV +Y GSL D+L+ + + +++A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA T +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 243 APEYAMTGQL-------TLKSDVYSFGVVLLEIITG 271
APE + + ++D+Y+ G+V EI
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G G FG V+ GRL + N +VA+K + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+V E + G L + RL T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RDL N L+ E K+SDFG+++ G + APE G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 256 SDVYSFGVVLLEIIT 270
SDV+SFG++L E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-49
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C +R L+ EY+P GSL D+L K+R+D ++ + KG+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
I+RDL NIL+ K+ DFGL K+ P + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-49
Identities = 71/205 (34%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VA+KQL +G R+F E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G ++ LV EY+P G L D L + RLD + + ++ KG+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
++RDL NIL+ H K++DFGLAKL P+ +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ +SDV+SFGVVL E+ T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-48
Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C +R L+ EY+P GSL D+L K+R+D ++ + KG+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
I+RDL NIL+ K+ DFGL K+ P + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-48
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C L+ + MP G L D++ + K + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V + T ++VA+K L G Q + E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C D LV EY+PLGSL D+L + + + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 244
I+RDL N+LL K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E + SDV+SFGV L E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V R ++T + VA+K L +G + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C + L+ E++P GSL+++L +K +++ +++ A KG++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 244
++RDL N+L+ + K+ DFGL K + + + AP
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E M + + SDV+SFGV L E++T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG V+KG ES V IK + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C G LV +Y+PLGSL DH+ + L + AKG+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++R+L N+LL +++DFG+A L P DK + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C L+ + MP G L D++ + K + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
R+L N L+GE + K++DFGL++L GD + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 257 DVYSFGVVLLEIIT 270
DV++FGV+L EI T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 66/207 (31%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG+G FG V +G VA+K L + + +F+ EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G +V E PLGSL D L + T R A A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 247
I+RDL N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK 273
T + SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-45
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V+ G + ++V AIK + R G +F+ E ++ L HP LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV E+M G L D+L + T + + +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE K+SDFG+ + V D + T GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 254 LKSDVYSFGVVLLEIIT-GRK 273
KSDV+SFGV++ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE + K++DFGL++L + T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV++FGV+L EI T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-44
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLV 129
D LG G FG V +G + VAIK L + G + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
LIG C + +LV E G L L ++ + + + + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 243
++RDL N+LL ++ K+SDFGL+K D + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
PE + + +SDV+S+GV + E ++ G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-44
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 17/236 (7%)
Query: 44 EASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD 103
+ ++ D I ++ + + D +G G F VYKG T VA +L
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 104 RNGLQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYMPLGSLEDHL 157
L + + F E ML L HPN+V G + +++ E M G+L+ +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 158 HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSD 216
K + KGL++LH + PP+I+RDLKC NI + G K+ D
Sbjct: 121 KRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GLA L + + V+GT + APE + DVY+FG+ +LE+ T
Sbjct: 176 LGLATLK----RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-44
Identities = 66/294 (22%), Positives = 107/294 (36%), Gaps = 46/294 (15%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K++ LGEGGF V A+K++ + Q E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 129 VNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ L+ YC L+ + G+L + + L L + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-------G 237
+H +RDLK +NILLG+ P L D G + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 238 TYGYCAPE------YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291
T Y APE + + + ++DV+S G VL ++ G D G+ +A
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--- 259
Query: 292 PLFKDRRKFSQMADPTLQGQY--PVRGLY--QALAVAAMCVQEQPNMRPLIADV 341
+Q Q P + + + P+ RP I +
Sbjct: 260 ----------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG + V VA+K L + N E L E ++ L +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L +L + + + + + G++YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 246
++RDL N+LL ++ K+SDFGL+K + + + + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ + KSDV+SFGV++ E + G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + VAIK ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL------HDLPPDKKRLDWTTRMRIAAGAAKGLE 184
L+G + G L++ E M G L+ +L P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV------MGT 238
YL+ ++RDL N ++ E + K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+PE G T SDV+SFGVVL EI T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ +VA+K L L ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAGA 179
G C DGD ++V+EYM G L L K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV---- 235
A G+ YL + ++RDL N L+G K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 236 --MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M PE M + T +SDV+SFGV+L EI T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ + V A+K + + G EF E + L HP LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EY+ G L ++L K L+ + + + +G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ K+SDFG+ + V D + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 254 LKSDVYSFGVVLLEIIT-GRK 273
KSDV++FG+++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-43
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ V AIK + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ EYM G L ++L + + R + + + +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ + K+SDFGL++ V D + T +G+ + PE M + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 254 LKSDVYSFGVVLLEIIT 270
KSD+++FGV++ EI +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-43
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL-----------HDLPPDKKRLDWTTRMRIAAGAA 180
G C +G L+V+EYM G L L L + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----- 235
G+ YL ++RDL N L+G+G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 236 -MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M PE + + T +SDV+SFGVVL EI T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 77 LGEGGFGRVYKGRLESTNQV-------VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG+G F +++KG V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C GD+ +LV E++ GSL+ +L +K ++ ++ +A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 190 ANPPVIYRDLKCSNILL--------GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
+I+ ++ NILL G KLSD G++ V+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 242 ------CAPEYAMTGQL-TLKSDVYSFGVVLLEIIT-GRK 273
PE + L +D +SFG L EI + G K
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-43
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VY+G + VA+K ++ N+ +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + + ++ E P G L +L +K L T + + K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 246
++RD+ NIL+ KL DFGL++ + D+ + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+ F V + EI++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-43
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
+G G G V GRL + VAIK L + R +FL E ++ HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G G ++V EYM GSL+ L + + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMT 249
++RDL N+L+ K+SDFGL+++ + D + G + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GRK 273
+ SDV+SFGVV+ E++ G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LGE FG+VYKG L Q VAIK L D+ EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAG 178
L+G +++ Y G L + L D K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV- 235
A G+EYL V+++DL N+L+ + + K+SD GL + D K ++ +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 236 ---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M APE M G+ ++ SD++S+GVVL E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 251
+RDL N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 252 LTLKSDVYSFGVVLLEIIT 270
+ KSDV+SFG++L EI +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG V+ G T +V AIK L + G FL E ++ L H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL+ +NIL+GE K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQV----VAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNL 131
+G G FG VYKG L++++ VAIK L + R +FL E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G + +++ EYM G+L+ L + + + G A G++YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAM 248
++RDL NIL+ K+SDFGL+++ + D + G + APE
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 249 TGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+SFG+V+ E++T G +
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
+G G FG V GRL VAIK L + R +FL E ++ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G ++V EYM GSL+ L + + + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMT 249
++RDL NIL+ K+SDFGL ++ + D + G + +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+S+G+VL E+++ G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG VY G L + A+K L+R + +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + L+V YM G L + + + + + AKG++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G+G FG VY G AIK L R +Q FL E L++ L+HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G + ++ YM G L + ++ + A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V T A E
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + +N + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 251
+RDL N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
+ KSDV+SFG++L EI + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG V +G L + T+ VA+K + D + + EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 132 IGYCADGDQR-----LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+G C + + +++ +M G L +L L K + T ++ A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV----MGT 238
YL ++ ++RDL N +L + ++DFGL+K GD + ++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T KSDV++FGV + EI T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-42
Identities = 70/215 (32%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLVNL 131
++GEG FG+V K R+ + AIK++ + +R+F E+ ++ L HHPN++NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAGA 179
+G C L EY P G+L D L L + AA
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV---- 235
A+G++YL K I+RDL NIL+GE Y K++DFGL++ V K R+
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRW 207
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M A E T SDV+S+GV+L EI++
Sbjct: 208 M------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNL 131
LG+G FG V + +L + + VA+K L + + + EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 132 IGYCADGDQR------LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGL 183
+G + +++ +M G L L + + L T +R A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV----MG 237
EYL + I+RDL N +L E ++DFGL++ GD + ++++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T+ SDV++FGV + EI+T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQV--VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
D LG G FG V +G + VAIK L E + E ++ L +P +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
LIG C + +LV E G L L ++ + + + + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 247
++R+L N+LL ++ K+SDFGL+K D + + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECI 511
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ + +SDV+S+GV + E ++ G+K
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G +V A+K L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L P +L + +AA A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL+ +NIL+ + K++DFGLA+L + D + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV+SFG++L EI+T
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G++ + + VA+K L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLH 187
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ I+RD+ N LL G G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E M G T K+D +SFGV+L EI +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG V+ G T +V AIK L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL+ +NIL+GE K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG VY G L + A+K L+R + +FL E +++ HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + L+V YM G L + + + + + AKG+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V + A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-41
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNL 131
+GEG FG V++G S VAIK +N +FL E L + HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + ++ E LG L L K LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPE 245
++RD+ N+L+ KL DFGL++ + D T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+ FGV + EI+ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 64/329 (19%), Positives = 111/329 (33%), Gaps = 33/329 (10%)
Query: 16 KKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADC 75
HH+ +D ++ + + + R + ++F+
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS 63
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEV-LMLSLLHHPNLVNLI 132
LG G +G V+K R + ++ A+K+ G + L EV + HP V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+G L E SL+ H L L +LH +
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++ D+K +NI LG KL DFGL +G + G Y APE + G
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE-LLQGSY 232
Query: 253 TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312
+DV+S G+ +LE+ L + Q+ L ++
Sbjct: 233 GTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQLRQGYLPPEF 273
Query: 313 PVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+ +V M ++ P +R +
Sbjct: 274 TAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ +V A+K + + G FL E ++ L H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ E+M GSL D L + + + +A A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL+ +NIL+ K++DFGLA++ + D + T G + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFT 363
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV+SFG++L+EI+T
Sbjct: 364 IKSDVWSFGILLMEIVT 380
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V VA+K L D + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L ++++ + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A+G+EYL + I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV++ EI T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G++ + + VA+K L + Q +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLH 187
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY--- 241
+ I+RD+ N LL G G K+ DFG+A+ D G
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 242 --CAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE M G T K+D +SFGV+L EI +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-40
Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLI 132
LG+G FG VY R + + ++A+K L + L+ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
GY D + L+ EY PLG++ L + D A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VI+RD+K N+LLG K++DFG + P + GT Y PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPEMIEGRMH 184
Query: 253 TLKSDVYSFGVVLLEIITGR 272
K D++S GV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V VA+K L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L ++++ + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A+G+EYL + I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV++ EI T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG FG V++G S VAIK + +FL E L + HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + ++ E LG L L K LD + + A + L YL K
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPEYA 247
++RD+ N+L+ KL DFGL++ + D T+ G + APE
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKWMAPESI 564
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ T SDV+ FGV + EI+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
+GEG FGRV++ R +VA+K L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPDKKRLDWT 170
L+G CA G L++EYM G L + L P L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
++ IA A G+ YL ++ ++RDL N L+GE K++DFGL++ D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ + M PE + T +SDV+++GVVL EI +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LGEG FG+V K + VA+K L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPDKKRLDWT 170
L G C+ LL+ EY GSL L PD++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
+ A ++G++YL + +++RDL NIL+ EG K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M A E T +SDV+SFGV+L EI+T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEV-LMLSLLHHPNLV 129
LG G FG+V + VA+K L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--------------HDLPPDKKRLDWTTRMRI 175
NL+G C G L++ EY G L + L + D+ LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-- 233
+ AKG+ +L K I+RDL NILL G K+ DFGLA+ V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 234 ----RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ M APE T +SDV+S+G+ L E+ +
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + E VA+K L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR----------MRIAAGA 179
NL+G C G L++ EY G L + L + + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G+ +L K I+RD+ N+LL G+ K+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 240 GYC------------APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
Y APE T++SDV+S+G++L EI +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 9e-39
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G G +GR K R +S +++ K+LD + + ++ LV EV +L L HPN+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 134 YCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D L V EY G L + +++ LD +R+ L+ H +++
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 192 PP--VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
V++RDLK +N+ L + KL DFGLA++ + T + +GT Y +PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 250 GQLTLKSDVYSFGVVLLEIITGRKA 274
KSD++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + +T + VA+K L + +R + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 NLIGYCADGDQ-RLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIA 176
NL+G C +++ E+ G+L +L K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTR 234
AKG+E+L + I+RDL NILL E K+ DFGLA+ R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 235 V----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ M APE T++SDV+SFGV+L EI +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 53/306 (17%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+F+ L+G GGFG+V+K + + IK++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 129 VNLIGYCADGDQRL----------------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
V+ G D + E+ G+LE + ++LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ + KG++Y+H K +I RDLK SNI L + K+ DFGL
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292
TR GT Y +PE + + D+Y+ G++L E++
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDT 220
Query: 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352
F+ + F+ + D + + + + + ++P RP +++ L L K
Sbjct: 221 AFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI---LRTLTVWK 273
Query: 353 YDPESQ 358
PE
Sbjct: 274 KSPEKN 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 30/273 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
+G G F VY+ VA+K++ L + + E+ +L L+HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ ++ +V E G L + K+ + T + LE++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 253 TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQY 312
KSD++S G +L E+ + P + D+ + Q Y
Sbjct: 214 NFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKKIEQCDY 255
Query: 313 P--VRGLY-QAL-AVAAMCVQEQPNMRPLIADV 341
P Y + L + MC+ P RP + V
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 46/220 (20%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----------------EVLM 119
L +G F ++ N+ A+K+ +++ L+ R+F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL----PPDKKRLDWTTRMRI 175
++ + + + G + D+ ++YEYM S+ + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
Y+H++ N + +RD+K SNIL+ + KLSDFG ++ K S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS--- 210
Query: 236 MGTYGYCAPEYAMTGQLT---LKSDVYSFGVVLLEIITGR 272
GTY + PE + + + K D++S G+ L +
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-38
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLI 132
LG+G FG VY R + ++A+K L ++ L+ + E+ + S L HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
Y D + L+ E+ P G L L R D A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VI+RD+K N+L+G K++DFG + P + GT Y PE
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 253 TLKSDVYSFGVVLLEIITGR 272
K D++ GV+ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-38
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V + VA+K L + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L + +++L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A A+G+EYL K I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV+L EI T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G FG+V K R ++ AIK++ + L EV++L+ L+H +V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 136 ADGDQRL-------------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ + + EY G+L D +H + R+ +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEA 128
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL-------------GPVGDKT 229
L Y+H + +I+RDLK NI + E + K+ DFGLAK G
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 230 HVSTRVMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVLLEIITG 271
++++ + GT Y A E TG K D+YS G++ E+I
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 25/219 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +G GG +V++ Q+ AIK ++ + E+ L+ L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 127 NL--VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + L Y +V E L L KK +D R + +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 141
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+H +++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 245 E-----------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
E +++ KSDV+S G +L + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 54/273 (19%), Positives = 98/273 (35%), Gaps = 27/273 (9%)
Query: 17 KHHNKPIDQIP--STSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRAD 74
HH+ +P S ++ ++ G D A + ++ + +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNL--VN 130
+G GG +V++ Q+ AIK ++ + E+ L+ L + +
Sbjct: 62 KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L Y +V E L L KK +D R + + +H
Sbjct: 121 LYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE----- 245
+++ DLK +N L+ +G KL DFG+A + V +G Y PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 246 ------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+++ KSDV+S G +L + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + VA+K L ++ + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL-------------------HDLPPDKKRLDWT 170
NL+G C L++EY G L ++L + D L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
+ A AKG+E+L K+ ++RDL N+L+ G K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ R+ M APE G T+KSDV+S+G++L EI +
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
LG GG VY N VAIK + + E L EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
I + D LV EY+ +L +++ L T + G+++ HD
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTG 250
+++RD+K NIL+ K+ DFG+AK + + + T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
+D+YS G+VL E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 25/219 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +G GG +V++ Q+ AIK ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 127 NL--VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + L Y +V E L L KK +D R + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+H +++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 245 E-----------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
E +++ KSDV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+GEG FG+ + + IK+++ + + RE EV +L+ + HPN+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ +V +Y G L ++ + L+++HD+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK--- 145
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+++RD+K NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 254 LKSDVYSFGVVLLEIITGRKA 274
KSD+++ G VL E+ T + A
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-36
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G G FG V++ + + T A+K++ + E++ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+G + E + GS L L L + A +GLEYLH + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 196 YRDLKCSNILLG-EGYHPKLSDFGLAK-LGPVGDKTHVSTR--VMGTYGYCAPEYAMTGQ 251
+ D+K N+LL +G L DFG A L P G + T + GT + APE M
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
K D++S ++L ++ G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-36
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGY 134
LG GGFG V++ + + + AIK++ + RE + EV L+ L HP +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 135 CADGD---------QRLLVY---EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ + ++ +Y + +L+D ++ + + + + I A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEA 130
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL----------GPVGDKTHVS 232
+E+LH K +++RDLK SNI K+ DFGL
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T +GT Y +PE + K D++S G++L E++
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
+ + LG+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
++V G+ D D +V E SL + +K L R G +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQ 129
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y A
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 183
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE + + DV+S G ++ ++ G+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
+ + LG+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
++V G+ D D +V E SL + +K L R G +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQ 155
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y A
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 209
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE + + DV+S G ++ ++ G+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
++F+ LLG+G F VY+ T VAIK +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
P+++ L Y D + LV E G + +L + K R G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEAR-HFMHQIITGML 126
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH +++RDL SN+LL + K++DFGLA +L +K + GT Y +
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYIS 180
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE A L+SDV+S G + ++ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
K + +G+G G VY +T Q VAI+Q++ + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+VN + GD+ +V EY+ GSL D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
VI+RD+K NILLG KL+DFG A++ P K T V GT + APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEV 187
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 74/322 (22%), Positives = 124/322 (38%), Gaps = 50/322 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGY 134
+L EGGF VY+ + + + A+K+L N + NR + EV M L HPN+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 135 CADGDQR-------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ G + L+ + G L + L + + L T ++I + ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---KLGPVGDKTHVSTRVM-------G 237
+ PP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 238 TYGYCAPE---YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294
T Y PE + K D+++ G +L + + + + + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE------DGAKLRIVNGKY 266
Query: 295 KDRRKFSQMADPTLQGQYPV-RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353
P QY V L + +Q P R IA+VV L +A +
Sbjct: 267 S---------IPPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 354 DPESQPV-----QSSRTGSSTP 370
P+ Q+ GS+T
Sbjct: 312 VNPKSPITELLEQNGGYGSATL 333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 22/221 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ +LG+G V++GR + T + AIK + + + E +L L+H
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 126 PNLVNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
N+V L + R L+ E+ P GSL L + P + L + + + G+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGM 125
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+L + +++R++K NI+ G KL+DFG A+ + D + GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTE 179
Query: 240 GYCAPE--------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y P+ + D++S GV TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ + LG+G FG+VYK + + T + A K ++ + +++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L+G + ++ E+ P G+++ + +L + L + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH 134
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDK--THVSTRVMGTYGYCAP 244
K +I+RDLK N+L+ +L+DFG+ AK K + + GT + AP
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAP 186
Query: 245 EYAMTGQLT-----LKSDVYSFGVVLLEIITG 271
E M + K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHP 126
+ F +G+G FG V+KG T +VVAIK +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ G + ++ EY+ GS D L LD T I KGL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE 245
H + I+RD+K +N+LL E KL+DFG+ +L K + +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPE 189
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITG 271
K+D++S G+ +E+ G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ +GEG G V R + + + VA+K +D Q EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V + G++ ++ E++ G+L D + + L+ + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH 158
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ VI+RD+K +ILL KLSDFG A++ K + V GT + APE
Sbjct: 159 AQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEV 212
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+ D++S G++++E++ G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
L+G GG G VY+ ++VA+K + L + F E L P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ Q + + L L P L + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+RD+K NIL+ L DFG+A T + +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T ++D+Y+ VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
++ ++G G V + VAIK+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT-TRMRIAA---GAAKGL 183
+V+ D+ LV + + GS+ D + + + IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYG 240
EYLH I+RD+K NILLGE +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 241 YCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ APE + K+D++SFG+ +E+ TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ F LGEG +G VYK + T Q+VAIKQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V G +V EY GS+ D + K L I KGLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH 142
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
I+RD+K NILL H KL+DFG+ +L K + V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
+ +LG+G V++GR + T + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 128 LVNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+V L + R L+ E+ P GSL L + P + L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L + +++R++K NI+ G KL+DFG A+ + D + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 242 CAPE--------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEV-LMLSLLHHPNL 128
LG G +G V K R + Q++A+K++ Q + L+++ + + + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V G + E M SL+ + + + +IA K LE+LH
Sbjct: 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
K + VI+RD+K SN+L+ K+ DFG+ L G Y APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERI 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
++KSD++S G+ ++E+ R
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
+LG GG V+ R ++ VA+K L R L + F + E + L+HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 132 --IGYCADGDQRLLVY---EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
G A+ L Y EY+ +L D +H + + + + A A + L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS 132
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCA 243
H +I+RD+K +NI++ K+ DFG+A+ + D + T+ V+GT Y +
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLS 187
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE A + +SDVYS G VL E++TG
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 59 FTFRELAAVTKN-FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---L 114
+ + E + ++ F +LG GGFG V+ ++++T ++ A K+L++ L+ + + +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM 173
VE +L+ +H +V+L Y + L LV M G + H++++ D R
Sbjct: 234 VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRA 291
Query: 174 RI-AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
A GLE+LH + +IYRDLK N+LL + + ++SD GLA G
Sbjct: 292 IFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TK 347
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT G+ APE + + D ++ GV L E+I R
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ LG GGFG V + + T + VAIKQ + NRE E+ ++ L+H
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 126 PNLVNLI------GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
PN+V+ A D LL EY G L +L+ + L + +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDI 130
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236
+ L YLH+ +I+RDLK NI+L + K+ D G AK + + V
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV- 184
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT Y APE + T+ D +SFG + E ITG
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 29/240 (12%), Positives = 65/240 (27%), Gaps = 52/240 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------------------- 112
+LG+ + + T + + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 113 -----FLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSLEDHLHDLPPD 163
F+ ++ ++ + D R +Y M L + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
K L R+++ + L LH +++ L+ +I+L + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGR 272
+ + G+ PE +T D ++ G+V+ I
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 65/275 (23%), Positives = 109/275 (39%), Gaps = 25/275 (9%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLV 129
F LG G G V+K + + V+A K + R ++ E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G + + E+M GSL+ L R+ +++ KGL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEY 246
+++RD+K SNIL+ KL DFG++ G + D + V GT Y +PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-----GTRSYMSPER 201
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR-----KAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
+++SD++S G+ L+E+ GR + A R
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336
+ + P +++ L V E P P
Sbjct: 262 RPLNKFGMDSRPPMAIFELL---DYIVNEPPPKLP 293
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-33
Identities = 28/243 (11%), Positives = 54/243 (22%), Gaps = 41/243 (16%)
Query: 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLM 119
L+ + + L G V+ R + A+K E
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 120 LSLLHHPNLVNLIGYC--------------------------ADGDQRLLVYEYMP--LG 151
+ L + LL+ L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211
L L + + + A + L K +++ N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232
Query: 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEII 269
L D VG + S+ Y E+ T T + + G+ + +
Sbjct: 233 LMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 270 TGR 272
Sbjct: 288 CLF 290
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G +G VY GR S +AIK++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
++ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDNQ- 142
Query: 192 PPVIYRDLKCSNILL--GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---Y 246
+++RD+K N+L+ G K+SDFG +K + + GT Y APE
Sbjct: 143 --IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDK 197
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
G +D++S G ++E+ TG+
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 42/225 (18%), Positives = 75/225 (33%), Gaps = 26/225 (11%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGLQGNREFLVEVLMLSL 122
+K LLGEG F +VY+ N Q +K EF + ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMER 120
Query: 123 L---HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAG 178
L + + +LV E G+L + ++ +K + + A
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-----------KLSDFGLAKLGPVGD 227
+E +HD +I+ D+K N +LG G+ L D G + +
Sbjct: 181 MLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
K + T T G+ E + D + + ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 53/294 (18%), Positives = 100/294 (34%), Gaps = 46/294 (15%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEV-LMLSLLH 124
T F +G G FG V+K + AIK+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H ++V A+ D L+ EY GSL D + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-----------LAKLGPVGDKTHVST 233
Y+H + +++ D+K SNI + P + + K+G +G T +S+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 234 R--VMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290
G + A E K+D+++ + ++
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------------------- 227
Query: 291 RPLFKDRRKFSQMAD---PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
PL ++ ++ ++ P + + + + + P RP +
Sbjct: 228 EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPDPERRPSAMAL 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 22/219 (10%)
Query: 68 TKNFRADCLLGEG--GFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLV-EVLMLSLL 123
+ ++G+G V R + T + V +++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA---GAA 180
+HPN+V ++ +V +M GS +D + D IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHV----STRV 235
K L+Y+H ++R +K S+IL+ LS + G + V
Sbjct: 139 KALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 236 MGTYGYCAPEYAMTGQL--TLKSDVYSFGVVLLEIITGR 272
+ + +PE KSD+YS G+ E+ G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 59 FTFRELAAVTKN-FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---L 114
+ + E VTKN FR +LG+GGFG V ++ +T ++ A K+L++ ++ + L
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM 173
E +L ++ +V+L Y + L LV M G L+ H++ + R
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RA 288
Query: 174 RI-AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
AA GLE LH + ++YRDLK NILL + H ++SD GLA P G
Sbjct: 289 VFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-- 343
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
RV GT GY APE + T D ++ G +L E+I G+
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS-LLHHP 126
F L+G G +G+VYKGR T Q+ AIK +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 127 NLVNLIG-----YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA--- 177
N+ G D +L LV E+ GS+ D + + + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVM 236
+GL +LH VI+RD+K N+LL E KL DFG+ A+L + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 237 GTYGYCAPEYAMTGQLT-----LKSDVYSFGVVLLEIITG 271
GT + APE + KSD++S G+ +E+ G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-32
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPNLVNL 131
+G G +G V K + + Q++A+K++ + + ++LM + P +V
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G + E M S + + + +I K L +L +
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+I+RD+K SNILL + KL DFG+ +L + TR G Y APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDP 199
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
A ++SDV+S G+ L E+ TGR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 9e-32
Identities = 30/239 (12%), Positives = 64/239 (26%), Gaps = 51/239 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------------------- 112
+LG+ + + T + + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 113 -----FLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSLEDHLHDLPPD 163
F+ ++ ++ + D R +Y M L + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
K L R+++ + L LH +++ L+ +I+L + L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 224 PVGDKTHVSTRVMGTYGYCAPEY----------AMTGQLTLKSDVYSFGVVLLEIITGR 272
G S G+ PE +T D ++ G+ + I
Sbjct: 260 RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 76/263 (28%), Positives = 106/263 (40%), Gaps = 26/263 (9%)
Query: 17 KHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCL 76
HH+ IP+T + + D A F + K F
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD---PEKLFSDLRE 61
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY GS D L K L + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYAMTGQ 251
+I+RD+K NILL E KL DFG A + ++ +GT + APE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMD 226
Query: 252 LT---LKSDVYSFGVVLLEIITG 271
K DV+S G+ +E+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAER 249
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 47/204 (23%), Positives = 76/204 (37%), Gaps = 24/204 (11%)
Query: 76 LLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIG 133
+ GG G +Y + V +K L +G + + E L+ + HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 134 YCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ D+ +V EY+ SL+ +L + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS 200
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
++Y DLK NI+L E KL D G + GT G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGTPGFQAPEIV- 249
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
T+ +D+Y+ G L +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 25/238 (10%)
Query: 44 EASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD 103
+ K G I + + +G G G+V+K R T V+A+KQ+
Sbjct: 5 SSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 104 RNGLQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
R+G + + ++ +V++ P +V G + E M + +
Sbjct: 60 RSGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR-- 116
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL- 219
+ + ++ K L YL +K VI+RD+K SNILL E KL DFG+
Sbjct: 117 --MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 220 AKLGPVGDKTHVSTRVMGTYGYCAPE-----YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+L R G Y APE +++DV+S G+ L+E+ TG+
Sbjct: 173 GRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 16/236 (6%)
Query: 42 KKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQ 101
+E G F + +++ ++ LG G +G V R + T+ AIK
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 102 LDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159
+ + + + + EV +L LL HPN++ L + D LV E G L D +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-- 127
Query: 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSD 216
+ + + I G+ YLH +++RDLK N+LL + K+ D
Sbjct: 128 --IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182
Query: 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
FGL+ + K +GT Y APE + + K DV+S GV+L ++ G
Sbjct: 183 FGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LGEG F V R +T++ AIK L++ + + E ++S L HP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D ++ Y G L ++ D T R A LEYLH K
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFD-ETCTRFYTAEIVSALEYLHGKG- 150
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+I+RDLK NILL E H +++DFG AK+ K + +GT Y +PE
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
SD+++ G ++ +++ G
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGY 134
+LG G G + R N+ VA+K++ +RE V++L HPN++
Sbjct: 31 VLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCT 86
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + + E +L++++ L+ T ++ GL +LH +
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSLN---I 139
Query: 195 IYRDLKCSNILLGE-----GYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY-- 246
++RDLK NIL+ +SDFGL K L + V GT G+ APE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 247 -AMTGQLTLKSDVYSFGVVLLEIITG 271
T D++S G V +I+
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLH- 124
+F ++G GGFG VY R T ++ A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 125 --HPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAA 180
P +V + Y +L + + M G L HL + + MR AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEII 302
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
GLE++H++ V+YRDLK +NILL E H ++SD GLA K H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 241 YCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
Y APE G S D +S G +L +++ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 17/226 (7%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
H F A + ++ +LG+G FG V + + T Q A+K + + ++ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 113 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
L EV +L L HPN++ L + D LV E G L D + +KR
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSE 125
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVG 226
RI G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HF 179
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + +GT Y APE + G K DV+S GV+L +++G
Sbjct: 180 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 17/220 (7%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
H ++ + F LG G FG V+ S+ IK ++++ Q E
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 113 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---D 168
E+ +L L HPN++ + D +V E G L + + K L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPV 225
M+ A L Y H + V+++DLK NIL K+ DFGLA+L
Sbjct: 126 VAELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--F 177
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
H + GT Y APE +T K D++S GVV+
Sbjct: 178 KSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 26/232 (11%)
Query: 53 HIAAHTFTFRELAAVTKNFRAD----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ 108
H H + RE F C+LG+G FG V K + T Q A+K +++ +
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 109 GNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ EV +L L HPN++ L D +V E G L D + +KR
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKR 117
Query: 167 L---DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220
D ++ + Y+H +++RDLK NILL + K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ +GT Y APE + G K DV+S GV+L +++G
Sbjct: 172 T---CFQQNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 74/258 (28%), Positives = 109/258 (42%), Gaps = 19/258 (7%)
Query: 23 IDQIPSTSEKLK--VNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEG 80
I + ++ LK + +D + + D + + F LLG+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159
Query: 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIGYCAD 137
FG+V + ++T + A+K L + + E L E +L HP L L Y
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218
Query: 138 GDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPVI 195
RL V EY G L HL ++R+ R R A L+YLH + N V+
Sbjct: 219 THDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSEKN--VV 271
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTL 254
YRDLK N++L + H K++DFGL K G T + GT Y APE
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGR 328
Query: 255 KSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 35/240 (14%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
I + ++ + +++ LG G +G V + ++ + AIK + ++ R
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 113 FLV-------------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159
E+ +L L HPN++ L D LV E+ G L + +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-- 137
Query: 160 LPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHP 212
R + AA K G+ YLH +++RD+K NILL +
Sbjct: 138 ----INRHKFDECD--AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
K+ DFGL+ K + +GT Y APE + + K DV+S GV++ ++ G
Sbjct: 189 KIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV + + + A+K LD+ + ++ L E +L ++ P LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D +V EY+ G + HL R R AA EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFS-EPHARFYAAQIVLTFEYLHSLD- 161
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK N+L+ + + +++DFG AK V +T + GT APE ++
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPEIILSKG 214
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D ++ GV++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHH 125
+ ++ +LG G G V + + VA+K++ + E +++L S H
Sbjct: 13 LKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALME--IKLLTESD-DH 68
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL---HDLPPDKKRLDWTTRMRIAAGAAKG 182
PN++ + E +L+D + + + K + + A G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 183 LEYLHDKANPPVIYRDLKCSNILL-------------GEGYHPKLSDFGLAKL---GPVG 226
+ +LH +I+RDLK NIL+ E +SDFGL K G
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 227 DKTHVSTRVMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVLLEIITG 271
+T+++ GT G+ APE +LT D++S G V I++
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
+ + K F +LG G F V+ + T ++ A+K + ++ + E+ +L
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
+ H N+V L LV + + G L D + +R +T + A+ +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI------LERGVYTEKD--ASLVIQ 113
Query: 182 ----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
++YLH+ +++RDLK N+L E ++DFGL+K+ ++ + +
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMST 166
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT GY APE + D +S GV+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 31/279 (11%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
P + + A + Q + + K + K + S +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL------ 118
+ + ++G G V + +T A+K ++ + + E L EV
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 119 ---MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTR 172
+ + HP+++ LI LV++ M G L D+L +K L + +
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSI 205
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
MR A + +LH +++RDLK NILL + +LSDFG + + +
Sbjct: 206 MRSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR 257
Query: 233 TRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVL 265
GT GY APE + D+++ GV+L
Sbjct: 258 ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
LLGEG +G+V + T A+K L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 132 --IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+ Y + + +V EY G E + D P+K+ GLEYLH +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLHSQ 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
++++D+K N+LL G K+S G+A+ G+ + PE A
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 250 GQL--TLKSDVYSFGVVLLEIITGR 272
K D++S GV L I TG
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 26/270 (9%)
Query: 9 KSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIA-AHTFTFRELAAV 67
+S KN+ + ++ + + VK + + D A F R + A
Sbjct: 22 QSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAK 81
Query: 68 TKNFRAD------CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
+ +LG G FG+V+K +T +A K + G++ E E+ +++
Sbjct: 82 QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
L H NL+ L + +LV EY+ G L D + D + + T K
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-----ESYNLTELD--TILFMK 194
Query: 182 ----GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
G+ ++H +++ DLK NIL + K+ DFGLA+ +K V
Sbjct: 195 QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---N 248
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE ++ +D++S GV+
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
+ + + + +G G +G V + T A K++ + ++ F E+ ++ L HP
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRIAAGAAKGL 183
N++ L D LV E G L + + K+ D M+ A +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVLSA---V 119
Query: 184 EYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Y H V +RDLK N L KL DFGLA + T+V GT
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPY 173
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVL 265
Y +P+ + G + D +S GV++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 53 HIAAHTFTFRELAAVTKNFRAD----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ 108
H H + RE F C+LG+G FG V K + T Q A+K +++ +
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 109 GNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ EV +L L HPN++ L D +V E G L D + +KR
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKR 117
Query: 167 L---DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220
D ++ + Y+H +++RDLK NILL + K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T + R+ GT Y APE + G K DV+S GV+L
Sbjct: 172 TC--FQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 55/267 (20%), Positives = 92/267 (34%), Gaps = 19/267 (7%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
PC + + K+ + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH 124
V ++ LG G FG V++ +T A K + E+ +S+L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HP LVNL D ++ +++YE+M G L + + D + + A +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-----EHNKMSEDE--AVEYMRQVC 265
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
GL ++H+ ++ DLK NI+ KL DFGL V GT
Sbjct: 266 KGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGT 319
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ APE A + +D++S GV+
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIGY 134
+G+G F +V R T + VAIK +D+ L + EV ++ +L+HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
L+ EY G + D+L R+ ++Y H K +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-- 252
++RDLK N+LL + K++DFG + VG K G Y APE G+
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LFQGKKYD 191
Query: 253 TLKSDVYSFGVVLLEIITGR 272
+ DV+S GV+L +++G
Sbjct: 192 GPEVDVWSLGVILYTLVSGS 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-26
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K R T Q+VAIK+ D + + L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY L L+ + +P K + W T + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--------LQAVNFCHK 120
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPE 245
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE 172
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
L + Y V V E+++G
Sbjct: 173 ------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
LGEG +G V T + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHDK 189
+G+ + L EY G L D + + R +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG-----VVYLHGI 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + DV+S G+VL ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+G+G FG+V + T ++ A+K +++ E E+ ++ L HP LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
Y ++ + +V + + G L HL + +++ L+YL ++
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM 248
+I+RD+K NILL E H ++DF +A + P + T + GT Y APE +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSR 189
Query: 249 TGQLTLKS-DVYSFGVVLLEIITGR 272
G + D +S GV E++ GR
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 37/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGY 134
+LGEG RV T+Q A+K +++ EV ++ H N++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MRIAAGAAKGLEYLHDK 189
+ D+ LV+E M GS+ H+H KR + ++ A A L++LH+K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH------KRRHFNELEASVVVQDVASA---LDFLHNK 130
Query: 190 ANPPVIYRDLKCSNILLGEGYHP------KLSDFGLAK-LGPVGDKTHVSTRVM----GT 238
+ +RDLK NIL HP K+ DF L + GD + +ST + G+
Sbjct: 131 G---IAHRDLKPENILC---EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 239 YGYCAPEYAMTGQLTLKS-----DVYSFGVVL 265
Y APE D++S GV+L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV+ R + A+K L + + ++ E LMLS++ HP ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
G D Q ++ +Y+ G L L +R + AA LEYLH K
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFP-NPVAKFYAAEVCLALEYLHSKD- 126
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK NILL + H K++DFG AK V D T+ T + GT Y APE T
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTKP 179
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D +SFG+++ E++ G
Sbjct: 180 YNKSIDWWSFGILIYEMLAGY 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE--------FLVEV 117
A+ + LG G G V T + VAI+ + + E+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+L L+HP ++ + + D + +V E M G L D + KRL
Sbjct: 192 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV----VGNKRLK----EATCK 242
Query: 178 GAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTH 230
++YLH+ +I+RDLK N+LL E K++DFG +K+ +G+ +
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 297
Query: 231 VSTRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVL 265
+ T GT Y APE T D +S GV+L
Sbjct: 298 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E + E +L HP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
Y RL V EY G L HL ++R+ R R A LEYLH +
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMT 249
V+YRD+K N++L + H K++DFGL K G T + GT Y APE +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE-VLE 178
Query: 250 GQLTLKS-DVYSFGVVLLEIITGR 272
++ D + GVV+ E++ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 22/211 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
R T + +G G + + ++TN A+K +D++ E +E+ +L
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLR 71
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRIAAG 178
HPN++ L DG +V E M G L D + +K + + +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITK 127
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHP-KLSDFGLAKLGPVGDKTHVSTR 234
+EYLH + V++RDLK SNIL ++ DFG AK + + T
Sbjct: 128 T---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTP 180
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T + APE D++S GV+L
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 50/256 (19%), Positives = 101/256 (39%), Gaps = 25/256 (9%)
Query: 16 KKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADC 75
HH+ ++ + K+N ++ K + +V +
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ------GSVYDYYDILE 57
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ ++T +V K ++ E+ +++ LHHP L+NL
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKAN 191
D + +L+ E++ G L D + + + + GL+++H+ +
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAA-----EDYKMSEAE--VINYMRQACEGLKHMHEHS- 169
Query: 192 PPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++ D+K NI+ + K+ DFGLA + V T + APE
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDR 224
Query: 250 GQLTLKSDVYSFGVVL 265
+ +D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 42/214 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V K R + T ++VAIK+ D + + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
C + LV+E++ L LE + L ++ + G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI--------INGIGFCHS 142
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPE 245
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE 194
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
L + Y V ++ E+ G
Sbjct: 195 ------LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 60/271 (22%), Positives = 103/271 (38%), Gaps = 37/271 (13%)
Query: 13 NAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFR 72
+ HH+ +P S N K K+ + ++
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEP---------------LESQYQ 46
Query: 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV------EVLMLSLLHH- 125
LLG GGFG VY G S N VAIK ++++ + E EV++L +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 126 -PNLVNLIGYCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
++ L+ + D +L+ E P+ L D + ++ L + +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAV 162
Query: 184 EYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ H+ V++RD+K NIL+ KL DFG L T + GT Y
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYS 215
Query: 243 APEYAMTGQLT-LKSDVYSFGVVLLEIITGR 272
PE+ + + V+S G++L +++ G
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
LGEG +G V T + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHDK 189
+G+ + L EY G L D + + R +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG-----VVYLHGI 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + DV+S G+VL ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLH 124
+ N+ LG+G F V + ++T A K ++ L + E + L
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HPN+V L + LV++ + G L + + R ++ A+ +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI------VAREFYSEAD--ASHCIQQIL 115
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
+ Y H +++R+LK N+LL +G KL+DFGLA V D G
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-G 169
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T GY +PE + D+++ GV+L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 23/230 (10%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
AS GG F + N+ LG+G F V + ++T A K ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 105 NGLQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP 162
L + E + L HPN+V L + LV++ + G L + +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----- 119
Query: 163 DKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLS 215
R ++ A+ + + Y H +++R+LK N+LL +G KL+
Sbjct: 120 -VAREFYSEAD--ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173
Query: 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
DFGLA V D GT GY +PE + D+++ GV+L
Sbjct: 174 DFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 59/264 (22%), Positives = 94/264 (35%), Gaps = 52/264 (19%)
Query: 57 HTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---- 112
F L + K + +G+G +G V T + AIK +++N ++
Sbjct: 14 LYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 113 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT 171
EV ++ LHHPN+ L D LV E G L D L+ D
Sbjct: 74 RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 172 RMRIAAG-----------------------------AAK-------GLEYLHDKANPPVI 195
++ + L YLH++ +
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---IC 190
Query: 196 YRDLKCSNILLG--EGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPE--YAM 248
+RD+K N L + + KL DFGL+K G+ ++T+ GT + APE
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTT 249
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
K D +S GV+L ++ G
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
+LG+G FG+V+ + TNQ AIK L ++ + + + +VE VL L+ HP L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 82
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
+ + L V EY+ G L H+ + D +R AA GL++LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFD-LSRATFYAAEIILGLQFLHS 136
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEY 246
K ++YRDLK NILL +G H K++DFG+ K +GD T GT Y APE
Sbjct: 137 KG---IVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 189
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + D +SFGV+L E++ G+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-25
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 48/220 (21%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K + T+++VA+K++ D G+ L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+E+ DL KK D + + K GL
Sbjct: 68 DVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
+ H + V++RDLK N+L+ KL++FGLA+ PV + V+ T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168
Query: 243 APEYAMTGQLTLKSDVYSFGV-------VLLEIITGRKAI 275
P+ + + +YS + + E+ + +
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVL 118
+ V ++ LG G F V K R + T + A K + + L +R E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRI 175
+L + HPN++ L + +L+ E + G L D L +K+ L + T ++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQ 116
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHV 231
G+ YLH K + + DLK NI+L + P KL DFG+A +
Sbjct: 117 ILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF 168
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE L L++D++S GV+
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 23/255 (9%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ + ++ ++ G + + + A++ F + L
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137
G G VY+ + + T + A+K L + + E+ +L L HPN++ L
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPP 193
+ LV E + G L D + ++ ++ R AA A K + YLH+
Sbjct: 120 PTEISLVLELVTGGELFDRI------VEKGYYSERD--AADAVKQILEAVAYLHENG--- 168
Query: 194 VIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDLK N+L K++DFGL+K+ V + + T GT GYCAPE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGC 225
Query: 251 QLTLKSDVYSFGVVL 265
+ D++S G++
Sbjct: 226 AYGPEVDMWSVGIIT 240
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 23/243 (9%)
Query: 40 DVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAI 99
+K KDG T ++ ++G G FG VY+ +L + ++VAI
Sbjct: 25 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAI 84
Query: 100 KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY-CADGDQRL-----LVYEYMPLGSL 153
K++ LQ R E+ ++ L H N+V L + + G+++ LV +Y+P ++
Sbjct: 85 KKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV 139
Query: 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP- 212
K+ L + L Y+H + +RD+K N+LL
Sbjct: 140 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVL 196
Query: 213 KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEII 269
KL DFG AK L + +R Y Y APE T DV+S G VL E++
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 270 TGR 272
G+
Sbjct: 252 LGQ 254
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G FG V +L++ ++V A+K L++ + E F E +L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDK 189
+ A D + LV +Y G L L + RL R A ++ +H
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLP-EEMARFYLAEMVIAIDSVHQL 194
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
++RD+K NIL+ H +L+DFG S V GT Y +PE
Sbjct: 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
Query: 250 GQLTLKS-----DVYSFGVVLLEIITGR 272
+ D +S GV + E++ G
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G FG V R +ST +V A+K L + + + F E +++ + P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ A D +V EYMP G L + + +D+P R A L+ +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVVLALDAIHS 186
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 245
I+RD+K N+LL + H KL+DFG T V GT Y +PE
Sbjct: 187 MG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 242
Query: 246 -YAMTGQLTLKSDVYSFGVVLLEIITGR 272
G + D +S GV L E++ G
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 22/215 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--------EVLML 120
+ + LG G FG V+ + N+ V +K + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYE-YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
S + H N++ ++ + LV E + L + RLD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQL 139
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+ YL K +I+RD+K NI++ E + KL DFG A G + GT
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 240 GYCAPEYAMTGQLTL--KSDVYSFGVVLLEIITGR 272
YCAPE + G + +++S GV L ++
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM----LSLLHHPNL 128
+LG+G FG+V+ K Q+ A+K L + L+ V M L ++HP +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVEVNHPFI 88
Query: 129 VNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
V L Y + +L L+ +++ G L L K+ + ++ A A L++L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHL 142
Query: 187 HDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 244
H +IYRDLK NILL EG H KL+DFGL+K +K GT Y AP
Sbjct: 143 HSLG---IIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAP 195
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E T +D +SFGV++ E++TG
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
++G+G FG+V R ++ A+K L + + +E + E VL+ ++ HP LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVG 103
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L + +L V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS 157
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEY 246
++YRDLK NILL +G H L+DFGL K + T T GT Y APE
Sbjct: 158 LN---IVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE- 209
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGR 272
+ Q ++ D + G VL E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-------------------- 115
+G+G +G V E+ N A+K L + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 116 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL 167
E+ +L L HPN+V L + + D +V+E + G + + P K L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPL 134
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
KG+EYLH + +I+RD+K SN+L+GE H K++DFG++ D
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 228 KTHVSTRVMGTYGYCAPEYAMTGQLTL----KSDVYSFGVVLLEIITGR 272
+S V GT + APE +++ + DV++ GV L + G+
Sbjct: 192 A-LLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 29/213 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G F V +++ T QV A+K +++ + E F E +L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHL----HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ A D + LV EY G L L +P + R A ++ +
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-------YLAEIVMAIDSV 178
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H ++RD+K NILL H +L+DFG V GT Y +PE
Sbjct: 179 HRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEI 234
Query: 247 AMTGQLTLKSDVY-------SFGVVLLEIITGR 272
+ Y + GV E+ G+
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 62/213 (29%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R E EV +L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ HPN++ L + +L+ E + G L D L K+ L A
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFI 121
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH K + + DLK NI+L H KL DFGLA G +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN- 177
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ GT + APE L L++D++S GV+
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 33/218 (15%)
Query: 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--------EV 117
A+ + LG G G V T + VAIK + + E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+L L+HP ++ + + D + +V E M G L D + KRL +
Sbjct: 67 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV----VGNKRL----KEATCK 117
Query: 178 GAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTH 230
++YLH+ +I+RDLK N+LL E K++DFG +K+ +G+ +
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 172
Query: 231 VSTRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVL 265
+ T GT Y APE T D +S GV+L
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
F+ + + G+G FG V G+ +ST VAIK++ ++ NRE L + L++LHHP
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHP 79
Query: 127 NLVNLI------GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
N+V L G D L +V EY+P +L + +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 180 AKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK-LGPVGDKTH-VSTRV 235
+ + LH N V +RD+K N+L+ E KL DFG AK L P + +R
Sbjct: 139 IRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR- 195
Query: 236 MGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
Y Y APE Q T D++S G + E++ G
Sbjct: 196 ---Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 22/199 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EV-LMLSLLHHPNLVNLIG 133
LG G F V + +ST Q A K L + + + E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDK 189
+ + +L+ EY G + + + + K G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSE-NDVIRLIKQILEGVYYLHQN 150
Query: 190 ANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+++ DLK NILL K+ DFG+++ +G + + GT Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEI 204
Query: 247 AMTGQLTLKSDVYSFGVVL 265
+T +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 75/245 (30%), Positives = 110/245 (44%), Gaps = 37/245 (15%)
Query: 38 TVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVV 97
T + + +G D + F F L +LG+G FG+V + T+++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNF--LM----------VLGKGSFGKVMLSERKGTDELY 48
Query: 98 AIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 151
A+K L ++ + + + +VE VL L P L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 152 SLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEG 209
L H+ R AA A GL +L K +IYRDLK N++L EG
Sbjct: 107 DLMYHIQQ----VGRFK-EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 210 YHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLE 267
H K++DFG+ K T T+ GT Y APE + Q KS D ++FGV+L E
Sbjct: 159 -HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 213
Query: 268 IITGR 272
++ G+
Sbjct: 214 MLAGQ 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 49/217 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VYK + +S ++VA+K++ + G+ + E+ +L LHHPN+V+LI
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
LV+E+M DL KK LD + + K G+
Sbjct: 86 DVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
+ H +++RDLK N+L+ KL+DFGLA+ PV TH V+ T Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186
Query: 243 APEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
AP+ + + S D++S G + E+ITG+
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 29/265 (10%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ D T+E L + E K+ + + + L ++F ++
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVI 60
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVNLI 132
G G + +V RL+ T+++ A++ + + + + + E V + +HP LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH 119
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
C + RL V EY+ G L H+ +++L R +A + L YLH++
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP-EEHARFYSAEISLALNYLHERG 173
Query: 191 NPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAM 248
+IYRDLK N+LL EG H KL+D+G+ K G T T GT Y APE +
Sbjct: 174 ---IIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-IL 225
Query: 249 TGQLTLKS-DVYSFGVVLLEIITGR 272
G+ S D ++ GV++ E++ GR
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGYC 135
LGEG F K + +NQ A+K + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MRIAAGAAKGLEYLHDKA 190
D LV E + G L + + KK+ ++ MR A + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERI------KKKKHFSETEASYIMRKLVSA---VSHMHDVG 126
Query: 191 NPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
V++RDLK N+L + K+ DFG A+L P ++ + T T Y APE
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELL 181
Query: 248 MTGQLTLKSDVYSFGVVL 265
D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPN 127
+LG+GG+G+V+ K +T ++ A+K L + + N + L + HP
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILEEVKHPF 82
Query: 128 LVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEY 185
+V+LI Y +L L+ EY+ G L L ++ + A + L +
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGH 136
Query: 186 LHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCA 243
LH K +IYRDLK NI+L +G H KL+DFGL K T GT Y A
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTV---THTFCGTIEYMA 189
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE M D +S G ++ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
+LG+G FG+V R++ T + A+K L ++ + + + + E +L L+ +HP L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 88
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L C RL V E++ G L H+ +R D R R AA L +LHD
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFD-EARARFYAAEIISALMFLHD 142
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 247
K +IYRDLK N+LL H KL+DFG+ K G T T GT Y APE
Sbjct: 143 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-I 195
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGR 272
+ L + D ++ GV+L E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-24
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-------QGNREFLVEVLMLSLLH---- 124
LLG+GGFG V+ G + VAIK + RN + L EV +L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 125 HPNLVNLIGYCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
HP ++ L+ + + +LV E +P L D++ +K L +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAI 152
Query: 184 EYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGD-KTHVSTRVMGTYGY 241
++ H + V++RD+K NIL+ KL DFG L GT Y
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVY 204
Query: 242 CAPEYAMTGQLT-LKSDVYSFGVVLLEIITGR 272
PE+ Q L + V+S G++L +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 9e-24
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 49/217 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VYK + + + A+K++ + G+ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ +LV+E++ DL KK LD + + AK G+
Sbjct: 67 DVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
Y HD+ V++RDLK N+L+ K++DFGLA+ PV TH ++ T Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167
Query: 243 APEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
AP+ + + S YS + + E++ G
Sbjct: 168 APD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 55/231 (23%)
Query: 74 DCLLGEGGFGRVYKGR--LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
C +G G +G VYK + ++ A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISL 83
Query: 132 IG-YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA--------- 180
+ + D+++ L+++Y HDL + + +
Sbjct: 84 QKVFLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 181 ------KGLEYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKL--GPVGDK 228
G+ YLH V++RDLK +NIL+ K++D G A+L P+
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
+ V+ T+ Y APE L L + D+++ G + E++T
Sbjct: 190 ADLDPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-24
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG+ + T+ +VA+K++ +G + EV +L L H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLEYLH 187
LV+EY+ DL K+ LD I K GL Y H
Sbjct: 70 HTEKSLTLVFEYLD--------KDL---KQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPE 245
+ V++RDLK N+L+ E KL+DFGLA+ P + V+ T Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD 170
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
+ L S YS + + E+ TGR
Sbjct: 171 ------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 61/213 (28%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R E EV +L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ H N++ L + +L+ E + G L D L K+ L A
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFI 121
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH K + + DLK NI+L H KL DFGLA + D
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK 176
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE L L++D++S GV+
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHHPNLVN 130
LG G FG+V G + T VA+K L+R ++ +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L + +V EY+ G L D++ R++ R+ ++Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
V++RDLK N+LL + K++DFGL+ + G+ S G+ Y APE ++G
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISG 184
Query: 251 QL--TLKSDVYSFGVVLLEIITGR 272
+L + D++S GV+L ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGN-----REFLVEVL-MLSLLHHP 126
+G G +G VYK R + VA+K + G G RE V +L L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 127 NLVNLI----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
N+V L+ D + ++ LV+E++ DL + LD + A K
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 182 --------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233
GL++LH +++RDLK NIL+ G KL+DFGLA+ + ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
V+ T Y APE + D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--------NGLQGNREF 113
+N+ +LG G V + + T + A+K +D +Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 114 L---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL--- 167
V++L + HPN++ L LV++ M G L D+L + K L
Sbjct: 70 TLKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEK 124
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
+ MR + LH +++RDLK NILL + + KL+DFG + +
Sbjct: 125 ETRKIMRALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDP 176
Query: 228 KTHVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVL 265
+ GT Y APE + D++S GV++
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 28/201 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG G G+V + T Q A+K L + +E V+ P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCILDVY 91
Query: 136 ADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA----AKGLEYLH 187
+ L++ E M G L + ++ +T R AA +++LH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTERE--AAEIMRDIGTAIQFLH 145
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ +RD+K N+L + KL+DFG AK + T T Y AP
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 245 EYAMTGQLTLKSDVYSFGVVL 265
E + D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 49/219 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
LGEG F VYK R ++TNQ+VAIK++ ++ L E+ +L L HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GL 183
+ LV+++M DL + + + + K GL
Sbjct: 78 LDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSHIKAYMLMTLQGL 125
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYG 240
EYLH +++RDLK +N+LL E KL+DFGLAK P TH V TR
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----W 177
Query: 241 YCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
Y APE L + +Y GV +L E++
Sbjct: 178 YRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 46/218 (21%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G + VYKG ++T VA+K++ + +G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA------------KGL 183
++ LV+E+M +DL KK +D T G +GL
Sbjct: 73 HTENKLTLVFEFMD--------NDL---KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGY 241
+ H+ +++RDLK N+L+ + KL DFGLA+ PV + V+ T Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWY 174
Query: 242 CAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
AP+ + + S YS + +L E+ITG+
Sbjct: 175 RAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHHPNLVNL 131
+G+G F V + T Q A+K +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLH 187
+ + +V+E+M L + + + +A+ + L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI----VKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
D +I+RD+K +LL KL FG+A +G+ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 245 EYAMTGQLTLKSDVYSFGVVL 265
E DV+ GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 77 LGEGGFGRVYKGR-LESTNQVVAIKQL----DRNGL--QGNREFLVEVL-MLSLLHHPNL 128
+GEG +G+V+K R L++ + VA+K++ G+ RE V VL L HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 129 VNLI----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-- 181
V L D + +L LV+E++ DL LD + K
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 182 ------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
GL++LH V++RDLK NIL+ KL+DFGLA+ + +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ T Y APE + D++S G + E+ +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
++G G + +V RL+ T+++ A+K + + + + + E V + +HP LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L C + RL V EY+ G L H+ +++L R +A + L YLH+
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP-EEHARFYSAEISLALNYLHE 128
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEY 246
+ +IYRDLK N+LL EG H KL+D+G+ K G T T GT Y APE
Sbjct: 129 RG---IIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE- 180
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGR 272
+ G+ S D ++ GV++ E++ GR
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-23
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R + EV +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ HPN++ L + +L+ E + G L D L +K+ L A
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLT----EEEATEFL 120
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH + + DLK NI+L K+ DFGLA G++
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 176
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ GT + APE L L++D++S GV+
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG +G VYK TN+ VAIK++ + G+ + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA------KGLEYL 186
+ L++EY +DL KK +D + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKL--GPVGDKTHVSTRVMGTY 239
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
Y PE + L S YS V + E++
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM------LSLL 123
+F +LG+G FG+V + T+++ A+K L ++ + + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 124 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAK 181
P L L C RL V EY+ G L H+ R AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFK-EPHAVFYAAEIAI 453
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYG 240
GL +L K +IYRDLK N++L H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE D ++FGV+L E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 24/247 (9%)
Query: 36 NSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ 95
N+ ++ K D + I + + ++G G FG V++ +L +++
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 96 VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMP 149
VAIK++ LQ R E+ ++ ++ HPN+V+L + + L LV EY+P
Sbjct: 67 -VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209
++ K+ + + L Y+H + +RD+K N+LL
Sbjct: 122 E-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPP 177
Query: 210 YHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVL 265
KL DFG AK L + +R Y Y APE T D++S G V+
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 266 LEIITGR 272
E++ G+
Sbjct: 233 AELMQGQ 239
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 35/206 (16%), Positives = 85/206 (41%), Gaps = 22/206 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ + + LG G FG V++ S+ + K + G ++ + E+ +L++ H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARH 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK---- 181
N+++L ++ ++++E++ + + ++ + R
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINT-----SAFELNERE--IVSYVHQVCE 113
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L++LH + + D++ NI+ K+ +FG A+ GD + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVL 265
Y APE ++ +D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLH 124
T+ ++ LG+G F V + Q A ++ L + E + LL
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HPN+V L ++ L+++ + G L + + R ++ A+ +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI------VAREYYSEAD--ASHCIQQIL 120
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
+ + H V++R+LK N+LL +G KL+DFGLA V + G
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAG 175
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T GY +PE D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 7e-23
Identities = 63/266 (23%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + +T + VA+K L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 130 NLIG--------------YCADGDQRLLVY------------------------------ 145
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 146 ---------------------EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
E L +E+ K L + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+L + I+RDL NILL E K+ DFGLA+ + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E T++SDV+SFGV+L EI +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 65/268 (24%), Positives = 103/268 (38%), Gaps = 24/268 (8%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ ++ +S S + T +NF +L
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL 62
Query: 78 GEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPNLV 129
G G +G+V+ K T ++ A+K L + + + + P LV
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 130 NLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLH 187
L Y + +L L+ +Y+ G L HL ++R ++I LE+LH
Sbjct: 123 TLH-YAFQTETKLHLILDYINGGELFTHLSQ----RERFT-EHEVQIYVGEIVLALEHLH 176
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+IYRD+K NILL G H L+DFGL+K + GT Y AP+
Sbjct: 177 KLG---IIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDI 231
Query: 247 AMTGQLTLKSDV--YSFGVVLLEIITGR 272
G V +S GV++ E++TG
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 38/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIG 133
+G G FG R + T ++VA+K ++R V E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHD 188
++ EY G L + + + R ++ + Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSG-----VSYCHS 134
Query: 189 KANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE- 245
+ +RDLK N LL P K+ DFG +K + + + V GT Y APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEV 188
Query: 246 -----YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y G+ +DV+S GV L ++ G
Sbjct: 189 LLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-22
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLI 132
LGEG FG+V T Q VA+K + R L+ + + E+ L LL HP+++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
++V EY G L D++ +KKR+ R +EY H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++RDLK N+LL + + K++DFGL+ + G+ S G+ Y APE + G+L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 253 --TLKSDVYSFGVVLLEIITGR 272
+ DV+S G+VL ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 52/274 (18%), Positives = 92/274 (33%), Gaps = 43/274 (15%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
P + + + P+ ++ + I ++
Sbjct: 10 PPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV 69
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLL 123
LG G G+V + + T + A+K L EV L
Sbjct: 70 ------------LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 112
Query: 124 HHPNLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MR 174
P++V ++ + L+V E + G L + D+ +T R M+
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMK 168
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHV 231
A ++YLH + +RD+K N+L KL+DFG AK + +
Sbjct: 169 SIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--L 220
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+T T Y APE + D++S GV++
Sbjct: 221 TTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-F----LVEVLMLSLLHHPNLVNL 131
+G+G FG V+K R T Q VA+K++ ++ +E F L E+ +L LL H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 132 IGYCADGDQRL--------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-- 181
I C LV+++ HDL L ++ K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRV 129
Query: 182 ------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVST 233
GL Y+H +++RD+K +N+L+ KL+DFGLA+ + + T
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 234 RVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
+ T Y PE L L D++ G ++ E+ T
Sbjct: 187 NRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLI 132
LG G FG+V G+ E T VA+K L+R ++ E+ L L HP+++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ +V EY+ G L D++ RLD R+ G++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE------Y 246
V++RDLK N+LL + K++DFGL+ + G+ S G+ Y APE Y
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLY 192
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
A G + D++S GV+L ++ G
Sbjct: 193 A--G---PEVDIWSSGVILYALLCGT 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 28/205 (13%), Positives = 58/205 (28%), Gaps = 41/205 (20%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPN 127
+R G + ++ + ++ VA+ +D G+ + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ ++ L+V E++ GSL++ +R A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH 146
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
V S + + L+
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-- 179
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ D+ G L ++ R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 34/166 (20%), Positives = 64/166 (38%), Gaps = 14/166 (8%)
Query: 116 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
++ + N V + + + + +L+D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK----------LGPV 225
A+ +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
T +GT Y +PE + K D++S G++L E++
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIG- 133
+G GGFG V++ + + + AIK++ + RE + EV L+ L HP +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
+ ++ E L + ++R
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V K ++ +G G G V ++ VAIK+L R N R E++++ +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCV 118
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+H N+++L+ + LV E M + +L + + LD +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLY 171
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT--HVSTRV 235
G+++LH A +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 172 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E++ +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V K ++ +G G G V + VAIK+L R N R + E++++ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 81
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+H N++ L+ + +V E M + +L + + LD +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELDHERMSYLLY 134
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKT-HVSTRV 235
G+++LH A +I+RDLK SNI++ K+ DFGLA G T +V TR
Sbjct: 135 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E+I G
Sbjct: 192 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 52/254 (20%), Positives = 95/254 (37%), Gaps = 67/254 (26%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
+K + LG G FG V + + + A+K++ ++ NRE + ++ +L H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHV 60
Query: 127 NLVNLIGY-------------------------------------CADGDQRL-LVYEYM 148
N++ L+ Y ++ L ++ EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 149 P------LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202
P L S +P + + + + ++H + +RD+K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISI-------YIYQLFRAVGFIH-SLG--ICHRDIKPQ 170
Query: 203 NILLGEGYHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDV 258
N+L+ + KL DFG AK L P + +R + Y APE + T D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 259 YSFGVVLLEIITGR 272
+S G V E+I G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
+ K + + +G G +G V + + + VAIK+L R + + R E+L+L +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHM 80
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR 172
H N++ L+ LV +M + L +K +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY----- 130
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH-V 231
+ KGL+Y+H A V++RDLK N+ + E K+ DFGLA+ + T V
Sbjct: 131 --LVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYV 184
Query: 232 STRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
TR Y APE ++ D++S G ++ E++TG+
Sbjct: 185 VTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLH 124
V + +GEG +G V VAIK++ + R L E+ +L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 125 HPNLVNLIG----YCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKR------L 167
H N++ + + + + +V + M E L+ L D L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVG 226
+GL+Y+H AN V++RDLK SN+LL K+ DFGLA+ P
Sbjct: 139 -------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
D T T + T Y APE + + T D++S G +L E+++ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH- 125
V +R +G G FG +Y G + + VAIK + + +E + ++
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGG 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + A+GD ++V E LG SLED + ++ T + +A +E
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMEL--LGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIE 119
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK---LSDFGLAKL-GPVGDKTHVSTR----VM 236
Y+H K I+RD+K N L+G G + DFGLAK H+ R +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 237 GTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
GT Y A G + + + D+ S G VL+ G
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 45/161 (27%), Positives = 62/161 (38%), Gaps = 15/161 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V NFR +G G FG + G+ TN+ VAIK L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGD 65
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ + + G +V E LG SLED + T + IA +EY
Sbjct: 66 GIPQVYYFGPCGKYNAMVLEL--LGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEY 120
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAK 221
+H K +IYRD+K N L+G + + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V +R +G G +G V T VAIK+L R + L R E+ +L +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHM 81
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLH------DLPPDKKRLDWTT 171
H N++ L+ + D LV +M L L D+ +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQF---- 132
Query: 172 RMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231
+ KGL Y+H A +I+RDLK N+ + E K+ DFGLA+ +V
Sbjct: 133 ---LVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 232 STRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
TR Y APE + T D++S G ++ E+ITG+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 50/234 (21%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLH 124
++ +F+ LLGEG +G V + T ++VAIK+++ L R L E+ +L
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFK 67
Query: 125 HPNLVNLIG-YCADGDQRL----LVYEYMPLGSLEDHLH------DLPPDKKR------L 167
H N++ + D + ++ E M + LH L D + L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA----KLG 223
+ ++ LH +N VI+RDLK SN+L+ K+ DFGLA +
Sbjct: 123 -------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 224 PVGDKTHVSTRVMGTY----GYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ M + Y APE +T + DV+S G +L E+ R
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V + ++ +G G +G V T VA+K+L R + + R E+ +L +
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHM 85
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKRLDWTT 171
H N++ L+ + + LV M L+ L D +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF---- 136
Query: 172 RMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT-H 230
+ +GL+Y+H A+ +I+RDLK SN+ + E K+ DFGLA+ + T +
Sbjct: 137 ---LIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 231 VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
V+TR Y APE + D++S G ++ E++TGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLVEVLMLSLLHH 125
+ + LG GG G V+ ++ VAIK++ + L E+ ++ L H
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDH 67
Query: 126 PNLVNLIG-YCADGDQRL-------------LVYEYMPLGSLEDHLH------DLPPDKK 165
N+V + G Q +V EYM E L L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHA 122
Query: 166 RLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAK-LG 223
RL +GL+Y+H AN V++RDLK +N+ + E K+ DFGLA+ +
Sbjct: 123 RL-------FMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
P + + T Y +P ++ T D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGYC 135
LG G + V++ + N+ V +K L ++ E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 136 ADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKR------LDWTTRMRIAAGAAKGLEYLH 187
D R LV+E++ + L R L K L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLG-PVGDKTH-VSTRVMGTYGYCAP 244
+++RD+K N+++ E +L D+GLA+ P + V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEIITGRKAI 275
E + Q+ S D++S G +L +I ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-H 125
V FR +G G FG +Y G TN+ VAIK + + + L E + +L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGG 62
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ N+ + +GD +LV + LG SLED + ++L T + +A +E
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDL--LGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 117
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK---LSDFGLAKL-GPVGDKTHVSTR----VM 236
++H K+ ++RD+K N L+G G + DFGLAK H+ R +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 237 GTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
GT Y A G + + + D+ S G VL+ + G
Sbjct: 175 GTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 60/245 (24%), Positives = 94/245 (38%), Gaps = 60/245 (24%)
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREF----- 113
EL A+ + + G +G V G ++S VAIK++ + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 114 ----LVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMPLGSLEDHLH------ 158
L E+ +L+ HHPN++ L + + +L LV E M L
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQ 127
Query: 159 --DLPPDKKR------LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210
+ P + L GL LH+ A V++RDL NILL +
Sbjct: 128 RIVISPQHIQYFMYHIL-------------LGLHVLHE-AG--VVHRDLHPGNILLADNN 171
Query: 211 HPKLSDFGLA-KLGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLE 267
+ DF LA + +KT +V+ R Y APE M T D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 268 IITGR 272
+ +
Sbjct: 227 MFNRK 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH- 125
V +++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGC 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ N+ + +G +LV + LG SLED L ++ T A ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDL--LGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQ 120
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAKL-GPVGDKTHVSTR---- 234
+H+K+ ++YRD+K N L+G + DFG+ K K H+ R
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 235 VMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
+ GT Y G + + + D+ + G V + + G
Sbjct: 178 LSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 28/158 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGYC 135
LG G G+V + + T + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 136 ADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MRIAAGAAKGLEYL 186
+ L+V E + G L + D+ +T R M+ A ++YL
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEA---IQYL 133
Query: 187 HDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAK 221
H + +RD+K N+L KL+DFG AK
Sbjct: 134 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 66/336 (19%), Positives = 112/336 (33%), Gaps = 88/336 (26%)
Query: 8 GKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAV 67
G S + A + HN S S++ + +SK S + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRK---QHHSSKPTASMPRPHSDWQ------I 51
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---------LVEVL 118
+ L+G G +G V + + +VVAIK++ R F L E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIA 104
Query: 119 MLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMP--LGSLEDHLHDLPPDKKR----- 166
+L+ L+H ++V + I + L +V E L L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 167 -LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225
L G++Y+H A +++RDLK +N L+ + K+ DFGLA+
Sbjct: 165 LL-------------VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 226 GDKTHVSTRVMGTYG-------------------------YCAPEYAMTGQL-TLKSDVY 259
+ + + Y APE + + T DV+
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
Query: 260 SFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295
S G + E++ K A PLF
Sbjct: 269 SIGCIFAELLNMIKENVAYHADR--------GPLFP 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 59/295 (20%), Positives = 102/295 (34%), Gaps = 72/295 (24%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V N+ L+G G +G VY ++T + VAIK+++R + + R L E+ +L+ L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRL 82
Query: 124 HHPNLVNL----IGYCADGDQRL-LVYEYMPLGSLEDHLH-------DLPPDKKR----- 166
++ L I L +V E + L L + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 167 -LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225
L G ++H+ + +I+RDLK +N LL + K+ DFGLA+
Sbjct: 138 LL-------------LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT--------------LKS-------DVYSFGVV 264
T++ + + QLT L D++S G +
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241
Query: 265 LLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQ 319
E++ ++ N PLF F D + + Q
Sbjct: 242 FAELLNMLQSHINDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 60/244 (24%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V + + LG+G +G V+K T +VVA+K++ N R E+++L+ L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTEL 65
Query: 124 H-HPNLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKR------LD 168
H N+VNL+ AD D+ + LV++YM E LH L P K+ +
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI- 119
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
K ++YLH +++RD+K SNILL H K++DFGL++ +
Sbjct: 120 ------------KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 229 THVSTRVMGTYG-------------------YCAPEYAMTGQL-TLKSDVYSFGVVLLEI 268
+ + Y APE + T D++S G +L EI
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 269 ITGR 272
+ G+
Sbjct: 225 LCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 30/175 (17%), Positives = 59/175 (33%), Gaps = 29/175 (16%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLEST--------NQVVAIKQLDRNG----------LQGN 110
+ ++ G +Y+ ST Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 111 REFLVEVLMLSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLD 168
+ + L + +G+ R LV LG SL+ L P K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLS 157
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
+ +++A LE+LH+ ++ ++ NI + + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIK----------QLDR-----NGLQGNREF 113
+ +G GGFG +Y + + A L + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 114 LVEVLMLSLLHHPNLVNLIGY----CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLD 168
+ + + L + + G R +V E LG L+
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISG----QNGTFK 149
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
+T +++ LEY+H+ ++ D+K +N+LLG + L+D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 1e-12
Identities = 43/262 (16%), Positives = 70/262 (26%), Gaps = 69/262 (26%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--------DRNGLQGN 110
F T+ + +GEG FG V++ + VAIK + + + +
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 111 REFLVEVLMLSLLH---------HPNLVNLIG-YCADG---------------------- 138
E L E+++ L + L +C G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 139 -------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
DQ +V E+ G + + K T I L
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR 182
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV------STRVMGTYGYC--- 242
+RDL N+LL + KL K + + + G
Sbjct: 183 --FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240
Query: 243 ---APEYAMTGQLTLKSDVYSF 261
E TG + D+Y
Sbjct: 241 DVSMDEDLFTGDGDYQFDIYRL 262
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH----------- 124
LG G F V+ + N VA+K + R E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 125 HPNLVNLIGY----CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+++ L+ + +G ++V+E LG +L + + + + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKY--EHRGIPLIYVKQISKQL 140
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP------KLSDFGLAKLGPVGDKTHVST 233
GL+Y+H + +I+ D+K N+L+ P K++D G A + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
R Y +PE + +D++S ++ E+ITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 33/178 (18%), Positives = 63/178 (35%), Gaps = 31/178 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQV-----VAIKQLDRNGLQ-----------GN 110
++ +G+GGFG +Y + S+ V +K +
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 111 REFLVEVLMLSLLHHPNLVNLIGY----CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKK 165
E + + + L + + G R ++ + G L+ K
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANA---K 147
Query: 166 RLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
R T ++++ LEY+H+ ++ D+K SN+LL + L D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL------HHPNLV 129
++G+G FG+V K +Q VA+K + RN + +R+ E+ +L L + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 130 NLIGY-------CADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAA 177
+++ C + +E + + +L + + R + A
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLPLVR-------KFAH 207
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDK--THVST 233
+ L+ LH +I+ DLK NILL + K+ DFG + + T++ +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQS 262
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
R Y APE + + + D++S G +L E++TG
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 48/264 (18%), Positives = 82/264 (31%), Gaps = 74/264 (28%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HH 125
+ LG G F V+ + VA+K + ++ L E+ +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 126 PNLVNLIGYC-------ADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAA 177
PN ++ +G +V+E LG L + + L +I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNY--QGLPLPCVKKIIQ 153
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLG------------------------------ 207
+GL+YLH K +I+ D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 208 -------------------EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
E K++D G A + TR Y + E +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
+D++S + E+ TG
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL--------HHPN 127
L+G+G FG+V K + VAIK + +N + +EV +L L+ ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYY-- 117
Query: 128 LVNLIGY-------CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAG 178
+V+L + C LV+E L +L+DL + + + + A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDK--THVSTR 234
L +L +I+ DLK NILL K+ DFG + +G + ++ +R
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSR 222
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y +PE + L D++S G +L+E+ TG
Sbjct: 223 F-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 86/248 (34%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HHPNLVN 130
+G+G FGRV + + A+K + RN + R +E +L + ++ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 131 LIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTTRMRIAA 177
G C L++E PLG SL + + + +
Sbjct: 101 YHGKFMYYDHMC-------LIFE--PLGPSLYEIITRNNYNGFHIEDIK-------LYCI 144
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP------------------------- 212
K L YL + + + DLK NILL + Y
Sbjct: 145 EILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 213 KLSDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGV 263
KL DFG A H ++TR Y APE + + SD++SFG
Sbjct: 202 KLIDFGCATF---KSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGC 247
Query: 264 VLLEIITG 271
VL E+ TG
Sbjct: 248 VLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 51/246 (20%), Positives = 80/246 (32%), Gaps = 86/246 (34%)
Query: 76 LLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL--------HHP 126
LGEG FG+V + VA+K + RN + +E+ +L +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKFL- 83
Query: 127 NLVNLIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTTRM 173
V + + C + +E LG + + L + P R
Sbjct: 84 -CVLMSDWFNFHGHMC-------IAFE--LLGKNTFEFLKENNFQPYPLPHVR------- 126
Query: 174 RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-------------------KL 214
+A L +LH+ + + DLK NIL ++
Sbjct: 127 HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 215 SDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVL 265
+DFG A + H V+TR Y PE +A DV+S G +L
Sbjct: 184 ADFGSATF---DHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCIL 229
Query: 266 LEIITG 271
E G
Sbjct: 230 FEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 56/248 (22%), Positives = 90/248 (36%), Gaps = 90/248 (36%)
Query: 76 LLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHP---- 126
LGEG FG+V + ++ + VA+K + +N + E+ +L L+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 127 --NLVNLIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTT 171
V ++ + C +V+E LG S D + + D R
Sbjct: 76 TFRCVQMLEWFEHHGHIC-------IVFE--LLGLSTYDFIKENGFLPFRLDHIR----- 121
Query: 172 RMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP------------------- 212
++A K + +LH + + DLK NIL + +
Sbjct: 122 --KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 213 KLSDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGV 263
K+ DFG A D+ H VSTR Y APE ++ DV+S G
Sbjct: 177 KVVDFGSATY---DDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGC 222
Query: 264 VLLEIITG 271
+L+E G
Sbjct: 223 ILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 7e-05
Identities = 44/264 (16%), Positives = 74/264 (28%), Gaps = 58/264 (21%)
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137
G G G K VA+ +Q +F ++ L+L C
Sbjct: 157 GVLGSG---K-------TWVALDVCLSYKVQCKMDF--KIFWLNL----------KNCNS 194
Query: 138 GDQRL-----LVYEYMP-LGSLEDHLHDLPPDKKRL-DWTTRMRIAAGAAKGLEYLHDKA 190
+ L L+Y+ P S DH ++ + R+ + L L +
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254
Query: 191 NPPVI-YRDLKCSNILLGEGYHPKLS-DFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 245
N +L C ILL + + TH+S + E
Sbjct: 255 NAKAWNAFNLSCK-ILL-------TTRFKQVTDFLSAATTTHISL-DHHSMTLTPDEVKS 305
Query: 246 ----YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
Y L +V + L II W + K +
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT---------WDNWKHVNCDKLT 356
Query: 302 QMADPTLQGQYP--VRGLYQALAV 323
+ + +L P R ++ L+V
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLSV 380
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.67 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.24 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.73 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.65 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.74 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-61 Score=442.51 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=217.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
..|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+++.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998766566677889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+||+|.+++.. .++++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 99999999864 56999999999999999999999999 999999999999999999999999999864322
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......+||+.|||||++.+..|+.++|||||||++|||++|..||......... ..+... ..+.
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------~~i~~~-------~~~~- 289 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM------KMIRDN-------LPPR- 289 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-------SCCC-
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHHcC-------CCCC-
Confidence 22344578999999999999999999999999999999999999999865432211 111110 0011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...+...+.++.+||.+||+.||++|||+.|+++|-+...
T Consensus 290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 1112344568899999999999999999999999977543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=437.16 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=214.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+++.++||||++++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999999999999999997532 233467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999975 467999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
..........+||+.|||||++.+..|+.++|||||||++|+|++|..||....... ....+.....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKIIKLEY------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC-------
Confidence 444444556789999999999999999999999999999999999999998654321 1111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
.++...+.++.+||.+||+.||++|||+.|++.+
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1223345578899999999999999999986433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=444.69 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=207.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999999765433 34568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
||+||+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-- 176 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC--
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec--
Confidence 99999999999652 2456799999999999999999999999 9999999999999999999999999998532
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........+||+.|||||++.+..|+.++|||||||++|||++|..||....... ........ .+ +
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~--~~-----~ 243 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIISG--SF-----P 243 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHT--CC-----C
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC--CC-----C
Confidence 11222345689999999999999999999999999999999999999998654321 11111111 00 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+...+.++.+||.+||+.||++|||+.|+++|-+
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 112234557889999999999999999999998744
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=435.38 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=211.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.|++.++||+|+||.||+|+++.+|+.||||+++..... .+|+.+++.++|||||++++++.+.+.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4688899999999999999999999999999999765332 36999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccccCCCC
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 227 (376)
+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999976 467999999999999999999999999 99999999999999887 69999999998643322
Q ss_pred cc---eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 228 KT---HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 228 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|..||.......... .+......+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCCc----
Confidence 11 11233679999999999999999999999999999999999999998654432211 111111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
..++...+..+.+||.+||+.||++|||+.||+++|...-..
T Consensus 276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 122334456888999999999999999999999998776543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-61 Score=433.04 Aligned_cols=262 Identities=30% Similarity=0.429 Sum_probs=216.8
Q ss_pred cCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
++|.+.+.||+|+||.||+|++. .++..||||+++.......+.+.+|+.++++++|||||++++++.+.+..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56889999999999999999875 3578899999987666666789999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 144 VYEYMPLGSLEDHLHDLP---------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
|||||++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 23457999999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......... ...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~------~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------ECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHH
Confidence 99999986444333333344679999999999999999999999999999999998 89999875432211 111
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. . . ....|...+.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 244 ~~-~-~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQ-G-R---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HH-T-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hc-C-C---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 0 0 012233445678899999999999999999999999998865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-60 Score=444.70 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=217.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666777899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+||+|.+++.. .++++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999864 56999999999999999999999999 999999999999999999999999999864322
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......+||+.|||||++.+..|+.++|||||||++|||++|..||......... ..+... ..+.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------~~i~~~-------~~~~~ 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM------KMIRDN-------LPPRL 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-------CCCCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHHcC-------CCCCC
Confidence 22344578999999999999999999999999999999999999999865432211 111110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
......+.++.+||.+||+.||++|||+.|+++|-+...
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 112234558889999999999999999999999877543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=433.52 Aligned_cols=262 Identities=30% Similarity=0.465 Sum_probs=210.4
Q ss_pred cCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
++|.+.++||+|+||.||+|++. .++..||||+++.......+.|.+|+.++++++|||||++++++.+....||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46788899999999999999875 3588999999987666666789999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 144 VYEYMPLGSLEDHLHDLPP-----------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
|||||++|+|.+++..... ...++++.+++.|+.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 2346999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
||+|||+++..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||......... .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~------~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------D 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH------H
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH------H
Confidence 9999999986544443334455789999999999999999999999999999999999 89999865432211 1
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.... .. ....|...+..+.+|+.+||+.||++|||+.||+++|+.+..
T Consensus 272 ~i~~-g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQ-GR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHH-TC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHc-CC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 00 012233445678899999999999999999999999998865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=418.97 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=198.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+|+.||||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976433 23456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||| +|+|.+++.. ..++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999876 467999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
. ......+||+.|+|||++.+..| +.++|||||||++|+|++|..||....... ..........
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i~~~~~------ 229 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNISNGVY------ 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC------
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC------
Confidence 2 22345789999999999998876 579999999999999999999998653321 1111111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.++...+.++.+||.+||+.||++|||+.|+++|-+.
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 1222345578899999999999999999999998774
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=421.25 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=205.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|++.. .||||+++.... ...+.+.+|+.++++++|||||++++++.+ +.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 568889999999999999998753 499999875432 334678999999999999999999998865 56899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
||++|+|.+++.. ...++++..+..|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999975 3467999999999999999999999999 999999999999999999999999999864433
Q ss_pred CcceeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.........+||+.|||||++.+ +.|+.++|||||||++|||+||..||......... ....... .
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~-----~ 254 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRG-----Y 254 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTT-----C
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC-----C
Confidence 33333455789999999999964 35899999999999999999999999865432110 1111110 1
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+.+ ...+...+..+.+|+.+||+.||++|||+.+|+++|+.++.
T Consensus 255 ~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 12233445678899999999999999999999999998864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=424.33 Aligned_cols=260 Identities=29% Similarity=0.421 Sum_probs=213.0
Q ss_pred cCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.++++.+.||+|+||.||+|.+. .+++.||||+++.... ...+.|.+|+.++++++|||||+++|++.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35778899999999999999864 3578999999975433 33467999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC
Q 017175 143 LVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~ 210 (376)
||||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1346899999999999999999999999 99999999999999999
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 289 (376)
.+||+|||+++.....+........+||+.|||||++.++.|+.++|||||||++|||+| |..||......+. ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~~- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---VE- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---HH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---HH-
Confidence 999999999986443333333445689999999999999999999999999999999998 8999987543221 11
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
. +.... ....|...+..+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 259 --~-i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --M-IRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --H-HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --H-HHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11110 1122334556788999999999999999999999999865
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-59 Score=418.66 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=203.0
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec----CCceEEE
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 144 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv 144 (376)
|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3677889999999999999999999999999975432 234568899999999999999999999865 3458999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~ 223 (376)
||||+||+|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||||+|||++. +|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999976 467999999999999999999999975 34999999999999974 789999999999753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .....+||+.|||||++.+ .|+.++|||||||++|||++|..||....... ......... .
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~~~------~ 246 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSG------V 246 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTT------C
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHHcC------C
Confidence 221 2345689999999998865 69999999999999999999999997543211 111111000 0
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..+. ++...+.++.+||.+||+.||++|||+.|+++|-+.
T Consensus 247 ~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 247 KPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp CCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0001 111223468899999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=423.16 Aligned_cols=252 Identities=27% Similarity=0.337 Sum_probs=204.7
Q ss_pred cCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999873 4688999999975432 223467889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|||||+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .......+||+.|||||++.+..|+.++|||||||++|+|++|..||........ .........
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~~----- 243 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMILKAKL----- 243 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-----
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHHcCCC-----
Confidence 222 2223457899999999999999999999999999999999999999986543211 111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
.+|...+.++.+||.+||+.||++||| ++|+++|-+.
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 123334567889999999999999998 5789887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=419.90 Aligned_cols=264 Identities=27% Similarity=0.374 Sum_probs=215.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCcc-chHHHHHHHHHHhhcCC-CCccceeEEEecC-
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHH-PNLVNLIGYCADG- 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~- 138 (376)
-.++|++.+.||+|+||.||+|.+..+ ++.||||.+...... ..+.+.+|+.+++++.| ||||+++++|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 357899999999999999999998654 368999999765433 34568899999999975 8999999999764
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
..+++|||||++|+|.++++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 568999999999999999975321 1345899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-- 296 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 296 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999986544444444556789999999999999999999999999999999998 9999986543211
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
........ .....|...+.++.+|+.+||+.||++|||+.+|+++|..+-
T Consensus 297 ----~~~~i~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 297 ----FCRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp ----HHHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111111 011223334557889999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=404.95 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=193.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCC-------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------- 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------- 139 (376)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 45699999999999999999999999999999999755433 3356889999999999999999999987544
Q ss_pred -----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 140 -----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 140 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
++|+|||||+||+|.+++.... .....++..++.++.||++||+|||+++ |+||||||+|||++.+|.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 3689999999999999997632 1233566778999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcc----------eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 017175 215 SDFGLAKLGPVGDKT----------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 284 (376)
+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||......
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--- 233 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--- 233 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---
Confidence 999999864332211 11234579999999999999999999999999999999996 77643210
Q ss_pred chhhhhhhhhhcccccccccCCcCCCCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 285 NLVAWARPLFKDRRKFSQMADPTLQGQYP---VRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....... . ...++ ......+.+||.+||+.||++|||+.|++++-+
T Consensus 234 --~~~~~~~----------~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 234 --VRTLTDV----------R----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp --HHHHHHH----------H----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred --HHHHHHH----------h----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 0000000 0 01122 123345678999999999999999999998755
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=401.26 Aligned_cols=273 Identities=24% Similarity=0.308 Sum_probs=201.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC----ceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~l 143 (376)
.++|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++||||+++++++.+.+ .+||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 356889999999999999999985 89999999965421 1122334666677889999999999997654 5799
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-----NPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-----~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
|||||++|+|.++++. .++++..+..++.|++.||.|||++. .++|+||||||+|||++.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999975 46899999999999999999999871 1229999999999999999999999999
Q ss_pred cccccCCCCcce--eecccccccCcccccccccC------CCCcccchhhHHHHHHHHHhCCCCCCCccccccc--chhh
Q 017175 219 LAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH--NLVA 288 (376)
Q Consensus 219 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~ 288 (376)
+++......... .....+||+.|||||++.+. .++.++|||||||++|||+||..||......... ....
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 997643332221 12345799999999999764 3678999999999999999999887643321110 0000
Q ss_pred hhhhhhhcccccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 289 WARPLFKDRRKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
. ..... .....+.....+...| ......+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 234 ~-~~~~~--~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 S-DPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp S-SCCHH--HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-cchHH--HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0 00000 0000011111111222 24556788999999999999999999999999988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=408.50 Aligned_cols=275 Identities=23% Similarity=0.267 Sum_probs=210.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec------C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------G 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~ 138 (376)
+.++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 34689999999999999999999999999999999975433 233567899999999999999999998754 3
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
..+|||||||. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence 67899999996 689999865 568999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCC--cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 219 LAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 219 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
+++...... ........+||+.|+|||++.+. .|+.++||||+||++|||++|.+||......+....+........
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997543221 12233457899999999998875 569999999999999999999999987644322111110000000
Q ss_pred cc----------cccccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 296 DR----------RKFSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 296 ~~----------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.. ........+.... ......+.++.+||.+||..||++|||+.|+++|-+.-.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 00 0000000000000 001123457889999999999999999999999977543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=401.21 Aligned_cols=270 Identities=20% Similarity=0.241 Sum_probs=203.0
Q ss_pred HHhcCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
.+.++|++.+.||+|+||.||+|+++ .+++.||+|++.... ....+.+|+.+++.+ +||||++++++|.+.+++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 46688999999999999999999875 467899999986543 345678899999988 599999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEcccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLA 220 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg~~ 220 (376)
|+|||||+||+|.+++. .+++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999983 4899999999999999999999999 9999999999999876 89999999999
Q ss_pred cccCCCCc--------------------------ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCC
Q 017175 221 KLGPVGDK--------------------------THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRK 273 (376)
Q Consensus 221 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~ 273 (376)
+....... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 75322211 0112335799999999999876 58999999999999999999999
Q ss_pred CCCCccccc-ccchh-hhh--------hhhh-------------------hccc----cccccc----CCcCCCCCCHHH
Q 017175 274 AIDNTRAAG-EHNLV-AWA--------RPLF-------------------KDRR----KFSQMA----DPTLQGQYPVRG 316 (376)
Q Consensus 274 p~~~~~~~~-~~~~~-~~~--------~~~~-------------------~~~~----~~~~~~----~~~~~~~~~~~~ 316 (376)
||....... ....+ ... ...+ .... ...... ............
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 996543211 00000 000 0000 0000 000000 000000011123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 317 LYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 317 ~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+.++.+||.+||+.||++|||++|+++|-+.
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 4578899999999999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=418.99 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=215.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC--CceEEcccccccccCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG--YHPKLSDFGLAKLGPV 225 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~--~~~kl~Dfg~~~~~~~ 225 (376)
|+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999865 3467999999999999999999999999 9999999999999854 8999999999986543
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .....+||+.|||||++.+..|+.++|||||||++|+|++|..||......... ..+......+ .
T Consensus 310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~------~~i~~~~~~~----~ 376 (573)
T 3uto_A 310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL------RNVKSCDWNM----D 376 (573)
T ss_dssp TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHTTCCCC----C
T ss_pred CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------HHHHhCCCCC----C
Confidence 32 234468999999999999999999999999999999999999999865432211 1111111111 1
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
. ......+..+.+||.+||+.||++|||+.|+++|-+
T Consensus 377 ~----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 377 D----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp S----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred c----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 1 111223457889999999999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=417.44 Aligned_cols=253 Identities=27% Similarity=0.354 Sum_probs=207.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHH---HHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
++|++.++||+|+||.||+|+++.+|+.||||++.+... .......+ ++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 569999999999999999999999999999999965321 11222333 456667788999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
||||||+||+|..++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999976 467999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..... ....+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||......+...+ ........
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~~---- 410 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMA---- 410 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHCC----
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCCC----
Confidence 43222 334689999999999975 5799999999999999999999999976543221111 11111111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
..++...+.++.+||.+||+.||.+|++ +.||++|-++
T Consensus 411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 1223344568899999999999999998 7999988764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=372.42 Aligned_cols=281 Identities=41% Similarity=0.679 Sum_probs=238.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
...++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35678999999999999999999965 58899999998776666678899999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.........+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999765444557999999999999999999999999 99999999999999999999999999976433
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.............+.... .....+....+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHHhcC
Confidence 33333334456999999999999999999999999999999999999999876655544444433322 22234556666
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
+......+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6666677788899999999999999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=371.19 Aligned_cols=291 Identities=43% Similarity=0.731 Sum_probs=240.9
Q ss_pred ccccCHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEE
Q 017175 56 AHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGY 134 (376)
Q Consensus 56 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~ 134 (376)
...+++.++....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 356788899999999999999999999999999854 5889999999764332 23468899999999999999999999
Q ss_pred EecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeeecCCCCCcEEECCCCc
Q 017175 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK---ANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 135 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~~i~Hrdikp~Nill~~~~~ 211 (376)
+.+....++||||+++++|.+++.........+++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999987665666799999999999999999999999 8 999999999999999999
Q ss_pred eEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccc--cccchhhh
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA--GEHNLVAW 289 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~~~~~~ 289 (376)
+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||+..... .......+
T Consensus 173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 99999999986433322 2234456999999999999889999999999999999999999999743322 11222222
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.... ........+.+......++...+..+.+++.+||+.||.+|||+.+|+++|+......
T Consensus 252 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 252 VKGL-LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp HTTT-TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHHH-hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 2222 2233455666666777788888999999999999999999999999999999766543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=367.06 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=216.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34689999999999999999999999999999999976666666778899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999965 46899999999999999999999999 999999999999999999999999998764322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .......
T Consensus 170 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~~-------- 233 (297)
T 3fxz_A 170 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT-------- 233 (297)
T ss_dssp T--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS--------
T ss_pred c--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC--------
Confidence 2 22344679999999999999999999999999999999999999997654321110 0000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+...+..+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 234 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 234 -PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp -CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 001122344557889999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=370.04 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=212.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 457899999999999999999999999999999998654332 2355789999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999865 456999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ... ....
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~-------- 224 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEK-------- 224 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH----HHTT--------
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----Hhcc--------
Confidence 333333445689999999999988775 77899999999999999999999865432110 000 0000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..........+..+.+|+.+||+.||++|||+.|++++.+...
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 225 --KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp --CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 0000011233457789999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=368.79 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=212.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999996532 233456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999875 467999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~------- 222 (337)
T 1o6l_A 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEEI------- 222 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-------
T ss_pred C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH------HHHHHcCCC-------
Confidence 2 1223456899999999999999999999999999999999999999976543211 111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
.++...+..+.+||.+||+.||++|| ++.+|++|-+.
T Consensus 223 -----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 12233455788999999999999999 99999998664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=370.86 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=213.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999975432 33456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999865 467999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCcceeecccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
+. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||........ .........
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~------ 231 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RERVLRGKY------ 231 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC------
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC------
Confidence 32 23456799999999999888765 789999999999999999999987543211 111111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+...+..+.+|+.+||..||.+|||+.+++++-+.-.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 122234557889999999999999999999999977543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=363.97 Aligned_cols=265 Identities=28% Similarity=0.388 Sum_probs=217.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46799999999999999999999999999999999766666667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999976 3467999999999999999999999999 9999999999999999999999999997543222
Q ss_pred cce------------eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 228 KTH------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 228 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFL- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccc-
Confidence 111 11145799999999999999999999999999999999999999876433221110000 0000
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
+. ..+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 241 ---------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 241 ---------DR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ---------HH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---------cc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0111223367889999999999999999999999999886443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=367.05 Aligned_cols=257 Identities=25% Similarity=0.287 Sum_probs=212.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 567899999999999999999999999999999999764432 24678899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~D 216 (376)
+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999965 467999999999999999999999999 99999999999998877 799999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+...
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~i~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITAV 233 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc
Confidence 99998643322 23346799999999999998999999999999999999999999976543211 1111111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...+ ++.. ....+..+.+||.+||..||++|||+.++++|-+.
T Consensus 234 ~~~~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 234 SYDF----DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp CCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCC----Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 0000 0000 01234578899999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=361.00 Aligned_cols=267 Identities=31% Similarity=0.435 Sum_probs=206.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
..++|++.+.||+|+||.||+|.+. +..||||++...... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3568999999999999999999874 888999999765433 235688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999997521 1123899999999999999999999986 349999999999999999999999999997522
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~~~-------- 254 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------GFK-------- 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HHS--------
T ss_pred cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc--------
Confidence 22 12233467999999999999999999999999999999999999999865432111100 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCC
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDP 355 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~ 355 (376)
......+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.....+|
T Consensus 255 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 255 --CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp --CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred --CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0011223344457889999999999999999999999999988654433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=370.69 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=207.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ......+..|..+++.+ +||||+++++++.+....|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999997532 22345677899999987 69999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999975 467999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+.....
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~~~----- 241 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEV----- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCC-----
Confidence 222 2233456899999999999998999999999999999999999999986543211 111111111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHHHh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI------ADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~~L~~ 347 (376)
.++...+..+.+||.+||+.||++||++ .+|++|-+.
T Consensus 242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 1223344578899999999999999998 889887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=369.95 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=215.4
Q ss_pred hcCcccCceecccCceEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
.++|++.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999874 3456899999976533 2345688999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976421 1245899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986443333233344567889999999999999999999999999999999 999998654321111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
. .... .....+...+..+.+|+.+||+.||++||++.+|+++|+.+-..
T Consensus 317 ~-------~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 L-------LKEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H-------HHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-------HhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0000 01122334455788999999999999999999999999987653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=368.86 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=210.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.++||+|+||.||+|+++.+++.||+|++.+... .....+..|..++.++ +||||+++++++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3679999999999999999999999999999999975432 2234577899999877 79999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999875 467999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc---chhhhhhhhhhccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH---NLVAWARPLFKDRRKF 300 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 300 (376)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. .............
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 222 22344578999999999999999999999999999999999999999754322110 1111111111111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI------ADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~~L~~ 347 (376)
..++...+..+.+||.+||+.||++||++ .+|++|-++
T Consensus 279 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 279 ---------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred ---------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 12233445678899999999999999985 788888654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=364.01 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=212.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCC---eEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+..++ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999997554 4599999975432 334568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999965 3457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCc-ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 224 PVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 224 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......... .. ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~-~~----- 269 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS------SV-EE----- 269 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH------HH-HT-----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH------HH-Hc-----
Confidence 33321 112223456788999999998999999999999999999999 999997654321111 00 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 270 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 270 -----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 001112233455788999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=357.38 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=220.1
Q ss_pred cccCHHHHHHHhcC----------cccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC
Q 017175 57 HTFTFRELAAVTKN----------FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126 (376)
Q Consensus 57 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ 126 (376)
..++..++..+.+. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 44666666655543 77888999999999999999999999999999876666667889999999999999
Q ss_pred CccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 127 ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
||+++++++......++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 999999999999999999999999999999854 46999999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccch
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 286 (376)
+.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--- 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--- 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---
T ss_pred CCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 999999999999987643221 123346799999999999999999999999999999999999999976543211
Q ss_pred hhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 287 VAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....... ..+.. ......+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 250 ---~~~~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 250 ---MKRLRDS-------PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ---HHHHHHS-------SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ---HHHHhcC-------CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 1111110 01111 111233457889999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=362.92 Aligned_cols=272 Identities=25% Similarity=0.339 Sum_probs=209.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC----ceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~l 143 (376)
.++|++.+.||+|+||.||+|++. ++.||||++.... ........|+.+++.++||||+++++++.+.. .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999886 7999999996543 22344566899999999999999999998754 3699
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeeecCCCCCcEEECCCCceE
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK----------ANPPVIYRDLKCSNILLGEGYHPK 213 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----------~~~~i~Hrdikp~Nill~~~~~~k 213 (376)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999965 4599999999999999999999999 8 99999999999999999999
Q ss_pred EcccccccccCCCCcceeecccccccCcccccccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh
Q 017175 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 288 (376)
|+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|..||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999764444333333446799999999999863 45678999999999999999999998654332221111
Q ss_pred hhhhh--hhc--ccccccccCCcCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 289 WARPL--FKD--RRKFSQMADPTLQGQ-YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 289 ~~~~~--~~~--~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..... ... .........+.+... .....+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 10000 000 000000011111110 112445678999999999999999999999999998875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=359.49 Aligned_cols=259 Identities=15% Similarity=0.218 Sum_probs=214.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999999999999999986543 344567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC--CCceEEcccccccccC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~--~~~~kl~Dfg~~~~~~ 224 (376)
|++|++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999965 3456999999999999999999999999 999999999999987 7899999999998644
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.+. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+
T Consensus 156 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~~---- 222 (321)
T 1tki_A 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTF---- 222 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCC----
T ss_pred CCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHcCCCCC----
Confidence 332 23346799999999999988899999999999999999999999976543211 11111111000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+.... ...+..+.+|+.+||..||++|||+.|++++-+...
T Consensus 223 ~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 223 DEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred Chhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 00000 122457889999999999999999999999988654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=365.96 Aligned_cols=262 Identities=20% Similarity=0.227 Sum_probs=211.3
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-----ccchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 5678999999999999999999999999999999986321 12356788999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc---eEEcccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFG 218 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~---~kl~Dfg 218 (376)
|+||||++|++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999887653233456899999999999999999999999 999999999999986655 9999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
++...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 179 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEGIIKGKY 249 (351)
T ss_dssp TCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHHHHHTCC
T ss_pred ceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHHHHcCCC
Confidence 99764332 22233467999999999999989999999999999999999999999864321 1111111100
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
. ..+... ...+..+.+||.+||+.||++|||+.++++|-+..
T Consensus 250 ~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 250 K----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp C----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred C----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 0 000000 12245788999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=371.08 Aligned_cols=260 Identities=20% Similarity=0.225 Sum_probs=212.7
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 5678999999999999999999999999999999999765433 33568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~~kl~Dfg~~ 220 (376)
||||+.||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999876 466999999999999999999999999 99999999999998 5678999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~- 231 (444)
T 3soa_A 161 IEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------YQQIKAGAYD- 231 (444)
T ss_dssp BCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTCCC-
T ss_pred EEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhCCCC-
Confidence 753322 2223446799999999999998999999999999999999999999976543211 1111111100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...+ . ....+..+.+||.+||+.||++|||+.+++++-+.-
T Consensus 232 --~~~~-~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 232 --FPSP-E----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp --CCTT-T----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred --CCcc-c----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 0011 1 112345788999999999999999999999986643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=353.66 Aligned_cols=276 Identities=18% Similarity=0.237 Sum_probs=217.3
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCC--ceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~l 143 (376)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3578999999999999999999999999999999997543 233466789999999999999999999998755 7899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----CCCCceEEccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGL 219 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill----~~~~~~kl~Dfg~ 219 (376)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999997632 1233999999999999999999999999 9999999999999 7888899999999
Q ss_pred ccccCCCCcceeecccccccCcccccccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAM--------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......... ....
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~ 237 (319)
T 4euu_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMY 237 (319)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH--HHHH
T ss_pred ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH--HHHH
Confidence 98643332 223457999999999986 4678999999999999999999999997543322111 1111
Q ss_pred hhhhc-cc----cccccc--------CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 292 PLFKD-RR----KFSQMA--------DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 292 ~~~~~-~~----~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
..... +. ...... .-.....+.......+.+++.+||+.||++|||+.|++++.++.+-.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 11110 00 000000 01112244567788999999999999999999999999999977643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.94 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=211.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999996532 233456778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999986322
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~------- 220 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAEL------- 220 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCC-------
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-------
Confidence 1234679999999999999999999999999999999999999997654321 1111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
.++...+..+.+++.+||+.||++|| ++++|++|-+.
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 12233445788999999999999999 99999988664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=363.49 Aligned_cols=258 Identities=20% Similarity=0.250 Sum_probs=212.0
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 5678899999999999999999999999999999999765432 34568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~Dfg~~ 220 (376)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999865 467899999999999999999999999 99999999999997654 5999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+
T Consensus 179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------~~~i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YAQIKAGAYDY 249 (362)
T ss_dssp BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCC
T ss_pred eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCCCCC
Confidence 7643222 22346799999999999998999999999999999999999999976543211 11111110000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..+ .....+..+.+||.+||+.||++||++.+++++-+.
T Consensus 250 ---~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 250 ---PSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp ---CTT-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred ---Ccc-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 000 011234578899999999999999999999987553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=356.89 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=211.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 457799999999999999999999999999999999754332 34678899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~D 216 (376)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999965 467999999999999999999999999 99999999999999887 899999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~ 232 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSAV 232 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHHT
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHhc
Confidence 99998643322 223457999999999999889999999999999999999999999765332111 011000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...+ .. ......+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 233 ~~~~----~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 233 NYEF----ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCCC----CH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCc----Cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 0000 00 0001224478899999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=366.75 Aligned_cols=271 Identities=27% Similarity=0.383 Sum_probs=216.4
Q ss_pred HHHHHHHhcCcccCceecccCceEEEEEE-----ECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeE
Q 017175 61 FRELAAVTKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIG 133 (376)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~ 133 (376)
........++|++.+.||+|+||.||+|. ...+++.||||++...... ..+.+.+|+.++..+ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 33444456889999999999999999998 4566789999999764332 345688999999999 7899999999
Q ss_pred EEecCC-ceEEEEEccCCCchhhhhccCCCC-------------------------------------------------
Q 017175 134 YCADGD-QRLLVYEYMPLGSLEDHLHDLPPD------------------------------------------------- 163 (376)
Q Consensus 134 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------- 163 (376)
++.+.+ ..++||||+++|+|.+++......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998755 489999999999999999764221
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcce
Q 017175 164 -------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (376)
Q Consensus 164 -------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (376)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 122899999999999999999999999 9999999999999999999999999998654444333
Q ss_pred eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcCC
Q 017175 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309 (376)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (376)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ....... ..
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~----------~~ 314 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEG----------TR 314 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHT----------CC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcC----------CC
Confidence 4455678999999999999999999999999999999998 99999865432110 0011110 00
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+...+..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11222334578899999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=347.73 Aligned_cols=286 Identities=40% Similarity=0.624 Sum_probs=230.4
Q ss_pred cccccCHHHHHHHhcCcccC------ceecccCceEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhhcC
Q 017175 55 AAHTFTFRELAAVTKNFRAD------CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----LQGNREFLVEVLMLSLLH 124 (376)
Q Consensus 55 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~ 124 (376)
....|++.++..++++|... +.||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34668889999999888776 8999999999999987 47899999986532 223456889999999999
Q ss_pred CCCccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcE
Q 017175 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (376)
Q Consensus 125 h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Ni 204 (376)
||||+++++++.+....++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999986421 2356899999999999999999999999 99999999999
Q ss_pred EECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc
Q 017175 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284 (376)
Q Consensus 205 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 284 (376)
+++.++.++|+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 999999999999999976444333333445679999999998865 5889999999999999999999999875443221
Q ss_pred chhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 285 NLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.............+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+|+++|+.+..
T Consensus 244 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 --LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111122222333344333 24566778889999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=365.47 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=210.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 142 (376)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.... ......+..|..++..+ +||||+++++++.+....|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997532 22345677889988876 8999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++..
T Consensus 95 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999975 456999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~----- 234 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDN----- 234 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-----
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHhCC-----
Confidence 32222 223456899999999999999999999999999999999999999986543211 11111111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHHHh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIA-DVVTALTY 347 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~~L~~ 347 (376)
..++...+..+.+||.+||+.||++||++. +|++|-+.
T Consensus 235 -------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 235 -------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 012223455788999999999999999998 88776553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=361.83 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=205.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeE----EEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.++|++.+.||+|+||.||+|++..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46799999999999999999999877765 5888775432 234567889999999999999999999998754 78
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+|++|+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 89999999999999976 3467999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~~----- 234 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EK----- 234 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HT-----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-------Hc-----
Confidence 544443333344567889999999999999999999999999999999 99999865443211111 10
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
......+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 001112233455788999999999999999999999999988753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=371.66 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=212.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46799999999999999999999989999999998754322 23457889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999975 2456899999999999999999999999 999999999999999999999999999753222
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
..........+++.|+|||++.+..++.++|||||||++|||++ |..||......... ......
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~-------- 331 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKG-------- 331 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTT--------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC--------
Confidence 11111112335778999999998899999999999999999998 99999865432111 111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 332 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 --GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0111223344578899999999999999999999999998864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=351.89 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=211.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+.++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 457899999999999999999999999999999998654332 23567899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++|++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999975 457999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~------ 228 (294)
T 4eqm_A 162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS------ 228 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC------
T ss_pred ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc------
Confidence 32221 122345799999999999999999999999999999999999999986543211 00000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhccc
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-LIADVVTALTYLACQK 352 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~~~~~~ 352 (376)
. +..........+..+.+++.+||+.||++|| ++.++.+.|..+-...
T Consensus 229 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 229 V-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp C-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred C-CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 0000011122345788899999999999999 9999999998776543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=363.81 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=208.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeE----EEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35799999999999999999999887765 7788775432 223345678999999999999999999886 46789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999975 2457899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..............||..|+|||++.+..++.++|||||||++|+|++ |..||............ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~--- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGE--- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTC---
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCC---
Confidence 554444334455678889999999999999999999999999999999 99999875432211111 1000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
. ...+...+..+.+++.+||+.||++||++.+++++|+.+...
T Consensus 235 ~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 R-------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp B-------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C-------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 011111223566799999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=359.43 Aligned_cols=253 Identities=26% Similarity=0.327 Sum_probs=210.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999986432 12235688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6899888865 467999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.+. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... .+
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i 220 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KV 220 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CC
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HH
Confidence 322 2334679999999999988776 689999999999999999999998643321110 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... ....+...+..+.+|+.+||+.||.+|||+.|++++-+.-.
T Consensus 221 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 221 NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000 01223334567889999999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=369.49 Aligned_cols=265 Identities=28% Similarity=0.384 Sum_probs=212.0
Q ss_pred hcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999994 45678999999965432 3345688999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEc
Q 017175 142 LLVYEYMPLGSLEDHLHDLP---PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLS 215 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~ 215 (376)
++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 22356999999999999999999999999 99999999999999555 59999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~------i- 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF------V- 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH------H-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------H-
Confidence 9999974322222222334568999999999999999999999999999999998 9999987543211110 0
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.... ....+...+..+.+|+.+||+.||++|||+.+|+++|+.+....
T Consensus 300 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0000 01112233457889999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=362.83 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=214.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 35789999999999999999999999999999999976655555678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC--CCceEEcccccccccC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~--~~~~kl~Dfg~~~~~~ 224 (376)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++....
T Consensus 129 ~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999865 3456999999999999999999999999 999999999999974 5789999999998643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......... .
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~~~~~----~ 269 (387)
T 1kob_A 203 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE----F 269 (387)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCC----C
T ss_pred CCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC----C
Confidence 322 22335799999999999999999999999999999999999999986543211 1111111000 1
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
+. ......+..+.+||.+||+.||++|||+.+++++-+..
T Consensus 270 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 270 DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 11 11123345788999999999999999999999986643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=351.58 Aligned_cols=269 Identities=19% Similarity=0.259 Sum_probs=207.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997554332 3567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++ +|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9985 55555543 2467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CcceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc-----ccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-----RKF 300 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 300 (376)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ............ ...
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhh
Confidence 22233457899999999998765 89999999999999999998887643321110 000000000000 000
Q ss_pred cccc---------CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMA---------DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.... ............+..+.+|+.+||+.||++|||+.|+++|-+.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 0000 00011122234556888999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=362.67 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=202.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999999999999999997543 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc--eEEcccccccccCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFGLAKLGPV 225 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~--~kl~Dfg~~~~~~~ 225 (376)
+++++|.+++.. ..++++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999865 456999999999999999999999999 999999999999987765 99999999874222
Q ss_pred CCcceeecccccccCcccccccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......... ............
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~~------ 239 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKY------ 239 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTCC------
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCCC------
Confidence 21 2234579999999999988887655 89999999999999999999865432211 111111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
........+..+.+||.+||+.||++|||+.++++|-+....
T Consensus 240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000111234578899999999999999999999999887554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=353.30 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=202.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------------------------chHHHHHHHHHHh
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------------------------GNREFLVEVLMLS 121 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~ 121 (376)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999754321 1245789999999
Q ss_pred hcCCCCccceeEEEec--CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCC
Q 017175 122 LLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL 199 (376)
Q Consensus 122 ~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdi 199 (376)
.++||||+++++++.+ ....|+||||+++++|.+++. ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 568899999999999988653 357999999999999999999999999 999999
Q ss_pred CCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCC
Q 017175 200 KCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAID 276 (376)
Q Consensus 200 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~ 276 (376)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999997643222 2234467999999999997765 4788999999999999999999997
Q ss_pred CcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 277 NTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
...... .......... .... ....+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 242 ~~~~~~------~~~~~~~~~~------~~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 242 DERIMC------LHSKIKSQAL------EFPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp CSSHHH------HHHHHHHCCC------CCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CccHHH------HHHHHhcccC------CCCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 653221 1111111100 0000 1123447889999999999999999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=356.41 Aligned_cols=263 Identities=30% Similarity=0.436 Sum_probs=215.2
Q ss_pred hcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|.+.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468999999999999999999883 4568999999975432 3346788999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP--------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp 201 (376)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 1234899999999999999999999999 99999999
Q ss_pred CcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccc
Q 017175 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (376)
Q Consensus 202 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 280 (376)
+||+++.++.++|+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986444333333344567889999999999899999999999999999999 9999986544
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...... .... .....+...+..+.+++.+||+.||++||++.+|+++|+.+..
T Consensus 259 ~~~~~~-------~~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNL-------LKTG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHHH-------HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH-------hhcC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221111 0100 0111223345578899999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=359.03 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=209.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|+++.+++.||+|++...... ....+.+|..+++.+ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765332 234577899999887 799999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999875 457999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc---cchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE---HNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 301 (376)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ..............
T Consensus 162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 22 1223456899999999999999999999999999999999999999975322111 00111111111111
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHHHHh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI------ADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~ell~~L~~ 347 (376)
..++...+..+.+||.+||+.||++||++ .++++|-+.
T Consensus 236 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 236 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 01233445578899999999999999995 788887654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=359.79 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=212.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986532 23345688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999975 356999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~------ 255 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKV------ 255 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC------
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHcCCC------
Confidence 21 234679999999999999999999999999999999999999998654321 1111111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTYL 348 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~~ 348 (376)
.++...+..+.+||.+||+.||++||+ +.+|++|-+.-
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 122334557889999999999999998 99999887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=364.29 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=209.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986432 23346788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+.||+|..++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999975 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ......
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~---- 236 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFETTV---- 236 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHHCC----
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhhcc----
Confidence 322 2345689999999999974 458999999999999999999999997543322111111 111100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHH
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-IADVVTALT 346 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~~L~ 346 (376)
..++...+..+.+||.+||+.||.+||+ +.+|+++-+
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 1223334558889999999999999998 788877644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=363.64 Aligned_cols=269 Identities=27% Similarity=0.391 Sum_probs=218.8
Q ss_pred hcCcccCceecccCceEEEEEEECC-------CCeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
.++|.+.+.||+|+||.||+|.+.. .+..||+|++...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4789999999999999999999753 3367999999765332 336688999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976431 1246999999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~- 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999986544333333444568899999999999999999999999999999999 99999865432111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCCC
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPE 356 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~~ 356 (376)
.. .... .....+...+..+.+|+.+||+.||++|||+.+|+++|+.+........
T Consensus 304 -----~~-~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 304 -----KL-LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -----HH-HHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -----HH-HHcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 11 1110 0111222334578899999999999999999999999999986554433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=355.66 Aligned_cols=277 Identities=28% Similarity=0.381 Sum_probs=211.9
Q ss_pred hcCcccCceecccCceEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--CCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 141 (376)
.++|++.+.||+|+||.||+|+ +..+++.||||++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5789999999999999999998 566899999999987665556778899999999999999999999865 3568
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999976 2456999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||.................... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH-HHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh-HHHH
Confidence 64332211 122334577889999999999999999999999999999999999875432100000000000000 0000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
...+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000011111122334456888999999999999999999999999988653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=362.22 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=211.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999999999999999997532 23345677899999887 79999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999975 356999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~----- 238 (353)
T 2i0e_A 172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNV----- 238 (353)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-----
T ss_pred ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCCC-----
Confidence 222 122345689999999999999999999999999999999999999998654321 1111111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
.++...+..+.+||.+||+.||++||+ +.+|++|-+.
T Consensus 239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 123344568889999999999999995 6899888654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=347.41 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=212.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3679999999999999999999874 7789999997554 3446788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999965 3456899999999999999999999999 9999999999999999999999999997532221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~------~~~~~~---------- 223 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTG---------- 223 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTT----------
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhcC----------
Confidence 112233457788999999998999999999999999999999 99999865432111 111000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0111122234578899999999999999999999999998864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=354.38 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=206.3
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+.++|++.+.||+|+||.||+|.+.. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 56789999999999999999999864 899999999754322 235678999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99998 588887765 3456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc--cccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR--RKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 301 (376)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+. ...... ....
T Consensus 171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF---SILGTPNPREWP 245 (311)
T ss_dssp SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH---HHHCCCCTTTSG
T ss_pred CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---HHHCCCChHHhh
Confidence 222 22334578999999999876 568999999999999999999999998654432211110 000000 0000
Q ss_pred -------------cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 -------------QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...............+.++.+|+.+||+.||++|||+.|+++|-+.-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 000000000001123457889999999999999999999999866443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=353.33 Aligned_cols=264 Identities=21% Similarity=0.217 Sum_probs=212.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++.+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 45789999999999999999999999999999999875432 34577899999999 8999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc-----eEEcccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLSDFGLA 220 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~-----~kl~Dfg~~ 220 (376)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 89999999762 467999999999999999999999999 999999999999998887 999999999
Q ss_pred cccCCCCcce-----eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 221 KLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 221 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~ 234 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG---D 234 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH---H
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH---h
Confidence 8643332211 1234679999999999999999999999999999999999999998764332211111110 0
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.... ........ ..+ .+.+++..||+.||.+||++.+|.+.|..+..
T Consensus 235 ~~~~---~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 235 TKRA---TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHH---SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhcc---CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 00000000 122 78899999999999999999999999987764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=356.42 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=197.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCe---EEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCce-
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR- 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~- 141 (376)
.++|++.+.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4679999999999999999999887665 79999997542 33456788999999999999999999999877655
Q ss_pred -----EEEEEccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 142 -----LLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 142 -----~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 99999999999999985421 22236899999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||........... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~------~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY------L 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH------H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH------H
Confidence 99999976443333333334557889999999999999999999999999999999 9999987544321111 1
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
.... ....+...+..+.+|+.+||+.||++|||+.++++.|+.+-...+.
T Consensus 253 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 IGGN-----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HTTC-----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcCC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 0000 0112223445788999999999999999999999999998875544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=365.95 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=211.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3468999999999999999999999999999999986421 1223457789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...
T Consensus 147 V~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999865 46899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeecccccccCcccccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ..+......
T Consensus 219 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~~ 291 (410)
T 3v8s_A 219 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHKNS 291 (410)
T ss_dssp CTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTHHHH
T ss_pred ccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH------HHHHhcccc
Confidence 3222 12234578999999999998765 789999999999999999999999865432111 111111000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHhhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTYLA 349 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~~~ 349 (376)
+ .-+ .....+..+.+||.+||+.+|.+ ||++.||++|-+.-.
T Consensus 292 ~---~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 292 L---TFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp C---CCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred c---cCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 0 000 00123457889999999999988 999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=369.07 Aligned_cols=264 Identities=21% Similarity=0.226 Sum_probs=212.9
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
....++|++.++||+|+||.||+|++..+++.||+|++..... .....+.+|..++..++||||+++++++.+....
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 3345789999999999999999999999999999999964221 1223477899999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
|+||||++||+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 150 ~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp EEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999975 2467999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
...... .......+||+.|+|||++. ...++.++|||||||++|||++|..||......... ..+...
T Consensus 224 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~ 296 (437)
T 4aw2_A 224 KLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNH 296 (437)
T ss_dssp ECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTH
T ss_pred hcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------Hhhhhc
Confidence 543322 22233468999999999997 457899999999999999999999999865433211 111111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHHHhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNM--RPLIADVVTALTYL 348 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~ell~~L~~~ 348 (376)
.. ...-+.. ....+..+.+||.+||+.+|++ ||+++|+++|-+.-
T Consensus 297 ~~---~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 297 KE---RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp HH---HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred cc---cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 00 0001111 1123457889999999998888 99999999997753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=358.36 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=212.7
Q ss_pred hcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999997 3457789999997542 23446788999999999 89999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPD-------------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp 201 (376)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999763211 134899999999999999999999999 99999999
Q ss_pred CcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccc
Q 017175 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (376)
Q Consensus 202 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 280 (376)
+||+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999976444433334445668899999999999999999999999999999998 9999976543
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
... ....... ......+...+..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus 281 ~~~------~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DAN------FYKLIQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHH------HHHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH------HHHHHhc----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 211 0011111 011122233455788999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=354.48 Aligned_cols=276 Identities=23% Similarity=0.315 Sum_probs=198.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999975432 234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 147 YMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 147 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|++ ++|.+++... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888642 122346899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-h----hhhhccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-R----PLFKDRR 298 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~----~~~~~~~ 298 (376)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... . ..+....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 221 223345789999999999764 6899999999999999999999999865433211111000 0 0000000
Q ss_pred ccccccCCcCC------------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 299 KFSQMADPTLQ------------GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 299 ~~~~~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..... .+... .......+..+.+|+.+||+.||++|||+.+++++-+.-..
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 238 KLPKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GCTTC-CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhc-ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 00000 00000 00011234578899999999999999999999998775553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=373.10 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=203.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999999999999999999753 223335577899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999865 4679999999999999999999998 89 999999999999999999999999999752
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~~----- 366 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEEI----- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC-----
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHHhCCC-----
Confidence 222 22234568999999999999999999999999999999999999999765432111 11111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYL 348 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~ 348 (376)
.++...+..+.+||.+||+.||.+|| ++.++++|-+.-
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 12233445788999999999999999 999999986654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=344.50 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=212.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4689999999999999999998864 67899999976543 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999875 2456999999999999999999999999 9999999999999999999999999997643332
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... ..... ..
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~----~~---- 223 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQG----HR---- 223 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTT----CC----
T ss_pred h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HHHcC----CC----
Confidence 2 22233456788999999998899999999999999999999 999998654321110 00000 00
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+...+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 01112234478899999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=359.87 Aligned_cols=265 Identities=27% Similarity=0.438 Sum_probs=214.1
Q ss_pred HhcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
..++|++.+.||+|+||.||+|.+. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999987 34589999999765332 34568899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCC
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPD--------------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK 200 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdik 200 (376)
.++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999999764221 257999999999999999999999999 9999999
Q ss_pred CCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcc
Q 017175 201 CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (376)
Q Consensus 201 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 279 (376)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999975332222222334568899999999999999999999999999999999 999998654
Q ss_pred cccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 280 AAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
..... ... ... .. ...+...+..+.+|+.+||+.||++||++.+|+++|+.+...
T Consensus 282 ~~~~~------~~~-~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 HEEVI------YYV-RDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHH------HHH-HTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred hHHHH------HHH-hCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 32111 000 000 00 012233445788999999999999999999999999988753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=355.96 Aligned_cols=260 Identities=24% Similarity=0.282 Sum_probs=209.2
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++...... ..+|+.++.++ +||||+++++++.+....|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999999999999999999765332 34688888877 799999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC----CceEEcccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG----YHPKLSDFGLA 220 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~----~~~kl~Dfg~~ 220 (376)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999875 456999999999999999999999999 9999999999998433 35999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+ ...+.....
T Consensus 168 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~~~~-- 240 (342)
T 2qr7_A 168 KQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGKF-- 240 (342)
T ss_dssp EECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHHCCC--
T ss_pred ccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHccCCc--
Confidence 8643322 223346799999999999888899999999999999999999999986432211111 111111100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+........+..+.+||.+||+.||++||++.++++|-+...
T Consensus 241 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 241 ------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp ------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 0111122234557889999999999999999999999988654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=353.44 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=199.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCc---
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--- 140 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999997653332 3467889999999999999999999876543
Q ss_pred -eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 141 -RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 141 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4999999999999999975 456999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 220 AKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 220 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC
Confidence 9753322211 122345699999999999999999999999999999999999999986543211 011111100
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.... .. ....+..+.+|+.+||+.||++||++.+++.+-.
T Consensus 237 ~~~~----~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 237 IPPS----AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp CCHH----HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCcc----cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 0000 00 0123447889999999999999997777665544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=363.59 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=201.8
Q ss_pred hcCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
..+|++.+.||+|+||.||+|++. .++..||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999886 4577899999975432 234568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 3457999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 224 PVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 224 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ... ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~------~~i-~~~---- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI------KAV-DEG---- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH------HHH-HTT----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-HcC----
Confidence 3322111 1122345788999999999999999999999999999998 99999765432111 000 000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00111223445788999999999999999999999999988653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=348.29 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=203.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 56899999999654322 23678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9974 89888865 2466899999999999999999999999 999999999999999999999999999753222
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc-----ccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-----RKF 300 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 300 (376)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+..... . ...... ...
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~-~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI--F-RILGTPNSKNWPNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-HHHCCCCTTTSTTG
T ss_pred c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-HHHCCCChhhchhh
Confidence 1 122345789999999999764 5899999999999999999999999865432211000 0 000000 000
Q ss_pred cc--ccCCcC-------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 301 SQ--MADPTL-------QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 301 ~~--~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.. ..++.. ...+....+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00 000000 001112345578899999999999999999999988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=353.60 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=202.4
Q ss_pred hcCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 6799999999976432 233457789999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999875 456899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~-- 238 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKILKCKL-- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTCC--
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCCC--
Confidence 742221 1223346799999999999999999999999999999999999999986543211 111111110
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
.++...+..+.+|+.+||+.||++|| ++.++++|-+.
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 12233455788999999999999999 88999998664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=352.06 Aligned_cols=265 Identities=27% Similarity=0.415 Sum_probs=215.8
Q ss_pred hcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 45678999999975543 3346788999999999 89999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP--------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976321 1235899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 9999999999999986544443333444568889999999999999999999999999999999 9999976543211
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
. ....... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+-..
T Consensus 257 ~----~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 F----YKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp H----HHHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHhccC----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0 0111100 00111223345788999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=348.18 Aligned_cols=274 Identities=25% Similarity=0.333 Sum_probs=207.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999999999999999986554322 355778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999988764 466999999999999999999999999 99999999999999999999999999976332
Q ss_pred CCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh--------hhhhhc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA--------RPLFKD 296 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 296 (376)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+........ ...+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 2 222334579999999999976 56899999999999999999999999876543221111100 001111
Q ss_pred ccccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 297 RRKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+.....+......+ ...+..+.+|+.+||+.||++|||+.+++++-+.-..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 11111111111110000 1234578899999999999999999999998775443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=355.35 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=197.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 5678999999999999999999999999999999997543 34567789999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEccccccccc
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFGLAKLG 223 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Dfg~~~~~ 223 (376)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999865 456899999999999999999999999 999999999999975 889999999999753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...........
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~~---- 269 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEYY---- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCCC----
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCCc----
Confidence 222 122346799999999999998999999999999999999999999976443210 11111111000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... ......+..+.+|+.+||+.||++|||+.+++++-+...
T Consensus 270 ~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 311 (349)
T 2w4o_A 270 FIS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311 (349)
T ss_dssp CCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred cCC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 011 111233457889999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=357.88 Aligned_cols=279 Identities=28% Similarity=0.371 Sum_probs=215.7
Q ss_pred hcCcccCceecccCceEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEe--cCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~ 141 (376)
.++|++.+.||+|+||.||+|+ +..+++.||+|++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3679999999999999999999 46779999999998776666677899999999999999999999886 45678
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999875 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 222 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc--cccccHHHH
Confidence 644333221 22335688899999999998999999999999999999999999976543210000000 000000000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
...+........+...+..+.+|+.+||+.||++|||+.+|+++|+.+......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 011111111223344556888999999999999999999999999998765444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=361.09 Aligned_cols=275 Identities=17% Similarity=0.206 Sum_probs=210.1
Q ss_pred hcCcccCceeccc--CceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+| +||.||+|++..+++.||||++...... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 9999999999999999999999754322 23567789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998762 2356999999999999999999999999 999999999999999999999999998642
Q ss_pred CCCCc-----ceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 224 PVGDK-----THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 224 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCc
Confidence 21111 111223478999999999987 578999999999999999999999997644322110 000000000
Q ss_pred ccc---------------------ccccc---------CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 297 RRK---------------------FSQMA---------DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 297 ~~~---------------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... ..... ........+...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 000 00000 000000122334567899999999999999999999999866
Q ss_pred hhh
Q 017175 347 YLA 349 (376)
Q Consensus 347 ~~~ 349 (376)
.-.
T Consensus 337 f~~ 339 (389)
T 3gni_B 337 FKQ 339 (389)
T ss_dssp GGG
T ss_pred HHH
Confidence 443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=346.18 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=209.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999887 47789999997554 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999975 2456999999999999999999999999 9999999999999999999999999997532221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... .....
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~~~~---------- 237 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQG---------- 237 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTT----------
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HHhcc----------
Confidence 112223457788999999998899999999999999999998 999998654321111 00000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 238 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0011122234578899999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=344.74 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=207.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccch-------HHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4689999999999999999999999999999999865433221 56889999999999999999999997655
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc-----eEEc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLS 215 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~-----~kl~ 215 (376)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998865 3567999999999999999999999986 35999999999999988776 9999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||......... .....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMI 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHH
Confidence 9999974221 233467999999999984 456789999999999999999999999765432110 00000
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.. .......+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 243 ~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE----------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH----------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc----------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 0111122334455788999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=342.34 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=214.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+.++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 35678999999999999999999999999999999998766666778999999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~~ 222 (376)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999998865 456899999999999999999999999 9999999999999 7889999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......... ........
T Consensus 159 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~---- 224 (277)
T 3f3z_A 159 FKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LKIREGTF---- 224 (277)
T ss_dssp CCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC----
T ss_pred ccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCCC----
Confidence 43322 2234579999999999865 4899999999999999999999999865432111 11111000
Q ss_pred ccCCcCCCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPV----RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+. ..+..+.+|+.+||+.||++|||+.+++++-+.-..
T Consensus 225 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 225 --------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred --------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 0111 224578899999999999999999999998775443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=353.87 Aligned_cols=263 Identities=24% Similarity=0.297 Sum_probs=190.2
Q ss_pred HhcCcccC---ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceE
Q 017175 67 VTKNFRAD---CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 67 ~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~ 142 (376)
+..+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 34566665 7899999999999999999999999999643 3356778999999997 999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceEEccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGL 219 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~kl~Dfg~ 219 (376)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999999999976 467999999999999999999999999 99999999999997766 899999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc-chhhhhhhhhhccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWARPLFKDRR 298 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 298 (376)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..............
T Consensus 156 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 156 ARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 9753322 22234467899999999999999999999999999999999999999865432111 11111111111000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+........+..+.+||.+||+.||++|||+.+++++-+.-.
T Consensus 234 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 234 --------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp --------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred --------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 0000000123557889999999999999999999998877543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=345.10 Aligned_cols=267 Identities=19% Similarity=0.224 Sum_probs=214.3
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4578999999999999999999999999999999986543 234577899999998 6999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc-----eEEcccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLSDFGLA 220 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~-----~kl~Dfg~~ 220 (376)
||+ +++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++. ++|+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 89999999762 456999999999999999999999999 999999999999987776 999999999
Q ss_pred cccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 221 KLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 764333221 123446799999999999999999999999999999999999999987543222111111100000
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
...... ... ..+..+.+++.+||+.||++||++.+|++.|..+....
T Consensus 239 -~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 239 -STPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -HSCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CccHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000000 011 22347889999999999999999999999999887543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=345.03 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=210.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999999999999999999864321 2235688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999875 356899999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ......
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-------- 222 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISRV-------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHT--------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH------HHHHhC--------
Confidence 21 223457999999999999989999999999999999999999999865432111 111000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
...++...+..+.+|+.+||+.||++|||+.+++++-+.-...
T Consensus 223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 0112223345788999999999999999999999998866543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=353.93 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=205.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeE----EEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46799999999999999999999887765 477776543 2344567889999999999999999999998764 78
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+|++|+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999976 3456999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~~----- 234 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EK----- 234 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HT-----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------Hc-----
Confidence 443333333334567889999999999999999999999999999999 99999875443211111 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
......+...+..+.+|+.+||+.||.+||++.++++.|..+...
T Consensus 235 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 -----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 001112233445788999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=342.22 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=198.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc----chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 357999999999999999999986 889999998754322 24568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC--------CCceEEc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--------GYHPKLS 215 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~--------~~~~kl~ 215 (376)
||||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999985 357999999999999999999999998555889999999999986 7789999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ....
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~- 227 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGVA- 227 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHH-
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhhh-
Confidence 999997532221 22357999999999999999999999999999999999999999865432110 0000
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
........+...+..+.+++.+||+.||++|||+.+++++|+.+
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 ---------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00111122233445788999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=345.92 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=217.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999999999999999996543 445678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999763 3456899999999999999999999999 999999999999999999999999999764332
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............ ..
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------~~--------- 227 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EK--------- 227 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HT---------
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hc---------
Confidence 2 223344567889999999999999999999999999999999 99999865433211110 00
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 228 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 228 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11112223344578899999999999999999999999988764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=348.16 Aligned_cols=257 Identities=25% Similarity=0.265 Sum_probs=211.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 467899999999999999999999999999999999754332 24678899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~D 216 (376)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999975 457899999999999999999999999 99999999999999888 799999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~ 233 (321)
T 2a2a_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITSV 233 (321)
T ss_dssp CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT
T ss_pred CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhc
Confidence 99997643322 22345799999999999988999999999999999999999999976533211 1111100
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
... .++.. ....+..+.+||.+||+.||++|||+.+++++-+.
T Consensus 234 ~~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 234 SYD----FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CCC----CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred ccc----cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 000 00000 01223478899999999999999999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=366.15 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=212.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999965322 2345688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999965 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.+. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ........
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~------ 232 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------FKKICDGI------ 232 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------HHHHHTTC------
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCC------
Confidence 322 2334679999999999988765 6899999999999999999999986543211 11111100
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. ..+...+..+.+|+.+||+.||++|||+.++++|-+...
T Consensus 233 ----~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 ----F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 0 112223457889999999999999999999999877544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=361.92 Aligned_cols=270 Identities=24% Similarity=0.329 Sum_probs=198.5
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcC-CCCccceeEEEecCC--c
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD--Q 140 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~--~ 140 (376)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 46789999999999999999999999999999999986432 233456778999999997 999999999997544 7
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
+|+|||||. ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 689998865 46899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-------------------cceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 221 KLGPVGD-------------------KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 221 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
+...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7532211 1112234689999999999987 5789999999999999999999999987643
Q ss_pred ccccchhhhhhhhhhcc--cccccc------------------cCCcCCCCCC------------HHHHHHHHHHHHHcc
Q 017175 281 AGEHNLVAWARPLFKDR--RKFSQM------------------ADPTLQGQYP------------VRGLYQALAVAAMCV 328 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~------------~~~~~~l~~li~~cl 328 (376)
......+. .....+ .....+ ........++ ...+..+.+|+.+||
T Consensus 237 ~~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 32211110 000000 000000 0000000000 022457889999999
Q ss_pred cCCCCCCCCHHHHHHHHHh
Q 017175 329 QEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 329 ~~~P~~Rps~~ell~~L~~ 347 (376)
+.||++|||+.|+++|-+.
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFV 332 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTT
T ss_pred ccCcccCCCHHHHhCCHHH
Confidence 9999999999999999553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=356.52 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=206.0
Q ss_pred cCccc--CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRA--DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..|.+ .+.||+|+||.||+|.+..+|+.||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34544 6789999999999999999999999999987666666788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE--CCCCceEEcccccccccC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL--GEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill--~~~~~~kl~Dfg~~~~~~ 224 (376)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999998865 3456899999999999999999999999 9999999999999 677899999999998643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+
T Consensus 241 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~~~---- 307 (373)
T 2x4f_A 241 PREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACRWDL---- 307 (373)
T ss_dssp TTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCS----
T ss_pred Cccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCCC----
Confidence 3322 2335699999999999988999999999999999999999999986543211 11111111100
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.... ....+..+.+||.+||+.||++|||+.+++++-+.-
T Consensus 308 ~~~~----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 308 EDEE----FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp CSGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred Chhh----hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 0000 112345788999999999999999999999976643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=349.48 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=206.4
Q ss_pred HhcCcccC-ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
+.++|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45789985 7899999999999999999999999999876555667888999999884 799999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc---eEEccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFGLAK 221 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~---~kl~Dfg~~~ 221 (376)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999975 456899999999999999999999999 999999999999988776 9999999987
Q ss_pred ccCCCCc-----ceeecccccccCccccccccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh----
Q 017175 222 LGPVGDK-----THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV---- 287 (376)
Q Consensus 222 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---- 287 (376)
....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 5322211 111223569999999999975 46889999999999999999999999865432210000
Q ss_pred -hhhhhhhhcccccccccCCcCCCCCCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 288 -AWARPLFKDRRKFSQMADPTLQGQYPV----RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 288 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
......+.. +..... .++. ..+..+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 243 ~~~~~~~~~~------i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 243 PACQNMLFES------IQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHH------HHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hhHHHHHHHH------HhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 000000000 000000 1111 13457889999999999999999999999876443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=352.64 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=214.2
Q ss_pred hcCcccCceecccCceEEEEEEEC-------CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999975 3567899999975532 2345688999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999976432 1235899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence 9999999999999986444333333344567889999999998899999999999999999999 99999865432111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
...... . ....+...+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus 270 -----~~~~~~-~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 -----KLLKEG-H----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -----HHHHHT-C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----HHHhcC-C----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111000 0 0112223445788999999999999999999999999998764443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=358.32 Aligned_cols=261 Identities=19% Similarity=0.230 Sum_probs=200.3
Q ss_pred HhcCcccC-ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHh-hcCCCCccceeEEEec----CCc
Q 017175 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~----~~~ 140 (376)
+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567776 789999999999999999999999999853 245678888874 4579999999999875 567
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Df 217 (376)
+|+||||++||+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 89999999999999999762 2346999999999999999999999999 999999999999987 789999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
|++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||............ ........
T Consensus 209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~i~~~~ 283 (400)
T 1nxk_A 209 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQ 283 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH--HHHHHHTC
T ss_pred ccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH--HHHHHcCc
Confidence 999853322 1233467999999999999999999999999999999999999999765432211100 00000000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
. ....+ .....+..+.+||.+||+.||++|||+.++++|.+....
T Consensus 284 ~---~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 284 Y---EFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp C---CCCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred c---cCCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 0 00000 011234578899999999999999999999999887654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=353.05 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=211.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEe----cCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999999999999999997665556677889999999999999999999986 3447899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998764444677999999999999999999999999 999999999999999999999999998642
Q ss_pred CCCCcce-------eecccccccCcccccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 224 PVGDKTH-------VSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 224 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~----~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL----A 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH----H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH----H
Confidence 2111000 012245799999999987654 688999999999999999999999643221110 000 0
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.... .....+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 260 ~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 260 VQNQ----------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hhcc----------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 0000 000111233457889999999999999999999999999887533
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=360.98 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=201.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHH-HhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|+++.+++.||+|++...... ....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999764332 23345667666 467899999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999875 456899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~----- 256 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKPL----- 256 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHSCC-----
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhccc-----
Confidence 2221 22345689999999999999999999999999999999999999998654321 1111111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI----ADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~ell~~L~ 346 (376)
.++...+..+.+||.+||+.||.+||++ .++++|-+
T Consensus 257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 1222334578899999999999999997 46666544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=342.09 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=211.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5678999999999999999999999999999999986543 233467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999999864 456999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ... . ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~-~~~~~---~~ 228 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----W-KEKKT---YL 228 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHH----H-HTTCT---TS
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----h-hhccc---cc
Confidence 332223344679999999999987765 77899999999999999999999865432110 000 0 00000 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
......+..+.+|+.+||+.||++|||+.+++++.+.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 229 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 0112334578899999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.32 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=209.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4668899999999999999999999999999999999765321 22346689999999999999999999999
Q ss_pred CCceEEEEEccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcc
Q 017175 138 GDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (376)
Q Consensus 138 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~D 216 (376)
....++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 99999999999766 99999875 456999999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 174 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------- 237 (335)
T 3dls_A 174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------- 237 (335)
T ss_dssp CTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------
T ss_pred cccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------
Confidence 99998643332 2234679999999999988876 789999999999999999999997532210
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.... ..+...+..+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 238 -----~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 238 -----EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp -----TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred -----hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 0000 11112345788999999999999999999999997643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=354.82 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=202.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCC--CCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++| +||+++++++.+....|+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999885 5889999999755332 23568899999999986 999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999976 467999999999999999999999999 99999999999997 578999999999864
Q ss_pred CCCCcceeecccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~---- 228 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS---- 228 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HH----
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HH----
Confidence 43333323345679999999999865 67889999999999999999999999753221 00
Q ss_pred hhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....+.++.....++...+..+.+|+.+||+.||.+|||+.+++++.+.-.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 011112222222333334457889999999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=350.53 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=198.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhc-CCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 143 (376)
+.++|++.++||+|+||.||+|.+..+++.||||++...... .......|+..+..+ +||||+++++++.+....++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 557899999999999999999999999999999998654322 223445566555554 89999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 6789888865 2456999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....... .. .. ..
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------~~-~~-----~~ 268 (311)
T 3p1a_A 208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---------QL-RQ-----GY 268 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---------HH-TT-----TC
T ss_pred ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------HH-hc-----cC
Confidence 3222 2334569999999998875 78999999999999999999977665432210 00 00 00
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+ .++...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 269 ~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 269 LPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 000 011123457889999999999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=344.81 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=202.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh--cCCCCccceeEEEec----CCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~----~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|..++.. ++||||+++++++.+ ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 467899999999999999999988 4899999998643 33445566666665 789999999998654 345
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeecCCCCCcEEECCCCce
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--------DKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
.++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence 8999999999999999953 57999999999999999999999 888 9999999999999999999
Q ss_pred EEcccccccccCCCCcce--eecccccccCcccccccccC------CCCcccchhhHHHHHHHHHhC----------CCC
Q 017175 213 KLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITG----------RKA 274 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----------~~p 274 (376)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997533332211 12234799999999999876 455789999999999999999 777
Q ss_pred CCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 275 IDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
|.......... ............. ........+...+..+.+|+.+||+.||++|||+.+|++.|+.++
T Consensus 233 f~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 233 FYDVVPNDPSF--EDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp TTTTSCSSCCH--HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccCCCCcch--hhhhHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 76543322110 0011111100000 000011122346778999999999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=350.99 Aligned_cols=268 Identities=21% Similarity=0.230 Sum_probs=214.4
Q ss_pred cCHHHHHHHhcCcccC-ceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcC-CCCccceeEE
Q 017175 59 FTFRELAAVTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGY 134 (376)
Q Consensus 59 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~ 134 (376)
..+.....+.++|.+. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444566788999998 89999999999999999999999999987533 233567889999999985 6999999999
Q ss_pred EecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCc
Q 017175 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYH 211 (376)
Q Consensus 135 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~ 211 (376)
+.+....++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999854 23467999999999999999999999999 999999999999987 789
Q ss_pred eEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------ 243 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------
Confidence 9999999998643222 2234579999999999999999999999999999999999999997654321110
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
....... ..........+..+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 244 ~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 244 NISQVNV--------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp HHHHTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred HHHhccc--------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 0000000 011111123345788999999999999999999999987743
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=370.42 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=215.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
..+|++.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467999999999999999999999989999999997553 3457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 371 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD- 371 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC-
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC-
Confidence 9999999999753 2356899999999999999999999999 999999999999999999999999999864322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||.......... ... .
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-------~~~----------~ 434 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLE----------K 434 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHH----------T
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHH----------c
Confidence 2222233456789999999998899999999999999999999 999998654321111 011 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111223344567889999999999999999999999999775
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=351.29 Aligned_cols=269 Identities=23% Similarity=0.224 Sum_probs=209.5
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC-----CccchHHHHHHHHHHhhcCCCCccceeEEEecC
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN-----GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 138 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 138 (376)
+..+.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456889999999999999999999999999999999998643 234456788999999999999999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPD------------------------------------KKRLDWTTRMRIAAGAAKG 182 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~~i~~a 182 (376)
...++||||+++++|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998531110 1224677889999999999
Q ss_pred HHHHhhCCCCCeeecCCCCCcEEECCCC--ceEEcccccccccCCCC--cceeecccccccCccccccccc--CCCCccc
Q 017175 183 LEYLHDKANPPVIYRDLKCSNILLGEGY--HPKLSDFGLAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMT--GQLTLKS 256 (376)
Q Consensus 183 l~~LH~~~~~~i~Hrdikp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 256 (376)
|.|||+.+ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 89999999997532221 1112334679999999999975 6789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 017175 257 DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP 336 (376)
Q Consensus 257 DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 336 (376)
|||||||++|+|++|..||......+. .......... ... ......+..+.+||.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC---FEN-----PNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC---TTS-----GGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc---cCC-----cccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999976543211 1111111100 000 00112345788999999999999999
Q ss_pred CHHHHHHHHHhhh
Q 017175 337 LIADVVTALTYLA 349 (376)
Q Consensus 337 s~~ell~~L~~~~ 349 (376)
++.+++++-+.-.
T Consensus 324 s~~~~l~hp~~~~ 336 (345)
T 3hko_A 324 DAMRALQHPWISQ 336 (345)
T ss_dssp CHHHHHHSHHHHT
T ss_pred CHHHHhcChhhcc
Confidence 9999999877543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=344.18 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=200.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 357899999999999999999998653 56799999875432 23456889999999999999999999984 46789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999975 2456899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+... .. ....
T Consensus 166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~------~i-~~~~--- 234 (281)
T 1mp8_A 166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RI-ENGE--- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HH-HTTC---
T ss_pred cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH------HH-HcCC---
Confidence 432221 11233457789999999998899999999999999999997 999998654332111 00 0000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....+...+..+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011223345578899999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=338.86 Aligned_cols=260 Identities=19% Similarity=0.231 Sum_probs=212.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 56889999999999999999999999999999999975432 2345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc---eEEccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFGLAK 221 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~---~kl~Dfg~~~ 221 (376)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999998865 466999999999999999999999999 999999999999976655 9999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ........
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~--- 224 (284)
T 3kk8_A 157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------AQIKAGAY--- 224 (284)
T ss_dssp ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTCC---
T ss_pred EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH------HHHHhccc---
Confidence 543222 223467999999999999999999999999999999999999999765432111 11111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.... ......+..+.+|+.+||+.||++|||+.+++++-+....
T Consensus 225 ~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 225 DYPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp CCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred cCCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 0000 0111234578899999999999999999999998876544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=344.76 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=207.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCC-------eEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTN-------QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999988766 5799999977665666789999999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc--------e
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--------P 212 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~--------~ 212 (376)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999976 2345999999999999999999999999 999999999999988887 9
Q ss_pred EEcccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCC-CCCCCcccccccchhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~ 290 (376)
+|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|. +||........
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------- 227 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------- 227 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-------
Confidence 9999999864211 223468999999999987 67899999999999999999955 55544332111
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
......... .+...+..+.+|+.+||+.||++|||+.+++++|+.+-.+..+
T Consensus 228 ~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 228 LQFYEDRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHHHTTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred HHHhhccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 011111111 1111123567899999999999999999999999988764433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=348.58 Aligned_cols=269 Identities=21% Similarity=0.334 Sum_probs=205.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4679999999999999999999999999999999975332 2345688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998654334567999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....... .. ...
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-~~-~~~---- 255 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKI-EQ-CDY---- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHH-HT-TCS----
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHh-hc-ccC----
Confidence 22 112234578999999999999999999999999999999999999997543211 1111111 00 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCC
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDP 355 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~ 355 (376)
.+.. ....+..+.+|+.+||+.||++|||+.+|++.|+.+......|
T Consensus 256 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 256 PPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0000 1223457889999999999999999999999999998765544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=343.69 Aligned_cols=262 Identities=23% Similarity=0.272 Sum_probs=207.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC----ccchHHHHHHHHHHhhcCCCCccceeEEEe--cCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----LQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4678999999999999999999999999999999997532 233467889999999999999999999984 4568
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||++++ |.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999865 76766553 2457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
................||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~- 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LFENIGKGS- 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC-
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHHHhcCC-
Confidence 8644333333344567999999999997644 4789999999999999999999998653221 111111110
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
. ..+...+..+.+|+.+||+.||++|||+.+++++.+......
T Consensus 230 -------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 230 -------Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -------C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -------C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 0 112233457889999999999999999999999987655433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=352.07 Aligned_cols=270 Identities=21% Similarity=0.293 Sum_probs=200.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
...++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999999999999999997543322 3456789999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-----CCCCceEEcccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-----GEGYHPKLSDFG 218 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill-----~~~~~~kl~Dfg 218 (376)
||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999997 599999876 456999999999999999999999999 9999999999999 455569999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhh-hc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF-KD 296 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 296 (376)
++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+ ..... ..
T Consensus 183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI--FEVLGLPD 258 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCC
T ss_pred CccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH--HHHhCCCc
Confidence 99753322 1223345789999999999875 4899999999999999999999999865432211110 00000 00
Q ss_pred cccc------ccccC--CcCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKF------SQMAD--PTLQGQ-----YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~------~~~~~--~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.... ..... +..... .+...+..+.+||.+||+.||++|||+.|+++|-+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 0000 00000 000000 011134678899999999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=346.02 Aligned_cols=259 Identities=25% Similarity=0.300 Sum_probs=205.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|.+.+.||+|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4578999999999999999999999999999999987543 234567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~~ 222 (376)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988653223467999999999999999999999999 9999999999999 5568899999999975
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.......... .........
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~-- 244 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEPNY-- 244 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCC--
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCccc--
Confidence 3322 2233467999999999885 578999999999999999999999998654321111 000000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.... ...+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 245 ---~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 245 ---AVEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp ---CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred ---cccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 0000 1123477899999999999999999999987553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=351.07 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=213.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 2345688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998865 457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~------ 258 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNEY------ 258 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCC------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCCC------
Confidence 222 123345799999999999998999999999999999999999999976532211 011111000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+...+..+.+|+.+||+.||++||++.+++++-+....
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1122234478889999999999999999999998775543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=347.50 Aligned_cols=273 Identities=25% Similarity=0.350 Sum_probs=210.2
Q ss_pred hcCcccCceecccCceEEEEEE----ECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecC--Cc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 140 (376)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3569999999999999999999 56789999999997543 23446788999999999999999999999876 67
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999965 2456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 221 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 221 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+................. .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 251 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ--MTVTR 251 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG--GHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc--cCHHH
Confidence 764433321 223345688899999999999999999999999999999999998764421100000000000 00000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.............+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000011111123334456888999999999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=352.02 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=203.3
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCC-----
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 139 (376)
.+.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 356789999999999999999999999999999999975433 34467889999999999999999999986543
Q ss_pred ----------------------------------------------------ceEEEEEccCCCchhhhhccCCCCCCCC
Q 017175 140 ----------------------------------------------------QRLLVYEYMPLGSLEDHLHDLPPDKKRL 167 (376)
Q Consensus 140 ----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 167 (376)
..++||||+++++|.+++.... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence 3799999999999999997643 23445
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc----------eeeccccc
Q 017175 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT----------HVSTRVMG 237 (376)
Q Consensus 168 ~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g 237 (376)
++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 77789999999999999999999 999999999999999999999999999864433211 12234579
Q ss_pred ccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHH
Q 017175 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGL 317 (376)
Q Consensus 238 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (376)
|+.|+|||++.+..++.++|||||||++|+|++|..|+...... .... . .... ........
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~--------~~~~-~------~~~~----~~~~~~~~ 299 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--------ITDV-R------NLKF----PLLFTQKY 299 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH--------HHHH-H------TTCC----CHHHHHHC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH--------HHHh-h------ccCC----CcccccCC
Confidence 99999999999999999999999999999999987765422110 0000 0 0000 00112334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 318 YQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 318 ~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+.+|+.+||+.||++|||+.+++++-+
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 56788999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=348.72 Aligned_cols=272 Identities=23% Similarity=0.284 Sum_probs=204.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-----cchHHHHHHHHHHhhcC---CCCccceeEEEec
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLH---HPNLVNLIGYCAD 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~ 137 (376)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 457899999999999999999999999999999999864321 12245667777777664 9999999999987
Q ss_pred CC-----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 138 GD-----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 138 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 65 5799999997 6999998763 2344999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .
T Consensus 160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~ 233 (308)
T 3g33_A 160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF---D 233 (308)
T ss_dssp EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH---H
T ss_pred EEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---H
Confidence 999999997543222 2344679999999999999999999999999999999999999997654332111110 0
Q ss_pred hhhcc--cccccc---cCCcCCC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFKDR--RKFSQM---ADPTLQG-------QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~~~--~~~~~~---~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..... ...... ....+.. ......+..+.+|+.+||+.||++|||+.|+++|-+.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 00000 000000 0000000 001123457889999999999999999999999876443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.85 Aligned_cols=261 Identities=22% Similarity=0.210 Sum_probs=209.7
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
...++|++.+.||+|+||.||+|+++.+|+.||+|++.+... .....+.+|..++..++||||+++++++.+....|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 345789999999999999999999999999999999965321 12234778999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||++||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++..
T Consensus 138 lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence 99999999999999975 2357999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcceeecccccccCcccccccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
...... ......+||+.|+|||++. ...++.++|||||||++|||++|..||......... ..+..
T Consensus 212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~ 284 (412)
T 2vd5_A 212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY------GKIVH 284 (412)
T ss_dssp CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT
T ss_pred ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH------HHHHh
Confidence 433221 1223468999999999997 356899999999999999999999999865432211 11111
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHHHHh
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMR---PLIADVVTALTY 347 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~ell~~L~~ 347 (376)
.... ...+.. +...+..+.+||.+||+ +|.+| |++.||++|-++
T Consensus 285 ~~~~---~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 285 YKEH---LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp HHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred cccC---cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 0000 001111 12234578899999999 99998 599999998775
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=366.38 Aligned_cols=268 Identities=23% Similarity=0.274 Sum_probs=202.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC--CccchHHHHHHHHHHhhcCCCCccceeEEEecC------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------ 138 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 457899999999999999999999999999999999754 223345688999999999999999999999654
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...|+||||+++ +|...+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999975 5666663 34899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh---------
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW--------- 289 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------- 289 (376)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+..
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99853322 223446899999999999999999999999999999999999999987643221111100
Q ss_pred -------hhhhhhcccc-----cccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 -------ARPLFKDRRK-----FSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 -------~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.......... +.......... ......+..+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 0000000000 00000000000 0001225678999999999999999999999998664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=342.51 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=190.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3679999999999999999999999999999999964321 2235688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999875 3467999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ...
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~ 225 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------KVV 225 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------HHh
Confidence 222 12234579999999999998889999999999999999999999998654321110 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
... ...+...+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 226 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 226 LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 000 01222344578899999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=347.64 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=211.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEE--EEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVV--AIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|++..++..+ |+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999998888865 999886432 23345688999999999 899999999999999999999
Q ss_pred EEccCCCchhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 145 YEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
|||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997632 22357999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 291 (376)
||+|||++.... .........+++.|+|||++.+..++.++|||||||++|+|++ |..||......... .
T Consensus 182 kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 252 (327)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred EEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------H
Confidence 999999987321 1112233457889999999998889999999999999999998 99999765432111 1
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
.. .. ......+...+..+.+|+.+||+.||++|||+.+++++|+.+......
T Consensus 253 ~~-~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 253 KL-PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HG-GG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred Hh-hc----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 10 00 011122233455788999999999999999999999999998775443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.09 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=213.5
Q ss_pred HhcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4678999999999999999999876 3578899999975433 234568899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEE
Q 017175 141 RLLVYEYMPLGSLEDHLHDLP------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl 214 (376)
.++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999986421 11245789999999999999999999999 999999999999999999999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~~~ 253 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFV 253 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------HHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH------HHH
Confidence 99999975433222222334567899999999999999999999999999999999 89999765432111 000
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. . .. ...+...+..+.+|+.+||+.||++|||+.+++++|+.+-.
T Consensus 254 ~~-~-~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 ME-G-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HT-T-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Hc-C-Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00 0 00 01122344578899999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=349.56 Aligned_cols=274 Identities=26% Similarity=0.316 Sum_probs=205.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-----hHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999997533221 2467899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||+++ +|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999985 88888865 3456889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh-cc-
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK-DR- 297 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~- 297 (376)
...... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+ ...... ..
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i--~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI--FETLGTPTEE 235 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCTT
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHcCCCChh
Confidence 753322 2223346799999999999764 5899999999999999999999999865432211100 000000 00
Q ss_pred --cccccccCCcCCC---CCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 298 --RKFSQMADPTLQG---QYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 298 --~~~~~~~~~~~~~---~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.......+..... ..+ ...+..+.+||.+||+.||++|||+.|++++.+.-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 0000000000000 011 2234688999999999999999999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=342.51 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=213.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4789999999999999999999999999999999865432 2345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998865 457899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ........
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~------- 231 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE------- 231 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC-------
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhcc-------
Confidence 222 123345799999999999988899999999999999999999999986543211 01110000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+...+..+.+++.+||+.||++|||+.+++++.+....
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 01122334578889999999999999999999998876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=354.99 Aligned_cols=276 Identities=21% Similarity=0.243 Sum_probs=211.2
Q ss_pred cCHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-----CCCccceeE
Q 017175 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----HPNLVNLIG 133 (376)
Q Consensus 59 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~ 133 (376)
+++.+...+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444455778999999999999999999999999999999999643 233455677999999886 999999999
Q ss_pred EEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-----
Q 017175 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----- 208 (376)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~----- 208 (376)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 999999999999999 89999999763 2345899999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHH
Q 017175 209 --------------------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268 (376)
Q Consensus 209 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 268 (376)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999753221 2345799999999999999999999999999999999
Q ss_pred HhCCCCCCCcccccccchhhhhhhhhh-----c--ccccccccC-Cc----CCCCCC----------------HHHHHHH
Q 017175 269 ITGRKAIDNTRAAGEHNLVAWARPLFK-----D--RRKFSQMAD-PT----LQGQYP----------------VRGLYQA 320 (376)
Q Consensus 269 l~g~~p~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~-~~----~~~~~~----------------~~~~~~l 320 (376)
++|..||......+............. . ........+ .. +..... ......+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999986543321111110000000 0 000000000 00 000000 0112567
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 321 LAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 321 ~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.+|+.+||+.||++|||+.|++++-+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 79999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=364.70 Aligned_cols=275 Identities=20% Similarity=0.254 Sum_probs=192.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEec-----CC
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GD 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~ 139 (376)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3578999999999999999999999999999999996532 2334568899999999999999999999843 35
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 7899999985 799998865 467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcc-------------------------eeecccccccCccccccc-ccCCCCcccchhhHHHHHHHHHh---
Q 017175 220 AKLGPVGDKT-------------------------HVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIIT--- 270 (376)
Q Consensus 220 ~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~--- 270 (376)
++........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 9864322110 122346789999999986 45679999999999999999999
Q ss_pred --------CCCCCCCccccccc--------------chhhhhhhhhhccc----------------ccccccCCcCC---
Q 017175 271 --------GRKAIDNTRAAGEH--------------NLVAWARPLFKDRR----------------KFSQMADPTLQ--- 309 (376)
Q Consensus 271 --------g~~p~~~~~~~~~~--------------~~~~~~~~~~~~~~----------------~~~~~~~~~~~--- 309 (376)
|.++|.+....... ........++...+ .+.........
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 55566443211000 00000000000000 00000000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 310 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.......+..+.+||.+||..||++|||+.|+++|-+.-.
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 0011223567889999999999999999999999977544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=338.90 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=212.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 367999999999999999999986 478899999976543 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 999999999976 2456899999999999999999999999 999999999999999999999999999753221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i~~~---------- 221 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG---------- 221 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTT----------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHHhcC----------
Confidence 1112223457788999999998899999999999999999999 8999986543211 1111000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+++.+||+.||++||++.+++++|..+..
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011122334578899999999999999999999999998865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=349.03 Aligned_cols=267 Identities=28% Similarity=0.410 Sum_probs=214.2
Q ss_pred HHHhcCcccCceecccCceEEEEEEE-----CCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEec
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCAD 137 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 137 (376)
....++|++.+.||+|+||.||+|.+ ..+++.||||++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34467899999999999999999985 356789999999765332 345688999999999 69999999999877
Q ss_pred CC-ceEEEEEccCCCchhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcE
Q 017175 138 GD-QRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (376)
Q Consensus 138 ~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Ni 204 (376)
.+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceE
Confidence 54 589999999999999999764321 223889999999999999999999999 99999999999
Q ss_pred EECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccc
Q 017175 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGE 283 (376)
Q Consensus 205 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 283 (376)
+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999986544433333445678899999999999999999999999999999998 9999976543211
Q ss_pred cchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 284 HNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.... ..... ....+...+..+.+++.+||+.||.+|||+.+|+++|+.+-.
T Consensus 260 -----~~~~-~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 -----FCRR-LKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -----HHHH-HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHH-hccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 11000 001122234578899999999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=351.14 Aligned_cols=270 Identities=23% Similarity=0.332 Sum_probs=203.5
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999996543221 12345799999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 589888876 3456999999999999999999999999 999999999999999999999999999753222
Q ss_pred cceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc--ccccc--
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR--RKFSQ-- 302 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 302 (376)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+. ...... .....
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF---RILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCTTTSTTGG
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCChHhchhhh
Confidence 222334578999999999876 568999999999999999999999998764432111110 000000 00000
Q ss_pred -------ccCCcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 -------MADPTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 -------~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+.... ......+..+.+|+.+||+.||++|||+.|++++-+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00000000 0011234578899999999999999999999999886654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.30 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=208.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC-ceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..|+|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 367999999999999999999986 7899999997653 4567899999999999999999999987665 7899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999762 2234799999999999999999999999 999999999999999999999999999753211
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||......... . . ....
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~-i~~~-------- 402 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P---R-VEKG-------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H---H-HHTT--------
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---H-HHcC--------
Confidence 122357889999999999999999999999999999998 99999865432211 1 0 1100
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11122334456888999999999999999999999999988753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=367.54 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=214.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|.+.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999965322 23456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++||+|..++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999775444567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ............
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-------- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC--------
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc--------
Confidence 321 23345899999999999999999999999999999999999999986532111 111111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
..++...+..+.+||.+||+.||++||+ +.+|++|-+.
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 1223344568889999999999999996 4888877554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=357.42 Aligned_cols=256 Identities=22% Similarity=0.298 Sum_probs=202.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcC--CCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~l 143 (376)
..+|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+|+.+++.+. ||||+++++++.....+|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999876 89999999975433 23456889999999996 5999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 557899999976 357899999999999999999999999 99999999999996 579999999999864
Q ss_pred CCCCcceeecccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 292 (376)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~-- 277 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-- 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH--
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH--
Confidence 33332223345679999999999865 36889999999999999999999999753211 0101
Q ss_pred hhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..++++.....++...+..+.+||.+||+.||++|||+.+++++.+..
T Consensus 278 --------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~ 325 (390)
T 2zmd_A 278 --------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325 (390)
T ss_dssp --------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence 111111112222223345788999999999999999999999987754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.88 Aligned_cols=276 Identities=18% Similarity=0.239 Sum_probs=216.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCC--ceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~l 143 (376)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35789999999999999999999999999999999975432 33466789999999999999999999998755 7799
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----CCCCceEEccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGL 219 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill----~~~~~~kl~Dfg~ 219 (376)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999997521 1233999999999999999999999999 9999999999999 7888899999999
Q ss_pred ccccCCCCcceeecccccccCccccccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~ 237 (396)
T 4eut_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMY 237 (396)
T ss_dssp CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHH
T ss_pred ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHH
Confidence 97643221 2234679999999999875 567889999999999999999999997543321111 1111
Q ss_pred hhhhcc-cc----ccccc--------CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 292 PLFKDR-RK----FSQMA--------DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 292 ~~~~~~-~~----~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
...... .. ..... ...............+.+++.+||+.||++||++.++++.+..+-..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111110 00 00000 01112234567788999999999999999999999999999887553
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=342.29 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=211.7
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45678999999999999999999999999999999998665445567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~~ 222 (376)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999865 456899999999999999999999999 9999999999999 7889999999999875
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~~--- 225 (304)
T 2jam_A 159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEKIKEGYYE--- 225 (304)
T ss_dssp CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHCCCC---
T ss_pred cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHcCCCC---
Confidence 3221 12335699999999999998999999999999999999999999976543211 1111111000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.........+..+.+|+.+||+.||++|||+.+++++.+.-.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 226 -----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 011112234457889999999999999999999999877543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=354.09 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=213.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCe-----EEEEEEeccCCc-cchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ-----VVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.+ +||||+++++++.+...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4689999999999999999999976654 799999976533 2345688999999999 89999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPP----------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~ 210 (376)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999864210 1346899999999999999999999999 99999999999999999
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 289 (376)
.++|+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----- 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF----- 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-----
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-----
Confidence 999999999975433333333344567889999999999999999999999999999998 99999765332110
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....... .....+...+..+.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 277 -~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 -YKLVKDG----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -HHHHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHhcC----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 0111100 0011122234578899999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=345.70 Aligned_cols=263 Identities=26% Similarity=0.372 Sum_probs=201.5
Q ss_pred hcCcccCceecccCceEEEEEEECC---CCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCC---
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--- 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--- 139 (376)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 5689999999999999999998765 566899999975433 23456889999999999999999999998754
Q ss_pred --ceEEEEEccCCCchhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 140 --QRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 140 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999984321 23467999999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......... ...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~~~ 263 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD------YLL 263 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHH
Confidence 9999976433332222334567889999999999999999999999999999999 889997654322111 000
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. .....+...+..+.+++.+||..||++|||+.+|+++|+.+..
T Consensus 264 ~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 HG-----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp TT-----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cC-----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 0011122334578899999999999999999999999998864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=349.40 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=204.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCC----eEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..+|++.+.||+|+||.||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 457889999999999999999886543 4699999975432 23456889999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975 3467999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... ... ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~~~-~~~--- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAI-NDG--- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHH-HTT---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH------HHH-HCC---
Confidence 4322211 11222356789999999998899999999999999999999 99999765432110 110 100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+++.+||+.||++||++.+|+++|+.+...
T Consensus 267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111223445788999999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.50 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=212.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986432 12345688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999875 356899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~-------- 227 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIVNV-------- 227 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTT--------
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHhcc--------
Confidence 221 2345799999999999998999999999999999999999999986543211 1111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+ ..++...+..+.++|.+||+.||++||++.+++++-+.-..
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0 11223344578899999999999999999999998775543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=341.45 Aligned_cols=262 Identities=29% Similarity=0.463 Sum_probs=197.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
..++|++.+.||+|+||.||+|.+.. .||+|++...... ..+.+.+|+.+++.++||||++++++. .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 35789999999999999999998753 4999998754332 345688999999999999999999965 55678999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999865 3567999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
............||+.|+|||++. +..++.++|||||||++|+|++|..||........ . ....... ..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~~~-~~- 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--I----IEMVGRG-SL- 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--H----HHHHHHT-SC-
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--H----HHHhccc-cc-
Confidence 322222334467999999999987 56788899999999999999999999986543211 0 0111110 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+.. .......+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 244 ---~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 ---SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0000 11122334578899999999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=379.90 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=212.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 142 (376)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999999999999999987431 23345677899999887 6999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||++||+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999976 457999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+... ....+....
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~----- 558 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN----- 558 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHSSC-----
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCC-----
Confidence 32222 22445789999999999999999999999999999999999999998754321 111111111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHHHh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLI-----ADVVTALTY 347 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~ell~~L~~ 347 (376)
..++...+.++.+||.+||+.||++||++ ++|++|-++
T Consensus 559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 12333455688999999999999999998 888887553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=340.64 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=213.0
Q ss_pred hcCcccCc-eecccCceEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADC-LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|.+.. .||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677776 9999999999999864 4678899999976532 3446688999999999999999999999 4567899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999865 3466999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 224 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 224 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......... . ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~-i~~~---- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------F-IEQG---- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH------H-HHTT----
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH------H-HhcC----
Confidence 333221 11223457899999999988889999999999999999998 999998654321110 0 0000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCCC
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPE 356 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~~ 356 (376)
.....+...+..+.+++.+||+.||++||++.+++++|+.+......+.
T Consensus 230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 0112233445688899999999999999999999999999876554443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=352.35 Aligned_cols=253 Identities=32% Similarity=0.413 Sum_probs=207.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999999999999999999754332 234678999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+. |+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 688887754 2467999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
. .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ........
T Consensus 206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~---- 269 (348)
T 1u5q_A 206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE---- 269 (348)
T ss_dssp S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC----
T ss_pred C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC----
Confidence 2 22357999999999985 46789999999999999999999999976543211 11111100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.+.. .+...+..+.+|+.+||+.||++|||+.+++++.+...
T Consensus 270 ---~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 ---SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0001 11123447889999999999999999999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=368.97 Aligned_cols=259 Identities=28% Similarity=0.375 Sum_probs=213.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999999999999999996532 22345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||++||+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998763 2345999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.+. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~~------- 405 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEVP------- 405 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHCC-------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhccc-------
Confidence 332 223458999999999999989999999999999999999999999865432111 11111111111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYL 348 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~ 348 (376)
..++...+..+.+||.+||+.||.+|| ++.||++|-+.-
T Consensus 406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 122233455888999999999999999 789999886643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.12 Aligned_cols=256 Identities=27% Similarity=0.356 Sum_probs=213.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4679999999999999999999999999999999975543 345678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999854 57999999999999999999999999 999999999999999999999999999753322
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ... .. ...+
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~------~~~~ 237 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL------FLI-PK------NNPP 237 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-HH------SCCC
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH------HHh-hc------CCCC
Confidence 1 1223457999999999999999999999999999999999999999865432111 000 00 0011
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. +...+..+.+|+.+||+.||++|||+.+++++.+....
T Consensus 238 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 11 12234478899999999999999999999999886654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.71 Aligned_cols=275 Identities=22% Similarity=0.229 Sum_probs=204.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC-----C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~ 139 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4678999999999999999999999999999999997532 23346788999999999999999999999776 5
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999996 699999865 466999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcc--------------------eeecccccccCccccccc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 220 AKLGPVGDKT--------------------HVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 220 ~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
++........ ......+||+.|+|||++ ....++.++|||||||++|+|++|..||...
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9864332211 122456899999999986 4567999999999999999999866555432
Q ss_pred ccccccc----------------------hhhhhhhhhhcccc-------------cccccC-CcCCCCC-----CHHHH
Q 017175 279 RAAGEHN----------------------LVAWARPLFKDRRK-------------FSQMAD-PTLQGQY-----PVRGL 317 (376)
Q Consensus 279 ~~~~~~~----------------------~~~~~~~~~~~~~~-------------~~~~~~-~~~~~~~-----~~~~~ 317 (376)
......- .......++...+. ....+. -...... ....+
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 1110000 00000000000000 000000 0000000 01235
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 318 YQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 318 ~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+.+|+.+||+.||++|||+.|+++|-+.-.
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 57889999999999999999999999877544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=350.58 Aligned_cols=271 Identities=25% Similarity=0.389 Sum_probs=208.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999999999999999986543332 345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999888654 456999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh--------hhhhhhc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW--------ARPLFKD 296 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~ 296 (376)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.............. ....+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 1223345799999999999875 789999999999999999999999987643321111100 0011111
Q ss_pred ccccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.........+......+ ...+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 11111111111111111 1335688999999999999999999999988664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=349.10 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=207.3
Q ss_pred hcCcccCceecccCceEEEEEE-----ECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|. +..++..||||.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4689999999999999999998 45678899999997543 23345688999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLS 215 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~ 215 (376)
|+||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976422 1245899999999999999999999999 999999999999984 4469999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......... . .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~-~ 258 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE------F-V 258 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH------H-H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH------H-H
Confidence 9999875333322222334568999999999999999999999999999999998 999998654321110 0 0
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.... ....+...+..+.+++.+||+.||.+||++.+|+++|+.+....
T Consensus 259 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 259 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0000 00112233457889999999999999999999999999887633
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=339.38 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=203.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+....|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999999999999999999999999997543222 3568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999975 356999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... .............
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~- 255 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAIPRPS- 255 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCCCCGG-
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCCCCcc-
Confidence 3221 112234579999999999999899999999999999999999999998654321 0111111000000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhcccC
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-LIADVVTALTYLACQKY 353 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~~~~~~~ 353 (376)
..+...+..+.+++.+||+.||++|| ++.++++.|..+-....
T Consensus 256 -------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 256 -------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11122334788899999999999999 99999999997765443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.76 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=207.6
Q ss_pred hcCcccCc-eecccCceEEEEEEE--CCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 68 TKNFRADC-LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999954 566789999999754322 245788999999999999999999999 567789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999976 456999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 223 GPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 223 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~--- 236 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKG--- 236 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTT---
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcC---
Confidence 43332221 1223456789999999998889999999999999999999 999998754321110 00100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+++.+||+.||++||++.++++.|+.+-..
T Consensus 237 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 -------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01122234455788999999999999999999999999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.98 Aligned_cols=259 Identities=24% Similarity=0.315 Sum_probs=198.7
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhhcCCCCccceeEEEe
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLHHPNLVNLIGYCA 136 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 136 (376)
..+.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3567899999999999999999999999999999999865321 11224778999999999999999999985
Q ss_pred cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---ceE
Q 017175 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPK 213 (376)
Q Consensus 137 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~---~~k 213 (376)
. ...|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 4 568999999999999998865 567999999999999999999999999 99999999999997544 599
Q ss_pred EcccccccccCCCCcceeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
|+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...
T Consensus 283 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~-- 355 (419)
T 3i6u_A 283 ITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD-- 355 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH--
T ss_pred EeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH--
Confidence 999999986332 222344679999999999864 5688899999999999999999999976432211 000
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
........ . .+... ...+..+.+|+.+||+.||++|||+.++++|-+.
T Consensus 356 -~i~~~~~~---~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 356 -QITSGKYN---F-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp -HHHTTCCC---C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred -HHhcCCCC---C-Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 00000000 0 00000 1224578899999999999999999999998664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=362.06 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=210.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35688999999999999999999999999999999986432 2345678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~~kl~Dfg~~ 220 (376)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 99 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999998865 467999999999999999999999999 99999999999995 4567999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... .........+
T Consensus 172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------KRVETGKYAF 241 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTCCCS
T ss_pred eECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCCCC
Confidence 7543322 2334579999999999865 5899999999999999999999999865432211 1111100000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
+. ......+..+.+||.+||+.||++|||+.+++++-+.-..
T Consensus 242 ----~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 242 ----DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ----CS----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ----CC----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 00 0012234578899999999999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=344.74 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=210.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEe--cCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4689999999999999999999999999999999976543 23456889999999999999999999875 3678899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999764334456999999999999999999999876 2349999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ....... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i~~~--~~- 233 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREG--KF- 233 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHT--CC-
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH------HHHHhhc--cc-
Confidence 633221 122335789999999999998999999999999999999999999986543211 1111110 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+...+..+.+++.+||+.||++||++.+|+++++..+.
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01222344578899999999999999999999998876554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=336.04 Aligned_cols=259 Identities=25% Similarity=0.314 Sum_probs=208.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 457899999999999999999999999999999998754322 34678899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~D 216 (376)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999965 456899999999999999999999999 99999999999998877 899999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ......
T Consensus 156 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~ 226 (283)
T 3bhy_A 156 FGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNISAV 226 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTT
T ss_pred cccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHhHhc
Confidence 99997543222 223456999999999999889999999999999999999999999865432111 000000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
... .... .....+..+.+|+.+||+.||++||++.+++++-+.-+
T Consensus 227 ~~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 227 NYD----FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCC----CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ccC----Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 000 0000 00122447889999999999999999999998765433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=362.44 Aligned_cols=257 Identities=25% Similarity=0.308 Sum_probs=205.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
+.++|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5678999999999999999999999999999999997543 23356788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC---CceEEccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLSDFGLAK 221 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~---~~~kl~Dfg~~~ 221 (376)
||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999998865 466999999999999999999999999 9999999999999764 459999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||......... .........
T Consensus 188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~~-- 255 (494)
T 3lij_A 188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL------RKVEKGKYT-- 255 (494)
T ss_dssp ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTCCC--
T ss_pred ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCCC--
Confidence 643222 233467999999999886 56999999999999999999999999875432211 111111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.... ...+..+.+||.+||+.||.+|||+.++++|-+..
T Consensus 256 --~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 256 --FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp --CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred --CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 011111 12344788999999999999999999999886643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=342.22 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=209.1
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--------
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------- 137 (376)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46788999999999999999999999999999999997543 356689999999999999999998854
Q ss_pred --------CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC
Q 017175 138 --------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (376)
Q Consensus 138 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~ 209 (376)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 34579999999999999999652 2357999999999999999999999999 9999999999999999
Q ss_pred CceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
+.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+..... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------F 227 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--------H
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--------H
Confidence 999999999997643322 12335699999999999998999999999999999999999988753211 0
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.... ....+ +...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 228 ~~~~----------~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FTDL----------RDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHH----------HTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHh----------hcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0000 00111 112234678899999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=341.37 Aligned_cols=254 Identities=31% Similarity=0.439 Sum_probs=199.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 57999999999999999999986 788999998643 344678899999999999999999998874 479999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeeecCCCCCcEEECCCCc-eEEcccccccccC
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD---KANPPVIYRDLKCSNILLGEGYH-PKLSDFGLAKLGP 224 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~~i~Hrdikp~Nill~~~~~-~kl~Dfg~~~~~~ 224 (376)
++++|.+++.... ....+++..++.++.|+++||.|||+ ++ |+||||||+||+++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999997521 12347899999999999999999999 67 999999999999988886 7999999997432
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........ . .
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~--~-----~ 221 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN--G-----T 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT--T-----C
T ss_pred cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc--C-----C
Confidence 11 2234699999999999998999999999999999999999999975432110 00000000 0 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.+. .+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 222 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 RPP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCC----CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCC----cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 11223447889999999999999999999999999987543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.54 Aligned_cols=267 Identities=22% Similarity=0.268 Sum_probs=207.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEE-ecCCceEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLV 144 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv 144 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+ .+....++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4568899999999999999999999999999999987654322 3477899999999988777766655 667788999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAK 221 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~ 221 (376)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 8999999875 2456999999999999999999999999 9999999999999 788999999999997
Q ss_pred ccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-hhhh
Q 017175 222 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-PLFK 295 (376)
Q Consensus 222 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~ 295 (376)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||................ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 64433221 12234679999999999999999999999999999999999999998755433322221111 1000
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.. .+.... ..+..+.+|+.+||+.||++|||+.+|++.|..+....
T Consensus 237 ~~-------~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 237 TP-------IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SC-------HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ch-------hhhhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 00 000001 12347889999999999999999999999999887643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=364.00 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=213.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5678999999999999999999999999999999996543 2345678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~ 220 (376)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999875 467999999999999999999999999 9999999999999 56789999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... .........+
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL------KKVEKGKYTF 246 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCCC
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCCCCC
Confidence 7643332 2234579999999999865 6899999999999999999999999875432111 1111110000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. ......+..+.+||.+||+.||++|||+.++++|-+.-..
T Consensus 247 ---~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 247 ---EL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---CS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---CC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 00 0011334578899999999999999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=341.65 Aligned_cols=255 Identities=20% Similarity=0.230 Sum_probs=205.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 142 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35688999999999999999999999999999999997543 23345678899999988 8999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-------------
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG------------- 209 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~------------- 209 (376)
+||||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999753222366899999999999999999999999 9999999999999844
Q ss_pred ------CceEEcccccccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 210 ------YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 210 ------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
..++|+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW- 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred cccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence 47999999999764322 124599999999999876 5678999999999999999998877543211
Q ss_pred ccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 283 EHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..... .. . ...+...+..+.+|+.+||+.||++|||+.+++++-+...
T Consensus 238 --------~~~~~--~~-----~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 238 --------HEIRQ--GR-----L----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp --------HHHHT--TC-----C----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred --------HHHHc--CC-----C----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 00000 00 0 1122233457889999999999999999999999876443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=336.24 Aligned_cols=268 Identities=22% Similarity=0.258 Sum_probs=212.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEE-ecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 45789999999999999999999999999999999865432 34688999999999988876666655 5677889999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~~ 222 (376)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||++ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8999999974 2457999999999999999999999999 9999999999999 4888999999999976
Q ss_pred cCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-hhhhc
Q 017175 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-PLFKD 296 (376)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 296 (376)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 4433221 11234679999999999999999999999999999999999999998754432222221111 11110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCC
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYD 354 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~ 354 (376)
. .+.... ..+..+.+++.+||+.||++|||+.+|++.|..+......
T Consensus 238 ~-------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 238 P-------IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp C-------HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred c-------hHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 000011 1234788899999999999999999999999988764433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=335.00 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=207.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecC--CceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 367999999999999999999986 88899999976543 2345688999999999999999999999887 78899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999762 2336899999999999999999999875 44999999999999999999999999887542
Q ss_pred CCCCcceeecccccccCcccccccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL---KSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
.. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||........ .......
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~---- 226 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALE---- 226 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHS----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhc----
Confidence 11 2346899999999998765554 79999999999999999999986543211 0111110
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01112223345578899999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=341.87 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=200.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 466789999999999999999999999999999999865432 112347789999999999999999999876
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc---eEE
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKL 214 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~---~kl 214 (376)
.. .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++. +||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 54 8999999999999999865 467999999999999999999999999 999999999999987665 999
Q ss_pred cccccccccCCCCcceeecccccccCcccccccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ .....
T Consensus 159 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~- 232 (322)
T 2ycf_A 159 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI- 232 (322)
T ss_dssp CCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH-
T ss_pred ccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH-
Confidence 999999763222 1223456999999999974 45788999999999999999999999976543211 11100
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
....... .+... ...+..+.+|+.+||+.||++||++.+++++
T Consensus 233 --~~~~~~~----~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 --TSGKYNF----IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --HHTCCCC----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HhCcccc----Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000000 00000 1224578899999999999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.70 Aligned_cols=272 Identities=18% Similarity=0.260 Sum_probs=205.0
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec--------
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 137 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------- 137 (376)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998654322 2379999999999999999999843
Q ss_pred ------------------------------CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 017175 138 ------------------------------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187 (376)
Q Consensus 138 ------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH 187 (376)
....++||||++ ++|.+.+.........+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999998 5877777543334678999999999999999999999
Q ss_pred hCCCCCeeecCCCCCcEEEC-CCCceEEcccccccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHH
Q 017175 188 DKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVL 265 (376)
Q Consensus 188 ~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il 265 (376)
+.+ |+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999997 68899999999998543332 23345789999999998875 489999999999999
Q ss_pred HHHHhCCCCCCCcccccccchh-hhhh-----hhhhccccccc-----ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 017175 266 LEIITGRKAIDNTRAAGEHNLV-AWAR-----PLFKDRRKFSQ-----MADPTLQGQYPVRGLYQALAVAAMCVQEQPNM 334 (376)
Q Consensus 266 ~~ll~g~~p~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 334 (376)
|+|++|..||......+....+ .... ........... .....+...++...+..+.+|+.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999875443221111 0000 00000000111 11111111123334567899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 017175 335 RPLIADVVTALTYL 348 (376)
Q Consensus 335 Rps~~ell~~L~~~ 348 (376)
|||+.|+++|-+.-
T Consensus 313 R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 313 RINPYEAMAHPFFD 326 (383)
T ss_dssp SCCHHHHHTSGGGH
T ss_pred CCCHHHHhcCHHHH
Confidence 99999999886643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.97 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=205.9
Q ss_pred hcCcccCceecccCceEEEEEEECC---CCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998653 34569999997653 2345678899999999999999999999865 45789
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999975 2456899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........... ......
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-------~~~~~~--- 232 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGDR--- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-------HHHTCC---
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-------HhcCCC---
Confidence 32221 11233457889999999998899999999999999999998 9999975443221110 000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+...+..+.+++.+||+.||++||++.+++++|+.+..
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 01122234578899999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=353.48 Aligned_cols=272 Identities=21% Similarity=0.258 Sum_probs=211.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999976532 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999975 45699999999999999999999995 8 99999999999999999999999999864211
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----hhhhc----
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----PLFKD---- 296 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---- 296 (376)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||................ .....
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12234579999999999999999999999999999999999999998654322110000000 00000
Q ss_pred c-----------------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 297 R-----------------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 297 ~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
. .....+.............+..+.+|+.+||+.||++|||+.++++|-+.-..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0 00000000000000111234578899999999999999999999998776554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=338.21 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=207.0
Q ss_pred CcccCceecccCceEEEEEEECCCCe---EEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce-EEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 144 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-~lv 144 (376)
.|.+.++||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57778999999999999999755443 799999975433 3346788999999999999999999999876665 999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 3567899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCc--ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA-IDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
.... ........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |............ ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~~--- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGR--- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-------HTTC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-------hcCC---
Confidence 2211 1122335688999999999999999999999999999999995554 5443322111100 0000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011122334578899999999999999999999999999876443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=347.36 Aligned_cols=267 Identities=15% Similarity=0.170 Sum_probs=201.9
Q ss_pred hcCcccCceecccCceEEEEEEECC---CCeEEEEEEeccCCcc-----------chHHHHHHHHHHhhcCCCCccceeE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQ-----------GNREFLVEVLMLSLLHHPNLVNLIG 133 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~ 133 (376)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999987 7889999998765322 1134667888899999999999999
Q ss_pred EEec----CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC
Q 017175 134 YCAD----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (376)
Q Consensus 134 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~ 209 (376)
++.+ ....|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77899999999 9999999975 347999999999999999999999999 9999999999999887
Q ss_pred C--ceEEcccccccccCCCCc-----ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 210 Y--HPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 210 ~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
+ .+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999975432211 111234579999999999999899999999999999999999999996432111
Q ss_pred ccchhhhhhhhhhc-ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 283 EHNLVAWARPLFKD-RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 283 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. ........... ......... ....+..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 268 ~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 10 00000000000 000000000 01233478899999999999999999999999998775
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=361.55 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=208.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-------------cchHHHHHHHHHHhhcCCCCccceeE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-------------QGNREFLVEVLMLSLLHHPNLVNLIG 133 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~~~ 133 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56889999999999999999999999999999999975432 22456889999999999999999999
Q ss_pred EEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC---
Q 017175 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY--- 210 (376)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~--- 210 (376)
++.+...+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999865 467999999999999999999999999 99999999999998776
Q ss_pred ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.........
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII------ 256 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 69999999998643322 233457999999999986 46899999999999999999999999875432211
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.........+ +.... ...+..+.+||.+||+.||.+|||+.+++++-+.-.
T Consensus 257 ~~i~~~~~~~----~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 257 KKVEKGKYYF----DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHHCCCCC----CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHcCCCCC----Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 1111100000 00000 122457889999999999999999999999987544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=347.21 Aligned_cols=275 Identities=22% Similarity=0.302 Sum_probs=207.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecC-------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG------- 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------- 138 (376)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999999999999999998654332 245678999999999999999999999773
Q ss_pred -CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 139 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
...++||||+.+ +|...+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999974 77777755 3456999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCc--ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh-
Q 017175 218 GLAKLGPVGDK--THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL- 293 (376)
Q Consensus 218 g~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 293 (376)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99976432221 122234678999999999876 45899999999999999999999999875433221111100000
Q ss_pred ----hhccccc--ccccCCcCCCCCCHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 294 ----FKDRRKF--SQMADPTLQGQYPVR-------GLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 294 ----~~~~~~~--~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
+...... ............... .+..+.+||.+||+.||++|||+.|++++-+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 0000000 000000000000000 1346889999999999999999999999987543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=338.83 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=206.0
Q ss_pred hcCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEe-cCCceE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRL 142 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~ 142 (376)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... .....+.+|+.+++.++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35699999999999999999987543 34689999875433 33466889999999999999999999864 456789
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 3466899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCc--ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 223 GPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 223 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.......... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~------~~~~~~-- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------YLLQGR-- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH------HHHTTC--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH------HHhcCC--
Confidence 432221 112233567889999999999999999999999999999999 556666543321110 000000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
....+...+..+.+++.+||+.||++|||+.++++.|..+.....
T Consensus 250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001112234578899999999999999999999999999876443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=339.44 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=204.6
Q ss_pred HHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh--cCCCCccceeEEEecC
Q 017175 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG 138 (376)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~ 138 (376)
......+.++|++.+.||+|+||.||+|.+. ++.||||++... .......|..++.. ++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3344566789999999999999999999986 899999998543 22334455555554 4899999999999887
Q ss_pred ----CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeeecCCCCCcEEE
Q 017175 139 ----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK--------ANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~~~~i~Hrdikp~Nill 206 (376)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 688999999999999999965 4699999999999999999999998 8 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcce--eecccccccCcccccccccCCCCcc------cchhhHHHHHHHHHhC-------
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQLTLK------SDVYSFGVVLLEIITG------- 271 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~ll~g------- 271 (376)
+.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997533222111 1124579999999999988766655 9999999999999999
Q ss_pred ---CCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 017175 272 ---RKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVT 343 (376)
Q Consensus 272 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 343 (376)
..||......... ........ .........+ ...+..+.+|+.+||+.||++|||+.+|++
T Consensus 256 ~~~~~p~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPS--YEDMREIV---------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp CCCCCTTTTTSCSSCC--HHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccHhhhcCCCCc--hhhhHHHH---------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 5555433222111 00000000 0011111122 256778999999999999999999999999
Q ss_pred HHHhhhccc
Q 017175 344 ALTYLACQK 352 (376)
Q Consensus 344 ~L~~~~~~~ 352 (376)
+|+.+....
T Consensus 325 ~L~~l~~~~ 333 (337)
T 3mdy_A 325 TLAKMSESQ 333 (337)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhhc
Confidence 999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=346.47 Aligned_cols=267 Identities=24% Similarity=0.299 Sum_probs=195.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEe--------cC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCA--------DG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--------~~ 138 (376)
..+|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999999999999997666556677889999999996 999999999984 33
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
..+++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999996 78988875421 2356999999999999999999999875 349999999999999999999999999
Q ss_pred cccccCCCCcce----------eecccccccCccccccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc
Q 017175 219 LAKLGPVGDKTH----------VSTRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN 285 (376)
Q Consensus 219 ~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 285 (376)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~- 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV- 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence 997643322111 11134689999999998 5667899999999999999999999999754322100
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCCCC
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~~~ 357 (376)
............+..+.+|+.+||+.||++|||+.+++++|+.+.........
T Consensus 263 -------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 263 -------------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred -------------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 00000000111123467899999999999999999999999999875544443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=347.93 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=202.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCC-----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 139 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999999999999999999654322 2356789999999999999999999997653
Q ss_pred -ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 140 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7899999865 46899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----h
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----P 292 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~ 292 (376)
++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 174 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 174 LARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9986322 1234578999999999987 679999999999999999999999998754322111110000 0
Q ss_pred hhhcc---------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 293 LFKDR---------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 293 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..... ..+.......+ .......+..+.+|+.+||+.||++|||+.++++|-+.-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 00000 00000000001 011223455788999999999999999999999986643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.06 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=210.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 35679999999999999999999864 6789999997643 45678999999999999999999999986 567899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999741 1236889999999999999999999999 999999999999999999999999999863221
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ........++..|+|||++....++.++|||||||++|||++ |..||......... . .. ...
T Consensus 338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i-~~~-------- 401 (454)
T 1qcf_A 338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R---AL-ERG-------- 401 (454)
T ss_dssp H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H---HH-HHT--------
T ss_pred c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH-HcC--------
Confidence 1 111223446788999999998999999999999999999999 99999865432111 1 10 100
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0011223345578899999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=348.98 Aligned_cols=269 Identities=16% Similarity=0.202 Sum_probs=204.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC-----CeEEEEEEeccCCccc-----------hHHHHHHHHHHhhcCCCCccce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQG-----------NREFLVEVLMLSLLHHPNLVNL 131 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni~~~ 131 (376)
.++|++.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999998764 5789999987553211 1223456667778889999999
Q ss_pred eEEEecC----CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC
Q 017175 132 IGYCADG----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (376)
Q Consensus 132 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~ 207 (376)
++++.+. ...|+||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999976 3467999999999999999999999999 99999999999998
Q ss_pred --CCCceEEcccccccccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 208 --EGYHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 208 --~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999753322111 111334599999999999999999999999999999999999999985432
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
... ........+ ......++++.+.. ...+..+.+++..||+.+|++||++.+|++.|..+-.
T Consensus 267 ~~~--~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPK--YVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHH--HHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 211 111111100 01111111111110 1223478889999999999999999999999887765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=345.68 Aligned_cols=275 Identities=27% Similarity=0.396 Sum_probs=211.3
Q ss_pred HhcCc-ccCceecccCceEEEEEEE----CCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEec--C
Q 017175 67 VTKNF-RADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--G 138 (376)
Q Consensus 67 ~~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~ 138 (376)
+.++| ++.+.||+|+||.||++.+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34556 9999999999999988764 44789999999976532 334568899999999999999999999987 4
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
..+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred ceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcc
Confidence 678999999999999999965 45999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++......... .......+|..|+|||++.+..++.++|||||||++|+|++|..||......... .......... .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~-~ 257 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMT-V 257 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHH-H
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchh-H
Confidence 99865443322 2233456888999999999989999999999999999999999999764321000 0000000000 0
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
......+........+...+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 000111111111222334456889999999999999999999999999988653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.50 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=211.2
Q ss_pred HHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------chHHHHHHHHHHhhc-CCCCccce
Q 017175 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLL-HHPNLVNL 131 (376)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~ni~~~ 131 (376)
......+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 344566778999999999999999999999989999999998754321 124577899999998 79999999
Q ss_pred eEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc
Q 017175 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~ 211 (376)
++++......|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999875 457999999999999999999999999 999999999999999999
Q ss_pred eEEcccccccccCCCCcceeecccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN 285 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 285 (376)
++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 314 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML- 314 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 9999999987643332 2234679999999999864 35888999999999999999999999764322111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.......... ..+.+ ...+..+.+|+.+||+.||++|||+.+++++-+
T Consensus 315 -----~~i~~~~~~~---~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 315 -----RMIMEGQYQF---SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp -----HHHHHTCCCC---CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -----HHHHhCCCCC---CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1111100000 00000 012346889999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=347.59 Aligned_cols=256 Identities=18% Similarity=0.163 Sum_probs=206.2
Q ss_pred hcCcccCceecccCceEEEEEE-----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC---CCCccceeEEEecCC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGD 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~ 139 (376)
.++|.+.+.||+|+||.||+|. +..+++.||+|++.... ...+..|+.+++.++ |+||+.+++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4679999999999999999994 66778999999997543 345667777777776 899999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC----------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---------- 208 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---------- 208 (376)
..|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999964221 2466999999999999999999999999 999999999999998
Q ss_pred -CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh
Q 017175 209 -GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 209 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 287 (376)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 899999999999754333333444557899999999999999999999999999999999999999965432110
Q ss_pred hhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhhcc
Q 017175 288 AWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMR-PLIADVVTALTYLACQ 351 (376)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~ell~~L~~~~~~ 351 (376)
.. ...+. .. .....+.+++..||..+|.+| |++.++.+.|..+-..
T Consensus 294 -----------~~----~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -----------KP----EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----------EE----CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------ee----chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00 00111 11 124567789999999999999 5788888888776543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.67 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=205.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 46789999999999999999999999999999999987666667788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK- 169 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999998865 2456999999999999999999999999 99999999999999999999999998753111
Q ss_pred CcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
.........||+.|+|||++. +..++.++|||||||++|+|++|..||........ ........ ..
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~--~~ 240 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSD--PP 240 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC--CC
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccC--Cc
Confidence 111122356899999999984 56788999999999999999999999986543211 11111100 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
....+...+..+.+++.+||+.||++|||+.+++++-+
T Consensus 241 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 241 -------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp -------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred -------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 00112233457889999999999999999999998755
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=347.51 Aligned_cols=268 Identities=23% Similarity=0.268 Sum_probs=199.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCC------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 139 (376)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4789999999999999999999999999999999975432 23356789999999999999999999997654
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..|+||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 6899999997 57888774 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh---------h-
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA---------W- 289 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------~- 289 (376)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. +
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9753221 12234679999999999999999999999999999999999999998754321110000 0
Q ss_pred ------hhhhhhcccc-----cccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 290 ------ARPLFKDRRK-----FSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 290 ------~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.......... +.......... ......+..+.+|+.+||+.||++|||+.++++|-+.-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0000000000 00000000000 00122366889999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=339.50 Aligned_cols=258 Identities=27% Similarity=0.346 Sum_probs=206.9
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34678999999999999999999999999999999997543 3467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999863 2467999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... .
T Consensus 178 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~-------~ 242 (314)
T 3com_A 178 T--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNP-------P 242 (314)
T ss_dssp T--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-------C
T ss_pred h--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC-------C
Confidence 2 11233457999999999999989999999999999999999999999865432110 0000000 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
+.. ..+...+..+.+|+.+||..||.+|||+.+++++-+.-
T Consensus 243 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 243 PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 000 11223345788999999999999999999999887644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.41 Aligned_cols=248 Identities=16% Similarity=0.177 Sum_probs=193.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccC---CccchHHHHHHHH---HHhhcCCCCcccee-------EE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVL---MLSLLHHPNLVNLI-------GY 134 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~ni~~~~-------~~ 134 (376)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999999999999999743 2334467889994 55556799999998 66
Q ss_pred EecCC-----------------ceEEEEEccCCCchhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 017175 135 CADGD-----------------QRLLVYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194 (376)
Q Consensus 135 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i 194 (376)
+.+.+ ..|+||||+ +|+|.+++... ......+++..++.++.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 58999998752 111223445888899999999999999999 9
Q ss_pred eecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccC-----------CCCcccchhhHHH
Q 017175 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----------QLTLKSDVYSFGV 263 (376)
Q Consensus 195 ~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~ 263 (376)
+||||||+|||++.++.+||+|||++... +. ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~--~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRD--GA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEET--TC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheec--CC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999852 11 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 017175 264 VLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVT 343 (376)
Q Consensus 264 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~ 343 (376)
++|+|++|..||............ .. . .. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~----------------~~-~-~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI----------------FR-S-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG----------------GS-S-CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh----------------hh-h-cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999765432211110 00 0 01 22347889999999999999999999998
Q ss_pred HHHh
Q 017175 344 ALTY 347 (376)
Q Consensus 344 ~L~~ 347 (376)
+-+.
T Consensus 360 hp~f 363 (377)
T 3byv_A 360 TPEY 363 (377)
T ss_dssp SHHH
T ss_pred ChHH
Confidence 6543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=344.75 Aligned_cols=271 Identities=28% Similarity=0.393 Sum_probs=212.9
Q ss_pred hcCcccCceecccCceEEEEEE----ECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC--ce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~ 141 (376)
.++|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4679999999999999999998 45679999999998766566678899999999999999999999987644 78
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999976 2356899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc-----cchhhhhhhhhh
Q 017175 222 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE-----HNLVAWARPLFK 295 (376)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~ 295 (376)
......... ......++..|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~--- 270 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF--- 270 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH---
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH---
Confidence 644332211 12234577889999999988899999999999999999999999875421100 000000000
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.+...+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 271 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 271 ---HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000000011111223345678899999999999999999999999998864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=345.25 Aligned_cols=272 Identities=21% Similarity=0.273 Sum_probs=209.3
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecC-----Cc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 457899999999999999999999999999999999754322 336688999999999999999999999764 46
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 599998864 46999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc-eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 221 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 221 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+. .......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCC
Confidence 753322111 112345799999999987654 58999999999999999999999998765432211111 0000000
Q ss_pred -------------c-cccccCCcCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 299 -------------K-FSQMADPTLQ--GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 299 -------------~-~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
. .......... .......+..+.+|+.+||+.||++|||+.+++++-+.-..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 0000000000 00011234578899999999999999999999999875543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=358.59 Aligned_cols=258 Identities=29% Similarity=0.426 Sum_probs=206.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4679999999999999999999876 4679999997654 345678999999999999999999999876 678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999641 1345899999999999999999999999 9999999999999999999999999997543221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........++..|+|||++.+..++.++|||||||++|+|++ |..||......... .. ....
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~------~~-i~~~--------- 397 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQ-VERG--------- 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HH-HHTT---------
T ss_pred -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH------HH-HHcC---------
Confidence 112223457789999999999999999999999999999999 99999865432111 00 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11122334455788999999999999999999999999988643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=340.03 Aligned_cols=260 Identities=21% Similarity=0.258 Sum_probs=194.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-h-HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... . ..+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999999999999999997543222 2 23444555678889999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||++ ++|.+++.........+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588777754333457799999999999999999999998 9 9999999999999999999999999997533
Q ss_pred CCCcceeecccccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..........
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~--- 230 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSC---
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccC---
Confidence 221 22334699999999996 45678999999999999999999999997532210 0001111100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.........+..+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 231 -------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 000111123457889999999999999999999999876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=350.02 Aligned_cols=259 Identities=26% Similarity=0.358 Sum_probs=207.5
Q ss_pred cCcccCceecccCceEEEEEEEC---CCCeEEEEEEeccCCc----cchHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++.+...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 67999999999999999999984 5789999999865321 2234566799999999 69999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999975 457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ...........
T Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE- 282 (355)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC-
T ss_pred eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC-
Confidence 7532221 1122346799999999999863 4789999999999999999999999754322111 11111111110
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~~~ 349 (376)
..++...+..+.+||.+||..||++|| ++.+++++.+...
T Consensus 283 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 283 -----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 112233445788999999999999999 9999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=335.17 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=201.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecC-CceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467999999999999999999885 8899999997543 456788999999999999999999997654 47899999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999998651 1123789999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .. ...
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~-~~~--------- 229 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PR-VEK--------- 229 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HH-HTT---------
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HH-Hhc---------
Confidence 223457889999999998899999999999999999998 99999865432111 00 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
......+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 230 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 230 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 011122233455788999999999999999999999999988753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=333.04 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=209.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 468999999999999999999976 46789999997543 345678899999999999999999999864 568999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999998641 1236899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........++..|+|||++.+..++.++|||||||++|+|++ |..||........ .... ...
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~-~~~--------- 226 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNL-ERG--------- 226 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHH-HTT---------
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHHH-hcc---------
Confidence 122233457889999999998889999999999999999999 9999976543211 0110 000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 00111223345788999999999999999999999999988754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=334.06 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=202.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999986432 22345788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999975 356899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ .........
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~----- 228 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------FKKIRGGVF----- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-----
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhcCcc-----
Confidence 322 2234568999999999987765 6899999999999999999999976432211 111111000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+...+..+.+++.+||+.||++|||+.+++++-+.-+
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 112223457889999999999999999999999877543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=351.33 Aligned_cols=268 Identities=18% Similarity=0.186 Sum_probs=208.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC--------CCCccceeEEEe--
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA-- 136 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~ni~~~~~~~~-- 136 (376)
+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467899999999999999999999999999999999643 233456788999999885 788999999987
Q ss_pred --cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCC---
Q 017175 137 --DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGY--- 210 (376)
Q Consensus 137 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~--- 210 (376)
+....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 566889999999 45666665441 235699999999999999999999998 8 99999999999999775
Q ss_pred ----------------------------------------------ceEEcccccccccCCCCcceeecccccccCcccc
Q 017175 211 ----------------------------------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244 (376)
Q Consensus 211 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 244 (376)
.+||+|||++...... .....||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999753221 2345799999999
Q ss_pred cccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc---------------------ccccccc
Q 017175 245 EYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD---------------------RRKFSQM 303 (376)
Q Consensus 245 E~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~ 303 (376)
|++.+..++.++|||||||++|+|++|..||..................... ......+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9999999999999999999999999999999865443222111111111100 0000000
Q ss_pred cCCcC---------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTL---------QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..... ....+...+..+.+|+.+||+.||++|||+.++++|-+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00000 01234566778999999999999999999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.32 Aligned_cols=272 Identities=19% Similarity=0.236 Sum_probs=207.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc------CCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~ 140 (376)
+..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456899999999999999999999999999999999653 23335567788888776 57799999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc--eEEcccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFG 218 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~--~kl~Dfg 218 (376)
.++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6899988762 2345899999999999999999999999 999999999999999887 9999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-----hhh
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-----RPL 293 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-----~~~ 293 (376)
++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+... ...
T Consensus 248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99753221 23457999999999999999999999999999999999999999876443221110000 000
Q ss_pred hhcccccccccC--------------------------------CcCCC----CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 017175 294 FKDRRKFSQMAD--------------------------------PTLQG----QYPVRGLYQALAVAAMCVQEQPNMRPL 337 (376)
Q Consensus 294 ~~~~~~~~~~~~--------------------------------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps 337 (376)
..........++ +.... ..+...+..+.+||.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 000000000000 00000 001112457889999999999999999
Q ss_pred HHHHHHHHHhhhc
Q 017175 338 IADVVTALTYLAC 350 (376)
Q Consensus 338 ~~ell~~L~~~~~ 350 (376)
+.|+++|-+....
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999875543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.65 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=209.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC-CCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.++||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.| ++|..+..++.+....++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999999999999999988654332 347789999999986 56666666677788899999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---CCCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill---~~~~~~kl~Dfg~~~~ 222 (376)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||++..
T Consensus 83 e~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 8999999975 2457999999999999999999999999 9999999999999 6889999999999976
Q ss_pred cCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-hhhhc
Q 017175 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-PLFKD 296 (376)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 296 (376)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA- 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-
Confidence 4433221 11225679999999999999999999999999999999999999998755432221111111 0000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+ ... .+.++.+|+.+||+.+|++||++.+|++.|..+.
T Consensus 235 -~~~~~l-----~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 235 -TSIEAL-----CRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp -SCHHHH-----HTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -ccHHHH-----hcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 000000 011 2347889999999999999999999999998874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=348.10 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred cCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEec-CCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l 143 (376)
..|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ....++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3578889999999999999987533 3468999986533 2345678899999999999999999998754 457899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999975 3456889999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcc--eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 224 PVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 224 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+.... ... ..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------~~~-~~-- 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------LLQ-GR-- 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH------HHT-TC--
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH------HHc-CC--
Confidence 222211 11233457889999999999999999999999999999999 6788876543221110 000 00
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
. ...+...+..+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 314 -~-------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 -R-------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -C-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 01122334578899999999999999999999999999876443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=337.47 Aligned_cols=273 Identities=23% Similarity=0.330 Sum_probs=212.3
Q ss_pred cCHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh--cCCCCccceeEEEe
Q 017175 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCA 136 (376)
Q Consensus 59 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~ 136 (376)
..+.....+.++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|..++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 445555678889999999999999999999984 899999998643 34566788888877 78999999999998
Q ss_pred cCC----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeecCCCCCcE
Q 017175 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--------DKANPPVIYRDLKCSNI 204 (376)
Q Consensus 137 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~~~~i~Hrdikp~Ni 204 (376)
... ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 876 78999999999999999965 46899999999999999999999 888 99999999999
Q ss_pred EECCCCceEEcccccccccCCCCcce--eecccccccCcccccccccC------CCCcccchhhHHHHHHHHHhC-----
Q 017175 205 LLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITG----- 271 (376)
Q Consensus 205 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~ll~g----- 271 (376)
+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997543332211 12345799999999999775 234689999999999999999
Q ss_pred -----CCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 272 -----RKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ-YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 272 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
..||......... ....... ... ....+.+... ........+.+|+.+||+.||++|||+.+|+++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~-~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS-VEEMRKV-VCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHHHHHH-HTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCccc-HHHHHHH-HHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6777654322111 0111000 000 0011111110 1235667899999999999999999999999999
Q ss_pred Hhhhcc
Q 017175 346 TYLACQ 351 (376)
Q Consensus 346 ~~~~~~ 351 (376)
+.+...
T Consensus 332 ~~i~~~ 337 (342)
T 1b6c_B 332 SQLSQQ 337 (342)
T ss_dssp HHHHHT
T ss_pred HHHHHH
Confidence 998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=348.11 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=191.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecC------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------ 138 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999999999999999996542 22345678999999999999999999999654
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6899988854 56999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+. ......
T Consensus 178 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~p 249 (367)
T 2fst_X 178 LARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTP 249 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSC
T ss_pred ccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCC
Confidence 9975321 1234679999999999987 678999999999999999999999998765432111110 000000
Q ss_pred -------------cccccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 298 -------------RKFSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 298 -------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..+...+...... ......+..+.+|+.+||+.||++|||+.++++|-+.-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0000000000000 000122457889999999999999999999999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.99 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=204.5
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccC
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 149 (376)
+|....+||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34555699999999999999999999999999987665666778899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcccccccccCCCCc
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 999999987631 2345678999999999999999999999 999999999999987 8999999999997533221
Q ss_pred ceeecccccccCcccccccccCC--CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ ......... ..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~--------~~- 244 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFK--------VH- 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHC--------CC-
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcccc--------cc-
Confidence 1223457999999999997653 88999999999999999999999975432110 000000000 01
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...+...+..+.+|+.+||+.||++||++.+++++-+.
T Consensus 245 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 245 ---PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred ---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 12223344578899999999999999999999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.79 Aligned_cols=266 Identities=17% Similarity=0.248 Sum_probs=206.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEec--CCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv 144 (376)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999999999999999998643 3467889999999997 9999999999987 6678999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEccccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLG 223 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~~ 223 (376)
|||+.+++|.+++.. +++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998843 889999999999999999999999 99999999999999776 8999999999764
Q ss_pred CCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccc--chhhhhh--hhh---h
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH--NLVAWAR--PLF---K 295 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~--~~~---~ 295 (376)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ....... ... .
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 33322 234579999999999987 67899999999999999999999999643221100 0000000 000 0
Q ss_pred c-----ccccccc--------cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 296 D-----RRKFSQM--------ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 296 ~-----~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. ...+... .........+...+..+.+||.+||+.||++|||+.++++|-+.-.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 0 0000000 0001111122234568899999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=353.47 Aligned_cols=270 Identities=22% Similarity=0.285 Sum_probs=202.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecC------Cce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~ 141 (376)
..+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++||||+++++++... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4579999999999999999999999999999999865422 233699999999999999999988542 236
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-CceEEcccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLA 220 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-~~~kl~Dfg~~ 220 (376)
++||||+++ +|...+..+......+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999974 666665433234577999999999999999999999999 9999999999999955 67899999999
Q ss_pred cccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccc-hhhhhh----hhh
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN-LVAWAR----PLF 294 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~----~~~ 294 (376)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......+... +..... ..+
T Consensus 205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8643332 22345789999999999765 78999999999999999999999998754322111 110000 000
Q ss_pred -hcccccccccCCcCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 295 -KDRRKFSQMADPTLQ-----GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 295 -~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+.....+.+. ..++...+..+.+||.+||..||.+||++.|+++|-+.-
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 000011111111111 012223456889999999999999999999999987753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=337.83 Aligned_cols=273 Identities=22% Similarity=0.310 Sum_probs=207.4
Q ss_pred HhcCcccCceecccCceEEEEEEEC-CCCeEEEEEEeccCCc--cchHHHHHHHHHHhhc---CCCCccceeEEEe----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLE-STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLL---HHPNLVNLIGYCA---- 136 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~---- 136 (376)
+.++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999864322 1223566777777766 8999999999987
Q ss_pred -cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 137 -DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 137 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
.....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 6999998763 2345899999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ....
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DVIG 236 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HHcC
Confidence 9999975321 112334678999999999999999999999999999999999999998654322111000 0000
Q ss_pred cc--ccccc-------cc---CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 296 DR--RKFSQ-------MA---DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 296 ~~--~~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.. ..+.. .. .......+....+..+.+|+.+||+.||++|||+.+++++-+.-+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00 00000 00 00000112223455788999999999999999999999887754443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.46 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=203.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec----CCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~ 142 (376)
..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458899999999999999999999999999999875432 334568899999999999999999999865 45689
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCceEEccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK 221 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~ 221 (376)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ .+|+||||||+||+++ .++.++|+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999975 466899999999999999999999986 3499999999999997 78999999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..... ......||+.|+|||++. +.++.++|||||||++|+|++|..||........ ....... .
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~-~---- 245 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTS-G---- 245 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTT-T----
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhc-c----
Confidence 53222 123357999999999886 4689999999999999999999999976432211 0000000 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.... .++...+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 246 -~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 246 -VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp -CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred -CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 0000 1111223468899999999999999999999987653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=343.99 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=203.2
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEec------C
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD------G 138 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~------~ 138 (376)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 35678999999999999999999999999999999986543 3456788999999998 79999999999977 4
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6789999999999999999752 2357899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||......... ...
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~ 246 (326)
T 2x7f_A 175 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLI 246 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH
T ss_pred CceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HHh
Confidence 98753221 11223457999999999997 457889999999999999999999999765432110 000
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
... . .+.. .+...+..+.+||.+||..||.+||++.+++++-+..
T Consensus 247 ~~~--~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 247 PRN--P-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp HHS--C-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred hcC--c-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 000 0 0000 1112244788999999999999999999999986643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=349.43 Aligned_cols=259 Identities=11% Similarity=-0.001 Sum_probs=187.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc---chHHHHHHHHHHhhc--CCCCcccee-------EEEe
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLL--HHPNLVNLI-------GYCA 136 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l--~h~ni~~~~-------~~~~ 136 (376)
.+|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999875432 234566775544444 699987755 5554
Q ss_pred cC-----------------CceEEEEEccCCCchhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCC
Q 017175 137 DG-----------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR------MRIAAGAAKGLEYLHDKANPP 193 (376)
Q Consensus 137 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~~i~~al~~LH~~~~~~ 193 (376)
.. ..+|+||||++ ++|.+++... ...+.+..+ +.++.||+.||.|||+++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 33 33799999998 8999999752 223444455 677899999999999999
Q ss_pred eeecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhC
Q 017175 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITG 271 (376)
Q Consensus 194 i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g 271 (376)
|+||||||+|||++.++.+||+|||++.... . ......+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG--T---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETT--C---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecC--C---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998532 1 1223567799999999987 6799999999999999999999
Q ss_pred CCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 272 RKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..||.............. ...........-......+..+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 290 ~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp SCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 999987643211110000 00000001111111123456888999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=364.74 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=204.6
Q ss_pred CcccCc-eecccCceEEEEEEEC--CCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 70 NFRADC-LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 70 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++.+.. .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999875 3567799999976433 345778999999999999999999999976 5689999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999965 3566999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 226 GDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+... .+...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~------ 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQG------ 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-------HHHTT------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcC------
Confidence 2211 11122346789999999999999999999999999999998 999998754432111 01110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
.....+...+..+.+|+.+||+.||++||++.+|++.|+.+-..
T Consensus 556 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 556 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11123334456888999999999999999999999999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=342.86 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=204.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCce---
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 141 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~--- 141 (376)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 467899999999999999999999999999999999764332 235678999999999999999999999877654
Q ss_pred ---EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 142 ---LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 142 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 68888873 34999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh-hh----h
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW-AR----P 292 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~----~ 292 (376)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.. .. .
T Consensus 190 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 190 LARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 9975321 1234578999999999987 6789999999999999999999999986543221111000 00 0
Q ss_pred hhhc-----ccccccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 293 LFKD-----RRKFSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 293 ~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.... .............. ......+..+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 0000 00000000000000 001123558889999999999999999999999977543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.36 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=196.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHH--HHHHhhcCCCCccceeEEEec-----CCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVE--VLMLSLLHHPNLVNLIGYCAD-----GDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e--~~~l~~l~h~ni~~~~~~~~~-----~~~ 140 (376)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..| +..+..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36799999999999999999987 48999999996432 2333344 444556899999999986542 235
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeeecCCCCCcEEECCCCc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK---------ANPPVIYRDLKCSNILLGEGYH 211 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---------~~~~i~Hrdikp~Nill~~~~~ 211 (376)
+++||||+++|+|.+++.. ...++..++.++.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999965 3458899999999999999999999 8 999999999999999999
Q ss_pred eEEcccccccccCCCC------cceeecccccccCccccccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 017175 212 PKLSDFGLAKLGPVGD------KTHVSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~g~~p~~~~ 278 (376)
+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997543221 1112234579999999999986 35667899999999999999998776543
Q ss_pred ccccccchh-h----------hhhhhhhcccccccccCCcCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 017175 279 RAAGEHNLV-A----------WARPLFKDRRKFSQMADPTLQGQ--YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345 (376)
Q Consensus 279 ~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L 345 (376)
......... . .......... ..+.+... .....+..+.+||.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 322111110 0 0000000000 01111111 1234566899999999999999999999999999
Q ss_pred Hhhhc
Q 017175 346 TYLAC 350 (376)
Q Consensus 346 ~~~~~ 350 (376)
+.+-.
T Consensus 314 ~~ll~ 318 (336)
T 3g2f_A 314 AELMM 318 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.75 Aligned_cols=271 Identities=17% Similarity=0.202 Sum_probs=207.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-----------CCCccceeEEEe
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCA 136 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~ 136 (376)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+. |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999999999999999996432 33456778999888876 899999999997
Q ss_pred cCC----ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEC----
Q 017175 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLG---- 207 (376)
Q Consensus 137 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~---- 207 (376)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 644 789999999 89999998763 235599999999999999999999998 9 99999999999994
Q ss_pred --CCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc
Q 017175 208 --EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN 285 (376)
Q Consensus 208 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 285 (376)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 445899999999975322 1233579999999999999999999999999999999999999998654322111
Q ss_pred hhhhhhhhhh---------------------cccccccccCCc---------CCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 017175 286 LVAWARPLFK---------------------DRRKFSQMADPT---------LQGQYPVRGLYQALAVAAMCVQEQPNMR 335 (376)
Q Consensus 286 ~~~~~~~~~~---------------------~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~R 335 (376)
.......... .......+.... -...++...+..+.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111111110 000000000000 0113456778899999999999999999
Q ss_pred CCHHHHHHHHHhhhc
Q 017175 336 PLIADVVTALTYLAC 350 (376)
Q Consensus 336 ps~~ell~~L~~~~~ 350 (376)
||+.+++++-+....
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 999999999876654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=331.95 Aligned_cols=258 Identities=23% Similarity=0.269 Sum_probs=209.7
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---------cchHHHHHHHHHHhhcC-CCCccceeEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLH-HPNLVNLIGYC 135 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~ni~~~~~~~ 135 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456889999999999999999999999999999999975431 11245778999999996 99999999999
Q ss_pred ecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 136 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999975 457999999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------ 237 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------ 237 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH------
Confidence 999997643322 223457999999999985 44688999999999999999999999976543211
Q ss_pred hhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.......... . ........+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 238 ~~~~~~~~~~---~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 238 LRMIMSGNYQ---F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp HHHHHHTCCC---C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHhcCCcc---c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 1111111000 0 001112345578899999999999999999999987664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=344.72 Aligned_cols=279 Identities=22% Similarity=0.272 Sum_probs=204.4
Q ss_pred CHHHHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-----------hHHHHHHHHHHhhcCCCCc
Q 017175 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----------NREFLVEVLMLSLLHHPNL 128 (376)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni 128 (376)
...++..+.++|++.+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 355677889999999999999999999999865 8999999986432211 2678899999999999999
Q ss_pred cceeEEEec-----CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCc
Q 017175 129 VNLIGYCAD-----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (376)
Q Consensus 129 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~N 203 (376)
+++++++.. ....|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999854 346899999997 688888765 3457999999999999999999999999 9999999999
Q ss_pred EEECCCCceEEcccccccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccc
Q 017175 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 282 (376)
|+++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999742222 22334579999999999887 678999999999999999999999998754322
Q ss_pred ccchhh-hhhh------hhhcccccccccCCcCC-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 283 EHNLVA-WARP------LFKDRRKFSQMADPTLQ-------GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 283 ~~~~~~-~~~~------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...... .... ................. .......+..+.+|+.+||+.||++|||+.++++|-+.-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 321 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence 111100 0000 00000000000000000 011122345788999999999999999999999987744
Q ss_pred h
Q 017175 349 A 349 (376)
Q Consensus 349 ~ 349 (376)
.
T Consensus 322 ~ 322 (362)
T 3pg1_A 322 S 322 (362)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=341.72 Aligned_cols=280 Identities=23% Similarity=0.267 Sum_probs=198.7
Q ss_pred HHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCc--
Q 017175 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-- 140 (376)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-- 140 (376)
......++|++.+.||+|+||.||+|.+..+++.||||++.... .......+++..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456689999999999999999999999999999999986543 233456678888889999999999999865333
Q ss_pred -----eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeecCCCCCcEEECC-CCce
Q 017175 141 -----RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--DKANPPVIYRDLKCSNILLGE-GYHP 212 (376)
Q Consensus 141 -----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~~~~i~Hrdikp~Nill~~-~~~~ 212 (376)
.++||||+++ +|...+.........+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999986 555444332234567899999999999999999999 899 999999999999996 8999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh-h
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW-A 290 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~ 290 (376)
||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+.. .
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999998543322 223457899999999987654 89999999999999999999999987543321111100 0
Q ss_pred --------hhhhhcccccccccC-----CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 291 --------RPLFKDRRKFSQMAD-----PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 291 --------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
............... ...........+..+.+|+.+||+.||.+|||+.|+++|-+.-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000000000000000 000111222346789999999999999999999999999876554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=337.53 Aligned_cols=269 Identities=26% Similarity=0.382 Sum_probs=191.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 45789999999999999999999988899999999865432 33456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 146 EYMPLGSLEDHLHDL----PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 146 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
||+++++|.+++... ......+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 112456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCc---ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 222 LGPVGDK---THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 222 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhccCC
Confidence 5433211 112234579999999999876 568999999999999999999999998654322110 0000000
Q ss_pred ccc-ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 298 RKF-SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 298 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
... ....++.. ....+..+.+|+.+||+.||.+||++.+++++-+.
T Consensus 245 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 245 PSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp CCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred Cccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 000 00111111 12234478899999999999999999999987653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=335.27 Aligned_cols=260 Identities=29% Similarity=0.392 Sum_probs=199.6
Q ss_pred hcCcccCceecccCceEEEEEEECC-CC--eEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-TN--QVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998643 33 368999987543 233467889999999999999999999998764 8
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999875 2356899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 222 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||........ ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~-- 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEG-- 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccC--
Confidence 643332221 2233567889999999998889999999999999999999 9999986543211 11111110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+++.+||..||++|||+.+++++|..+..
T Consensus 242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0001122344578899999999999999999999999998875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=341.51 Aligned_cols=268 Identities=17% Similarity=0.193 Sum_probs=207.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC--------CeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccc---------
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST--------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVN--------- 130 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~--------- 130 (376)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 46899999999999999999999874 789999998654 45778999999999999887
Q ss_pred ------eeEEEec-CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCc
Q 017175 131 ------LIGYCAD-GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (376)
Q Consensus 131 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~N 203 (376)
+++++.. ....|+||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6677765 67889999999 99999999762 1367999999999999999999999999 9999999999
Q ss_pred EEECCCC--ceEEcccccccccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 017175 204 ILLGEGY--HPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (376)
Q Consensus 204 ill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 276 (376)
||++.++ .++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999753322111 11133579999999999999899999999999999999999999998
Q ss_pred CcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccC
Q 017175 277 NTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKY 353 (376)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~ 353 (376)
....... ............. ..+...... ....+..+.+|+.+||+.||++||++.+|++.|..+.....
T Consensus 270 ~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFVDKP---GPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHH-HHHHHHHHHHHSC---CCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHH-HHHHHHHhccCCh---hhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 6542211 1111111111111 111110000 01223578899999999999999999999999998876443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.83 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=200.9
Q ss_pred ceecccCceEEEEEEE--CCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999975432 234678999999999999999999999965 568899999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc-
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT- 229 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 229 (376)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 467999999999999999999999999 999999999999999999999999999764333221
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........... ... ..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~----------~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEK----------GE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHT----------TC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHc----------CC
Confidence 12233457889999999999999999999999999999998 9999987544221110 111 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....+...+..+.+|+.+||+.||++||++.+|++.|..+..
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233445688899999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=361.65 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=209.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...|+||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4679999999999999999999876 4679999997654 345678999999999999999999999876 678999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+.+|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 416 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence 9999999999641 1345899999999999999999999999 999999999999999999999999999753221
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
.........++..|+|||++.+..++.++|||||||++|||++ |..||......... . . ....
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~---~-i~~~--------- 480 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---D---Q-VERG--------- 480 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---H---H-HHTT---------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---H-HHcC---------
Confidence 1111223456788999999999999999999999999999999 99999865432111 0 0 0100
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 0111223345578899999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.08 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=199.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC------ce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~ 141 (376)
..+|++.+.||+|+||.||+|++..++. ||+|++...... ..+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4679999999999999999999987666 888887543222 236999999999999999999985533 37
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCceEEcccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLA 220 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~ 220 (376)
++||||++++ +...+.........+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999864 44433322223567999999999999999999999999 99999999999998 7999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh-----hh
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR-----PL 293 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~-----~~ 293 (376)
.....+. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+ .... ..
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8643332 22345789999999998765 5899999999999999999999999876433211111 0000 00
Q ss_pred hhcccc-----cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 294 FKDRRK-----FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 294 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
...... +.......+...++...+..+.+|+.+||+.||++|||+.|+++|-+.-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 000000 0000111111111223455889999999999999999999999986643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=346.86 Aligned_cols=279 Identities=22% Similarity=0.288 Sum_probs=191.6
Q ss_pred HHhcCccc-CceecccCceEEEEEEEC--CCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEe--cCCc
Q 017175 66 AVTKNFRA-DCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 140 (376)
Q Consensus 66 ~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~ 140 (376)
.+.+.|.+ .++||+|+||.||+|++. .+++.||||++..... ...+.+|+.+++.++||||+++++++. ....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34566887 458999999999999976 5688999999975533 346789999999999999999999995 4678
Q ss_pred eEEEEEccCCCchhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----CCCCc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLP-----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYH 211 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill----~~~~~ 211 (376)
.|+||||+. ++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 999999997 57877765311 12235999999999999999999999999 9999999999999 77889
Q ss_pred eEEcccccccccCCCCc-ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc---ch
Q 017175 212 PKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH---NL 286 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~---~~ 286 (376)
+||+|||++........ .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999976432211 1223346799999999999874 5899999999999999999999999754332100 00
Q ss_pred hhhhhhhhhcccc-----cccc------------cCCcCCCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHH
Q 017175 287 VAWARPLFKDRRK-----FSQM------------ADPTLQGQYP---------VRGLYQALAVAAMCVQEQPNMRPLIAD 340 (376)
Q Consensus 287 ~~~~~~~~~~~~~-----~~~~------------~~~~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~e 340 (376)
......++...+. ...+ .......... ...+..+.+||.+||+.||.+|||+.|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 0001111000000 0000 0000000000 011346789999999999999999999
Q ss_pred HHHHHHhhhc
Q 017175 341 VVTALTYLAC 350 (376)
Q Consensus 341 ll~~L~~~~~ 350 (376)
+++|-+....
T Consensus 331 ~L~hp~f~~~ 340 (405)
T 3rgf_A 331 AMQDPYFLED 340 (405)
T ss_dssp HHTSGGGTSS
T ss_pred HhcChhhccC
Confidence 9999887553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.51 Aligned_cols=259 Identities=25% Similarity=0.327 Sum_probs=209.0
Q ss_pred HHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 356789999999999999999999999999999999986532 234567889999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC---CceEEccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLSDFGL 219 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~---~~~kl~Dfg~ 219 (376)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999998865 356899999999999999999999999 9999999999999754 4699999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........ ..........
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGKYA 240 (287)
T ss_dssp GGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC
T ss_pred ceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCC
Confidence 97543222 1223468999999998865 589999999999999999999999986543211 1111110000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.... ...+..+.+++.+||+.||++|||+.+++++-+..
T Consensus 241 ----~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 241 ----FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp ----CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred ----CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 000000 12245788999999999999999999999976543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.84 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=204.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCc----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---- 140 (376)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 357899999999999999999999999999999999764322 23567899999999999999999999987654
Q ss_pred --eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 141 --RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 141 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
+|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 68888763 35899999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+. ......
T Consensus 172 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~---~~~~~~ 243 (353)
T 3coi_A 172 LARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL---KVTGVP 243 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH---HHHCBC
T ss_pred cccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCC
Confidence 9975321 1234578999999999887 678999999999999999999999998754322111000 000000
Q ss_pred -----------------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 298 -----------------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 298 -----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
..........+ .......+..+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 00000000001 112234456889999999999999999999999987754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=335.67 Aligned_cols=260 Identities=20% Similarity=0.212 Sum_probs=181.3
Q ss_pred HhcCcccCc-eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHH-HHHhhcCCCCccceeEEEec----CCc
Q 017175 67 VTKNFRADC-LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 67 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~----~~~ 140 (376)
+.++|.+.+ +||+|+||.||+|.+..+++.||||++... ....+|+ ..++.+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 568899955 699999999999999999999999998643 2222333 34566789999999999876 445
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Df 217 (376)
.++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 89999999999999999763 2356999999999999999999999999 999999999999976 455999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
|++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .......
T Consensus 176 g~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 249 (336)
T 3fhr_A 176 GFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRIRLGQ 249 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhhhccc
Confidence 999753221 2234578999999999988889999999999999999999999997654321100000 0000000
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.. .........+..+.+|+.+||+.||++|||+.+++++.+.-..
T Consensus 250 ---~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 250 ---YG-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---cc-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 0001112334578899999999999999999999999886554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=333.23 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=201.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEe----------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA---------- 136 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~---------- 136 (376)
+.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4578999999999999999999999999999999997665555677889999999999999999999874
Q ss_pred ----cCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCc
Q 017175 137 ----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYH 211 (376)
Q Consensus 137 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~ 211 (376)
+....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699999853 56899999999999999999999999 99999999999997 5679
Q ss_pred eEEcccccccccCCCCc-ceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh
Q 017175 212 PKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 289 (376)
+||+|||++........ ........+|..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999975322211 112233567999999998876 6789999999999999999999999987543221110000
Q ss_pred h---------hhhhhcccc-cc-cccCCcC-CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 290 A---------RPLFKDRRK-FS-QMADPTL-QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 290 ~---------~~~~~~~~~-~~-~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
. ......... .. ....+.. ........+..+.+|+.+||+.||++|||+.+++++-+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 0 000000000 00 0000000 0000112345788999999999999999999999987743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=337.02 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=207.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---h--------------HHHHHHHHHHhhcCCCCccc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---N--------------REFLVEVLMLSLLHHPNLVN 130 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~--------------~~~~~e~~~l~~l~h~ni~~ 130 (376)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... . ..+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 79999999986432211 1 77889999999999999999
Q ss_pred eeEEEecCCceEEEEEccCCCchhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCc
Q 017175 131 LIGYCADGDQRLLVYEYMPLGSLEDH------LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSN 203 (376)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~N 203 (376)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 433 125679999999999999999999999 99 9999999999
Q ss_pred EEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccC-CCCc-ccchhhHHHHHHHHHhCCCCCCCcccc
Q 017175 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTL-KSDVYSFGVVLLEIITGRKAIDNTRAA 281 (376)
Q Consensus 204 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~ 281 (376)
|+++.++.++|+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999764322 23446799999999999887 6666 999999999999999999999865431
Q ss_pred cccchhhhhhhhhhccccccc----ccCCcC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 282 GEHNLVAWARPLFKDRRKFSQ----MADPTL---QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. ............+.. ...+.. ........+..+.+|+.+||+.||++|||+.+++++-+.
T Consensus 259 ~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 259 V-----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp H-----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred H-----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 0 011111111000000 000000 000112345588899999999999999999999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=335.52 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=207.4
Q ss_pred HhcCcccCceecccCceEEEEEEE-CCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC------CccceeEEEecCC
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRL-ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP------NLVNLIGYCADGD 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------ni~~~~~~~~~~~ 139 (376)
+.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.++|+ +++++++++.+..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999998 567899999999643 23345677899999888654 5999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-----------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----------- 208 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~----------- 208 (376)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 78999998762 2346899999999999999999999999 999999999999987
Q ss_pred --------CCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 209 --------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 209 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999753221 2345799999999999999999999999999999999999999986543
Q ss_pred ccccchhhhhhh-----hhhcccccc--------------------cccCC-cCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 017175 281 AGEHNLVAWARP-----LFKDRRKFS--------------------QMADP-TLQGQYPVRGLYQALAVAAMCVQEQPNM 334 (376)
Q Consensus 281 ~~~~~~~~~~~~-----~~~~~~~~~--------------------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~ 334 (376)
............ ......... ....+ ..........+..+.+|+.+||+.||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 321111100000 000000000 00000 0001122345678999999999999999
Q ss_pred CCCHHHHHHHHHh
Q 017175 335 RPLIADVVTALTY 347 (376)
Q Consensus 335 Rps~~ell~~L~~ 347 (376)
|||+.|++++-+.
T Consensus 320 Rpt~~ell~hp~f 332 (339)
T 1z57_A 320 RITLREALKHPFF 332 (339)
T ss_dssp SCCHHHHTTSGGG
T ss_pred ccCHHHHhcCHHH
Confidence 9999999988553
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=333.24 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=201.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcC--CCCccceeEEEecCCce
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQR 141 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~ 141 (376)
...++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+|+.+++.++ |+||+++++++.+....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345789999999999999999999864 88999999975433 23456889999999997 59999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||++++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 557899999976 457899999999999999999999999 999999999999965 899999999997
Q ss_pred ccCCCCcceeecccccccCccccccccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~ 249 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL 249 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHH
Confidence 6433332222334579999999999875 46888999999999999999999999754221 0000
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....++.....++...+..+.+++.+||+.||++||++.+++++.+...
T Consensus 250 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 250 ----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp ----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred ----------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 1111111112222233457889999999999999999999999987544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=339.19 Aligned_cols=270 Identities=21% Similarity=0.281 Sum_probs=205.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecC-----Cc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 140 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 45789999999999999999999999999999999965432 2335677999999999999999999988654 67
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 699998865 46999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcce--------eecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 221 KLGPVGDKTH--------VSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 221 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~ 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---F 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---H
Confidence 7643221111 1223578999999998765 67899999999999999999999999875432111000 0
Q ss_pred hhhhccc------------------ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 292 PLFKDRR------------------KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 292 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....... .........+ .......+..+.+|+.+||+.||++|||+.+++++-+.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000000 0000000000 0001133457889999999999999999999999877543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=336.00 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=198.8
Q ss_pred HHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhc----CCCCccceeE
Q 017175 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLL----HHPNLVNLIG 133 (376)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~ni~~~~~ 133 (376)
...+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345678999999999999999999999999999999999765432 223355789999888 8999999999
Q ss_pred EEecCCceEEEEEc-cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCc
Q 017175 134 YCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYH 211 (376)
Q Consensus 134 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~ 211 (376)
++.+.+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 99999999999999 788999999975 456999999999999999999999999 99999999999998 8899
Q ss_pred eEEcccccccccCCCCcceeecccccccCcccccccccCCCC-cccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh
Q 017175 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA 290 (376)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 290 (376)
++|+|||++....... .....||..|+|||++.+..+. .++|||||||++|+|++|..||......
T Consensus 179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------- 245 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------- 245 (312)
T ss_dssp EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---------
Confidence 9999999997643222 2345699999999999877664 5899999999999999999999754211
Q ss_pred hhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 291 RPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.... ..++...+..+.+|+.+||+.||++|||+.+++++.+...
T Consensus 246 ---~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 246 ---LEAE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp ---HHTC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred ---hhhc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 0000 0122233457889999999999999999999999877443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=330.42 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=198.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec---------
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 137 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------- 137 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 567899999999999999999999999999999999643 2334668899999999999999999998865
Q ss_pred ----CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceE
Q 017175 138 ----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (376)
Q Consensus 138 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~k 213 (376)
....|+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3567999999999999999975 2456788999999999999999999999 99999999999999999999
Q ss_pred EcccccccccCCCCc------------ceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 214 LSDFGLAKLGPVGDK------------THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 214 l~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999975332110 1122345699999999999864 68999999999999999998 5543211
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. .......... ...+...++...+..+.+++.+||+.||++|||+.+++++-+.
T Consensus 234 ~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 234 R-----VNILKKLRSV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp H-----HHHHHHHHST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred H-----HHHHHhcccc--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 1 0001111000 1111122333445578899999999999999999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.26 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=186.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHH-HHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36799999999999999999999999999999999765322 2334555665 677789999999999999999999999
Q ss_pred EccCCCchhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 146 EYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 146 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||+++ +|.+++... ......+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99984 777776421 11246789999999999999999999998 9 999999999999999999999999999753
Q ss_pred CCCCcceeecccccccCccccccc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... .. .
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~-------~ 241 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LT-------Q 241 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-------C
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HH-------H
Confidence 2221 22334699999999998 4567899999999999999999999999864321000 00 0
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+.+........+..+.+|+.+||+.||++||++.+|+++.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000001111111112334578899999999999999999999998776554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.18 Aligned_cols=254 Identities=15% Similarity=0.115 Sum_probs=189.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999999999999999997654332 3568899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||++|++|.+++.. . ....++..++.||+.||.|||++| |+||||||+|||++.+|.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999853 2 356678999999999999999999 9999999999999999999998543
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
|++ .++.++|||||||++|+|++|..||............. . .....
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~------~~~~~ 221 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---R------DTAGQ 221 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---B------CTTSC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---H------HhccC
Confidence 333 36889999999999999999999998754432110000 0 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcccCCCCCCCcccCCCCCCCc
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSSRTGSSTP 370 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (376)
... ........+..+.+|+.+||+.||++| |+.++++.|..+..........|..+.++.+..|
T Consensus 222 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~p~~~~~~~~~p 285 (286)
T 3uqc_A 222 PIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285 (286)
T ss_dssp BCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--------------------
T ss_pred CCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCCCCCCCCcccCC
Confidence 000 000111234578899999999999999 9999999999998766655544444444444333
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=340.36 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=206.4
Q ss_pred HHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcC--CCCccceeEE
Q 017175 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLH--HPNLVNLIGY 134 (376)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~ni~~~~~~ 134 (376)
+...+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+. |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3345678899999999999999999999999999999999754322 2234667999999986 5999999999
Q ss_pred EecCCceEEEEEccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCce
Q 017175 135 CADGDQRLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHP 212 (376)
Q Consensus 135 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~ 212 (376)
+.+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999976 899999875 457899999999999999999999999 99999999999998 78999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 190 kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------- 255 (320)
T 3a99_A 190 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------- 255 (320)
T ss_dssp EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------
T ss_pred EEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----------
Confidence 99999999764322 1234569999999999987765 68899999999999999999999764311
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..... .++...+..+.+|+.+||+.||++|||+.+|+++-+...
T Consensus 256 --~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 256 --IRGQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp --HHCCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred --hcccc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 00000 011122347889999999999999999999999876433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=337.94 Aligned_cols=270 Identities=21% Similarity=0.259 Sum_probs=205.8
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CC-----CccceeEEEecCC
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCADGD 139 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni~~~~~~~~~~~ 139 (376)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. |+ +|+++++++....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4568999999999999999999999999999999999643 223455667888888775 44 4999999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeeecCCCCCcEEEC--CCCceEEc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD--KANPPVIYRDLKCSNILLG--EGYHPKLS 215 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--~~~~~i~Hrdikp~Nill~--~~~~~kl~ 215 (376)
..++||||+. ++|.+++... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999996 5999998763 23568999999999999999999994 67 99999999999994 57889999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh----
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR---- 291 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---- 291 (376)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+....
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999864221 234679999999999999999999999999999999999999998754332111110000
Q ss_pred -hhhhccc----ccccccCCcC-------------------------------------CCCCCHHHHHHHHHHHHHccc
Q 017175 292 -PLFKDRR----KFSQMADPTL-------------------------------------QGQYPVRGLYQALAVAAMCVQ 329 (376)
Q Consensus 292 -~~~~~~~----~~~~~~~~~~-------------------------------------~~~~~~~~~~~l~~li~~cl~ 329 (376)
....... .+..+.+..+ ...........+.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0000000 0000000000 001112334578999999999
Q ss_pred CCCCCCCCHHHHHHHHHh
Q 017175 330 EQPNMRPLIADVVTALTY 347 (376)
Q Consensus 330 ~~P~~Rps~~ell~~L~~ 347 (376)
.||++|||+.|+++|-+.
T Consensus 359 ~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp SCTTTSCCHHHHTTSGGG
T ss_pred CChhhCCCHHHHhcCccc
Confidence 999999999999998664
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=334.88 Aligned_cols=271 Identities=18% Similarity=0.213 Sum_probs=206.5
Q ss_pred HhcCcccCceecccCceEEEEEEECCCC-eEEEEEEeccCCccchHHHHHHHHHHhhcCCCC------ccceeEEEecCC
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGD 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~~~~ 139 (376)
+.++|++.+.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4678999999999999999999998776 78999999643 233456778999999887655 899999999999
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-------------
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL------------- 206 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill------------- 206 (376)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 56777776542 2356999999999999999999999999 9999999999999
Q ss_pred ------CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 017175 207 ------GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (376)
Q Consensus 207 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 280 (376)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999753221 2345799999999999999999999999999999999999999986543
Q ss_pred ccccchhhhhh-----hhhhcccccccc--------------------cCC-cCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 017175 281 AGEHNLVAWAR-----PLFKDRRKFSQM--------------------ADP-TLQGQYPVRGLYQALAVAAMCVQEQPNM 334 (376)
Q Consensus 281 ~~~~~~~~~~~-----~~~~~~~~~~~~--------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~ 334 (376)
........... ............ ..+ ..........+..+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 22111100000 000000000000 000 0000112344668899999999999999
Q ss_pred CCCHHHHHHHHHhhh
Q 017175 335 RPLIADVVTALTYLA 349 (376)
Q Consensus 335 Rps~~ell~~L~~~~ 349 (376)
|||+.+++++-+.-.
T Consensus 325 Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 325 RITLAEALLHPFFAG 339 (355)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred CcCHHHHhcChhhcC
Confidence 999999999877554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.22 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=199.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4679999999999999999999864 399999875422 22345678999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.++|+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999975 3456899999999999999999999999 99999999999998 67999999999865321
Q ss_pred CC---cceeecccccccCccccccccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhh
Q 017175 226 GD---KTHVSTRVMGTYGYCAPEYAMT---------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293 (376)
Q Consensus 226 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 293 (376)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHh
Confidence 11 1112233568999999999875 35788999999999999999999999865432110 110
Q ss_pred hhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
... . .+... ....+..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 256 ~~~--~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTG--M-----KPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTT--C-----CCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccC--C-----CCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0 00000 011223678899999999999999999999999988754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=357.48 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=206.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 357899999999999999999998643 56799999875432 23357889999999999999999999985 45689
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999975 2456899999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.. ... ....
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~------~~i-~~~~--- 609 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------GRI-ENGE--- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHH-HHTC---
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHH-HcCC---
Confidence 432221 12233457889999999998899999999999999999997 99999865432211 010 0000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....+...+..+.+|+.+||..||++|||+.+|++.|..+-
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00122334457889999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=324.16 Aligned_cols=256 Identities=25% Similarity=0.328 Sum_probs=185.1
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-h-HHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... . +.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999999999999999997654322 2 23444555677889999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||+ ++.+..+... ....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566555543 246789999999999999999999995 8 9999999999999999999999999987532
Q ss_pred CCCcceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... ............
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~- 247 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-
Confidence 221 223457999999999994 456889999999999999999999999864321 111111111100
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
+... .....+..+.+|+.+||+.||.+||++.+|+++-+.
T Consensus 248 ------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 248 ------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp ------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred ------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 0000 001234478899999999999999999999987553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=335.04 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=190.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+....|+|||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3557778999999999998754 456899999998643 234567899999876 79999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC-------------C
Q 017175 147 YMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-------------Y 210 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~---~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~-------------~ 210 (376)
||. |+|.+++......... .++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 996 6999999763221111 133356789999999999999999 9999999999999754 4
Q ss_pred ceEEcccccccccCCCCcce--eecccccccCccccccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCccc
Q 017175 211 HPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (376)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 280 (376)
.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999998644332111 1234579999999999976 568999999999999999999 9999975432
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.. .......... +......+...+..+.+|+.+||+.||++|||+.+|++|-+.
T Consensus 246 ~~--------~~i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 246 RE--------SNIIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp HH--------HHHHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hH--------HHHhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 11 0011110010 111112234567789999999999999999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=332.20 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=188.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.+|.+.+.||+|+||.|+. ....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+....|+||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4699999999999999664 33456899999999654332 245799999998 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-----CCceEEcccccccc
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-----GYHPKLSDFGLAKL 222 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-----~~~~kl~Dfg~~~~ 222 (376)
|. |+|.+++... .....+..++.++.||+.||.|||+.+ |+||||||+|||++. ...++|+|||++..
T Consensus 100 ~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 6999998762 333455567889999999999999999 999999999999953 23578999999976
Q ss_pred cCCCCcc-eeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcc
Q 017175 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||........ ..... .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~-~ 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLG-A 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTT-C
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhc-c
Confidence 4333211 22334679999999999974 567889999999999999999 8999965422110 00000 0
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... .. .......+..+.+||.+||+.||++|||+.++++|-+
T Consensus 245 ~~~-----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 245 CSL-----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp CCC-----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred CCc-----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 000 00 0112345567889999999999999999999997644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=347.43 Aligned_cols=276 Identities=25% Similarity=0.294 Sum_probs=205.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEec------CCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~ 140 (376)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999999999999999987542 2334568899999999999999999998765 667
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCc---eEEccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDF 217 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~---~kl~Df 217 (376)
.++||||++|++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997632 2346889999999999999999999999 999999999999987765 899999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc-cchhhh-hhh---
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE-HNLVAW-ARP--- 292 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~-~~~--- 292 (376)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ...
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9998643332 23346799999999999999999999999999999999999999975421100 000000 000
Q ss_pred hhhc-ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH-----HHHHHhhhc
Q 017175 293 LFKD-RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV-----VTALTYLAC 350 (376)
Q Consensus 293 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~el-----l~~L~~~~~ 350 (376)
.... .....-..............+..+.+++.+||..||++|||+.++ .+.+..+-.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 000000000011123445678899999999999999999999884 444554444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.06 Aligned_cols=237 Identities=19% Similarity=0.260 Sum_probs=187.8
Q ss_pred HhcCcccC-ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHH-hhcCCCCccceeEEEec----CCc
Q 017175 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQ 140 (376)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~----~~~ 140 (376)
+.++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +.++||||+++++++.+ ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 35678887 789999999999999999999999999853 34567888887 55689999999999876 677
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Df 217 (376)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 89999999999999999762 2346999999999999999999999999 999999999999998 789999999
Q ss_pred ccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 297 (376)
|++.... +..++.++|||||||++|+|++|..||............
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---------- 210 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---------- 210 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----------
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----------
Confidence 9986421 245678999999999999999999999765432110000
Q ss_pred cccccccCCcCCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 298 RKFSQMADPTLQGQYP----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 298 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
...+.... ...+ ...+..+.+|+.+||+.||++|||+.+++++.+.....
T Consensus 211 --~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 211 --KTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp --CCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred --HHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000000 0111 12355788999999999999999999999998876653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=327.92 Aligned_cols=244 Identities=16% Similarity=0.160 Sum_probs=184.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHHHHHHHhhcCC-CCc---------cceeEE-
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH-PNL---------VNLIGY- 134 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------~~~~~~- 134 (376)
..|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.+.| +|. +..++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458888999999999999999999999999999874332 235678899999999876 221 111111
Q ss_pred -----------Eec-----CCceEEEEEccCCCchhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 017175 135 -----------CAD-----GDQRLLVYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195 (376)
Q Consensus 135 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~ 195 (376)
+.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 22457777776 58999888421 123456788899999999999999999999 99
Q ss_pred ecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCccccccc----------ccCCCCcccchhhHHHHH
Q 017175 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----------MTGQLTLKSDVYSFGVVL 265 (376)
Q Consensus 196 Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il 265 (376)
||||||+|||++.++.+||+|||+++... . .....+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~--~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--A---SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT--E---EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecC--C---ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999987522 1 1344578 999999999 555688899999999999
Q ss_pred HHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 266 LEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 266 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
|+|++|..||........... ++.. ...+ +..+.+|+.+||+.||++||++.+++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~----------------~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEW----------------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGG----------------GGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchhhhHHH----------------HHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999986543221110 0010 0122 2478899999999999999998877654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.71 Aligned_cols=241 Identities=23% Similarity=0.329 Sum_probs=194.5
Q ss_pred HhcCcccCceecccCceEEEEEEECC-CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCc----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---- 140 (376)
+.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 45789999999999999999999976 789999999865433 233567899999999999999999999987665
Q ss_pred -eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 141 -RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 141 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.|+||||++|++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999988763 26999999999999999999999999 9999999999999985 999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccc
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (376)
+...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~--------------- 285 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP--------------- 285 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------
T ss_pred chhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---------------
Confidence 9763322 345799999999998765 488999999999999999999888753211000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHhh
Q 017175 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-IADVVTALTYL 348 (376)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~ell~~L~~~ 348 (376)
........+..+.+||.+||+.||++||+ ++++...|..+
T Consensus 286 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001122357888999999999999995 55566666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.73 Aligned_cols=246 Identities=17% Similarity=0.118 Sum_probs=187.6
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--------cchHHHHHHHHHHhhcC---------CCCccc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLH---------HPNLVN 130 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~ni~~ 130 (376)
.++|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 589999999976532 22367888999988875 777777
Q ss_pred eeEEEe-----------------c-------------CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 017175 131 LIGYCA-----------------D-------------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180 (376)
Q Consensus 131 ~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~ 180 (376)
+.+.+. + ....|+||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 766542 2 6789999999999977776633 5689999999999999
Q ss_pred HHHHHHh-hCCCCCeeecCCCCCcEEECCCC--------------------ceEEcccccccccCCCCcceeeccccccc
Q 017175 181 KGLEYLH-DKANPPVIYRDLKCSNILLGEGY--------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (376)
Q Consensus 181 ~al~~LH-~~~~~~i~Hrdikp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (376)
.||.||| +++ |+||||||+|||++.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999985332 1347999
Q ss_pred CcccccccccCCCCcccchhhHHHH-HHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHH
Q 017175 240 GYCAPEYAMTGQLTLKSDVYSFGVV-LLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLY 318 (376)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (376)
.|+|||++.+.. +.++||||||++ .+++++|..||....... ......... .. .............+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-----~~~~~~~~~-~~----~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-----YLTDKMLKQ-MT----FKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-----HHHHHHHHT-CC----CSSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-----HHHHhhhhh-hc----cCcccchhhhhhcCH
Confidence 999999998766 889999998777 778888999986421100 000000100 00 000111112235678
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH-HHHH
Q 017175 319 QALAVAAMCVQEQPNMRPLIADVV-TALT 346 (376)
Q Consensus 319 ~l~~li~~cl~~~P~~Rps~~ell-~~L~ 346 (376)
++.+||.+||+.| |+.|++ +|-+
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred HHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 8999999999976 999999 7643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=281.10 Aligned_cols=185 Identities=16% Similarity=0.097 Sum_probs=132.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeccCCcc----------chHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEEE
Q 017175 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+.|++|.+..++..-.|+.||+|++...... ..+.+.+|+.+|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56677777777666667889999999754321 224688999999999 5999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||++|++|.+++.. ..+++.. +|+.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999976 4556654 58899999999999999 99999999999999999999999999986332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 274 (376)
. .......+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 223345789999999999975 467789999999999888766443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=247.88 Aligned_cols=186 Identities=19% Similarity=0.219 Sum_probs=144.5
Q ss_pred ccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc--------hHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
...+.||+|+||.||+|... +..+++|+........ .+.+.+|+.++++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999544 7789999875433221 2347899999999999999966666667778899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999853 4689999999999999999 999999999999998 9999999999864
Q ss_pred CCCCcce-----eecccccccCccccccccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 017175 224 PVGDKTH-----VSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAID 276 (376)
Q Consensus 224 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~ 276 (376)
....... ......||+.|+|||++.. ..|+..+|+|+.++-..+.+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3321111 1235689999999999987 568888999999999888887776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=207.28 Aligned_cols=158 Identities=15% Similarity=0.045 Sum_probs=124.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------------------chHHHHHHHHHHhhcCCCCcc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------------------GNREFLVEVLMLSLLHHPNLV 129 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~ni~ 129 (376)
...|.+.+.||+|+||.||+|.+ .+|+.||+|+++..... ....+.+|+.+++.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 44567779999999999999999 78999999999643221 2345789999999998 5 6
Q ss_pred ceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCC
Q 017175 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (376)
Q Consensus 130 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~ 209 (376)
++++++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ +
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 66665543 56699999999999988 421 124579999999999999999 99999999999999 9
Q ss_pred CceEEcccccccccCCCCcceeecccccccCccccccccc----------CCCCcccchhh
Q 017175 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT----------GQLTLKSDVYS 260 (376)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws 260 (376)
+.++|+|||++. .+..+.|||++.+ ..|+..+|+|.
T Consensus 229 ~~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 229 EGIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TEEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CcEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999986 2345789998854 33455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=177.27 Aligned_cols=136 Identities=15% Similarity=0.075 Sum_probs=107.3
Q ss_pred cccCceecccCceEEEEEEECCCCeE--EEEEEeccCCccc------------------------hHHHHHHHHHHhhcC
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNGLQG------------------------NREFLVEVLMLSLLH 124 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 124 (376)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999667888 9999875432110 125778999999998
Q ss_pred CCCc--cceeEEEecCCceEEEEEccCC-C----chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeee
Q 017175 125 HPNL--VNLIGYCADGDQRLLVYEYMPL-G----SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-DKANPPVIY 196 (376)
Q Consensus 125 h~ni--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~~~~i~H 196 (376)
|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 8764 344432 357899999942 3 67666432 234567889999999999999 999 999
Q ss_pred cCCCCCcEEECCCCceEEcccccccc
Q 017175 197 RDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 197 rdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
|||||+|||++. .++|+|||++..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-19 Score=165.62 Aligned_cols=134 Identities=13% Similarity=0.102 Sum_probs=99.3
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--------------chH--------HHHHHHHHHhhcCCCCc
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------------GNR--------EFLVEVLMLSLLHHPNL 128 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~h~ni 128 (376)
|.+.+.||.|++|.||+|.+. +|+.||||+++..... ... ....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999985 5899999987532110 001 12346666666654443
Q ss_pred c--ceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 129 V--NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 129 ~--~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
. ..++. ...+|||||++|++|..+... .....++.||+.+|.+||+.| ||||||||.|||+
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 2 22322 234799999999888665421 134568899999999999999 9999999999999
Q ss_pred CCCC----------ceEEcccccccc
Q 017175 207 GEGY----------HPKLSDFGLAKL 222 (376)
Q Consensus 207 ~~~~----------~~kl~Dfg~~~~ 222 (376)
+++| .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8776 389999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=9.5e-14 Score=122.90 Aligned_cols=145 Identities=17% Similarity=0.085 Sum_probs=113.4
Q ss_pred HHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEE
Q 017175 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 144 (376)
.....|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.++++++.+....|+|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34457999999999999999999754 6789999986532223345788999999885 67788999999988899999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA---------------------------------- 190 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---------------------------------- 190 (376)
|||++|.+|.+.... ......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999876421 1123467889999999999811
Q ss_pred ----------------------CCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 191 ----------------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 191 ----------------------~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1238999999999999876566799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=9.5e-12 Score=109.59 Aligned_cols=136 Identities=16% Similarity=0.100 Sum_probs=99.1
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccceeEEEecCCceEEEEEc
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~ 147 (376)
.|.+..+.+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455444444666799999965 44677999987644 2245678999998886544 55688888888889999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------- 190 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~------------------------------------- 190 (376)
++|.+|. ... .+ ...++.+++.+|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 1356777888888888743
Q ss_pred ------------------CCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 191 ------------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 191 ------------------~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=3.1e-11 Score=111.71 Aligned_cols=142 Identities=13% Similarity=0.174 Sum_probs=106.1
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEec--cCC-ccchHHHHHHHHHHhhcC--CCCccceeEEEecC---CceEEE
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNG-LQGNREFLVEVLMLSLLH--HPNLVNLIGYCADG---DQRLLV 144 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~---~~~~lv 144 (376)
..+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567899999999998765 4678899875 322 122346778999999887 45578888888776 348999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA---------------------------------- 190 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---------------------------------- 190 (376)
|||++|..+.+.. ...++......++.+++.+|..||...
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999988775422 234678888899999999999999731
Q ss_pred ---------------------CCCeeecCCCCCcEEECCCCc--eEEcccccccc
Q 017175 191 ---------------------NPPVIYRDLKCSNILLGEGYH--PKLSDFGLAKL 222 (376)
Q Consensus 191 ---------------------~~~i~Hrdikp~Nill~~~~~--~kl~Dfg~~~~ 222 (376)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.6e-11 Score=111.05 Aligned_cols=184 Identities=17% Similarity=0.173 Sum_probs=121.1
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCC--ccceeEEEecCC---ceEEEEEc
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEY 147 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--i~~~~~~~~~~~---~~~lv~e~ 147 (376)
.+.++.|....||++. ..+++|+.... .....+.+|+.+++.+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 34889986432 33456888999998874 333 344544443333 34789999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------- 190 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~------------------------------------- 190 (376)
++|.+|..... ..++..+...++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 23677777888888888888888621
Q ss_pred ------------------CCCeeecCCCCCcEEECC--CCceEEcccccccccCCCCcceeecccccccCc---cccccc
Q 017175 191 ------------------NPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY---CAPEYA 247 (376)
Q Consensus 191 ------------------~~~i~Hrdikp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~ 247 (376)
...++|+|++|.||+++. .+.+.|+||+.+......... .....+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHH
Confidence 134899999999999988 556789999998653221100 000111 222221
Q ss_pred cc-----C---------CCCcccchhhHHHHHHHHHhCCCCCC
Q 017175 248 MT-----G---------QLTLKSDVYSFGVVLLEIITGRKAID 276 (376)
Q Consensus 248 ~~-----~---------~~~~~~DiwslG~il~~ll~g~~p~~ 276 (376)
.. + ......+.|++|.++|.+.+|..+|.
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 10 0 01123689999999999999987764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=5.6e-08 Score=85.91 Aligned_cols=135 Identities=18% Similarity=0.139 Sum_probs=98.9
Q ss_pred ecccCce-EEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEEccCCCchh
Q 017175 77 LGEGGFG-RVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (376)
Q Consensus 77 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 154 (376)
+..|..+ .||+......+..+++|+-... ....+.+|...|+.+. +--+.+++.++.+.+..++||++++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 6998887777778999986432 2345778999998875 334678889998889999999999998887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-------------------------------------------
Q 017175 155 DHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN------------------------------------------- 191 (376)
Q Consensus 155 ~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~------------------------------------------- 191 (376)
+.... .......+..++...|..||....
T Consensus 109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76532 112234566677777777776321
Q ss_pred ------------CCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 192 ------------PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 192 ------------~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
..++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1379999999999999887778999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.8e-07 Score=84.39 Aligned_cols=136 Identities=21% Similarity=0.136 Sum_probs=93.4
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC---CccceeEEEe-cCCceEEEEEccC
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMP 149 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~-~~~~~~lv~e~~~ 149 (376)
...++.|....||+. +..+++|+-.. ......+..|+.+++.+.+. .+.+++.+.. ..+..++||++++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356788888899987 45588887532 22345678899999998752 3556666664 4456789999999
Q ss_pred CCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 017175 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--------------------------------------- 190 (376)
Q Consensus 150 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--------------------------------------- 190 (376)
|..|..... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 12344555555555555555555432
Q ss_pred ------------------CCCeeecCCCCCcEEECC---CCc-eEEcccccccc
Q 017175 191 ------------------NPPVIYRDLKCSNILLGE---GYH-PKLSDFGLAKL 222 (376)
Q Consensus 191 ------------------~~~i~Hrdikp~Nill~~---~~~-~kl~Dfg~~~~ 222 (376)
...++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999987 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=7.5e-07 Score=81.97 Aligned_cols=82 Identities=7% Similarity=-0.005 Sum_probs=55.6
Q ss_pred Ccee-cccCceEEEEEEEC---C---CCeEEEEEEeccCC---ccchHHHHHHHHHHhhcC-C--CCccceeEEEecC--
Q 017175 74 DCLL-GEGGFGRVYKGRLE---S---TNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLH-H--PNLVNLIGYCADG-- 138 (376)
Q Consensus 74 ~~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~ni~~~~~~~~~~-- 138 (376)
.+.| +.|....+|+.... . ++..+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999988653 1 15678899765432 111245678888888775 3 3567788877655
Q ss_pred -CceEEEEEccCCCchhh
Q 017175 139 -DQRLLVYEYMPLGSLED 155 (376)
Q Consensus 139 -~~~~lv~e~~~~~~L~~ 155 (376)
...++|||+++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2.4e-06 Score=79.82 Aligned_cols=76 Identities=16% Similarity=0.094 Sum_probs=49.2
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCc-------cchHHHHHHHHHHhhcCC--CC-ccceeEEEecCCceEE
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-------QGNREFLVEVLMLSLLHH--PN-LVNLIGYCADGDQRLL 143 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-i~~~~~~~~~~~~~~l 143 (376)
.+.||.|..+.||++....+++.+++|....... .....+..|..+++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4578999999999997665678899998643211 123456678888887742 33 4455543 3456789
Q ss_pred EEEccCCC
Q 017175 144 VYEYMPLG 151 (376)
Q Consensus 144 v~e~~~~~ 151 (376)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=7.9e-06 Score=74.40 Aligned_cols=142 Identities=19% Similarity=0.325 Sum_probs=78.4
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC--CCccceeE------EEecCCceEEEEE
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--PNLVNLIG------YCADGDQRLLVYE 146 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~------~~~~~~~~~lv~e 146 (376)
..|+.|..+.||++... +..+++|+.... ...+..|+.+++.+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778899998764 345899998652 2334445555555431 12333332 1234567889999
Q ss_pred ccCCCchh--------------hhhcc----CC-CCC-----CCCCHHH-------------------------------
Q 017175 147 YMPLGSLE--------------DHLHD----LP-PDK-----KRLDWTT------------------------------- 171 (376)
Q Consensus 147 ~~~~~~L~--------------~~l~~----~~-~~~-----~~~~~~~------------------------------- 171 (376)
|++|..+. ..++. .. ... ..-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 01111 10 000 0011211
Q ss_pred HHHHHHHHHHHHHHHhh----------CCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 172 RMRIAAGAAKGLEYLHD----------KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 172 ~~~i~~~i~~al~~LH~----------~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+..+...+..++.+|+. ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11111223445666653 0123399999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.2e-05 Score=69.50 Aligned_cols=139 Identities=19% Similarity=0.211 Sum_probs=90.1
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC---CCCccceeEEEecCCceEEEEEccCC
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
.+.|+.|....+|+.... +..+++|+.... ....+..|+..|+.+. ...+.+++.+....+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456899999999998753 677889987533 2456778998888874 35688888888878889999999998
Q ss_pred Cchhh-----------hhccCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHH
Q 017175 151 GSLED-----------HLHDLPP-DK-----------------KRLDWTTRM---RIA----------------AGAAKG 182 (376)
Q Consensus 151 ~~L~~-----------~l~~~~~-~~-----------------~~~~~~~~~---~i~----------------~~i~~a 182 (376)
..+.. .++.... .. -.-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 75421 1222211 00 011343221 111 112222
Q ss_pred H-HHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 183 L-EYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 183 l-~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 2235599999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=6.3e-05 Score=66.82 Aligned_cols=79 Identities=19% Similarity=0.215 Sum_probs=56.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCC---CccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~~~~~~~lv~ 145 (376)
....-...+|.|..+.||+.... +|+.|++|+-..........+..|+..|+.+.-- -+.+++++. ..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 34556678999999999999865 4788999987655444445677899999888521 344555542 347899
Q ss_pred EccCCCc
Q 017175 146 EYMPLGS 152 (376)
Q Consensus 146 e~~~~~~ 152 (376)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.95 E-value=6.5e-05 Score=70.62 Aligned_cols=75 Identities=16% Similarity=0.208 Sum_probs=45.6
Q ss_pred eeecCCCCCcEEECCCCceEEcccccccccCCCCcceeeccccc--ccCcccccccccCC---CCcccchhhHHHHHHHH
Q 017175 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG--TYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEI 268 (376)
Q Consensus 194 i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwslG~il~~l 268 (376)
++|+|++|.|||++.++ +.|+||+.+........ ...... ...|++|+...... -....++.+++..+|+.
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 99999999999998876 99999999874221110 000111 13456665443111 11234555777788877
Q ss_pred HhCC
Q 017175 269 ITGR 272 (376)
Q Consensus 269 l~g~ 272 (376)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00035 Score=62.88 Aligned_cols=159 Identities=13% Similarity=0.113 Sum_probs=86.3
Q ss_pred cCHHHHHHHhcCcccC-----ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--ccce
Q 017175 59 FTFRELAAVTKNFRAD-----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNL 131 (376)
Q Consensus 59 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~ 131 (376)
.+..++..+..+|.+. +.|+.|....+|++.... | .+++|+..... ....+..|+.+++.+...+ +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4556666666677652 346678888999987653 3 68899886531 2234556777776664212 2333
Q ss_pred eEE------EecCCceEEEEEccCCCchhh--------------hhcc----CCCCC-CCCC---HHHHHH---------
Q 017175 132 IGY------CADGDQRLLVYEYMPLGSLED--------------HLHD----LPPDK-KRLD---WTTRMR--------- 174 (376)
Q Consensus 132 ~~~------~~~~~~~~lv~e~~~~~~L~~--------------~l~~----~~~~~-~~~~---~~~~~~--------- 174 (376)
+.. ....+..++++++++|..+.. .++. ..... .... |.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999998765321 0111 11100 0011 111000
Q ss_pred ---HHHHHHHHHHHHhhC----CCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 175 ---IAAGAAKGLEYLHDK----ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 175 ---i~~~i~~al~~LH~~----~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
+...+...+.+++.. .+..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555431 12349999999999999987666899998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00015 Score=60.56 Aligned_cols=98 Identities=13% Similarity=0.083 Sum_probs=65.9
Q ss_pred chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCccee
Q 017175 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (376)
Q Consensus 152 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (376)
+|.+.+.. .+.++++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 78888876 47899999999999999999877622111 12334568999999999998764 1111
Q ss_pred ecccccccCcccccccccCCCCcccchhhHHHHHHHHHh
Q 017175 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270 (376)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 270 (376)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888763 345678899999999999886
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00014 Score=64.90 Aligned_cols=71 Identities=8% Similarity=0.053 Sum_probs=44.6
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEcc-CCC
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYM-PLG 151 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~-~~~ 151 (376)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+...++ .+++.+ +.+.-+++++|+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 677888999999998 34889987643211 1123468877777653333 455543 344457899999 665
Q ss_pred ch
Q 017175 152 SL 153 (376)
Q Consensus 152 ~L 153 (376)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00048 Score=65.25 Aligned_cols=74 Identities=14% Similarity=0.042 Sum_probs=47.8
Q ss_pred ceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEEEccCCCch
Q 017175 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
+.|+.|-...+|++.....+..+++|+..... ...-...+|+.+++.+...++ .++++.+. + .+||+|++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 45778888999999876545789999874432 111112478888888875444 56777663 2 259999987554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00023 Score=67.07 Aligned_cols=74 Identities=19% Similarity=0.249 Sum_probs=50.0
Q ss_pred CceecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc-cceeEEEecCCceEEEE
Q 017175 74 DCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 145 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~ 145 (376)
.+.|+.|....||++.... .+..+++|+..... ....+..|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998653 25678999884321 11455679998888863334 567766543 3899
Q ss_pred EccCCCch
Q 017175 146 EYMPLGSL 153 (376)
Q Consensus 146 e~~~~~~L 153 (376)
+|++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00036 Score=64.36 Aligned_cols=142 Identities=19% Similarity=0.219 Sum_probs=83.0
Q ss_pred ceecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEEE
Q 017175 75 CLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.|..|-...+|++.... ++..+++|+... .........+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457778888999987642 357899998633 2234456678999998876 3333566766644 28999
Q ss_pred ccCCCchhhh-----------------hccCCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 017175 147 YMPLGSLEDH-----------------LHDLPP-DKKRLD--WTTRMRIAAGAAK-------------------GLEYL- 186 (376)
Q Consensus 147 ~~~~~~L~~~-----------------l~~~~~-~~~~~~--~~~~~~i~~~i~~-------------------al~~L- 186 (376)
|++|.+|..- ++.... ...... +..+.+++.++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987655321 111111 111122 3445555544321 22333
Q ss_pred ---hhC-CCCCeeecCCCCCcEEECCC----CceEEccccccc
Q 017175 187 ---HDK-ANPPVIYRDLKCSNILLGEG----YHPKLSDFGLAK 221 (376)
Q Consensus 187 ---H~~-~~~~i~Hrdikp~Nill~~~----~~~kl~Dfg~~~ 221 (376)
... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 12349999999999999876 789999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0014 Score=59.30 Aligned_cols=31 Identities=29% Similarity=0.276 Sum_probs=27.0
Q ss_pred CCeeecCCCCCcEEECCC----CceEEcccccccc
Q 017175 192 PPVIYRDLKCSNILLGEG----YHPKLSDFGLAKL 222 (376)
Q Consensus 192 ~~i~Hrdikp~Nill~~~----~~~kl~Dfg~~~~ 222 (376)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6899999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0027 Score=57.14 Aligned_cols=161 Identities=12% Similarity=0.069 Sum_probs=87.9
Q ss_pred cccCHHHHHHHhcCccc-----CceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC--cc
Q 017175 57 HTFTFRELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LV 129 (376)
Q Consensus 57 ~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i~ 129 (376)
...+...+..+...|.+ ...|+ |....||++... +|+.+++|...... .....+..|..+++.+.... +.
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence 34455555555555543 23466 778899987653 35678999986432 23455667888887765222 33
Q ss_pred ceeEE-----EecCCceEEEEEccCCCchhh-----------h---hcc----CCC-CCCCCCHHHH-------------
Q 017175 130 NLIGY-----CADGDQRLLVYEYMPLGSLED-----------H---LHD----LPP-DKKRLDWTTR------------- 172 (376)
Q Consensus 130 ~~~~~-----~~~~~~~~lv~e~~~~~~L~~-----------~---l~~----~~~-~~~~~~~~~~------------- 172 (376)
+++.. ....+..+++|++++|..+.. . ++. ... .....+....
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44432 122455678999998754321 0 111 000 0111222111
Q ss_pred ---------HHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 173 ---------MRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 173 ---------~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
...+..++..+.-+-. ..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222211 1223389999999999999 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00086 Score=61.67 Aligned_cols=75 Identities=9% Similarity=0.028 Sum_probs=44.2
Q ss_pred CceecccCceEEEEEEECC--------CCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC-ccceeEEEecCCceEEE
Q 017175 74 DCLLGEGGFGRVYKGRLES--------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLV 144 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv 144 (376)
...|+.|....+|++.... .+..+++|+..... ........|..+++.+...+ +.++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457778888999987653 12678889875431 11112356888888775333 44666554 2 3689
Q ss_pred EEccCCCch
Q 017175 145 YEYMPLGSL 153 (376)
Q Consensus 145 ~e~~~~~~L 153 (376)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0037 Score=56.74 Aligned_cols=30 Identities=20% Similarity=0.299 Sum_probs=27.0
Q ss_pred CeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 193 ~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.036 Score=51.77 Aligned_cols=75 Identities=11% Similarity=0.024 Sum_probs=47.8
Q ss_pred CceecccCceEEEEEEECCC-------CeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEE
Q 017175 74 DCLLGEGGFGRVYKGRLEST-------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+.|..|-...+|++..... +..+++|+..... ...-...+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34577788889999887521 5778999864432 22222347888888775 333455665432 26899
Q ss_pred EccCCCch
Q 017175 146 EYMPLGSL 153 (376)
Q Consensus 146 e~~~~~~L 153 (376)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.12 Score=47.91 Aligned_cols=29 Identities=31% Similarity=0.316 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEE------CCCCceEEcccccccc
Q 017175 194 VIYRDLKCSNILL------GEGYHPKLSDFGLAKL 222 (376)
Q Consensus 194 i~Hrdikp~Nill------~~~~~~kl~Dfg~~~~ 222 (376)
++|+|+.+.||++ ++++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.73 E-value=0.82 Score=38.13 Aligned_cols=116 Identities=11% Similarity=0.098 Sum_probs=77.3
Q ss_pred cCCCCccceeEEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeecCCCC
Q 017175 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE-YLHDKANPPVIYRDLKC 201 (376)
Q Consensus 123 l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~-~LH~~~~~~i~Hrdikp 201 (376)
..||++ --.+-.+.+.+.+.++.-+++.=...+. .++....++++.+|+.... +++. -+|--|+|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 368888 4455567777777777654443333443 3788899999999887666 4433 47778999
Q ss_pred CcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccch-hhHHHHHHHHHhCCCCCCC
Q 017175 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDV-YSFGVVLLEIITGRKAIDN 277 (376)
Q Consensus 202 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~~ll~g~~p~~~ 277 (376)
+||+++.++.+++.-.|+-.. ++|.-+ + ..|. -.+=|++..++.++..|+.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred ceEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999987665432 233211 1 1122 2566888888888887763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.65 E-value=0.72 Score=38.31 Aligned_cols=123 Identities=11% Similarity=0.143 Sum_probs=81.2
Q ss_pred HHHHHhhcCCCCccceeEEEecCCceEEEEEccCCC-chhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 017175 116 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194 (376)
Q Consensus 116 e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i 194 (376)
|+.+|. ..||+++.. .+-.+.+.+.+.++.-+.+ ++.. + ...+....++++.+|+....+++. =
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r 100 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----R 100 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----S
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----c
Confidence 444443 368988876 5666667766666654422 3322 3 347889999999999887755443 3
Q ss_pred eecCCCCCcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 017175 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274 (376)
Q Consensus 195 ~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 274 (376)
+|--|+|+||+++.++.+++.--|+-.. ++|.- ++...=+-.+=|++..+++++..
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccC-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCC
Confidence 6778999999999999999987665432 12221 11111122566888899999888
Q ss_pred CCC
Q 017175 275 IDN 277 (376)
Q Consensus 275 ~~~ 277 (376)
|+.
T Consensus 157 Fe~ 159 (215)
T 4ann_A 157 FDA 159 (215)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.74 E-value=0.11 Score=48.98 Aligned_cols=62 Identities=6% Similarity=0.077 Sum_probs=18.2
Q ss_pred cCceecccCceEEEEEEECCCCeEEEE------EEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEec
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAI------KQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 137 (376)
+.+.|| ||.||+|.+.....+||+ |........ ....+.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 456676 999999998765567888 665432222 22457788888888999999999887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 376 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-78 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-65 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-55 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 8e-78
Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 27/285 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPN 127
+G G FG VYKG+ VA+K L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
++ +GY Q +V ++ SL HLH + + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
K +I+RDLK +NI L E K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 248 MT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304
+ +SDVY+FG+VL E++TG+ N + + L D K
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
++ + A C++++ + RPL ++ ++ LA
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-68
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNL 128
+F LG G G V+K + + V+A K + R + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V G + + E+M GSL+ L R+ +++ KGL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K +++RD+K SNIL+ KL DFG++ ++ +GT Y +PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAID 276
+++SD++S G+ L+E+ GR I
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-68
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+ + LG G FG V+ G + VA+K L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + ++ EYM GSL D L P +L + +AA A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ I+RDL+ +NIL+ + K++DFGLA+L ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE--HNLVAWARPLFKDRRKFSQMADP 306
G T+KSDV+SFG++L EI+T + E NL R + D +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--NCPE---- 237
Query: 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+ + +C +E+P RP + + L
Sbjct: 238 ------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 4e-66
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 23/280 (8%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+ LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L+G C ++ E+M G+L D+L + +++ + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K I+RDL N L+GE + K++DFGL++L GD + APE
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308
+ ++KSDV++FGV+L EI T + D + ++ +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKDY 233
Query: 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
+ + P + + C Q P+ RP A++ A +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 9e-66
Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 25/277 (9%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K+ LG G FG V G+ VAIK + EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L G C ++ EYM G L ++L + R + + + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K ++RDL N L+ + K+SDFGL++ D+ S + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308
+ + KSD+++FGV++ EI + K E + + ++ P L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQGLRLYRPHL 225
Query: 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+ + + C E+ + RP +++ +
Sbjct: 226 ASE-------KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-65
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 25/279 (8%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
++ +G G +GR K R +S +++ K+LD + + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 128 LVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+V D L V EY G L + +++ LD +R+ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 186 LHDK--ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
H + V++RDLK +N+ L + KL DFGLA++ + T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303
PE KSD++S G +L E+ + R+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYR 237
Query: 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
+ + + + RP + +++
Sbjct: 238 YSD------------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-65
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 25/281 (8%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+G G FG V+ G VAIK + R G +F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L G C + LV+E+M G L D+L + T + + +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
VI+RDL N L+GE K+SDFG+ + D+ ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308
+ + KSDV+SFGV++ E+ + K R+ E + +D ++ P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
+ C +E+P RP + ++ L +A
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 3e-65
Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 38/307 (12%)
Query: 58 TFTFRELAAVTKNF---------RADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRN 105
FTF + + F + + ++G G FG V G L+ + VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 106 GLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK 164
+ R+FL E ++ HPN+++L G +++ E+M GSL+ L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ + + G A G++YL + ++RDL NIL+ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 225 VGDKTHVSTRV---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281
T + APE + T SDV+S+G+V+ E+++ + R
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPY 234
Query: 282 GEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+ + +D R P+ + C Q+ N RP +
Sbjct: 235 WDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 342 VTALTYL 348
V L +
Sbjct: 284 VNTLDKM 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-65
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 29/297 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V++G+ + VA+K + + E+ +L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-- 190
+ Q LV +Y GSL D+L+ + + +++A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 191 ---NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPE 245
P + +RDLK NIL+ + ++D GLA T +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 246 YAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE-HNLVAWARPLFKDRR 298
+ ++D+Y+ G+V EI + + + P ++ R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 299 KF--SQMADPTLQGQYPVRGLYQALA-VAAMCVQEQPNMRPLIADVVTALTYLACQK 352
K Q P + ++ + +A + C R + L+ L+ Q+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 8e-65
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 29/295 (9%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNL 131
++G G FG VY G L + A+K L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 132 IGYCADGDQR-LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+G C + L+V YM G L + + + + AKG+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ ++RDL N +L E + K++DFGLA+ D H T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308
T + T KSDV+SFGV+L E++T + N L + RR L
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRR--------LL 254
Query: 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQPVQSS 363
Q +Y LY+ V C + MRP +++V+ ++ + V ++
Sbjct: 255 QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-64
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 26/276 (9%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPN 127
+++ LGEG +G V T + VA+K +D E E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V G+ +G+ + L EY G L D + + R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 248 MTGQL-TLKSDVYSFGVVLLEIITGRKAID-NTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
+ DV+S G+VL ++ G D + + E++ + +K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS--- 234
Query: 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
LA+ + E P+ R I D+
Sbjct: 235 -------------APLALLHKILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-64
Identities = 75/337 (22%), Positives = 122/337 (36%), Gaps = 54/337 (16%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTK-NFRADCLLGEGGFGRVYKGRLESTNQ-----VVA 98
S D ++ + + + N +LG G FG+V ++ VA
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 99 IKQLDRNGLQGNRE-FLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH 156
+K L RE + E+ +M L H N+VNL+G C L++EY G L ++
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131
Query: 157 LH-------------------DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYR 197
L + D L + + A AKG+E+L K ++R
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188
Query: 198 DLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 257
DL N+L+ G K+ DFGLA+ V + APE G T+KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
Query: 258 VYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD---RRKFSQMADPTLQGQYPV 314
V+S+G++L EI + + F ++ + P
Sbjct: 249 VWSYGILLWEIFSLG------------------VNPYPGIPVDANFYKLIQNGFKMDQPF 290
Query: 315 RGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351
+ + C RP ++ ++L CQ
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLT---SFLGCQ 324
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-64
Identities = 71/281 (25%), Positives = 115/281 (40%), Gaps = 32/281 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + D +G G F VYKG T VA +L L + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 127 NLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
N+V + +LV E M G+L+ +L K + KG
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 124
Query: 183 LEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L++LH + PP+I+RDLKC NI + G K+ D GLA L + + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
APE + DVY+FG+ +LE+ T + A + +
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YR 223
Query: 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
++ + + + + C+++ + R I D++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-64
Identities = 75/291 (25%), Positives = 111/291 (38%), Gaps = 39/291 (13%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLS-LLHHPNL 128
LG G FG+V + VA+K L + RE + E+ +LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHD--------------LPPDKKRLDWTTRMR 174
VNL+G C G L++ EY G L + L + D+ LD +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
+ AKG+ +L K I+RDL NILL G K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLF 294
+ APE T +SDV+S+G+ L E+ + + P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY---------------PGM 251
Query: 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
KF +M + P + + C P RP +V +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (516), Expect = 1e-63
Identities = 69/305 (22%), Positives = 111/305 (36%), Gaps = 45/305 (14%)
Query: 70 NFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLL 123
N +GEG FGRV++ R +VA+K L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD--------------------LPPD 163
+PN+V L+G CA G L++EYM G L + L P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
L ++ IA A G+ YL ++RDL N L+GE K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
D + PE + T +SDV+++GVVL EI + G
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY----GM 246
Query: 284 HNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVT 343
+ + + + + +C + P RP +
Sbjct: 247 AHEEVIYYVRDGNILACPENCPL------------ELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 344 ALTYL 348
L +
Sbjct: 295 ILQRM 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-63
Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHH 125
++F LG+G FG VY R + + ++A+K L + L+ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
PN++ L GY D + L+ EY PLG++ L + D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSY 121
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
H K VI+RD+K N+LLG K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
K D++S GV+ E + G+ + + + + + F
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDFVT 228
Query: 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
A + + ++ P+ RP++ +V+
Sbjct: 229 E------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 6e-63
Identities = 59/271 (21%), Positives = 110/271 (40%), Gaps = 30/271 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+VYK + + T+ + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ E+ G+++ + +L ++ L + + L YLHD +I+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL---- 252
RDLK NIL KL+DFG++ +GT + APE M
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 253 -TLKSDVYSFGVVLLEIITGRKAI-DNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310
K+DV+S G+ L+E+ + + P ++S
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS-------- 243
Query: 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
C+++ + R + +
Sbjct: 244 --------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-63
Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 31/281 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K + +G+G FG V G VA+K + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 129 VNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
V L+G + L +V EYM GSL D+L + L ++ + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++RDL N+L+ E K+SDFGL K + + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 172
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307
+ + KSDV+SFG++L EI + + R + P
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
+ V C MRP + L ++
Sbjct: 229 VY------------EVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-62
Identities = 80/317 (25%), Positives = 130/317 (41%), Gaps = 38/317 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGL-QGNREFLVEV-LMLSLLH 124
+ + ++GEG FG+V K R++ AIK++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD------------LPPDKKRLDWTTR 172
HPN++NL+G C L EY P G+L D L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ AA A+G++YL K I+RDL NIL+GE Y K++DFGL++ V K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP 292
T + A E T SDV+S+GV+L EI++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYEK 238
Query: 293 LFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352
L + R + P+ + + C +E+P RP A ++ +L + ++
Sbjct: 239 LPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 353 YDPESQPVQSSRTGSST 369
+ + T +
Sbjct: 288 KTYVNTTLYEKFTYAGI 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 8e-62
Identities = 74/272 (27%), Positives = 109/272 (40%), Gaps = 35/272 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY + + KK L + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL DFG A + + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQG 310
Q K DV+S G+ +E+ + + N A +A +S+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE-------- 241
Query: 311 QYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
C+Q+ P RP ++
Sbjct: 242 --------YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-61
Identities = 81/293 (27%), Positives = 125/293 (42%), Gaps = 30/293 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R + LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + +V EYM GSL D L K L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
++RDL+ +NIL+GE K++DFGLA+L ++ + APE A+
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR--RKFSQMADP 306
G+ T+KSDV+SFG++L E+ T R + R+ +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKG------------------RVPYPGMVNREVLDQVER 229
Query: 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPESQP 359
+ P + C +++P RP + L +P+ QP
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY-FTSTEPQYQP 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-61
Identities = 69/289 (23%), Positives = 114/289 (39%), Gaps = 28/289 (9%)
Query: 62 RELAAVTKNFR-ADCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGLQGNRE-FLVEV 117
++L N AD LG G FG V +G VAIK L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
++ L +P +V LIG C + +LV E G L L ++ + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVM 236
+ G++YL +K ++RDL N+LL ++ K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296
+ APE + + +SDV+S+GV + E ++ + A
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK----KMKGPEVMAFIEQGK 229
Query: 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
R + P L A+ + C + RP V +
Sbjct: 230 RMECPPECPPELY------------ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-61
Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
++G G FG VYKG L++++ VAIK L + R +FL E ++ H N++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G + +++ EYM G+L+ L + + + G A G++YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
N ++RDL NIL+ K+SDFGL++ L + T+ ++ + APE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 250 GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQ 309
+ T SDV+SFG+V+ E++T + + + + +
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAINDGFR 231
Query: 310 GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
P+ + C Q++ RP AD+V+ L L
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 9e-61
Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 35/277 (12%)
Query: 77 LGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG + + VA+K L E L E ++ L +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L +L + + + + + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RDL N+LL ++ K+SDFGL+K L + T + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 252 LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ 311
+ KSDV+SFGV++ E + + ++ K S++ +G+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYG------------------QKPYRG-MKGSEVTAMLEKGE 227
Query: 312 YPVRGLY---QALAVAAMCVQEQPNMRPLIADVVTAL 345
+ + +C RP A V L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 27/276 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
K + +G+G G VY +T Q VAI+Q++ + E+L++ +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+VN + GD+ +V EY+ GSL D + + +D + + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H VI+RD+K NILLG KL+DFG + + + ++GT + APE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEV 187
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRKA-IDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
K D++S G++ +E+I G ++ + + P ++ K S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA--- 244
Query: 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
C+ R ++
Sbjct: 245 -------------IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 32/286 (11%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDR-NGLQGNREFLVEVLMLSLLHH 125
F+ +LG G FG VYKG + VAIK+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P++ L+G C +L + + MP G L D++ + K + + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
L D+ +++RDL N+L+ H K++DFGLAKL +K + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR--RKFSQM 303
+ T +SDV+S+GV + E++T + + S +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG------------------SKPYDGIPASEISSI 225
Query: 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349
+ + P + C + RP +++ + +A
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-58
Identities = 77/285 (27%), Positives = 112/285 (39%), Gaps = 29/285 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGL---QGNREFLVEVLMLSL 122
K+ R LG+G FG V +G ++ + VA+K L + L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
L H NL+ L G ++ V E PLGSL D L + T R A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGY 241
+ YL K I+RDL N+LL K+ DFGL + P D +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301
CAPE T + SD + FGV L E+ T + N + K+ +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLP 235
Query: 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346
+ D V C +P RP + L
Sbjct: 236 RPEDCPQ----------DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-57
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHP 126
+F+ +LGEG F V R +T++ AIK L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
V L D ++ Y G L ++ D T A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H +I+RDLK NILL E H +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
SD+++ G ++ +++ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-57
Identities = 71/277 (25%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
+GEG FG V++G S VAIK RE FL E L + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + + ++ E LG L L K LD + + A + L YL K
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RD+ N+L+ KL DFGL++ + +++ + APE +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 252 LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTLQGQ 311
T SDV+ FGV + EI+ G N R +R PTL
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQ----GVKNNDVIGRIENGERLPMPPNCPPTLY-- 239
Query: 312 YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
++ C P+ RP ++ L+ +
Sbjct: 240 ----------SLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-56
Identities = 69/289 (23%), Positives = 114/289 (39%), Gaps = 31/289 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSL 122
+ LG+G FG VY+G + VAIK ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL------PPDKKRLDWTTRMRIA 176
+ ++V L+G + G L++ E M G L+ +L L P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236
A G+ YL+ ++RDL N ++ E + K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296
+ +PE G T SDV+SFGVVL EI T + G N +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ----GLSNEQVLRFVMEGG 252
Query: 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTAL 345
+ MC Q P MRP ++++++
Sbjct: 253 LLDKPDNCPD------------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-55
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 38/299 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQG-NREFLVEV-LMLSL 122
+ LG G FG+V + +T + VA+K L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 123 LHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSLEDHLHD------------LPPDKKRLDW 169
HH N+VNL+G C G +++ E+ G+L +L K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
+ + AKG+E+L + I+RDL NILL E K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
+ APE T++SDV+SFGV+L EI + + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDEE 245
Query: 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
K+ + + P + C +P+ RP +++V L L
Sbjct: 246 FCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 1e-53
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 11/208 (5%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V ++ LG G FG V++ +T A K + E+ +S+L HP
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
LVNL D ++ +++YE+M G L + + D + ++ + KGL ++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 187 HDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
H+ ++ DLK NI+ KL DFGL D GT + AP
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAP 194
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E A + +D++S GV+ +++G
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-53
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 40/300 (13%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGN-REFLVEV-LML 120
LGEG FG+V ++ VA+K L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLD 168
+ H N++NL+G C ++ EY G+L ++L P +++L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
+ A A+G+EYL K I+RDL N+L+ E K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288
+T + APE T +SDV+SFGV+L EI T + V
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVE 244
Query: 289 WARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348
L K+ + P + + C P+ RP +V L +
Sbjct: 245 ELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 2e-53
Identities = 45/199 (22%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ ++T +V K ++ E+ +++ LHHP L+NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
D + +L+ E++ G L D + + ++ + A +GL+++H+ ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 196 YRDLKCSNILL--GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+ D+K NI+ + K+ DFGLA + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVG 206
Query: 254 LKSDVYSFGVVLLEIITGR 272
+D+++ GV+ +++G
Sbjct: 207 FYTDMWAIGVLGYVLLSGL 225
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 177 bits (450), Expect = 5e-53
Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLH-- 124
+F ++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 125 -HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
P +V + D+ + + M G L HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
E++H++ V+YRDLK +NILL E H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 244 PEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
PE G +D +S G +L +++ G + +H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-52
Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSL-LHH 125
+F +LG+G FG+V+ + TNQ AIK L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P L ++ + V EY+ G L H+ + D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH K ++YRDLK NILL + H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + D +SFGV+L E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 5e-52
Identities = 58/282 (20%), Positives = 99/282 (35%), Gaps = 22/282 (7%)
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLM 119
+++ + + +LG G F V + T ++VAIK + + L+G E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
L + HPN+V L G L+ + + G L D + +K R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
++YLHD + L E +SDFGL+K+ D V + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTP 173
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRK 299
GY APE + D +S GV+ ++ G + N + K +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE------NDAKLFEQILKAEYE 227
Query: 300 FSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
F + A +++ P R
Sbjct: 228 FDSPYWDDISD--------SAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (434), Expect = 1e-51
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLI 132
+LG GG V+ R ++ VA+K L + + F E + L+HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 133 GYCAD----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
G +V EY+ +L D +H + + + + A A + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 129
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYA 247
+I+RD+K +NI++ K+ DFG+A+ + G+ + V+GT Y +PE A
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGRKAI--DNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
+ +SDVYS G VL E++TG D+ + ++ P S
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA--- 243
Query: 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVV 342
AV + + P R A +
Sbjct: 244 -------------DLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-50
Identities = 36/199 (18%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ S+ + K + G E+ +L++ H N+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
++ ++++E++ + + ++ L+ + + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 196 YRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+ D++ NI+ K+ +FG A+ GD + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 254 LKSDVYSFGVVLLEIITGR 272
+D++S G ++ +++G
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (426), Expect = 6e-50
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
++F+ LG G FGRV+ R + A+K L + + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P ++ + G D Q ++ +Y+ L L +R AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH K +IYRDLK NILL + H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRK 273
T D +SFG+++ E++ G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 3e-49
Identities = 60/288 (20%), Positives = 101/288 (35%), Gaps = 40/288 (13%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEV-LM 119
N+ +LG G V + + T + A+K +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ HPN++ L LV++ M G L D+L +K L +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+ + LH +++RDLK NILL + + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 240 GYCAPEYAMTGQL------TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPL 293
Y APE + D++S GV++ ++ G + R +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMI 227
Query: 294 FKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+F + + + QP R +
Sbjct: 228 MSGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-49
Identities = 72/282 (25%), Positives = 112/282 (39%), Gaps = 25/282 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVN 130
LGEG F VYK R ++TNQ+VAIK++ NR L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L+ LV+++M D + + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDLK +N+LL E KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 251 QL-TLKSDVYSFGVVLLEIITGRKAI--DNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307
++ + D+++ G +L E++ + D+ P + + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 308 LQGQYPVRGLY--------QALAVAAMCVQEQPNMRPLIADV 341
+P L+ L + P R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 7e-49
Identities = 73/313 (23%), Positives = 119/313 (38%), Gaps = 22/313 (7%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHH 125
V + +GEG +G V VAIK++ Q + L E+ +L H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
N++ + + Y+ + L+ L + L +GL+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKY 124
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAP 244
+H V++RDLK SN+LL K+ DFGLA+ P D T T + T Y AP
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEIITGRK--AIDNTRAAGEHNLVAWARPLFKDRRKFS 301
E + + KS D++S G +L E+++ R + H L P +D
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 302 QMADPTLQGQYPVRGLY-----------QALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350
+ P + +AL + + P+ R + + A YL
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL-AHPYLE- 299
Query: 351 QKYDPESQPVQSS 363
Q YDP +P+ +
Sbjct: 300 QYYDPSDEPIAEA 312
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 30/285 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
++G G FG VY+ +L + ++VAIK++ ++ NR E+ ++ L H N+V L +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFF 82
Query: 136 ADGDQR------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
++ LV +Y+P H K+ L + L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 190 ANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ +RD+K N+LL + KL DFG AK + + + Y
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFG 196
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR------------KAIDNTRAAGEHNLVAWARPLFKD 296
T DV+S G VL E++ G+ I + P + +
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
KF Q+ + R +A+A+ + ++ P R +
Sbjct: 257 -FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 4e-47
Identities = 57/302 (18%), Positives = 105/302 (34%), Gaps = 28/302 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V +R +G G FG +Y G + + VAIK + + +E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGG 62
Query: 127 NLVNLIGYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ I +C A+GD ++V E + + ++ T + +A +EY
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEY 118
Query: 186 LHDKANPPVIYRDLKCSNIL---LGEGYHPKLSDFGLAKL-----GPVGDKTHVSTRVMG 237
+H K I+RD+K N L +G + DFGLAK + + G
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR 297
T Y + + + + + D+ S G VL+ G +AA + +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERIS 229
Query: 298 RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDPES 357
K L YP + C + + +P + + L ++
Sbjct: 230 EKKMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
Query: 358 QP 359
Sbjct: 286 YV 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-47
Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLMLSLLHHPNLV 129
LG G F V K R +ST A K + + + +R + EV +L + HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
L + +L+ E + L D +K+ L G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 190 ANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
+ + DLK NI+L K+ DFGLA G++ + GT + APE
Sbjct: 133 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
L L++D++S GV+ +++G V+ F+D
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--------- 237
Query: 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+Y A + + P R I D
Sbjct: 238 -----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (398), Expect = 3e-46
Identities = 52/304 (17%), Positives = 99/304 (32%), Gaps = 30/304 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HH 125
V +++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGC 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ N+ + +G +LV + + L ++ T A ++
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKL-----GPVGDKTHVSTRV 235
+H+K ++YRD+K N L+G + DFG+ K +
Sbjct: 117 IHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295
GT Y + + + + + D+ + G V + + G +AA +
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ER 227
Query: 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQKYDP 355
K L +P Y+ + P + + + +
Sbjct: 228 IGEKKQSTPLRELCAGFP-EEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
Query: 356 ESQP 359
E +
Sbjct: 284 EDEN 287
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-45
Identities = 54/273 (19%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG G G+V + + T + A+K L ++ + RE L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 136 ----ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
A L+V E + G L + D + I + ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 192 PPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ +RD+K N+L KL+DFG AK + T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308
+ D++S GV++ ++ G H L + R + +P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
+ + ++ +P R I +
Sbjct: 242 SEVSE-----EVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-45
Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 48/278 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE------FLVEVLMLSLLH--HPN 127
LLG GGFG VY G S N VAIK ++++ + E +EV++L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
++ L+ + D +L+ E L D ++ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ V++RD+K NIL+ KL DFG L K V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 247 AMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305
+ + V+S G++L +++ G F+ +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG-------------------DIPFEHD-------E 214
Query: 306 PTLQGQYPVRGLY--QALAVAAMCVQEQPNMRPLIADV 341
++GQ R + + C+ +P+ RP ++
Sbjct: 215 EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 4e-45
Identities = 60/292 (20%), Positives = 109/292 (37%), Gaps = 25/292 (8%)
Query: 68 TKNFRADCLLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLL- 123
+ + +GEG +G+V+K R L++ + VA+K++ + + EV +L L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 124 --HHPNLVNLIGYCADGDQRLLVYEYMPLGSL--EDHLHDLPPDKKRLDWTTRMRIAAGA 179
HPN+V L C + + + + + + T +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+GL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 126 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 179
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT----------RAAGEHNLVAW 289
Y APE + D++S G + E+ + + G W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 290 ARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADV 341
R + R+ F + ++ ++ + C+ P R
Sbjct: 240 PRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-44
Identities = 57/285 (20%), Positives = 108/285 (37%), Gaps = 20/285 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPN 127
NF+ +GEG +G VYK R + T +VVA+K++ + + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
V++RDLK N+L+ KL+DFGLA+ V +T+ + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307
+ D++S G + E++T R + + + + P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 308 LQGQYPVRGLY-----------QALAVAAMCVQEQPNMRPLIADV 341
+ +P ++ + + PN R
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-44
Identities = 63/207 (30%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
+F LLG+G FG+V R ++T + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P L L D+ V EY G L HL ++ A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEY 120
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH + V+YRD+K N++L + H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-42
Identities = 61/299 (20%), Positives = 110/299 (36%), Gaps = 34/299 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
+ +G+G FG V+K R T Q VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 128 LVNLIGYCADGDQR--------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+VNLI C LV+++ + L + + R+
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS--TRVMG 237
GL Y+H +++RD+K +N+L+ KL+DFGLA+ + + + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 238 TYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRA--------AGEHNLVA 288
T Y PE + + D++ G ++ E+ T + ++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 289 WARPLFKDRRKFSQMADPTLQGQYPVRGLY------QALAVAAMCVQEQPNMRPLIADV 341
P + + ++ Q + L AL + + P R D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 53/287 (18%), Positives = 104/287 (36%), Gaps = 22/287 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +GEG +G V+K + T+++VA+K++ + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+V L + LV+E+ +D LD KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RDLK N+L+ KL++FGLA+ + + + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRK---AIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303
+ D++S G + E+ + ++ + P + +++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 304 ADPTLQGQYPVRGLY---------QALAVAAMCVQEQPNMRPLIADV 341
D YP + ++ P R +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (360), Expect = 1e-40
Identities = 53/278 (19%), Positives = 108/278 (38%), Gaps = 22/278 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK + + + A+K++ ++ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
+ +LV+E++ + + L+ T G+ Y HD+ V
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RDLK N+L+ K++DFGLA+ + + + ++ + + + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYST 180
Query: 255 KSDVYSFGVVLLEIITGRKAIDNT----------RAAGEHNLVAWARPLFKDRRKFSQMA 304
D++S G + E++ G R G N W + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 305 DPTLQGQYPVRGL-YQALAVAAMCVQEQPNMRPLIADV 341
L + ++GL + + + ++ PN R
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-40
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 9/208 (4%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH 124
V +R +G G +G V T VAIK+L R + E+ +L +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H N++ L+ + ++ + ++L + KGL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y+H +RDLK N+ + E K+ DFGLA+ + ++ V+ +
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPE 188
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D++S G ++ E+ITG+
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-40
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 15/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV + + + A+K LD+ + ++ L E +L ++ P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D +V EY+ G + HL R AA EYLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---D 161
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+IYRDLK N+L+ + + +++DFG AK T + GT APE ++
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216
Query: 254 LKSDVYSFGVVLLEIITGR 272
D ++ GV++ E+ G
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (341), Expect = 2e-37
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNL 128
+++ LG G + V++ + N+ V +K L + + E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 129 VNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ L D R LV+E++ + L R K L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEILKALDYC 145
Query: 187 HDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
H +++RD+K N+++ E +L D+GLA+ G + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 246 YAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ Q+ D++S G +L +I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 69 KNFRADCLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL----QGNREFLVEVLMLS 121
+NF +LG G +G+V+ R T ++ A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 122 LL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P LV L + L+ +Y+ G L HL ++R
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE+LH +IYRD+K NILL H L+DFGL+K V D+T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 241 YCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
Y AP+ G D +S GV++ E++TG
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-35
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 9/208 (4%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH 124
V + ++ +G G +G V T VA+K+L R + E+ +L +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H N++ L+ + + L + ++L + +GL+
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y+H +RDLK SN+ + E K+ DFGLA+ +V+TR +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPE 188
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
D++S G ++ E++TGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-34
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 54 IAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNR 111
+ TFT V K ++ +G G G V ++ VAIK+L R +
Sbjct: 8 VGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 112 EFLVEVLMLSLLHHPNLVNLIGYCA------DGDQRLLVYEYMPLGSLEDHLHDLPPDKK 165
E++++ ++H N+++L+ + LV E M + +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QM 114
Query: 166 RLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225
LD + G+++LH + +I+RDLK SNI++ K+ DFGLA+
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 168
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + T + T Y APE + D++S G ++ E++ +
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (303), Expect = 7e-32
Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 16/210 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G F V+ + N VA+K + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 136 ADGDQRLLVYEY------------MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
A+ +LL + + + + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 184 EYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+Y+H + +I+ D+K N+L+ L +A LG T + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+PE + +D++S ++ E+ITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 2e-18
Identities = 22/160 (13%), Positives = 46/160 (28%), Gaps = 30/160 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL----------QGNREFLVEVLMLSLLHH 125
L+GEG V+ E +K G+ F V + +
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 126 PNLVNLIGYCA----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
L L G + ++ E + + R+ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILE 114
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221
+ + + +++ DL N+L+ E + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 376 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.41 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.23 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-60 Score=420.70 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=212.0
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 346799999999999999999999999999999999765432 3356889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999865 567999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... .. .....
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~~-~~~~~------ 223 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SD-WKEKK------ 223 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----HH-HHTTC------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----HH-HhcCC------
Confidence 444444456789999999999988776 578999999999999999999997654321100 00 00000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.........+..+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 224 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 224 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ---CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 0001112334578899999999999999999999987653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=420.50 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=215.8
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
+||+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998864 46999999999999999999999999 9999999999999999999999999998643222
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ ........ ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~---------~~ 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG---------TP 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC---------SC
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC---------CC
Confidence 233456899999999999999999999999999999999999999976543211 11111100 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
....+...+..+.+||.+||+.||++|||+.|+++|-+.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 012223445688999999999999999999999998653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-59 Score=411.03 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=212.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999986432 233456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999975 467999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~-------- 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISRVE-------- 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC--------
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH------HHHHcCC--------
Confidence 2 223467999999999999999999999999999999999999999865432111 1111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..++...+.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCc
Confidence 01223345678899999999999999999999998664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=415.35 Aligned_cols=253 Identities=25% Similarity=0.302 Sum_probs=209.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986432 233456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999875 567999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ .........
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLEY------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTCC-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH------HHHHHcCCC-------
Confidence 4433344456899999999999999999999999999999999999999986543211 111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.++...+..+.+||.+||+.||++|||++|++++.+
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 122334557889999999999999999999866544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=414.47 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=213.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
+.|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46999999999999999999999999999999998776666778899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999998765 2456999999999999999999999999 99999999999999999999999999964211 1
Q ss_pred ceeecccccccCcccccccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccc
Q 017175 229 THVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQM 303 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (376)
.......+||+.|+|||++. +..|+.++|||||||++|+|++|..||......... .......
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~~------ 231 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSE------ 231 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHSC------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcCC------
Confidence 12233467999999999984 456889999999999999999999999865433211 1111110
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 304 ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 304 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
......+...+.++.+||.+||+.||++|||+.|+++|-+
T Consensus 232 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 232 ---PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp ---CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred ---CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0011122344568899999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-59 Score=412.55 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=200.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEec--CCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 144 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999999999999999999765433 23568899999999999999999999865 4568999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
||||++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998654334567999999999999999999999854 12399999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+. ....... ..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~------~~~i~~~--~~-- 231 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREG--KF-- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHT--CC--
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH------HHHHHcC--CC--
Confidence 4322 2223457899999999999999999999999999999999999999986543211 1111110 00
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTA 344 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~ 344 (376)
...+...+.++.+|+.+||+.||++|||+.||++|
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01223345578899999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=404.16 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=204.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC--ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.++|++.+.||+|+||.||+|+++ ..||||+++... ....+.+.+|+.++++++||||+++++++.+ +.+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 367999999999999999999865 359999997543 3344678899999999999999999998754 5689999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999975 3456999999999999999999999999 99999999999999999999999999976544
Q ss_pred CCcceeecccccccCcccccccccC---CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
...........||+.|+|||++.+. .|+.++|||||||++|||++|..||......... .......
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~----- 225 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRG----- 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHT-----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcC-----
Confidence 3333344556899999999999643 5889999999999999999999999865432111 0001100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
...+.. ...+...+..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 226 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 001100 11222334578899999999999999999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-58 Score=417.95 Aligned_cols=269 Identities=21% Similarity=0.263 Sum_probs=209.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|++..+|+.||+|+++..... ....+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999999999999999999764332 34568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+||+|.+++.. ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999975 4579999999999999999999997 58 99999999999999999999999999975321
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh-hhhhhhhc-------c
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA-WARPLFKD-------R 297 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~-------~ 297 (376)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+......... ........ .
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 12234689999999999999999999999999999999999999997654321100000 00000000 0
Q ss_pred ------------------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 298 ------------------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 298 ------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.....+.............+.++.+|+.+||+.||++|||+.|+++|-+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 00000000000000001234578899999999999999999999998553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-57 Score=409.39 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=198.9
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|+++.+|+.||||++....... ...+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999999999999999997654332 345778999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC---CCCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~---~~~~~kl~Dfg~~~~ 222 (376)
|||+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999975 567999999999999999999999999 99999999999994 578999999999985
Q ss_pred cCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ .........
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~---- 226 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAEY---- 226 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHTTCC----
T ss_pred ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHhccCC----
Confidence 33222 23346799999999999999999999999999999999999999986543211 111111110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
..........+..+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 227 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 227 ----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 01111222345578899999999999999999999998553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.6e-57 Score=413.57 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=214.7
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
-++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC--CCCceEEcccccccccCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~--~~~~~kl~Dfg~~~~~~~ 225 (376)
|+||+|.+++.. ...++++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999864 3467999999999999999999999999 99999999999995 467899999999986433
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........+ .
T Consensus 179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~----~ 245 (350)
T d1koaa2 179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNM----D 245 (350)
T ss_dssp TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCS----C
T ss_pred cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC----C
Confidence 22 23446799999999999999999999999999999999999999986543211 11111111110 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.......+..+.+||.+||+.||++|||+.|+++|-+
T Consensus 246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1111233457889999999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-57 Score=405.51 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=215.4
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467999999999999999999999999999999997553 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999998652 3467899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCC-cccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN-TRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+.... . .... .
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~---~----~~i~----------~ 231 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y----ELLE----------K 231 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H----HHHH----------T
T ss_pred -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH---H----HHHh----------c
Confidence 2233445689999999999999999999999999999999997766543 222110 0 0111 1
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11122333445688999999999999999999999999987753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=409.48 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=214.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997532 233466889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999876 567999999999999999999999999 99999999999999999999999999985332
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.... .........
T Consensus 158 ~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~i~~~~~------- 222 (337)
T d1o6la_ 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEEI------- 222 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-------
T ss_pred C--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------HHHHhcCCC-------
Confidence 2 2233457899999999999999999999999999999999999999987654221 111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
.+|...+.++.+||.+||+.||.+|++ +.++++|-+.
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 223344557889999999999999994 8999987553
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-56 Score=412.60 Aligned_cols=256 Identities=20% Similarity=0.265 Sum_probs=215.2
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999999999999999999876655666788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC--CCCceEEcccccccccCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~--~~~~~kl~Dfg~~~~~~~ 225 (376)
|+||+|.+++.. ...++++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988765 3457999999999999999999999999 99999999999997 678999999999986443
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||........ ..........
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~------ 246 (352)
T d1koba_ 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE------ 246 (352)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCC------
T ss_pred CC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC------
Confidence 32 23446799999999999999999999999999999999999999986543211 1111111111
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
+........+.++.+||.+||+.||.+|||+.|+++|-+
T Consensus 247 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 247 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 111122234557889999999999999999999998744
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=402.78 Aligned_cols=257 Identities=25% Similarity=0.305 Sum_probs=212.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc------chHHHHHHHHHHhhcCCCCccceeEEEecCCc
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 140 (376)
+.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999999999999999999654322 24678899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC----ceEEcc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~----~~kl~D 216 (376)
+|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999975 467999999999999999999999999 99999999999998776 499999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
||++.....+. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 161 fG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~~ 231 (293)
T d1jksa_ 161 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANVSAV 231 (293)
T ss_dssp CTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHTT
T ss_pred hhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HHHHhc
Confidence 99998643332 233467999999999999999999999999999999999999999865432111 111111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...+. ...+...+..+.+||.+||+.||++|||+.|+++|-+.
T Consensus 232 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 232 NYEFE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCCCC--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCCC--------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 00000 00111234578899999999999999999999998553
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-57 Score=399.88 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=201.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 579999999999999999999864 6789999997643 34567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999875 3567899999999999999999999999 99999999999999999999999999976433222
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......||+.|+|||++.+..++.++|||||||++|||+++ .+||........ .... ...
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~------~~~i-~~~---------- 218 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDI-STG---------- 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH------HHHH-HHT----------
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH------HHHH-Hhc----------
Confidence 122345789999999999999999999999999999999995 555554332111 1111 100
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....|...+..+.+|+.+||+.||++|||+++|+++|+++.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011122233457889999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-57 Score=407.47 Aligned_cols=251 Identities=30% Similarity=0.382 Sum_probs=207.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
.+.|+..+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 346999999999999999999999999999999997654433 34588999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||||.+|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999999877654 467999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeecccccccCccccccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
. .....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||........ ....... .
T Consensus 167 ~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~--~-- 230 (309)
T d1u5ra_ 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN--E-- 230 (309)
T ss_dssp S------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS--C--
T ss_pred C------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhC--C--
Confidence 2 234679999999999864 4589999999999999999999999976543211 1111110 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.+.. .+...+..+.+||.+||+.||++|||+.|+++|-+.
T Consensus 231 ---~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 231 ---SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp ---CCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 0001 111234578899999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-57 Score=399.33 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=201.8
Q ss_pred Cc-ccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec----CCceE
Q 017175 70 NF-RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 142 (376)
Q Consensus 70 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~ 142 (376)
+| ++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+ ...+|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 44 677889999999999999999999999999875432 234568899999999999999999999865 34679
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC-CCCceEEccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK 221 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~-~~~~~kl~Dfg~~~ 221 (376)
+|||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999975 467999999999999999999999875 3499999999999996 57899999999997
Q ss_pred ccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ........
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~~~----- 228 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSG----- 228 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTT-----
T ss_pred eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHHcC-----
Confidence 53221 2334689999999999865 699999999999999999999999975432211 11111000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..... ++...+.++.+|+.+||+.||++|||+.|+++|-+
T Consensus 229 -~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 229 -VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp -CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred -CCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 00111 11122346889999999999999999999998744
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-56 Score=403.91 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=202.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCe---EEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.++||+|+||.||+|+++.+++ .||||.+...... ..+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568889999999999999999976654 5899988654333 345789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||||++|+|.+++.. ....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 3457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcce---eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 225 VGDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 225 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.......... .. ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~------~i-~~---- 248 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN------AI-EQ---- 248 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HH-HT----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH------HH-Hc----
Confidence 322211 1122458999999999999999999999999999999998 899998654321111 10 10
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+-.
T Consensus 249 ------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01112233445678899999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=408.45 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=210.3
Q ss_pred cCcccCceecccCceEEEEEEECCCC-----eEEEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCce
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 141 (376)
++|++.+.||+|+||.||+|++..++ ..||+|.+.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57999999999999999999986554 369999986543 33446788999999988 899999999999999999
Q ss_pred EEEEEccCCCchhhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCC
Q 017175 142 LLVYEYMPLGSLEDHLHDLPP-------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~ 202 (376)
|+|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975321 1245899999999999999999999999 999999999
Q ss_pred cEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccc
Q 017175 203 NILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (376)
Q Consensus 203 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 281 (376)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544444444455678999999999999999999999999999999998 89999865432
Q ss_pred cccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 282 GEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.. ....... ......+...+..+.+||.+||+.||++|||+.||+++|.
T Consensus 274 ~~------~~~~~~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN------FYKLIQN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH------HHHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH------HHHHHhc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 0111111 1111233344568899999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=391.63 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=213.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|+++ +++.||||+++.... ..+.+.+|+.++++++||||+++++++.+...+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57999999999999999999985 578999999976543 4567999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++|+|..++.. ....+++..+++++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999765 3567899999999999999999999999 99999999999999999999999999976433322
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCc
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPT 307 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (376)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. .. +...
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~------~~-i~~~---------- 217 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EH-IAQG---------- 217 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH------HH-HHTT----------
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH------HH-HHhC----------
Confidence 22334679999999999999999999999999999999998 89999866433211 11 1110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 308 LQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 308 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....|...+..+.+|+.+||+.||++|||+.+|+++|.++
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11122233445788999999999999999999999999753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=394.35 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=209.1
Q ss_pred cCcccCce-ecccCceEEEEEEECC--CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCL-LGEGGFGRVYKGRLES--TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|.+... ||+|+||.||+|.++. ++..||||++..... ...+.+.+|+.++++++||||+++++++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45777774 9999999999998754 456899999975433 334678999999999999999999999865 568999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865 3567999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 225 VGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 225 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+. .. .+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~----~i~~~----- 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA----FIEQG----- 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HH----HHHTT-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcC-----
Confidence 43322 22234568999999999999999999999999999999998 8999986543211 11 11110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 229 -----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112333445688899999999999999999999999886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-55 Score=399.74 Aligned_cols=248 Identities=29% Similarity=0.388 Sum_probs=211.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999999999999999996432 234467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
|||+||+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999876 567899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ .........
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~------- 218 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAEL------- 218 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHCCC-------
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHcCCC-------
Confidence 2 2346899999999999999999999999999999999999999986543211 111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHH
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALT 346 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~ 346 (376)
.++...+.++.+++.+||..||.+|+ |++++++|-+
T Consensus 219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 12233445788999999999999996 9999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=392.34 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=207.0
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357999999999999999999986 47889999997543 445679999999999999999999998755 567999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987541 2346899999999999999999999999 9999999999999999999999999998644332
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCC-CCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA-IDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
........||+.|+|||++.++.++.++|||||||++|||+||..| |........ .... ...
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~------~~~i-~~~--------- 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNL-ERG--------- 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHH-HTT---------
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH------HHHH-Hhc---------
Confidence 2233446799999999999999999999999999999999996555 443322111 1111 100
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111122334457889999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=391.24 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=200.2
Q ss_pred ceecccCceEEEEEEEC--CCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEccCC
Q 017175 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (376)
Q Consensus 75 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~ 150 (376)
++||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 3567899999965432 234578999999999999999999999865 467899999999
Q ss_pred CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCcc-
Q 017175 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT- 229 (376)
Q Consensus 151 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 229 (376)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999876 467999999999999999999999999 999999999999999999999999999864433322
Q ss_pred eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||......... . .+... .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~----~i~~~----------~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---A----MLEKG----------E 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HHHTT----------C
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---H----HHHcC----------C
Confidence 22234579999999999999999999999999999999998 89999865432111 1 11111 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
....+...+..+.+|+.+||+.||++|||+.+|++.|...
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122334456888999999999999999999998887654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-54 Score=388.87 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=206.7
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---hHHHHHHHHHHhhcCCCCccceeEEEecCC----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 139 (376)
+.++|++.+.||+|+||.||+|++..+|+.||||++......+ ...+.+|+.+++.++||||+++++++....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4578999999999999999999999999999999997654332 346889999999999999999999987643
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..|+|||||+|++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 37899999999999998865 467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 220 AKLGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 220 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
+........ .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC
Confidence 875333222 2223446799999999999999999999999999999999999999986543211 111111111
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-LIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~ell~~L~~~~ 349 (376)
.... ......+..+.+||.+||+.||++|| |+++++..|.++.
T Consensus 232 ~~~~--------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGG--------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCc--------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1101 11112345788999999999999999 8999999998774
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=391.04 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=203.2
Q ss_pred cCcccCceecccCceEEEEEEECCCC----eEEEEEEeccCCcc-chHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
+.|++.++||+|+||.||+|.++.++ ..||||++...... ....+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56889999999999999999987654 47999999754333 23468899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
|||||.+++|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998765 3567999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcc-eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
...... .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... ..... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~~-i~------- 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKA-IN------- 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH-HH-------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHHHH-Hh-------
Confidence 333221 22234568999999999999999999999999999999999665554322110 00110 11
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.......+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 228 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 ---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111112333445678899999999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-55 Score=400.81 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=211.2
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 145 (376)
++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999986432 233456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~ 225 (376)
||+.+|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999875 457999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~------- 255 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKV------- 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHhcCCC-------
Confidence 1 234679999999999999999999999999999999999999998654321 1111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
..+...+.++.+||.+||+.||.+|+ |+++|++|-+.
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 11223445788999999999999994 99999987553
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=395.42 Aligned_cols=257 Identities=15% Similarity=0.216 Sum_probs=212.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
+.++|++.+.||+|+||.||+|.++.+|+.||||++.... .+...+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999999999999999997654 334567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC--CCceEEcccccccccC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~--~~~~kl~Dfg~~~~~~ 224 (376)
||+||+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++....
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999975 2447999999999999999999999999 999999999999974 4589999999998643
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||........ ..........+...
T Consensus 156 ~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~- 225 (321)
T d1tkia_ 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTFDEE- 225 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCCCHH-
T ss_pred cCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCChh-
Confidence 332 23446799999999999999999999999999999999999999987643211 11111111111000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. ....+.++.+||.+||..||++|||+.|+++|-+.
T Consensus 226 ---~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 226 ---A----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ---H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ---h----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0 01234578899999999999999999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=398.58 Aligned_cols=250 Identities=30% Similarity=0.450 Sum_probs=207.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCC---ccchHHHHHHHHHHh-hcCCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996432 223345666776665 68999999999999999999999
Q ss_pred EEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccC
Q 017175 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~ 224 (376)
||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999976 567899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccccccccc
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMA 304 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (376)
... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||........ ........
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~------- 219 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDN------- 219 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-------
T ss_pred ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC-------
Confidence 322 233446899999999999999999999999999999999999999986543211 11111110
Q ss_pred CCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHHHH
Q 017175 305 DPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIA-DVVTAL 345 (376)
Q Consensus 305 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-ell~~L 345 (376)
+ .++...+..+.+||.+||+.||++||++. +|++|-
T Consensus 220 -~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 220 -P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp -C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred -C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 1 12233455788999999999999999996 787653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-54 Score=385.43 Aligned_cols=255 Identities=24% Similarity=0.266 Sum_probs=211.3
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc---------hHHHHHHHHHHhhcC-CCCccceeEEEec
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCAD 137 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~ni~~~~~~~~~ 137 (376)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999997654321 135778999999997 9999999999999
Q ss_pred CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccc
Q 017175 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (376)
Q Consensus 138 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Df 217 (376)
.+..|||||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999975 467999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccCccccccccc------CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh
Q 017175 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 291 (376)
|++.....+. ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||......... .
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~------~ 225 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------R 225 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------H
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH------H
Confidence 9998644332 2344679999999999864 34688999999999999999999999876432211 1
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
........ +........+.++.+|+.+||+.||++|||+.||++|-+
T Consensus 226 ~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 226 MIMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp HHHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 11111110 111112244568899999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=395.31 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=206.6
Q ss_pred cCcccCceecccCceEEEEEEECCCCe----EEEEEEeccCC-ccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.+|++.++||+|+||.||+|.+..+|+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999988776 58888886432 33456789999999999999999999999875 5678
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
+++|+.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 4567999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
.............||+.|+|||++.++.++.++|||||||++|||+| |..||...........+ ...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~----- 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKG----- 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHT-----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcC-----
Confidence 54444444445679999999999999999999999999999999998 78999865433211111 110
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....+...+..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0112233445578899999999999999999999999998864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=394.57 Aligned_cols=257 Identities=19% Similarity=0.219 Sum_probs=205.1
Q ss_pred hcCcccCc-eecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhh-cCCCCccceeEEEec----CCce
Q 017175 68 TKNFRADC-LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD----GDQR 141 (376)
Q Consensus 68 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~----~~~~ 141 (376)
.++|.+.. .||+|+||.||+|++..+++.||||+++. ...+.+|+.++.+ ++||||++++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798875 69999999999999999999999999853 3567789988655 579999999999875 4668
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEcccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFG 218 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Dfg 218 (376)
|+|||||+||+|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999752 2357999999999999999999999999 999999999999975 5679999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||............
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----------- 225 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----------
Confidence 998643332 234467999999999999999999999999999999999999999765432111000
Q ss_pred ccccccCCcCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 299 KFSQMADPTLQ--GQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 299 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
...+...... .......+.++.+||.+||+.||++|||+.|+++|-+...
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred -HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 0001111110 0111234568899999999999999999999999866544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=389.74 Aligned_cols=266 Identities=25% Similarity=0.277 Sum_probs=201.2
Q ss_pred cCceecccCceEEEEEEECCCCeEEEEEEeccCCccc-----hHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEc
Q 017175 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 147 (376)
.+++||+|+||+||+|+++.+|+.||||++....... ...+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999997543222 24688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+.++++..+... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998777766543 567899999999999999999999999 9999999999999999999999999997533322
Q ss_pred cceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-h----hhhhcccccc
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-R----PLFKDRRKFS 301 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~----~~~~~~~~~~ 301 (376)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||......+....+... . ..+.......
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 223346799999999998754 6799999999999999999999999865433211111000 0 0000000000
Q ss_pred cccCCcCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 302 QMADPTLQGQYP-----VRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...........+ ...+..+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 000000000111 1234578999999999999999999999998663
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-54 Score=398.21 Aligned_cols=253 Identities=27% Similarity=0.358 Sum_probs=205.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc---cchHHHHH---HHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+ ++.+++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999999999999999864322 11222333 466777788999999999999999999
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999975 567899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccc
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFS 301 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (376)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..........+. .....
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~------ 223 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT------ 223 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSSS------
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhccc------
Confidence 43322 234679999999999975 46899999999999999999999999865433211111 00000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHHh
Q 017175 302 QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPL-----IADVVTALTY 347 (376)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~ell~~L~~ 347 (376)
....++...+..+.+||.+||+.||++||| ++|+++|-+.
T Consensus 224 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 224 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp ------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 001122234557899999999999999999 7999987553
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-54 Score=387.45 Aligned_cols=270 Identities=22% Similarity=0.258 Sum_probs=204.4
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999999999999999965432 234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
|+.++.+...... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975444433332 3567999999999999999999999999 999999999999999999999999999764322
Q ss_pred CcceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCcccccccchh-hhhh-------hhhhcc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV-AWAR-------PLFKDR 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~-------~~~~~~ 297 (376)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+....+ .... ......
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 22334467999999999987765 578999999999999999999999865432111000 0000 000000
Q ss_pred cccccccCCcCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 RKFSQMADPTLQGQ---YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
.............. .....+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 00000000000000 01123457889999999999999999999999855
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=384.71 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=200.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 143 (376)
.++|++.+.||+|+||.||+|++..+ +..||||.+....... .+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 36799999999999999999998654 3568999986543332 4568899999999999999999999964 67899
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~ 223 (376)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 3567999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccccc
Q 017175 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQ 302 (376)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (376)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+ ....
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~---- 226 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGE---- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTC----
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC----
Confidence 33222 22344678999999999999999999999999999999998 89999876543211110 1100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 303 MADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 303 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
....+...+..+.+||.+||+.||++|||+.+|+++|+.+.
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01223344568899999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=380.85 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=201.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec-CCceEEEEEc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEY 147 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~ 147 (376)
++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+|+||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 56899999999999999999986 788999999654 344678999999999999999999999865 4668999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999998651 1235899999999999999999999999 99999999999999999999999999975322
Q ss_pred cceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhcccccccccCC
Q 017175 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADP 306 (376)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (376)
......+|..|+|||++.+..++.++|||||||++|||++ |.+||...........+ . .
T Consensus 156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-------~----------~ 215 (262)
T d1byga_ 156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------E----------K 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------T----------T
T ss_pred ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------H----------c
Confidence 2233568999999999999999999999999999999998 68888765433211110 0 0
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 307 TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 307 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
.....++...+..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11123334445688899999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=383.74 Aligned_cols=257 Identities=29% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEEcc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 148 (376)
++|++.+.||+|+||.||+|+++.+ ..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 5799999999999999999999765 569999996553 445779999999999999999999999855 5689999999
Q ss_pred CCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCCc
Q 017175 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (376)
Q Consensus 149 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 228 (376)
++|+|..++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 999999988651 2356999999999999999999999999 9999999999999999999999999997543222
Q ss_pred ceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccCCcC
Q 017175 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMADPTL 308 (376)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (376)
........||+.|+|||++.++.++.++|||||||++|||++|..|+....... ..... ... ..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~-i~~----------~~ 231 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ-VER----------GY 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHH-HHT----------TC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHH-HHh----------cC
Confidence 222334679999999999999999999999999999999999766554432210 00100 000 01
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 309 QGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 309 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....+...+..+.+|+.+||+.||++||++.+|++.|+....
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 112233345578899999999999999999999999987664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=386.02 Aligned_cols=263 Identities=28% Similarity=0.405 Sum_probs=210.8
Q ss_pred hcCcccCceecccCceEEEEEEECCCC-------eEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEecC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTN-------QVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~ 138 (376)
.++|++.+.||+|+||.||+|++..++ ..||||+++..... ....+.+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 368999999999999999999976554 47999999765433 346678898888888 799999999999999
Q ss_pred CceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
...++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975321 2356899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.+||+|||++................||+.|+|||++.++.|+.++|||||||++|||++ |.+||.........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~- 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-
Confidence 9999999999999986544444444455779999999999999999999999999999999998 78888765432111
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
..+... .....+...+..+.+||.+||+.||++|||+.||++.|+++-+
T Consensus 248 ------~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 ------KLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------HHHHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHcC----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111111 1112223344578999999999999999999999999998865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-54 Score=387.17 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=211.3
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCccc-hHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|++++ ++..||||++....... ...+.+|+.++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4679999999999999999999753 46789999997654333 45689999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 017175 142 LLVYEYMPLGSLEDHLHDLP--------------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp 201 (376)
+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986421 12345889999999999999999999999 99999999
Q ss_pred CcEEECCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCccc
Q 017175 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRA 280 (376)
Q Consensus 202 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~ 280 (376)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999997544433333444567999999999999999999999999999999999985 67776543
Q ss_pred ccccchhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 281 AGEHNLVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.+.. ... ... .. ...+...+.++.+|+.+||+.+|++|||+.||++.|+++
T Consensus 249 ~e~~------~~v-~~~-~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 EEVI------YYV-RDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHH------HHH-HTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHH------HHH-HcC-CC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2211 111 110 00 112333445788999999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=387.59 Aligned_cols=262 Identities=27% Similarity=0.381 Sum_probs=199.8
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEecC-C
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 139 (376)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|..++.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3679999999999999999999754 3578999999754333 345677788877776 589999999998664 5
Q ss_pred ceEEEEEccCCCchhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEC
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~ 207 (376)
.+++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999865321 2345899999999999999999999999 99999999999999
Q ss_pred CCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCcccccccch
Q 017175 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNL 286 (376)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~ 286 (376)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +||........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999998654444333444568999999999999999999999999999999999974 67865433211
Q ss_pred hhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 287 VAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......... ....+...+..+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 246 ---~~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 ---FCRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011111110 1122233445788999999999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=384.92 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=202.8
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccc------hHHHHHHHHHHhhcC--CCCccceeEEEecC
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG------NREFLVEVLMLSLLH--HPNLVNLIGYCADG 138 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~ 138 (376)
+.++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 3578999999999999999999999999999999987543221 233568999999986 89999999999999
Q ss_pred CceEEEEEccCC-CchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-CCceEEcc
Q 017175 139 DQRLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSD 216 (376)
Q Consensus 139 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-~~~~kl~D 216 (376)
+..|+||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 999999999976 577777765 467999999999999999999999999 999999999999985 57999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCC-CcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.. ..
T Consensus 155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~~ 218 (273)
T d1xwsa_ 155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IR 218 (273)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HH
T ss_pred cccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------hh
Confidence 9999763222 2334679999999999987765 57789999999999999999999864311 11
Q ss_pred cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 296 DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... .++...+.++.+||.+||+.||++|||++|+++|-+
T Consensus 219 ~~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 219 GQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp CCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ccc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 000 111223457889999999999999999999999855
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=382.83 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=209.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeE--EEEEEeccCC-ccchHHHHHHHHHHhhc-CCCCccceeEEEecCCceEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 144 (376)
++|++.+.||+|+||.||+|+++.+|.. ||||.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5799999999999999999999888764 6778775432 23445789999999998 699999999999999999999
Q ss_pred EEccCCCchhhhhccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 145 YEYMPLGSLEDHLHDL------------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 145 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
|||+++|+|.++++.. ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 123467999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCcccccccchhhhhh
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNLVAWAR 291 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~ 291 (376)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||......... .
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~------~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 237 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH------H
Confidence 99999999753222 1223456899999999999999999999999999999999976 567654332111 1
Q ss_pred hhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 292 PLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
.. .. ......+...+..+.+||.+||+.||++|||+.+|+++|+++....
T Consensus 238 ~i-~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 KL-PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HG-GG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HH-Hh----------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 10 00 0111223344568899999999999999999999999999987543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=379.07 Aligned_cols=257 Identities=30% Similarity=0.409 Sum_probs=198.6
Q ss_pred cCcccCceecccCceEEEEEEECCC---CeEEEEEEeccCCc---cchHHHHHHHHHHhhcCCCCccceeEEEecCCceE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 142 (376)
++|++.+.||+|+||.||+|++..+ ...||||++..... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999986533 24689999875432 234578899999999999999999999976 4678
Q ss_pred EEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccc
Q 017175 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 143 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+|||||++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999988765 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCcce-eecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccchhhhhhhhhhccccc
Q 017175 223 GPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWARPLFKDRRKF 300 (376)
Q Consensus 223 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (376)
........ ......|+..|+|||++.+..++.++|||||||++|||++ |..||......+. ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~--- 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEG--- 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCC---
Confidence 54443322 2234568889999999999999999999999999999998 8999986543321 11111111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 301 SQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.....+...+..+.+|+.+||+.||++|||+.+|.+.|...
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122233445788999999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=380.70 Aligned_cols=270 Identities=21% Similarity=0.263 Sum_probs=203.5
Q ss_pred hcCcccCceecccCceEEEEEEECCC-CeEEEEEEeccCCc--cchHHHHHHHHHHhhc---CCCCccceeEEEec----
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLEST-NQVVAIKQLDRNGL--QGNREFLVEVLMLSLL---HHPNLVNLIGYCAD---- 137 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~---- 137 (376)
.++|++++.||+|+||.||+|++..+ ++.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999655 67899999864322 2233466788777665 79999999999853
Q ss_pred -CCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcc
Q 017175 138 -GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (376)
Q Consensus 138 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~D 216 (376)
....+++|||+.++.+...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467999999998777655443 3567999999999999999999999999 99999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhh-h----
Q 017175 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWA-R---- 291 (376)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~---- 291 (376)
||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|..||......+....+... .
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987532 222344578999999999999999999999999999999999999999866433211111000 0
Q ss_pred hhhhcccccc----cccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 292 PLFKDRRKFS----QMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 292 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
..+....... ..........+....+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0000000000 000000011122234567889999999999999999999999855
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=381.53 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=214.3
Q ss_pred hcCcccCceecccCceEEEEEEEC-----CCCeEEEEEEeccCCcc-chHHHHHHHHHHhhc-CCCCccceeEEEecCCc
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~ 140 (376)
.++|++.+.||+|+||.||+|++. .+++.||||+++..... ....+.+|+.+++.+ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368999999999999999999863 45678999999765433 345688999999999 69999999999999999
Q ss_pred eEEEEEccCCCchhhhhccCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 017175 141 RLLVYEYMPLGSLEDHLHDLP--------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill 206 (376)
.++|||||++|+|.+++.... .....+++..+..++.||+.||.|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999987532 12346899999999999999999999999 9999999999999
Q ss_pred CCCCceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCcccccccc
Q 017175 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHN 285 (376)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 285 (376)
+.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999987555544444556789999999999999999999999999999999999 5555655433211
Q ss_pred hhhhhhhhhhcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 017175 286 LVAWARPLFKDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLAC 350 (376)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~ 350 (376)
....... ......+...+..+.+||.+||+.||++|||+.+|++.|+++-+
T Consensus 257 ----~~~~i~~----------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 ----FYKMIKE----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----HHHHHHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHhc----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111111 11112223345578999999999999999999999999987644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-52 Score=374.54 Aligned_cols=268 Identities=20% Similarity=0.256 Sum_probs=204.0
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++.+.||+|+||.||+|+++ +|+.||||++...... ....+.+|+.++++++||||+++++++.+.+..+++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 6899999999765322 24678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
++.++.+..+... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987776666543 577999999999999999999999999 999999999999999999999999999764332
Q ss_pred CcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----hhhhccccc
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----PLFKDRRKF 300 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 300 (376)
. .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+.... .........
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 2 223345689999999998764 57899999999999999999999997654322111000000 000000000
Q ss_pred ccc------cCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 301 SQM------ADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 301 ~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... ..+..........+..+.+|+.+||+.||++|||++|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000 0000011122334568889999999999999999999998744
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=373.20 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=204.0
Q ss_pred cCceecccCceEEEEEEECCCC---eEEEEEEeccC-CccchHHHHHHHHHHhhcCCCCccceeEEEec-CCceEEEEEc
Q 017175 73 ADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEY 147 (376)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~ 147 (376)
+.++||+|+||+||+|++..++ ..||||+++.. .......+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3578999999999999986543 36999999753 33344679999999999999999999999865 4578999999
Q ss_pred cCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCCC
Q 017175 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (376)
Q Consensus 148 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 227 (376)
|++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999999876 4566888999999999999999999999 9999999999999999999999999998643332
Q ss_pred cc--eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcccccccccC
Q 017175 228 KT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRRKFSQMAD 305 (376)
Q Consensus 228 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (376)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|..||....... .... ..... .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~---~i~~g-~------- 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLLQG-R------- 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTT-C-------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH---HHHcC-C-------
Confidence 21 12233578999999999999999999999999999999999888776533211 1111 11110 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcc
Q 017175 306 PTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQ 351 (376)
Q Consensus 306 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~ 351 (376)
....+...+..+.+|+.+||+.||++||++.||+++|+.+...
T Consensus 252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0011223345788999999999999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=378.75 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=200.6
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEecCC-----
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 139 (376)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 467899999999999999999999999999999999754332 2356889999999999999999999997654
Q ss_pred -ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 140 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
.+|+||||+ +.+|..++.. .++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 579999999 5678877753 57999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----h
Q 017175 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----P 292 (376)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~ 292 (376)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||................ .
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 99863221 2346799999999998764 56899999999999999999999998764322111100000 0
Q ss_pred hhh---------cccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 293 LFK---------DRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 293 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
... ............+ .......+..+.+||.+||..||++|||+.|+++|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000 0000000000000 1112234557889999999999999999999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=373.83 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=211.6
Q ss_pred hcCcccCceecccCceEEEEEEECC-----CCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCCce
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 141 (376)
.++|++.+.||+|+||.||+|.+.. ++..||||+++.... .....+.+|+.++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3689999999999999999998753 357899999975433 2334688999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 142 LLVYEYMPLGSLEDHLHDL------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
++||||+++|+|.+++... ......+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988542 112345789999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCC-CCCCCcccccccchhhhhhhhh
Q 017175 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAGEHNLVAWARPLF 294 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~ 294 (376)
|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||......... ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~~i- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFV- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------HHH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-
Confidence 999998644443333344567999999999999999999999999999999999985 777654332111 111
Q ss_pred hcccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 295 KDRRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
... . ....+...+..+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 249 ~~~-~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 MEG-G---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HhC-C---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 110 0 1112233445789999999999999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=371.18 Aligned_cols=269 Identities=24% Similarity=0.296 Sum_probs=200.9
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEecCC----ceEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 143 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~l 143 (376)
..+|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++||||+++++++.+.+ .+|+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 357889999999999999999874 89999999964421 1122334556666789999999999997643 5799
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCCCCeeecCCCCCcEEECCCCceEEc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD--------KANPPVIYRDLKCSNILLGEGYHPKLS 215 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--------~~~~~i~Hrdikp~Nill~~~~~~kl~ 215 (376)
|||||++|+|.+++.. ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEE
Confidence 9999999999999975 468999999999999999999997 46 9999999999999999999999
Q ss_pred ccccccccCCCCcce--eecccccccCcccccccccCC------CCcccchhhHHHHHHHHHhCCCCCCCcccccccch-
Q 017175 216 DFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL- 286 (376)
Q Consensus 216 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~- 286 (376)
|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||...........
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 999997644333221 223467999999999987642 56789999999999999999988854332211100
Q ss_pred -------hhhhhhhhhcccccccccCCcCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhccc
Q 017175 287 -------VAWARPLFKDRRKFSQMADPTLQGQY-PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLACQK 352 (376)
Q Consensus 287 -------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~~~~ 352 (376)
........ ......+.+.... +......+.+|+.+||+.||++|||+.||+++|.++..+.
T Consensus 231 ~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 00000000 0011111111111 2234567889999999999999999999999999887543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=374.87 Aligned_cols=267 Identities=23% Similarity=0.286 Sum_probs=200.2
Q ss_pred CcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCccceeEEEec------CCceEE
Q 017175 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLL 143 (376)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~l 143 (376)
+|+..++||+|+||+||+|++..+|+.||||++...... ..+|+.++++++||||++++++|.. ..++|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 699999999999999999999999999999999754322 2379999999999999999999854 335789
Q ss_pred EEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccc
Q 017175 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKL 222 (376)
Q Consensus 144 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~ 222 (376)
|||||+++.+ ..+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999986543 333222223567999999999999999999999999 99999999999999775 899999999986
Q ss_pred cCCCCcceeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhh---------hhh
Q 017175 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW---------ARP 292 (376)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------~~~ 292 (376)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||......+....+.. ...
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 43332 2334679999999998875 4789999999999999999999999976543321111000 000
Q ss_pred hhhc--ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 293 LFKD--RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 293 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
.... ...+.......+........+..+.+|+.+||+.||++|||+.|+++|-+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0000 000111111111111122345678899999999999999999999988553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=366.04 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=202.1
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEec--------C
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------G 138 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~ 138 (376)
++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 689999999999999999999999999999999865432 334678899999999999999999998855 3
Q ss_pred CceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccc
Q 017175 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (376)
Q Consensus 139 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg 218 (376)
...|+||||+.++.+...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 468999999987766655433 567999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCcc--eeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhh
Q 017175 219 LAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFK 295 (376)
Q Consensus 219 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 295 (376)
++......... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~---~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS---QLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH---HhcC
Confidence 99754332211 122335799999999998765 68999999999999999999999997654322111111 0000
Q ss_pred c-ccc-cccc--------cCCcCCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 296 D-RRK-FSQM--------ADPTLQGQYPV-------RGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 296 ~-~~~-~~~~--------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
. ... .... ........... ..+..+.+|+.+||+.||++|||++|+++|-+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 0 000 0000 00000000111 113467889999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=375.34 Aligned_cols=272 Identities=20% Similarity=0.237 Sum_probs=201.4
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc-cchHHHHHHHHHHhhcCCCCccceeEEEecCC----ce
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QR 141 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~ 141 (376)
++.+|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+++|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45789999999999999999999999999999999975433 23456889999999999999999999997643 23
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
+++++++.+|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 444556668999999964 46999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCcc-eeecccccccCccccccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc--
Q 017175 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-- 297 (376)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 297 (376)
........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|..||......+...............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 54332211 12244679999999999855 467899999999999999999999998654322111110000000000
Q ss_pred ------cccccccCCcCCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 017175 298 ------RKFSQMADPTLQGQY-----PVRGLYQALAVAAMCVQEQPNMRPLIADVVTALT 346 (376)
Q Consensus 298 ------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~ 346 (376)
............... ....+..+.+|+.+||+.||++|||+.|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 000000000000011 1123457889999999999999999999999854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=362.15 Aligned_cols=268 Identities=19% Similarity=0.239 Sum_probs=210.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecCCceEEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 146 (376)
++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 589999999999999999999999999999999965433 234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccccccCCC
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~~~~~~ 226 (376)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998888765 567899999999999999999999999 999999999999999999999999999864333
Q ss_pred CcceeecccccccCcccccccccCC-CCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhcc--------
Q 017175 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDR-------- 297 (376)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 297 (376)
.. ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||......... ...........
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTG
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhh
Confidence 22 233456788999999987664 689999999999999999999997543321110 00000000000
Q ss_pred ------cccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 298 ------RKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 298 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
...................+..+.+|+.+||+.||++|||++|+++|-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 00000000011112223445678899999999999999999999998653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-50 Score=366.39 Aligned_cols=263 Identities=17% Similarity=0.227 Sum_probs=203.3
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEec--CCceEEEE
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVY 145 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~ 145 (376)
++|++.++||+|+||.||+|++..+|+.||||++... ..+.+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999643 3456889999999996 9999999999974 45689999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCC-ceEEcccccccccC
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGP 224 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~-~~kl~Dfg~~~~~~ 224 (376)
|||.+++|..+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .++|+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997764 35899999999999999999999999 99999999999998655 69999999998643
Q ss_pred CCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccc--chhhhhh-----hh---
Q 017175 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH--NLVAWAR-----PL--- 293 (376)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~-----~~--- 293 (376)
... .....++|+.|+|||++.+. .++.++|||||||++|+|++|..||......... .+..... ..
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 332 23446799999999998775 4799999999999999999999999764322110 0000000 00
Q ss_pred --hhcccccccccCC--------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 017175 294 --FKDRRKFSQMADP--------TLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTY 347 (376)
Q Consensus 294 --~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~ 347 (376)
......+...... ..........+.++.+||.+||+.||++|||++|+|+|-++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0000001111110 01111112345678999999999999999999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=367.31 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=207.1
Q ss_pred cCcccCceecccCceEEEEEEE---CCCCeEEEEEEeccCCc----cchHHHHHHHHHHhhcCC-CCccceeEEEecCCc
Q 017175 69 KNFRADCLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQ 140 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~ 140 (376)
++|++.+.||+|+||.||+|++ +.+|+.||||++..... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999987 44689999999875432 234567789999999976 899999999999999
Q ss_pred eEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEcccccc
Q 017175 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (376)
Q Consensus 141 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~ 220 (376)
.+++|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999876 466889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccCcccccccccC--CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhccc
Q 017175 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKDRR 298 (376)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (376)
....... ........|++.|+|||.+.+. .++.++|||||||+||+|++|..||...........+. ......
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~-- 251 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS-- 251 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC--
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcccC--
Confidence 7543222 2223446799999999999764 46889999999999999999999998765433221111 111000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHHh
Q 017175 299 KFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRP-----LIADVVTALTY 347 (376)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~ell~~L~~ 347 (376)
...++...+.++.+|+.+||+.||++|| |++|+++|-+.
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 0122334556889999999999999999 58999987553
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-49 Score=357.24 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=201.1
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCC-ccceeEEEecCCceEEEE
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~ 145 (376)
+.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+.+++.++|+| |+.+.+++.+.+..++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 34689999999999999999999999999999999875432 235778999999998766 455566667788899999
Q ss_pred EccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC---CCceEEcccccccc
Q 017175 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFGLAKL 222 (376)
Q Consensus 146 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~---~~~~kl~Dfg~~~~ 222 (376)
||+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||+++.
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9995 566666554 3567999999999999999999999999 999999999999853 55799999999986
Q ss_pred cCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhh-hhhc
Q 017175 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARP-LFKD 296 (376)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~ 296 (376)
....... .......||+.|+|||++.+..++.++|||||||++|||++|..||................. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 4333221 122346799999999999999999999999999999999999999987654332222111110 0000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
. .+.... ..+.++.+++.+||+.+|++||++.+|.+.|+.+-
T Consensus 236 --~-----~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 --P-----IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp --C-----HHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred --C-----hhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 001111 22347888999999999999999998888777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-49 Score=358.76 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=208.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC-CCccceeEEEecCCceEEEEE
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 146 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e 146 (376)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+..++.+.| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 578999999999999999999999999999999986543 23446788899988875 899999999999999999999
Q ss_pred ccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECC-----CCceEEccccccc
Q 017175 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-----GYHPKLSDFGLAK 221 (376)
Q Consensus 147 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~-----~~~~kl~Dfg~~~ 221 (376)
|+ +++|.+++.. ....+++..+..++.|++.||.|||++| |+||||||+|||++. .+.++|+|||+++
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 6899998866 3457999999999999999999999999 999999999999964 5789999999998
Q ss_pred ccCCCCcc-----eeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhhhhhhc
Q 017175 222 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWARPLFKD 296 (376)
Q Consensus 222 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 296 (376)
........ ......+||+.|+|||++.+..++.++|||||||++|+|++|..||................... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-Q 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-H
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-C
Confidence 64332211 12334679999999999999999999999999999999999999998654432221111110000 0
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 017175 297 RRKFSQMADPTLQGQYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYLA 349 (376)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~~ 349 (376)
..... .+...+ +.++.+++..|+..+|++||+++.+.+.|..+-
T Consensus 234 ~~~~~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 234 STPLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HSCHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCChH-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00000 111122 346888999999999999999999888777653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=368.62 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=197.5
Q ss_pred hcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc--chHHHHHHHHHHhhcCCCCccceeEEEec------CC
Q 017175 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------GD 139 (376)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~ 139 (376)
.++|++.++||+|+||+||+|++..+|+.||||++...... ....+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999755332 23467899999999999999999999964 46
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
.+|+|||||.++.+. .+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 789999999765554 442 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhh---------h-
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA---------W- 289 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------~- 289 (376)
+....... .....+||+.|+|||++.+..++.++||||+||++|+|++|..||...+.......+. +
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 87543322 3345679999999999999999999999999999999999999997654321111000 0
Q ss_pred ------hhhhhhccc-----ccccccCCcCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 290 ------ARPLFKDRR-----KFSQMADPTLQG---QYPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 290 ------~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
......... ............ ......+..+.+|+.+||..||++|||++|+|+|-+.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 000000000 000001101110 11234567889999999999999999999999997643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=362.83 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=201.2
Q ss_pred HhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCc--cchHHHHHHHHHHhhcCCCCccceeEEEecC-----C
Q 017175 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (376)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~ 139 (376)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46789999999999999999999999999999999975433 2335678999999999999999999998643 3
Q ss_pred ceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCceEEccccc
Q 017175 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (376)
Q Consensus 140 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~ 219 (376)
..+++|+|+.+|+|.+++.. .++++..++.++.||+.||.|||++| |+||||||+|||++.+|.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 34566777789999999854 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccCcccccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCcccccccchhhhhh-----hh
Q 017175 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWAR-----PL 293 (376)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~ 293 (376)
+.... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..
T Consensus 168 a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 87421 223346799999999987765 46889999999999999999999998654322111110000 00
Q ss_pred hhcc-----cccccccCCcCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 017175 294 FKDR-----RKFSQMADPTLQGQ---YPVRGLYQALAVAAMCVQEQPNMRPLIADVVTALTYL 348 (376)
Q Consensus 294 ~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~ell~~L~~~ 348 (376)
.... .............. .....+..+.+||.+||+.||++|||+.|+++|-+.-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0000 00000000000000 0112345788999999999999999999999986543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-44 Score=332.07 Aligned_cols=271 Identities=17% Similarity=0.173 Sum_probs=195.9
Q ss_pred cCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-----------CCCccceeEEEec
Q 017175 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD 137 (376)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~~ 137 (376)
++|++.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999999999999999997543 22356778888887765 5789999998864
Q ss_pred --CCceEEEEEccCCCchh-hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEECCCC---
Q 017175 138 --GDQRLLVYEYMPLGSLE-DHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGY--- 210 (376)
Q Consensus 138 --~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~~i~Hrdikp~Nill~~~~--- 210 (376)
....+++|.++..+... ..... .....+++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 34566677666544322 22222 245678999999999999999999998 88 99999999999998665
Q ss_pred ---ceEEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccchh
Q 017175 211 ---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287 (376)
Q Consensus 211 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 287 (376)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|..||............
T Consensus 167 ~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 389999999975322 223467999999999999999999999999999999999999999765432211111
Q ss_pred hhhhhhhhc---------------------ccccccccCC---------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 017175 288 AWARPLFKD---------------------RRKFSQMADP---------TLQGQYPVRGLYQALAVAAMCVQEQPNMRPL 337 (376)
Q Consensus 288 ~~~~~~~~~---------------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 337 (376)
......+.. ......+... ..........+..+.+|+.+||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111000000 0000000000 0011334566788999999999999999999
Q ss_pred HHHHHHHHHhhhc
Q 017175 338 IADVVTALTYLAC 350 (376)
Q Consensus 338 ~~ell~~L~~~~~ 350 (376)
+.|+|+|-+.-..
T Consensus 322 a~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 322 AGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhcCcccCCC
Confidence 9999998665433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.5e-26 Score=191.56 Aligned_cols=170 Identities=14% Similarity=0.050 Sum_probs=119.8
Q ss_pred cccCceecccCceEEEEEEECCCCeEEEEEEeccCCcc-----c-------------hHHHHHHHHHHhhcCCCCcccee
Q 017175 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----G-------------NREFLVEVLMLSLLHHPNLVNLI 132 (376)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~-------------~~~~~~e~~~l~~l~h~ni~~~~ 132 (376)
+.+.+.||+|+||.||+|.+. +|+.||||+++..... . ......|+..+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 456789999999999999985 5899999987532111 0 12244688889999999999988
Q ss_pred EEEecCCceEEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEECCCCce
Q 017175 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (376)
Q Consensus 133 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~~i~Hrdikp~Nill~~~~~~ 212 (376)
++. ..+++|||+++..+..+ +...+..++.|++.+|.|||+++ |+||||||+|||++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 764 23799999987655432 23345679999999999999999 9999999999999965 58
Q ss_pred EEcccccccccCCCCcceeecccccccCcccccccccCCCCcccchhhHHHHH
Q 017175 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265 (376)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 265 (376)
+|+|||++.............. +... -.+.+ .+.|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~r---d~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILER---DVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHH---HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHH---HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 9999999975322211110000 0000 01222 45788899999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.94 E-value=3.7e-09 Score=90.98 Aligned_cols=148 Identities=17% Similarity=0.092 Sum_probs=105.6
Q ss_pred HHHHHhcCcccCceecccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCce
Q 017175 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 141 (376)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 141 (376)
++......|+..+..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 5566677888777766566679998753 36678899886554444445678888888775 33367788888888889
Q ss_pred EEEEEccCCCchhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC------------------------------
Q 017175 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN------------------------------ 191 (376)
Q Consensus 142 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~------------------------------ 191 (376)
++||++++|.++...... . . ....++.++...+..||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~-----~-~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-----E-Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-----C-S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc-----c-c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999998888665422 1 1 123345666667777775321
Q ss_pred --------------------------CCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 192 --------------------------PPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 192 --------------------------~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999987667799999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.30 E-value=3.5e-06 Score=71.29 Aligned_cols=129 Identities=19% Similarity=0.140 Sum_probs=85.2
Q ss_pred ecccC-ceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC--CCccceeEEEecCCceEEEEEccCCCch
Q 017175 77 LGEGG-FGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (376)
Q Consensus 77 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~~~L 153 (376)
+..|. .+.||+..... +..+++|....... ..+..|...++.+.. -.+.+++.+..+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 36889887643 66688897654432 235677777776653 2356778888888889999999998765
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 017175 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------------- 190 (376)
Q Consensus 154 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~------------------------------------------- 190 (376)
.+.. ... ...+.++...|.-||...
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4321 111 112334444555555321
Q ss_pred ------------CCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 191 ------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 191 ------------~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0137999999999999987667899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.19 E-value=6.1e-06 Score=74.70 Aligned_cols=77 Identities=18% Similarity=0.121 Sum_probs=48.0
Q ss_pred CceecccCceEEEEEEECCCCeEEEEEEecc----CC---ccchHHHHHHHHHHhhcC-C-C-CccceeEEEecCCceEE
Q 017175 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDR----NG---LQGNREFLVEVLMLSLLH-H-P-NLVNLIGYCADGDQRLL 143 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~---~~~~~~~~~e~~~l~~l~-h-~-ni~~~~~~~~~~~~~~l 143 (376)
.+.||.|....||++.+..+++.++||.-.. .+ .........|+..|+.+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999999887788899996432 11 112234556888887663 2 3 34555543 4556789
Q ss_pred EEEccCCCc
Q 017175 144 VYEYMPLGS 152 (376)
Q Consensus 144 v~e~~~~~~ 152 (376)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=0.00016 Score=63.32 Aligned_cols=136 Identities=13% Similarity=0.103 Sum_probs=75.6
Q ss_pred eEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCCCCc--ccee-----EEEecCCceEEEEEccCCCchhh
Q 017175 83 GRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL--VNLI-----GYCADGDQRLLVYEYMPLGSLED 155 (376)
Q Consensus 83 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--~~~~-----~~~~~~~~~~lv~e~~~~~~L~~ 155 (376)
-.||++... +|..|++|+.+.. ......+..|...+..|...++ +..+ ..+......+.++++++|..+..
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 489998764 4788999987644 3345667788888877752222 1111 12344567788999987643210
Q ss_pred ------------------hhccCC-CCCCCCCH----------------------HHHHHHHHHHHHHHHHH-hhCCCCC
Q 017175 156 ------------------HLHDLP-PDKKRLDW----------------------TTRMRIAAGAAKGLEYL-HDKANPP 193 (376)
Q Consensus 156 ------------------~l~~~~-~~~~~~~~----------------------~~~~~i~~~i~~al~~L-H~~~~~~ 193 (376)
...... ......+. ......+..+...+.-+ ....+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 000000 01111111 11222233333333222 1222334
Q ss_pred eeecCCCCCcEEECCCCceEEcccccccc
Q 017175 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (376)
Q Consensus 194 i~Hrdikp~Nill~~~~~~kl~Dfg~~~~ 222 (376)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.0006 Score=61.20 Aligned_cols=75 Identities=17% Similarity=0.202 Sum_probs=50.2
Q ss_pred CceecccCceEEEEEEECC-------CCeEEEEEEeccCCccchHHHHHHHHHHhhcC-CCCccceeEEEecCCceEEEE
Q 017175 74 DCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (376)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~ 145 (376)
.+.|+.|-.=.+|++.... ..+.|.+++.-.. .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567878888999988653 2456777776532 23345567998888876 4334567777643 5889
Q ss_pred EccCCCchh
Q 017175 146 EYMPLGSLE 154 (376)
Q Consensus 146 e~~~~~~L~ 154 (376)
+|++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.23 E-value=0.0019 Score=55.71 Aligned_cols=160 Identities=14% Similarity=0.045 Sum_probs=82.3
Q ss_pred ccCHHHHHHHhcCcccCceec-----ccCceEEEEEEECCCCeEEEEEEeccCCccchHHHHHHHHHHhhcCC-----CC
Q 017175 58 TFTFRELAAVTKNFRADCLLG-----EGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-----PN 127 (376)
Q Consensus 58 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-----~n 127 (376)
..+.+++..+..+|.+.+... .|---+.|+..... | .+++|++.... ....+..|+.++..|.. |.
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 356678888889998865543 45556789887653 3 48999986532 22344456666666542 22
Q ss_pred cccee---EEEecCCceEEEEEccCCCchhh--------------hhc----cCCC-CCCCCC-----------------
Q 017175 128 LVNLI---GYCADGDQRLLVYEYMPLGSLED--------------HLH----DLPP-DKKRLD----------------- 168 (376)
Q Consensus 128 i~~~~---~~~~~~~~~~lv~e~~~~~~L~~--------------~l~----~~~~-~~~~~~----------------- 168 (376)
.+... .+.........++.+..+..... .++ .... ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22211 01122344556666665432211 000 0000 000000
Q ss_pred -HHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEECCCCceEEccccccc
Q 017175 169 -WTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (376)
Q Consensus 169 -~~~~~~i~~~i~~al~~LH~~-~~~~i~Hrdikp~Nill~~~~~~kl~Dfg~~~ 221 (376)
.......+..+...+...+.. -+..+||+|+.++||+++.+...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001112222223333333221 12349999999999999988777899999886
|